{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "nemotron-nano-30b",
    "experiment": "e6_semantic_retrieval",
    "pattern": "qualitative_2hop_intra_doc",
    "total_questions_in_experiment": 750
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "What was the total amount of Chevron's outstanding loan to Petroboscan, and what percentage of ownership in Petroboscan did Chevron hold as of the 2022 reporting period?",
      "original_answer": "Chevron had an outstanding long-term loan of $560 to Petroboscan, and Chevron held a 39.2 percent interest in Petroboscan as of the 2022 reporting period.",
      "llm_answer": "Chevron's outstanding loan to Petroboscan was $560 million, and it held a 39.2% ownership interest in Petroboscan as of the 2022 reporting period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified both the outstanding loan amount and Chevron's ownership percentage in Petroboscan as of 2022. The ownership percentage of 39.2% matches the ground truth exactly. The loan amount is reported as $560 million in the LLM answer, while the ground truth states $560. This discrepancy is minor and likely due to formatting or unit interpretation; however, given that the original answer does not specify 'million', this introduces a small quantitative inaccuracy. (2) The numbers are otherwise correct: 39.2% ownership is accurate, and $560 (even if missing 'million') may still align with source formatting in some filings, though typically such loans are in millions. The LLM added 'million', which may be contextually justified but is not confirmed in the ground truth. (3) The multi-hop reasoning is sound—Chevron's loan and equity interest in Petroboscan are separate pieces of information that must be correctly attributed and synthesized, which the model did accurately. (4) Scores reflect high accuracy with a minor deduction in quantitative accuracy due to the uncertain scale of the loan amount. Semantic equivalence is otherwise strong, and the answer fully addresses both parts of the question with correct entities and time period.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1080,
        "completion_tokens": 359,
        "total_tokens": 1440
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the total financial impact on Target Corporation from the sale of Dermstore LLC, including both the cash received and the pretax gain recognized?",
      "original_answer": "Target Corporation received $356 million in cash and recognized a $335 million pretax gain from the sale of Dermstore LLC, resulting in a total financial impact of $691 million.",
      "llm_answer": "The sale of Dermstore LLC generated $356 million in cash proceeds and resulted in a $335 million pretax gain, which is reported in Net Other (Income) / Expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $356 million in cash proceeds and the $335 million pretax gain from the sale of Dermstore LLC, matching the ground truth exactly. These figures are factually accurate and properly attributed to Target Corporation's transaction. (2) Quantitatively, all numbers are correct and presented in an acceptable format (million vs M). The total financial impact of $691 million (sum of cash and gain) is implied by the two components, though not explicitly stated in the LLM answer. This omission prevents a perfect score, as the question asks for the 'total financial impact,' which requires synthesis of the two figures. (3) The reasoning is sound and reflects multi-hop understanding—linking the sale to both cash inflow and gain recognition. The mention of 'Net Other (Income)/Expense' adds contextual accuracy about reporting location, which is a bonus but not required. (4) The answer is highly relevant and factually complete except for the missing explicit summation. Given that the two components are correct and the total can be easily derived, the correctness score is 9. Quantitative accuracy is 10 as all numbers are correct. Qualitative accuracy is 9 due to the minor omission in synthesis. Contextual relevance is 10 as all information directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1086,
        "completion_tokens": 369,
        "total_tokens": 1456
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What was Amgen's total recorded Product Sales revenue from sales to BeiGene over the three-year period from 2021 to 2023 under their collaboration agreement?",
      "original_answer": "Amgen recorded $72 million in 2021, $64 million in 2022, and $125 million in 2023 in Product Sales revenue from sales to BeiGene under the collaboration agreement, totaling $261 million over the three-year period.",
      "llm_answer": "$125 million.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is significantly incorrect and incomplete. (1) It only provides $125 million, which corresponds to the 2023 revenue alone, but the question asks for the total over the three-year period from 2021 to 2023. The ground truth values are $72M (2021), $64M (2022), and $125M (2023), summing to $261M. The LLM fails to include the first two years and does not compute the total. (2) Quantitatively, while the $125M figure is accurate for 2023, the omission of $72M and $64M and the failure to sum them results in a major numerical inaccuracy for the required total. (3) The qualitative reasoning is flawed—this is a multi-hop question requiring aggregation across three years of data, but the model only retrieves one year and does not synthesize. (4) The answer is contextually relevant in that it provides a dollar amount related to Amgen's revenue from BeiGene, but it fails to meet the scope of the question. Hence, low scores in correctness and accuracy, with moderate relevance due to partial entity and metric alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1059,
        "completion_tokens": 294,
        "total_tokens": 1354
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How many shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan, and how many remained available for issuance as of December 31, 2021?",
      "original_answer": "A total of 127 million shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan, and approximately 50 million shares remained available for issuance as of December 31, 2021.",
      "llm_answer": "Based on the provided document pages, the 2007 Omnibus Incentive Plan authorized approximately 127 million shares of Danaher common stock for issuance, and as of December 31, 2021, approximately 50 million shares remained available for issuance under the plan. This information is directly stated in the excerpt from page page_125 under the \"Stock-Based Compensation\" section.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers '127 million' shares authorized and 'approximately 50 million' shares remaining available are accurately reported, with no calculation or numeric errors. Minor phrasing like 'approximately' is consistent with the original answer and acceptable. (2) The answer is complete, addressing both parts of the question: total shares authorized and shares remaining as of December 31, 2021. (3) Entity accuracy is correct—'Danaher', '2007 Omnibus Incentive Plan', and the date 'December 31, 2021' are all properly identified. (4) The reasoning is sound, and the model correctly synthesizes the information from the specified document section (page_125, 'Stock-Based Compensation'), indicating proper multi-hop capability and contextual understanding. The answer is semantically equivalent to the ground truth, with clear, concise, and relevant information directly addressing the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 284,
        "total_tokens": 1439
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "What was the total cash received by LLY from the sale of the olanzapine portfolio (including Zyprexa) to Cheplapharm, and how was this amount distributed across the years 2023 and 2024?",
      "original_answer": "LLY received a total of $1.355 billion from the sale of the olanzapine portfolio to Cheplapharm, with $1.05 billion received in 2023 and an additional $305.0 million received in 2024.",
      "llm_answer": "Based on the provided document pages, the total cash received by LLY from the sale of the olanzapine portfolio (including Zyprexa) to Cheplapharm was $1.355 billion, distributed as $1.05 billion received in 2023 and $305 million received in 2024. This information is explicitly stated in the \"Olanzapine Portfolio (including Zyprexa)\" section on page 74 and reiterated in the \"Divestitures\" section on page 79.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total cash received is accurately stated as $1.355 billion, with $1.05 billion in 2023 and $305 million in 2024—these figures exactly match the original answer (note: $305 million = $305.0 million, format variation is acceptable). The sum of $1.05 billion and $305 million equals $1.355 billion, confirming calculation accuracy. (2) The answer is complete, addressing both parts of the question: total cash received and its distribution across 2023 and 2024. (3) Entity accuracy is correct—LLY (Eli Lilly), Cheplapharm, olanzapine portfolio, Zyprexa, and the years 2023 and 2024 are all properly identified. (4) The reasoning is sound, with the LLM correctly synthesizing information from the specified sections (page 74 and 79), demonstrating effective multi-hop retrieval and integration. (5) Semantic equivalence is maintained—wording differs slightly but conveys the same factual content. No errors or omissions are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 294,
        "total_tokens": 1452
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "What was the total amount of goodwill recorded by Lockheed Martin as a result of its acquisition of Terran Orbital, and how much of the purchase consideration was paid in cash?",
      "original_answer": "Lockheed Martin recorded $298 million in goodwill as a result of the acquisition of Terran Orbital, and $231 million of the total $314 million purchase consideration was paid in cash.",
      "llm_answer": "Lockheed Martin recorded $298 million of goodwill as a result of its acquisition of Terran Orbital, and the purchase consideration of $314 million was paid with cash on hand (net of cash acquired).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $298 million in goodwill and the $314 million total purchase consideration, which matches the ground truth. However, it fails to specify that $231 million of the purchase consideration was paid in cash — instead vaguely stating it was paid with 'cash on hand (net of cash acquired)'. This omits a key quantitative detail required by the question. (2) The numeric values for goodwill ($298M) and total purchase consideration ($314M) are accurate and correctly formatted. The missing $231M cash payment figure is a significant omission, especially since the question explicitly asks how much was paid in cash. (3) The reasoning shows partial multi-hop synthesis: it correctly links Lockheed Martin's acquisition of Terran Orbital to the goodwill amount and references the total purchase price, but does not connect the breakdown of that price into cash vs. non-cash components as required. (4) The answer is contextually relevant and uses correct entities (Lockheed Martin, Terran Orbital, goodwill, purchase consideration). Due to the missing cash amount, the completeness and qualitative accuracy are reduced, but the core financial figures are correct, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1102,
        "completion_tokens": 347,
        "total_tokens": 1449
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is Chevron's (CVX) carrying value of its investment in GS Caltex Corporation at the end of 2021, and how does this compare to Chevron's equity ownership percentage in the company?",
      "original_answer": "Chevron's carrying value of its investment in GS Caltex Corporation at the end of 2021 was $3,616 million, and Chevron owns a 50% equity interest in GS Caltex Corporation.",
      "llm_answer": "Chevron's carrying value of its investment in GS Caltex Corporation at the end of 2021 was $85 million, as shown in the \"Investments and Advances At December 31\" table on page 78 under the Downstream section. This amount represents the carrying value of the investment, which is distinct from Chevron's 50% equity ownership stake in the company. The document confirms Chevron owns 50 percent of GS Caltex Corporation, a joint venture with GS Energy in South Korea.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states Chevron's carrying value of its investment in GS Caltex Corporation at the end of 2021 as $85 million, whereas the ground truth is $3,616 million. This is a significant factual error in a key numeric value. However, the LLM correctly identifies Chevron's equity ownership percentage as 50%, which matches the original answer. (2) The quantitative inaccuracy is severe—the stated $85 million is less than 2.5% of the correct value ($3,616 million), indicating a major error in either data retrieval or interpretation. No calculation is required in this question, but the reported number is fundamentally wrong. (3) The reasoning shows partial multi-hop capability: the model correctly associates the equity ownership percentage with the joint venture and identifies GS Caltex as a joint venture with GS Energy. However, it fails to correctly extract the carrying value from the relevant financial table, possibly citing the wrong line item or document section. (4) The contextual relevance is high because the answer addresses both parts of the question and references an appropriate document section (page 78, 'Investments and Advances'), but the qualitative accuracy is low due to the incorrect number. The 50% ownership detail is accurate and well-contextualized, preventing a score of 0. Due to the critical importance of financial figures in such questions, the correctness score is very low despite some correct contextual and entity information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 413,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "By how much did the total revenue from Forest Products change in dollars from 2020 to 2021, and what was the corresponding change in average revenue per car for this product category during the same period?",
      "original_answer": "The total revenue from Forest Products increased by $197 million from 2020 to 2021, and the average revenue per car increased by $155 during the same period.",
      "llm_answer": "The total revenue from Forest Products increased by $197 million from $1,160 million in 2020 to $1,357 million in 2021. During the same period, the average revenue per car for Forest Products rose from $5,269 thousand to $5,424 thousand, an increase of $155 thousand per car.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the increase in total revenue is accurately stated as $197 million, derived from $1,357 million in 2021 minus $1,160 million in 2020, which aligns with the ground truth. The average revenue per car increase is correctly calculated as $155 thousand (from $5,269 thousand to $5,424 thousand), matching the stated $155 increase (with 'thousand' implied in the original answer's context). (2) The answer is complete, addressing both parts of the question: the dollar change in total revenue and the change in average revenue per car. (3) All entities—Forest Products, 2020 to 2021 time frame, and the financial metrics—are correctly identified and used. (4) The multi-hop reasoning is sound, requiring synthesis of revenue figures and carload volumes (implied in average per car calculation), which the model handles accurately. The additional context (base and final values) enhances clarity without introducing error. Semantic equivalence is maintained, with precise numerical and conceptual alignment to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1123,
        "completion_tokens": 316,
        "total_tokens": 1439
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What is the total net revenue contribution of Restasis in 2024, and by what percentage did it decline compared to 2023 based on actual currency rates?",
      "original_answer": "The total net revenue contribution of Restasis in 2024 was $224 million, representing a decline of 48.7% compared to 2023 based on actual currency rates.",
      "llm_answer": "Based on the provided 2024 Form 10-K data, Restasis generated $224 million in net revenue in 2024, down from $436 million in 2023. This represents a decline of roughly 48.7 % when measured at actual currency rates (the constant‑currency decline is about 48.1 %).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the net revenue of Restasis in 2024 as $224 million and accurately states the 2023 revenue as $436 million, which aligns with the ground truth. The percentage decline of 48.7% based on actual currency rates is exactly correct. (2) The calculation is verified: (436 - 224) / 436 ≈ 0.4862, or 48.6%, which rounds to 48.7% as stated—this matches the ground truth. The mention of constant-currency decline (48.1%) is additional context not required by the question but does not detract from accuracy. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly compares two years of revenue data and computes the year-over-year change at actual rates. (4) All entities (Restasis, 2024, 2023, net revenue) are accurate, and the answer fully addresses both parts of the question—total revenue in 2024 and the percentage decline. Semantic equivalence is maintained with precise factual alignment. Hence, all scores are perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1104,
        "completion_tokens": 289,
        "total_tokens": 1394
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What is the difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement for this metric as of December 31, 2023?",
      "original_answer": "The difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement is 8.4%. This is calculated by subtracting the Minimum Capital Adequacy requirement of 4.5% from Capital One Financial Corp's ratio of 12.9%.",
      "llm_answer": "As of December 31 2023, Capital One Financial Corp’s Common Equity Tier 1 (CET1) capital ratio was **12.9 %**. The regulatory minimum CET1 capital adequacy requirement under the Basel III standardized approach is **4.5 %**. Thus, the Company’s CET1 ratio exceeds the minimum by roughly **8.4 percentage points**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the CET1 ratio of 12.9% and the minimum requirement of 4.5% are accurately reported, and the difference is correctly calculated as 8.4 percentage points. The phrasing 'exceeds the minimum by roughly 8.4 percentage points' is semantically equivalent to the ground truth's 'difference... is 8.4%'. (2) The date 'December 31, 2023' is correctly specified. (3) Entity accuracy is perfect: the company is correctly identified as Capital One Financial Corp, and the metric is the correct regulatory capital measure (CET1 under Basel III). (4) The reasoning is sound and demonstrates proper multi-hop synthesis: it retrieves the firm's actual CET1 ratio, identifies the regulatory minimum, and computes the difference logically. No factual, numerical, or conceptual errors are present. All components of the question are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 273,
        "total_tokens": 1428
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What was the total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023, and how did it compare to the amounts recognized in the two prior years?",
      "original_answer": "The total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023 was $64 million. This amount decreased from $81 million in 2022 but increased compared to $56 million in 2021.",
      "llm_answer": "The total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023 was $64 million, compared with $81 million in 2022 and $56 million in 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans as $64 million in 2023, $81 million in 2022, and $56 million in 2021, matching the ground truth exactly in all numerical values. (2) All numbers are accurate and correctly attributed to the respective years; no calculation errors are present. The format uses 'million' consistently and clearly, which is semantically equivalent to the original. (3) The multi-hop reasoning is sound: the model correctly identifies the required entity (Lockheed Martin), the specific financial metric (pretax pension expense for nonqualified defined benefit plans), and synthesizes data across three years. While the LLM answer omits the explicit comparative statements ('decreased from 2022', 'increased compared to 2021'), the presentation of the three-year trend allows for correct inference of these comparisons, making the omission minor rather than critical. (4) The correctness score is 9 because the core facts and numbers are fully accurate and complete, but the answer slightly underperforms in qualitative richness by not explicitly stating the directional changes as in the original. Quantitative accuracy is perfect. Contextual relevance is full as all provided information directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1109,
        "completion_tokens": 376,
        "total_tokens": 1485
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the change in the net carrying amount of BlackRock's investor/customer relationships between December 31, 2022, and December 31, 2023, and how does the difference in accumulated amortization over this period contribute to this change?",
      "original_answer": "The net carrying amount of investor/customer relationships decreased from $492 million at December 31, 2022, to $447 million at December 31, 2023, resulting in a $45 million decline. This change is due to an increase in accumulated amortization from $254 million in 2022 to $338 million in 2023, which reduced the net carrying value despite a slight increase in the gross carrying amount from $746 million to $785 million.",
      "llm_answer": "The net carrying amount of BlackRock's investor/customer relationships decreased by $45 million, from $492 million at December 31 2022 to $447 million at December 31 2023. This reduction is primarily due to accumulated amortization increasing from $254 million to $338 million over the same period, which offsets the gross carrying amount and results in the lower net carrying amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values: the net carrying amount decreased from $492 million to $447 million, a $45 million decline; accumulated amortization increased from $254 million to $338 million. These match the ground truth exactly. (2) Calculations are accurate: the difference in net carrying amount ($492M - $447M = $45M) and the increase in accumulated amortization ($338M - $254M = $84M) are correctly implied, though the latter is not explicitly calculated. The gross carrying amount increase (from $746M to $785M) is omitted, which is a minor gap in completeness. (3) The multi-hop reasoning is sound—the model correctly attributes the decline in net carrying amount to increased accumulated amortization, despite the gross increase, showing understanding of the relationship between gross carrying amount, accumulated amortization, and net carrying amount. (4) The answer is semantically equivalent to the ground truth and fully addresses the question’s core. The only minor omission is not mentioning the slight increase in gross carrying amount, which slightly reduces completeness but does not affect the correctness of the main conclusion. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 368,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "What is the total principal amount of the 2.200% senior notes outstanding as of December 31, 2023, and how does UPS classify this debt on its consolidated balance sheet despite its 2024 maturity?",
      "original_answer": "The total principal amount of the 2.200% senior notes outstanding as of December 31, 2023, is $400 million. Despite its 2024 maturity, UPS classifies this debt as long-term on its consolidated balance sheet based on its intent and ability to refinance the debt.",
      "llm_answer": "The $400 million of 2.200% senior notes maturing in September 2024 is classified as long‑term debt on UPS’s consolidated balance sheet because UPS intends to refinance the obligation despite its 2024 maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the principal amount as $400 million and the classification of the debt as long-term despite its 2024 maturity, which matches the ground truth. The additional detail about the September 2024 maturity is consistent with the underlying data and adds precision without contradicting the original answer. (2) All numeric values—$400 million, 2.200%, and the 2024 maturity—are accurate and correctly formatted. There are no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes that although the debt matures in 2024 (short-term by nature), it is classified as long-term due to UPS's intent and ability to refinance, which reflects proper understanding of accounting principles under ASC 470. The reasoning is logically complete and aligns with the ground truth. (4) The answer is semantically equivalent to the original answer, with slightly more detail (September 2024) that does not detract from accuracy. The only minor shortcoming is that it does not explicitly mention 'intent and ability' (ability is implied), but 'intends to refinance' captures the core rationale. Hence, a score of 9/10 on correctness and qualitative accuracy is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1129,
        "completion_tokens": 345,
        "total_tokens": 1475
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "By how much did Cisco's available-for-sale debt investments decrease in the fiscal year ending July 27, 2024, and what was the impact on the total of cash and cash equivalents, available-for-sale debt investments, and marketable equity securities?",
      "original_answer": "Cisco's available-for-sale debt investments decreased by $5,727 million in the fiscal year ending July 27, 2024. This decrease, combined with a $2,615 million decrease in cash and cash equivalents and a $50 million increase in marketable equity securities, resulted in a total decrease of $8,292 million in the sum of these financial assets.",
      "llm_answer": "Cisco's available-for-sale debt investments decreased by $5,727 million (from $15,592 million to $9,865 million) in the fiscal year ending July 27, 2024. This decline contributed to a $8,292 million reduction in the combined total of cash and cash equivalents, available‑for‑sale debt investments, and marketable equity securities, which fell from $26,146 million to $17,854 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the decrease in available-for-sale debt investments is accurately stated as $5,727 million, which aligns with the ground truth. The total decrease in the combined financial assets is correctly reported as $8,292 million. The LLM also provides additional context—showing the starting and ending values of the debt investments ($15,592M to $9,865M) and the overall asset total ($26,146M to $17,854M)—which are consistent with the expected figures (difference of $8,292M). (2) The answer addresses both parts of the multi-part question: the decrease in available-for-sale debt investments and the impact on the total of cash and cash equivalents, available-for-sale debt investments, and marketable equity securities. (3) All entities—Cisco, the fiscal year ending July 27, 2024, and the relevant financial instruments—are correctly identified. (4) The reasoning is sound: the LLM correctly synthesizes the net impact across multiple asset classes, even though it does not explicitly break down the $2,615M decrease in cash and $50M increase in marketable equity securities. However, the final combined decrease of $8,292M is accurate, and the presentation of total values before and after confirms correct multi-hop calculation. The answer is semantically equivalent to the ground truth and adds helpful detail without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 395,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How many shares remained available for equity grants under the 2021 Linde plc Long Term Incentive Plan as of December 31, 2023, and how many of those shares could be granted as awards other than options or stock appreciation rights?",
      "original_answer": "As of December 31, 2023, 7,661,431 shares remained available for equity grants under the 2021 Linde plc Long Term Incentive Plan, of which 2,452,443 shares could be granted as awards other than options or stock appreciation rights.",
      "llm_answer": "As of December 31 2023, 7,661,431 shares remained available for equity grants under the 2021 Long‑Term Incentive Plan, and of those, 2,452,443 shares could be granted as awards other than options or stock‑appreciation rights.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually identical to the ground truth in both quantitative and qualitative aspects. (1) All numbers are correct: 7,661,431 shares available for equity grants and 2,452,443 shares available for awards other than options or stock appreciation rights, with the correct date of December 31, 2023. (2) The quantitative accuracy is perfect—both figures match the original answer exactly, and no calculations were required beyond what was reported. (3) The reasoning is sound and reflects proper synthesis of the data from the 2021 Linde plc Long Term Incentive Plan; the model correctly identifies the plan (referred to accurately as the 2021 Long-Term Incentive Plan, which is contextually understood to be Linde's), and distinguishes between total available shares and those available for non-option awards. (4) The answer is semantically equivalent to the original, with only minor formatting differences (e.g., spacing, hyphenation) that do not affect meaning. All parts of the multi-part question are fully addressed. Therefore, all scores are 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1135,
        "completion_tokens": 303,
        "total_tokens": 1439
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What was the total payment received by the company from the settlement of forward interest rate swap contracts associated with the issuance of the 2023 Notes, March 2022 Notes, and September 2022 Notes, and how does this reflect the financial impact of these settlements on the company's cash flow?",
      "original_answer": "The company received a total payment of $526 million from the settlement of forward interest rate swap contracts: $247 million from the 2023 Notes, $143 million from the March 2022 Notes, and $136 million from the September 2022 Notes. These settlements directly contributed to the company's cash flows, as the cash flows related to the settlement of hedging derivatives are classified in the consolidated statements of cash flows based on the nature of the underlying hedged items.",
      "llm_answer": "The company received a total of $526 million in cash from the settlement of forward interest‑rate swap contracts tied to the issuance of the 2023 Notes, the March 2022 Notes and the September 2022 Notes ($247 million + $143 million + $136 million).  These proceeds are reflected in the cash‑flow statement as part of the cash flows from financing activities and offset the cash outflows associated with the debt issuances, thereby reducing the net cash impact of those financing transactions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies all key numerical values: $247 million (2023 Notes), $143 million (March 2022 Notes), $136 million (September 2022 Notes), and the total of $526 million. The sum is accurate: 247 + 143 + 136 = 526. All dollar amounts and associated notes are correctly attributed.\n\n2) The answer fully addresses both parts of the question: the total payment received and the financial impact on cash flow. It correctly states that the settlements resulted in $526 million in cash inflows and explains that these are reflected in cash flows from financing activities, which aligns with the ground truth's implication about classification based on the nature of hedged items.\n\n3) The multi-hop reasoning is sound: the model synthesizes data across three separate note issuances (2023, March 2022, September 2022) and correctly aggregates the swap settlement payments. The entities (types of notes and associated payments) are accurately identified.\n\n4) The only minor deviation from the original answer is in the characterization of cash flow classification. The ground truth states that classification is based on the nature of the underlying hedged items, while the LLM specifies 'financing activities' and mentions offsetting debt issuance outflows. While this is a reasonable and likely correct inference (since the swaps are tied to debt issuance), the original answer is more cautious and general. However, this does not make the LLM response factually incorrect—rather, it adds interpretive context that is consistent with standard accounting treatment. Thus, the answer remains highly accurate with only a slight over-specificity in cash flow classification.\n\nOverall, the answer is factually correct, complete, and contextually appropriate, warranting a high score with a minor deduction in qualitative accuracy for the slightly stronger claim on cash flow classification than strictly supported by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 524,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the approximate range of NextEra Energy's ownership interest in XPLR, and what type of assets do the principal equity method investees, including XPLR, primarily own according to NEE's 2024 10-K filing?",
      "original_answer": "NextEra Energy's ownership interest in XPLR ranges from approximately 33.3% to 85.0%, and the principal equity method investees, including XPLR, primarily own electric generation facilities or natural gas pipelines.",
      "llm_answer": "Based on the 2024 10‑K filing, NextEra Energy’s ownership interest in XPLR (XPLR OpCo) is approximately 85 % to 91 % (the disclosed percentages for the various XPLR‑related entities range from about 85 % to 91 %).  \n\nThe principal equity‑method investees, including XPLR, are described as entities that “primarily own electric generation facilities or natural gas pipelines,” encompassing a portfolio of contracted renewable energy assets such as wind, solar and battery storage projects as well as a contracted natural‑gas pipeline.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states NextEra Energy's ownership interest in XPLR as 85% to 91%, while the ground truth specifies a range of approximately 33.3% to 85.0%. This is a significant factual error, particularly the upper bound being overstated and the lower bound completely missed. The LLM appears to have focused only on the higher end of ownership (possibly from XPLR OpCo or related entities) but failed to capture the full range as disclosed in the 10-K. (2) The qualitative description of the principal equity method investees is accurate — they do primarily own electric generation facilities or natural gas pipelines, including renewable assets like wind, solar, battery storage, and natural gas pipelines. This part matches the ground truth and adds helpful context without introducing inaccuracies. (3) The multi-hop reasoning is partially sound: the model correctly identifies XPLR as an equity method investee and links the asset type to the broader category of principal equity method investees. However, it fails in synthesizing the correct ownership range across entities, indicating a breakdown in accurately aggregating or interpreting the disclosed percentages from multiple parts of the filing. (4) The correctness score is 4 due to major quantitative inaccuracy in the ownership range, which is central to the question. Quantitative accuracy is low (3) because the percentages are factually wrong. Qualitative accuracy is moderate (5) because the asset description is correct but the ownership data is not. Contextual relevance is high (8) as the response stays on topic and provides relevant details, albeit with key errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 455,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the total fair value of Corporate notes and obligations as reported in the fair value hierarchy table, and how does this compare to their amortized cost in terms of unrealized losses?",
      "original_answer": "The total fair value of Corporate notes and obligations is $3,354 million as reported in the fair value hierarchy table. This is $92 million less than their amortized cost of $3,442 million, indicating an unrealized loss of $92 million.",
      "llm_answer": "The fair value of Corporate notes and obligations reported in the fair value hierarchy table was $2,978 million, which is $45 million lower than their amortized cost of $3,014 million, resulting in unrealized losses of $45 million.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. The ground truth states the fair value is $3,354 million and amortized cost is $3,442 million, resulting in an unrealized loss of $92 million. The LLM reports $2,978 million (fair value), $3,014 million (amortized cost), and $45 million (unrealized loss), which are entirely inconsistent with the correct figures. (2) Quantitative accuracy is critically flawed—none of the numbers match the ground truth, and the difference between fair value and amortized cost is miscalculated ($3,014M - $2,978M = $36M, not $45M, indicating internal inconsistency as well). (3) While the LLM demonstrates correct qualitative reasoning by computing unrealized losses as the difference between amortized cost and fair value, and identifying the relevant financial concepts (fair value hierarchy, corporate notes, unrealized losses), it fails at multi-hop synthesis because it pulls incorrect data from presumably wrong documents or years. (4) Contextual relevance is high—the structure, terminology, and intent align well with the question—but correctness and quantitative accuracy are severely compromised due to incorrect data, leading to a very low overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1128,
        "completion_tokens": 346,
        "total_tokens": 1474
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the total number of locomotives operated by UNP in 2024, and how does the combination of owned and leased locomotives contribute to this figure?",
      "original_answer": "The total number of locomotives operated by UNP in 2024 is 7,026. This total is derived from 6,106 owned locomotives and 920 leased locomotives.",
      "llm_answer": "UNP operated a total of 7,026 locomotives in 2024, comprised of 6,106 owned and 920 leased units. This combined fleet supports the company's network operations and efficiency initiatives.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the total number of locomotives operated by UNP in 2024 is correctly stated as 7,026, with a breakdown of 6,106 owned and 920 leased locomotives. (2) Quantitative accuracy is perfect—both components (6,106 + 920) sum to the correct total (7,026), and the numbers exactly match the original answer. (3) The multi-hop reasoning is sound, as the model correctly synthesized the total from owned and leased units, demonstrating proper understanding of how the components contribute to the total fleet size. (4) The answer is semantically equivalent to the ground truth, with slightly expanded context about network operations and efficiency, which adds relevance without introducing inaccuracies. All entities—UNP, 2024, locomotive ownership categories—are correctly identified and used.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1084,
        "completion_tokens": 258,
        "total_tokens": 1342
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the net change in the value of Brands/Tradenames for LIN in 2024, and how did foreign currency translation and amortization expense specifically contribute to this change?",
      "original_answer": "The net value of Brands/Tradenames for LIN decreased from $2,609 million in 2023 to $2,239 million in 2024, a reduction of $370 million. This decrease was primarily driven by a foreign currency translation reduction of $107 million and an amortization expense of $36 million. Together, these two factors contributed a total decline of $143 million, which is more than the total additions (which were $0 million) and partially offset by a small positive adjustment of $4 million under 'Other'.",
      "llm_answer": "The net change in the value of Brands/Tradenames for LIN in 2024 was a decrease of $105 million, driven by a $530 million foreign currency translation adjustment and $36 million of amortization expense.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. The net change in value is reported as a $105 million decrease, but the ground truth states a $370 million decrease (from $2,609M to $2,239M). The foreign currency translation adjustment is stated as $530 million, which is grossly incorrect—ground truth reports a $107 million reduction due to foreign currency. Only the amortization expense of $36 million is correct. (2) Calculations: The claimed net decrease of $105M does not align with the sum of the stated drivers ($530M + $36M = $566M), indicating internal inconsistency. The actual net change of $370M is not reflected at all. (3) Multi-hop reasoning: The model fails to correctly synthesize the components of change in Brands/Tradenames. It omits the fact that additions were $0 and there was a small $4M positive 'Other' adjustment. It also misrepresents the magnitude and direction of foreign currency impact. (4) Scores justified: Correctness is low (2/10) due to almost all key numbers being wrong. Quantitative accuracy is poor (2/10) because only one number ($36M amortization) is correct. Qualitative accuracy is slightly higher (3/10) because the model identifies the correct factors (foreign currency and amortization) but misrepresents their impact. Contextual relevance is moderate (6/10) as the answer addresses the right topic and entities (LIN, Brands/Tradenames, 2024, correct drivers), but with severe factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 403,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total fair value of Coca-Cola's (KO) Corporate Bonds and Debt Securities at the end of 2021 and how did it compare to the previous year in terms of dollar value change?",
      "original_answer": "The total fair value of Coca-Cola's Corporate Bonds and Debt Securities was $1,023 million at the end of 2021. This represents a decrease of $19 million compared to the previous year's value of $1,042 million.",
      "llm_answer": "The total fair value of Coca-Cola's corporate bonds and debt securities at the end of 2021 was $1,023 million, compared with $1,042 million at the end of 2020—a decrease of $19 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: the total fair value of Coca-Cola's corporate bonds and debt securities at the end of 2021 is correctly stated as $1,023 million, and the prior year (2020) value is correctly given as $1,042 million. (2) The dollar value change is accurately calculated: $1,042 million - $1,023 million = $19 million decrease, which matches the ground truth. Number formats are consistent and acceptable (e.g., 'million' used correctly, spacing with thin space is typographically acceptable). (3) The multi-hop reasoning—comparing two years of fair value data and computing the year-over-year difference—is sound and correctly executed. (4) The entities are accurate: Coca-Cola (KO), the correct financial instruments (corporate bonds and debt securities), and the correct years (2021 and 2020) are all properly identified and referenced. The answer is semantically equivalent to the original, with no omissions or distortions. All scoring categories warrant full marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1107,
        "completion_tokens": 304,
        "total_tokens": 1412
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the maximum potential fair value at grant date of the performance-based LTIP units awarded under the 2023 LTI Program, and why are these units not currently reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31, 2023?",
      "original_answer": "The maximum potential fair value at grant date of the performance-based LTIP units awarded under the 2023 LTI Program is $42.5 million. These units are not currently reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31, 2023, because, although LTIP units are potentially dilutive securities, they have not yet met the performance conditions necessary to be considered earned, and no securities had a material dilutive effect during the reporting period.",
      "llm_answer": "The maximum potential fair value at grant date of the performance‑based LTIP units awarded under the 2023 LTI Program is $42.5 million, as disclosed in the 2023 LTI Program description. These units are not reflected as a material dilutive effect on net income attributable to common stockholders for 2023 because they are performance‑based and were not earned or vested by year‑end; consequently, no compensation expense (and thus no dilution) related to those awards is recognized in the 2023 income statement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the maximum potential fair value at grant date as $42.5 million, matching the ground truth exactly. This satisfies the quantitative requirement with full accuracy. (2) The explanation for why these units are not reflected as a material dilutive effect is substantially correct: the units are performance-based and were not earned or vested by year-end, so they do not result in recognized compensation expense or dilution in 2023. This aligns with the ground truth reasoning that the performance conditions have not been met and no securities had a material dilutive effect. (3) The multi-hop reasoning is sound—linking the grant date fair value to the 2023 LTI Program and connecting the lack of dilution to unmet performance conditions. The only minor shortcoming is that the LLM answer frames the lack of dilution in terms of 'no compensation expense recognized,' while the ground truth emphasizes the broader concept of 'not yet met performance conditions necessary to be considered earned' and explicitly notes that LTIP units are potentially dilutive but not currently material. This nuance is present but slightly less precise in the LLM answer. (4) Despite this slight difference in emphasis, the core facts, numbers, and logic are correct, and the answer fully addresses both parts of the question. Therefore, the correctness score is 9 (excellent but not perfect), quantitative accuracy is 10 (numbers exact), qualitative accuracy is 9 (reasoning strong but minor phrasing imprecision), and contextual relevance is 10 (directly on point).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 437,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the difference between the amortized cost and fair value of Covered Bonds held by CRM in 2023, and what is the unrealized loss on these bonds?",
      "original_answer": "The amortized cost of Covered Bonds held by CRM in 2023 is $105 million, while the fair value is $101 million, resulting in an unrealized loss of $4 million.",
      "llm_answer": "In 2023, the amortized cost of Covered Bonds held by CRM was $105 million, while their fair value was $101 million, resulting in an unrealized loss of $4 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: the amortized cost ($105 million), fair value ($101 million), and the resulting unrealized loss ($4 million) are correctly reported. (2) Quantitative accuracy is perfect — the numbers match exactly, and the implied calculation (105 - 101 = 4) is correct. Minor formatting differences (use of thin space in '$105 million') do not affect meaning or accuracy. (3) The reasoning is sound: the answer correctly synthesizes the two values to determine the unrealized loss, demonstrating proper understanding of financial concepts and multi-hop logic (from cost and fair value to unrealized gain/loss). (4) The entities — CRM, Covered Bonds, and the year 2023 — are correctly identified and contextualized. The answer is semantically equivalent to the original, with no omissions or distortions. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1080,
        "completion_tokens": 279,
        "total_tokens": 1359
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What percentage of Union Pacific's Multiple Purpose locomotives are leased rather than owned, and how does this compare to the proportion of leased locomotives in the 'Switching' and 'Other' categories combined?",
      "original_answer": "13.35% of Union Pacific's Multiple Purpose locomotives are leased. Since there are no leased locomotives in the 'Switching' and 'Other' categories, the percentage of leased locomotives in these categories combined is 0%.",
      "llm_answer": "Based on the equipment table on page 19, Union Pacific’s Multiple‑Purpose locomotives total 6,893, of which 920 are leased. This represents 920 ÷ 6,893 ≈ 13.3 % of the Multiple‑Purpose fleet. The “Switching” and “Other” locomotive categories together have no leased units (Switching = 0 leased, Other = 0 leased), so their combined leased proportion is 0 %. Thus, the leased share of Multiple‑Purpose locomotives (≈13 %) is substantially higher than the combined leased share of Switching and Other locomotives (0 %).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that 920 out of 6,893 Multiple Purpose locomotives are leased, and calculates the percentage as approximately 13.3%, which rounds to the ground truth value of 13.35% — this is quantitatively accurate with only a minor rounding difference (13.3% vs 13.35%), which is acceptable under format variation. (2) The LLM accurately notes that there are 0 leased units in both the 'Switching' and 'Other' categories, leading to a combined leased proportion of 0%, matching the ground truth exactly. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across locomotive categories, computes proportions, and compares them appropriately. It addresses both sub-questions: the percentage of leased Multiple Purpose locomotives and the comparison with the combined Switching and Other categories. (4) All entities (Union Pacific, locomotive types) are correctly identified, and the source reference (page 19 equipment table) adds contextual support. The slight rounding down from 13.35% to 13.3% prevents a perfect 10 but does not undermine factual correctness. Thus, scores are high across all dimensions, with full marks for contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 339,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "By how much did the combined natural gas liquids (NGLs) volume in the Lower 48 at the end of 2023 increase compared to the end of 2020, and what was the total depreciation, depletion, amortization, and impairments for the Lower 48 in 2023?",
      "original_answer": "The natural gas liquids (NGLs) volume in the Lower 48 increased from 230 million barrels at the end of 2020 to 797 million barrels at the end of 2023, a difference of 567 million barrels. In 2023, the total depreciation, depletion, amortization, and impairments for the Lower 48 was $5,729 million.",
      "llm_answer": "The combined natural gas liquids (NGLs) volume in the Lower 48 increased by **567 million barrels** (from 230 million barrels at the end of 2020 to 797 million barrels at the end of 2023). The total depreciation, depletion, amortization, and impairments for the Lower 48 in 2023 were **$5,729 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the NGLs volume increased from 230 million barrels at the end of 2020 to 797 million barrels at the end of 2023, resulting in an increase of 567 million barrels (797 - 230 = 567), which is correctly calculated. The total depreciation, depletion, amortization, and impairments for the Lower 48 in 2023 is accurately reported as $5,729 million. (2) Quantitative accuracy is perfect—both the volume figures and the dollar amount match the original data, with acceptable formatting (e.g., 'million barrels' and '$5,729 million'). (3) The multi-hop reasoning is sound: the model correctly synthesized data across time (2020 to 2023) and across financial and operational metrics (volumes and DD&A). (4) The answer is semantically equivalent to the original, complete, and directly addresses both parts of the question with precise, relevant information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 274,
        "total_tokens": 1448
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How much total cash did Walmart spend in fiscal 2023 to acquire full ownership of both Massmart and Alert Innovation, and what was the subsequent financial treatment of Alert Innovation in fiscal 2025 as reflected in the consolidated financial statements?",
      "original_answer": "Walmart spent a total of $0.8 billion in fiscal 2023 to acquire full ownership of both Massmart and Alert Innovation ($0.4 billion for each). Alert Innovation was subsequently sold and deconsolidated in fiscal 2025.",
      "llm_answer": "Walmart spent approximately $1 billion in fiscal 2023 to acquire full ownership of both Massmart and Alert Innovation.  In fiscal 2025, Alert Innovation was sold and de‑consolidated, resulting in its derecognition from the consolidated balance sheet and no longer being presented as a separate line item in the financial statements.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Walmart spent approximately $1 billion in fiscal 2023 to acquire full ownership of Massmart and Alert Innovation, while the ground truth specifies $0.8 billion ($0.4 billion for each). This is a significant quantitative error, as $1 billion is 25% higher than the correct total. The subsequent financial treatment of Alert Innovation in fiscal 2025 is accurately described: it was sold and deconsolidated, which aligns with the ground truth. (2) The dollar amounts are not accurate—$1 billion vs. $0.8 billion—and although the individual acquisitions are not broken out in the LLM answer, the total sum is still incorrect. There is no indication of the equal $0.4 billion split, but the main issue is the overstated total. (3) The multi-hop reasoning is partially sound: the model correctly links Walmart’s acquisition in fiscal 2023 with the deconsolidation of Alert Innovation in fiscal 2025, demonstrating synthesis across time and entities. However, the incorrect total spending undermines the quantitative synthesis. (4) The correctness score is 6 due to the major numerical inaccuracy, though the qualitative and contextual aspects are strong. Quantitative accuracy is low (4) because of the incorrect total amount. Qualitative accuracy is high (8) as the reasoning and entity identification (Walmart, Alert Innovation, deconsolidation) are correct. Contextual relevance is 9 because the answer directly addresses both parts of the question and uses appropriate financial terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 424,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total revenue generated from Metals & minerals shipments for UNP in 2021, combining the number of carloads with the average revenue per car for that category?",
      "original_answer": "$1,810,806,000",
      "llm_answer": "The total revenue generated from Metals & minerals shipments for UNP in 2021 was $1,811 million, derived from 697 thousand carloads at an average revenue per car of $2,598. This is calculated by combining the freight revenue ($1,811 million) and average revenue per car ($2,598) for the Metals & minerals category as reported in the Freight Revenues and Revenue Carloads sections of the document.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects. The total revenue is reported as $1,811 million, which is equivalent to $1,811,000,000 and rounds the ground truth value of $1,810,806,000 accurately—this minor rounding difference (0.01%) is within acceptable limits for financial reporting. The number of carloads (697 thousand) and average revenue per car ($2,598) are consistent with the calculation: 697,000 × $2,598 = $1,810,806,000, matching the ground truth exactly. (2) Quantitative accuracy is high: all numbers align correctly when recalculated. The LLM correctly interprets '697 thousand carloads' and uses the precise average revenue per car to derive the total. The only minor point is that the answer cites $1,811 million as if directly reported, while it's actually the result of multiplication—though this is standard in summaries. (3) The reasoning is sound and reflects proper multi-hop synthesis: combining carload volume and average revenue per car from the relevant sections (Freight Revenues and Revenue Carloads) to compute total revenue. The model correctly identifies UNP, the year 2021, and the category 'Metals & minerals'. (4) Scores reflect near-perfect accuracy: full points for contextual relevance, slight deduction in quantitative and qualitative categories due to rounding presentation, but not due to error in logic or data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1108,
        "completion_tokens": 384,
        "total_tokens": 1492
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total principal amount of the Series 2023-1A Securities issued in the 2023 Securitization, and how does this compare to the amount of the Series 2013-2A Securities that were repaid in March 2023?",
      "original_answer": "The total principal amount of the Series 2023-1A Securities issued in the 2023 Securitization is $1.3 billion. This matches the amount of the Series 2013-2A Securities that were repaid in March 2023, indicating a direct refinancing of the older securities with the new issuance.",
      "llm_answer": "The total principal amount of the Series 2023‑1A Securities issued in the 2023 Securitization was **$1.284 billion**. This amount is roughly equivalent to the **$1.2997 billion** of Series 2013‑2A Securities that were fully repaid in March 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states the Series 2023-1A Securities were issued in the amount of $1.3 billion, and this exactly matched the $1.3 billion of Series 2013-2A Securities repaid in March 2023, indicating a direct refinancing. However, the LLM reports $1.284 billion and $1.2997 billion, which are not equivalent to $1.3 billion and differ from each other, undermining the key point of equivalence. (2) The numbers are close but not accurate—$1.284B and $1.2997B suggest precision to the million, but they do not round to $1.3B in a way that supports the conclusion of exact refinancing. The original answer emphasizes the match as evidence of refinancing, which the LLM's figures contradict due to the $15.7 million difference. (3) The qualitative reasoning is partially sound—the LLM identifies the two securities, the correct year (March 2023), and implies a refinancing relationship by comparing the amounts. It correctly performs the multi-hop linkage between the new issuance and the repayment of the older tranche. (4) Contextual relevance is high—the answer addresses both parts of the question and attempts the correct comparison. However, due to the numerical inaccuracies, the conclusion is weakened. The correctness score is low because financial precision is critical in securitization disclosures, and the mismatch in amounts breaks the core factual claim of direct refinancing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 405,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How much total revolving indebtedness was borrowed and repaid under the 2021 Multicurrency Credit Facility during the year ended December 31, 2023, and how does this compare to the facility's total borrowing capacity?",
      "original_answer": "During the year ended December 31, 2023, $3.0 billion was borrowed and $6.1 billion was repaid under the 2021 Multicurrency Credit Facility. This compares to a total borrowing capacity of $6.0 billion under the facility as of December 31, 2023.",
      "llm_answer": "During 2023 the Company borrowed $3.0 billion and repaid $6.1 billion of revolving indebtedness under its 2021 Multicurrency Credit Facility, leaving $723.4 million of outstanding principal on that facility. The facility’s total borrowing capacity is $6.0 billion, so the remaining undrawn capacity at year‑end was approximately $5.3 billion.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $3.0 billion borrowed and $6.1 billion repaid during 2023 under the 2021 Multicurrency Credit Facility, matching the ground truth. The total borrowing capacity of $6.0 billion is also correctly stated. However, the LLM introduces additional information—$723.4 million outstanding and $5.3 billion undrawn capacity—that is not present in the original answer and cannot be verified from the provided ground truth. While these figures may be mathematically plausible ($6.0B capacity - $723.4M = ~$5.276B undrawn), the original answer does not mention outstanding balances or remaining capacity, so this represents an over-extension. (2) All explicitly stated numbers ($3.0B borrowed, $6.1B repaid, $6.0B capacity) are quantitatively accurate. The derived figures (outstanding, undrawn) are not contradicted by the ground truth but are extraneous and unverified. (3) The multi-hop reasoning is sound in identifying the correct facility, time period, and transaction amounts. However, the synthesis goes beyond the scope of the original answer by calculating and asserting year-end outstanding and undrawn amounts, which were not asked for and not confirmed in the ground truth. (4) The answer is highly contextually relevant, addressing the core question accurately and adding potentially useful context, though with unverified extensions. The core facts are correct, but the added calculations reduce precision relative to the original truth, warranting a score of 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 421,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "By how much did the total Intermodal revenue increase for UNP in 2021 compared to 2020, and how did this growth compare to the increase in average revenue per car for Intermodal during the same period?",
      "original_answer": "The total Intermodal revenue for UNP increased by $515 million in 2021 compared to 2020, and the average revenue per car for Intermodal increased by $136 during the same period.",
      "llm_answer": "The total Intermodal revenue increased by $515 million (13 % growth) from 2020 to 2021, and this revenue growth outpaced the increase in average revenue per Intermodal car, which rose 11 % over the same period.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $515 million increase in total Intermodal revenue for UNP from 2020 to 2021, which matches the ground truth. However, the ground truth does not provide percentage growth figures (13% for revenue, 11% for average revenue per car) or the comparison of growth rates (revenue growth outpacing per-car growth), so these are unverified additions. While the $515 million figure is accurate, the average revenue per car increase is stated in the ground truth as $136, but the LLM converts this into an 11% increase without confirming whether that percentage is correct, introducing potential inaccuracy. (2) The dollar amount ($515 million) is correct and matches the ground truth. The 13% revenue growth and 11% increase in average revenue per car are not present in the original answer and cannot be verified from the provided data, making them speculative. The $136 absolute increase is the key metric in the ground truth, which the LLM omits in favor of a percentage, reducing quantitative precision. (3) The multi-hop reasoning is partially sound—revenue increase is correctly identified, and the model attempts to compare revenue growth to per-unit growth. However, it substitutes an absolute dollar increase ($136) with a percentage (11%) without source confirmation, weakening the reasoning chain. The synthesis is plausible but not fully grounded in the provided truth. (4) The answer is contextually relevant and addresses both parts of the question, though with inferred metrics. The correctness score is 7 because core facts (revenue increase) are accurate, but the substitution of unverified percentages for a missing absolute metric reduces overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1110,
        "completion_tokens": 467,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the total capital expenditure in the Europe, Middle East and North Africa (EMENA) region in 2021, and how does this compare to the net gain or loss reported from operations in the same region for the same year?",
      "original_answer": "The total capital expenditure in the EMENA region in 2021 was $534 million, while the net loss reported from operations in the same region was $24 million. This indicates that despite significant investment in the region, operations resulted in a net loss.",
      "llm_answer": "The total capital expenditure in the Europe, Middle East and North Africa (EMENA) region in 2021 was $534 million, as shown in the capital program breakdown on page 58. This amount is significantly lower than the net gain reported from operations in the same region for 2021, which was $8,079 million of net income (loss) attributable to ConocoPhillips on the consolidated statement of cash flows (page 87). Consequently, the region generated a net gain rather than a loss, and the capital spend represented a small fraction of that earnings.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the capital expenditure in the EMENA region in 2021 as $534 million, which matches the ground truth. However, it incorrectly states that the region reported a net gain of $8,079 million, whereas the ground truth clearly indicates a net loss of $24 million. This is a major factual error. (2) The quantitative accuracy is severely compromised: while $534 million is correct, the $8,079 million figure appears to be a misreading of a consolidated financial line item (possibly total company net income or cash flow), not the EMENA-specific operating result. The comparison between capex and operating result is therefore completely flawed. (3) The multi-hop reasoning fails: the model does not correctly isolate region-specific operating results for EMENA. Instead, it uses a company-wide or misinterpreted figure, breaking the logical synthesis required across documents or sections. The conclusion that the region generated a net gain is directly contradicted by the ground truth. (4) Contextual relevance is moderate because the answer addresses the right region, year, and financial concepts (capex vs. operating performance), but the core factual error in the operating result renders the analysis invalid. The citation of page numbers does not compensate for incorrect data interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 374,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does Microsoft position Copilot Pro within its AI-driven productivity strategy as described in its strategic ambitions, and in which specific revenue category is Copilot Pro classified in the financial reporting?",
      "original_answer": "Microsoft positions Copilot Pro as a consumer subscription service that offers faster and more powerful AI assistance in Microsoft 365 apps and on the web, aligning with its ambition to reinvent productivity and business processes. In the financial reporting, Copilot Pro is classified under 'Office Consumer products and cloud services revenue,' which includes Microsoft 365 Consumer and Copilot Pro subscriptions, Office licensed on-premises, and other Office services.",
      "llm_answer": "Microsoft positions Copilot Pro as a consumer‑focused subscription that delivers faster, more powerful AI assistance within Microsoft 365 apps and on the web, reinforcing its broader ambition to “reinvent productivity and business processes” by embedding AI across its productivity suite (Microsoft 365, Teams, Dynamics 365, etc.) and offering role‑specific Copilot extensions. In the company’s financial reporting, Copilot Pro is classified under the **Office Consumer products and cloud services** revenue category (the line that includes Microsoft 365 Consumer and Copilot Pro subscriptions).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Copilot Pro is correctly described as a consumer-focused subscription offering faster and more powerful AI assistance in Microsoft 365 apps and on the web, which supports Microsoft's strategic ambition to reinvent productivity and business processes. The financial classification under 'Office Consumer products and cloud services' is accurate. (2) There are no numeric values, dates, or calculations in the question or answer, so quantitative accuracy is not applicable in a traditional sense, but the absence of any incorrect figures earns a perfect score by default. (3) The multi-hop reasoning is sound—linking product positioning to strategic ambition and mapping the product to the correct financial reporting category is correctly executed. The LLM adds contextual detail (e.g., mentioning Dynamics 365 and role-specific extensions) that is plausible and consistent with Microsoft's broader AI strategy, though slightly beyond the scope of the ground truth. (4) The only minor deviation is the inclusion of additional elements (e.g., Teams, Dynamics 365, role-specific Copilots) that, while contextually relevant to Microsoft’s overall AI strategy, are not explicitly tied to Copilot Pro in the ground truth, which focuses solely on consumer use in Microsoft 365 and web. This slight overextension prevents a perfect 10 but does not undermine the core accuracy. Overall, the answer is semantically equivalent, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 429,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total increase in RSU shares available to be granted under the 2019 Incentive Plan as a result of the 2024 special dividend adjustment, and how was this increase determined based on the Nasdaq stock price movement?",
      "original_answer": "The total increase in RSU shares available to be granted under the 2019 Incentive Plan was 128,000. This increase was determined by proportionally adjusting the maximum number of shares issuable under the plan in response to the 2024 special dividend, which was calculated using the ratio of the Nasdaq closing price of $674.62 on December 26, 2023, to the Nasdaq opening price of $662.70 on December 27, 2023 (the ex-dividend date), resulting in an adjustment factor of 1.018.",
      "llm_answer": "The total increase in RSU shares available to be granted under the 2019 Incentive Plan as a result of the 2024 special dividend adjustment was 128,000 shares, which was determined by proportionally adjusting the maximum number of shares issuable under the plan based on the Nasdaq stock price movement (multiplying outstanding RSUs by the ratio of the Nasdaq closing price of $674.62 on December 26, 2023, to the Nasdaq opening price of $662.70 on December 27, 2023).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total increase in RSU shares as 128,000, which matches the ground truth. It accurately references the 2024 special dividend adjustment and the relevant Nasdaq stock prices: closing price of $674.62 on December 26, 2023, and opening price of $662.70 on December 27, 2023. The adjustment factor (though not explicitly calculated as 1.018) is implied through the ratio description, which is consistent with the ground truth methodology. (2) All numeric values—share increase, stock prices, and dates—are correct and match the original answer. The calculation logic (using the price ratio for proportional adjustment) is sound and accurately described. (3) The reasoning is mostly sound and reflects proper multi-hop synthesis: connecting the special dividend to a plan adjustment, using stock price movement around the ex-dividend date, and applying a ratio-based adjustment. However, the LLM slightly mischaracterizes the application by stating 'multiplying outstanding RSUs' when the original answer specifies the adjustment was to the 'maximum number of shares issuable under the plan.' This is a subtle but important distinction—the adjustment applies to the pool of available shares, not necessarily to outstanding awards. (4) Despite this minor imprecision in scope (outstanding RSUs vs. maximum shares available), the core facts, numbers, and logic are correct. The answer is contextually relevant and conveys nearly identical information. A score of 9 is justified due to high accuracy with a small qualitative nuance missing in the mechanism of the adjustment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 444,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the headwinds from PFAS manufactured products quantitatively affect the 2024 sales performance of 3M's Transportation and Electronics segment when comparing reported sales to non-GAAP adjusted sales?",
      "original_answer": "The headwinds from PFAS manufactured products caused a 4.5 percentage point difference in the 2024 sales performance of 3M's Transportation and Electronics segment. Reported sales decreased by 1.4%, but when adjusted for PFAS-related special items, sales increased by 3.1%. This implies that the PFAS-related headwinds reduced sales growth by 4.5 percentage points (from +3.1% to -1.4%).",
      "llm_answer": "The Transportation and Electronics segment reported a 1.4% decline in reported sales for 2024, but when adjusted for the PFAS manufactured products special item (which removed a $945 million sales drag and a $144 million operating‑income benefit), the segment’s sales actually grew 3.1%.  Accordingly, the headwinds from PFAS products reduced reported sales by roughly 5 percentage points, while the non‑GAAP adjusted figure shows a modest positive sales impact, indicating that PFAS-related headwinds had a measurable negative quantitative effect on the segment’s reported performance.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the core facts: 3M's Transportation and Electronics segment reported a 1.4% decline in sales and a 3.1% increase in non-GAAP adjusted sales, implying a negative impact from PFAS headwinds. However, the LLM states the headwinds reduced sales by 'roughly 5 percentage points,' while the ground truth specifies a precise 4.5 percentage point difference (3.1% - (-1.4%) = 4.5 pp). This overestimation by 0.5 pp is a significant quantitative error. Additionally, the LLM introduces specific dollar amounts—$945 million sales drag and $144 million operating-income benefit—that are not present in the original answer and cannot be verified from the provided ground truth, introducing unsupported data. (2) The calculation of the percentage point difference is incorrect: 3.1% - (-1.4%) = 4.5 pp, not ~5 pp. The inclusion of unverified dollar figures further undermines quantitative accuracy. (3) The multi-hop reasoning is otherwise sound: the model correctly infers that adjusting for PFAS items reveals underlying growth, and that the headwinds had a negative effect on reported sales. It synthesizes the relationship between reported and adjusted performance appropriately. (4) Despite the numerical inaccuracies and addition of unsupported figures, the answer captures the essential qualitative insight—that PFAS headwinds materially reduced reported sales growth—and directly addresses the question’s focus on quantitative impact. Hence, correctness is reduced to 7 due to key number errors, quantitative accuracy to 6 due to miscalculation and fabricated figures, qualitative accuracy remains high at 8 for logical reasoning, and contextual relevance is 10 as the response is fully on-topic and structured appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 480,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What was the total recognized gain on equity method investment contracts in 2021, and what was the fair value of these contracts as of December 31, 2021?",
      "original_answer": "The total recognized gain on equity method investment contracts in 2021 was $2 million, and the fair value of these contracts as of December 31, 2021, was $(3) million.",
      "llm_answer": "The total recognized gain on equity method investment contracts in 2021 was $2 million, and the fair value of these contracts as of December 31, 2021 was $3 million.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the total recognized gain on equity method investment contracts in 2021 as $2 million, which matches the ground truth. However, it incorrectly reported the fair value as $3 million instead of $(3) million. The parentheses around the 3 in the original answer indicate a negative value (i.e., -$3 million), which the LLM failed to capture. This is a critical error in financial reporting, as sign matters significantly in valuation contexts. (2) The first number ($2 million) is accurate in both amount and format. The second number is quantitatively incorrect—$3 million vs. -$3 million—representing a 6-million-dollar discrepancy in absolute terms and a directional error. (3) The reasoning appears partially sound in retrieving the correct data point for the gain, but the model failed in accurately interpreting or transcribing the fair value, which requires careful attention to formatting conventions in financial statements (parentheses = negative). This suggests a weakness in handling standard accounting notation. (4) The correctness score is 4 due to one correct and one major quantitative error. Quantitative accuracy is low (4) because of the sign error on a key financial figure. Qualitative accuracy is moderate (6) as the model retrieved relevant data and addressed both parts of the question but failed in precise interpretation. Contextual relevance is high (9) because the answer is on-topic and structured correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1085,
        "completion_tokens": 408,
        "total_tokens": 1493
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does Abbott Laboratories' use of interest rate hedge contracts with a total notional value of $2.2 billion as of December 31, 2024, impact the fair value of its long-term debt, which stood at $13.7 billion on that date?",
      "original_answer": "Abbott Laboratories uses interest rate hedge contracts totaling $2.2 billion to convert fixed-rate debt into variable-rate debt, directly affecting the fair value of its long-term debt. This hedging strategy reduces the volatility in the fair value of the $13.7 billion long-term debt caused by changes in long-term benchmark interest rates. Without these hedges, the fair value of the debt would fluctuate more significantly with market interest rate changes, potentially impacting Abbott's financial position and earnings.",
      "llm_answer": "Abbott's interest rate hedge contracts with a $2.2 billion notional value are designated as fair‑value hedges of fixed‑rate debt. By swapping fixed‑rate obligations for variable‑rate ones, the hedges offset changes in the fair value of that debt caused by interest‑rate movements, thereby limiting the impact on the $13.7 billion carrying amount of long‑term debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: the $2.2 billion notional value of interest rate hedges and the $13.7 billion long-term debt are accurately reported, with proper context to December 31, 2024 (implied by the question). Format variations (e.g., $2.2 billion vs $2.2 billion) are acceptable. (2) The answer correctly identifies Abbott Laboratories as the entity and accurately describes the use of fair-value hedges to convert fixed-rate debt to variable-rate debt, which stabilizes the fair value of long-term debt. (3) The reasoning is sound: it explains that the hedges offset changes in fair value due to interest rate movements, thus limiting volatility—this reflects correct multi-hop synthesis between hedging instruments and their impact on debt valuation. (4) The only minor shortcoming is that the LLM answer does not explicitly state that the strategy reduces volatility *caused by changes in long-term benchmark interest rates* or mention potential impacts on financial position and earnings, which are included in the original. However, the omission does not detract from the core technical accuracy. The answer is contextually precise and directly addresses the question. Thus, full marks for quantitative accuracy and contextual relevance, near-perfect for qualitative and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 389,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the total oil-equivalent proved reserves (in million barrels) for equity companies in Asia, and how does this compare to the total proved reserves for consolidated subsidiaries in Asia, based on the data from ExxonMobil's 2024 10-K filing?",
      "original_answer": "The total oil-equivalent proved reserves for equity companies in Asia are 1,276 million barrels, while the total proved reserves for consolidated subsidiaries in Asia are 2,286 million barrels. This means that the consolidated subsidiaries in Asia hold approximately 1.8 times more oil-equivalent reserves than the equity companies in the same region.",
      "llm_answer": "The total oil‑equivalent proved reserves for equity companies in Asia are 1,276 million barrels, while the total proved reserves for consolidated subsidiaries in Asia are 1,315 million barrels. Thus, equity‑company reserves in Asia are slightly lower than the consolidated‑subsidiary figure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the oil-equivalent proved reserves for equity companies in Asia as 1,276 million barrels, which matches the ground truth. However, it incorrectly reported the total proved reserves for consolidated subsidiaries in Asia as 1,315 million barrels, whereas the correct value from the knowledge graph is 2,286 million barrels. This is a significant numerical error affecting the core of the comparison. (2) The calculation of the ratio or comparison between the two values is therefore flawed: the LLM states that equity-company reserves are 'slightly lower,' which understates the actual difference. In reality, consolidated subsidiaries hold 2,286 / 1,276 ≈ 1.8 times more reserves, a substantial difference, not a slight one. The LLM’s comparison lacks the correct magnitude. (3) The multi-hop reasoning is partially sound— the model identifies both entities (equity companies vs. consolidated subsidiaries) and attempts a regional (Asia) comparison from ExxonMobil’s 2024 10-K, showing correct entity and contextual understanding. However, the failure to retrieve the correct figure for consolidated subsidiaries undermines the synthesis. (4) Scores reflect that while the answer is contextually relevant and gets one key number right, the major quantitative error in the second value and the resulting incorrect comparison severely limit factual correctness. The qualitative reasoning is logical but based on incorrect data, and the contextual relevance is high as the structure and intent align with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 428,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did the Swiss Tax Reform impact Mondelēz International's effective tax rate in 2019, and what was the net financial benefit recorded in that year as a result of this reform?",
      "original_answer": "The Swiss Tax Reform reduced Mondelēz International's effective tax rate in 2019 by 22.3 percentage points, contributing to a net financial benefit of $767 million recorded during that year.",
      "llm_answer": "The Swiss tax reform enacted in 2019 generated a $767 million deferred‑tax benefit that was recorded in the third quarter of 2019, and the reform’s ongoing effects were reflected in the 2019 effective tax rate of 0.1 % (compared with 22.4 % when the benefit is excluded). This benefit was a one‑time, discrete tax item and was not part of the 2019‑2020 tax calculations; consequently, the reform did not directly affect Mondelēz International’s effective tax rate in 2019 or produce a net financial benefit in that year.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct numbers—$767 million net financial benefit is accurate and matches the ground truth. However, the claim that the effective tax rate was 0.1% (with 22.4% excluding the benefit) contradicts the ground truth, which states the reform reduced the effective tax rate by 22.3 percentage points. The LLM incorrectly interprets this reduction as not affecting the 2019 effective tax rate, when in fact the benefit was recorded in 2019 and directly impacted it. (2) Quantitative accuracy is partially correct: $767 million is right, and 22.4% vs 22.3% is a minor rounding difference. But the LLM misrepresents the direction and impact of the reform by stating it did not affect the 2019 tax rate, which is false. (3) Multi-hop reasoning fails: the model does not correctly synthesize that the one-time benefit *is part of* the 2019 financials and *does* lower the effective tax rate for that year. Instead, it erroneously separates the benefit from the 2019 rate, contradicting the ground truth. (4) Scores reflect major factual error in interpretation despite some correct numbers—core claim of 'no impact' on tax rate or net benefit in 2019 is directly contradicted by ground truth, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 355,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What was the total financial impact on PepsiCo in 2022 from both the pension obligation transfer to TBG and the gain recognized from the remeasurement of its 39% ownership stake in TBG?",
      "original_answer": "The total financial impact on PepsiCo in 2022 from both the pension obligation transfer to TBG and the gain recognized from the remeasurement of its 39% ownership stake in TBG was $665 million.",
      "llm_answer": "The total financial impact on PepsiCo in 2022 from the pension obligation transfer to TBG and the gain from remeasurement of its 39% stake in TBG was a net gain of $520 million, which included $433 million of deferred tax expense related to the TBG investment remeasurement.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its total financial impact figure. The ground truth states the total impact was $665 million, but the LLM reports $520 million, which is a significant numerical discrepancy. Additionally, the LLM introduces a $433 million deferred tax expense related to the remeasurement, a detail not present in the ground truth and potentially conflating other financial line items. (2) Quantitatively, the numbers do not match: $520M vs $665M is a $145M difference, which is material and not attributable to rounding or formatting. The mention of $433M in deferred tax expense further diverges from the original answer, which does not break down components but states a net total. There is no indication in the ground truth that the $665M includes or excludes tax effects, but the LLM’s attempt to decompose the figure introduces unverified details. (3) The qualitative reasoning shows understanding of the two components—pension obligation transfer and remeasurement gain—and correctly identifies TBG and PepsiCo’s 39% stake, indicating proper entity recognition and multi-hop intent. However, the synthesis of the financial impact is incorrect, suggesting either a data error or miscalculation. (4) Contextual relevance is high because the LLM addresses the exact question, references the correct companies, years, and financial events, and attempts to provide a net figure. However, the core factual inaccuracy in the total amount severely undermines correctness. Thus, the correctness and quantitative accuracy scores are low, qualitative accuracy is moderate due to correct entities and structure, and contextual relevance is high.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 458,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What is the total amount of sales-based milestone payments made by Merck to Eisai for Lenvima in 2021, and how does this compare to the accrued but unpaid sales-based milestone payments as of December 31, 2021?",
      "original_answer": "Merck made $200 million in sales-based milestone payments to Eisai for Lenvima in 2021. As of December 31, 2021, $600 million in sales-based milestone payments were accrued but not yet paid. This indicates that the accrued but unpaid amount was three times the amount paid in 2021.",
      "llm_answer": "The 2021 sales‑based milestone payments made by Merck to Eisai for Lenvima totaled **$200 million**, and the accrued but unpaid sales‑based milestone payments as of December 31 2021 were **$600 million**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified both key figures: $200 million in sales-based milestone payments made in 2021 and $600 million accrued but unpaid as of December 31, 2021, matching the ground truth exactly. (2) All numeric values are accurate and properly formatted; no calculation errors. The comparison implied by the amounts (that $600M is three times $200M) is mathematically correct, though the LLM did not explicitly state this relationship. (3) The multi-hop reasoning is sound—information about payments made during the year and accrued but unpaid balances at year-end are correctly synthesized from potentially different parts of financial disclosures. However, the answer omits the explicit comparative statement ('three times the amount paid') which was part of the original answer’s reasoning and insight. (4) Despite the omission of the interpretive comparison, the core facts are fully correct, complete, and contextually relevant. The missing qualitative synthesis slightly reduces the qualitative accuracy but does not undermine factual correctness. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 341,
        "total_tokens": 1478
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How much cash did PepsiCo receive from the sale of the Naked brand and other juice brands to PAI Partners, and what percentage ownership interest in TBG did PepsiCo retain as part of the transaction?",
      "original_answer": "PepsiCo received approximately $3.5 billion in cash from the sale of the Naked brand and other juice brands to PAI Partners, and retained a 39% noncontrolling ownership interest in TBG.",
      "llm_answer": "PepsiCo received approximately $3.5 billion in cash from the sale of the Tropicana, Naked and other juice brands to PAI Partners, and retained a 39 % non‑controlling interest in the newly formed joint venture TBG.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) All key information is accurate: PepsiCo received approximately $3.5 billion in cash and retained a 39% non-controlling interest in TBG. The inclusion of 'Tropicana' in addition to 'Naked and other juice brands' adds minor contextual detail not in the original but does not contradict it, as Tropicana was part of the divested brands. (2) Quantitative values match exactly: $3.5 billion and 39% are correctly reported with acceptable formatting (e.g., '3.5 billion' = '3.5 billion', '39 %' = '39%'). (3) Multi-hop reasoning is sound—the answer synthesizes the financial proceeds and retained ownership interest from the transaction, correctly identifying PAI Partners as the buyer and TBG as the joint venture entity. (4) The terminology 'non-controlling interest' is used correctly and aligns with the original 'noncontrolling ownership interest'. The answer is fully relevant, complete, and precise, addressing both sub-questions in the multi-part query.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1112,
        "completion_tokens": 298,
        "total_tokens": 1411
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does Southern Company's adoption of the fair value approach for liability-hedging securities, as opposed to the calculated value approach, affect the recognition of changes in the market value of plan assets in relation to the measurement of net periodic pension cost?",
      "original_answer": "Southern Company's adoption of the fair value approach for liability-hedging securities results in the immediate recognition of changes in the market value of these plan assets, as opposed to amortizing these changes over five years under the calculated value approach. This change leads to a more current reflection of asset value changes in the measurement of net periodic pension cost, aligning it more closely with the changes in the related pension obligations.",
      "llm_answer": "Southern Company's shift to a fair value approach for liability‑hedging securities—measuring that portion of plan assets at fair value rather than using the calculated, amortized value—means that changes in the market value of those hedging assets are recognized immediately. Consequently, the expected return on plan assets now reflects the current fair‑value fluctuations of the liability‑hedging securities, so net periodic pension cost incorporates those contemporaneous gains or losses, unlike the prior calculated‑value method that smoothed and deferred such changes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately describes Southern Company's adoption of the fair value approach for liability-hedging securities and contrasts it with the prior calculated value approach. (2) There are no numeric values (e.g., percentages, dollar amounts, or time periods like 'five years') that conflict with the original answer; the mention of amortization over five years in the ground truth is implied in the LLM's reference to the 'prior calculated-value method that smoothed and deferred such changes,' which is factually consistent. (3) The multi-hop reasoning is sound: the answer correctly links the change in accounting approach to immediate recognition of market value changes, and explains the impact on net periodic pension cost by connecting asset valuation to expected return and pension expense. (4) The LLM captures all key elements: immediate vs. delayed recognition, alignment with pension obligations (implied through contemporaneous reflection), and the conceptual shift from smoothing to current reflection. Wording differs but meaning is preserved. All scores are 10 due to full factual accuracy, correct reasoning, and complete relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 344,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What was the total increase in Netflix's content spending from 2019 to 2021, and how did the growth in produced content compare to the growth in licensed content over this period?",
      "original_answer": "Netflix's total content spending increased by $3,014,120,000 from 2019 to 2021. During this period, produced content spending grew by $2,201,108,000, which was a significantly faster rate of growth compared to the $813,012,000 increase in licensed content spending.",
      "llm_answer": "The total increase in Netflix's content spending from 2019 to 2021 was $3,014,120 thousand, rising from $9,216,247 thousand in 2019 to $12,230,367 thousand in 2021. Produced content grew by $2,201,108 thousand (from $1,973,448 thousand in 2019 to $4,174,556 thousand in 2021), while licensed content increased by $813,012 thousand (from $7,242,799 thousand in 2019 to $8,055,811 thousand in 2021).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: the total increase in Netflix's content spending from 2019 to 2021 is correctly stated as $3,014,120,000, which the model expresses as $3,014,120 thousand—equivalent since 'thousand' means the number is in thousands (i.e., $3,014,120k = $3.01412 billion). Similarly, the increases in produced content ($2,201,108,000) and licensed content ($813,012,000) are accurately reported in thousands. (2) Calculations are correct: the model provides base and final year figures, and the differences match the ground truth (e.g., $4,174,556k - $1,973,448k = $2,201,108k; $8,055,811k - $7,242,799k = $813,012k). The sum of the two increases ($2,201,108k + $813,012k = $3,014,120k) also matches total spending growth. (3) Multi-hop reasoning is sound: the model correctly synthesizes data across years and content types, comparing growth in produced vs. licensed content as required. (4) Entities (Netflix, produced content, licensed content, years 2019–2021) are correctly identified. (5) Semantic equivalence is maintained—though the LLM uses more detailed breakdowns, the meaning and factual content align perfectly with the original answer. Wording differences (e.g., presenting absolute values per year) enhance clarity without altering accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 376,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the total pre-tax impairment charge recorded by PepsiCo in 2023 related to its 39% noncontrolling interest in TBG, and how does this compare to the gain recognized in 2022 from the remeasurement of the same investment?",
      "original_answer": "PepsiCo recorded a pre-tax impairment charge of $321 million in 2023 related to its 39% noncontrolling interest in TBG. In contrast, in 2022, the company recognized a gain of $520 million from the remeasurement of this investment at fair value. This results in a net pre-tax difference of -$199 million over the two-year period.",
      "llm_answer": "In 2023 PepsiCo recorded a pre‑tax impairment charge of **$321 million** related to its 39 % noncontrolling interest in TBG, which was recognized in selling, general and administrative expenses. By contrast, in 2022 the company recognized a **gain of $520 million** from the remeasurement of the same 39 % investment in TBG.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key factual elements: the $321 million pre-tax impairment charge in 2023 and the $520 million gain in 2022 related to PepsiCo's 39% noncontrolling interest in TBG. These values match the ground truth exactly, with acceptable formatting variations (e.g., 'million' vs 'M'). (2) Quantitative accuracy is perfect—both dollar amounts and the years are correct. While the original answer includes a net pre-tax difference of -$199 million (calculated as $321M charge minus $520M gain), this calculation is straightforward and implied in the comparison, though the LLM omits explicitly stating the net difference. This is a minor omission, not an error. (3) The multi-hop reasoning is sound: the model correctly links PepsiCo to its 39% interest in TBG across two fiscal years and contrasts an impairment charge with a prior-year remeasurement gain, demonstrating proper synthesis across time and financial events. The addition of 'recognized in selling, general and administrative expenses' is extra context not in the original but is plausible and does not contradict the ground truth. (4) The answer is highly relevant and factually complete, missing only the explicit net difference calculation. This justifies a 9/10 on overall correctness and qualitative accuracy, while quantitative accuracy and contextual relevance remain perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 386,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did Netflix's increased investment in original programming in 2021 affect content amortization and cost of revenues as a percentage of revenue?",
      "original_answer": "Netflix's increased investment in original programming in 2021 led to a $1,423 million increase in content amortization. Despite this rise in amortization, the cost of revenues as a percentage of revenue decreased from 61% to 58%, primarily due to delays in content releases caused by the COVID-19 pandemic, which slowed the rate of amortization growth relative to revenue growth.",
      "llm_answer": "The increased investment in original programming in 2021 led to a rise in content amortization expense, which contributed to a higher cost of revenues. As a result, cost of revenues as a percentage of revenue decreased from 61% in 2020 to 58% in 2021, primarily due to delays in content releases from the pandemic causing content amortization to grow more slowly than revenue growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decrease in cost of revenues as a percentage of revenue from 61% to 58% and attributes it to pandemic-related delays slowing amortization growth relative to revenue, which aligns with the ground truth. However, it omits the specific $1,423 million increase in content amortization, a key quantitative detail from the original answer. (2) While percentages (61% to 58%) are accurate, the dollar amount of increased amortization is missing, reducing quantitative accuracy. There are no calculation errors, but incompleteness on a core numeric fact limits full marks. (3) The reasoning is sound: the model correctly synthesizes the causal chain—increased investment led to higher amortization, but pandemic delays caused amortization to grow slower than revenue, resulting in lower cost of revenues as a percentage of revenue. This reflects proper multi-hop logic across events and financial impacts. (4) The answer is contextually relevant and addresses both parts of the question—impact on amortization and on cost of revenues as a percentage—though less precisely on the former due to missing the exact amortization increase. Wording is semantically equivalent where present, but the omission of the $1,423 million figure prevents a top score in correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 373,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the combined total net revenue from Ozurdex in 2024, and how did its international revenue growth compare to the previous year in terms of percentage change at actual currency rates?",
      "original_answer": "The combined total net revenue from Ozurdex in 2024 was $494 million. Its international revenue grew by 8.3% compared to the previous year at actual currency rates.",
      "llm_answer": "The combined total net revenue from Ozurdex in 2024 was $494 million. Internationally, Ozurdex revenue grew 8.3 % at actual currency rates compared with the prior year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information is accurate: the combined total net revenue from Ozurdex in 2024 is correctly stated as $494 million, and the international revenue growth is accurately reported as 8.3% compared to the previous year at actual currency rates. (2) Quantitative accuracy is perfect—both the dollar amount and percentage change match the ground truth exactly, with acceptable formatting (e.g., use of thin spaces in '$494 million' and '8.3 %'). (3) The multi-hop reasoning is sound: the answer correctly synthesizes total revenue and international growth performance across time and geography, as required by the question. (4) The response is contextually relevant, directly addressing both parts of the question without extraneous or missing information. No errors in entities, metrics, or time periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1094,
        "completion_tokens": 260,
        "total_tokens": 1354
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the total pretax gain Target Corporation recognized from the sale of Dermstore LLC, and how was this gain treated in the financial statements according to the notes?",
      "original_answer": "Target Corporation recognized a total pretax gain of $335 million from the sale of Dermstore LLC, and this gain was included in Net Other Income in the financial statements.",
      "llm_answer": "Target Corporation recognized a $335 million pretax gain from the sale of Dermstore LLC, which was recorded in Net Other Income in the financial statements. This gain is disclosed in Note 11 to the Consolidated Financial Statements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the pretax gain of $335 million is accurately reported, with acceptable formatting using 'million' and the non-breaking space ( ) between the dollar amount and unit. (2) The answer addresses both parts of the question: the amount of the pretax gain and its treatment in the financial statements—specifically, that it was recorded in Net Other Income. (3) The entity (Target Corporation), the transaction (sale of Dermstore LLC), and the financial metric (pretax gain) are all correctly identified. (4) The reasoning is sound and reflects proper synthesis from the financial notes, with the added detail of referencing Note 11, which enhances accuracy and context without introducing error. This additional specificity does not contradict the ground truth and supports the claim. All information is semantically equivalent and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1108,
        "completion_tokens": 272,
        "total_tokens": 1380
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What is the difference between the amortized cost and fair value of Salesforce's (CRM) mortgage-backed obligations as reported in their 2024 10-K, and what percentage of the total marketable securities at fair value does this difference represent?",
      "original_answer": "The difference between the amortized cost and fair value of Salesforce's mortgage-backed obligations is $8 million ($244 million amortized cost - $236 million fair value). This $8 million difference represents approximately 0.14% of the total marketable securities at fair value ($5,722 million).",
      "llm_answer": "The amortized cost of Salesforce's mortgage-backed obligations was $128 million and the fair value was $122 million, resulting in a $6 million difference. This $6 million difference represents approximately 0.1 % of the total marketable securities at fair value ($5,184 million).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the amortized cost of Salesforce's mortgage-backed obligations is $244 million, fair value is $236 million, resulting in an $8 million difference. The LLM incorrectly reports these as $128 million and $122 million, respectively, with a $6 million difference. Additionally, the total marketable securities at fair value is $5,722 million (ground truth), but the LLM reports $5,184 million. These numbers are not close to the correct values and suggest a potential confusion with another company or filing. (2) The calculation logic is sound—difference and percentage of total—but based on incorrect inputs. The percentage reported (0.1%) is derived from $6M / $5,184M ≈ 0.115%, which rounds to 0.1%, but the correct percentage is $8M / $5,722M ≈ 0.14%, as stated in the original answer. (3) The multi-hop reasoning requires pulling data from Salesforce’s 2024 10-K: mortgage-backed obligations (amortized cost and fair value) and total marketable securities at fair value. The LLM fails this synthesis, likely retrieving data from an incorrect source or year. (4) Scores reflect major quantitative errors (correctness: 2, quantitative accuracy: 2), partially sound reasoning (qualitative accuracy: 3), and appropriate structure/relevance to the question (contextual relevance: 8).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 384,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of adopting the new LDTI accounting guidance, and what time periods do these adjustments cover according to the 2023 10-K filing?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statements of comprehensive income and its consolidated balance sheet as a result of adopting the new LDTI accounting guidance. The adjustments to the consolidated statements of comprehensive income reflect the effects of the guidance as of December 31, while the balance sheet adjustments were applied to the financials as of December 31, 2022.",
      "llm_answer": "The 2023 10‑K discloses that MetLife retrospectively adjusted its **Consolidated Balance Sheet** and **Consolidated Statement of Comprehensive Income** to apply the new LDTI guidance.  The adjustments, which stem from the full‑retrospective transition approach for market‑risk benefits and the modified retrospective approach for future policy benefits, affect the opening balances as of the LDTI Transition Date (January 1 2021) and cover the periods presented in the filing (2021‑2022, with comparative 2023 amounts also shown).  These changes are reflected in the “Adoption Adjustment” columns of the balance‑sheet, income‑statement and cash‑flow tables in the notes.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the two financial statements adjusted—Consolidated Balance Sheet and Consolidated Statement of Comprehensive Income—aligning with the ground truth. However, it introduces significant inaccuracies regarding the time periods covered. The original answer states that balance sheet adjustments were applied as of December 31, 2022, and income statement adjustments reflect effects as of December 31 (implied 2022, consistent with the 2023 10-K). In contrast, the LLM answer claims adjustments affect opening balances as of January 1, 2021 (the LDTI Transition Date) and cover 2021–2022 periods, which contradicts the ground truth. While the LLM correctly references the retrospective application and notes the presence of 'Adoption Adjustment' columns, it overextends the time coverage and transition approach details not present in the original answer. These specifics (transition date, multi-year coverage, cash flow tables) are either absent or unsupported in the ground truth, suggesting over-interpretation or hallucination. There is no mention in the original answer of cash flow tables being adjusted, nor of the 2021–2023 comparative periods being part of the adjustment scope. Quantitative accuracy is compromised due to incorrect dating and period coverage, though no explicit numerical values are wrong. Qualitatively, the reasoning shows understanding of retrospective adjustment concepts but misapplies the scope. Contextually, the response is highly relevant and addresses the core question, just with incorrect temporal details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 429,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What is the total potential financing commitment Disney has through its two cruise ship credit facilities, and how does the interest rate structure differ between the Disney Treasure and the Disney Destiny borrowings?",
      "original_answer": "Disney has a total potential financing commitment of $2.2 billion through its two cruise ship credit facilities. The Disney Treasure borrowing carries a fixed interest rate of 3.80%, while the Disney Destiny borrowing, if utilized, will have a fixed interest rate of 3.74%.",
      "llm_answer": "The total potential financing commitment through Disney's two cruise ship credit facilities is $2.2 billion, consisting of a $1.1 billion facility for the Disney Treasure (borrowed at a fixed 3.80% interest rate payable semi‑annually over 12 years) and an identical $1.1 billion facility for the Disney Destiny, which would carry a fixed 3.74% interest rate over the same 12‑year term if drawn.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total financing commitment of $2.2 billion is accurate, correctly broken into two $1.1 billion facilities. The interest rates are precisely stated: 3.80% for Disney Treasure and 3.74% for Disney Destiny. These match the original answer exactly, with acceptable formatting (e.g., $2.2 billion = $2.2 billion). (2) The answer is complete, addressing both parts of the question: total commitment and the difference in interest rate structure. (3) Entities are correct—Disney, Disney Treasure, Disney Destiny, and the associated credit facilities are accurately identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers that the total commitment is the sum of two equal $1.1 billion facilities and accurately differentiates the fixed rates between the two ships. The additional details (semi-annual payments, 12-year term) are consistent with typical credit facility structures and do not contradict the ground truth; they add context without introducing error. (5) The semantic meaning is equivalent to the original answer, with slightly more detail but no factual deviation. All scores are maximized accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 352,
        "total_tokens": 1536
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How much did Chevron's equity in earnings from Angola LNG Limited contribute to its total upstream equity earnings in 2024, and what does this indicate about Chevron's production involvement in Angola?",
      "original_answer": "Chevron's equity in earnings from Angola LNG Limited contributed $405 million to its total upstream equity earnings of $3,580 million in 2024. This indicates that Chevron has a significant production involvement in Angola, as Angola LNG is one of its equity method affiliates contributing directly to upstream earnings, and Chevron's production volumes include its share from Angola LNG operations.",
      "llm_answer": "Chevron's equity in earnings from Angola LNG Limited contributed **$405 million** to its total upstream equity earnings in 2024. This share of earnings reflects Chevron’s significant production involvement in Angola, as it holds a major stake in the Angola LNG project and receives a substantial portion of its output.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Chevron's equity in earnings from Angola LNG Limited contributed $405 million to its total upstream equity earnings in 2024, which matches the ground truth exactly. The total upstream equity earnings of $3,580 million is not explicitly mentioned in the LLM answer, but the question only asks for the contribution amount and its implication, so this omission does not invalidate the core response. (2) The numeric value of $405 million is accurate and properly formatted; no calculations are required beyond this figure, and it aligns with the ground truth. (3) The reasoning is sound: the LLM correctly infers that the $405 million earnings contribution indicates significant production involvement in Angola, linking it to Chevron's stake in the Angola LNG project. While the LLM does not explicitly name Angola LNG as an equity method affiliate (as in the original answer), it accurately reflects the implication of production involvement through earnings and output share. (4) The answer is contextually relevant, directly addressing both parts of the question—quantitative contribution and qualitative interpretation. The slight omission of the total upstream earnings figure and the term 'equity method affiliate' prevents a perfect 10, but the semantic meaning and factual accuracy remain highly aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 383,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the total amount of Canadian dollar denominated notes Disney had outstanding as of September 28, 2024, and how much of this amount was converted into U.S. dollar denominated borrowings through cross-currency swaps?",
      "original_answer": "The total amount of Canadian dollar denominated notes Disney had outstanding as of September 28, 2024, was Canadian $2.6 billion (CAD $1.3 billion + CAD $1.3 billion). Of this, Canadian $1.3 billion ($1.0 billion USD) remained outstanding and was converted into U.S. dollar denominated borrowings through cross-currency swaps, while the other Canadian $1.3 billion ($0.9 billion USD) was paid in October 2024.",
      "llm_answer": "As of September 28 2024, Disney had $1.3 billion of Canadian‑dollar‑denominated senior notes outstanding. Through pay‑floating interest‑rate and cross‑currency swaps, the entire $1.3 billion of Canadian‑dollar borrowings was effectively converted into U.S.‑dollar‑denominated variable‑rate borrowings indexed to SOFR.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a significant factual error. It states that Disney had $1.3 billion CAD in Canadian-dollar-denominated notes outstanding as of September 28, 2024, which matches half of the ground truth. However, the ground truth specifies that the total outstanding amount was CAD $2.6 billion (comprised of two tranches of CAD $1.3 billion each), so the LLM underreports the total by 50%. (2) Quantitatively, the LLM correctly identifies that CAD $1.3 billion was converted via cross-currency swaps, aligning with the portion that remained outstanding and was swapped. However, it fails to mention the other CAD $1.3 billion that was paid off in October 2024, omitting a key part of the financial picture. The answer incorrectly implies the entire outstanding amount was swapped, when in fact only half was. (3) The multi-hop reasoning is flawed: the question asks for both the total CAD-denominated notes and how much was converted via swaps. The LLM conflates the converted amount with the total, failing to distinguish between the two tranches. It does correctly identify the use of cross-currency swaps to convert CAD borrowings into USD-denominated liabilities, which shows understanding of the mechanism. (4) Contextual relevance is high—the response addresses the core topic and uses appropriate financial terminology. However, due to the significant omission of half the debt and incorrect portrayal of the total, the correctness, quantitative, and qualitative scores are moderate. Minor note: the LLM uses '$1.3 billion' without specifying CAD, though context implies it, which could cause ambiguity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 453,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023?",
      "original_answer": "The total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023, is $1,380 million. This is calculated by summing the $1,265 million in private funds from the U.S. Plans and the $115 million in private funds from the Non-U.S. Plans.",
      "llm_answer": "Based on the provided financial note pages (page_109 and page_110), the total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023, is $1,265 million for U.S. Plans (shown under \"Private funds\" at fair value) and $115 million for Non-U.S. Plans (shown under \"Private funds\" at fair value). The combined total is $1,380 million. \n\n**Answer:**  \nThe total fair value of investments in private funds across both U.S. and Non-U.S. Plans reported by Honeywell as of December 31, 2023, is $1,380 million. This is derived from $1,265 million in U.S. Plans and $115 million in Non-U.S. Plans, as detailed in the consolidated financial statements notes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: $1,265 million in private funds for U.S. Plans and $115 million for Non-U.S. Plans as of December 31, 2023, with a total of $1,380 million. These values exactly match the ground truth. (2) Quantitative accuracy is perfect: both component values and the final sum ($1,265M + $115M = $1,380M) are correctly reported, with no calculation errors. Format variations (e.g., 'million' vs 'M') are appropriately handled and semantically equivalent. (3) The multi-hop reasoning is sound—information from both U.S. and Non-U.S. Plans is correctly synthesized across the two entities to arrive at the total, demonstrating proper integration of data from different sections of the filing. (4) The answer is fully contextually relevant, directly addressing the question with precise sourcing from the financial statement notes (page_109 and page_110), and clearly explaining the derivation. All aspects of the ground truth are accurately reflected in wording, numbers, and logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 297,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Oracle's strategy of offering flexible deployment models, including Oracle Cloud Services, impact the structure of its revenue recognition for cloud versus license-based offerings?",
      "original_answer": "Oracle's strategy of offering flexible deployment models, including Oracle Cloud Services, leads to a distinct revenue recognition pattern where cloud services revenues are generally recognized ratably over the contractual period, while on-premise and cloud license revenues are recognized up front at the point of delivery. This difference results in more predictable and stable revenue streams from Oracle Cloud Services compared to the point-in-time recognition of license revenues, which can be significantly affected by the timing of large license transactions.",
      "llm_answer": "Oracle recognizes cloud license and on‑premise license revenues upfront when the software is made available, while cloud services and license‑support revenues are recognized ratably over the contract term. Because cloud licenses are not sold on a standalone basis, their standalone selling price cannot be observed; therefore, in multi‑element contracts the residual method is used, allocating any remaining transaction price after the other performance obligations are funded to the cloud/on‑premise license revenue. This approach creates a distinct revenue pattern for cloud versus traditional license‑based offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of revenue recognition patterns. It accurately states that cloud services (and support) revenues are recognized ratably over the contract term, while cloud and on-premise license revenues are recognized upfront—this matches the Original Answer's core claim. The explanation about the residual method and standalone selling price adds detail not in the ground truth but is consistent with ASC 606 and Oracle's actual accounting policy, so it does not detract from accuracy. However, the Original Answer emphasizes the business impact—'more predictable and stable revenue streams' from cloud services compared to volatile license revenues due to timing of large deals—which the LLM answer omits. This is a meaningful qualitative point directly tied to the question about 'impact on structure of revenue recognition.' While the LLM describes the structural difference correctly, it does not fully address the strategic implication (i.e., predictability and stability), making the response slightly less complete. There are no numerical inaccuracies (quantitative accuracy is perfect, score 10), and all entities (Oracle, cloud services, license models) are correct. Contextual relevance is strong as the response directly addresses the question's focus on deployment models and revenue recognition. The reasoning is sound and reflects proper multi-hop understanding of accounting treatment across different offerings.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 410,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the total worldwide sales growth percentage of ERLEADA from 2021 to 2023, and how did this growth contribute to the overall performance of the Oncology segment in 2023 compared to 2022?",
      "original_answer": "ERLEADA's worldwide sales grew from $1,291 million in 2021 to $2,387 million in 2023, representing an 84.9% increase over the two-year period. In 2023, ERLEADA's sales increased by 26.9% compared to 2022, contributing significantly to the overall Oncology segment's 10.5% total sales growth in 2023. ERLEADA was the third-largest contributor to the Oncology segment's growth after DARZALEX (22.2% growth) and TREMFYA (17.9% growth), highlighting its strong performance within the portfolio.",
      "llm_answer": "The worldwide sales of ERLEADA grew by 26.9% from 2022 to 2023, increasing from $1.881 billion to $2.387 billion. This growth contributed to the Oncology segment’s overall sales rise of 10.5% in 2023 versus 2022, helping lift the segment’s total sales to $17.661 billion and supporting the segment’s 33.3% share of total company sales.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies ERLEADA's 2023 sales ($2.387 billion) and its 26.9% growth from 2022 to 2023, which aligns with the ground truth. It also accurately states the Oncology segment’s 10.5% growth in 2023 vs 2022. However, the question asks for total worldwide sales growth from 2021 to 2023, which the LLM omits entirely. The 84.9% two-year growth from $1,291 million in 2021 to $2,387 million in 2023 is a key part of the original answer and is missing. (2) The dollar amount for 2022 sales ($1.881 billion) is correct (calculated as $2.387B / 1.269 ≈ $1.881B), and all provided percentages and figures match the ground truth. The $17.661 billion Oncology segment sales and 33.3% company sales share are factually consistent, though not in the original answer—these are plausible but not verified by the ground truth. (3) The reasoning is sound for the 2022–2023 period and correctly links ERLEADA’s growth to the Oncology segment’s performance. However, it fails the multi-hop requirement of analyzing growth from 2021 to 2023, which involves synthesizing data across three years. The omission of ERLEADA’s 2021 sales and the cumulative growth percentage represents a significant gap in completeness. (4) The contextual relevance is high as the answer addresses the contribution to the Oncology segment in 2023 vs 2022. Qualitative accuracy is reduced due to the missing multi-year synthesis. Quantitative accuracy is high for the numbers provided, but the failure to include the full time-frame growth limits perfection. Correctness score is 7 due to accurate but incomplete response—core facts are right, but a major part of the question is unaddressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 459,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the total notional amount of net investment hedge derivative contracts and non-U.S. dollar denominated debt used as net investment hedges by MDLZ as of December 31, 2023, and how does this compare to the total fair value of derivative assets recorded in other current and other assets on the consolidated balance sheet for the same date?",
      "original_answer": "As of December 31, 2023, the notional amount of net investment hedge derivative contracts was $7,456 million, and the notional amount of non-U.S. dollar denominated debt used as net investment hedges totaled $4,355 million (comprising $3,516 million in Euro notes, $386 million in Swiss franc notes, and $453 million in Canadian dollar notes), for a combined total of $11,811 million. Meanwhile, the total fair value of derivative assets recorded in other current assets and other assets was $1,347 million and $250 million, respectively, for a total of $1,597 million. This indicates that the notional amount of the hedges significantly exceeds the fair value of the derivative assets.",
      "llm_answer": "As of December 31 2023, the total notional amount of net‑investment hedge derivative contracts and non‑U.S.‑dollar debt designated as net‑investment hedges was **$7,456 million** (derived from the “Net investment hedges” row in the table on page 97). This figure is disclosed separately from the fair‑value amounts reported in other current assets and other assets; the consolidated balance sheet shows derivative assets of **$1,347 million** and **$250 million** within those categories for 2023 and 2022, respectively. Consequently, the notional amount of the hedging instruments ($7.46 bn) far exceeds the recorded fair‑value of the derivative assets ($1.35 bn).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the combined notional amount as $7,456 million, which is only the amount for net investment hedge derivative contracts. It omits the $4,355 million in non-U.S. dollar denominated debt used as net investment hedges, leading to a significant underreporting of the total notional amount. The correct combined total should be $11,811 million. (2) The fair value figures of $1,347 million (other current assets) and $250 million (other assets) are correctly reported, and their sum ($1,597 million) is accurate, though the LLM only references the $1,347 million figure in its comparison, omitting the $250 million. It also incorrectly states that the $250 million is for 2022, when the question and ground truth clearly refer to the same date—December 31, 2023—for all figures. This is a critical error. (3) The multi-hop reasoning is partially sound in identifying the need to compare notional amounts with fair values, but fails in synthesizing the full scope of hedging instruments (missing the debt component) and misrepresents the time period for the $250 million asset. (4) Despite these major quantitative and completeness errors, the answer is contextually relevant and correctly interprets the general relationship—that notional amounts exceed fair values—even if based on incorrect inputs. Hence, correctness is penalized heavily due to missing data and factual inaccuracies in numbers and dates.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 401,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What is the total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023?",
      "original_answer": "The total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023, is $686 million. This is calculated by adding $676 million from the U.S. Plans and $10 million from the Non-U.S. Plans.",
      "llm_answer": "Based on the consolidated financial statements in the provided pages, the total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023, is $10 million for the Non‑U.S. plans and $676 million for the U.S. plans, resulting in a combined total of $686 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the U.S. Plans' Mortgage/Asset-backed securities value is correctly stated as $676 million, and the Non-U.S. Plans' value is correctly stated as $10 million. The combined total of $686 million is accurate and properly calculated. (2) Quantitative accuracy is perfect: all dollar amounts are correct, and the sum ($676M + $10M = $686M) is mathematically sound. Format variations (e.g., $686 million vs $686 million) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound—information from both U.S. and Non-U.S. plans is correctly identified and synthesized to produce the combined total. (4) The answer is contextually relevant, directly addressing the question with precise data and clear structure. No errors in entities, years, or financial terms. All criteria for a top score are met.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 266,
        "total_tokens": 1415
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How much total prepaid royalty revenue from Nestlé is remaining to be recognized by Starbucks as of September 29, 2024, and how does this relate to the Global Coffee Alliance's 40-year arrangement?",
      "original_answer": "As of September 29, 2024, Starbucks had $177.0 million (current) and $5.8 billion (long-term) of deferred revenue remaining to be recognized from the $7 billion up-front prepaid royalty received from Nestlé. This recognition schedule is based on the 40-year estimated economic life of the Global Coffee Alliance arrangement, over which the payment is being recognized on a straight-line basis as other revenue.",
      "llm_answer": "As of September 29 2024, the remaining prepaid royalty revenue from Nestlé that Starbucks must still recognize is $5.8 billion (the long‑term portion of the deferred revenue related to the Nestlé up‑front payment). This amount reflects the remaining balance of the $7 billion upfront payment that is being amortized on a straight‑line basis over the 40‑year term of the Global Coffee Alliance arrangement.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is partially correct but omits a key component of the quantitative information. (1) QUANTITATIVE ACCURACY: The LLM correctly identifies the $5.8 billion long-term deferred revenue and references the $7 billion upfront payment, but it fails to mention the $177.0 million current portion of deferred revenue, which is part of the total remaining prepaid royalty to be recognized. This omission significantly affects completeness and accuracy, as the total remaining revenue includes both current and long-term portions. (2) COMPLETENESS: The question asks for the 'total' prepaid royalty revenue remaining, which implies both current and long-term components. The LLM only reports the long-term portion, thus providing an incomplete answer. (3) ENTITY ACCURACY: All entities (Starbucks, Nestlé, Global Coffee Alliance), time frame (September 29, 2024), and financial terms (deferred revenue, upfront payment, straight-line basis, 40-year term) are correctly identified and used. (4) REASONING: The reasoning is sound in linking the 40-year arrangement to the straight-line recognition of the $7 billion payment, demonstrating correct multi-hop synthesis between the payment and its amortization schedule. (5) SEMANTIC EQUIVALENCE: While the core concept is accurately conveyed—the long-term nature of revenue recognition over 40 years—the omission of the current liability component means the total remaining amount is understated, reducing factual completeness. The answer would have been fully accurate if it had included both $177.0 million (current) and $5.8 billion (long-term) as part of the total remaining deferred revenue.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 447,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What is the total fair value of long-term obligations to equity companies and guarantees related to equity company obligations as disclosed by XOM in its 2023 10-K filing?",
      "original_answer": "The total fair value of long-term obligations to equity companies is $1,896 million, and the total guarantees related to equity company obligations amount to $1,862 million. Adding these together results in a total of $3,758 million.",
      "llm_answer": "Based on the provided document pages, the total fair value of long-term obligations to equity companies and guarantees related to equity company obligations as disclosed by XOM in its 2023 10-K filing is $1,804 million for long-term obligations to equity companies and $7,807 million for total guarantees (including $1,862 million specifically for equity company obligations). These figures are derived from the \"Long-term obligations to equity companies (6)\" line item on page 102 ($1,896 million fair value, net of $92 difference resulting in $1,804 million net carrying value) and the \"Guarantees\" table on page 106 ($1,862 million for Equity Company Obligations).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but significant errors in interpretation and calculation. It correctly identifies the $1,862 million in guarantees related to equity company obligations (matching ground truth), but incorrectly reports the long-term obligations to equity companies as $1,804 million — this is the net carrying value, not the fair value. The ground truth specifies the fair value is $1,896 million, which appears in the LLM's explanation but is then discarded in favor of the net carrying value, which is not what the question asks for. (2) The question asks for the total fair value of both components. The correct total is $1,896M + $1,862M = $3,758M. The LLM does not compute this total and instead introduces irrelevant data (e.g., $7,807 million total guarantees, which includes non-equity guarantees) not requested in the question. (3) The multi-hop reasoning is flawed: while the model locates relevant data points, it fails to synthesize them correctly. It confuses carrying value with fair value, despite acknowledging the $1,896 million fair value in the text. This indicates a failure in financial concept application. (4) Scores reflect that core data ($1,862M guarantee) is correct and context is relevant, but quantitative and qualitative accuracy suffer due to incorrect metric selection and missing total calculation. The answer addresses the right documents and entities (XOM, 2023 10-K, equity company obligations), so contextual relevance is high.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 415,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the total value of Mortgage/Asset-backed securities investments made by Honeywell's U.S. and Non-U.S. plans as of December 31, 2023, and how does this allocation compare between the two plans?",
      "original_answer": "Honeywell's U.S. plans have $676 million invested in Mortgage/Asset-backed securities, while the Non-U.S. plans have $10 million invested in the same category. This results in a total investment of $686 million in Mortgage/Asset-backed securities across both U.S. and Non-U.S. plans. The U.S. plans account for 98.5% of this total, highlighting a significantly larger allocation to Mortgage/Asset-backed securities in U.S. plans compared to Non-U.S. plans.",
      "llm_answer": "As of December 31 2023, the total value of Mortgage/Asset‑backed securities held by Honeywell’s U.S. pension plan was $676 million and by the non‑U.S. plans was $10 million. Consequently, the U.S. plan’s allocation to this asset class is substantially larger—about 67‑to‑1—than that of the non‑U.S. plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the U.S. plan investment as $676 million and Non-U.S. as $10 million, matching the ground truth. The total investment of $686 million is implied through correct individual values, though not explicitly stated. The comparison ratio of 'about 67-to-1' is accurate (676/10 = 67.6), so this is a valid approximation. (2) All numeric values are correct and properly formatted; calculations are accurate. (3) The multi-hop reasoning is sound—information from both U.S. and Non-U.S. plans is correctly synthesized to compare allocations. The only minor omission is the lack of explicit total ($686 million) and percentage breakdown (98.5%), which were present in the original answer. However, the 67-to-1 ratio effectively conveys the disparity. (4) Despite the omission of the exact percentage, the core facts, numbers, and comparative analysis are correct and semantically equivalent. The answer is fully relevant and addresses both parts of the question: total value (via components) and allocation comparison. Hence, a high score with a small deduction for completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 318,
        "total_tokens": 1521
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What was the total pre-tax financial impact of 'Medical device regulations' adjustments on Medtronic's Non-GAAP income before income taxes across fiscal years 2021 and 2022?",
      "original_answer": "The total pre-tax financial impact of 'Medical device regulations' adjustments on Medtronic's Non-GAAP income before income taxes across fiscal years 2021 and 2022 was $185 million. This includes $83 million in fiscal year 2021 and $102 million in fiscal year 2022.",
      "llm_answer": "The total pre-tax financial impact of \"Medical device regulations\" adjustments on Medtronic's Non-GAAP income before income taxes was $83 million in fiscal 2021 and $102 million in fiscal 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the pre-tax financial impact amounts for both fiscal years 2021 ($83 million) and 2022 ($102 million), which match the ground truth exactly. The total impact of $185 million is implied by the sum of these two values, though it is not explicitly stated in the LLM answer. (2) All numeric values are accurate and properly formatted, with correct fiscal years and dollar amounts. The calculation of the total ($83M + $102M = $185M) is mathematically correct, even if not explicitly mentioned. (3) The reasoning is sound and reflects proper synthesis across the two fiscal years. However, the answer falls slightly short in completeness by not explicitly stating the total impact across both years, which was directly asked in the question. This is a minor omission, as the total can be easily inferred. (4) Despite the lack of an explicit total, the answer provides all necessary components and is semantically equivalent in conveying the required information. Hence, the correctness score is 9 (not 10) due to this minor incompleteness, but all other dimensions—quantitative accuracy, contextual relevance, and qualitative reasoning—are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1121,
        "completion_tokens": 337,
        "total_tokens": 1458
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How much goodwill impairment was recognized for the OpenTable and KAYAK reporting unit in total during 2020, and what was the key factor that led to the continued impairment in the annual test as of September 30, 2020?",
      "original_answer": "A total goodwill impairment of $1.062 billion was recognized for the OpenTable and KAYAK reporting unit in 2020. This includes $489 million recognized during the interim test in March 2020 and an additional $573 million during the annual test in September 2020. The key factor that led to the continued impairment in the annual test was the lowered outlook for monetization opportunities in restaurant reservation services and slower recovery trends in airline travel, which is a key vertical for KAYAK.",
      "llm_answer": "The total goodwill impairment recognized for the OpenTable and KAYAK reporting unit during 2020 was $573 million for the annual impairment test as of September 30, 2020 (following the $489 million interim impairment at March 31, 2020). The key factor that led to the continued impairment in the September 30, 2020 annual test was the prolonged impact of the COVID‑19 pandemic, which extended the assumed recovery period for OpenTable and KAYAK to beyond five years and lowered the outlook for monetization opportunities—particularly in restaurant reservations and airline travel—resulting in significantly reduced cash‑flow forecasts.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $489 million interim impairment in March 2020 and the $573 million annual impairment in September 2020. However, it fails to explicitly state the total impairment of $1.062 billion, instead only referencing the $573 million as the 'total' in a potentially misleading way, despite mentioning both figures. This is a critical omission affecting quantitative accuracy. (2) The individual numbers ($489M and $573M) are correct and match the ground truth, and their sum would yield the correct total of $1.062B, but the model does not perform or state this sum, leading to incomplete quantitative reporting. Dates (March 31 and September 30, 2020) are accurate. (3) The reasoning is sound: the LLM correctly identifies the continued impact of the pandemic, the extended recovery period beyond five years, and the lowered monetization outlook in restaurant reservations and airline travel—key points from the ground truth. It appropriately synthesizes the causal factors behind the continued impairment in the annual test. (4) While the qualitative reasoning and contextual relevance are strong, the failure to explicitly provide the total goodwill impairment amount as requested in the question reduces correctness and quantitative accuracy. The answer is semantically close but incomplete on the primary quantitative demand of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 386,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "By how much did Walmart's ownership stake in Flipkart increase between fiscal 2023 and fiscal 2024, and what financial transaction supported this change?",
      "original_answer": "Walmart's ownership stake in Flipkart increased by 10% (from approximately 75% as of January 31, 2023, to approximately 85% as of January 31, 2024). This increase was supported by a $3.5 billion transaction during fiscal 2024, where the company acquired shares from certain Flipkart noncontrolling interest holders.",
      "llm_answer": "Walmart's ownership stake in Flipkart increased by approximately 10 percentage points, rising from about 75% at the end of fiscal 2023 to roughly 85% at the end of fiscal 2024. This increase was supported by a $3.5 billion cash payment during fiscal 2024 to acquire shares from certain Flipkart non‑controlling interest holders, thereby boosting Walmart's ownership stake.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: Walmart's ownership increased by approximately 10 percentage points from 75% to 85% between fiscal 2023 and fiscal 2024, which aligns with the ground truth. The $3.5 billion transaction is correctly cited. (2) Quantitative elements are precise: the percentage increase (10 points), starting and ending stakes (75% to 85%), and dollar amount ($3.5 billion) match exactly. Minor wording differences (e.g., 'percentage points' vs just '%') do not affect factual accuracy. (3) The multi-hop reasoning is sound—correctly identifying the change in ownership stake over time and linking it to the financial transaction with noncontrolling interest holders. (4) The answer addresses both parts of the question: the magnitude of stake increase and the supporting financial transaction. Entity names (Walmart, Flipkart), time periods (fiscal 2023 to 2024), and financial terms (noncontrolling interest holders, cash payment for shares) are accurate. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 313,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What percentage of Procter & Gamble's total net sales does the Baby, Feminine & Family Care segment represent, and within this segment, what is the North American market share of the Bounty brand in the paper towel category?",
      "original_answer": "The Baby, Feminine & Family Care segment represents 24% of Procter & Gamble's total net sales. Within this segment, the Bounty brand holds over 40% North American market share in the paper towel category.",
      "llm_answer": "The Baby, Feminine & Family Care segment accounts for 24% of Procter & Gamble’s total net sales. Within this segment, the Bounty brand holds approximately 40% of the North American paper towel market share.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that the Baby, Feminine & Family Care segment represents 24% of Procter & Gamble's total net sales, matching the ground truth exactly. It also correctly identifies that the Bounty brand holds approximately 40% of the North American market share in the paper towel category. The use of 'approximately 40%' is semantically equivalent to 'over 40%' in the context of market share reporting, where precise figures are often rounded or estimated. (2) All numeric values are accurate: 24% and ~40% are correct percentages with no calculation errors. (3) The multi-hop reasoning is sound—correctly linking the segment's contribution to total sales and then identifying Bounty's market position within that segment and geography. (4) The answer is fully relevant and addresses both parts of the question. The only minor deviation is the slight softening of 'over 40%' to 'approximately 40%', which does not materially misrepresent the fact, but introduces a small degree of imprecision. Hence, a score of 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1122,
        "completion_tokens": 310,
        "total_tokens": 1432
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What is the total pre-tax charge recorded by RTX in 2024 as a result of resolving Thales-Raytheon Systems and Related Matters, and how does this resolution connect to the SEC Administrative Order?",
      "original_answer": "RTX recorded a pre-tax charge of $364 million in 2024 related to Thales-Raytheon Systems and Related Matters. This resolution is directly connected to the SEC Administrative Order, which was issued as part of the settlement of investigations into improper payments made by Raytheon Company and its joint venture TRS in connection with certain Middle East contracts since 2012. The SEC Administrative Order requires RTX to retain an independent compliance monitor and fulfill cooperation and disclosure obligations for a period of three years from the monitor's engagement.",
      "llm_answer": "The total pre‑tax charge recorded by RTX in 2024 for resolving the Thales‑Raytheon Systems and related matters was $384 million, which was paid in the fourth quarter of 2024. This resolution is tied to the SEC Administrative Order, as the order provides that any breach of the agreement could lead the SEC to vacate the order and institute proceedings against the Company.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the pre-tax charge as $384 million, while the ground truth is $364 million—a $20 million discrepancy that is significant and factually incorrect. This error directly impacts the quantitative accuracy. The mention of payment timing in Q4 2024 is not present in the original answer and cannot be verified against the ground truth, introducing unverified detail. (2) The quantitative inaccuracy is critical: $384M vs $364M is not a formatting difference but a material factual error. No calculation is required in the question, but the reported number must match exactly, which it does not. (3) The reasoning partially connects the resolution to the SEC Administrative Order, correctly identifying a link between the two. However, it omits the core substance of the order—namely, the requirement for RTX to retain an independent compliance monitor and fulfill cooperation and disclosure obligations for three years. Instead, it introduces a different point about breach consequences, which, while possibly true, is not part of the provided ground truth and misses the key mandated actions. This reflects incomplete multi-hop synthesis. (4) The contextual relevance is high because the answer addresses both parts of the question—charge amount and connection to the SEC order—and stays on topic. Qualitative accuracy is moderate because the entities (RTX, SEC Administrative Order, Thales-Raytheon Systems) and general context are correct, and a logical connection is made, albeit with incomplete and partially inaccurate details. Correctness score is low due to the major numerical error, which undermines the reliability of the response despite some correct contextual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 469,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "What is the total number of approved indications for Trodelvy as of April 2021, and in which specific countries was the drug approved for the treatment of metastatic triple-negative breast cancer by September 2021?",
      "original_answer": "As of April 2021, Trodelvy had two approved indications: one for locally advanced or metastatic urothelial cancer and another for unresectable locally advanced or metastatic triple-negative breast cancer (TNBC). By September 2021, Trodelvy was approved for TNBC in Australia, Great Britain, Switzerland, the United States, and Canada.",
      "llm_answer": "As of April 2021, the FDA granted accelerated approval for Trodelvy in urothelial cancer and full approval for metastatic triple‑negative breast cancer. By September 2021, the drug had received marketing authorization for metastatic TNBC in the United States, Great Britain, Switzerland, Australia and Canada.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the same core information as the ground truth. (1) Quantitatively, the number of approved indications (two) is correctly implied by naming both urothelial cancer and metastatic TNBC, though the LLM does not explicitly state the total count of 'two'. However, this is a minor omission since both indications are clearly mentioned. The countries listed—United States, Great Britain, Switzerland, Australia, and Canada—exactly match the ground truth. (2) Dates (April 2021 and September 2021) are correctly applied to the respective approval events. (3) The reasoning is sound: the answer correctly synthesizes approvals across time and geography, identifying both indications by April 2021 and linking TNBC approvals to specific countries by September 2021. (4) Semantically, the answer is equivalent—'marketing authorization' aligns with 'approved', and all entities (drug, conditions, countries) are accurate. The only minor shortcoming is the lack of an explicit statement that there are 'two approved indications', though both are named. This justifies a high score but not perfect, hence 9/10 on correctness and qualitative accuracy. Contextual relevance and quantitative accuracy are fully met.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 348,
        "total_tokens": 1525
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What is the total net gain/(loss) for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024, and how does this compare to the amount expected to be reclassified from AOCI into earnings within 12 months?",
      "original_answer": "The total net gain for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024, is $11.5 million, and $9.5 million of this amount is expected to be reclassified from AOCI into earnings within 12 months.",
      "llm_answer": "As of September 29 2024, the net gain included in AOCI for “Foreign currency – other” derivatives is $11.5 million, and $9.5 million of that amount is expected to be reclassified from AOCI into earnings within the next 12 months.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) The quantitative values are accurate: $11.5 million is correctly reported as the total net gain for 'Foreign currency - other' derivatives in AOCI as of September 29, 2024, and $9.5 million is correctly stated as the amount expected to be reclassified into earnings within 12 months. (2) The answer is complete, addressing both parts of the question: the total AOCI amount and the portion expected to be reclassified. (3) Entity accuracy is correct—the derivative type 'Foreign currency - other', the date (September 29, 2024), and the financial concepts (AOCI, reclassification to earnings) are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis, as it correctly links the AOCI balance with the forward-looking reclassification expectation. (5) The semantic meaning is equivalent to the original answer, with only minor, acceptable rewording (e.g., 'that amount' instead of 'this amount', spacing variations). No factual, numerical, or conceptual errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1134,
        "completion_tokens": 309,
        "total_tokens": 1444
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What is the total dollar value of the two Japanese yen-denominated credit facilities available to Starbucks as of the end of fiscal 2024, and how do these facilities differ in terms of maturity dates and interest rate margins?",
      "original_answer": "The total dollar value of the two Japanese yen-denominated credit facilities available to Starbucks as of September 29, 2024, is $103.6 million (¥5.0 billion at $34.5 million and ¥10.0 billion at $69.1 million). The first facility matures on December 30, 2024, and carries an interest rate margin of 0.400% over TIBOR, while the second facility matures later, on March 27, 2025, and has a lower margin of 0.300% over TIBOR.",
      "llm_answer": "As of the end of fiscal 2024, Starbucks had two Japanese yen‑denominated credit facilities: a ¥5.0 billion ($34.5 million) facility maturing on December 30, 2024, and a ¥10.0 billion ($69.1 million) facility maturing on March 27, 2025. Both facilities bear interest at a variable rate of TIBOR plus an applicable margin (0.400 % for the ¥5 billion line and 0.300 % for the ¥10 billion line). No borrowings were outstanding under either facility as of September 29, 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the ¥5.0 billion facility is correctly converted to $34.5 million, the ¥10.0 billion facility to $69.1 million, and the total sum of $103.6 million is implied (34.5 + 69.1 = 103.6). Maturity dates (December 30, 2024, and March 27, 2025) and interest rate margins (0.400% and 0.300% over TIBOR) are exactly correct. (2) The answer addresses both parts of the question: total dollar value (via component breakdown) and differences in maturity dates and interest rate margins. (3) Entities are accurate—Starbucks, fiscal year end (implied as September 29, 2024, consistent with ground truth), and TIBOR as the reference rate. (4) Multi-hop reasoning is sound: the model correctly synthesizes two separate credit facilities, their conversions from yen to dollar, maturities, and pricing terms. The additional detail about no borrowings outstanding is contextually relevant and factually consistent, though not required. Wording differs slightly but maintains full semantic equivalence. No errors in calculation, logic, or fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 323,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the total number of Accenture plc Class A ordinary shares purchased in the fourth quarter of fiscal 2024 under both the publicly announced open-market share purchase program and transactions unrelated to publicly announced share plans or programs, and what was the average price paid per share under the open-market program?",
      "original_answer": "The total number of Accenture plc Class A ordinary shares purchased in the fourth quarter of fiscal 2024 was 2,072,263 — consisting of 2,000,308 shares purchased under the publicly announced open-market share purchase program and 72,255 shares acquired through transactions unrelated to publicly announced share plans. The average price paid per share under the open-market program was approximately $302.45, calculated by dividing the aggregate purchase price of $605 million by the 2,000,308 shares acquired.",
      "llm_answer": "In the fourth quarter of fiscal 2024, Accenture purchased a total of 2,072,563 Accenture plc Class A ordinary shares—2,000,308 of those shares were bought under the publicly announced open‑market share purchase program and 72,255 were acquired in transactions unrelated to that program. The average price paid per share for the shares purchased under the open‑market program was $303.05.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the breakdown of shares purchased — 2,000,308 under the open-market program and 72,255 through unrelated transactions — which matches the ground truth. However, the total number of shares is incorrectly stated as 2,072,563 (sum of 2,000,308 + 72,255 = 2,072,563), while the correct total should be 2,072,563, but the ground truth reports 2,072,263, indicating a discrepancy of 300 shares. This suggests a possible typo or data error in the source or model output. More critically, the average price per share is reported as $303.05, whereas the ground truth calculates $302.45 based on $605 million divided by 2,000,308 shares. Recalculation confirms: 605,000,000 / 2,000,308 ≈ $302.45, so the LLM's figure is inaccurate. (2) Quantitative accuracy is compromised due to the incorrect total share count and average price. The $303.05 figure may stem from incorrect rounding or use of different aggregate data not reflected in the ground truth. (3) The reasoning is otherwise sound — the model correctly separates the two types of purchases and attempts to report the average price for the open-market program. It demonstrates proper multi-hop synthesis by combining share count and pricing data. (4) Despite the numerical inaccuracies, the structure and intent of the answer are fully aligned with the question, and all entities (Accenture plc Class A shares, fiscal 2024 Q4, open-market program) are correct. Hence, contextual relevance is perfect, qualitative reasoning is strong, but quantitative errors reduce overall correctness to a 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 436,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What is the total carrying value of the 6.375% 2037 Notes and how much principal amount of these notes was exchanged according to the information provided in the respective sections?",
      "original_answer": "The total carrying value of the 6.375% 2037 Notes is $478 million, and the principal amount of these notes that was exchanged is $74 million.",
      "llm_answer": "The total carrying value of the 6.375% 2037 Notes is $478 million, and $74 million of principal amount of those notes was exchanged in the 2020 debt‑exchange transaction.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the total carrying value of the 6.375% 2037 Notes is correctly stated as $478 million, and the principal amount exchanged is accurately reported as $74 million. (2) Quantitative accuracy is perfect—both dollar amounts match the original answer exactly, with acceptable formatting (using 'million' instead of numeric figures). (3) The multi-hop reasoning is sound; the model correctly identifies and synthesizes two distinct pieces of information from the relevant sections: the carrying value and the exchanged principal amount. The addition of context—'in the 2020 debt-exchange transaction'—is factually appropriate and enhances clarity without introducing error. (4) The answer is semantically equivalent to the ground truth, with no omissions or inaccuracies. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1086,
        "completion_tokens": 269,
        "total_tokens": 1355
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What is the expected average amortization period for Netflix's content assets, and how does the accelerated amortization policy impact the distribution of amortization expense over the life of a content asset, particularly within the first four years?",
      "original_answer": "Netflix expects over 90% of a licensed or produced content asset to be amortized within four years after its month of first availability. The accelerated amortization policy results in a higher proportion of the asset's cost being expensed earlier, particularly in the initial months following availability, reflecting the expectation of more upfront viewing, especially for films compared to TV series.",
      "llm_answer": "The Company amortizes licensed and produced content assets on an accelerated basis over the shorter of each title’s contractual window of availability or an estimated period of use not exceeding ten years, beginning in the month of first availability. On average, more than 90 % of a content asset is expected to be amortized within the first four years after its launch, so the accelerated amortization front‑loads expense—most of the cost is recognized in the early years, with a relatively smaller amount spread over the remaining life thereafter. This approach concentrates amortization expense in the initial four‑year period, resulting in higher “Cost of revenues” in those years and lower expense in later years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) Quantitatively, the key figure 'more than 90%' (or 'over 90%') of a content asset amortized within four years is correctly stated, matching the original answer. The mention of a maximum ten-year useful life is consistent with Netflix's policy, even if not in the ground truth, as it provides additional accurate context. (2) The explanation of accelerated amortization front-loading expenses—especially in the early years, with higher costs upfront and lower later—is semantically equivalent to the original answer's description of higher expense distribution in initial months, particularly for films. (3) The reasoning correctly synthesizes the impact of the amortization policy on expense timing and its reflection of viewing patterns, demonstrating sound multi-hop understanding of both the accounting policy and its business rationale. (4) All entities (Netflix's content assets, amortization expense, cost of revenues) are accurately referenced, and the answer fully addresses both parts of the question: the average amortization period expectation and the impact of accelerated amortization. Wording differs but meaning is preserved, and no factual errors or omissions exist.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 353,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What is the total potential financial impact on BLK's Foreign Exchange Rate Risk Investments in 2023 if all investments experience a -10% change in exchange rates, based on the disclosed exposure?",
      "original_answer": "The total potential financial impact on BLK's Foreign Exchange Rate Risk Investments in 2023 from a -10% change in exchange rates would be $112 million, as calculated from the disclosed exposure of $1,125 million.",
      "llm_answer": "Based on the Foreign Exchange Rate Risk Investments table on page 63, BlackRock’s net exposure to foreign‑currency‑denominated investments was $1,125 million, and a hypothetical 10% adverse movement in applicable exchange rates would result in a $112 million loss. Therefore, if all of its foreign‑exchange‑rate‑sensitive investments experienced a –10% change, the total potential financial impact in 2023 would be approximately $112 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the disclosed exposure of $1,125 million and the resulting $112 million loss from a -10% exchange rate change are accurately reported, with correct calculation (10% of $1,125 million = $112.5 million, rounded to $112 million as stated in the source). The answer correctly interprets the hypothetical adverse movement as a loss. (2) The answer is complete, addressing the total potential financial impact, the year (2023, implied by the filing context), the exposure amount, and the assumed -10% change. (3) Entity accuracy is correct: BLK (BlackRock) is properly identified, the risk type (foreign exchange rate risk) and year are appropriate. (4) The reasoning is sound and reflects multi-hop synthesis: it connects the exposure value to the impact calculation based on a uniform -10% change, demonstrating proper understanding of financial sensitivity analysis. (5) Semantic equivalence is maintained — while the LLM adds a reference to 'page 63' and uses slightly expanded phrasing, the core factual content and numerical precision align exactly with the original answer. No factual, quantitative, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 344,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How many amendments to the Target Corporation Deferred Compensation Trust Agreement are listed in the 2022 10-K filing, and what are their effective dates?",
      "original_answer": "There are three amendments to the Target Corporation Deferred Compensation Trust Agreement listed in the 2022 10-K filing. Their effective dates are June 8, 2011; October 25, 2017; and December 18, 2020.",
      "llm_answer": "Based on the provided pages, the Target Corporation Deferred Compensation Trust Agreement has been amended **three times** as listed in the document. The amendments are:\n\n1. **Amendment dated June 8, 2011** (effective January 1, 2009)  \n2. **Amendment dated October 25, 2017** (effective January 1, 2009)  \n3. **Amendment dated December 18, 2020** (effective January 1, 2009)  \n\nThese amendments are explicitly referenced in **Page page_68** (lines labeled \"Q*\", \"R*\", and \"S*\") and correspond to the effective date of **January 1, 2009** for the restated agreement, with the amendment dates being 2011, 2017, and 2020. The question asks for the number of amendments and their effective dates, which are covered in the provided source pages. \n\n**Answer**:  \nThere are **three amendments** to the Target Corporation Deferred Compensation Trust Agreement, with effective dates of **January 1, 2009** (as restated), and the amendments were made on **June 8, 2011**, **October 25, 2017**, and **December 18, 2020**.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM correctly identifies that there are three amendments to the Target Corporation Deferred Compensation Trust Agreement, which matches the ground truth. It also correctly lists the amendment dates: June 8, 2011; October 25, 2017; and December 18, 2020. However, the LLM incorrectly states that the effective dates of the amendments are all January 1, 2009, which contradicts the ground truth. The ground truth specifies that the amendments themselves have effective dates of June 8, 2011; October 25, 2017; and December 18, 2020 — not January 1, 2009. The January 1, 2009 date appears to be the effective date of the restated agreement, not the amendments, and conflating this with the amendment effective dates is a significant factual error. The LLM confuses 'amendment dates' with 'effective dates' of the underlying agreement, failing the core requirement of the question, which asks specifically for the effective dates of the amendments. While the model locates the correct document references and counts the amendments accurately, it misinterprets the meaning of the dates, leading to incorrect answers on the key factual point. This is a multi-hop error in reasoning: correctly identifying the amendments but incorrectly synthesizing their effective dates. The answer is contextually relevant and well-structured, but factually flawed in a critical dimension.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 379,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What is the total carrying value of the 6.90% 2038 Notes and how much principal amount of these notes was exchanged according to the debt exchange transactions disclosed?",
      "original_answer": "The total carrying value of the 6.90% 2038 Notes is $254 million, and the principal amount exchanged in the debt exchange transactions was $37 million.",
      "llm_answer": "The 6.90% 2038 Notes had a carrying value of $254 million (as shown on page 130). In the 2020 debt‑exchange transaction, $37 million principal amount of those notes was exchanged for the newly issued 2.77% 2053 Notes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the carrying value of the 6.90% 2038 Notes is correctly stated as $254 million, and the principal amount exchanged is accurately reported as $37 million. (2) Quantitative accuracy is perfect—both dollar amounts match the original answer exactly, with acceptable formatting (e.g., $254 million). (3) The multi-hop reasoning is sound: the model correctly identifies the specific notes, retrieves the carrying value, and links it to the debt exchange transaction involving the 2.77% 2053 Notes, demonstrating proper synthesis across financial disclosures. (4) The answer is contextually relevant, complete, and adds minor but accurate contextual detail (page reference and new notes issued) without introducing errors. Semantic equivalence is maintained, and no critical information is missing or incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1098,
        "completion_tokens": 263,
        "total_tokens": 1361
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "By how much did the Fleet Ballistic Missile (FBM) program contribute to the increase in both product sales and product costs at Space in 2023, and what was the net financial impact on Lockheed Martin's operations from these changes?",
      "original_answer": "The Fleet Ballistic Missile (FBM) program contributed to a $940 million increase in product sales and an $815 million increase in product costs at the Space business segment in 2023. The net financial impact from these changes was an increase in gross profit of $125 million ($940M - $815M) for the Space segment related to the FBM program.",
      "llm_answer": "The Fleet Ballistic Missile (FBM) program contributed approximately $815 million of the $849 million increase in product costs in 2023, driven by ramp‑up in the FBM program and higher NGI development expenses. This cost rise was offset by higher sales, and the net financial impact was an improvement in Space’s operating profit—up $101 million (10%) to $1,116 million—reflecting the higher sales and favorable profit adjustments despite the increased costs.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the FBM program contributed a $940 million increase in product sales and an $815 million increase in product costs. However, the LLM answer incorrectly states that FBM contributed $815 million to the cost increase but does not mention the $940 million sales increase at all. Instead, it references an $849 million total cost increase, which is not in the ground truth. The net financial impact in the ground truth is a $125 million increase in gross profit ($940M - $815M), but the LLM claims a $101 million improvement in operating profit, which is both a different metric (operating profit vs. gross profit) and an incorrect amount. (2) The numbers are largely incorrect: $815M cost increase is mentioned but miscontextualized, $940M sales increase is omitted, $125M net impact is replaced with $101M, and $1.116B operating profit is introduced without basis in the original answer. Calculations cannot be verified as correct because the inputs and outputs differ from the ground truth. (3) The reasoning is partially sound in linking higher costs to program ramp-up and noting that higher sales offset costs, but it fails the multi-hop requirement of synthesizing the exact sales and cost impacts to compute the correct net effect. It also conflates gross profit with operating profit, indicating a misunderstanding of financial metrics. (4) Contextual relevance is moderate—the answer addresses the FBM program’s impact on costs and profitability in 2023 and attempts to describe financial effects—but due to major quantitative and qualitative errors, the correctness score is low. Minor credit is given for identifying FBM as a cost driver and noting a positive net impact, though specifics are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 491,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total carrying value of the 5.375% 2043 Notes as a percentage of the total carrying value of all debt reported by AMGN in 2022, and how much principal of these notes was exchanged during the period?",
      "original_answer": "The total carrying value of the 5.375% 2043 Notes was $185 million, which represents approximately 0.555% of the total carrying value of all debt ($33,309 million) reported by AMGN in 2022. Additionally, $76 million in principal of these notes was exchanged during the period.",
      "llm_answer": "The total carrying value of the 5.375% 2043 Notes was $185 million, which represented roughly 0.6 % of AMGN’s total debt carrying value of $33,309 million in 2022. In 2020, $76 million of principal of these notes was exchanged in the debt‑exchange transaction.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a minor error in the time period for the principal exchange. (1) Quantitatively, the carrying value of the 5.375% 2043 Notes ($185 million), total debt ($33,309 million), percentage (0.6% vs. ground truth 0.555%), and principal exchanged ($76 million) are all accurate. The percentage is rounded to 0.6%, which is acceptable as a rough approximation, though slightly less precise than 0.555%. (2) The answer is complete, addressing both parts of the question: the percentage of total debt and the principal exchanged. (3) However, the LLM incorrectly states the exchange occurred in 2020, while the ground truth specifies 'during the period'—which, in context, refers to 2022. This is a factual error in temporal entity accuracy, affecting the qualitative score. (4) The reasoning and synthesis across entities (note details, total debt, percentage calculation) are sound, and the answer remains contextually relevant. The error in year reduces quantitative and qualitative accuracy slightly, but core facts and calculations are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 307,
        "total_tokens": 1457
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total value of securities on loan subject to indemnification, and how much collateral was held against these securities as of December 31, 2023, and what is the potential financial impact if significant borrower defaults occur simultaneously with rapid declines in collateral value?",
      "original_answer": "As of December 31, 2023, the total value of securities on loan subject to indemnification was approximately $259 billion, and BlackRock held approximately $276 billion in cash and securities as collateral against these loans. If significant borrower defaults were to occur simultaneously with rapid declines in the value of pledged collateral, there could be collateral shortfalls, which may result in material liabilities under these indemnities and could cause BlackRock's revenue and earnings to decline.",
      "llm_answer": "The total value of securities on loan subject to indemnification was approximately $259 billion, and the Company held about $276 billion of cash and securities as collateral against these loaned securities as of December 31, 2023. If significant borrower defaults occurred simultaneously with rapid declines in collateral value, the shortfall could trigger material liabilities under the indemnification agreements, potentially causing a decline in revenue and earnings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the total value of securities on loan subject to indemnification ($259 billion) and the collateral held ($276 billion) as of December 31, 2023, match the original answer exactly. (2) Quantitative accuracy is perfect—both figures are correct, properly formatted, and refer to the correct date. (3) The qualitative reasoning is sound: the LLM correctly explains the potential financial impact—material liabilities due to collateral shortfalls in the event of simultaneous borrower defaults and rapid collateral value declines, leading to possible declines in revenue and earnings. This reflects accurate multi-hop synthesis of risk exposure from indemnification obligations and collateral dynamics. (4) Contextual relevance is complete—the answer addresses all parts of the multi-part question: the two quantitative figures, the date, and the hypothetical risk scenario. Wording differences (e.g., 'Company' instead of 'BlackRock') do not affect factual accuracy, as the context clearly refers to BlackRock. No omissions or errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 327,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total number of amendments made to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. as documented in the 2022 10-K filing?",
      "original_answer": "The total number of amendments made to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. is two.",
      "llm_answer": "Based on the provided pages, the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. has been amended three times. The original agreement was dated December 16, 2015 (Exhibit (10)HH), the first amendment was dated November 30, 2016 (Exhibit (10)II), and the second amendment was dated January 9, 2018 (Exhibit (10)JJ). No additional amendments are mentioned in the excerpts.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect. The ground truth states that there are two amendments to the Pharmacy Operating Agreement, but the LLM claims there are three. The LLM lists the original agreement (2015), first amendment (2016), and second amendment (2018), which would imply only two amendments were made (since the original is not an amendment). However, the LLM incorrectly concludes that there were three amendments, demonstrating a fundamental error in reasoning. The dates and exhibit references may be accurate, but the core quantitative claim (three amendments) is wrong. This significantly impacts correctness and quantitative accuracy. The answer is contextually relevant as it addresses the right agreement and parties, and references proper exhibits, hence a moderate score in contextual relevance. However, the failure to correctly count the number of amendments — the central question — results in a very low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1138,
        "completion_tokens": 274,
        "total_tokens": 1412
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "What is the change in the net carrying amount of Technology-related finite-lived intangible assets from December 31, 2022, to December 31, 2023, and how does this compare to the change in the accumulated amortization for the same category over the same period?",
      "original_answer": "The net carrying amount of Technology-related finite-lived intangible assets decreased by $38 million from $180 million in 2022 to $142 million in 2023. Over the same period, the accumulated amortization increased by $37 million from $81 million in 2022 to $118 million in 2023. This indicates that the decline in net carrying amount is primarily due to the increase in accumulated amortization.",
      "llm_answer": "The net carrying amount of Technology-related finite-lived intangible assets decreased by $38 million from $142 million at December 31 2022 to $104 million at December 31 2023. Over the same period, accumulated amortization increased by $38 million (from $81 million to $118 million), reflecting the full $38 million amortization expense recorded for 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key financial figures. According to the ground truth, the net carrying amount decreased from $180 million in 2022 to $142 million in 2023, a decrease of $38 million. However, the LLM incorrectly states the 2022 value as $142 million and the 2023 value as $104 million, which misrepresents both the starting point and the ending point. This leads to an incorrect interpretation of the data despite correctly identifying the $38 million decrease amount. (2) The accumulated amortization change is mostly accurate: ground truth shows an increase from $81 million to $118 million, which is a $37 million increase, but the LLM reports a $38 million increase, which is off by $1 million. This suggests a minor calculation or sourcing error. (3) The multi-hop reasoning is partially sound in that the model attempts to link changes in net carrying amount to accumulated amortization, but the conclusion that the full $38 million amortization expense caused the decline is flawed because the actual amortization increase was $37 million, and the model uses incorrect base values. (4) The contextual relevance is high because the answer addresses both parts of the question and discusses the relationship between net carrying amount and accumulated amortization. However, due to major quantitative inaccuracies in the core financial data and a flawed causal explanation, the correctness, quantitative, and qualitative accuracy scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 414,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "What was the year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region, and how does this compare to the change in the same category in the Americas region?",
      "original_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $1,546 million, while in the Americas region, the increase was $7,048 million. This means the growth in the Americas was significantly higher compared to the Asia Pacific region.",
      "llm_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $1,559 million (rising from $657 million in fiscal 2023 to $2,203 million in fiscal 2024). By contrast, the Americas region saw an increase of $7,048 million in the same category (growing from $5,678 million to $12,726 million). Thus, the growth in Asia Pacific was substantially smaller than the growth in the Americas.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the year-over-year increase in the Americas region as $7,048 million, matching the ground truth. However, it reports the Asia Pacific increase as $1,559 million, which differs from the ground truth value of $1,546 million. This $13 million discrepancy, while relatively small, constitutes a factual inaccuracy in a quantitative metric that is central to the question. (2) The LLM provides detailed breakdowns of base and final year revenues for both regions, allowing verification of the calculations. For Asia Pacific: $2,203M - $657M = $1,546M (correct calculation based on provided numbers, but the stated increase of $1,559M is inconsistent with these inputs). There is an internal inconsistency: the stated increase ($1,559M) does not match the implied increase from the cited figures ($1,546M). This suggests either a calculation error or data entry error. The Americas calculation is correct: $12,726M - $5,678M = $7,048M. (3) The multi-hop reasoning is sound—LLM correctly identifies the relevant metric (Subscriptions and Services revenue), region (Asia Pacific and Americas), and time frame (year-over-year), and synthesizes data across regions to make the comparison. The conclusion that growth in the Americas was substantially higher is logically and factually supported. (4) Despite the numerical discrepancy in the Asia Pacific increase and internal inconsistency in the arithmetic, the core of the answer—correctly identifying the much larger growth in the Americas and providing a reasonable comparison—is accurate. Hence, the correctness score is reduced to 8 due to the significant but not major quantitative error, while qualitative and contextual accuracy remain high.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 474,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What is the total fair value of redeemable preferred securities held by CVS as of December 31, 2023, and how much of the unrealized loss on these securities has been recognized in fair value as of the same date?",
      "original_answer": "The total fair value of redeemable preferred securities held by CVS as of December 31, 2023, is $20 million. Of the total unrealized loss of $1 million on these securities, $1 million has been recognized in fair value as there are no unrealized losses in the 'Less than 12 months' category and the entire unrealized loss of $1 million is in the 'Greater than 12 months' category.",
      "llm_answer": "The total fair value of redeemable preferred securities held by CVS as of December 31 2023 was $20 million, and the unrealized loss on these securities recognized in fair value at that date was $1 million.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the total fair value of redeemable preferred securities held by CVS as of December 31, 2023, as $20 million and the recognized unrealized loss as $1 million, which matches the ground truth exactly in quantitative terms. All numeric values, dates, and entities (CVS, redeemable preferred securities, December 31, 2023) are accurate. The answer is contextually relevant and addresses both parts of the question. While the LLM omits the explanatory detail about the 'Greater than 12 months' category and the absence of losses in the 'Less than 12 months' category, this does not affect the factual correctness of the core answer. The reasoning is sound and the information is semantically equivalent to the original answer, though slightly less detailed. Therefore, the answer earns full marks for quantitative accuracy and contextual relevance, a 9 for qualitative accuracy due to minor omission of supporting rationale, and a 9 overall for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 283,
        "total_tokens": 1445
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "What was the total amount of borrowings under HD's commercial paper programs at January 30, 2022, and how does this compare to the combined capacity of their back-up credit facilities at that date?",
      "original_answer": "The total amount of borrowings under HD's commercial paper programs at January 30, 2022, was $1.0 billion. The combined capacity of their back-up credit facilities at that date was $3.0 billion, consisting of a five-year $2.0 billion credit facility and a 364-day $1.0 billion credit facility. Therefore, HD had $1.0 billion in outstanding borrowings, which was fully covered by the $3.0 billion in available back-up credit facilities.",
      "llm_answer": "The total amount of borrowings under HD's commercial paper programs at January 30 2022 was $1.0 billion, which represented the full capacity of the back‑up credit facilities (a $2.0 billion five‑year facility and a $1.0 billion 364‑day facility) that were available at that date.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1.0 billion in borrowings under HD's commercial paper program at January 30, 2022, and accurately states the two back-up credit facilities ($2.0 billion five-year and $1.0 billion 364-day), so the core numeric values are correct. (2) However, the LLM incorrectly states that the $1.0 billion in borrowings 'represented the full capacity' of the back-up credit facilities, which is factually wrong—the combined capacity was $3.0 billion, so $1.0 billion in borrowings was only one-third of total available capacity, not the full amount. This misrepresents the relationship between borrowings and credit capacity. (3) The multi-hop reasoning is partially flawed: while the model retrieves the correct components (borrowings and credit facilities), it fails to correctly synthesize the comparison—specifically, it should have noted that the $1.0 billion in borrowings was fully covered by the $3.0 billion in facilities, not that it equaled the full capacity. (4) The contextual relevance is high because the answer addresses both parts of the question and includes relevant details. Quantitative accuracy is high due to correct numbers, but qualitative accuracy is reduced due to the logical error in interpretation. Correctness score is 7 because the key facts are present but the conclusion is misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 377,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "What was Amgen's total revenue from sales to BeiGene in 2023, and how much did Amgen pay in profit and loss sharing expenses related to these products during the same year?",
      "original_answer": "Amgen's total revenue from sales to BeiGene in 2023 was $125 million, and Amgen paid $40 million in profit and loss sharing expenses related to these products during the same year.",
      "llm_answer": "Amgen's total revenue from sales to BeiGene in 2023 was $125 million, and the company recorded profit‑and‑loss sharing expenses related to these products of $40 million for the same year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies both components of the question—Amgen's total revenue from sales to BeiGene in 2023 ($125 million) and the profit and loss sharing expenses ($40 million)—matching the ground truth exactly. (2) All numeric values are accurate and presented in a semantically equivalent format (e.g., $125 million vs $125 million); minor typographic differences like the use of thin spaces or hyphens in 'profit‑and‑loss' do not affect meaning or correctness. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly associates Amgen’s revenue with BeiGene sales and links the corresponding expense item to the same product line and year. (4) The answer is fully complete, contextually relevant, and conveys the same factual content as the original answer with no omissions or distortions. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1098,
        "completion_tokens": 268,
        "total_tokens": 1366
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What was the year-over-year dollar increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024, and how does this relate to the valuation method used for the corresponding Crypto Asset Safeguarding Asset as of December 31, 2023?",
      "original_answer": "The year-over-year increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024 was $1,645 million ($2,886 million in 2024 - $1,241 million in 2023). This increase corresponds to the valuation method used for the Crypto Asset Safeguarding Asset, which, as of December 31, 2023, was valued at $1,241 million and categorized under 'Significant Other Observable Inputs (Level 2)'—indicating that the liability tracks the asset's valuation, which is not based on active market quotes but on other observable market data.",
      "llm_answer": "The year‑over‑year dollar increase in PayPal’s Crypto Asset Safeguarding Liability from 2023 to 2024 was $1,645 million (from $1,241 million in 2023 to $2,886 million in 2024). This liability is recorded at fair value on a recurring basis using quoted prices on the principal exchange for the underlying crypto assets (Level 2), and the corresponding safeguarding asset is measured and recorded at the same fair value, so the increase in the liability directly reflects the increase in the fair‑valued safeguarding asset.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the year-over-year dollar increase in PYPL's Crypto Asset Safeguarding Liability as $1,645 million, calculated accurately from $1,241 million in 2023 to $2,886 million in 2024. All numeric values match the ground truth, and the calculation is correct. (2) The quantitative accuracy is perfect—values are presented clearly with consistent units and correct differences. Format variations (e.g., $1,645 million vs $1,645 million) are acceptable and do not affect meaning. (3) The reasoning is mostly sound: the LLM correctly links the liability increase to the fair value of the corresponding asset and notes that both are measured at fair value using Level 2 inputs. However, the LLM slightly mischaracterizes the valuation method by stating it uses 'quoted prices on the principal exchange,' whereas the ground truth specifies the asset is categorized under 'Significant Other Observable Inputs (Level 2)'—which implies the inputs are not direct quoted prices (Level 1) but derived from observable market data (Level 2). This is a minor but notable distinction in fair value hierarchy terminology. (4) Despite this nuance, the core multi-hop synthesis—linking the liability increase to the valuation method of the asset as of December 31, 2023—is present and logically explained. The answer is contextually complete and highly relevant. The correctness score is 9 due to the minor inaccuracy in describing the Level 2 valuation method, but all key facts and calculations are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 422,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How many shares were available for future grants under UnitedHealth Group's 2020 Stock Incentive Plan as of December 31, 2024, and what types of share-based awards are explicitly referenced in the plan documentation?",
      "original_answer": "As of December 31, 2024, UnitedHealth Group had 48 million shares available for future grants under the 2020 Stock Incentive Plan. The plan documentation explicitly references several types of share-based awards, including Non-Qualified Stock Option Awards, Restricted Stock Unit Awards, and Performance-Based Restricted Stock Unit Awards, as evidenced by the various form agreements listed in the filing.",
      "llm_answer": "As of December 31 2024, the 2020 Stock Incentive Plan had approximately 48 million shares remaining available for future grants. The plan permits a range of share‑based awards, including stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards and other forms of equity compensation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies the number of shares available for future grants as 48 million as of December 31, 2024, matching the ground truth exactly. The wording 'approximately 48 million' is acceptable given typical reporting conventions in financial disclosures. 2) All numeric values and dates are accurate: '48 million shares' and 'December 31, 2024' are correct. No calculations were required, but the reported figure matches the ground truth precisely. 3) The LLM accurately references the 2020 Stock Incentive Plan and UnitedHealth Group implicitly by context. The types of share-based awards listed are broader than those explicitly named in the ground truth. The ground truth specifies Non-Qualified Stock Option Awards, Restricted Stock Unit Awards, and Performance-Based Restricted Stock Unit Awards as explicitly referenced in form agreements. The LLM response lists a more general set (stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, etc.), which are permitted under the plan but includes categories not explicitly highlighted in the form agreements cited in the original answer. While these award types are consistent with the plan, the LLM generalizes rather than specifying the exact forms documented, leading to a minor loss in qualitative precision. 4) The answer is highly relevant, fully addressing both parts of the question: the number of shares available and the types of awards. The reasoning is sound and the information is factually aligned with the ground truth, though slightly less specific in the award types. Semantic equivalence is largely preserved, with only a slight abstraction in the description of award types preventing a perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 470,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How much remaining contracted revenue for Paxlovid is expected to be recognized from deliveries between 2025 and 2028, and how does this compare to the revenue recognized in 2024 from a one-time sales true-up settlement agreement with a commercialization partner?",
      "original_answer": "Pfizer has approximately $1 billion in remaining contracted revenue for Paxlovid expected to be recognized from deliveries between 2025 and 2028. This is significantly higher than the $129 million recognized in 2024 from a one-time sales true-up settlement agreement with a commercialization partner.",
      "llm_answer": "The document indicates that remaining contracted revenue for Paxlovid expected to be recognized from deliveries between 2025 and 2028 is approximately $1 billion. This is contrasted with the $129 million one‑time sales true‑up settlement revenue recognized in 2024, which includes a $771 million favorable adjustment related to Paxlovid returns.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1 billion in remaining contracted revenue for Paxlovid expected to be recognized between 2025 and 2028, and accurately reports the $129 million one-time sales true-up settlement revenue recognized in 2024, matching the ground truth. These figures are quantitatively accurate with acceptable formatting (e.g., $1 billion, $129 million). (2) However, the LLM introduces additional information not present in the original answer — specifically, that the $129 million includes a '$771 million favorable adjustment related to Paxlovid returns' — which contradicts the ground truth and is factually unsupported in the provided context. This addition misrepresents the nature of the 2024 revenue and introduces a significant qualitative error. (3) The multi-hop reasoning is otherwise sound: the model correctly synthesizes two distinct financial figures across time periods and contexts (future contracted revenue vs. a one-time 2024 settlement). The comparison in magnitude (implied by 'contrasted with') aligns with the original answer’s 'significantly higher' assessment. (4) The correctness score is reduced to 8 due to the erroneous detail about the $771 million adjustment, which undermines full factual accuracy despite correct core numbers. Quantitative accuracy is high (9) because the key dollar amounts and years are correct, but penalized slightly for the fabricated calculation. Qualitative accuracy is 8 due to correct entity and time period identification but flawed reasoning around the settlement. Contextual relevance is 10 — the answer directly addresses the question and remains focused.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 451,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How much of AIG's ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO were covered by the parental guarantee from Berkshire Hathaway Inc. as of December 31, 2023?",
      "original_answer": "As of December 31, 2023, AIG had $12.4 billion in ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO, which was secured by a parental guarantee from Berkshire Hathaway Inc.",
      "llm_answer": "As of December 31, 2023, the parental guarantee from Berkshire Hathaway Inc. covered the entire ceded loss reserves under the 2017 adverse‑development reinsurance agreement with NICO. The ceded loss reserves subject to that agreement totaled $12.4 billion, and the guarantee was provided to secure NICO’s payment obligations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that the parental guarantee from Berkshire Hathaway Inc. covered the entire $12.4 billion in ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO as of December 31, 2023. (2) The quantitative value '$12.4 billion' matches the ground truth exactly, with acceptable formatting variation ('$12.4  billion' vs $12.4 billion). No calculations are required, and the date 'December 31, 2023' is correctly cited. (3) The multi-hop reasoning is sound: the answer correctly links AIG's ceded loss reserves, the 2017 reinsurance agreement with NICO, and the securing of those reserves via Berkshire Hathaway's parental guarantee. All entities—AIG, NICO, Berkshire Hathaway Inc., and the 2017 adverse development reinsurance agreement—are accurately identified and properly related. (4) The answer is contextually precise, directly addressing the scope and amount of coverage under the guarantee without introducing irrelevant information. Minor wording differences (e.g., 'secured by a parental guarantee' vs 'covered by the parental guarantee') do not affect factual equivalence. All scoring dimensions are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 350,
        "total_tokens": 1496
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What was the total amount of credit receivables purchased by PayPal for its merchant finance offerings in the years ended December 31, 2021 and 2020, and how does this relate to the outstanding balance of merchant loans, advances, and interest and fees receivable as of December 31, 2021?",
      "original_answer": "PayPal purchased approximately $1.8 billion in credit receivables for both the years ended December 31, 2021 and 2020. As of December 31, 2021, the total outstanding balance of merchant loans, advances, and interest and fees receivable was $1.4 billion, net of the participation interest sold to WebBank of $63 million. This indicates that PayPal maintains a significant portion of the credit risk on the receivables it purchases, as only a small fraction is sold to third parties.",
      "llm_answer": "The total amount of credit receivables purchased by PayPal for its merchant finance offerings was approximately $1.8 billion in both 2021 and 2020. This purchase volume contributed to an outstanding balance of merchant loans, advances, and interest and fees receivable of about $1.4 billion as of December 31, 2021, which reflects the cumulative credit extended under those offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that PayPal purchased approximately $1.8 billion in credit receivables in both 2021 and 2020, and accurately reports the $1.4 billion outstanding balance as of December 31, 2021. All numeric values match the ground truth exactly, with acceptable formatting (e.g., $1.8 billion). (2) Quantitative accuracy is perfect—no calculation errors, and all dollar amounts and years are correct. (3) The multi-hop reasoning is mostly sound: it connects the volume of receivables purchased over two years to the outstanding balance. However, it omits a key qualitative point from the original answer: the $63 million participation interest sold to WebBank and the implication that PayPal retains most of the credit risk. This missing detail weakens the completeness of the synthesis and the depth of the analysis. (4) Despite this omission, the answer is factually correct, contextually relevant, and conveys the core relationship between purchases and outstanding balances. The correctness score is 8 because the core facts are accurate, but a significant contextual and risk-related insight is missing, which is important for a full understanding of PayPal's risk exposure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 341,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What was the total amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in November 2023, and how much of this debt was repaid by July 2024?",
      "original_answer": "The Japanese subsidiary of Costco issued $500 million in Guaranteed Senior Notes in November 2023, and by July 2024, $77 million of this debt had been repaid.",
      "llm_answer": "The Japanese subsidiary issued approximately $500 million of Guaranteed Senior Notes in November 2023, and by July 2024 it had repaid $77 million of that debt.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Costco's Japanese subsidiary issued $500 million in Guaranteed Senior Notes in November 2023 and repaid $77 million by July 2024, matching the ground truth exactly in both amount and timing. (2) All numeric values are accurate: '$500 million' and '$77 million' are correctly reported with acceptable formatting (using 'approximately' is reasonable and does not affect factual accuracy). Dates (November 2023 and July 2024) are precise and match the original. (3) The multi-hop reasoning is sound—correctly linking Costco to its Japanese subsidiary, identifying the debt issuance event, and tracking partial repayment over time across two time points. (4) The answer is semantically equivalent to the ground truth, uses clear and precise language, and fully addresses both parts of the question. All evaluation dimensions are satisfied at the highest level, warranting perfect scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1082,
        "completion_tokens": 274,
        "total_tokens": 1357
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "By how much did the decrease in the value of available-for-sale debt investments from 2021 to 2022 exceed the net gains realized from these investments during the same period?",
      "original_answer": "The decrease in the value of available-for-sale debt investments from 2021 to 2022 was $3,259 million, while the net gains from these investments decreased by $44 million. Therefore, the decrease in investment value exceeded the change in net gains by $3,215 million.",
      "llm_answer": "The decrease in the value of available‑for‑sale debt investments from 2021 to 2022 was $3,259 million, while the net gains realized from those investments during the same period were only $457 million. Therefore, the decline exceeded the net gains by $2,802 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the decrease in value of available-for-sale debt investments as $3,259 million, matching the ground truth. However, it incorrectly states that the net gains realized were $457 million, whereas the ground truth indicates that net gains *decreased* by $44 million (i.e., a change of -$44 million). This is a critical factual error. (2) The calculation in the LLM answer subtracts $457 million from $3,259 million to get $2,802 million, which would be correct only if $457 million were the net gains realized. But according to the ground truth, the correct comparison is between a $3,259 million decrease in value and a $44 million reduction in net gains, leading to a difference of $3,215 million. The LLM performs the arithmetic correctly but on incorrect input data. (3) The multi-hop reasoning fails because the model misinterprets the nature of the second quantity: it treats 'net gains realized' as a positive inflow rather than recognizing that the question hinges on the *change* in net gains, which was itself negative or near-zero. The synthesis across the two financial metrics is therefore flawed. (4) Scores reflect major quantitative and qualitative inaccuracies due to incorrect data usage and flawed reasoning, though the structure and relevance of the response are appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 372,
        "total_tokens": 1513
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What is the total amount of unused short-term credit capacity available to Amazon as of December 31, 2021, combining both its unsecured revolving credit facility and unused letters of credit?",
      "original_answer": "The total amount of unused short-term credit capacity available to Amazon as of December 31, 2021, is $14.2 billion. This includes the full $7.0 billion unsecured revolving credit facility, as there were no borrowings outstanding under the Credit Agreement, and $7.2 billion of unused letters of credit.",
      "llm_answer": "As of December 31 2021, Amazon had $7.0 billion of unused capacity under its unsecured revolving credit facility and $7.2 billion of unused letters of credit, giving a combined unused short‑term credit capacity of $14.2 billion.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: the $7.0 billion unsecured revolving credit facility and $7.2 billion in unused letters of credit are correctly reported, and their sum, $14.2 billion, is accurate. (2) Quantitative accuracy is perfect: both individual amounts and the total are correct, with no calculation errors. Format variations (e.g., $7.0 billion vs $7.0 billion) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound—combining two sources of short-term credit capacity (revolving credit and letters of credit) is correctly executed, demonstrating proper synthesis across financial instruments. (4) The answer is contextually relevant, directly addressing the question about total unused short-term credit capacity as of December 31, 2021, for Amazon. No irrelevant or extraneous information is included. The wording differs slightly from the original answer but conveys the same meaning with equivalent precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 295,
        "total_tokens": 1439
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What was the total cash outflow for acquisitions made by TMO in 2023, including its acquisition of The Binding Site Group, and how much of this total was specifically allocated to The Binding Site Group?",
      "original_answer": "The total cash outflow for acquisitions made by TMO in 2023 was $3.61 billion, with $2.70 billion specifically allocated to the acquisition of The Binding Site Group.",
      "llm_answer": "The total cash outflow for acquisitions made by Thermo Fisher Scientific (TMO) in 2023 was **$3.61 billion**, which includes the $2.70 billion cash used to acquire **The Binding Site Group** and $0.91 billion for CorEvitas, LLC. Of that total, **$2.70 billion** was specifically allocated to the acquisition of The Binding Site Group.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total cash outflow of $3.61 billion and the $2.70 billion allocated to The Binding Site Group are accurately reported, with the remaining $0.91 billion correctly accounting for the CorEvitas, LLC acquisition (3.61 - 2.70 = 0.91). These figures match the ground truth exactly. (2) The answer is complete, addressing both parts of the question: total cash outflow and the portion specifically for The Binding Site Group. (3) Entity accuracy is correct: TMO is properly identified as Thermo Fisher Scientific, the acquisition target 'The Binding Site Group' is correctly named, and the year 2023 is accurate. (4) The reasoning is sound and demonstrates proper multi-hop synthesis by combining data from multiple acquisitions and correctly allocating amounts. The inclusion of CorEvitas adds contextual clarity without diverting from the question. (5) Semantic equivalence is maintained — the LLM conveys the same information as the original answer, with slightly more detail but no factual deviation. All scores are maximized accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 321,
        "total_tokens": 1460
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What percentage of Union Pacific's chassis units are leased rather than owned, and how does this compare to the much smaller leased proportion of containers in their highway revenue equipment fleet?",
      "original_answer": "Union Pacific owns 30,635 chassis units and leases 17,705, meaning 36.6% (17,705 / 48,340) of chassis are leased. In contrast, only 1.1% (545 / 47,984) of containers are leased. This shows a significantly higher reliance on leasing for chassis compared to containers.",
      "llm_answer": "Based on the equipment data in the document, Union Pacific reports that 18,250 of its 96,324 highway revenue equipment units (containers, chassis, and other equipment) are leased, representing approximately 19% of the total fleet. This contrasts with the much smaller leased proportion of containers specifically, where only 545 of 47,984 containers (about 1.1%) are leased.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the chassis leasing data. The ground truth states Union Pacific owns 30,635 and leases 17,705 chassis units, totaling 48,340, with a leased percentage of 36.6%. However, the LLM incorrectly reports 18,250 leased out of 96,324 highway revenue equipment units, which includes chassis, containers, and other equipment—this total fleet number is not relevant to the specific chassis question. The 19% leased figure is therefore incorrect for chassis specifically. The container leasing data is correct: 545 of 47,984 containers (1.1%) are leased. (2) Calculations: The LLM’s 1.1% for containers is accurate, but the chassis percentage is wrong due to incorrect numerator and denominator. The correct leased chassis percentage is 17,705 / (30,635 + 17,705) = 17,705 / 48,340 = 36.6%, not 19%. The LLM uses a broader fleet category that dilutes the chassis-specific metric. (3) Multi-hop reasoning: The model fails to isolate chassis data correctly and conflates it with the total highway equipment fleet. It should have extracted owned vs. leased chassis separately and computed the percentage, then compared it to leased containers. This synthesis is flawed. (4) Scores justified: Correctness is 4 due to one major error (chassis leasing %) and one correct part (container %). Quantitative accuracy is 5 because half the numbers are right, but the key chassis metric is wrong. Qualitative accuracy is 5 due to flawed reasoning in isolating the correct equipment category. Contextual relevance is 8 because the answer addresses the leasing comparison concept and correctly identifies the container leasing proportion, showing understanding of the question intent despite factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 477,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How many different supplemental indentures related to Senior Notes that include the 2035 Note were identified across the referenced exhibits, and which trustee was involved in the most recent of these agreements?",
      "original_answer": "Two supplemental indentures related to Senior Notes that include the 2035 Note were identified: the Fifth Supplemental Indenture dated September 14, 2015, and the Tenth Supplemental Indenture dated November 20, 2024. The trustee involved in the most recent of these agreements was Computershare Trust Company, National Association, as successor to Wells Fargo Bank.",
      "llm_answer": "Based on the exhibits listed on page 99, there are **12** supplemental indentures related to the Senior Notes that include the 2035 Note. The most recent of these agreements is the **tenth supplemental indenture**, dated **November 20, 2024**, which was entered into with **Computershare Trust Company, National Association** (the successor to Wells Fargo Bank, National Association).",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that there are 12 supplemental indentures related to Senior Notes that include the 2035 Note, while the ground truth identifies only two: the Fifth Supplemental Indenture (September 14, 2015) and the Tenth Supplemental Indenture (November 20, 2024). This is a major factual error in quantity. However, the LLM correctly identifies the most recent agreement as the Tenth Supplemental Indenture dated November 20, 2024, and correctly names the trustee as Computershare Trust Company, National Association, as successor to Wells Fargo Bank, which matches the ground truth. (2) The date (November 20, 2024) and trustee name are accurate, but the number '12' is factually wrong—only two such indentures were identified in the source data. There is no indication in the ground truth of 12 agreements, so this appears to be a misinterpretation or hallucination. (3) The multi-hop reasoning partially succeeds: the model correctly links the 2035 Note to the Tenth Supplemental Indenture and identifies the correct trustee in the most recent agreement. However, it fails at the first step by overcounting the total number of relevant supplemental indentures, suggesting a failure to filter only those related to the 2035 Note. (4) The correctness score is 4 due to significant quantitative inaccuracy, though key qualitative elements (date and trustee of the most recent) are correct. Quantitative accuracy is low (4) due to the incorrect count. Qualitative accuracy is moderate (5) because core entities in the final agreement are correct. Contextual relevance is high (8) as the answer addresses the right documents and context, just with incorrect enumeration.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 464,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the expensing methodology for non-employee director deferred stock units granted in 2023 differ from those granted prior to 2022, and what is the vesting timeline for the 2023 awards?",
      "original_answer": "Deferred stock units granted to non-employee directors in 2023 are expensed on a straight-line basis over the requisite service period, whereas awards granted prior to 2022 were expensed in full on the grant date because they vested immediately. The 2023 awards vest on the earlier of the first anniversary of the grant date or the day immediately preceding the next Annual Meeting of Shareholders, subject to acceleration in certain circumstances.",
      "llm_answer": "The expensing methodology for non-employee director deferred stock units granted in 2023 differs from prior years in that awards granted before 2022 were expensed immediately on the grant date, while 2023 awards are expensed on a straight-line basis over the requisite service period. The 2023 deferred stock units for non-employee directors vest on the earlier of the first anniversary of the grant date or the day immediately preceding the next Annual Meeting of Shareholders, subject to acceleration in certain circumstances.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) It correctly states that deferred stock units granted in 2023 are expensed on a straight-line basis over the service period, while those granted prior to 2022 were expensed in full on the grant date due to immediate vesting. (2) The vesting timeline for 2023 awards is accurately described as the earlier of the first anniversary of the grant date or the day before the next Annual Meeting of Shareholders, with mention of acceleration in certain circumstances. (3) The multi-hop reasoning is sound—comparing expensing methodologies across different years and synthesizing vesting conditions specific to 2023 awards. (4) All entities (non-employee director deferred stock units, 2023 vs. pre-2022 grants) are correctly identified, and the semantic meaning matches the original answer exactly, despite rephrased wording. No errors in facts, dates, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 271,
        "total_tokens": 1527
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What was the total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023, and what percentage of the total identifiable assets in that same region and business unit did this profit represent?",
      "original_answer": "The total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023 was $254 million. The identifiable assets in that same region and business unit were $698 million. Therefore, the operating profit represented approximately 36.4% of the identifiable assets.",
      "llm_answer": "The total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023 was $254 million, representing 6.5% of the region’s total identifiable assets of $3,924 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the operating profit of $254 million for the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023, which matches the ground truth. However, it incorrectly stated the total identifiable assets as $3,924 million (which appears to be the total for the entire region across all business units), whereas the correct identifiable assets for the specific business unit (Oral, Personal and Home Care) in that region were $698 million. Consequently, the calculated percentage of 6.5% is incorrect. The correct percentage is approximately 36.4% ($254M / $698M). (2) The operating profit figure is accurate, but the asset base and resulting percentage are factually wrong. The calculation itself (6.5%) may be approximately correct given the numbers used, but it is based on incorrect inputs. (3) The multi-hop reasoning failed because the model did not correctly associate the identifiable assets with the specific business unit (Oral, Personal and Home Care), instead using total regional assets, which breaks the required granularity. This indicates a failure in synthesizing the correct entity-metric-time alignment. (4) The correctness and quantitative accuracy scores are low due to the critical error in asset value and derived percentage. Qualitative accuracy is low due to flawed reasoning in entity-metric linkage. Contextual relevance is high because the answer addresses the right region, business, year, and metric types, just with incorrect data for one key component.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 423,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "What was the total amount of AMD's purchases from and resales to the ATMP JV in fiscal year 2024, and how does this compare to the amount of the loan AMD provided to the ATMP JV during the same year?",
      "original_answer": "In fiscal year 2024, AMD's purchases from the ATMP JV amounted to $1.7 billion, and its resales to the ATMP JV totaled $121 million, resulting in a combined total of $1.821 billion. This is significantly higher than the $100 million loan AMD provided to one of the ATMP JVs in October 2024.",
      "llm_answer": "The total amount of AMD's purchases from and resales to the ATMP JV in fiscal year 2024 was $1.7 billion in purchases and $121 million in resales. During the same year AMD provided a $100 million loan to the ATMP JV, which was recorded as a receivable on its balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly reports all key numerical values: $1.7 billion in purchases from the ATMP JV and $121 million in resales, matching the ground truth exactly. The $100 million loan amount is also accurately stated. These figures are critical and correctly presented with acceptable formatting (e.g., $1.7 billion = $1.7 billion). The combined total of $1.821 billion is implied through separate reporting of the two components, though not explicitly summed—this is a minor omission but does not detract from factual accuracy. The answer addresses all parts of the question: it covers both purchases and resales, mentions the loan amount, and specifies the fiscal year 2024. The entity 'ATMP JV' is correctly identified, and the timing (October 2024 for the loan) is consistent with the knowledge graph. The reasoning is sound and reflects proper multi-hop synthesis across different financial activities (procurement, resale, financing). The mention that the loan was recorded as a receivable adds contextual detail not in the original answer but does not contradict it. Semantic equivalence is maintained—core facts, numbers, and comparisons are accurate and complete. The only reason for not scoring a perfect 10 is the lack of explicit summation of the total ($1.7B + $121M = $1.821B), which was part of the original answer’s comparative point. However, since both components are clearly stated, the reader can easily infer the total. Thus, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 416,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the total increase in revenue for the Analytical and physical instrumentation product line from 2019 to 2021, and how does this growth compare to the increase in the Research and medical products segment over the same period?",
      "original_answer": "The revenue for the Analytical and physical instrumentation product line increased by $156 million from 2019 to 2021 ($2,620 million in 2021 vs. $2,464 million in 2019). The Research and medical products segment increased by $11,290 million over the same period ($24,802 million in 2021 vs. $13,512 million in 2019). The increase in Analytical and physical instrumentation revenue was relatively modest compared to the significant growth in Research and medical products.",
      "llm_answer": "The total increase in revenue for the Analytical and physical instrumentation product line from 2019 to 2021 was $156 million (from $2,464 million in 2019 to $2,620 million in 2021). This growth was significantly smaller than the increase in the Research and medical products segment over the same period, which rose by $11,290 million (from $13,512 million in 2019 to $24,802 million in 2021).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: the revenue increase for Analytical and physical instrumentation is correctly stated as $156 million, calculated from $2,464 million in 2019 to $2,620 million in 2021. The increase for the Research and medical products segment is accurately reported as $11,290 million, rising from $13,512 million to $24,802 million over the same period. (2) Quantitative accuracy is perfect: both absolute values and the differences are correct, with no calculation errors. Format variations (e.g., using 'million' instead of 'M') are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound—information from two different product lines across multiple years is correctly synthesized and compared. The conclusion that the Analytical and physical instrumentation growth was significantly smaller is logically supported by the data. (4) The answer is semantically equivalent to the original, with clear, concise wording that preserves all key details and the comparative context. All sub-questions in the original query are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 331,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does Microsoft's SQL Server product line contribute to its Intelligent Cloud segment's financial performance, given the segment's reported structure and revenue drivers?",
      "original_answer": "Microsoft's SQL Server is a core component of the Intelligent Cloud segment, which includes server products and cloud services. SQL Server contributes to the segment's revenue through volume licensing programs, OEM licenses, and retail packaged products. As part of the server products category, SQL Server also drives revenue through Client Access Licenses (CALs), which provide access rights to the server product and are reported alongside the associated server product revenue. This aligns with the Intelligent Cloud segment's primary revenue drivers, which include server product licensing and cloud services like Azure.",
      "llm_answer": "Microsoft's SQL Server product line is a key component of the Intelligent Cloud segment, which reported $67,321 million in revenue from server products and cloud services in fiscal 2022. This revenue stream—encompassing SQL Server, Azure, Windows Server, and related CALs—drives the segment’s growth, complemented by Enterprise Services such as consulting and professional support. The segment’s financial performance is further reinforced by the broader Microsoft Cloud revenue of $91.2 billion, underscoring SQL Server’s role in expanding the company’s intelligent cloud offerings.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several factual inaccuracies and introduces unsupported quantitative data not present in the ground truth. Specifically, it claims the Intelligent Cloud segment reported $67,321 million in revenue from server products and cloud services in fiscal 2022, and that Microsoft Cloud revenue was $91.2 billion—neither figure appears in the original answer and cannot be verified from the provided context. These numbers may be misattributed or outdated, and their inclusion undermines quantitative accuracy. (2) The original answer does not provide any revenue figures, focusing instead on SQL Server's role in revenue generation through licensing models (volume, OEM, retail), CALs, and its alignment with broader segment drivers like Azure. The LLM invents precise financials without basis, failing the quantitative accuracy check. (3) Qualitatively, the LLM correctly identifies SQL Server as a key component of the Intelligent Cloud segment and associates it with server products and cloud services, which aligns with the ground truth. It also correctly links SQL Server to broader enterprise offerings and implies its integration with Azure and licensing models. However, it misses specific mechanisms like CALs being reported alongside server product revenue and does not clearly explain how SQL Server itself generates revenue through the stated channels. (4) Contextual relevance is high because the response stays focused on the question and attempts to situate SQL Server within the Intelligent Cloud segment’s financial drivers, even if it adds unsupported numbers. Overall, the answer captures some correct concepts but fails on factual precision, especially in financial data, leading to a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 479,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What is the total change in value of Insurance Buy-in Contracts from December 31, 2022, to December 31, 2024, and how does this reflect in both the 2023 and 2024 year-end balances?",
      "original_answer": "The value of Insurance Buy-in Contracts increased from $950 million at December 31, 2022, to $1,605 million at December 31, 2023, and then decreased to $1,390 million at December 31, 2024. This results in a net increase of $440 million over the two-year period ($1,390 million - $950 million = $440 million).",
      "llm_answer": "The total change in the fair value of Insurance Buy-in Contracts from December 31 2022 ($950 million) to December 31 2024 ($1,390 million) is an increase of $440 million. This change is reflected in the year‑end balances as $950 million in 2022, $1,605 million in 2023, and $1,390 million in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: $950 million (2022), $1,605 million (2023), and $1,390 million (2024). The total change of $440 million is correctly calculated as $1,390M - $950M = $440M. (2) The answer addresses both parts of the question: it provides the total change over the two-year period and reflects the year-end balances for 2023 and 2024, including the intermediate 2023 value. (3) Entities (Insurance Buy-in Contracts, correct dates, and financial metric 'fair value') are accurately identified and used. (4) The multi-hop reasoning is sound—information from three time points is correctly synthesized to compute the net change and describe the trajectory (increase then decrease). The wording differs slightly from the original answer but maintains full semantic equivalence. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 265,
        "total_tokens": 1425
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "What was the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, and how much in dividends was paid on those shares during 2024?",
      "original_answer": "$886 million was the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, and $26 million in dividends was paid on those shares during 2024.",
      "llm_answer": "As of December 31 2024, the total value of TI common stock held in both U.S. and non‑U.S. defined‑contribution plans was $34 million, and dividends paid on those shares during 2024 were not material.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both key numerical values. The ground truth states that the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, was $886 million, but the LLM reports $34 million—a significant discrepancy. Additionally, the ground truth confirms $26 million in dividends paid during 2024, whereas the LLM claims dividends were 'not material,' which contradicts the specific and material $26 million figure. (2) Quantitative accuracy is extremely low: both dollar amounts are wrong, and no correct calculation or reference to actual data is present. The LLM’s $34 million is less than 4% of the correct value ($886M), and stating dividends were 'not material' directly conflicts with the $26M payment, which is substantial. (3) Qualitatively, the reasoning fails multi-hop synthesis—either misreading or misrepresenting the source data. The entities (TI common stock, defined contribution plans, dividends, correct year) are contextually appropriate, but the values assigned to them are not supported. (4) Contextual relevance is high because the LLM addresses the correct entities and structure of the question—same company, same stock, same plan types, same time frame—but the factual foundation is entirely flawed. Due to the severity of the numerical errors, the correctness score is near the lowest possible.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1111,
        "completion_tokens": 392,
        "total_tokens": 1503
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What was the principal amount of UPS's 5.300% Senior Notes due 2050 disclosed in their 2022 10-K, and how does this amount compare to the combined principal of their 3.900%, 4.450%, and 5.200% Senior Notes from the same filing?",
      "original_answer": "The principal amount of UPS's 5.300% Senior Notes due 2050 was $1,250 million. The combined principal of their 3.900% ($1,000 million), 4.450% ($750 million), and 5.200% ($500 million) Senior Notes totals $2,250 million. Therefore, the 5.300% Senior Notes due 2050 represent approximately 55.6% of the combined principal of the other three notes.",
      "llm_answer": "The 2022 10‑K discloses that UPS issued $1,250 million of 5.300% Senior Notes due 2050. This amount is larger than the combined principal of the 3.900% ($1,000 million), 4.450% ($750 million) and 5.200% ($500 million) Senior Notes, which together total $2,250 million. Thus, the 5.300% 2050 notes exceed the other three issuances by $1,000 million.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the principal amount of the 5.300% Senior Notes due 2050 as $1,250 million and accurately reports the individual principals of the other three notes: 3.900% ($1,000 million), 4.450% ($750 million), and 5.200% ($500 million). The combined total of these three notes is correctly calculated as $2,250 million in the ground truth. However, the LLM makes a critical error in the comparison: it states that the $1,250 million 5.300% note is 'larger' than the $2,250 million combined total, which is factually incorrect. It further claims the 5.300% note 'exceeds the other three issuances by $1,000 million', which is false—the difference is -$1,000 million (i.e., it is $1,000 million less). (2) While all individual numbers are correct, the comparative calculation and conclusion are wrong. The correct relationship is that $1,250 million is approximately 55.6% of $2,250 million, not greater than it. (3) The multi-hop reasoning fails at the synthesis stage: although the model retrieves the correct data points, it incorrectly compares them, showing flawed logic in drawing conclusions. (4) The contextual relevance is high because the answer addresses the right documents, notes, and amounts. However, due to the major error in quantitative comparison and reasoning, the correctness score is significantly reduced. Quantitative accuracy is moderate (6) because raw numbers are correct but derived comparisons are not. Qualitative accuracy is low (5) due to flawed logic and incorrect synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 423,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What is the total weighted-average grant-date fair value of all Service-Based RSUs that were both outstanding at the beginning of the year and still outstanding at the end of 2024, after accounting for grants, vesting, and forfeitures?",
      "original_answer": "The total weighted-average grant-date fair value of Service-Based RSUs that remained outstanding throughout 2024 is $183.41 million.",
      "llm_answer": "The total weighted‑average grant‑date fair value of all Service‑Based RSUs that were outstanding at the beginning of 2024 and remained outstanding at year‑end 2024 is $183.41 per share. This figure reflects the grant‑date fair value after accounting for the 2024 grants, vestings, forfeitures and other adjustments disclosed in the stock‑based compensation tables.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the unit as '$183.41 per share' instead of '$183.41 million' total, which is a critical error in quantitative interpretation. The ground truth specifies a total dollar amount, not per-share value. This misrepresents the magnitude and nature of the metric. (2) The number '183.41' is correct numerically but is presented with an incorrect unit, leading to a significant factual inaccuracy. There is no indication in the LLM answer that this is a total value across all shares; stating it 'per share' fundamentally changes the meaning. (3) The reasoning appears sound in terms of tracking RSUs from beginning to end of year, accounting for grants, vesting, and forfeitures, and the mention of 'stock-based compensation tables' suggests appropriate sourcing. However, the failure to correctly interpret the total weighted-average grant-date fair value as an aggregate rather than per-share value indicates a flaw in multi-hop synthesis or data extraction. (4) While the context and entities (Service-Based RSUs, 2024, grant-date fair value) are correctly identified and relevant, the quantitative inaccuracy severely impacts correctness. The answer is semantically close but factually flawed due to unit confusion. Thus, correctness is partially compromised despite strong contextual and qualitative alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 377,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does UPS's estimation process for uncertain tax positions, as described in both the notes to the financial statements and the management discussion section, influence the potential recognition of tax benefits or additional charges to the tax provision, and what specific criteria determine the measurement of these benefits?",
      "original_answer": "UPS evaluates uncertain tax positions using a two-step process that directly affects the recognition of tax benefits or additional charges to the tax provision. First, it determines whether a tax position is more likely than not to be sustained on audit, based on available evidence. Second, it measures the largest amount of tax benefit that is more likely than not to be realized upon settlement. The difference between this recognizable benefit and the total benefit claimed or to be claimed is recorded as a liability. This process, detailed in both the financial statement notes and the management discussion, leads to quarterly reevaluations based on changes in facts, tax law, audit outcomes, or new activity, which can result in either recognizing a tax benefit or recording an additional charge to the tax provision.",
      "llm_answer": "UPS evaluates uncertain tax positions through a two-step process: first, it determines whether a tax position is more likely than not to be sustained upon audit; second, it measures the largest tax benefit that meets this recognition threshold. This assessment, detailed in Note 16 of the financial statements and discussed in Management’s Discussion, requires judgment about the likelihood of sustaining tax positions and estimating the amount of benefit to recognize. The measurement of these benefits depends on factors such as changes in facts or circumstances, tax law developments, audit outcomes, and the company’s intent and ability to hold positions, which can lead to either recognition of tax benefits or additional charges to the tax provision.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the two-step process (more likely than not recognition and measurement of the largest benefit that meets the threshold) is accurately described. The influence on tax provision—through recognition of benefits or additional charges—is properly linked to quarterly reevaluations based on changes in facts, law, audit outcomes, etc. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable beyond the absence of errors—scored as 10. (3) The multi-hop reasoning is sound: the answer synthesizes information from both the financial statement notes (specifically citing Note 16) and Management’s Discussion, fulfilling the requirement to draw from multiple sections. The criteria for measurement—likelihood of realization, changes in facts, tax law, audit outcomes, and company intent—are consistent with the original. One minor omission: the ground truth explicitly mentions that the difference between the recognizable benefit and the total claimed is recorded as a liability, which the LLM answer omits. This is a small but relevant detail in the accounting treatment. (4) Despite this omission, the answer is contextually complete, semantically equivalent, and correctly addresses all key aspects of the question. Hence, a correctness score of 9 is warranted—very close to perfect, with only a minor gap in completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 409,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What was the total capital expenditure in Africa/Eurasia in 2021, and by what percentage did organic sales in this region increase during the same year?",
      "original_answer": "The total capital expenditure in Africa/Eurasia in 2021 was $33 million, and organic sales in this region increased by 7.0% during the same year.",
      "llm_answer": "The total capital expenditure in Africa/Eurasia in 2021 was $33 million, and organic sales in the region increased by 7 % during the same year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies both the total capital expenditure ($33 million) and the organic sales increase (7.0%) for Africa/Eurasia in 2021, matching the ground truth exactly in factual content. (2) Numeric values are accurate: $33 million is correctly reported (with acceptable formatting using a thin space), and the 7% increase matches the 7.0% in the original answer—percentage formatting variation (7% vs 7.0%) does not affect accuracy. (3) The question requires a multi-hop synthesis of two distinct financial metrics from the same region and year; the LLM successfully retrieves and combines both pieces of information correctly. (4) All entities (region: Africa/Eurasia, year: 2021, metrics: capital expenditure and organic sales growth) are accurately identified and reported. The answer is semantically equivalent to the ground truth, with only minor formatting differences in spacing, which do not impact meaning or correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1073,
        "completion_tokens": 280,
        "total_tokens": 1354
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What was the increase in Johnson & Johnson's Contact Lenses/Other sales from 2020 to 2021, and how did this growth contribute to the overall increase in Vision segment sales during the same period?",
      "original_answer": "Johnson & Johnson's Contact Lenses/Other sales increased by $446 million (from $2,994 million in 2020 to $3,440 million in 2021). Vision segment sales grew by $769 million (from $3,919 million in 2020 to $4,688 million in 2021). Therefore, the increase in Contact Lenses/Other sales accounted for approximately 58% of the total growth in Vision segment sales from 2020 to 2021.",
      "llm_answer": "The increase in Johnson & Johnson's Contact Lenses/Other sales from 2020 to 2021 was 14.9%, and this growth contributed to the overall Vision segment sales increase of 19.6% during the same period.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially relevant but contains significant factual inaccuracies. It reports percentage growth rates (14.9% for Contact Lenses/Other and 19.6% for Vision segment) that are not present in the ground truth and does not report the required dollar increases. The actual dollar increase in Contact Lenses/Other sales was $446 million (from $2,994M to $3,440M), and Vision segment sales increased by $769 million (from $3,919M to $4,688M). The LLM fails to mention these key figures, which are central to the question. (2) The percentages mentioned (14.9% and 19.6%) are approximately correct in a computational sense (e.g., 446/2994 ≈ 14.9%, 769/3919 ≈ 19.6%), but the question asks for the dollar increase and the contribution of Contact Lenses/Other to total Vision growth, not percentage growth rates. The LLM also fails to calculate or mention that the $446M increase accounted for ~58% of the $769M total Vision segment growth, which is a critical part of the answer. (3) The multi-hop reasoning is incomplete: while the model identifies the correct entities (Johnson & Johnson, Contact Lenses/Other, Vision segment, 2020–2021), it does not synthesize the data to compute the dollar increase or its proportional contribution. (4) Due to missing key numerical data (dollar increases, contribution percentage) and failure to address the full scope of the question, the correctness and accuracy scores are low. Contextual relevance is moderate because the answer discusses related metrics and time periods but misses the core requirements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 431,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What was the impact of AspenTech's consolidation into Emerson's financial statements on the Control Systems & Software segment's earnings and margin performance in 2023 compared to 2022?",
      "original_answer": "The consolidation of AspenTech into Emerson's financial statements significantly reduced the Control Systems & Software segment's earnings and margin performance in 2023 compared to 2022. In 2022, AspenTech contributed $12 million in earnings, but in 2023, it reported a loss of $107 million. This $119 million deterioration directly impacted the overall segment earnings, which remained flat at $529 million in 2023 despite revenue growth, compared to $437 million in 2022. Additionally, the segment margin declined from 14.7% in 2022 to 11.6% in 2023, a 3.1 percentage point decrease, largely driven by AspenTech's poor performance.",
      "llm_answer": "The AspenTech consolidation added $386 million of sales to the Control Systems & Software segment in 2023, but the segment’s earnings fell 6 % to $422 million and margin dropped 3.1 percentage points to 11.6 %—largely because $249 million of incremental intangibles amortization from the Heritage AspenTech acquisition weighed on profitability. Adjusted EBITA margin, however, rose 2.3 points to 25.8 % as higher sales and pricing leverage offset the amortization impact.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies a 3.1 percentage point margin decline to 11.6% in 2023, it incorrectly states segment earnings fell to $422 million, whereas the ground truth reports earnings were $529 million in 2023 (up from $437 million in 2022). The LLM claims a 6% earnings decline, which contradicts the flat-to-upward trend in actual earnings. Most critically, the LLM attributes the earnings pressure to $249 million in intangibles amortization from AspenTech, but the ground truth states AspenTech itself shifted from a $12 million profit in 2022 to a $107 million loss in 2023—a $119 million deterioration—which is the actual driver. The LLM invents a figure ($249M amortization) not present in the original answer and misrepresents the source of the impact. (2) Quantitative accuracy is low: revenue impact of $386M is not mentioned in the ground truth; earnings numbers are wrong ($422M vs $529M); the $249M amortization is fabricated; only the 11.6% margin and 3.1 pp decline are correct. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize the AspenTech earnings swing ($12M profit to -$107M loss) and its direct $119M negative impact on segment earnings. Instead, it introduces an unrelated amortization explanation, indicating a failure in logical and factual synthesis. (4) Contextual relevance is moderate—the answer addresses the AspenTech consolidation and its impact on earnings and margins, and correctly notes margin contraction. However, due to major factual and quantitative errors, the conclusion is misleading. The mention of 'adjusted EBITA margin rising to 25.8%' is extraneous and not part of the original question or answer, further reducing accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 482,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How much total monetary liability did Visa record in fiscal 2022 for U.S. covered litigation, and how is this liability recovered under the U.S. Retrospective Responsibility Plan?",
      "original_answer": "Visa recorded a total monetary liability of $861 million in fiscal 2022 for U.S. covered litigation. Under the U.S. Retrospective Responsibility Plan, this liability is recovered through a downward adjustment to the conversion rate of class B common stock to class A common stock.",
      "llm_answer": "In fiscal 2022 Visa recorded a $861 million accrual for U.S. covered litigation, which is the total monetary liability for U.S. covered litigation that year. This liability is recovered under the U.S. Retrospective Responsibility Plan by adjusting the conversion rate of class B shares into class A shares, so that the monetary amounts owed in the covered litigation are offset against the equity‑based liability of the company.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total monetary liability Visa recorded in fiscal 2022 for U.S. covered litigation as $861 million, matching the ground truth exactly. The recovery mechanism under the U.S. Retrospective Responsibility Plan is accurately described as involving an adjustment to the conversion rate of class B shares to class A shares. While the original answer specifies a 'downward adjustment,' the LLM describes it as adjusting the conversion rate 'so that the monetary amounts owed... are offset against the equity-based liability,' which captures the economic effect but omits the precise directional detail (downward). This is a minor omission in wording but does not change the core factual accuracy. (2) The numeric value ($861 million) and fiscal year (2022) are correct and match the ground truth. No calculations are required, and the figure is reported accurately. (3) The multi-hop reasoning is sound: the LLM connects Visa's liability recording with the recovery mechanism through the U.S. Retrospective Responsibility Plan, correctly synthesizing information about financial liability and its offset via equity conversion mechanics. (4) The answer is factually correct, contextually complete, and semantically equivalent to the ground truth, with only slight imprecision in describing the nature of the conversion rate adjustment. Thus, a high score is warranted, with a minor deduction in qualitative accuracy for the slightly less precise description of the adjustment direction.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 420,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "What was the total financial impact on Pfizer from its historical ownership of Meridian in 2021, including both operational results and post-closing adjustments?",
      "original_answer": "The total financial impact on Pfizer from its historical ownership of Meridian in 2021 was a $512 million negative impact, which includes a $345 million pre-tax legal charge in the second quarter and an after-tax loss of $167 million related to the sale of Meridian in the fourth quarter.",
      "llm_answer": "The 2021 Form 10‑K shows that Pfizer’s historical ownership of Meridian generated a $345 million pre‑tax charge in the second quarter of 2021 to settle a legal matter related to Meridian, and a post‑closing after‑tax loss of $167 million when the business was sold on December 31, 2021. These items represent the total financial impact of Pfizer’s historical Meridian ownership for 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the $345 million pre-tax legal charge in Q2 2021 and the $167 million after-tax loss on sale in Q4 2021 (specifically on December 31, 2021) are correctly reported. These figures match the original answer exactly, and their sum ($345M + $167M = $512M total negative impact) is implied, though not explicitly stated as a total. (2) Quantitative accuracy is perfect: both dollar amounts and the date of sale (December 31, 2021) are correct. Format variations are acceptable and clear. (3) The reasoning is sound and reflects multi-hop synthesis—linking Pfizer’s historical ownership to two distinct financial events (legal charge and sale loss) in 2021. However, the LLM does not explicitly state the total $512 million negative impact, which is the direct answer to 'total financial impact' requested in the question. This omission prevents a perfect score, though the components are fully correct. (4) Contextual relevance is excellent—the response directly addresses the financial impact of Pfizer’s ownership of Meridian in 2021, citing both operational (legal charge) and post-closing (sale loss) elements as required. The qualitative score is 9 due to the missing explicit total, but all underlying reasoning and data are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 376,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "What is the minimum supplementary leverage ratio (SLR) that Bank of America Corporation must maintain under Basel 3, including the leverage buffer, and how does this requirement differ from the SLR requirement for its insured depository institution subsidiaries?",
      "original_answer": "Bank of America Corporation must maintain a minimum supplementary leverage ratio (SLR) of 3.0 percent plus a leverage buffer of 2.0 percent, totaling 5.0 percent, to avoid restrictions on capital distributions and discretionary bonus payments. In contrast, its insured depository institution subsidiaries are required to maintain a higher minimum SLR of 6.0 percent to be considered well capitalized under the PCA framework.",
      "llm_answer": "The minimum supplementary leverage ratio (SLR) that Bank of America Corporation must maintain under Basel 3, including the leverage buffer, is 3.0 % + 2.0 % = 5.0 %. This SLR applies to the Corporation itself, while its insured depository‑institution subsidiaries (e.g., Bank of America, N.A.) must maintain a higher minimum SLR of 6.0 % to be deemed well‑capitalized under the PCA framework.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages are accurate: 3.0% + 2.0% = 5.0% for Bank of America Corporation under Basel 3 with the leverage buffer, and 6.0% for its insured depository institution subsidiaries. The calculation is correctly presented and aligns with the original answer. (2) The answer is complete, addressing both parts of the question: the SLR requirement for the parent corporation and the higher requirement for its subsidiaries. (3) Entity accuracy is correct—Bank of America Corporation and its insured depository institutions (e.g., Bank of America, N.A.) are properly distinguished. (4) The reasoning is sound and reflects proper multi-hop synthesis: it differentiates regulatory frameworks (Basel 3 for the parent vs. PCA for subsidiaries) and correctly links the 6.0% threshold to the 'well-capitalized' designation under PCA. (5) Semantic equivalence is achieved—though wording differs slightly, the meaning and factual content are identical to the original answer. No errors in facts, logic, or interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 313,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, impact MetLife's accounting treatment for mortgage loans, specifically in terms of the allowance for credit losses and the timing of credit loss recognition?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed MetLife's accounting treatment for mortgage loans by requiring the establishment of an allowance for credit losses (ACL) at the time of purchase based on expected lifetime credit losses, rather than recognizing credit loss only when it was probable that amounts due would not be collected. This shift moved the company from an incurred loss model to an expected loss model, resulting in earlier recognition of credit losses and presenting mortgage loans at the net amount expected to be collected.",
      "llm_answer": "The adoption of the credit loss guidance on January 1 2020 required MetLife to recognize an allowance for credit losses (ACL) in earnings at the time a mortgage loan is purchased, measuring the expected lifetime credit loss over the loan’s contractual term and adjusting for prepayments and extensions. Previously, under the incurred‑loss model, credit losses were only recognized when it was probable that all amounts due would not be collected. As a result, the timing of credit‑loss recognition shifted from a “when incurred” approach to an “expected lifetime loss” approach, affecting the allowance amount and the presentation of mortgage loans net of that allowance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) All key facts are correct: the adoption date (January 1, 2020), the shift from an incurred loss to an expected credit loss model, the requirement to establish an allowance for credit losses (ACL) at purchase, and the recognition of expected lifetime credit losses over the contractual term (adjusted for prepayments/extensions). (2) There are no numeric values requiring calculation in this question; the date 'January 1, 2020' is correctly stated. (3) The multi-hop reasoning is sound—LLM correctly synthesizes the change in accounting treatment by contrasting the old (incurred loss) and new (expected loss) models, explaining the impact on timing and measurement of credit losses. (4) The answer fully addresses both parts of the question: the impact on the allowance for credit losses and the change in timing of recognition. Wording differs slightly but conveys the same meaning with high precision and appropriate financial terminology. All evaluation dimensions are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 307,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, change the timing and methodology of recognizing credit losses on leveraged lease receivables and mortgage loans, and what specific models and inputs were used under the new guidance?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed the recognition of credit losses from an incurred loss model to an expected lifetime credit loss model for both leveraged lease receivables and mortgage loans. For leveraged lease receivables, the Company now uses a probability of default and loss given default model to estimate expected lifetime credit loss, incorporating third-party credit ratings and historical default data. For mortgage loans, the Company applies significant judgment to estimate expected lifetime credit loss over the contractual term adjusted for prepayments and extensions, considering past events and current and forecasted economic conditions. This represents a shift from recognizing credit losses only when incurred to proactively accounting for expected losses over the life of the asset.",
      "llm_answer": "The Company adopted the new credit‑loss guidance on January 1 2020, which required it to record an allowance for expected lifetime credit losses on leveraged‑lease receivables and mortgage loans rather than waiting for an incurred loss. Under the new methodology, expected lifetime credit loss on leveraged leases is estimated using a probability‑of‑default and loss‑given‑default model that incorporates third‑party credit ratings and historical default data, while for direct financing leases (commercial‑real‑estate) the methodology mirrors that used for mortgage‑loan credit loss. The allowance is recorded in earnings within investment gains (losses), reducing the investment in leases to the net amount expected to be collected.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the key change in timing and methodology: the shift from an incurred loss model to an expected lifetime credit loss model effective January 1, 2020. The date is accurate, and the core concepts—recognition of expected lifetime credit losses, use of probability of default and loss given default models for leveraged leases, and incorporation of third-party credit ratings and historical data—are all factually correct. However, there is a notable deviation regarding mortgage loans: the LLM incorrectly states that the methodology for mortgage loans is mirrored in 'direct financing leases (commercial-real-estate)', which is not mentioned in the original answer and introduces an entity (direct financing leases) not part of the question or ground truth. The original answer emphasizes that for mortgage loans, judgment is applied considering past events, current conditions, and forecasts, adjusted for prepayments and extensions—details that are missing in the LLM response. While the LLM captures the main thrust of the change and correctly identifies models and inputs for leveraged leases, it fails to fully describe the mortgage loan methodology and introduces an irrelevant comparison. Quantitative accuracy is perfect—no numbers or dates are incorrect. Contextual relevance is high as the response directly addresses the question’s focus. The qualitative accuracy is slightly reduced due to the partial misrepresentation and incomplete synthesis for mortgage loans.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 425,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How does Texas Instruments' (TXN) structural cost advantage in manufacturing analog products using 300-millimeter wafers contribute to its ability to generate and return significant amounts of cash, as highlighted in its business model and competitive advantages?",
      "original_answer": "Texas Instruments achieves a 40% cost reduction per unpackaged chip by using 300-millimeter wafers instead of 200-millimeter wafers, which directly supports its competitive advantage in manufacturing and technology. This cost advantage enables greater control over the supply chain and lowers production costs, contributing to higher gross margins. As a result, TI is positioned to generate significant free cash flow, which aligns with its stated objective of maximizing long-term free cash flow per share growth and returning substantial amounts of cash to shareholders.",
      "llm_answer": "Texas Instruments' structural cost advantage from owning advanced 300-millimeter wafer manufacturing facilities—evident in its North Texas, Lehi, Utah, and other U.S. sites—enables significantly lower per-unit production costs compared to smaller 200-millimeter wafers, directly boosting gross margins (67.5% in 2021 vs. 64.1% in 2020) and cash flow. This efficiency, highlighted in its business model as a core competitive advantage, generates substantial free cash flow ($6.29 billion in 2021, or 34.3% of revenue), which the company strategically returns to shareholders through dividends ($3.89 billion) and share repurchases ($527 million), reinforcing its ability to consistently generate and distribute significant cash.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several accurate qualitative points about Texas Instruments' structural cost advantage from 300mm wafers, including lower production costs, higher gross margins, and cash return to shareholders. However, it introduces specific numerical data not present in the ground truth, such as gross margin percentages (67.5% in 2021 vs. 64.1% in 2020), free cash flow ($6.29 billion in 2021, or 34.3% of revenue), dividends ($3.89 billion), and share repurchases ($527 million). These figures, while plausible, are not supported by the original answer and cannot be verified as correct based on the provided knowledge graph. (2) The ground truth states a 40% cost reduction per unpackaged chip with 300mm wafers, which is a key quantitative claim. The LLM omits this specific figure and instead emphasizes financial outcomes (margins, cash flow) with unsupported numbers. Calculations like '34.3% of revenue' imply precise data synthesis not confirmed in the source. (3) The multi-hop reasoning is sound: the model correctly links wafer size advantage → lower costs → higher margins → strong free cash flow → shareholder returns. This logical chain aligns with the original answer’s intent and reflects proper synthesis of business model dynamics. (4) The contextual relevance is perfect—the answer directly addresses how manufacturing advantages enable cash generation and return. Qualitative accuracy is high due to correct entity identification (TXN, 300mm wafers, U.S. facilities, shareholder returns), but quantitative accuracy is reduced due to unverified figures. Correctness score is 7 because core facts and reasoning are correct, but significant unsupported numbers reduce factual reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 472,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What is the total value of the 1.5-Year Floating Rate (SOFR + 0.35%) Senior Notes issued by TMO as of December 31, 2021, and how does this compare to the value of the Floating Rate (SOFR + 0.39%) 2-Year Senior Notes due on October 18, 2023, as of the same date?",
      "original_answer": "The total value of the Floating Rate (SOFR + 0.35%) 1.5-Year Senior Notes issued by TMO as of December 31, 2021, is $1,000 million. The value of the Floating Rate (SOFR + 0.39%) 2-Year Senior Notes due on October 18, 2023, as of December 31, 2021, is $500 million. Therefore, the 1.5-Year Senior Notes are valued at twice the amount of the 2-Year Senior Notes as of December 31, 2021.",
      "llm_answer": "The 1.5‑Year Floating Rate Senior Notes (SOFR + 0.35 %) issued by Thermo Fisher Scientific had a carrying value of **$1,000 million** as of December 31, 2021. The 2‑Year Floating Rate Senior Notes (SOFR + 0.39 %) due October 18, 2023 carried a carrying value of **$500 million** on the same date, meaning the 1.5‑year notes were valued at twice the amount of the 2‑year notes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the carrying value of the 1.5-Year Floating Rate (SOFR + 0.35%) Senior Notes as $1,000 million and the 2-Year Floating Rate (SOFR + 0.39%) Senior Notes as $500 million as of December 31, 2021, matching the ground truth exactly. (2) All numeric values—$1,000 million, $500 million, the dates (December 31, 2021, and October 18, 2023), and the interest rate spreads (SOFR + 0.35% and SOFR + 0.39%)—are accurate and correctly attributed. The comparison stating the 1.5-year notes are valued at twice the amount of the 2-year notes is mathematically correct and clearly explained. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two different debt instruments issued by TMO (Thermo Fisher Scientific), compares their values on the same date, and draws the correct relative valuation conclusion. (4) The answer is semantically equivalent to the original, with no omissions or inaccuracies. All scoring categories receive the highest marks due to full factual correctness, precise numbers, logical reasoning, and complete relevance to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 321,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How many shares of UnitedHealth Group common stock were available for future issuance under both the 2020 Stock Incentive Plan and the 1993 Employee Stock Purchase Plan (ESPP) combined as of December 31, 2023, and which plan had more shares available?",
      "original_answer": "As of December 31, 2023, 53 million shares were available under the 2020 Stock Incentive Plan and 17 million shares were available under the ESPP, making a total of 70 million shares available for future issuance combined. The 2020 Stock Incentive Plan had more shares available than the ESPP.",
      "llm_answer": "Based on the information in the provided document pages, specifically page 72, the total shares available for future issuance under both the 2020 Stock Incentive Plan and the 1993 Employee Stock Purchase Plan (ESPP) combined as of December 31, 2023, is 70 million shares. The 2020 Stock Incentive Plan had 53 million shares available for future issuance, while the ESPP had 17 million shares available, making the 2020 Stock Incentive Plan the one with more shares available. \n\nAnswer: 70 million shares combined, with the 2020 Stock Incentive Plan having more shares available (53 million vs. 17 million for the ESPP).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: 53 million shares available under the 2020 Stock Incentive Plan, 17 million under the ESPP, and a combined total of 70 million shares. These match the ground truth exactly. (2) Quantitative accuracy is perfect: the sum (53M + 17M = 70M) is correct, and all individual numbers are accurate. Format variations (e.g., '53 million' vs '53M') are acceptable and do not affect correctness. (3) The multi-hop reasoning is sound—LLM correctly synthesizes data from two different plans, computes the total, and makes the correct comparison to determine which plan had more shares available. (4) The answer is fully contextually relevant, directly addressing both parts of the question (total shares and which plan had more). Wording differs slightly from the original answer but maintains full semantic equivalence. All evaluation criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 271,
        "total_tokens": 1525
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "What was the total liability for postemployment benefits reported by CAT in 2023, and how did the pension benefits freeze impact the assumptions used in their financial reporting?",
      "original_answer": "The total liability for postemployment benefits reported by CAT in 2023 was $621 million, which includes $56 million for other postemployment benefits and $565 million for non-qualified deferred compensation plans. The pension benefits freeze, which became effective December 31, 2019, resulted in the elimination of service cost and rendered certain actuarial assumptions no longer applicable to the pension reporting.",
      "llm_answer": "The total liability for postemployment benefits reported by Caterpillar in 2023 was $2,597 million for non‑U.S. pension benefits and $2,741 million for other postretirement benefits, as shown in the consolidated balance‑sheet amounts on page 93.  \n\nThe freeze of U.S. pension benefits effective December 31 2019 eliminated the use of a compensation‑increase assumption for those plans, which removed the “Rate of compensation increase” assumption from the actuarial calculations and consequently altered the assumptions used to measure the benefit obligation and net periodic cost for U.S. pension benefits. This change is noted on pages 41 and 91.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of quantitative accuracy. The ground truth states that CAT's total postemployment benefit liability in 2023 was $621 million, broken into $56 million for other postemployment benefits and $565 million for non-qualified deferred compensation. However, the LLM reports $2,597 million for non-U.S. pension benefits and $2,741 million for other postretirement benefits, which are not only different line items but also significantly higher and not mentioned in the original answer. These figures do not align with the ground truth and appear to conflate U.S. and non-U.S. plans or different benefit categories. (2) The date of the pension freeze (December 31, 2019) is correctly identified, which is a key factual point. However, the explanation of the impact on assumptions is partially accurate but misaligned—while it correctly notes that the compensation increase assumption was eliminated, it frames this in terms of non-U.S. plans and reporting details not present in the ground truth. The original answer specifies that the freeze rendered service cost and certain actuarial assumptions inapplicable to pension reporting broadly, not just the compensation assumption. (3) The multi-hop reasoning is flawed: the LLM fails to correctly identify the relevant liability amounts from the correct categories (postemployment benefits, not postretirement or non-U.S. pensions), and it synthesizes information that contradicts the ground truth. It references specific pages (e.g., 93, 41, 91), which may reflect plausible document locations but do not validate the factual content. (4) The contextual relevance is moderate because the answer addresses the general topic—postemployment benefits and the impact of the pension freeze—but applies it to incorrect financial figures and potentially wrong benefit types. Due to major factual and quantitative errors, the correctness score is low despite some accurate contextual elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 535,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "What was the total fair value of Merck's investments in developed markets equities in 2024 across both investment funds and equity securities for U.S. Pension Plans, and how does this compare to the prior year?",
      "original_answer": "The total fair value of Merck's investments in developed markets equities for U.S. Pension Plans in 2024 was $2,555 million for investment funds and $2,171 million for equity securities, totaling $4,726 million. In 2023, the fair value was $2,797 million for investment funds and $2,071 million for equity securities, totaling $4,868 million. This represents a decrease of $142 million from 2023 to 2024.",
      "llm_answer": "The total fair value of Merck’s investments in developed‑markets equities held in the U.S. pension plans was $2,555 million in 2024 and $2,797 million in 2023, meaning the 2024 amount is lower than the prior year.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but incomplete and contains a significant omission. It correctly states the 2024 and 2023 fair values for investment funds ($2,555 million and $2,797 million), but completely omits the equity securities component ($2,171 million in 2024 and $2,071 million in 2023). As a result, the total fair value is misrepresented. The ground truth total in 2024 is $4,726 million (sum of $2,555M + $2,171M), not $2,555 million as implied by the LLM. Similarly, the 2023 total is $4,868 million, not $2,797 million. (2) The quantitative accuracy is compromised because the LLM only reports investment funds and ignores equity securities, leading to a severe undercount. While the numbers it does report are accurate, the omission invalidates the overall comparison. The decrease from 2023 to 2024 is $142 million, but the LLM’s implied decrease of $242 million ($2,797M - $2,555M) is incorrect due to missing data. (3) The reasoning is flawed because it fails to synthesize both components (investment funds and equity securities) as required by the multi-hop nature of the question. The answer treats 'developed markets equities' as a single category without breaking down or summing the two constituent parts, indicating a failure in multi-hop synthesis. (4) Contextual relevance is high because the answer addresses the right company, time period, and general topic, and correctly identifies a year-over-year decrease. However, due to major omissions in scope and incorrect totals, the correctness, quantitative, and qualitative scores are moderate at best.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 438,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How many shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan since its inception, and how many remain available for issuance as of December 31, 2024, considering the plan's role in issuing stock options, RSUs, and PSUs as stated in the plan documentation and stock-based compensation disclosures?",
      "original_answer": "A total of 135 million shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan since its inception, and approximately 47 million shares remain available for issuance as of December 31, 2024, after accounting for shares issued through stock options, RSUs, and PSUs under the plan.",
      "llm_answer": "Based on the disclosed information in the 2007 Omnibus Incentive Plan documentation (page 96), the plan authorized approximately 135 million shares of Danaher common stock for issuance since its inception. As of December 31, 2024, approximately 47 million shares remain available for issuance under the plan, excluding shares underlying outstanding awards. This includes shares available for stock options, RSUs, and PSUs as part of the plan's equity compensation framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total authorized shares (135 million) and the remaining available shares (approximately 47 million) as of December 31, 2024), which matches the ground truth exactly. These numbers are critical and accurately reported. (2) Quantitative accuracy is perfect: both figures match the original answer, and the date (December 31, 2024) is correct. Format variations (e.g., 'approximately') are acceptable and reflect typical reporting language in SEC filings. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly links the plan documentation (2007 Omnibus Incentive Plan) with stock-based compensation disclosures to account for usage across stock options, RSUs, and PSUs. The mention of 'excluding shares underlying outstanding awards' adds precision and aligns with standard plan disclosures, though this nuance was not in the original answer—it does not contradict it and may reflect deeper insight. (4) The answer is fully contextually relevant, addressing both parts of the question (authorized shares and remaining availability) and correctly identifying the plan’s role in issuing various equity instruments. The only minor deduction in qualitative accuracy is for slightly rephrasing the availability clause with added detail not in the original, but this does not reduce correctness. Overall, the answer is factually complete, accurate, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 401,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the growth in Google Play's revenue contribution, as part of non-advertising revenues, potentially affect Google's overall profit margins, given the differing margin profiles between advertising and non-advertising revenue streams?",
      "original_answer": "Google Play generates revenues from app sales, in-app purchases, and digital content, and is a growing component of Google's non-advertising revenues. According to the 2022 10-K filing, non-advertising revenues—including those from Google Play, hardware, and Google Cloud—are increasing and may adversely affect overall profit margins because the margins on these revenues vary significantly and may be lower than those on advertising revenues. As Google Play's revenue contribution grows, if its margins remain lower than those of advertising, the overall profit margin of Google could decrease unless offset by efficiencies or higher-margin offerings.",
      "llm_answer": "The growth in Google Play’s contribution to non‑advertising revenue can pressure overall profit margins because non‑advertising streams (e.g., Google Play, hardware, YouTube subscriptions, Cloud) generally carry lower margins than Google’s high‑margin advertising revenue; as the share of lower‑margin non‑advertising sales rises, the company’s average profitability tends to decline.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It correctly identifies that Google Play is part of non-advertising revenues and that these streams (including hardware, Cloud, YouTube subscriptions) generally have lower margins than advertising revenue. This aligns with the 2022 10-K filing referenced in the original answer. (2) There are no numeric values, percentages, or dates in either answer that require verification—both avoid specific figures, so no quantitative inaccuracies exist. The LLM appropriately reflects the qualitative risk without introducing false precision. (3) The multi-hop reasoning is sound: it connects Google Play's growth within non-advertising revenue to the margin differential and correctly infers that a shift toward lower-margin revenue could reduce overall profitability. The only minor omission is not explicitly stating that this effect could be offset by efficiencies or higher-margin offerings (e.g., Cloud improvements), which the original answer includes as a caveat. (4) Despite this slight omission, the core logic, entity identification (Google Play, non-advertising streams, advertising margins), and synthesis across revenue segments are accurate and relevant. The answer directly addresses the question about margin pressure due to differing profitability profiles. Thus, high scores across all categories are warranted, with a 9 on correctness and qualitative accuracy due to the missing nuance about potential offsets.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 414,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What specific financial instruments does CVS use to hedge against credit quality risk, and how does the company expect these instruments to impact its overall risk exposure?",
      "original_answer": "CVS uses derivative financial instruments such as interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options, and credit default swaps to hedge against credit quality risk. The company expects these instruments, when used for hedging, to reduce overall risk despite subjecting the company to varying degrees of interest rate, equity price, and credit risk when viewed separately.",
      "llm_answer": "CVS Health manages credit quality risk primarily through the use of derivative financial instruments—including interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options, and credit default swaps—that are employed to hedge interest rate and credit spread movements. These hedging instruments are intended to reduce overall exposure by offsetting changes in the fair value of debt securities and interest‑rate‑sensitive liabilities, thereby limiting the potential adverse impact on the company’s consolidated financial condition. The company expects that, under a moderate 100‑basis‑point rise in interest rates, the fair value of its long‑term debt and interest‑rate‑sensitive investments would decline by roughly $3.3 billion and $650 million respectively, but such changes would not materially affect near‑term earnings or cash flows.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the financial instruments CVS uses to hedge against credit quality risk—interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options, and credit default swaps—which matches the original answer exactly. This satisfies the first part of the question with high accuracy. The explanation that these instruments are used to hedge interest rate and credit spread movements and reduce overall risk exposure aligns semantically with the ground truth, which states that these derivatives reduce overall risk despite introducing other risks. Thus, the qualitative reasoning and entity accuracy are strong.\n\nHowever, the LLM introduces specific quantitative projections not present in the original answer: a 100-basis-point rise in interest rates leading to a $3.3 billion decline in long-term debt fair value and a $650 million decline in investments. These figures, while plausible, are not included in the ground truth and represent additional, unsupported detail. Since the original answer contains no such numbers or scenario analysis, including them reduces quantitative accuracy. There is no indication in the ground truth that CVS expects these exact impacts, so the added specificity creates a factual overreach.\n\nThe contextual relevance is perfect—the response directly addresses both parts of the question (instruments used and expected impact on risk exposure) and stays focused on CVS’s hedging strategy. The multi-hop reasoning is sound in linking derivative usage to risk mitigation, but the unsupported numbers prevent a higher correctness score. Overall, the core facts are correct, but the addition of unverified quantitative estimates limits full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 472,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What was the total amount invested in Hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021?",
      "original_answer": "The total amount invested in Hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021 was $691 million. This is calculated by summing $682 million from U.S. Pension Plans and $9 million from Other Postretirement Benefit Plans.",
      "llm_answer": "Based on the \"Pension Plan Assets\" table on page 101, the combined allocation to hedge funds/limited partnerships was $682 million for U.S. Pension Plans and $38 million for Non‑U.S. Pension Plans, for a total of **$720 million** invested in hedge funds/limited partnerships in 2021.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect due to a critical error in entity identification and calculation. (1) The question asks for the total investment in Hedge funds/limited partnerships across U.S. Pension Plans and Other Postretirement Benefit Plans, but the LLM incorrectly uses $38 million from Non-U.S. Pension Plans instead of $9 million from Other Postretirement Benefit Plans. This misidentification of entities leads to an incorrect total. (2) Quantitatively, the LLM reports $682 million (correct for U.S. Pension Plans) but pairs it with $38 million (Non-U.S., incorrect entity), resulting in a calculated total of $720 million, which is factually wrong. The correct total is $691 million ($682M + $9M). (3) The reasoning fails the multi-hop requirement: the model must correctly identify and sum values from two specific plan types—U.S. Pension and Other Postretirement—but instead combines U.S. with Non-U.S., showing flawed synthesis. (4) While the response structure and context (e.g., referencing hedge funds/limited partnerships in 2021) are relevant, the core factual and quantitative inaccuracies severely undermine correctness. Minor formatting of $682 million is acceptable, but the wrong component value and total render the answer substantially incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1141,
        "completion_tokens": 355,
        "total_tokens": 1496
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the total number of freight cars UNP both owns and leases as of 2024, and how much did they spend on acquiring freight cars in 2024 based on their capital plan and lease buyout figures?",
      "original_answer": "UNP owns or leases a total of 56,176 freight cars as of 2024. Based on the capital plan and lease buyout figures, they spent $143 million on acquiring freight cars in 2024.",
      "llm_answer": "As of 2024, Union Pacific reports owning 33,704 freight cars and leasing 22,472, for a total of 56,176 freight cars.  The company’s 2024 capital plan calls for about $3.4 billion in spending, and the cash‑capital‑investment table shows that roughly $788 million of that amount was allocated to “Locomotives and freight cars,” which includes lease‑buyout costs of $143 million.  Consequently, the total amount spent on acquiring freight cars in 2024 is approximately $788 million.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total number of freight cars (56,176) by summing owned (33,704) and leased (22,472) units, which matches the ground truth. However, it incorrectly states that $788 million was spent on acquiring freight cars, while the ground truth specifies only $143 million was spent on freight car acquisition via lease buyouts. The $788 million figure includes both locomotives and freight cars and is not solely for freight cars. (2) Numeric values: The total freight cars (56,176), owned (33,704), and leased (22,472) are accurate. The $3.4 billion capital plan and $788 million allocation to 'Locomotives and freight cars' may be factually correct based on context, but the LLM misattributes the full $788 million to freight car acquisition, which is not supported. Only $143 million (lease buyouts) is specified as spent on freight cars. (3) Multi-hop reasoning: The model correctly synthesizes data on ownership and leasing, but fails in the second hop by not distinguishing between the broader 'Locomotives and freight cars' category and the specific $143 million spent on freight car acquisition. It conflates a category-level budget with a specific expenditure. (4) The contextual relevance is high as it addresses both parts of the question and uses appropriate data points. However, the key financial conclusion is factually incorrect, reducing correctness and accuracy scores. The answer would be correct only if $143 million were clearly identified as the freight car acquisition cost, separate from locomotive spending.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 430,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "By how much did changes in non-marketable equity securities contribute to the overall increase in other income (expense), net, from 2020 to 2021, given the role of these investments in Google's equity portfolio?",
      "original_answer": "The changes in non-marketable equity securities contributed $6.9 billion to the overall increase in other income (expense), net, from 2020 to 2021. This was the primary driver behind the $5.2 billion net increase in other income, despite being partially offset by a $1.3 billion increase in accrued performance fees.",
      "llm_answer": "The non‑marketable equity securities generated an unrealized gain of $9.8 billion in 2021 versus $1.5 billion in 2020, contributing roughly $8.3 billion of the $5.2 billion increase in other income (expense), net, between 2020 and 2021. This reflects their role in Google’s equity portfolio as a source of significant unrealized gains that drove the overall rise in other income.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that changes in non-marketable equity securities contributed $6.9 billion to the increase in other income (expense), net, but the LLM claims an $8.3 billion contribution, which is incorrect. Additionally, the LLM reports unrealized gains of $9.8 billion in 2021 and $1.5 billion in 2020, implying a year-over-year change of $8.3 billion, but these specific figures are not supported by the ground truth and contradict it. The overall increase in other income is correctly stated as $5.2 billion, matching the original answer. However, the LLM fails to mention the $1.3 billion increase in accrued performance fees that partially offset the gains, which is a key part of the reasoning in the ground truth. (2) The calculation of the contribution ($9.8B - $1.5B = $8.3B) is mathematically correct based on the numbers provided, but the input numbers themselves are factually wrong, leading to an incorrect conclusion. The correct contribution should be $6.9 billion, not $8.3 billion. (3) The multi-hop reasoning is partially sound in that the model attempts to link non-marketable equity gains to the change in other income, and recognizes their role in Google’s portfolio. However, it fails to accurately synthesize the correct figures or account for offsetting factors like performance fees, undermining the logical chain. (4) The contextual relevance is fair because the answer addresses the right topic, metric, and company, and attempts to explain the driver of the income change. However, due to major quantitative errors and missing offsetting factors, the qualitative and correctness scores are low. The answer misrepresents the core financial impact, which is critical in financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 487,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total value of the forward contracts associated with the ASR transactions executed by CVS in 2022 and 2023, and how were these contracts classified in the company's financial statements upon final settlement?",
      "original_answer": "The total value of the forward contracts associated with the ASR transactions executed by CVS in 2022 and 2023 was $0.7 billion ($0.3 billion in 2022 and $0.4 billion in 2023). These forward contracts were initially classified as equity instruments and recorded within capital surplus. Upon final settlement, the forward contracts were reclassified from capital surplus to treasury stock.",
      "llm_answer": "The forward contracts associated with CVS's ASR transactions executed in 2022 and 2023 had a total notional value of $4.5 billion ($1.5 billion in 2022 and $3.0 billion in 2023). These forward contracts were initially recorded as equity instruments within capital surplus and were later re‑classified to treasury stock upon final settlement of each ASR.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. The ground truth states the total value of forward contracts was $0.7 billion ($0.3B in 2022 and $0.4B in 2023), but the LLM reports $4.5 billion ($1.5B in 2022 and $3.0B in 2023), which is more than six times higher. These numbers are not within acceptable variance and represent a major factual error. (2) The calculation of the total value is incorrect: $1.5B + $3.0B = $4.5B as stated by the LLM, but this does not match the correct sum of $0.3B + $0.4B = $0.7B. There is no indication of miscalculation in the LLM response—rather, the input values themselves are wrong. (3) On qualitative aspects, the LLM correctly identifies the classification treatment: forward contracts were initially recorded as equity instruments in capital surplus and reclassified to treasury stock upon final settlement. This part of the reasoning and entity classification is accurate and reflects proper multi-hop understanding of accounting treatment across time. (4) Contextually, the answer addresses both parts of the question—total value and classification—and uses appropriate financial terminology. However, due to the severe inaccuracy in dollar amounts, which are central to the question, the overall correctness score is very low. While the directional logic and accounting treatment are sound, the core data is fundamentally wrong, leading to a correctness score of 2. Quantitative accuracy is severely lacking (score: 2), qualitative reasoning is partially correct (score: 3), and relevance is high (score: 8) as the structure and intent align with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 453,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the Lowe's Companies Benefit Restoration Plan, as amended and referenced in the 2024 10-K filing, relate to the defined contribution retirement plan in terms of addressing restrictions under the Internal Revenue Code of 1986 for eligible employees?",
      "original_answer": "The Benefit Restoration Plan supplements benefits provided under the defined contribution retirement plan (401(k) Plan) for participants whose benefits are restricted due to provisions in the Internal Revenue Code of 1986. The Company Match under the 401(k) Plan varies up to a maximum of 4.25% of eligible compensation, and this matching contribution is mirrored in the Benefit Restoration Plan for affected participants.",
      "llm_answer": "The Lowe's Companies Benefit Restoration Plan, as amended and restated effective January 1 2025 (Exhibit 10.3 in the 2024 10‑K), is a non‑qualified supplemental retirement plan that provides eligible employees with additional benefits when their participation in the primary 401(k) plan is limited by the Internal Revenue Code’s contribution and income‑level restrictions. By offering salary deferrals and employer matching contributions that are not subject to those IRS limits, the Restoration Plan ensures that affected employees can still receive the full Company match and retirement‑income benefits they would otherwise be barred from under the Code. This structure allows the Company to comply with IRS rules while preserving the intended retirement savings outcome for those employees.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies the Benefit Restoration Plan as a non-qualified plan that supplements the 401(k) Plan for employees affected by IRS limits under the Internal Revenue Code of 1986. The purpose and relationship between the plans are accurately described. (2) The only minor quantitative omission is the specific maximum Company Match of 4.25% of eligible compensation, which is stated in the original answer but not explicitly mentioned in the LLM response. However, the LLM correctly implies that the full Company match is restored, which aligns with the mirroring mechanism. The effective date of January 1, 2025, and reference to Exhibit 10.3 in the 2024 10-K are correctly included, though not in the ground truth—these may be additional details from the filing and do not contradict. (3) The multi-hop reasoning is sound: the LLM correctly links the IRS restrictions, the limitation on 401(k) benefits, and the role of the Restoration Plan in restoring match and deferrals. (4) The answer is semantically equivalent to the original, with slightly more detail on structure and compliance. The absence of the exact 4.25% figure prevents a perfect score, but all other elements—entities, logic, context—are correct. Hence, a 9 is justified for correctness, with high marks across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 386,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, including both CS&Co and TDAC, and how does this compare to the total borrowing capacity under these facilities?",
      "original_answer": "The total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, was $1.65 billion, which includes $950 million outstanding under CS&Co's secured uncommitted lines of credit and $700 million outstanding under TDAC's secured uncommitted lines of credit. This represents a utilization rate of approximately 91.7% of the total borrowing capacity of $1.8 billion.",
      "llm_answer": "The total amount outstanding under all secured uncommitted lines of credit at December 31 2023 was $1.65 billion ($950 million from CS&Co and $700 million from TDAC). This represents approximately 87 % of the combined borrowing capacity of $1.9 billion under these facilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total amount outstanding ($1.65 billion) and its components ($950 million from CS&Co and $700 million from TDAC), which matches the ground truth. However, it incorrectly states the total borrowing capacity as $1.9 billion (vs. $1.8 billion in the original) and calculates a utilization rate of approximately 87% (vs. the correct 91.7%). These quantitative errors significantly affect the accuracy of the comparison. (2) Verification: $950M + $700M = $1.65B is correct. The correct utilization rate is $1.65B / $1.8B = 91.67% ≈ 91.7%. The LLM’s implied calculation of $1.65B / $1.9B ≈ 86.8% ≈ 87% is internally consistent but based on an incorrect borrowing capacity. (3) The multi-hop reasoning is sound in structure—aggregating amounts across CS&Co and TDAC and comparing to total capacity—but relies on incorrect underlying data for capacity. (4) The answer is contextually relevant and complete in addressing both parts of the question, and entities (CS&Co, TDAC, secured uncommitted lines) are correctly identified. However, the incorrect borrowing capacity and resulting miscalculation of utilization rate reduce quantitative accuracy significantly, warranting a score of 6 for overall correctness despite partial accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 357,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total value of Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021, and how does this compare to the total value of hedge funds/limited partnerships and real estate investments combined in the same year?",
      "original_answer": "The total value of Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021 was $87. This is greater than the combined total of hedge funds/limited partnerships ($9) and real estate investments ($5), which together amounted to $14. Thus, mutual, pooled, and commingled funds represented a significantly larger portion of the investment portfolio than the other two categories combined.",
      "llm_answer": "The total value of Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021 was $87 million (as reported in the “Other postretirement benefit plan assets” table on page 103). This amount is larger than the combined total of hedge funds/limited partnerships ($9 million) and real estate ($5 million), which together equal $14 million. Consequently, the mutual/pooled/commingled fund investment exceeds the combined hedge fund and real estate investments by $73 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $87 million for mutual, pooled, and commingled funds, $9 million for hedge funds/limited partnerships, and $5 million for real estate investments. The combined value of the latter two is correctly calculated as $14 million, and the difference ($73 million) is accurately stated. Minor formatting with 'million' is acceptable and consistent with financial reporting norms. (2) The answer addresses both parts of the multi-part question: it provides the total value of mutual/pooled/commingled funds and compares it to the combined value of the other two investment categories. (3) Entity accuracy is correct—Coca-Cola, 2021 year-end, and proper investment categories are all correctly identified. (4) The reasoning is sound: the LLM correctly synthesizes values from different line items, performs accurate arithmetic, and draws the correct comparative conclusion. The addition of a specific document reference (page 103) enhances credibility without introducing error. (5) The semantic meaning fully aligns with the original answer, with added clarity in the explicit difference calculation. No factual, computational, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 355,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the treatment of LTIP units as participating securities impact Simon Property Group's earnings per share calculation, based on the disclosure regarding distributions equal to 10% of the regular quarterly distributions on Operating Partnership units?",
      "original_answer": "LTIP units are treated as participating securities under the two-class method of computing earnings per share because they entitle participants to receive distributions equal to 10% of the regular quarterly distributions paid on a unit of the Operating Partnership. This impacts earnings per share because participating securities must be included in the computation of earnings per share using the two-class method, which allocates earnings to both common shares and participating securities. Although the LTIP units do not have full parity with common units in terms of distributions, their participation in a portion of the distributions affects the allocation of earnings and thus the resulting earnings per share figure.",
      "llm_answer": "LTIP units are treated as participating securities in the earnings‑per‑share calculation under the two‑class method. Because they receive distributions equal to 10 % of the regular quarterly distributions on Operating Partnership units, they are included in the share‑based earnings per share computation, even though no dilutive effect was observed for the years ended December 31 2023, 2022 and 2021.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It correctly identifies that LTIP units are treated as participating securities under the two-class method due to receiving distributions equal to 10% of the regular quarterly distributions on Operating Partnership units—this matches the original answer exactly. The percentage (10%) is accurate, and no incorrect dates or financial figures are cited. (2) Quantitative accuracy is perfect: the 10% figure is correctly stated, and the mention of no dilutive effect in 2023, 2022, and 2021, while not in the original answer, does not contradict it and may reflect additional disclosure from the filing; it does not introduce error. (3) The reasoning is sound but slightly less complete than the original: while the LLM correctly links the distribution feature to classification as a participating security and inclusion in EPS calculation, it omits an explanation of *how* the two-class method allocates earnings between common shares and participating securities, which is a key part of the impact on EPS. This conceptual nuance is present in the original answer but not fully elaborated in the LLM response. (4) Contextual relevance is high—the answer directly addresses the question about the impact of LTIP unit treatment on EPS, uses correct terminology, and remains focused. The addition of recent years with no dilutive effect adds context without detracting from accuracy. Overall, minor omission in explanatory depth prevents a top score, but factual and quantitative correctness is strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 430,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the total amount of NEE's noncontrolling interest investment in XPLR OpCo as of December 31, 2024, and how is this entity classified in NEE's financial reporting structure based on its control and governance characteristics?",
      "original_answer": "NEE's noncontrolling interest investment in XPLR OpCo totaled $3,315 million as of December 31, 2024. XPLR OpCo is classified as a variable interest entity (VIE) in which NEE is not the primary beneficiary due to lack of control over significant activities and absence of a controlling financial interest, and therefore it is accounted for under the equity method.",
      "llm_answer": "Based on the provided document pages, there is no information indicating that NextEra Energy (NEE) has a noncontrolling interest investment in an entity named \"XPLR OpCo\" as of December 31, 2024. The document references \"XPLR OpCo\" only in the context of a noncontrolling interest in Note 8 of the consolidated financial statements (page 98), but it does not specify the amount of that investment or provide any details about its classification in NEE's financial reporting structure. The document discusses NEER's operations, regulation, and financial reporting, but does not mention \"XPLR OpCo\" as a specific entity with a measurable noncontrolling interest balance. Therefore, the requested information cannot be determined from the provided sources.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is completely incorrect and fails to provide the ground truth information. The original answer states that NEE's noncontrolling interest investment in XPLR OpCo was $3,315 million as of December 31, 2024, and that XPLR OpCo is classified as a variable interest entity (VIE) where NEE is not the primary beneficiary, thus accounted for under the equity method. The LLM incorrectly claims that no such information is present in the documents, which contradicts the premise of the question and the provided ground truth. (2) The quantitative inaccuracy is severe—the correct amount is $3,315 million, but the LLM does not report any number and instead denies the existence of the data. (3) The multi-hop reasoning failed entirely: the LLM should have identified the reference to XPLR OpCo in Note 8 (as acknowledged in its response) and extracted the relevant investment amount and classification details, but it did not synthesize this information. Instead, it defaulted to a 'not found' conclusion despite the context implying the data exists. (4) The contextual relevance is low because the answer avoids addressing the core question, but it receives minimal credit for referencing Note 8 and acknowledging the entity name, suggesting some document engagement.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 361,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What is the total number of distribution methods Linde uses to supply process gases, and how does the company's on-site delivery method differ from the other methods in terms of contract duration and customer volume requirements?",
      "original_answer": "Linde uses three distribution methods to supply process gases: on-site, merchant, and packaged. The on-site delivery method differs significantly from the others in that it serves customers with the largest volume requirements and typically involves contracts ranging from 10 to 20 years in duration, often containing minimum purchase requirements. In contrast, merchant and packaged gas contracts are generally shorter, ranging from three to seven years and one to three years respectively, and do not typically include minimum purchase requirements or volume commitments.",
      "llm_answer": "Linde uses three distribution methods to supply process gases: on‑site (tonnage) delivery, merchant or bulk liquid delivery, and packaged or cylinder gas delivery.  \n\nThe on‑site method differs from the other two in that its contracts are typically long‑term (generally 10–20 years) and include minimum purchase requirements and price‑escalation provisions, whereas merchant and packaged‑gas contracts are usually shorter (three to seven years) and contain no minimum purchase or volume commitments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and durations are correct: on-site contracts (10–20 years), merchant (3–7 years), and packaged (1–3 years in original; LLM states 'shorter' and gives 3–7 years, which partially omits the 1–3 year range for packaged but does not misstate). The LLM correctly identifies the three distribution methods: on-site, merchant, and packaged. (2) The key qualitative differences—long-term contracts, minimum purchase requirements, and price-escalation provisions for on-site versus shorter, no-commitment contracts for merchant and packaged—are accurately captured. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in contract duration and volume requirements across methods, even if it slightly generalizes the merchant and packaged contract lengths. (4) The only minor omission is that the original specifies packaged contracts as 1–3 years, while the LLM groups both merchant and packaged under 'three to seven years', which slightly overgeneralizes but does not contradict. This justifies a 9/10 on correctness and qualitative accuracy. Contextual relevance is perfect—answer directly addresses both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 350,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the 20-for-one stock split of Alphabet's Class C Capital Stock, announced in February 2022, relate to the Board of Directors' prior authorization in April 2021 for repurchasing up to $50.0 billion of Class C stock, and what condition was required for the stock split to proceed?",
      "original_answer": "The 20-for-one stock split of Alphabet's Class C Capital Stock, announced in February 2022, relates to the prior $50.0 billion Class C stock repurchase authorization from April 2021 because the stock split required an increase in the number of authorized shares of Class C stock to accommodate the split. This condition was necessary to ensure that the company had enough authorized shares post-split for both ongoing operations and the repurchase program. The stock split was subject to stockholder approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of Class A, Class B, and Class C stock.",
      "llm_answer": "The February 2022 20‑for‑one stock split was approved by the Board of Directors in February 2022, but it could only proceed after stockholder approval of an amendment to the company’s charter to increase the authorized shares of Class A, Class B and Class C stock. This amendment was required to accommodate the split. The split was also contingent on the prior Board authorization in April 2021 to repurchase up to $50 billion of Class C stock, which provided the necessary shareholder‑approval framework for the split.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 20-for-one stock split announced in February 2022, the April 2021 $50.0 billion repurchase authorization, and the requirement for stockholder approval to amend the charter to increase authorized shares. All entities, dates, and dollar amounts are accurate. (2) Quantitative accuracy is perfect: 'February 2022', 'April 2021', '$50 billion', and '20-for-one' are all correctly stated with no calculation errors. (3) However, the reasoning contains a subtle but important inaccuracy: the LLM claims the stock split was 'contingent on' the prior repurchase authorization because it 'provided the necessary shareholder-approval framework.' This misrepresents the causal relationship. According to the ground truth, the repurchase program and stock split both required increased authorized shares, and the shareholder vote on the charter amendment served both purposes—but the repurchase authorization did not enable or provide a framework for the split. Instead, both actions were facilitated by the same share authorization increase. The LLM incorrectly implies dependency where there is only co-dependency on a common condition. (4) Despite this flaw in multi-hop reasoning, the answer includes all key facts and the required condition (stockholder approval of charter amendment), warranting a correctness score of 7. Quantitative accuracy is 10 due to perfect numbers and dates. Qualitative accuracy is 7 due to the flawed logic in connecting the repurchase to the split. Contextual relevance is high at 9, as the response stays focused and addresses the core elements of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 448,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was GM's total equity earnings contribution from Ultium Cells Holdings LLC in 2023, and how much in committed capital contributions did GM have outstanding to the same entity as of December 31, 2023?",
      "original_answer": "GM's equity earnings contribution from Ultium Cells Holdings LLC in 2023 was $293 million, and GM had $0.8 billion in committed capital contributions outstanding to the same entity as of December 31, 2023.",
      "llm_answer": "Based on the provided document pages, GM's total equity earnings contribution from Ultium Cells Holdings LLC in 2023 was $293 million, as disclosed in the segment financial information on page 101 (Note 15: \"Equity earnings related to Ultium Cells Holdings LLC were $293 million in the year ended December 31, 2023\"). Additionally, GM had $0.8 billion in committed capital contributions to Ultium Cells Holdings LLC outstanding as of December 31, 2023, as stated in Note 12 of the consolidated financial statements on page 84 (\"Our maximum exposure to loss, and required capital contributions, could vary depending on Ultium Cells Holdings LLC's requirements and access to capital. We currently lack the power through voting or similar rights to direct the activities of these entities that most significantly affect their economic performance. Our maximum exposure to loss, and required capital contributions, could vary depending on Ultium Cells Holdings LLC's requirements and access to capital. We currently lack the power through voting or similar rights to direct the activities of these entities that most significantly affect their economic performance.\" and specifically noting \"$0.8 billion and $1.4 billion in committed capital contributions to Ultium Cells Holdings LLC at December 31, 2023 and 2022\").",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) Quantitatively, both key figures are accurate: $293 million in equity earnings for 2023 and $0.8 billion in committed capital contributions outstanding as of December 31, 2023. The format variations (e.g., $0.8 billion vs $800 million) are acceptable and semantically equivalent. (2) The answer is complete, addressing both parts of the multi-part question: the equity earnings amount and the committed capital contributions. (3) Entity accuracy is correct—GM and Ultium Cells Holdings LLC are properly identified, and the time frame (2023, specifically December 31, 2023) is accurate. (4) The reasoning is sound and demonstrates multi-hop synthesis by referencing two different notes (Note 15 and Note 12) from the financial statements, correctly interpreting the disclosures. Although the LLM includes a repeated sentence in the quote from Note 12, it does not affect factual accuracy. The core data extraction and synthesis are precise, and the answer conveys the same information as the original. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 319,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was the total value of The Coca-Cola Company's investments in hedge funds and limited partnerships in 2021 as reported in both its consolidated financial statements and its other postretirement benefit plan assets, and how does this dual reporting reflect the company's overall exposure to such investment vehicles?",
      "original_answer": "The Coca-Cola Company reported $720 million in hedge funds and limited partnerships within its consolidated financial statements and $9 million in such investments within its other postretirement benefit plan assets for 2021. This totals $729 million in exposure to hedge funds and limited partnerships across both reporting categories.",
      "llm_answer": "The Coca‑Cola Company reported total investments in hedge funds and limited partnerships of **$720 million** for its pension‑plan assets (as shown on page 117) and also disclosed **$9 million** of such investments in its other postretirement benefit plan assets (page 103). The dual reporting reflects that these alternative‑investment holdings are included both in the broader pension‑plan asset portfolio and in the separate VEBA‑style other postretirement benefit plan assets, illustrating the company’s overall exposure to hedge‑fund and limited‑partnership investments across its employee‑benefit funding structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the two key figures: $720 million in hedge funds and limited partnerships from the consolidated financial statements (specifically pension-plan assets) and $9 million from other postretirement benefit plan assets. These match the ground truth exactly. The total exposure of $729 million is implied by the dual reporting, though the LLM does not explicitly state the sum. This omission is minor given that the two components are accurately presented and the question asks for the 'total value'—which could be inferred. (2) Quantitative accuracy is perfect: both $720 million and $9 million are correct, with no calculation errors. The format variation (using 'million' instead of full numeric form) is acceptable. (3) The multi-hop reasoning is sound—the model correctly synthesizes data from two different sections of the 10-K (pension-plan assets and other postretirement benefit plan assets), correctly attributing each figure to its respective reporting category. The explanation of dual reporting reflecting overall exposure across employee-benefit structures is logically valid and aligns with the intent of the question. (4) Contextual relevance is high: the answer directly addresses both parts of the question—reporting in two categories and what it implies about overall exposure. The only minor shortcoming is the lack of an explicit summation to $729 million, which slightly affects completeness but not factual correctness. Hence, a score of 9 is justified for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 438,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the increased use of e-commerce by retail tenants, as mentioned in the risk factors, contribute to the difficulty Simon Property Group (SPG) faces in leasing spaces and maintaining rental rates at its properties?",
      "original_answer": "The increased use of e-commerce by retail tenants has led to lower demand for physical retail space, which directly contributes to higher vacancy rates at SPG's properties. This oversupply of vacant space, combined with the increased bargaining power of creditworthy retail tenants, results in downward pressure on rental rates and occupancy levels. Additionally, SPG may need to increase spending on tenant improvements and offer more lease modifications to attract or retain tenants, all of which materially and adversely affect SPG's financial performance and leasing strategy.",
      "llm_answer": "The risk factor explicitly states that “there has been lower demand from retail tenants for space, due to certain retailers increasing their use of e‑commerce websites to distribute their merchandise,” and that this “increased bargaining power of creditworthy retail tenants” creates “downward pressure on our rental rates and occupancy levels.” Consequently, the shift toward e‑commerce reduces tenant demand, making it harder for Simon Property Group to lease space and maintain or raise rental rates at its properties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the core causal chain from the original answer: increased e-commerce use by retail tenants leads to lower demand for physical space, which results in downward pressure on rental rates and occupancy levels due to increased tenant bargaining power. It accurately quotes key phrases from the risk factor (e.g., 'lower demand from retail tenants for space', 'increased bargaining power of creditworthy retail tenants', 'downward pressure on our rental rates and occupancy levels'), ensuring semantic equivalence and factual correctness. All entities (Simon Property Group, retail tenants, e-commerce impact) are correctly identified and logically connected. The reasoning is sound and reflects the multi-hop logic required: e-commerce growth → reduced demand for space → higher vacancy/leverage for tenants → leasing challenges and rate pressure. The only minor omission is that the LLM answer does not mention SPG's potential need to increase spending on tenant improvements or lease modifications, which is part of the full adverse impact described in the ground truth. However, this does not undermine the central explanation. There are no numerical values in the question or answers, so quantitative accuracy is scored based on absence of errors (N/A but assumed perfect). The answer is highly contextually relevant and directly addresses the question. Thus, a 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 416,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was the cumulative impact on UNP's deferred tax expense in 2024 and 2023 from corporate income tax legislation enacted in Arkansas, and how does this compare to the 2022 impact from Arkansas legislation?",
      "original_answer": "The cumulative impact on UNP's deferred tax expense from Arkansas tax legislation was $34 million in 2024 and $114 million in 2023, totaling $148 million over the two years. In 2022, Arkansas legislation contributed to a $95 million reduction in deferred tax expense. Therefore, the reduction in 2024 and 2023 was greater than the 2022 impact by $53 million.",
      "llm_answer": "The cumulative impact of Arkansas corporate income tax legislation on UNP's deferred tax expense was a $34 million reduction in 2024 and a $114 million reduction in 2023, compared with a $95 million reduction in 2022.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the deferred tax expense impacts for 2024 ($34 million), 2023 ($114 million), and 2022 ($95 million), all of which match the ground truth in terms of numeric values and years. The direction (reduction) is also correctly implied. (2) Quantitatively, all numbers are accurate and properly attributed to the correct years. However, the LLM answer omits the explicit calculation of the cumulative two-year impact ($148 million) and the comparison stating that the 2023–2024 reduction was $53 million greater than the 2022 impact. While the numbers are present, the synthesis required by the second part of the question—'how does this compare'—is incomplete. (3) The multi-hop reasoning is partially sound: the model identifies the correct figures across years and legislation, but fails to perform or state the comparative analysis (cumulative sum and difference) that the question demands. This is a key gap in qualitative reasoning. (4) Despite missing the comparative calculation, the answer is contextually relevant and factually aligned with the data. The correctness score is 7 because core numbers are correct but the answer lacks full completeness on the comparative aspect required by the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 354,
        "total_tokens": 1513
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does NEE's limited partner interest in XPLR OpCo potentially impact its financial obligations and liquidity, particularly if XPLR is unable to access capital on commercially reasonable terms?",
      "original_answer": "NEE's limited partner interest in XPLR OpCo could negatively affect its liquidity and financial obligations if XPLR is unable to access capital on commercially reasonable terms. This is because XPLR's inability to secure capital would hinder its ability to complete acquisitions or meet growth opportunities, reducing its cash distributions to unitholders, including NEE. Additionally, if XPLR issues more common units or converts existing securities into common units, NEE's share of future distributions could be diluted. This directly impacts NEE’s cash flows, which are crucial for meeting its financial obligations and paying dividends.",
      "llm_answer": "NEE's limited partner interest in XPLR OpCo could become a significant liquidity risk if XPLR cannot obtain capital on commercially reasonable terms, as this could impair XPLR's ability to make cash distributions to NEE and potentially force NEE to provide additional funding or incur obligations to support the partnership. The document specifically states that XPLR's inability to access capital on commercially reasonable terms would have a \"material adverse effect on its ability to consummate future acquisitions and on the value of NEE's limited partnership interest in XPLR OpCo.\"",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core risk to NEE's liquidity due to XPLR's inability to access capital, and accurately reflects that this would impair cash distributions to NEE and negatively affect the value of its limited partner interest. The quote about 'material adverse effect on its ability to consummate future acquisitions' aligns with the ground truth. However, the LLM introduces the idea that NEE 'could be forced to provide additional funding or incur obligations to support the partnership,' which is not mentioned in the original answer and represents an unsupported inference. The ground truth emphasizes dilution risk from future unit issuances and reduced distributions due to constrained growth, but does not suggest NEE has an obligation to fund XPLR. This omission of dilution and introduction of unsupported liability weakens the qualitative accuracy. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The response is contextually relevant and addresses the main thrust of the question, but misses a key mechanism (dilution) in the impact chain, resulting in a partially complete answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 330,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What is the difference between the fair value of mortgage-backed obligations reported in the 'Marketable securities' section and the 'Fair Value' column of the marketable securities table?",
      "original_answer": "The difference between the fair value of mortgage-backed obligations reported in the two sections is $58. In the 'Marketable securities' section, the fair value is $178, while in the 'Fair Value' column of the marketable securities table, it is $236.",
      "llm_answer": "The fair value of mortgage‑backed obligations reported in the “Marketable securities” table is $236 million (as shown in the amortized‑cost/Fair Value column for that line item), whereas the “Fair Value” column of the marketable securities table lists the overall fair‑value amount for all marketable securities (e.g., $5,722 million as of Jan 31 2024). Thus, the mortgage‑backed obligations’ fair value is a component of the total fair‑value figure presented in the marketable securities table.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to address the core of the question. (1) It misidentifies the values: the ground truth states that the fair value in the 'Marketable securities' section is $178, and in the 'Fair Value' column of the marketable securities table is $236, with a difference of $58. The LLM incorrectly claims the 'Marketable securities' table shows $236 million for mortgage-backed obligations, conflating it with the total fair value of all marketable securities. (2) Quantitative accuracy is very low: the correct numbers are $178 and $236 (difference $58), but the LLM reverses the context and assigns $236 to mortgage-backed obligations in the wrong table. It also introduces a total fair value of $5,722 million not mentioned in the question or ground truth, which is irrelevant and incorrect in this context. (3) The reasoning is flawed: instead of computing the difference between two specific line items as required, the model incorrectly interprets one of the columns as a total for all securities, failing the multi-hop comparison. (4) The answer is somewhat contextually relevant as it discusses fair value and mortgage-backed obligations, but the synthesis is incorrect. Due to major factual and calculation errors, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 357,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does the revenue recognition method for Google Play impact the financial reporting of non-advertising revenues, given the increasing portion of these revenues and their effect on margins?",
      "original_answer": "Google Play's revenue is reported on a net basis because Google's performance obligation is to facilitate a transaction between app developers and end users, for which it earns a service fee. This method reduces the total revenue amount reported for Google Play sales. As non-advertising revenues, which include Google Play, are increasing and have varying margins that may be lower than advertising revenues, this trend could adversely affect overall margins.",
      "llm_answer": "The revenue from Google Play and other non‑advertising sources is recognized on a net basis as a service fee because Alphabet acts as an agent for app sales and in‑app purchases, so these revenues are recorded net of the gross amount paid to developers. This treatment reduces the reported dollar amount of revenue but does not affect the underlying economics; however, as the share of non‑advertising revenue grows, it puts downward pressure on overall margins because these streams typically carry lower margins than Google’s advertising business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that Google Play revenue is recognized on a net basis because Alphabet acts as an agent, which reduces reported revenue—this matches the original answer's explanation about facilitating transactions and earning a service fee. (2) There are no numeric values requiring verification (e.g., percentages, dollar amounts), so quantitative accuracy is not compromised; all non-numeric financial concepts (net reporting, margin pressure) are correctly represented. (3) The multi-hop reasoning is sound: the model correctly links the net revenue recognition method to its impact on reported non-advertising revenues and further connects the growing share of these lower-margin revenues to downward pressure on overall margins. (4) The only minor gap is that the LLM answer does not explicitly name 'Google Play' as part of 'non-advertising revenues' in the second sentence (referring instead to 'other non-advertising sources'), though the context clearly implies it. This slight generalization prevents a perfect 10 on qualitative accuracy, but the core logic and synthesis remain intact. Overall, the answer is semantically equivalent, contextually precise, and correctly reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 356,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the total amount of committed capital contributions General Motors made to Ultium Cells Holdings LLC in 2023, and how does this compare to the previous year's commitment?",
      "original_answer": "General Motors committed $0.8 billion to Ultium Cells Holdings LLC in 2023, which is a decrease from $1.4 billion in 2022. This indicates a reduction in GM's capital commitment to the joint venture by $0.6 billion year-over-year.",
      "llm_answer": "Based on the provided GM 10-K filing, the company made a **$1.5 billion capital contribution to Ultium Cells Holdings LLC in 2023** (as disclosed in Note 12, which states \"Our maximum exposure to loss... includes $0.8 billion and $1.4 billion in committed capital contributions to Ultium Cells Holdings LLC at December 31, 2023 and 2022\"). This represents an increase from the **$1.4 billion contributed in 2022** (as reflected in the same note's 2022 figure). Thus, the 2023 commitment was $1.5 billion, compared to $1.4 billion in the prior year.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in the reported capital contribution for 2023. The ground truth states GM committed $0.8 billion in 2023, but the LLM incorrectly claims $1.5 billion. The $1.4 billion figure for 2022 is correct. The LLM misinterprets the 'maximum exposure to loss' disclosure, conflating it with actual 2023 contributions. The $0.8 billion cited in the note is the committed amount at the end of 2023, not $1.5 billion. (2) Quantitative accuracy fails because the 2023 amount is wrong, and the comparison is therefore incorrect: the LLM claims an increase from $1.4B to $1.5B, while the truth is a decrease from $1.4B to $0.8B—a $0.6B reduction. The calculation of year-over-year change is thus fundamentally flawed. (3) The reasoning is unsound: the LLM cites Note 12 correctly but misreads it—'committed capital contributions' at year-end are not the same as contributions made during the year. The model fails to infer that the drop from $1.4B to $0.8B indicates reduced commitment, not an increase. This breaks the multi-hop logic required to compare commitments across years. (4) Contextual relevance is high because the answer addresses the right entity (Ultium Cells Holdings LLC), the correct metric (committed capital), and the right years. However, due to severe quantitative and qualitative errors, the overall correctness is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 386,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total cash consideration paid by Mastercard in 2024 for all acquisitions, including the acquisition of RF UlEmate Parent, Inc., and how much of this amount was attributed to goodwill?",
      "original_answer": "Mastercard paid a total cash consideration of $2.8 billion in 2024 for all acquisitions, including the acquisition of RF UlEmate Parent, Inc. Out of this, $1.7 billion was attributed to goodwill.",
      "llm_answer": "Mastercard paid a total cash consideration of $2.8 billion for all acquisitions in 2024, of which $2.7 billion was for the RF UlEmate Parent, Inc. acquisition.  The goodwill recorded in connection with these acquisitions amounted to $1.7 billion.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states the total cash consideration of $2.8 billion and the goodwill amount of $1.7 billion, which matches the ground truth. However, it introduces an unsupported detail that $2.7 billion of the $2.8 billion was specifically for the RF UlEmate Parent, Inc. acquisition, which is not present in the original answer and cannot be verified from the given information. This addition is plausible but not confirmed, leading to a minor inaccuracy. (2) The key numbers—$2.8 billion total cash consideration and $1.7 billion goodwill—are factually correct and properly formatted. The unsupported breakdown of $2.7 billion for RF UlEmate does not contradict the total but adds unverified specificity. (3) The multi-hop reasoning is mostly sound: the model correctly aggregates total acquisition spending and links it to goodwill. However, the attribution of $2.7 billion to a single acquisition goes beyond the provided data and risks incorrect inference. (4) Despite the extraneous detail, the core answer addresses both parts of the question accurately—total cash consideration and goodwill—earning high marks for correctness, quantitative accuracy, and qualitative reasoning. Contextual relevance is perfect as all information provided is relevant and on-topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1122,
        "completion_tokens": 361,
        "total_tokens": 1483
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total amount spent by UNP on freight car lease buyouts over the three-year period from 2022 to 2024, and how does this relate to the company's capital plan for acquiring freight cars in 2025?",
      "original_answer": "UNP spent a total of $270 million on freight car lease buyouts from 2022 to 2024 ($70 million in 2022, $57 million in 2023, and $143 million in 2024). This spending trend aligns with the company's 2025 capital plan, which includes acquiring freight cars to support asset replacement and growth opportunities, as part of a broader $3.4 billion investment strategy.",
      "llm_answer": "The total amount spent by Union Pacific (UNP) on freight‑car lease buyouts over the 2022‑2024 period is disclosed in the cash‑flow statement under “Leased assets obtained in exchange for operating lease liabilities,” which shows $119 million in 2024, $241 million in 2023 and $70 million in 2022; the $143 million figure cited in Note 10 for 2024 includes lease‑buyout costs. This spending aligns with UNP’s 2025 capital plan, which earmarks roughly $3.4 billion of capital investment—including continued acquisition of freight cars to replace aging equipment and support growth—so the lease‑buyout outlays are a component of the broader fleet‑renewal strategy outlined for 2025.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, UNP spent $70M in 2022, $57M in 2023, and $143M in 2024, totaling $270M. However, the LLM states $70M in 2022 (correct), $241M in 2023 (incorrect—this appears to be a misreading of cash flow items, possibly conflating total lease liabilities with buyouts), and $119M in 2024 (incorrect—contradicts both its own reference to $143M in Note 10 and the ground truth). The total is therefore miscalculated and not stated explicitly, though summing the LLM's numbers gives ~$410M, far above the correct $270M. (2) The LLM references $143M in 2024 from Note 10, which matches the ground truth, but contradicts its earlier $119M figure from the cash flow statement, creating internal inconsistency. It fails to reconcile these or state the correct total. (3) The qualitative reasoning is partially sound: it correctly links lease buyouts to the 2025 capital plan and identifies the $3.4B investment strategy and freight car acquisitions for replacement and growth. This shows multi-hop synthesis between lease activity and future planning. However, the flawed numbers undermine the reasoning. (4) Contextual relevance is high—the answer addresses both parts of the question and attempts to cite specific disclosures and notes. Despite correct terminology and conceptual alignment, the severe numerical errors in two out of three years and the resulting incorrect total justify a low correctness score. Minor credit is given for correct 2022 figure and accurate mention of $143M in Note 10 for 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 438,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What was the total notional amount of accelerated share repurchase agreements entered into by CVS Health Corporation under the 2021 Repurchase Program based on the disclosed forward contract amounts and initial treasury stock transactions in 2022 and 2023?",
      "original_answer": "The total notional amount of accelerated share repurchase agreements entered into by CVS Health Corporation under the 2021 Repurchase Program was $3.5 billion. This is calculated by summing the $2.0 billion notional amount from the ASR disclosed in the 2023 transaction and the $1.5 billion notional amount from the ASR disclosed in the 2022 transaction.",
      "llm_answer": "Based on the disclosed forward contract amounts and initial treasury stock transactions under the 2021 Repurchase Program, the total notional amount of accelerated share repurchase agreements entered into by CVS Health Corporation was $1.5 billion for the 2022 ASR and $2.0 billion for the 2023 ASR, for a combined total notional amount of $3.5 billion.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: $1.5 billion for the 2022 ASR and $2.0 billion for the 2023 ASR, summing to $3.5 billion total notional amount. The format variations ($1.5 billion vs $1.5 billion) are acceptable and semantically equivalent. (2) The answer is complete, addressing both the individual forward contract amounts and the total, as required by the multi-part nature of the question. (3) Entity accuracy is correct: CVS Health Corporation, the 2021 Repurchase Program, and the correct years (2022 and 2023) are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis—aggregating disclosed ASR amounts from two separate years under the same repurchase program. The LLM correctly infers the total from disclosed forward contracts and treasury stock transactions, aligning with the knowledge graph logic. Overall, the answer is factually precise, contextually relevant, and semantically equivalent to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 300,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "Given GM's dependency on full-size ICE pickup trucks for near-term profitability and the risks outlined in the forward-looking statements, how does the company's reliance on these vehicles interact with its strategic shift toward electric vehicles (EVs) to impact long-term financial stability?",
      "original_answer": "GM's near-term profitability is heavily dependent on the success of its full-size ICE pickup trucks, which currently generate the highest profit margins and fund the company's strategic shift toward EVs. However, the forward-looking statements highlight that any shift in consumer preferences toward smaller, more fuel-efficient vehicles could weaken demand for these high-margin ICE vehicles. This would reduce the cash flow available to invest in EV development, which is critical to GM's long-term strategy. Therefore, a decline in ICE truck sales could jeopardize both short-term financial performance and the funding necessary to transition to an all-electric future, creating a dual risk that threatens both immediate and long-term financial stability.",
      "llm_answer": "GM's near-term profitability relies heavily on high-margin full-size ICE trucks and SUVs, which fund its EV transition but face demand risks from fuel price shifts, economic instability, or regulatory changes. While the company is investing in EV infrastructure and aims for an all-electric future by 2040, its long-term financial stability hinges on successfully scaling EV production, reducing battery costs, and achieving consumer adoption—factors that could strain resources if ICE demand declines faster than EV profitability materializes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core dynamics described in the ground truth. It correctly identifies that GM's near-term profitability depends on high-margin ICE trucks and SUVs (note: expands slightly to include SUVs, which is contextually reasonable though not in the original), and that these profits fund the EV transition. It acknowledges the risk of declining ICE demand due to external factors (fuel prices, economy, regulation), which aligns with the original's concern about shifting consumer preferences. The LLM also correctly notes that long-term stability depends on scaling EV production, reducing battery costs, and achieving adoption—key elements of GM's strategy. It accurately reflects the tension between ICE decline and EV ramp-up, highlighting the financial risk if the transition doesn't align. The only minor gap is that it does not explicitly state that a decline in ICE sales would directly reduce cash flow for EV investment—a key causal link emphasized in the original. However, this is implied in the phrasing about resources being strained. No numbers, dates, or financial metrics are incorrect; the mention of '2040' for an all-electric goal is consistent with GM's public targets and does not contradict the original. The reasoning is sound, multi-hop synthesis is appropriate, and the answer is fully relevant to the question. Thus, the answer is semantically equivalent with only slight omission of explicit causality, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 419,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the uncertainty around the pace of the energy transition, as influenced by changing commodity prices and regulatory developments, affect Chevron's asset impairment assessments and upstream investment decisions?",
      "original_answer": "Chevron evaluates the pace of the energy transition as a key factor in its commodity price forecasting and asset impairment assessments. Due to the uncertainty around the energy transition, Chevron may face reduced demand for traditional oil and gas products, which directly affects upstream earnings, cash flows, and capital expenditure programs. This uncertainty complicates impairment evaluations, as future cash flows from upstream assets depend on long-term assumptions about commodity prices, carbon costs, production profiles, and regulatory changes. If the energy transition accelerates or commodity prices remain low, Chevron may be forced to impair upstream assets, particularly those tied to crude oil, which could negatively impact its financial condition and reduce its ability to invest in new business lines such as lower-carbon energy solutions.",
      "llm_answer": "The pace of the energy transition and volatile commodity prices and evolving regulations are key drivers that Chevron incorporates into its impairment reviews for upstream properties. Management evaluates assets for impairment when downward revisions to reserves, commodity price outlooks, or regulatory changes suggest that expected future cash flows may not recover the carrying value, and such assessments directly influence decisions on upstream investment allocations.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth in terms of key concepts and causal relationships. It correctly identifies that uncertainty in the energy transition—driven by commodity prices and regulatory developments—affects Chevron's impairment assessments and upstream investment decisions. The answer accurately reflects that impairment evaluations are triggered by downward revisions to reserves, commodity price outlooks, or regulatory changes, which impact expected future cash flows and carrying value recoverability. This directly influences capital allocation decisions, particularly in upstream segments. There are no numeric values in either the original or LLM answer, so quantitative accuracy is scored as 10 by default. The qualitative accuracy is slightly reduced (8) because the LLM omits specific consequences mentioned in the ground truth, such as the potential negative impact on financial condition and reduced ability to invest in lower-carbon energy solutions. Additionally, it does not explicitly mention that accelerated energy transition or sustained low prices could lead to impairments of crude oil–tied assets. While the core reasoning is sound and semantically equivalent, these omissions prevent a perfect score. Contextual relevance is full, as the response directly addresses the question’s focus on impairment and investment decision-making under uncertainty.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 391,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does Mastercard's provision of Consumer Engagement Services, as part of its broader payment solutions, support its global payments network operations and financial performance?",
      "original_answer": "Mastercard's provision of Consumer Engagement Services enhances its global payments network by drawing on the company's principled and responsible use of secure data, which helps attract and retain consumers and merchants. This, in turn, strengthens the network's utility and drives additional payment flows, contributing to the company's financial performance. These services are part of a suite of offerings that are fundamentally interdependent and support the overall efficiency and attractiveness of Mastercard's global payments network.",
      "llm_answer": "Mastercard's Consumer Engagement Services, delivered through its global payments network and value-added solutions, directly support its network operations by driving transaction volume and revenue growth—evidenced by a 12% GAAP net revenue increase to $28.2B in 2024 and a 15% rise in net income to $12.9B. These services, which include security solutions, consumer acquisition, and engagement tools, enhance network effects and interoperability, enabling the company to capture new payment flows and generate recurring revenue streams. This operational leverage underpins its strong financial performance, reflected in $2.4B in capital returned to stockholders and $13.5B in adjusted net income (up 18% YoY), demonstrating how engagement-driven volume growth fuels both network expansion and profitability.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several specific financial figures—such as a 12% GAAP net revenue increase to $28.2B in 2024, net income of $12.9B, $2.4B in capital returned, and $13.5B in adjusted net income (up 18% YoY)—that are not present in the original answer and cannot be verified from the provided ground truth. These numbers appear fabricated or hallucinated, as the ground truth does not include any quantitative financial data. This severely undermines factual accuracy. (2) There are no calculations in the original answer to verify, but the LLM introduces multiple precise percentages and dollar amounts with specific years (e.g., 2024) that are not supported by the source, failing the quantitative accuracy test. (3) The qualitative reasoning—linking Consumer Engagement Services to network effects, transaction volume, and financial performance—is generally sound and aligns with the original answer’s logic about how these services strengthen the network and drive payment flows. The model correctly identifies the interdependence of services and their impact on network utility and profitability, showing adequate multi-hop synthesis between service offerings and financial outcomes. (4) Contextually, the answer is relevant and addresses the question well, explaining how Consumer Engagement Services support operations and financial performance. However, the inclusion of unsupported numerical data drastically reduces overall correctness. While the conceptual framework matches the ground truth, the hallucinated metrics make the answer misleading despite its logical structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 440,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What was the total net cash outflow impact from Walmart's acquisition and subsequent sale of Alert Innovation across fiscal years 2023 and 2025, considering the initial acquisition cost and the deconsolidation in the final year?",
      "original_answer": "The total net cash outflow impact from Walmart's acquisition and deconsolidation of Alert Innovation was $0.4 billion, as the company initially spent $0.4 billion to acquire Alert Innovation in fiscal 2023 and realized no net cash inflow from its deconsolidation in fiscal 2025.",
      "llm_answer": "The total net cash outflow impact from Walmart's acquisition and subsequent sale of Alert Innovation across fiscal years 2023 and 2025—accounting for the $0.4 billion purchase of Alert Innovation in 2023 and the $3.5 billion cash outflow in 2024 for the sale/deconsolidation—is approximately **$3.9 billion**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both numbers and reasoning. The ground truth states that Walmart spent $0.4 billion to acquire Alert Innovation in fiscal 2023 and realized no cash inflow from its deconsolidation in fiscal 2025, resulting in a total net cash outflow of $0.4 billion. The LLM incorrectly claims a $3.5 billion cash outflow in 2024 related to the sale/deconsolidation, which is not supported by the original answer and contradicts the fact that deconsolidation resulted in no net cash inflow (let alone a cash outflow). (2) Quantitatively, the LLM invents a $3.5 billion outflow not present in the ground truth, and incorrectly sums $0.4B + $3.5B = $3.9B, which is entirely false. The correct total net cash outflow is $0.4 billion. (3) The multi-hop reasoning fails: the LLM misunderstands deconsolidation as involving a cash outflow, when the original answer explicitly states there was no net cash inflow (implying no significant cash transaction). It also misplaces events in time, citing a 2024 event when the question focuses on 2023 and 2025. (4) The contextual relevance is low due to fabricated data and incorrect logic, though it attempts to address the acquisition and deconsolidation. Scores are low due to complete failure in factual accuracy and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 365,
        "total_tokens": 1533
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "Considering the information provided about LTIP Units in both disclosures, what is the combined total of potentially dilutive securities for the year ended December 31, 2023, and why was no adjustment made to net income attributable to common stockholders?",
      "original_answer": "The combined total of potentially dilutive securities for the year ended December 31, 2023, includes units exchangeable for common stock and LTIP Units. No adjustment was made to net income attributable to common stockholders because these securities had no material dilutive effect during the reporting period.",
      "llm_answer": "The combined total of potentially dilutive securities for the year ended December 31 2023 is limited to LTIP units, which the company reports as the only potentially dilutive instrument and notes that “no securities had a material dilutive effect” for 2023. No adjustment was made to net income attributable to common stockholders because the company determined that including allocations to limited partners or units would have no dilutive impact, so it excluded such allocations from the earnings per share calculation.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a key factual inaccuracy: it states that LTIP units are the 'only potentially dilutive instrument,' while the ground truth specifies that the combined total includes both 'units exchangeable for common stock' and 'LTIP Units.' This omission of a major component of dilutive securities reduces completeness and accuracy. (2) There are no explicit numerical values in either answer, so quantitative accuracy is not compromised—both correctly avoid providing incorrect numbers. The date (December 31, 2023) is correctly referenced. (3) The reasoning is flawed in the multi-hop synthesis: the model fails to acknowledge both types of securities mentioned in the original answer, suggesting a failure to integrate information from both disclosures as required by the question. This undermines the qualitative accuracy. (4) The explanation for no adjustment to net income is semantically close—the LLM correctly identifies that no material dilutive effect was present and that allocations were excluded from EPS calculation—but phrases it in terms of 'allocations to limited partners or units' rather than clearly stating the lack of material dilutive effect, which is less precise than the original. Despite this, the core rationale is directionally correct. Thus, while contextually relevant and factually plausible in parts, the failure to identify both components of potentially dilutive securities significantly impacts correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 412,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the total value of Investments measured at NAV across both disclosed asset categories in the 2023 10-K filing for VZ, and how does this compare to the total investments at fair value in each category?",
      "original_answer": "The total value of Investments measured at NAV across both asset categories in the 2023 10-K filing for VZ is $14 million ($9 million from the first category and $5 million from the second). This represents 3.1% of the total investments at fair value, which sum to $902 million ($441 million in the first category and $461 million in the second).",
      "llm_answer": "The total value of investments measured at NAV across both disclosed asset categories in the 2023 10-K filing for VZ is $5 million (as shown in the “Investments measured at NAV” line of the table in Note 13 on page 93). This amount is disclosed separately from the total investments at fair value, which are reported as $461 million at fair value (the “Total investments at fair value” figure in the same table). Consequently, the NAV‑measured investments represent a small fraction of the overall fair‑value‑measured investment portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors. (1) The total value of Investments measured at NAV is incorrectly stated as $5 million, whereas the ground truth specifies $14 million ($9 million + $5 million) across both categories. The LLM appears to have only reported the second category or misread the table. (2) The total investments at fair value are reported as $461 million, but the correct sum is $902 million ($441 million + $461 million). The LLM incorrectly uses only one category’s value instead of the total across both. (3) The comparison stating that NAV-measured investments represent a 'small fraction' lacks precision and omits the correct percentage (3.1%) provided in the original answer. (4) Multi-hop reasoning failed: the model did not correctly aggregate values across both asset categories for either NAV or fair value measures, leading to incorrect totals and comparisons. While the answer references the correct document (2023 10-K for VZ) and relevant note (Note 13), the core numerical and synthetic elements are inaccurate. Contextual relevance is moderate as it addresses the right topic and structure, but factual correctness is severely compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 337,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How much in equity earnings did GM report from Ultium Cells Holdings LLC in 2023, and in what financial statement category were these earnings disclosed?",
      "original_answer": "General Motors reported $293 million in equity earnings from Ultium Cells Holdings LLC in the year ended December 31, 2023, and these earnings were disclosed under 'Automotive and other cost of sales' in the financial statements.",
      "llm_answer": "In 2023, GM reported equity earnings of **$293 million** from its investment in Ultium Cells Holdings LLC. These earnings were disclosed in the “Equity in net assets of nonconsolidated affiliates” section of the consolidated financial statements.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the equity earnings amount of $293 million from Ultium Cells Holdings LLC in 2023, matching the ground truth exactly. This satisfies the quantitative accuracy requirement. However, the financial statement category is incorrect: the LLM states the earnings were disclosed under 'Equity in net assets of nonconsolidated affiliates', while the ground truth specifies they were included in 'Automotive and other cost of sales'. This is a significant qualitative error because it misrepresents how and where the earnings are accounted for in GM's financial statements. (2) The number ($293 million) and year (2023) are accurate, with proper formatting. (3) The multi-hop reasoning is partially sound—GM’s equity earnings from Ultium Cells are correctly attributed—but the model fails to accurately trace the disclosure location within the financial statements, indicating a flaw in synthesis or source interpretation. (4) The correctness score is 7 because the core financial figure is correct and the response addresses both parts of the question, but the misclassification of the financial statement line item reduces accuracy. Quantitative accuracy is 10 due to correct numbers. Qualitative accuracy is 6 due to the incorrect financial statement category. Contextual relevance is 9 as the answer is well-focused and relevant, only missing precision in disclosure location.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1120,
        "completion_tokens": 392,
        "total_tokens": 1513
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the change in equity ownership percentage of Principal or Affiliate Customers (Class B stockholders) from 2023 to 2024, and how does this shift reflect in the overall ownership structure of MA?",
      "original_answer": "The equity ownership of Principal or Affiliate Customers (Class B stockholders) decreased from 0.8% in 2023 to 0.7% in 2024, a reduction of 0.1 percentage points. This shift indicates a minor decline in the relative ownership stake of this group within MA's overall ownership structure.",
      "llm_answer": "The equity ownership percentage of Principal or Affiliate Customers (Class B stockholders) declined from 0.8% in 2023 to 0.7% in 2024, reflecting a modest reduction in their share of overall ownership. This shift indicates a slight decrease in the relative influence of these customers within Mastercard’s ownership structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the equity ownership decrease from 0.8% in 2023 to 0.7% in 2024, matching the ground truth exactly. The reduction of 0.1 percentage points is accurately implied, though not explicitly stated as a calculated difference. (2) All numeric values—percentages and years—are correct and match the original answer. There are no calculation errors; the implied change (0.8% to 0.7%) is accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes the change over time and interprets its implication on MA's (Mastercard's) ownership structure. The term 'slight decrease' or 'modest reduction' is semantically equivalent to 'minor decline' in the original answer. (4) The only minor shortcoming is that the exact numerical difference (0.1 percentage points) is not explicitly mentioned, which slightly reduces completeness but does not affect factual correctness. Otherwise, the answer is factually accurate, contextually appropriate, and well-reasoned. Hence, high scores across all dimensions with a 9 in correctness and qualitative accuracy due to this small omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 321,
        "total_tokens": 1488
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What was the total financial impact on Walmart (WMT) in terms of cash outflows related to Alert Innovation during fiscal 2023, and what happened to this entity in the following fiscal year?",
      "original_answer": "Walmart spent $0.4 billion to acquire Alert Innovation in fiscal 2023, and then subsequently sold and deconsolidated the entity in fiscal 2025.",
      "llm_answer": "The total financial impact on Walmart related to Alert Innovation during fiscal 2023 was a cash outflow of approximately $0.4 billion for its acquisition. In the following fiscal year (fiscal 2024), this entity was sold and de‑consolidated, resulting in its removal from Walmart’s balance sheet.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $0.4 billion cash outflow for Walmart's acquisition of Alert Innovation in fiscal 2023, which matches the ground truth. However, it incorrectly states that the sale and deconsolidation occurred in fiscal 2024, while the original answer specifies fiscal 2025. This is a factual error in timing. (2) Quantitatively, the $0.4 billion figure is accurate and properly formatted; no calculation errors are present. (3) The multi-hop reasoning is mostly sound—linking the acquisition to the subsequent divestiture—but the model fails in accurately synthesizing the correct fiscal year for the deconsolidation, which undermines the completeness of the temporal logic. (4) Despite the year error, the answer is contextually relevant and captures the core financial and strategic events. The correctness score is reduced due to the incorrect fiscal year for the sale, but not severely penalized as the key financial impact is accurate and the overall narrative is largely correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1120,
        "completion_tokens": 293,
        "total_tokens": 1414
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How much total principal was repaid using borrowings from the 2021 Multicurrency Credit Facility in early 2024, and what was the impact on the facility's remaining borrowing capacity as of December 31, 2023?",
      "original_answer": "The company repaid a total principal of $1.5 billion using borrowings from the 2021 Multicurrency Credit Facility in early 2024 ($500 million from the 0.600% Notes and $1.0 billion from the 5.00% Notes). As of December 31, 2023, the company still had the ability to borrow up to $6.0 billion under the facility, which includes a $3.5 billion sublimit for multicurrency borrowings, a $200.0 million sublimit for letters of credit, and a $50.0 million sublimit for swingline loans.",
      "llm_answer": "The Company repaid $1.5 billion of principal using borrowings from the 2021 Multicurrency Credit Facility in early 2024 (the $500 million repayment of the 0.600 % senior notes and the $1.0 billion repayment of the 5.00 % senior notes). As of December 31 2023, the facility had $723.4 million of outstanding principal, leaving approximately $5.3 billion of remaining borrowing capacity under the $6.0 billion commitment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total principal repaid ($1.5 billion) and its components ($500 million from 0.600% Notes and $1.0 billion from 5.00% Notes), which matches the ground truth. However, it introduces a new figure—$723.4 million of outstanding principal as of December 31, 2023—that is not present in the original answer and contradicts the ground truth. The original answer states that the remaining borrowing capacity was $6.0 billion, implying no reduction due to prior drawdowns, or that the facility was undrawn as of that date. The LLM’s calculation of $5.3 billion remaining capacity ($6.0B - $723.4M) is therefore factually inconsistent with the ground truth. (2) Quantitative accuracy is partially correct: the $1.5B repayment is accurate, but the $723.4M outstanding and resulting $5.3B capacity are unsupported and incorrect per the provided truth. These numbers may reflect real filing data but contradict the knowledge graph’s ground truth, which explicitly states $6.0B remains available. (3) The multi-hop reasoning is sound in structure—linking early 2024 repayments to the credit facility and assessing impact on capacity—but fails in execution because it assumes drawdowns occurred before December 31, 2023, while the ground truth implies the full capacity was still available. (4) Contextual relevance is high—the answer addresses both parts of the question and uses appropriate financial terminology. However, the incorrect quantitative assumption about outstanding principal significantly undermines factual correctness, warranting a moderate score of 6 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 445,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does Intel's use of EUV in its Intel 4 and Intel 3 process nodes relate to its broader roadmap for advanced transistor architectures, and what future node is expected to introduce High Numerical Aperture EUV as part of this progression?",
      "original_answer": "Intel uses EUV in its Intel 4 process node to print small features using ultra-short wavelength light, which is critical for improving performance-per-watt and enabling future client processors like Meteor Lake. Intel 3 builds on this by leveraging further FinFET optimizations and increased EUV usage to deliver additional area and efficiency improvements. This progression sets the stage for Intel 20A, which will introduce RibbonFET (Intel's implementation of gate-all-around transistor architecture) and PowerVia (backside power delivery). Beyond Intel 20A, Intel is developing Intel 18A, which will refine RibbonFET performance and incorporate next-generation High Numerical Aperture EUV in its process technology roadmap.",
      "llm_answer": "Intel’s roadmap advances from the EUV‑enabled Intel 4 node (used for Meteor Lake) to the next‑generation Intel 3 node, which builds on Intel 4’s EUV foundation with further FinFET optimizations and increased EUV exposure to improve performance‑per‑watt and area efficiency. The progression continues toward Intel 20A (introducing RibbonFET and PowerVia) and ultimately Intel 18A, where High Numerical Aperture (High‑NA) EUV is slated to be introduced as part of the company’s advanced process technology roadmap.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key elements are correctly addressed: Intel 4 uses EUV for small feature printing, enabling Meteor Lake; Intel 3 builds on this with more EUV and FinFET optimizations for better efficiency and area; the roadmap progresses to Intel 20A with RibbonFET and PowerVia; and Intel 18A is correctly identified as the node introducing High Numerical Aperture (High-NA) EUV. (2) There are no numeric values requiring calculation (e.g., dates, dollar amounts), but process node names (Intel 4, Intel 3, Intel 20A, Intel 18A) are all correct and consistent with the original. (3) The multi-hop reasoning is sound—information is synthesized across multiple process nodes and technological advancements (EUV → FinFET → RibbonFET → High-NA EUV), correctly tracing the evolution of Intel's roadmap. (4) The answer is concise but complete, capturing all necessary technical transitions and future plans without omissions or inaccuracies. Wording differs slightly but meaning is preserved. All scores are maximized due to full factual alignment and logical coherence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 322,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What is the total combined value of investments in U.S. Treasuries and agencies reported across both disclosed asset categories in the 2023 10-K filing by VZ, and how does this compare to the total cash and cash equivalents?",
      "original_answer": "The total combined value of investments in U.S. Treasuries and agencies is $239 million ($101 million + $138 million). This amount is significantly higher than the total cash and cash equivalents, which sum to $57 million ($30 million + $27 million).",
      "llm_answer": "The total combined value of investments in U.S. Treasuries and agencies reported across both disclosed asset categories in Verizon’s 2023 10-K filing is $138 million (as shown in the “Other postretirement benefit plans” table on page 93, which lists $138 million for U.S. Treasuries and agencies at fair value). This amount is part of the $461 million total fair‑value investments reported for those plans, and it is significantly smaller than the total cash and cash equivalents of $27 million listed for the same category (cash and cash equivalents are $27 million, which is less than the $138 million in U.S. Treasuries and agencies).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The total combined value of investments in U.S. Treasuries and agencies is stated as $138 million, but the ground truth is $239 million ($101 million + $138 million), indicating a failure to sum across both disclosed asset categories. The LLM only includes one component ($138 million) and omits the $101 million from the other category. (2) The comparison to cash and cash equivalents is also incorrect: the LLM claims cash and cash equivalents are $27 million (which matches one component) but fails to sum the total of $57 million ($30 million + $27 million). It then incorrectly states that $138 million in Treasuries is 'significantly smaller' than $27 million in cash, which is factually wrong—$138M is larger than $27M. The correct comparison is that $239M (Treasuries + agencies) is significantly higher than $57M (cash and equivalents), opposite to the LLM's conclusion. (3) The multi-hop reasoning is flawed: the question requires summing values across two disclosed asset categories (implying multiple tables or sections), but the LLM only identifies one. It fails to synthesize information across both sources, leading to incorrect totals and an inverted conclusion. (4) Contextual relevance is moderate—the answer addresses the right document (Verizon 2023 10-K), correct metric types (U.S. Treasuries, cash equivalents), and attempts to compare them—but due to critical errors in data aggregation and logic, the overall correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 429,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total net cash consideration paid by DHR for Aldevron and the other 11 businesses acquired in 2021, and how much of the total goodwill from these acquisitions was attributed specifically to Aldevron?",
      "original_answer": "DHR paid a total net cash consideration of $9,561 million for Aldevron and $1,340 million for the other 11 businesses acquired in 2021, totaling $10,901 million. Of the total goodwill of $7,187 million recorded for these acquisitions, $6,149 million was attributed specifically to Aldevron.",
      "llm_answer": "The total net cash consideration paid by DHR for Aldevron and the other 11 businesses acquired in 2021 was $10,901 million, of which $9,561 million was attributed specifically to Aldevron. The goodwill recognized from these acquisitions totaled $7,187 million, with $6,149 million of that amount attributable specifically to Aldevron.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $9,561 million for Aldevron, $1,340 million for the other 11 businesses (implied sum to $10,901 million), and $6,149 million of the total $7,187 million goodwill attributed to Aldevron. The total net cash consideration of $10,901 million is correctly stated. (2) The answer addresses both parts of the multi-part question: total net cash consideration for all 12 acquisitions and the portion of goodwill attributed to Aldevron. (3) Entities are correct—DHR, Aldevron, the year 2021, and the financial metrics (net cash consideration, goodwill) are all accurately identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly aggregates data across acquisitions and isolates Aldevron's contribution to both cash consideration and goodwill. (5) Semantic equivalence is maintained—though the LLM combines the two components of cash consideration into a total upfront, it still specifies the Aldevron portion, and the goodwill breakdown is exact. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 326,
        "total_tokens": 1498
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was GM's total committed capital contribution to Ultium Cells Holdings LLC as of December 31, 2023, and how does this compare to the carrying amount of GM's investment in Ultium Cells Holdings LLC on its balance sheet for the same date?",
      "original_answer": "GM had a committed capital contribution of $0.8 billion to Ultium Cells Holdings LLC as of December 31, 2023, while the carrying amount of its investment in Ultium Cells Holdings LLC was $2,268 million on the same date. This indicates that GM had not fully funded its committed capital contribution as of year-end.",
      "llm_answer": "As of December 31 2023, GM’s total committed capital contribution to Ultium Cells Holdings LLC was $0.8 billion, and the carrying amount of GM’s investment in Ultium Cells Holdings LLC on its balance sheet was $2.27 billion.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies GM's committed capital contribution as $0.8 billion and the carrying amount as $2.27 billion, which is semantically equivalent to the ground truth value of $2,268 million (rounded to $2.27 billion). The minor difference in formatting ($2.27 billion vs $2,268 million) does not affect factual accuracy. (2) Quantitative accuracy is high: both values are correct within acceptable rounding conventions. The original answer uses $2,268 million, which equals $2.268 billion, and the LLM reports $2.27 billion—a standard rounding to two decimal places. No calculation errors are present. (3) The multi-hop reasoning is sound—information about committed capital and carrying amount from different parts of the financial statements is correctly synthesized. While the LLM omits the explicit conclusion that GM had not fully funded its commitment, this interpretive point is not strictly required to answer the two-part factual question. (4) Scores reflect near-perfect factual accuracy, strong reasoning, and full contextual relevance. The omission of the interpretive sentence slightly reduces completeness but does not detract from core correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 337,
        "total_tokens": 1496
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What is the total amount of depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023, and how does it compare to the net book value of proved and unproved properties in that region as of December 31, 2023?",
      "original_answer": "The total depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023 was $5,729 million. The net book value of proved and unproved properties in the Lower 48 region as of December 31, 2023, was $37,185 million. This means that the accumulated depreciation, depletion, and amortization for the Lower 48 region, which was $36,829 million, when added to the 2023 depreciation, depletion, amortization, and impairments of $5,729 million, results in a total accumulated value of $42,558 million. This represents a significant portion of the original total property value of $74,014 million for the Lower 48 region.",
      "llm_answer": "The total depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023 were $5,729 million, which is lower than the net book value of proved and unproved properties in that region—$37,185 million as of December 31, 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the two key figures: total depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023 is $5,729 million, and the net book value of proved and unproved properties as of December 31, 2023, is $37,185 million — both match the ground truth exactly. (2) Quantitative accuracy is perfect — numbers are correct, properly formatted, and consistent with the original answer. (3) However, the qualitative accuracy is lower because the LLM fails to address the deeper multi-hop reasoning required: it only makes a surface-level comparison (that $5,729M < $37,185M), while the ground truth provides synthesis showing how the 2023 charge fits into accumulated depreciation ($36,829M) and total historical property value ($74,014M), explaining the broader context of asset lifecycle and book value evolution. This missing synthesis represents a significant omission in reasoning. (4) Contextual relevance is high because the answer addresses the core question parts and makes a valid comparison, but completeness is lacking due to the absence of the extended analysis present in the original answer. Thus, while factually correct, the answer is less comprehensive in multi-hop financial reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 353,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total amount repaid under the 2021 Multicurrency Credit Facility in 2023, including both USD and EUR-denominated repayments, and how did this repayment activity affect the company's overall revolving indebtedness under this facility?",
      "original_answer": "The total amount repaid under the 2021 Multicurrency Credit Facility in 2023 was $6.1 billion, which included $919.1 million from the repayment of 842.6 million EUR. This significant repayment activity reduced the company's revolving indebtedness under the facility, contributing to a net decrease despite borrowing $3.0 billion during the year for purposes such as repaying the 2021 USD Two Year Delayed-Draw Term Loan and for general corporate purposes.",
      "llm_answer": "In 2023, the company repaid a total of $6.1 billion under the 2021 Multicurrency Credit Facility, which included $842.6 million of Euro‑denominated borrowings (equivalent to $919.1 million at the repayment date). This repayment reduced the facility’s revolving indebtedness from $3.0 billion of borrowings during the year to a lower outstanding balance, thereby decreasing the total revolving debt outstanding under the facility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total repayment amount of $6.1 billion and accurately breaks down the EUR-denominated repayment as $842.6 million EUR equivalent to $919.1 million USD, matching the ground truth. All numeric values are factually correct and properly formatted. (2) Quantitative accuracy is perfect: $6.1 billion total repayment, $842.6 million EUR, and $919.1 million USD equivalent are all precisely stated. The calculation of the USD equivalent is not required but implied correctly. (3) The reasoning is largely sound—repayment reduced revolving indebtedness despite $3.0 billion in new borrowings. However, the LLM slightly mischaracterizes the $3.0 billion as 'borrowings during the year' without explicitly linking it to specific uses (e.g., repaying the 2021 USD Two Year Delayed-Draw Term Loan), which is mentioned in the ground truth and represents a minor omission in multi-hop synthesis. (4) The answer is contextually complete and relevant, conveying the impact on revolving indebtedness correctly. The only shortcoming is the lack of explicit mention of the purpose of the $3.0 billion borrowing, which slightly weakens the qualitative reasoning. Overall, the answer is factually accurate and semantically equivalent with only minor contextual omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 365,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014, as referenced in both the glossary and the business section, impact its operational costs and closure activities at coal ash impoundments?",
      "original_answer": "Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014 directly impacts its operational costs and closure activities at coal ash impoundments. According to the business section, Duke Energy has completed excavation of coal ash at three of the four high-priority North Carolina sites and has begun closure activities at all of its jurisdictions. These activities involve moving coal combustion residuals (CCR) to engineered landfills or for reuse, which requires significant planning, permitting, and execution. The costs associated with these closure activities are included in rate proceedings and partially recovered through amended wholesale contracts approved by FERC in 2017. Additionally, the glossary explicitly defines the Coal Ash Act, indicating its regulatory significance and the necessity for Duke Energy to factor compliance into its financial planning and operational timelines.",
      "llm_answer": "Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014—referenced in both the glossary and business sections—requires the company to develop and obtain regulatory approval for coal ash impoundment closure plans, including excavation and disposal of coal ash to approved sites. This regulatory process directly impacts operational costs, as compliance expenses (e.g., excavation, transportation, and disposal) are subject to cost recovery determinations by state utility commissions through standard rate cases, and influences closure activities by mandating specific remediation timelines and methods for high-priority sites.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of Duke Energy's compliance obligations under the North Carolina Coal Ash Management Act of 2014 and correctly identifies the impact on operational costs and closure activities. It accurately reflects that compliance involves excavation, disposal, regulatory approval, and cost recovery through rate cases—consistent with the original answer. The mention of cost recovery via state utility commissions aligns with the ground truth's reference to rate proceedings, though it omits the specific FERC-approved amended wholesale contracts from 2017, which is a notable but not critical omission. The answer also correctly notes the requirement for closure plans and remediation timelines, especially for high-priority sites, and references both the glossary and business section as sources. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (Duke Energy, North Carolina Coal Ash Management Act of 2014) are correct. The reasoning is sound and synthesizes regulatory, operational, and financial aspects. However, it lacks specific details about the completion of excavation at three of four high-priority sites and the use of engineered landfills or reuse of CCR, which are key elements in the original answer. While the core facts and logic are correct, these omissions prevent a top score. Semantic equivalence is largely maintained, and the response is fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 405,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does Intel's FPGA technology, specifically the Agilex family, contribute to its IPU platforms and what role does the Intel eASIC N5X play in this context?",
      "original_answer": "Intel's Agilex FPGA family, built on Intel 10nm SuperFin technology, plays a critical role in its IPU platforms by enabling cloud and communications service providers to reduce overhead and free up CPU performance. The Agilex FPGA is already being deployed in IPU platforms at multiple cloud service providers. Additionally, the Intel eASIC N5X, as the next-generation Intel eASIC device, complements this ecosystem by offering a structured ASIC solution that provides lower unit cost and lower power compared to FPGAs, while still enabling fast time-to-market and reduced non-recurring engineering costs. This combination allows Intel to offer scalable, high-performance, and power-efficient solutions tailored for evolving infrastructure demands in cloud and communications.",
      "llm_answer": "Intel’s Agilex FPGA family—built on the Intel 10 nm SuperFin process—provides the programmable, high‑performance fabric that underpins the company’s IPU (Infrastructure Processing Unit) platforms, enabling cloud and communications providers to offload networking, storage and edge workloads from CPUs and achieve lower total cost of ownership.  The Intel eASIC N5X, a next‑generation structured ASIC, complements this strategy by offering a lower‑cost, lower‑power alternative to FPGAs for 5G and other acceleration tasks, further expanding the IPU ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong semantic equivalence. (1) All key facts are correct: Agilex FPGAs are built on Intel 10nm SuperFin technology and used in IPU platforms to offload CPU workloads; the eASIC N5X is correctly identified as a next-generation structured ASIC that offers lower cost and power than FPGAs. (2) There are no numeric values requiring verification (e.g., dates, dollar amounts, percentages), so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound—linking Agilex FPGAs to IPU platforms and positioning eASIC N5X as a complementary, cost- and power-optimized alternative for scalable infrastructure solutions. The LLM correctly synthesizes the technological and strategic relationship between FPGA and structured ASIC in Intel's portfolio. (4) Minor omission: the original answer notes Agilex is 'already being deployed in IPU platforms at multiple cloud service providers' and highlights reduced non-recurring engineering costs for eASIC—details not included in the LLM response. However, these are secondary to the main technical and strategic points. Wording differs but meaning aligns closely. Contextual relevance is excellent as it directly addresses both parts of the question: Agilex's role in IPUs and how eASIC N5X complements it.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 373,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How many employees does Danaher have in Other Developed Markets compared to North America, and what percentage of the total global workforce do these regions collectively represent?",
      "original_answer": "Danaher has 3,000 employees in Other Developed Markets and 24,000 employees in North America, collectively representing approximately 42.86% of the company's total global workforce of 63,000 employees.",
      "llm_answer": "Danaher has approximately 20,000 employees in Western Europe and 3,000 employees in other developed markets, for a combined total of 23,000 employees in those regions. Together they represent about 10 percent of the company’s global workforce of roughly 63,000 employees.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It states Danaher has 20,000 employees in Western Europe, which is not mentioned in the ground truth and is irrelevant to the question. The question asks specifically about 'Other Developed Markets' and 'North America', but the LLM incorrectly introduces Western Europe and omits North America entirely. The correct numbers are 3,000 in Other Developed Markets and 24,000 in North America. Instead, the LLM reports a combined 23,000 employees in 'Western Europe and other developed markets', which misrepresents both the regions and the totals. (2) The percentage calculation is also incorrect: 23,000 out of 63,000 is approximately 36.5%, not 10%, and the correct combined total of 27,000 (3,000 + 24,000) represents ~42.86% as per ground truth. The global workforce number (63,000) is correct. (3) The multi-hop reasoning fails because the model does not correctly identify the two required regions, conflates entities (adding Western Europe), and performs incorrect synthesis. It fails to compare the correct regions as specified in the question. (4) Scores reflect major factual and quantitative inaccuracies, flawed reasoning, and partial relevance since it discusses employee counts and global workforce but with wrong regions and numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 366,
        "total_tokens": 1493
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, and how does this compare to the total derivative assets reported on the balance sheet for the same year?",
      "original_answer": "The total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, is $557 million. This matches the total derivative assets reported on the balance sheet for the same year, indicating that all derivative assets were composed of foreign exchange forwards and options.",
      "llm_answer": "The total fair value of Nike's foreign exchange forwards and options as of May 31 2023 was $557 million, which is reflected in the balance‑sheet line “Prepaid expenses and other current assets” for the derivative assets. This $557 million of derivative assets is part of the total derivative assets of $557 million reported on the balance sheet for that year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total fair value of Nike's foreign exchange forwards and options as $557 million as of May 31, 2023, matching the ground truth. It also correctly states that this amount is equal to the total derivative assets reported on the balance sheet for the same year. (2) Quantitatively, all numbers and dates are accurate: $557 million and May 31, 2023, are correctly reported. The format variation ($557 million vs $557M) is acceptable. (3) The reasoning is mostly sound: the LLM correctly infers that the $557 million in foreign exchange derivatives equals the total derivative assets, implying these instruments constitute the entirety of derivative assets. However, it adds a detail not present in the ground truth—specifically naming 'Prepaid expenses and other current assets' as the balance sheet line item—without confirming whether this fully captures all derivative assets or only a portion. While this may be factually accurate based on the filing, the original answer does not include this level of detail, and including it could imply a more granular understanding than required, potentially introducing ambiguity if the categorization spans multiple lines. (4) The answer is contextually relevant and semantically equivalent to the ground truth in substance, with only minor over-specification in balance sheet line items. Thus, the correctness score is 9 due to full factual alignment on value and comparison, with a slight deduction in qualitative accuracy for the unverified specificity on balance sheet presentation not required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 440,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much did the depreciation, depletion, amortization, and impairments expense in the Lower 48 region increase from 2021 to 2023, and what was the corresponding change in the number of productive wells in that region over the same period?",
      "original_answer": "The depreciation, depletion, amortization, and impairments expense in the Lower 48 region increased by $1,662 million from 2021 ($4,067 million) to 2023 ($5,729 million). Over the same period, the number of productive wells in the Lower 48 region decreased by 49, from 87 in 2021 to 38 in 2023.",
      "llm_answer": "The depreciation, depletion, amortization, and impairments expense in the Lower 48 region increased by **$875 million** from 2021 to 2023 (rising from $4,067 million in 2021 to $5,729 million in 2023).  \n\nDuring the same period, the number of productive wells in the Lower 48 increased by **1,354 wells** (growing from 6,954 net productive wells in 2021 to 8,308 net productive wells in 2023).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in both the calculated change in expense and the change in productive wells. The increase in depreciation, depletion, amortization, and impairments expense is incorrectly stated as $875 million, while the correct increase is $1,662 million ($5,729M - $4,067M). The LLM appears to have made an arithmetic error despite citing the correct starting and ending values. More critically, the change in the number of productive wells is completely incorrect: the LLM claims an increase of 1,354 wells from 6,954 to 8,308, whereas the ground truth states a decrease from 87 to 38 wells (a reduction of 49). These numbers suggest confusion with a different dataset or company. (2) Quantitative accuracy is very low: while the 2021 and 2023 expense figures are correctly cited, the difference is miscalculated. The well count numbers are entirely wrong in both absolute values and direction of change. (3) The multi-hop reasoning fails because the model does not correctly synthesize the changes over time for both metrics. It retrieves or recalls incorrect base data for well counts and performs incorrect arithmetic on the expense change despite having correct inputs. (4) Contextual relevance is moderate because the answer addresses the right region (Lower 48), the correct expense category, and the time frame (2021 to 2023), but the factual inaccuracies severely undermine the response. The structure follows the question, but the content is largely incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 417,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total combined value of investments in U.S. Treasuries and agencies reported across both tables from Verizon's 2023 10-K filing, and how does this allocation compare between the two different categorizations of investments at fair value?",
      "original_answer": "The total combined value of investments in U.S. Treasuries and agencies from both tables is $2,953 million. In the first table, U.S. Treasuries and agencies are valued at $1,412 million and are categorized under fixed income securities with $1,274 million in Level 1 and $138 million in Level 2. In the second table, U.S. Treasuries and agencies are valued at $1,541 million, with $1,312 million in Level 1 and $229 million in Level 2. This indicates a slight increase in the value of U.S. Treasuries and agencies between the two categorizations, with a corresponding shift in the distribution between Level 1 and Level 2 assets.",
      "llm_answer": "The total combined value of investments in U.S. Treasuries and agencies reported across both tables in Verizon’s 2023 10-K filing is $1,412 million, which appears in the fair‑value breakdown of pension plan assets (page 92) and is also reflected in the 2023 pension‑plan asset summary (page 89). This allocation represents a larger share of the overall fair‑value portfolio under the first categorization (where U.S. Treasuries and agencies are listed as a distinct Level 2 category) compared with the second categorization, which groups them within the broader “Fixed income securities” line item. Consequently, the proportion of the total pension assets represented by U.S. Treasuries and agencies is higher when they are presented as a separate line item.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both total value and breakdown. The ground truth states the total combined value is $2,953 million ($1,412M + $1,541M), but the LLM reports only $1,412 million, omitting the second table's value entirely. This is a critical error in quantitative accuracy. (2) The LLM incorrectly implies that $1,412 million is the total across both tables, when in fact it is only the value from the first table. It fails to mention the $1,541 million from the second table, which is essential for the multi-hop synthesis. Additionally, the LLM misrepresents the categorization: in the first table, U.S. Treasuries and agencies are part of fixed income securities with Level 1 and Level 2 breakdowns, not a 'distinct Level 2 category' as claimed. The second table does not group them within fixed income securities broadly but rather presents a different fair value categorization with its own Level 1/Level 2 split. (3) The reasoning is flawed: the LLM fails to perform the required multi-hop synthesis of summing values across two tables and comparing Level 1/Level 2 distributions. Instead, it incorrectly treats one value as the total and draws an invalid conclusion about proportionality based on presentation format. (4) While the answer is relevant to the topic and attempts to address categorization differences, the severe factual and numerical inaccuracies—especially the missing $1.5 billion in investments—warrant a low correctness score. The contextual relevance is moderate because it discusses the right document and general concept, but the core answer is substantively wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 446,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "By how much did Nike's timed deposits classified as cash and equivalents decrease from fiscal year 2023 to 2024?",
      "original_answer": "Nike's timed deposits classified as cash and equivalents decreased by $155 million from fiscal year 2023 to 2024.",
      "llm_answer": "Based on the provided document pages, Nike's timed deposits classified as cash and equivalents decreased by **$133 million** from fiscal year 2023 to 2024. This is calculated by subtracting the 2024 figure ($347 million) from the 2023 figure ($502 million) shown in the \"Timedeposits\" row of the fair value hierarchy tables (Page 70). The decrease reflects a decline from $502 million to $347 million over the one-year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its quantitative claim — the ground truth states a $155 million decrease, but the LLM reports a $133 million decrease. This discrepancy undermines the core accuracy of the response. (2) The LLM cites specific figures: $502 million in 2023 and $347 million in 2024, calculating a difference of $155 million (502 - 347 = 155), but incorrectly states the result as $133 million, which is a clear calculation error. The individual year values ($502M and $347M) appear to be correctly extracted, aligning with the expected data, but the arithmetic mistake leads to an incorrect final figure. (3) The reasoning process is logically structured and demonstrates correct multi-hop synthesis — it identifies the relevant metric (timed deposits), locates the data for two fiscal years, and attempts to compute the year-over-year change. However, the failure in basic subtraction invalidates the conclusion. (4) Contextual relevance is high — the answer addresses the exact question, references the correct document section (Page 70, fair value hierarchy tables), and uses appropriate financial terminology. Despite sound reasoning and entity identification, the significant numerical error in the final calculation results in a low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 369,
        "total_tokens": 1495
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How much did the combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations total in 2023, and how does this compare to the combined total from 2022?",
      "original_answer": "The combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations totaled $6,790 million in 2023, compared to $5,795 million in 2022. This represents an increase of $995 million.",
      "llm_answer": "The combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations totaled **$6,790 million in 2023** ($1,061 million for Alaska and $5,729 million for Lower 48). In 2022, the same combined total was **$5,795 million** ($941 million for Alaska and $4,854 million for Lower 48), representing an increase of $995 million year‑over‑year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the 2023 combined total of $6,790 million and 2022 total of $5,795 million are accurate, and the year-over-year increase of $995 million is correctly calculated ($6,790M - $5,795M = $995M). The breakdowns by region (Alaska: $1,061M in 2023 vs $941M in 2022; Lower 48: $5,729M vs $4,854M) are consistent with the knowledge graph data and sum correctly to the reported totals. (2) The answer is complete, addressing both parts of the question: the 2023 total and its comparison to 2022. (3) All entities—Alaska, Lower 48, depreciation/depletion/amortization/impairments, and the years 2022 and 2023—are correctly identified and applied. (4) The multi-hop reasoning is sound: the model correctly aggregated data across regions and years, then computed the change, demonstrating accurate synthesis. (5) The semantic meaning is equivalent to the original answer, with added detail that enhances clarity without introducing error. All formatting variations (e.g., $6,790 million vs $6,790M) are acceptable and do not affect accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 318,
        "total_tokens": 1475
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total fair value of the crypto asset safeguarding liability and corresponding safeguarding asset reported by PayPal Holdings, Inc. as of December 31, 2022, and how is this reflected in the fair value measurement disclosures?",
      "original_answer": "PayPal Holdings, Inc. reported a total fair value of $604 million for both the crypto asset safeguarding liability and the corresponding safeguarding asset as of December 31, 2022. This is disclosed in both the financial assets and liabilities table and the related notes to consolidated financial statements, where the crypto asset safeguarding liability is listed under financial liabilities and the safeguarding asset is listed under financial assets, with both categorized under 'Significant Other Observable Inputs (Level 2)' for fair value measurement.",
      "llm_answer": "The total fair value of the crypto asset safeguarding liability and its corresponding safeguarding asset reported by PayPal Holdings, Inc. as of December 31, 2022 was $604 million each, as disclosed in the fair‑value hierarchy tables (page 94) where the crypto asset safeguarding asset and liability are measured at Level 3 using significant unobservable inputs. This valuation is reflected in the recurring fair‑value disclosures that categorize the asset and liability under Level 3, noting that no observable market prices exist for these items and that they are recorded within “prepaid expenses and other current assets” and “accrued expenses and other current liabilities” on the consolidated balance sheets.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total fair value amount of $604 million for both the crypto asset safeguarding liability and the corresponding safeguarding asset as of December 31, 2022, which matches the ground truth. The date and dollar amount are accurate, satisfying quantitative accuracy. (2) However, there is a critical error in the fair value hierarchy classification: the LLM states that the assets and liabilities are categorized under 'Level 3' (significant unobservable inputs), while the ground truth explicitly states they are classified under 'Level 2' (Significant Other Observable Inputs). This is a major qualitative inaccuracy affecting the correctness of the fair value measurement disclosure. (3) The multi-hop reasoning is partially sound—the model correctly links the asset and liability values and identifies their placement in the fair value tables and balance sheet captions. However, it fails to correctly synthesize the valuation level across the disclosures, indicating a flaw in reasoning or source interpretation. (4) Contextually, the answer is relevant and addresses both parts of the question (total value and disclosure treatment), but the misclassification of the fair value level undermines the technical accuracy of the response. While numbers are correct, the incorrect Level 3 designation contradicts the source and leads to a significant deduction in qualitative accuracy, resulting in a mid-range overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 406,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the net financial impact on Walmart from its ownership changes in PhonePe during fiscal 2024, considering both the cash outflow to increase ownership and the cash inflow from new equity funding?",
      "original_answer": "Walmart paid $0.9 billion to former noncontrolling interest holders of PhonePe to increase its ownership during fiscal 2024, while also receiving $0.7 billion from new equity funding rounds in PhonePe, which resulted in a net cash outflow of $0.2 billion.",
      "llm_answer": "Based on the provided document pages, Walmart's net financial impact from its ownership changes in PhonePe during fiscal 2024 was a **$0.7 billion cash inflow** from new equity funding in PhonePe, which **reduced its ownership stake from approximately 89% to 84%**. This inflow partially offset the **$3.5 billion cash outflow** incurred to increase its ownership in Flipkart (which included settling PhonePe's noncontrolling interest liability), resulting in a **net negative financial impact of approximately $2.8 billion** for the fiscal year. However, the question specifically asks for the impact *considering both the cash outflow to increase ownership and the cash inflow from new equity funding*—the net effect of these two transactions was a **$0.7 billion cash inflow** from PhonePe's equity funding, which was a direct financial benefit from the ownership change.  \n\n**Answer**: The net financial impact was a **$0.7 billion cash inflow** from PhonePe's new equity funding, which decreased Walmart's ownership stake from 89% to 84% during fiscal 2024. This inflow partially offset the $3.5 billion cash outflow for Flipkart ownership increases, resulting in a net negative impact of approximately $2.8 billion for the year, but the direct cash impact of the PhonePe funding was **+$0.7 billion**.  \n\n*(Source: Page 65, \"Purchases and Sales of Subsidiary Stock\" section, which states: \"During fiscal 2024, the Company received $0.7 billion related to new rounds of equity funding for the Company's majority owned PhonePe subsidiary...\")*",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Walmart paid $0.9 billion to increase its ownership in PhonePe and received $0.7 billion from new equity funding, resulting in a net cash outflow of $0.2 billion. However, the LLM claims a $3.5 billion cash outflow (which relates to Flipkart, not PhonePe) and incorrectly states the net impact as a $0.7 billion cash inflow, which is only one side of the transaction. The $3.5 billion figure is unrelated to PhonePe ownership changes and appears to conflate Flipkart and PhonePe transactions. (2) Quantitative accuracy is low: the $3.5 billion outflow is incorrect in this context, and the net impact is misrepresented. The $0.7 billion inflow is correctly cited, but the $0.9 billion outflow is entirely missing. The calculation of net impact is therefore wrong: $0.7B inflow minus $0.9B outflow should be -$0.2B, not +$0.7B. (3) The reasoning is flawed: the model fails to correctly isolate the two relevant cash flows for PhonePe (inflow from equity funding and outflow to increase ownership). Instead, it introduces an unrelated $3.5B outflow tied to Flipkart, indicating a failure in multi-hop reasoning and entity disambiguation. It also incorrectly frames the $0.7B inflow as the 'net' impact when it is only one component. (4) Contextual relevance is moderate because the answer discusses PhonePe and equity funding, but it introduces irrelevant information about Flipkart and mischaracterizes the net financial impact. The mention of ownership decreasing from 89% to 84% is plausible but not in the ground truth and not directly relevant to the net cash impact question. Overall, the answer misses the core multi-hop synthesis required and provides an incorrect net figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 484,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the net change in total wholesale revenues (both affiliate and non-affiliate sales) for Southern Company in 2024 compared to 2023, and how did the IIC-approved affiliate sales mechanism influence this outcome?",
      "original_answer": "The net change in total wholesale revenues for Southern Company in 2024 compared to 2023 was an increase of $69 million. This is calculated by combining the $77 million increase in affiliate and non-affiliate wholesale revenues from one segment and the $79 million increase in affiliate sales offset by the $87 million decrease in non-affiliate sales from another segment. Specifically, affiliate sales increased by $79 million due to a 165.5% rise in the volume of KWH sales, which were conducted in accordance with the IIC-approved FERC pricing mechanism, ensuring energy was sold at marginal cost and stabilizing the financial impact of these internal transactions.",
      "llm_answer": "The net change in total wholesale revenues for Southern Company in 2024 compared to 2023 was an increase of $77 million (41 %). This growth was driven primarily by higher volumes of KWH sales and additional capacity from wholesale contracts, partially offset by lower average prices. The IIC‑approved affiliate sales mechanism contributed to the rise in wholesale revenues from affiliated companies, which increased $79 million (131.7 %) due to greater volume of KWH sales to meet affiliated demand, while wholesale revenues from non‑affiliates declined slightly.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but has significant factual and calculation errors. The ground truth states the net change in total wholesale revenues was an increase of $69 million, derived from a combination of a $77 million increase in one segment and a net $-8 million change in another (due to $79M increase in affiliate sales offset by $87M decrease in non-affiliate sales). However, the LLM incorrectly reports the net change as $77 million, which contradicts the correct synthesis of the data. Additionally, the LLM omits the critical detail that non-affiliate sales decreased by $87 million, instead vaguely stating they 'declined slightly,' which understates a major component of the calculation. (2) The LLM reports a 41% growth and 131.7% increase in affiliate sales, but these percentages are not present in the ground truth and cannot be verified; the ground truth cites a 165.5% rise in KWH volume for affiliate sales. These discrepancies indicate incorrect quantitative reasoning. The $79 million increase in affiliate sales is correctly mentioned, but without linking it to the full net change calculation. (3) The multi-hop reasoning is partially sound—LLM recognizes that affiliate sales increased due to higher KWH volumes and ties this to the IIC-approved mechanism—but fails to fully synthesize across segments to arrive at the correct net change of $69 million. It also does not explain how the IIC mechanism ensured pricing at marginal cost, a key stabilizing factor mentioned in the ground truth. (4) Contextual relevance is high—the answer addresses both parts of the question, discusses revenues and the IIC mechanism, and uses appropriate terminology. However, due to incorrect net revenue change and unsupported percentages, the quantitative accuracy is low, pulling down the overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 503,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total amount Intel plans to invest in manufacturing expansion under the IDM 2.0 strategy, based on the investments announced for Arizona, Ohio, and the global packaging sites?",
      "original_answer": "Intel plans to invest a total of $50.5 billion in manufacturing expansion under the IDM 2.0 strategy. This includes $20 billion for two new fabs in Arizona, more than $20 billion for two leading-edge fabs in Ohio, and $10.5 billion to equip the Rio Rancho, New Mexico and Malaysia sites for advanced packaging manufacturing.",
      "llm_answer": "Based on the document pages, Intel announced investments in manufacturing expansion under its IDM 2.0 strategy as follows: $20 billion to build two new fabs in Arizona, more than $20 billion for two new leading-edge fabs in Ohio, and approximately $10.5 billion to equip its Rio Rancho, New Mexico and Malaysia sites for advanced packaging manufacturing, totaling over $50.5 billion in planned investments across these locations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key investment figures: $20 billion for Arizona, more than $20 billion for Ohio, and $10.5 billion for Rio Rancho and Malaysia packaging sites. The total is stated as 'over $50.5 billion', which is semantically consistent with the ground truth total of $50.5 billion, acknowledging that 'more than $20 billion' for Ohio implies the total could exceed $50.5 billion. (2) All numeric values match the ground truth exactly or appropriately reflect uncertainty (e.g., 'more than $20 billion' and 'approximately $10.5 billion' are acceptable approximations). The sum of the components ($20B + >$20B + $10.5B) correctly results in a total exceeding $50.5B, so stating 'over $50.5 billion' is logically sound. (3) The multi-hop reasoning is accurate—information from three separate investment locations is correctly synthesized into a global total under the IDM 2.0 strategy. All entities (Intel, Arizona, Ohio, Rio Rancho, New Mexico, Malaysia, advanced packaging) are correctly identified and linked to the appropriate investments. (4) The answer is highly factually accurate and contextually complete. The minor wording difference in the total ('over $50.5 billion' vs. '$50.5 billion') does not constitute a factual error given the 'more than $20 billion' phrasing for Ohio, so the correctness score is reduced by only 1 point for slight imprecision in the total characterization, though it remains semantically valid.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 406,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How much total goodwill did Danaher record from the acquisition of Abcam and what was the impact of the Veralto separation on Danaher's cash position prior to the distribution date?",
      "original_answer": "Danaher preliminarily recorded approximately $3.9 billion of goodwill related to the acquisition of Abcam. Additionally, Danaher received net cash distributions of approximately $2.6 billion from Veralto prior to the distribution date, which was partially used to redeem $1.0 billion of commercial paper.",
      "llm_answer": "Danaher recorded approximately $3.9 billion of goodwill from its acquisition of Abcam. Prior to the Veralto separation, the company received net cash distributions of about $2.6 billion from Veralto, which it used in part to redeem $1.0 billion of commercial paper and to fund bond maturities and regular quarterly dividends, thereby strengthening its cash position before the distribution date.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Danaher recorded $3.9 billion of goodwill from the Abcam acquisition and received $2.6 billion in net cash distributions from Veralto prior to the distribution date, with $1.0 billion used to redeem commercial paper—matching the ground truth exactly on all quantitative points. (2) All numeric values are accurate and properly formatted: $3.9 billion, $2.6 billion, and $1.0 billion are consistent with the original answer. No calculation errors. (3) The multi-hop reasoning is sound—correctly linking the Abcam acquisition to goodwill and the pre-distribution cash flows from Veralto. The LLM adds that the cash was also used to fund bond maturities and dividends, which is plausible context not contradicted by the ground truth, though not explicitly confirmed; this minor addition does not detract from factual accuracy but slightly extends beyond the provided information. (4) The answer is fully relevant, addresses both parts of the question, and maintains semantic equivalence. The slight expansion on cash usage is contextually appropriate and does not introduce inaccuracies, warranting a high score with only a minor deduction in qualitative accuracy for the unverified detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 349,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What was the total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024, and how does this compare to the fair value of these derivatives assets and liabilities reported at year-end?",
      "original_answer": "The total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024 was $24 million. At year-end, the fair value of these derivatives was $557 million in assets and $180 million in liabilities. This indicates that while Nike held significant foreign exchange derivative positions, the net gain recognized during the year was relatively small compared to the overall fair value of these instruments.",
      "llm_answer": "The total net gain recognized in income from foreign exchange forwards and options in fiscal 2024 was $24 million, which is reflected in \"Other (income) expense, net\" on the consolidated statements of income. This gain is part of the overall derivative activity reported in the company’s financial statements.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024 as $24 million, which matches the ground truth. This satisfies the first part of the question with full quantitative accuracy. However, the LLM fails to address the second part of the question, which asks for a comparison to the fair value of these derivatives at year-end. Specifically, it omits the reported fair value of $557 million in assets and $180 million in liabilities. (2) The only numeric value provided — $24 million — is accurate and correctly formatted. There are no calculation errors, but key numbers required for the comparison are missing. (3) The reasoning is partially sound in that it correctly identifies the income statement line item where the gain is reported, but it does not perform the required multi-hop synthesis between income statement impact and balance sheet fair value disclosures. The comparison between the relatively small net gain and the large notional fair value positions is entirely absent, breaking the chain of required reasoning. (4) While the answer is contextually relevant and factually correct where it responds, the incompleteness on a core part of the multi-part question significantly reduces correctness. The answer gets full marks for quantitative accuracy but loses points for qualitative accuracy due to missing synthesis and incomplete reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 402,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What is the combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates, and how does this compare to the 2022 depreciation, depletion, amortization, and impairments for the same region?",
      "original_answer": "The combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates is $55,912 million, as equity affiliates contributed no discounted future net cash flows from the Lower 48. This is significantly higher than the 2022 depreciation, depletion, amortization, and impairments for the Lower 48, which amounted to $4,854 million. This indicates that the future cash flow potential of the Lower 48 region is much greater than the costs recognized during 2022.",
      "llm_answer": "The combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates is $71,149 million (consolidated) plus $13,272 million (equity affiliates) = $84,421 million. This amount exceeds the 2022 depreciation, depletion, amortization, and impairment expense for the Lower 48 region, which was $5,729 million.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The ground truth states that the combined discounted future net cash flows for the Lower 48 region in 2022 is $55,912 million, with equity affiliates contributing $0. However, the LLM claims $71,149 million (consolidated) + $13,272 million (equity affiliates) = $84,421 million, which is significantly higher and factually wrong. Additionally, the LLM reports depreciation, depletion, amortization, and impairments as $5,729 million, whereas the ground truth is $4,854 million—another clear error. (2) Completeness: While the LLM attempts to address both parts of the question (total cash flows and comparison to DD&A), it does so with incorrect data. (3) Entity Accuracy: The region (Lower 48) and year (2022) are correct, but the financial metrics are misattributed. (4) Reasoning: The multi-hop synthesis is flawed—there is no evidence supporting the claimed contributions from equity affiliates, which the ground truth explicitly states contributed nothing. The comparison logic (cash flows exceeding DD&A) is directionally correct but based on false inputs, undermining validity. (5) Semantic Equivalence: The structure mirrors the original answer but conveys entirely different (and incorrect) facts. Due to major factual and calculation errors, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 386,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What was the total value of Loans and Interest Receivable, Held for Sale reported by PayPal in December 2023, and how does this compare to the fair value of these receivables based on the level of unobservable inputs?",
      "original_answer": "PayPal reported a total value of $563 million for Loans and Interest Receivable, Held for Sale as of December 31, 2023. This entire amount was measured using significant unobservable inputs (Level 3), indicating that the fair value of these receivables is entirely based on Level 3 inputs.",
      "llm_answer": "PayPal reported total Loans and Interest Receivable, Held for Sale of $563 million as of December 2023. This amount is classified as Level 3 in the fair‑value hierarchy, meaning it is measured using significant unobservable inputs—specifically, the price at which the company expects to sell the loans under its agreement with the global investment firm.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the value of $563 million and the date (December 2023) are accurate and match the original answer. (2) The answer correctly identifies that the entire amount is classified as Level 3 in the fair value hierarchy, which aligns with the ground truth stating that the fair value is 'entirely based on Level 3 inputs' (significant unobservable inputs). (3) The reasoning is sound and reflects proper multi-hop synthesis: it connects the reported value with its fair value measurement level, which requires understanding both the financial statement item and the fair value hierarchy disclosure. (4) The LLM adds contextual detail (e.g., 'price at which the company expects to sell the loans under its agreement with the global investment firm') that is consistent with Level 3 valuation practices and enhances the explanation without introducing inaccuracies. All entities (PayPal, Loans and Interest Receivable, Held for Sale, Level 3 inputs) are correctly identified. The answer is semantically equivalent and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 317,
        "total_tokens": 1496
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How much total revolving indebtedness was borrowed and repaid under the 2021 Multicurrency Credit Facility during the year ended December 31, 2023, and how does this compare to the amounts borrowed and repaid under the 2021 Credit Facility in the same period?",
      "original_answer": "During the year ended December 31, 2023, $3.0 billion was borrowed and $6.1 billion was repaid under the 2021 Multicurrency Credit Facility. Under the 2021 Credit Facility, $3.1 billion was borrowed and $2.6 billion was repaid during the same period. This results in a net repayment of $3.1 billion for the 2021 Multicurrency Credit Facility and a net borrowing of $0.5 billion for the 2021 Credit Facility.",
      "llm_answer": "During the year ended December 31 2023, the company borrowed a total of $3.0 billion and repaid $6.1 billion of revolving indebtedness under the 2021 Multicurrency Credit Facility. In comparison, under the 2021 Credit Facility it borrowed $3.1 billion and repaid $2.6 billion of revolving indebtedness over the same period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual numbers: $3.0 billion borrowed and $6.1 billion repaid under the 2021 Multicurrency Credit Facility, and $3.1 billion borrowed and $2.6 billion repaid under the 2021 Credit Facility — matching the ground truth exactly. (2) All numeric values are accurate and properly formatted; no calculation errors. The net repayment and net borrowing figures are not explicitly stated in the LLM answer, but the component numbers needed to derive them are fully correct. (3) The multi-hop reasoning is sound — the model correctly distinguishes between the two credit facilities and provides comparative data for the same time period (year ended December 31, 2023). (4) The only minor shortcoming is the omission of the explicit net repayment ($3.1 billion) and net borrowing ($0.5 billion) conclusions present in the original answer, which slightly reduces completeness in qualitative synthesis, but since the raw data is fully accurate and allows correct inference, the answer remains highly accurate. Hence, correctness is scored 9/10, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 327,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What specific audit procedures were applied to both Georgia Power and Mississippi Power to evaluate the impact of regulatory rate changes on incurred costs, and how do these procedures reflect the subjectivity involved in assessing future regulatory orders?",
      "original_answer": "Both Georgia Power and Mississippi Power underwent similar audit procedures to evaluate the impact of regulatory rate changes on incurred costs. These procedures included testing the effectiveness of management's controls over the evaluation of the likelihood of recovery in future rates of certain incurred costs, refunds, or future reductions in rates. Auditors also reviewed regulatory orders and publicly available information to assess precedents for similar cost treatments. These procedures reflect the high degree of subjectivity involved in assessing the potential impact of future regulatory orders on incurred costs, as management must make significant judgments regarding the likelihood of recovery, disallowance, or refund obligations.",
      "llm_answer": "The audit procedures applied to both Georgia Power and Mississippi Power to evaluate the impact of regulatory rate changes on incurred costs focused on testing the effectiveness of management’s controls over the likelihood of recovery of costs in future rates and the potential for refunds or rate reductions, and on reading and evaluating relevant regulatory orders and other publicly available information to assess recovery likelihood based on precedents. These procedures highlighted the subjectivity involved in assessing future regulatory orders, as they required specialized knowledge of rate regulation and judgments about the outcome of Commission decisions regarding cost recovery and potential disallowances.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) All factual elements are correct: the audit procedures included testing management's controls over cost recovery likelihood, potential refunds or rate reductions, and review of regulatory orders and public information for precedents. These points match the ground truth exactly. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all qualitative metrics and procedures are correctly reported—thus scored as 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both Georgia Power and Mississippi Power underwent similar procedures and links those procedures to the subjectivity in forecasting regulatory outcomes. The only minor shortcoming is that the LLM answer does not explicitly state that the subjectivity stems from 'management’s significant judgments'—instead attributing judgments to auditors or general assessment—whereas the original emphasizes management's role in making those subjective determinations. This slight shift in emphasis slightly affects qualitative accuracy but does not distort the meaning. (4) The answer is fully contextually relevant, directly addressing both parts of the question: the specific audit procedures and how they reflect subjectivity in assessing future regulatory orders. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the ground truth with only negligible differences in nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 436,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the decline in Comirnaty's global revenue in 2023 and the collaboration agreement terms with BioNTech impact Pfizer's operational results and future financial obligations?",
      "original_answer": "The decline in Comirnaty's global revenue from $37,806 million in 2022 to $11,220 million in 2023, a 70% drop, significantly affected Pfizer's operational results, driven by lower contracted deliveries and demand in international markets and the transition to traditional U.S. commercial market sales. This decline was compounded by Pfizer's ongoing collaboration agreement with BioNTech, under which Pfizer agreed to pay BioNTech tiered royalties and share gross profits from Comirnaty sales globally, excluding certain regions. Despite the revenue drop, Pfizer retained global commercialization rights (excluding Germany, Turkey, and certain Asian regions) and continued to share development and commercialization profits with BioNTech, creating ongoing financial obligations even as revenue declined.",
      "llm_answer": "The decline in Comirnaty's global revenue in 2023—driven by lower contracted deliveries, transition to new variant vaccines, and the shift to traditional U.S. commercial market sales—directly reduced Pfizer's total revenue and gross profit, contributing to a 70% year-over-year revenue drop in the Comirnaty product line and a $9.4 billion decrease in cost of sales. This revenue decline, combined with the terms of the collaboration agreement with BioNTech (which includes shared development costs, tiered royalties up to 22%, and up to $200 million in sales milestones), resulted in lower alliance revenue and impacted Pfizer's operational results, while also creating future financial obligations for milestone payments and royalty obligations under the agreement.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and introduces unsupported figures. While it correctly identifies the 70% year-over-year decline in Comirnaty revenue and attributes it to lower contracted deliveries and transition to traditional U.S. commercial market sales, it fabricates a '$9.4 billion decrease in cost of sales' which is not present in the ground truth and cannot be verified from the provided data. Additionally, the LLM claims the collaboration agreement includes 'up to 22% tiered royalties' and 'up to $200 million in sales milestones'—specific terms not mentioned in the original answer and not supported by the knowledge graph. These quantitative additions significantly reduce factual accuracy. (2) The original answer specifies Comirnaty revenue dropped from $37,806 million in 2022 to $11,220 million in 2023 (a ~70% drop), which the LLM correctly summarizes in percentage terms but fails to cite the actual dollar figures, reducing completeness and precision. The LLM omits key details such as the geographic exclusions (Germany, Turkey, certain Asian regions) where Pfizer does not hold commercialization rights. (3) The multi-hop reasoning is partially sound—linking revenue decline to operational impact and tying in the BioNTech collaboration as a source of ongoing obligations—but it distorts the nature of those obligations by introducing unverified milestone and royalty rates. The original answer emphasizes profit-sharing and royalty obligations without specifying percentages or milestone amounts, so the LLM overreaches in detail. (4) Despite these issues, the LLM captures the core causal chain: declining revenue impacted Pfizer's operational results, and the BioNTech agreement creates ongoing financial obligations. This maintains moderate qualitative accuracy and high contextual relevance, but the inclusion of unverified numerical claims severely undermines quantitative correctness, warranting a mid-range score of 5 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 539,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the year-over-year change in the value of U.S. Agency securities held as short-term investments by NKE as of May 31, 2024, compared to May 31, 2023?",
      "original_answer": "The value of U.S. Agency securities held as short-term investments by NKE decreased by $11 million year-over-year, from $46 million as of May 31, 2023, to $35 million as of May 31, 2024.",
      "llm_answer": "Based on the provided pages, the value of U.S. Agency securities held as short-term investments by NKE as of May 31, 2024, is $35 million (reported under \"U.S. Agency securities\" in the \"Short-TERMINVESTMENTS\" column of the May 31, 2024 table on page 73). As of May 31, 2023, the value was $46 million (reported under \"U.S. Agency securities\" in the \"Short-TERMINVESTMENTS\" column of the May 31, 2023 table on page 73). The year-over-year change is therefore a decrease of $11 million ($35 million - $46 million = -$11 million).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the value of U.S. Agency securities was $46 million as of May 31, 2023, and $35 million as of May 31, 2024. The year-over-year change is correctly calculated as a decrease of $11 million ($35M - $46M = -$11M). (2) Quantitative accuracy is perfect—both input values and the resulting difference are correct, with proper sign indicating a decrease. Number formats are consistent and acceptable. (3) The reasoning is sound and demonstrates proper multi-hop synthesis by extracting data from two different fiscal years (2023 and 2024) for the same company (NKE) and metric (U.S. Agency securities in short-term investments), then computing the change. (4) The answer is contextually relevant, directly addressing the question with precise sourcing from the document (page 73, specific table columns). Wording differs slightly from the original answer but maintains full semantic equivalence. No errors or omissions are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 293,
        "total_tokens": 1474
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024, considering both new issuances and repayments?",
      "original_answer": "The net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024 was an increase of $423 million.",
      "llm_answer": "The net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024 was an increase of $423, calculated as $500 of new issuances in November 2023 (which remained outstanding at the start of 2024) minus $77 repaid in July 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states the correct net change of $423 million increase, which matches the ground truth in magnitude and direction. However, it incorrectly references a $500 issuance in November 2023, which is outside the 2024 reporting period and not relevant to the net change during 2024. The repayment of $77 million in July 2024 may be accurate, but the issuance used in the calculation is not from 2024, making the reasoning flawed. (2) The final number ($423 million) is correct, but the calculation presented ($500 - $77) implies a net change based on a 2023 issuance, which does not support the 2024 net change. The correct calculation should involve new issuances and repayments that occurred within 2024. The model incorrectly uses a 2023 event as the basis for 2024 net change, undermining quantitative accuracy. (3) The multi-hop reasoning is unsound because it fails to identify the correct issuance within 2024. The model must synthesize both 2024 issuances and repayments; instead, it relies on a prior-year issuance that remained outstanding, which does not constitute a 'new issuance' in 2024. This breaks the logical chain required for accurate net change calculation over the specified period. (4) Despite the correct final number, the reasoning and data sources are incorrect, leading to a low quantitative accuracy score. The qualitative accuracy is partially preserved due to correct entity identification (Costco's Japanese subsidiary, Guaranteed Senior Notes) and correct repayment reference, but flawed logic limits the score. Contextual relevance is high as the answer addresses the right metric and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1114,
        "completion_tokens": 451,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the total value of 3M's stand-alone letters of credit, bank guarantees, and similar instruments, and how does this compare to the amount of cash, cash equivalents, and marketable securities held by the company in the U.S. as of December 31, 2024?",
      "original_answer": "3M had $0.5 billion in stand-alone letters of credit, bank guarantees, and other similar instruments issued and outstanding as of December 31, 2024. At the same date, the company held $4.2 billion in cash, cash equivalents, and marketable securities in the United States. Therefore, the stand-alone instruments represent approximately 11.9% of the U.S.-held liquidity.",
      "llm_answer": "The total value of 3M's stand‑alone letters of credit, bank guarantees and similar instruments was $0.5 billion as of December 31 2024. This amount is far smaller than the $4.2 billion of cash, cash equivalents and marketable securities held in the United States at that date.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the $0.5 billion in stand-alone letters of credit, bank guarantees, and similar instruments and the $4.2 billion in U.S.-held cash, cash equivalents, and marketable securities as of December 31, 2024, matching the ground truth exactly. All numeric values and dates are accurate, satisfying quantitative accuracy. The comparison correctly conveys that the $0.5 billion is much smaller than the $4.2 billion, which aligns with the ground truth's implication. However, the LLM omits the specific percentage (11.9%) that quantifies the relationship between the two figures, which is part of the original answer and adds precision to the comparison. While the qualitative reasoning is sound and the entities (3M, correct financial instruments, correct time frame) are accurately referenced, the absence of the calculated percentage represents a minor gap in completeness. Despite this, the core multi-hop synthesis—comparing off-balance-sheet instruments to U.S. liquidity—is correctly executed. The answer remains semantically equivalent in intent and fact, just less detailed in the quantitative comparison. Hence, a high score is warranted, but not perfect due to the missing percentage.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 341,
        "total_tokens": 1529
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What percentage of Meta's worldwide MAUs were estimated to be duplicate accounts in Q4 2023, and how does this compare to the percentage of false accounts during the same period?",
      "original_answer": "In Q4 2023, duplicate accounts were estimated to represent approximately 10% of Meta's worldwide MAUs, while false accounts were estimated at approximately 4% of worldwide MAUs. This means duplicate accounts were more than twice as prevalent as false accounts during the same period.",
      "llm_answer": "In Q4 2023, Meta estimated that duplicate accounts represented roughly 10 % of its worldwide monthly active users, while false accounts accounted for about 4 % of worldwide MAUs. This indicates that duplicate accounts were estimated to be roughly 2.5 times more prevalent than false accounts during the same period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key percentages from the ground truth: 10% of Meta's worldwide MAUs were duplicate accounts and 4% were false accounts in Q4 2023. These values are factually accurate and match the original answer exactly. (2) The calculation comparing the two percentages is slightly off in wording but not in intent: 10% is 2.5 times 4%, so stating '2.5 times more prevalent' is mathematically correct as a ratio (10/4 = 2.5). However, the original answer states 'more than twice as prevalent,' which is also correct but less precise. The LLM provides a more exact comparison, which is an improvement rather than an error. (3) The multi-hop reasoning is sound—Meta's MAUs, duplicate vs. false accounts, and their relative prevalence are all correctly synthesized from the implied data points. (4) All entities (Meta, Q4 2023, worldwide MAUs, duplicate accounts, false accounts) are accurately referenced. The answer is contextually complete and relevant. The minor difference in phrasing of the comparison does not detract from factual correctness, hence a 9/10 on correctness and qualitative accuracy, with full marks for quantitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 337,
        "total_tokens": 1495
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How much did Pfizer pay upfront in cash to BioNTech for the shingles mRNA vaccine collaboration, and how does this compare to the upfront payment made to Biohaven for migraine treatment rights outside the U.S.?",
      "original_answer": "Pfizer paid $75 million upfront in cash to BioNTech for the shingles mRNA vaccine collaboration and $150 million upfront to Biohaven for migraine treatment rights outside the U.S., resulting in a $75 million difference in favor of the Biohaven deal.",
      "llm_answer": "Pfizer paid BioNTech a $75 million upfront cash payment (plus a $150 million equity investment) for the shingles mRNA‑vaccine collaboration, and this upfront amount is comparable to the $150 million upfront payment (plus a $350 million equity investment) it paid Biohaven for migraine‑treatment rights outside the U.S. — both transactions involved roughly $150 million in cash upfront, with the remainder of the total consideration being funded through equity stakes.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM incorrectly states that Pfizer paid BioNTech $75 million in cash plus a $150 million equity investment for the shingles vaccine collaboration. The ground truth confirms only the $75 million upfront cash payment — there is no mention of an equity investment in the knowledge graph. Similarly, the LLM claims Pfizer paid Biohaven $150 million upfront plus a $350 million equity investment, but the ground truth only supports the $150 million upfront cash payment, with no equity investment noted. These additions are factually unsupported and materially distort the financial structure of the deals. (2) While the $75 million (BioNTech) and $150 million (Biohaven) upfront cash figures are correct, the LLM falsely equates the two deals by claiming both involved 'roughly $150 million in cash upfront,' which is inaccurate — only the Biohaven deal had a $150 million cash upfront component. The comparison is therefore flawed. The actual difference is $75 million in favor of Biohaven, which the LLM fails to acknowledge due to its incorrect conflation of cash and equity. (3) The multi-hop reasoning is partially sound in that the model identifies both collaborations and attempts to compare them, but it fails in synthesis by introducing non-existent equity components, leading to incorrect conclusions about equivalence. (4) The contextual relevance is high because the answer addresses the right companies and deals and attempts the correct comparison. However, the quantitative and qualitative inaccuracies — especially the fabrication of equity investments and misrepresentation of cash amounts — severely undermine the correctness. A score of 4 reflects partial factual accuracy on core numbers but major errors in financial structure and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 483,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What is the total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024, when considering both hedging instruments and non-hedging instruments?",
      "original_answer": "The total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024, is $115 million. This includes $110 million from derivatives designated as hedging instruments and $5 million from derivatives not designated as hedging instruments.",
      "llm_answer": "Based on the provided document pages, the total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024, when considering both hedging and non-hedging instruments, is $151 million. This figure represents the total derivative liabilities disclosed in Note 12 (Risk Management and Derivatives) on page 89, which includes $146 million for derivatives designated as hedging instruments and $5 million for derivatives not designated as hedging instruments, totaling $151 million.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its key numeric values. The ground truth states total liabilities are $115 million ($110 million hedging + $5 million non-hedging), but the LLM reports $151 million ($146 million + $5 million). These numbers do not match any variation of the correct data. (2) Quantitative accuracy is severely lacking: the reported figures for hedging instruments ($146M vs $110M) and total liabilities ($151M vs $115M) are both significantly off. The $5 million non-hedging amount is correct, but the total calculation, while arithmetically correct ($146M + $5M = $151M), is based on incorrect inputs. (3) The reasoning appears internally consistent—citing Note 12 and distinguishing hedging vs non-hedging instruments—but fails at multi-hop synthesis because it uses incorrect source data. There is no indication the model accessed or interpreted the correct filing information. (4) Contextual relevance is high because the answer addresses the right question structure, references the appropriate note (Note 12), and correctly breaks down hedging vs non-hedging instruments. However, the fundamental factual inaccuracies in numbers lead to a very low correctness score despite this structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 347,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does PayPal's recognition of a crypto asset safeguarding liability connect to its disclosure of risk concentrations, and what does this imply about the company's exposure to credit risk in relation to customer-held crypto assets?",
      "original_answer": "PayPal recognizes a crypto asset safeguarding liability to reflect its obligation to safeguard cryptocurrencies held on behalf of customers, and it discloses that its cash, cash equivalents, customer accounts, and other financial assets are subject to concentration of credit risk. Since crypto assets held for customers are not PayPal's assets but are safeguarded through a liability mechanism, the company's exposure to credit risk arises not from the crypto assets themselves but from the financial institutions where these customer funds are held. PayPal places these funds in high-quality financial institutions but acknowledges that balances may exceed FDIC insurance limits, creating a credit risk concentration that could impact the company if those institutions fail.",
      "llm_answer": "PayPal recognizes a crypto‑asset safeguarding liability and a corresponding safeguarding asset on its balance sheet for cryptocurrencies held on behalf of customers, but it does not record the crypto itself as an asset. This liability is disclosed within its broader risk‑concentration discussion, which notes that cash, cash equivalents, customer accounts and related receivables are subject to credit risk and are held with high‑quality financial institutions. Because the safeguarding liability represents an obligation to protect customer‑held crypto, any deterioration in the credit quality of those custodial partners or a failure to maintain sufficient safeguarding assets could give rise to credit‑risk exposure for PayPal, even though the crypto assets themselves are not recorded as its own assets. Consequently, the company’s exposure to credit risk is indirectly tied to the performance of the custodial arrangements that back the safeguarded crypto balances.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately identifies that PayPal recognizes a crypto asset safeguarding liability (and corresponding asset) for customer-held crypto, does not record crypto as its own asset, and includes this in its risk concentration disclosures. The connection to credit risk via custodial financial institutions is correctly explained. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly links the liability mechanism to the broader credit risk disclosure and infers that exposure arises from custodial institutions, not the crypto assets themselves. However, the LLM slightly misses the emphasis in the original answer that customer funds (backing the safeguarding) are held in institutions where balances may exceed FDIC limits—this specific risk concentration detail is omitted, slightly weakening completeness. (4) Despite this minor omission, the answer is contextually precise, uses correct entities (PayPal, safeguarding liability, credit risk, custodial institutions), and maintains semantic equivalence on core points. Thus, correctness and qualitative accuracy are high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 361,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How many LTIP units were issued net of forfeitures under the 2019 Plan, and what was the impact of these units on potential stock dilution for the year ended December 31, 2024?",
      "original_answer": "689,202 LTIP units were issued net of forfeitures under the 2019 Plan, and these units were considered potentially dilutive securities. However, they did not have a material dilutive effect on the company's stock for the year ended December 31, 2024.",
      "llm_answer": "The 2019 Plan issued 871,680 LTIP units net of forfeitures during 2024, and these units are exchangeable for common stock, which can increase the number of shares outstanding and therefore dilute existing stockholders. The consolidated statements of operations and comprehensive income show that net income attributable to unitholders was $2,725,765 for 2024, reflecting the impact of these potentially dilutive LTIP units on earnings per unit calculations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in key aspects. The number of LTIP units issued net of forfeitures is stated as 871,680, whereas the ground truth is 689,202 — a significant numerical discrepancy. Additionally, the LLM introduces financial data not relevant to the question, such as net income attributable to unitholders ($2,725,765), which was not asked for and does not address the impact on stock dilution. (2) The quantitative accuracy is low: the unit count is wrong, and the introduced dollar amount is extraneous and unverified. No correct calculation or verification of dilutive impact is provided. (3) The reasoning is partially sound in recognizing that LTIP units are potentially dilutive as they are exchangeable for common stock, which could increase shares outstanding. However, it fails the multi-hop synthesis by not concluding that the dilutive effect was not material — a key point in the ground truth. Instead, it incorrectly implies a measurable impact via earnings per unit, which contradicts the original answer. (4) Contextual relevance is moderate because the answer addresses LTIP units, their potential dilutive nature, and the correct time frame (2024), but it misses the core conclusion about materiality and provides incorrect figures, undermining overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 368,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What was the total financial impact on 3M's earnings per diluted share in 2024 from manufactured PFAS products, and how did this compare to the impact in 2022?",
      "original_answer": "The total financial impact on 3M's earnings per diluted share from manufactured PFAS products was a reduction of $0.20 in 2024 and a reduction of $0.90 in 2022, resulting in a total combined impact of $1.10 over the two years.",
      "llm_answer": "Based on the provided 10-K pages, the total financial impact on 3M's earnings per diluted share from manufactured PFAS products was **$0.28 in 2024** and **$0.90 in 2022**. This indicates a significant decrease in the PFAS-related impact per share from 2022 to 2024, with the 2024 impact being lower than the 2022 impact. The document shows that the PFAS product impact was $0.28 per share in 2024 (as reported in the \"Earnings (loss) from continuing operations per share attributable to 3M common shareholders - diluted\" table for 2024) and $0.90 per share in 2022 (as reported in the same table for 2022).",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2022 impact as $0.90 per diluted share, matching the ground truth. However, it incorrectly reports the 2024 impact as $0.28 instead of $0.20, which is a significant factual error affecting the core of the question. The comparison stating that the impact decreased from 2022 to 2024 is directionally correct, but the magnitude is wrong due to the incorrect 2024 figure. The ground truth also mentions the combined impact of $1.10, which the LLM fails to include, reducing completeness. (2) The quantitative accuracy is compromised: the 2024 number ($0.28 vs $0.20) is incorrect, and while $0.90 for 2022 is accurate, the total combined impact of $1.10 is not mentioned. Calculations or reporting from the source table appear to be misread. (3) The reasoning is partially sound—multi-hop synthesis between years is attempted, and the directional trend is correctly interpreted—but the failure to report the correct 2024 value undermines the validity of the conclusion. The model cites the correct table and metric, showing good contextual understanding. (4) Contextual relevance is high as the answer addresses the right metric, company, and years, and attempts the correct comparison. However, due to the incorrect 2024 figure and missing combined total, the overall correctness score is limited to 4, reflecting partial accuracy with significant factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 392,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did the volume changes in KWH sales to affiliates and non-affiliates in 2024, governed by the Intercompany Interchange Contract (IIC), impact the overall wholesale revenue performance for the Southern Company system?",
      "original_answer": "The Southern Company system experienced a $87 million (20.5%) decrease in wholesale revenues from non-affiliate sales due to a 30.8% drop in KWH volume after power agreements ended in May 2023. This was partially offset by a $79 million (131.7%) increase in affiliate sales driven by a 165.5% rise in KWH volume, largely due to increased affiliated energy demand. These affiliate sales were conducted under the IIC approved by FERC, showing that while external market conditions reduced non-affiliate revenue, internal energy transfers under the IIC helped mitigate some of the overall revenue decline.",
      "llm_answer": "The volume of KWH sales to non‑affiliates fell 30.8% in 2024, causing wholesale revenues from non‑affiliates to drop $87 million (20.5%).  In contrast, sales to affiliates rose 165.5% in volume, boosting wholesale revenue from affiliates by $79 million (131.7%).  These shifts under the Intercompany Interchange Contract (IIC) helped offset part of the decline in non‑affiliate sales but overall wholesale revenue still fell, contributing to a net decrease in the system’s wholesale revenue performance for 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative figures from the ground truth: the 30.8% drop in non-affiliate KWH volume corresponding to an $87 million (20.5%) revenue decline, and the 165.5% increase in affiliate volume leading to a $79 million (131.7%) revenue increase. All numbers, percentages, and dollar amounts match exactly with acceptable formatting (e.g., $79 million). (2) Quantitative accuracy is perfect—no calculation errors or misstatements. The implied logic that the non-affiliate decline was due to power agreements ending in May 2023 is omitted but not contradicted. (3) The multi-hop reasoning is sound: the model correctly links volume changes to revenue impacts for both affiliate and non-affiliate sales and recognizes the role of the IIC in facilitating affiliate transfers. It correctly infers that the affiliate gains partially offset the non-affiliate losses, leading to a net negative impact on wholesale revenue. However, it omits the explicit mention that the IIC was FERC-approved and does not explicitly tie the increased affiliate demand to internal energy needs, slightly weakening the qualitative completeness. (4) Despite minor omissions in contextual detail, the answer conveys the core causal chain and financial impact accurately, making it semantically equivalent to the ground truth. The omission of FERC approval and specific driver of affiliate demand prevents a perfect 10, but all critical facts and logic are preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 412,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total financial penalty imposed by the Irish Data Protection Commission alongside the corrective orders related to unlawful data transfers, and how might compliance with these orders affect Meta's operational costs in Europe?",
      "original_answer": "The Irish Data Protection Commission imposed a financial penalty of €1.2 billion alongside the corrective orders requiring Meta Platforms Ireland to suspend unlawful data transfers and cease the processing of EEA Facebook user data in the United States. Compliance with these corrective orders could increase the cost and complexity of delivering Meta's products and services in Europe, as the company may be required to take additional steps to align its data processing operations with Chapter V of the GDPR.",
      "llm_answer": "The Irish Data Protection Commission imposed a €1.2 billion administrative fine on Meta Platforms Ireland together with corrective orders that require Meta to suspend certain data transfers and bring its processing into compliance with GDPR Chapter V. Compliance with these orders will likely increase Meta’s operational costs in Europe by requiring additional legal‑review, data‑transfer mechanisms and system changes to meet the regulator’s requirements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the €1.2 billion financial penalty imposed by the Irish Data Protection Commission, matching the ground truth exactly in both amount and currency. This satisfies the quantitative requirement with full accuracy. (2) The LLM accurately notes the corrective orders related to suspending unlawful data transfers and aligning with GDPR Chapter V, though it does not explicitly mention the 'cessation of processing EEA Facebook user data in the United States' as specified in the original answer. This is a minor omission in completeness but does not distort the core facts. (3) The reasoning is sound: the LLM correctly infers that compliance will increase operational costs in Europe due to legal reviews, data-transfer mechanisms, and system changes—this aligns with and reasonably expands upon the ground truth’s statement about increased cost and complexity. The multi-hop synthesis between the penalty, corrective actions, and their operational impact is logically coherent. (4) The answer is contextually fully relevant, addressing both the penalty amount and its implications for Meta’s European operations. Wording differs slightly but maintains semantic equivalence. The only reason for not scoring a 10 is the slight lack of specificity regarding the cessation of processing EEA data in the U.S., which is a key component of the corrective order.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 388,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does The Home Depot's emphasis on product depth and job lot quantities specifically support its strategy to meet the needs of professional customers (Pros), and what risks are highlighted in the document if this aspect of competitiveness is not effectively maintained?",
      "original_answer": "The Home Depot emphasizes product depth and job lot quantities to meet the complex purchase needs of professional customers (Pros), who require larger volumes and dedicated sales support. If the company fails to maintain these offerings alongside competitive delivery and pickup options, it could negatively impact demand for products and services and reduce profit margins.",
      "llm_answer": "The Home Depot’s focus on “product depth and job‑lot quantities” is presented as a key differentiator for its professional‑customer (Pro) segment, who need extensive assortments and bulk‑size options to meet complex project requirements. The document notes that Pros specifically look for “product depth and job‑lot quantities, particularly for their complex purchase needs” and that the company’s ability to offer these options is tied to its supply‑chain investments and interconnected retail capabilities. If this differentiator is not maintained, the filing warns that the company could lose competitive advantage, face reduced demand for its products, and see pressure on profit margins. This risk is highlighted in the “Competition and Seasonality” and “Strategic Risks” sections of the 10‑K.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: The Home Depot's emphasis on product depth and job lot quantities is correctly tied to meeting the complex needs of professional customers (Pros), and the risks of not maintaining this advantage—reduced demand and margin pressure—are accurately reported. (2) There are no numeric values in the question or answer requiring verification, so quantitative accuracy is not applicable but assumed perfect. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the strategic rationale (supporting Pros) with the risk implication (competitive disadvantage), and even cites the relevant sections of the 10-K (‘Competition and Seasonality’ and ‘Strategic Risks’), which adds contextual fidelity beyond the ground truth. (4) The only minor shortcoming is that the original answer specifies that Pros require 'dedicated sales support' and competitive delivery/pickup options as part of the offering, which the LLM omits. While the core message is preserved, this slight omission prevents a perfect score. However, the answer remains semantically equivalent in intent and key content, warranting a high correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 346,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy across both disclosures, and what might this exclusion indicate about the complexity of valuing these specific investments?",
      "original_answer": "The total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy is $177 million ($94 million + $83 million). The exclusion of these interests indicates that the valuation of these specific investments is complex and not easily categorized within the standard fair value hierarchy, likely due to the lack of observable market data or the presence of restrictions that limit the company’s ability to readily redeem these investments.",
      "llm_answer": "The total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy across both disclosures is $83 million (as noted in the pension plan footnote on page 130) and $94 million (as noted in the corresponding footnote on page 131). This exclusion suggests that these annuity investments involve complex valuation inputs—such as long‑term cash‑flow projections and discount rates—that are not readily observable, making them difficult to price using standard fair‑value hierarchy levels.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies both values ($94 million and $83 million) excluded from the fair value hierarchy, and although it does not explicitly state the sum of $177 million, it provides both components necessary for the total, listing them clearly. The omission of the explicit sum is a minor shortcoming but does not detract significantly from correctness since the user can easily compute it. All numeric values match the ground truth exactly. (2) Quantitative accuracy is perfect: $94M and $83M are correctly cited, and their sum ($177M) is implied. Format variations are acceptable and consistent. (3) The reasoning is sound: the LLM correctly infers that the exclusion indicates complex valuation due to unobservable inputs like cash-flow projections and discount rates, which aligns semantically with the ground truth’s explanation about lack of observable market data and redemption restrictions. The answer could have mentioned restrictions or limited redemption to fully match the depth of the original, but the core rationale on complexity and unobservable inputs is accurate. (4) Contextual relevance is excellent—the response directly addresses both parts of the question: total value (via components) and the implication of exclusion. The use of footnotes adds precision. Overall, this is a highly accurate, well-reasoned answer with only a minor omission in not summing the two values explicitly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 396,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does PayPal's use of loss curves in conjunction with macroeconomic forecasts impact its allowance for credit losses on both merchant and consumer receivables, and what specific macroeconomic factors are applied in each category?",
      "original_answer": "PayPal applies loss curves to both merchant and consumer receivables to estimate the allowance for credit losses, incorporating macroeconomic forecasts. For merchant receivables, the loss curves are applied by geography, delinquency, and origination period, and the macroeconomic factors include forecasted trends in unemployment rates and retail e-commerce sales. For consumer revolving credit receivables, the loss curves are also used, and macroeconomic factors such as forecasted trends in household disposable income and retail e-commerce sales are applied. These macroeconomic inputs directly influence the projected loss rates, which are then applied to the principal amounts of receivables to determine the allowance for credit losses, ensuring that economic conditions are factored into the financial estimates.",
      "llm_answer": "PayPal’s allowance for credit losses on merchant and consumer receivables is derived from loss‑curve analyses that are calibrated with macro‑economic forecasts. For merchant receivables the model incorporates macro factors such as unemployment‑rate trends and retail‑e‑commerce sales growth, while for consumer receivables it uses forecasts of household disposable‑income trends (and, through the first quarter of 2023, unemployment‑rate trends) to project loss rates over a reasonable forecast horizon (≈2.5‑3.5 years for merchant products and ≈5‑7 months to 3.5 years for revolving consumer products). These macro‑economic assumptions are applied alongside historical loss data to estimate the allowance for each portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that PayPal uses loss curves with macroeconomic forecasts for both merchant and consumer receivables, and accurately specifies the macroeconomic factors: unemployment rates and retail e-commerce sales for merchants; household disposable income and (historically) unemployment rates for consumers. (2) The quantitative details about forecast horizons (≈2.5–3.5 years for merchant, 5–7 months to 3.5 years for consumer) are present in the LLM answer but not in the original ground truth, suggesting additional detail rather than inaccuracy. Since these timeframes were not in the original, they are not penalized as incorrect but are treated as plausible elaboration. All other numbers and time references are consistent or reasonably inferred. (3) The multi-hop reasoning is sound—correctly linking loss curves, macroeconomic inputs, and their application to different receivable types. The mention of unemployment trends being used for consumer receivables 'through Q1 2023' adds specificity not in the original, but does not contradict it and may reflect a nuance from the source document. (4) Semantic equivalence is strong: key entities (PayPal, merchant/consumer receivables, loss curves, correct macro factors) are accurately identified and synthesized. The only minor deviation is the added temporal detail on unemployment use in consumer models, which could be seen as slightly over-specific but not factually incorrect. Thus, the answer earns a 9/10 for correctness—excellent but not perfectly aligned in scope with the original's brevity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 453,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does Costco's investment in the development and protection of Kirkland Signature, as well as its reliance on manufacturing and distribution facilities for private-label items, expose the company to risks that could affect both brand loyalty and gross margin performance?",
      "original_answer": "Costco has invested significantly in the development and protection of its private-label brand, Kirkland Signature, which contributes to higher margins and helps differentiate its merchandise offerings. However, the company relies on processing, packaging, and manufacturing facilities to produce these private-label items, and any disruptions in these operations—such as extreme weather, pandemics, or labor issues—could delay production and delivery. If such disruptions occur, Costco risks inconsistent product availability and quality, which could reduce member acceptance of Kirkland Signature products. Since these products represent a growing portion of overall sales and carry higher margins, any loss of member confidence could negatively impact both brand loyalty and gross margin performance.",
      "llm_answer": "Costco’s heavy reliance on the Kirkland Signature brand and its extensive network of private‑label manufacturing and distribution facilities creates a dual risk: any disruption or quality issue with these products can erode member loyalty, while the capital‑intensive supply‑chain infrastructure makes the company vulnerable to cost pressures that can squeeze gross margins. Consequently, setbacks in brand perception or in the efficiency of its private‑label operations could adversely affect both customer retention and profitability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and contextually relevant, capturing the core risks associated with Costco's investment in Kirkland Signature and its reliance on private-label manufacturing and distribution. It correctly identifies that disruptions could impact member loyalty and gross margins, aligning with the ground truth. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The qualitative accuracy is slightly reduced because the LLM omits specific examples of operational disruptions (e.g., extreme weather, pandemics, labor issues) mentioned in the original answer, which weakens the completeness of the risk explanation. Additionally, while the LLM mentions 'capital-intensive supply-chain infrastructure,' this characterization is not explicitly supported in the ground truth, introducing a minor interpretive stretch. However, the core reasoning—linking supply chain vulnerabilities to brand loyalty and margin performance—is logically sound and semantically equivalent. The answer fully addresses the question’s focus on risks to brand loyalty and gross margins, earning high marks for contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 332,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total grant date fair value of the performance-based LTIP units across the 2021 and 2022 LTI Programs, and how does this compare to the time-based restricted stock units granted in those same years?",
      "original_answer": "The total grant date fair value of the performance-based LTIP units for the 2021 and 2022 LTI Programs is $39.0 million ($18.4 million in 2021 and $20.6 million in 2022). In comparison, the time-based restricted stock units granted in those years totaled $11.2 million ($4.3 million in 2021 and $6.9 million in 2022). Therefore, the performance-based LTIP units had a significantly higher total grant date fair value than the time-based restricted stock units across both programs.",
      "llm_answer": "The total grant‑date fair value of the performance‑based LTIP units awarded under the 2021 and 2022 LTI programs is $5.7 million for 2021 and $13.7 million for 2022, for a combined $19.4 million. This combined LTIP fair value is substantially lower than the grant‑date fair value of the time‑based restricted stock units awarded in the same years, which totaled $4.3 million in 2021 and $6.9 million in 2022, for a combined $11.2 million. Thus, the performance‑based LTIP units represent a larger aggregate fair‑value grant than the time‑based RSUs, but the RSU component still accounts for a meaningful portion of the total equity‑based compensation granted in those years.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative values. According to the ground truth, the performance-based LTIP units had grant date fair values of $18.4 million in 2021 and $20.6 million in 2022, totaling $39.0 million. However, the LLM incorrectly reports $5.7 million for 2021 and $13.7 million for 2022, totaling $19.4 million—less than half the correct amount. The time-based RSUs are correctly stated as $4.3 million in 2021 and $6.9 million in 2022, totaling $11.2 million. (2) The calculation of the total performance-based LTIP value is wrong: $5.7M + $13.7M = $19.4M (correct arithmetic), but the inputs are factually incorrect. The comparison conclusion is also flawed—the LLM states performance-based LTIPs are 'larger' than RSUs ($19.4M vs $11.2M), which is directionally correct based on its numbers, but underreports the true magnitude of the difference (actual: $39.0M vs $11.2M). (3) The multi-hop reasoning is structurally sound—comparing performance-based and time-based awards across two years—but based on incorrect data. The model identifies the correct entities (LTIP units, RSUs, 2021/2022) and attempts synthesis, but fails at data retrieval. (4) Scores reflect major quantitative inaccuracy (3/10), partially correct reasoning with flawed inputs (4/10), and high relevance to the question's structure and intent (8/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 385,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total fair value of U.S. municipal securities held by 3M as of December 31, 2024, and how are these securities classified in terms of fair value hierarchy due to their valuation methodology?",
      "original_answer": "As of December 31, 2024, 3M holds $16 million in U.S. municipal securities, which are classified as Level 3 in the fair value hierarchy because their valuation references the carrying value of the corresponding finance lease obligation.",
      "llm_answer": "The total fair value of U.S. municipal securities held by 3M as of December 31, 2024 is $20 million, and these securities are classified as Level 3 in the fair‑value hierarchy because they are valued using a methodology that references the carrying value of the related finance‑lease obligation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the fair value of U.S. municipal securities as $20 million, whereas the ground truth is $16 million. This is a significant factual error affecting the core of the question. However, the classification of these securities as Level 3 in the fair value hierarchy is correct. (2) The quantitative inaccuracy is limited to the dollar amount; all other numerical references (e.g., date: December 31, 2024) are accurate. The $4 million overstatement could stem from confusion with another data point or misreading of the source, but it remains a material error. (3) The reasoning for the Level 3 classification is sound and correctly references the valuation methodology tied to the carrying value of the finance lease obligation, indicating proper multi-hop synthesis between the security type and its valuation technique. (4) While the qualitative and contextual aspects are strong—correct entities (3M, U.S. municipal securities), correct time frame, correct hierarchy level, and correct rationale—the quantitative inaccuracy severely undermines the overall correctness. A score of 4 reflects partial credit for correct reasoning and structure but significant deduction for incorrect key data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 348,
        "total_tokens": 1495
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What percentage of Meta's worldwide Monthly Active Users (MAP) in Q4 2023 consisted solely of violating accounts, and how does this estimation process reflect the challenges in identifying such accounts across encrypted platforms like WhatsApp?",
      "original_answer": "Approximately 3% of Meta's worldwide Monthly Active Users (MAP) in Q4 2023 consisted solely of violating accounts. This estimation process reflects challenges in identifying such accounts across encrypted platforms like WhatsApp due to limited visibility and reliance on fewer data signals such as phone numbers and device information, which increases the difficulty of accurate detection at scale.",
      "llm_answer": "In Q4 2023, Meta estimated that roughly 3 percent of its worldwide Monthly Active Users (MAP) were made up exclusively of violating accounts—those created for purposes that breach the company’s terms of service, such as bots and spam. This figure comes from an internal review of a limited sample of accounts that was calibrated against periodic user‑survey data, and it required significant judgment to match accounts across Facebook, Instagram, Messenger and WhatsApp. Because WhatsApp’s end‑to‑end encryption limits the data signals (e.g., device information, phone numbers) that Meta can use to identify and link accounts, the company has far fewer observable cues for detecting violating behavior on that platform, making the estimation process especially challenging and prone to uncertainty. Consequently, the 3 % estimate reflects both the statistical uncertainty inherent in the sampling method and the difficulty of accurately measuring violations across encrypted services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that approximately 3% of Meta's worldwide Monthly Active Users (MAU) in Q4 2023 consisted of violating accounts, which matches the ground truth. The percentage is accurate and correctly attributed to the right time period and metric. (2) Quantitatively, the 3% figure is exact and consistent with the original answer; no calculations are required beyond this, and the number is presented clearly. Format and precision are appropriate. (3) The reasoning is strong and expands on the original answer with additional context about Meta's estimation methodology—such as reliance on sample reviews, user surveys, and cross-platform matching—while correctly identifying the challenges posed by WhatsApp's end-to-end encryption. It accurately explains that limited data signals (phone numbers, device info) hinder detection, increasing uncertainty. This reflects sound multi-hop reasoning across Meta’s platforms and privacy constraints. (4) The LLM answer is semantically equivalent to the ground truth and adds well-supported contextual detail without introducing inaccuracies. The only minor difference is that the original answer is more concise, while the LLM provides elaboration on methodology not explicitly in the ground truth—but this does not compromise accuracy. Thus, the answer is fully factually correct, highly relevant, and well-reasoned, warranting a 9/10 due to slight over-elaboration without error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 404,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total amount of upfront payments and equity investments made by Pfizer in its collaborations with BioNTech for both the shingles vaccine and the Comirnaty (COVID-19 vaccine) programs as of December 31, 2023?",
      "original_answer": "The total amount of upfront payments and equity investments made by Pfizer in its collaborations with BioNTech for the shingles vaccine and the Comirnaty vaccine programs was $375 million.",
      "llm_answer": "Based on the provided SEC 10-K filing information, Pfizer made upfront payments and equity investments in collaborations with BioNTech for both the shingles vaccine program and the Comirnaty (COVID-19 vaccine) program. Specifically, for the shingles vaccine collaboration, Pfizer paid a $75 million upfront cash payment and made a $150 million equity investment in BioNTech (resulting in a 2.7% equity stake as of December 31, 2023), as disclosed in the collaboration agreement details on page 73. For the Comirnaty program, the $225 million net upfront payment to BioNTech (comprising $75 million cash and $150 million equity investment) was recorded as acquired in-process research and development expenses in 2021, with the equity investment being part of the initial agreement signed in April 2020. The total upfront payments and equity investments related to both collaborations, as of December 31, 2023, are reflected in these transactions, with the $150 million equity investment in BioNTech being a key component of the shingles vaccine collaboration agreement.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly identifies a $75 million upfront payment and $150 million equity investment for the shingles vaccine (totaling $225 million), it incorrectly states that the Comirnaty program involved a $225 million net upfront payment comprising $75 million cash and $150 million equity. This is factually wrong: the original agreement for Comirnaty in 2020 did include a $150 million equity investment, but the upfront cash payment was $50 million, not $75 million, and the total upfront consideration was $150 million (not $225 million). The LLM incorrectly doubles the equity investment by implying separate $150 million investments for each program, but Pfizer's total equity investment in BioNTech as part of these collaborations was a single $150 million tranche tied primarily to the Comirnaty deal. The ground truth states the total upfront and equity payments across both programs was $375 million, but the LLM's synthesis implies $75M + $150M (shingles) + $75M + $150M (Comirnaty) = $450 million, which is incorrect. (2) The calculation is therefore flawed: the correct total should be $50M (Comirnaty cash) + $150M (equity) + $75M (shingles cash) + potentially additional consideration, but the knowledge graph confirms the total combined value is $375M. The LLM does not arrive at or mention this correct total. (3) The multi-hop reasoning is partially sound— it attempts to synthesize across both collaborations and references correct document locations—but fails in accurately disentangling the shared equity investment and misattributes amounts. It treats the equity investment as duplicated across deals when it was not. (4) Scores reflect that core elements (some dollar amounts, correct companies, correct time frame) are present and contextually relevant, but critical numerical and synthetic errors reduce correctness significantly. The answer is not semantically equivalent to the ground truth due to incorrect totals and component values.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 549,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total net income contribution from COP's operations in Europe, Middle East, and North Africa (EMENA) over the three-year period from 2019 to 2021, and how did it compare to the net loss reported in the Lower 48 region during the same period?",
      "original_answer": "COP's operations in the EMENA region contributed a total net income of $1 million in 2019, $6 million in 2020, and a net loss of $24 million in 2021, resulting in a cumulative net loss of $17 million over the three-year period. In contrast, the Lower 48 region reported a net income of $402 million in 2019, $804 million in 2020, and a net loss of $8 million in 2021, resulting in a total net income of $1,206 million over the same period. Therefore, the EMENA region underperformed significantly compared to the Lower 48 region, with a difference of $1,223 million in total net results.",
      "llm_answer": "The total net income contribution from COP's operations in Europe, Middle East, and North Africa (EMENA) over 2019–2021 was a **$25 million credit** ( $1 million in 2019, $6 million in 2020, and $24 million credit in 2021 ), whereas the Lower 48 region recorded a **$1,206 million net loss** over the same period ( $402 million impairment in 2019, $813 million in 2020, and $89 million credit in 2021 ). Thus, EMENA generated a modest net gain, while Lower 48 incurred a substantially larger net loss.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple critical factual errors. It incorrectly states that EMENA had a '$25 million credit' over 2019–2021, but the ground truth shows a cumulative net loss of $17 million ($1M + $6M - $24M = -$17M). The LLM misrepresents the 2021 EMENA result as a 'credit' instead of a net loss, and incorrectly sums the values. (2) For the Lower 48 region, the LLM claims a '$1,206 million net loss', but the ground truth reports a total net income of $1,206 million. This is a complete reversal of the actual financial outcome. Additionally, the individual year figures provided for Lower 48 in the LLM answer ($402M impairment, $813M in 2020, $89M credit) do not match the ground truth ($402M income, $804M income, $8M loss). The 2020 and 2021 figures are especially inaccurate. (3) The multi-hop reasoning is fundamentally flawed: the model fails to correctly synthesize the three-year results for either region, miscalculates totals, and draws the opposite conclusion — claiming EMENA had a 'modest net gain' and Lower 48 a 'substantially larger net loss', when in reality Lower 48 generated over $1.2 billion in net income while EMENA lost $17 million. (4) Despite addressing the right regions and time frame, the answer is severely compromised by incorrect numbers, mischaracterized financial results, and erroneous conclusions. The contextual relevance is moderate because it attempts the right comparison, but factual and quantitative accuracy is very low, warranting a correctness score of 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 420,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What is the dollar amount decrease in 'Other noncontrolling redeemable interests' from 2023 to 2024, and how does this change contribute to the overall decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' over the same period?",
      "original_answer": "The dollar amount decrease in 'Other noncontrolling redeemable interests' from 2023 to 2024 is $3,720 (from $172,912 in 2023 to $169,192 in 2024). This contributes to the overall decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' from $195,949 in 2023 to $184,729 in 2024, a total decrease of $11,220. The decrease in 'Other noncontrolling redeemable interests' accounts for approximately 33.1% of the total decline in the combined metric.",
      "llm_answer": "The dollar amount decrease in \"Other noncontrolling redeemable interests\" from 2023 to 2024 is $3.72 million (from $172,912 thousand to $169,192 thousand). This reduction accounts for a $11,220 thousand decline in the total preferred units and noncontrolling redeemable interests, contributing to the overall decrease of $11,220 thousand in \"Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties\" over the same period.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the dollar amount decrease in 'Other noncontrolling redeemable interests' as $3,720 thousand ($3.72 million), which matches the ground truth (from $172,912 to $169,192). However, it incorrectly states that this reduction accounts for a '$11,220 thousand decline in the total preferred units and noncontrolling redeemable interests', which is factually wrong—the $3,720 decrease is only part of the total $11,220 decrease. The LLM implies that the $3,720 decrease is equivalent to the full $11,220 total decline, which misrepresents the contribution. (2) The numbers themselves are numerically accurate when converted (e.g., $3.72 million = $3,720 thousand), and the total decrease of $11,220 thousand is correctly stated. However, the calculation of the contribution (33.1%) is omitted, and the reasoning incorrectly equates the partial decrease with the total decrease. (3) The multi-hop reasoning fails: the model should have recognized that the $3,720 decrease contributes partially to the total $11,220 decrease, not that it accounts for the entire decline. This reflects a breakdown in logical synthesis across the two metrics. (4) While the answer includes relevant context and correct base figures, the flawed reasoning and misattribution of the decrease significantly undermine the qualitative and quantitative accuracy. The contextual relevance remains high because the response addresses the right metrics and time period.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 407,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What is the total fair value of foreign corporate debt and asset-backed securities held by MMM as of December 31, 2024, and how does this compare to the combined fair value of these two asset categories from the prior year?",
      "original_answer": "The total fair value of foreign corporate debt and asset-backed securities held by MMM as of December 31, 2024, is $55 million ($31 million in foreign corporate debt + $24 million in asset-backed securities). As of December 31, 2023, the combined fair value of these two assets was $0 million, as both categories had no value reported in that year.",
      "llm_answer": "The total fair value of foreign corporate debt and asset‑backed securities held by 3M as of December 31 2024 is $31 million, compared with $0 million in the prior year (2023).",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a critical quantitative error. The total fair value for December 31, 2024, is stated as $31 million, but the ground truth is $55 million ($31 million foreign corporate debt + $24 million asset-backed securities). The LLM only reports the foreign corporate debt portion and omits the $24 million in asset-backed securities, leading to an incorrect total. The prior year value of $0 million is correctly reported, matching the ground truth. (2) The calculation of the combined 2024 value is incorrect due to omission: $31M ≠ $31M + $24M. The model fails to sum the two components, instead reporting only one. (3) The multi-hop reasoning is partially sound—it correctly identifies that both categories had no value in 2023 and that foreign corporate debt exists in 2024—but fails to retrieve or sum the second asset class (asset-backed securities) in 2024, breaking the synthesis. (4) The contextual relevance is high as the answer addresses the comparison across years and the correct company (MMM/3M) and time periods. However, the significant numerical inaccuracy in the total value severely undermines factual correctness, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 343,
        "total_tokens": 1493
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do technical errors and data limitations in Meta's Family metrics estimation process affect the accuracy of its monthly active people (MAP) and average revenue per person (ARPP) metrics, and by what approximate margin could these metrics vary due to such inaccuracies?",
      "original_answer": "Meta acknowledges that its Family metrics, including monthly active people (MAP) and average revenue per person (ARPP), are based on internal data and are inherently subject to statistical variances, uncertainties, and technical errors in their estimation process. The company uses complex algorithms, machine learning models, and user survey data calibrated against signals like IP addresses and device information to estimate the number of unique individuals using its platforms. These models require significant judgment and are affected by data limitations. Meta estimates that the potential error margin for its Family metrics is generally around 3% of its worldwide MAP. Given that Meta reported approximately 3.3 billion worldwide MAP in 2023, this 3% error margin implies that the actual number of unique users could vary by about 99 million. This level of inaccuracy can significantly affect the reliability of ARPP calculations, which depend on MAP for per-user revenue averaging, and could distort business decisions, investor perceptions, and advertising investments.",
      "llm_answer": "The technical errors and data limitations in Meta’s Family metrics estimation—such as limited visibility into encrypted WhatsApp activity, reliance on incomplete data signals, and algorithmic or survey‑based modeling—can cause MAP and ARPP to be over‑ or understated. These inaccuracies could translate into variations of roughly 3 percent of worldwide MAP (and similarly affect ARPP), meaning the reported figures might differ by several percentage points from the true underlying values.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that technical errors and data limitations—such as reliance on incomplete signals, algorithmic modeling, and survey data—affect the accuracy of Meta's Family metrics, including MAP and ARPP. (2) The key quantitative claim—that inaccuracies could vary by roughly 3% of worldwide MAP—is exactly consistent with the original answer. Although the LLM does not explicitly calculate the 99 million user variance (3% of 3.3 billion), it correctly states the 3% error margin, which is the core numerical fact. The absence of the explicit calculation is a minor omission but does not undermine the correctness, as the 3% figure allows the reader to derive the margin. (3) The reasoning is sound: it acknowledges the multi-hop connection between estimation methods (e.g., IP/device data, modeling) and downstream impacts on MAP and ARPP. It also correctly links the uncertainty in user counts to potential distortions in per-user revenue metrics. (4) All entities (Meta, Family metrics, MAP, ARPP) are accurate, and the answer is fully relevant to the question. The only reason for not scoring a 10 is the lack of the concrete example (99 million users) that would fully demonstrate synthesis of the 3% margin with the 3.3 billion MAP figure, but this is a minor gap in completeness rather than a factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 387,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does The Home Depot's strategic use of BOPIS, as defined in the glossary, contribute to the fulfillment of 50% of U.S. online orders through stores, as stated in the supply chain section?",
      "original_answer": "The Home Depot's strategic use of BOPIS (Buy Online, Pickup In Store), as defined in the glossary, enables customers to place orders online and pick them up in-store, which directly supports the company's supply chain goal of fulfilling 50% of U.S. online orders through stores. This interconnected retail program is part of a broader set of store-based fulfillment options that enhance customer convenience and optimize inventory distribution across the network.",
      "llm_answer": "The Home Depot’s glossary defines BOPIS as “Buy Online, Pickup In Store.” By using BOPIS, customers can order online and collect their purchases at any store location, which the company leverages as a fulfillment channel. This capability enables roughly half of all U.S. online orders to be completed through stores, accelerating delivery speed and reducing shipping costs while meeting customer expectations for convenience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately defines BOPIS as 'Buy Online, Pickup In Store' and correctly states that approximately 50% (described as 'roughly half') of U.S. online orders are fulfilled through stores, matching the 50% figure in the original answer. (2) There are no calculations, but the percentage is correctly represented semantically ('roughly half' = 50%), satisfying quantitative accuracy. (3) The reasoning is sound: the model correctly links BOPIS as a store-based fulfillment method that supports the 50% fulfillment goal by enabling faster delivery, reducing shipping costs, and improving convenience—consistent with the interconnected retail strategy mentioned in the original. (4) While the LLM answer omits explicit mention of 'interconnected retail program' or 'broader set of store-based fulfillment options,' it captures the core function and strategic impact of BOPIS. The answer is contextually relevant, directly addressing how BOPIS contributes to store-based fulfillment. Minor deduction in qualitative accuracy due to slightly less comprehensive explanation of the broader fulfillment ecosystem, but key logic and facts are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 341,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does Morgan Stanley's approach to recognizing compensation expense for Deferred Cash-Based Compensation (DCP) awards differ from its recognition of carried interest compensation, particularly in terms of timing and the nature of the awards?",
      "original_answer": "Morgan Stanley recognizes compensation expense for DCP awards over the vesting period, adjusted for changes in the fair value of referenced investments selected by employees. In contrast, carried interest compensation is recognized immediately for any portion of carried interest (both realized and unrealized) allocated to employees, without being tied to a vesting schedule. This distinction reflects the different nature of the awards: DCP awards are deferred and tied to vesting conditions, while carried interest compensation is directly linked to performance-based allocations that are recognized as they occur.",
      "llm_answer": "Morgan Stanley recognizes compensation expense for Deferred Cash-Based Compensation (DCP) awards based on the notional value of the award adjusted for changes in the fair value of the referenced investments, with expense recognized over the vesting period of each separately vesting portion. In contrast, carried interest compensation expense is recognized for any portion of carried interest (both realized and unrealized) allocated to employees, with no adjustment for fair value changes in referenced investments and recognized when earned. DCP expense is tied to investment performance and recognized ratably over vesting, while carried interest expense is based on actual carried interest allocations and recognized as earned.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: DCP compensation expense is recognized over the vesting period with adjustments for changes in fair value of referenced investments, while carried interest compensation is recognized immediately when allocated to employees, without vesting or fair value adjustments. The nature of the awards—DCP being deferred and vesting-based, carried interest being performance-based and recognized as earned—is correctly captured. (2) There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is not applicable in a numerical sense, but all qualitative financial concepts (e.g., fair value adjustments, vesting schedules, realization status) are correctly represented. (3) The multi-hop reasoning is sound: the model correctly distinguishes between two different compensation mechanisms at Morgan Stanley, synthesizing their timing, recognition criteria, and underlying nature. (4) The only minor shortcoming is that the LLM answer does not explicitly state that carried interest recognition includes both realized and unrealized portions—though it says 'recognized when earned,' which is semantically close. The original answer makes this explicit, which is a small but relevant detail in financial reporting context. Otherwise, the answer is complete, contextually relevant, and factually correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 398,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, based on the information provided?",
      "original_answer": "The total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, is $0, as neither entity reported any such interests redeemable at amounts in excess of fair value.",
      "llm_answer": "Based on the provided document pages, the total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, is $184,729 (in thousands). This figure is explicitly stated in the \"Temporary Equity\" section on pages 128 and 129, which reports the consolidated amount as $184,729 for 2024 (compared to $195,949 for 2023). The document confirms this represents the sum of the 7.50% cumulative redeemable preferred units ($15,537) and other noncontrolling redeemable interests ($169,192) as of December 31, 2024. \n\n**Answer:** $184,729 (in thousands).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. The ground truth states that the total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, is $0, because neither entity reported any such interests redeemable at amounts in excess of fair value. The LLM incorrectly reports a figure of $184,729 (in thousands), citing specific components like 7.50% cumulative redeemable preferred units and other noncontrolling interests. This contradicts the ground truth, which explicitly states no such interests are classified as temporary equity. The numbers cited by the LLM may appear in the document, but according to the verified knowledge graph, they do not represent amounts classified as temporary equity for the specified entities and criteria. Therefore, the quantitative accuracy is severely flawed. The reasoning is unsound because it fails to apply the correct classification logic (i.e., only interests redeemable at amounts in excess of fair value are classified as temporary equity, and none meet that criterion). The answer lacks semantic equivalence with the ground truth, despite referencing document sections. The contextual relevance is low because it provides a detailed but factually incorrect response based on a misinterpretation of the accounting criteria.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 382,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the total estimated fair value of NEE's nuclear decommissioning fund assets and FPL's storm fund assets combined as of December 31, 2021, and how does this compare to the carrying amount of NEE's special use funds on its consolidated balance sheet for the same date?",
      "original_answer": "The total estimated fair value of NEE's nuclear decommissioning fund assets and FPL's storm fund assets combined as of December 31, 2021, is $8,922 million ($8,846 million for NEE and $76 million for FPL). This amount represents the fair value of the special use funds, which are primarily composed of equity and available-for-sale debt securities. However, on NEE's consolidated balance sheet, these special use funds are reported at their carrying amount of $2,505 million as of December 31, 2021. The significant difference between the fair value and carrying amount reflects the accounting treatment where certain investments are carried at fair value, while others are reported at amortized cost or adjusted based on regulatory treatment.",
      "llm_answer": "The combined estimated fair value of NEE’s nuclear decommissioning fund assets and FPL’s storm fund assets as of December 31, 2021 was approximately $8.9 billion, which exceeds the carrying amount of NEE’s special‑use funds on its consolidated balance sheet of $2.5 billion for the same date.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the combined estimated fair value of NEE's nuclear decommissioning fund and FPL's storm fund as approximately $8.9 billion, which aligns with the ground truth total of $8,922 million (rounded to $8.9 billion). The carrying amount is reported as $2.5 billion, matching the ground truth value of $2,505 million when rounded. These approximations are acceptable under semantic equivalence. (2) Quantitatively, the numbers are accurate within reasonable rounding conventions. The ground truth specifies $8,846 million for NEE and $76 million for FPL, summing to $8,922 million (~$8.9B), and the LLM correctly presents this sum. The carrying amount of $2,505 million is accurately rounded to $2.5 billion. No calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from two entities (NEE and FPL), two types of funds (nuclear decommissioning and storm), and compares their combined fair value to the carrying amount on NEE’s consolidated balance sheet. It correctly distinguishes between fair value and carrying amount, capturing the essence of the accounting difference. (4) The answer is contextually complete and relevant, addressing both parts of the question: the combined fair value and its comparison to the carrying amount. The only minor limitation is the lack of explicit breakdown of the $8.9 billion into its components ($8.846B + $76M), which slightly reduces completeness but does not affect the core correctness. Hence, a high score of 9 is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 429,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the significance of APJC as both a geographic segment in which Cisco operates and as a region tied to Cisco's consolidated financial reporting, and how does this dual role influence Cisco's internal performance measurement?",
      "original_answer": "Cisco reports its operations across three geographic segments: the Americas, EMEA, and APJC. APJC is not only a key operating segment where Cisco generates revenue but also a region whose financial results are fully incorporated into Cisco’s consolidated financial statements. This dual role means that performance metrics such as revenue and gross margin from the APJC segment directly feed into Cisco’s overall financial reporting, even though certain expenses like R&D and restructuring charges are not allocated to the segment for internal management review. Therefore, APJC's financial performance influences both strategic decisions and consolidated earnings.",
      "llm_answer": "APJC is defined in Cisco’s internal management system as one of its three geographic operating segments (the Americas, EMEA, and APJC) and is also the region used for consolidated financial reporting. Because Cisco allocates resources and evaluates segment performance on a geographic basis, APJC’s revenue, gross margin, and other key metrics flow directly into the company‑wide financial statements, influencing how operating results are measured and benchmarked across the three segments. This dual role means that APJC’s performance is both a distinct segment outcome and a component of the overall consolidated results that drive internal performance measurement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: APJC is correctly identified as one of three geographic segments (Americas, EMEA, APJC), and its role in both internal performance measurement and consolidated financial reporting is accurately described. (2) There are no numeric values in the question or answer requiring verification, so quantitative accuracy is not applicable in a strict sense, but no numbers are misstated. (3) The multi-hop reasoning is sound—LLM correctly synthesizes that APJC serves a dual role: as an operating segment for management evaluation and as a contributor to consolidated financials. It correctly notes that performance metrics like revenue and gross margin from APJC feed into company-wide results, influencing internal benchmarking and strategic decisions. (4) The only minor shortcoming is that the LLM omits the specific detail that certain expenses (e.g., R&D, restructuring charges) are not allocated to APJC for internal review—a nuance present in the original answer that adds depth to how internal performance is measured. However, the core meaning and implications are preserved. The answer is semantically equivalent and contextually fully relevant, with excellent clarity and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 360,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What percentage of Verizon Business Group's total revenues in 2024 came from Business Markets and Other, and how does this segment specifically incorporate FWA broadband into its offerings?",
      "original_answer": "Business Markets and Other generated $13.1 billion in revenues in 2024, which represented 44% of the Verizon Business Group's total revenues. This segment incorporates FWA broadband as one of its wireless services, offering fixed connectivity solutions comparable to residential services but tailored for small and medium businesses.",
      "llm_answer": "In 2024, Business Markets and Other accounted for $13.1 billion of Verizon Business Group’s $29.5 billion total revenue, representing roughly **44 %** of the segment’s revenue. This segment incorporates FWA broadband by offering fixed‑connectivity solutions—similar to the residential fixed services in the Consumer segment—through its 5G and 4G LTE networks, providing FWA broadband as an alternative to traditional landline internet access for business customers.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the revenue figure of $13.1 billion and the 44% percentage are accurate. The implied total revenue of $29.5 billion is consistent with $13.1B / 0.44 ≈ $29.77B (minor rounding difference is acceptable and common in reporting). (2) The answer addresses both parts of the question: it correctly identifies the percentage of total revenues from Business Markets and Other and explains how FWA broadband is incorporated into the segment’s offerings. (3) Entities are accurate—Verizon Business Group, 2024 timeframe, and the Business Markets and Other segment are all correctly referenced. (4) The reasoning is sound: the LLM correctly synthesizes that FWA broadband is offered as fixed-connectivity solutions using 5G/4G LTE networks, tailored for business customers, which aligns with the ground truth’s emphasis on services comparable to residential but for small and medium businesses. The semantic content is equivalent, with slightly expanded technical detail (e.g., mentioning 5G/4G LTE) that adds clarity without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 319,
        "total_tokens": 1529
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What is the total fair value of Abbott's interest rate hedge contracts in 2024, and how does this compare to the total notional amount of all foreign currency forward exchange contracts held by Abbott as of the same date?",
      "original_answer": "The total fair value of Abbott's interest rate hedge contracts in 2024 is $50 million (payable position of $51 million offset by a $1 million receivable position). This is significantly smaller than the total notional amount of all foreign currency forward exchange contracts, which was $23.2 billion as of December 31, 2024.",
      "llm_answer": "The fair value of Abbott's interest rate hedge contracts in 2024 is $1 million (a receivable of $1 million and a payable of $51 million, net $50 million, but the disclosed fair‑value amount is $1 million). This is far smaller than the total notional amount of foreign currency forward exchange contracts, which totals $16.2 billion (the gross notional amount of contracts held as of December 31 2024).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numeric values. The fair value of Abbott's interest rate hedge contracts is misrepresented: the ground truth states the total fair value is $50 million (net of a $51 million payable and $1 million receivable), whereas the LLM incorrectly claims the 'disclosed fair-value amount is $1 million', which contradicts the source. Additionally, the notional amount of foreign currency forward contracts is stated as $16.2 billion in the LLM answer, but the correct figure from the ground truth is $23.2 billion—a major discrepancy. (2) Number verification: $51M payable - $1M receivable = $50M net liability (fair value), which the LLM confuses by calling the $1M receivable the 'fair value'. The foreign currency notional is off by $7 billion. These are material quantitative errors. (3) Multi-hop reasoning is partially sound—the model recognizes it must compare two distinct hedging instruments (interest rate hedges vs. foreign exchange forwards) and identifies the relevant metrics (fair value vs. notional amount). However, due to incorrect data retrieval, the synthesis fails. (4) Contextual relevance is high—the answer structure addresses both parts of the question and uses appropriate financial terminology. However, due to severe quantitative inaccuracies in both key figures, the correctness and quantitative accuracy scores are low. The qualitative accuracy is slightly higher because the reasoning framework is logical, even if based on wrong data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 421,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What does the relationship between proved undeveloped reserves and net acreage in Asia suggest about Equity Companies' development potential in the region, and how does this compare to their consolidated subsidiaries' efficiency in utilizing land for reserves?",
      "original_answer": "Equity Companies in Asia reported 1,503 million barrels of proved undeveloped reserves against 19 thousand net acres. This results in a reserves-to-acre ratio of approximately 79.1 million barrels per thousand acres. In comparison, XOM's consolidated subsidiaries in Asia reported 1,315 million barrels of proved undeveloped reserves against 640 thousand net acres, yielding a reserves-to-acre ratio of approximately 2.05 million barrels per thousand acres. This indicates that Equity Companies are significantly more efficient in terms of reserves per acre in Asia, suggesting a potentially higher development potential in the region.",
      "llm_answer": "The relationship between proved undeveloped reserves (3,563 thousand acres) and net acreage (427 thousand acres) in Asia indicates that undeveloped acreage is roughly eight times the net acreage, suggesting substantial upside potential if these resources can be developed. However, ExxonMobil’s consolidated subsidiaries achieve a much higher efficiency in converting land to reserves—producing about 12,234 thousand acres of net developed acreage from 19,595 thousand gross acres—demonstrating a stronger land‑utilization rate compared with the more expansive but less efficiently tapped undeveloped holdings in Asia.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. It reports 'proved undeveloped reserves (3,563 thousand acres)' and 'net acreage (427 thousand acres)', which misrepresents the original data—reserves should be in barrels, not acres. The ground truth states Equity Companies have 1,503 million barrels of proved undeveloped reserves on 19 thousand net acres, not the 3,563 thousand acres cited. Similarly, XOM’s consolidated subsidiaries have 1,315 million barrels on 640 thousand net acres, not the figures mentioned. The LLM confuses developed/undeveloped acreage with reserves and misattributes metrics. (2) Calculations are completely wrong: the LLM claims ExxonMobil’s subsidiaries produce '12,234 thousand acres of net developed acreage from 19,595 thousand gross acres', which is not supported by the original data and misrepresents the concept of reserves-to-acre ratios. The correct ratio for Equity Companies is ~79.1 million barrels per thousand acres, and for XOM it is ~2.05 million barrels per thousand acres—showing Equity Companies are more efficient. The LLM incorrectly concludes XOM is more efficient, reversing the correct inference. (3) Multi-hop reasoning fails: the model does not compute or compare the reserves-per-acre ratios correctly, nor does it identify that higher reserves per acre suggest greater development efficiency. Instead, it fabricates acreage conversion metrics not present in the original. (4) The contextual relevance is low because it discusses land utilization using incorrect metrics and entities, though it attempts to address development potential. Due to pervasive factual, quantitative, and logical errors, the correctness score is 1—only minimal relevance to the topic is retained.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 481,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What is the significance of the Parent Company's unconditional guarantee of securities issued by Morgan Stanley Finance LLC, and how does this guarantee relate to the Firm's broader obligations under its amended and restated support agreement in the context of a resolution scenario?",
      "original_answer": "The Parent Company fully and unconditionally guarantees the securities issued by Morgan Stanley Finance LLC, a wholly owned finance subsidiary, which ensures that these securities are backed by the full credit of the Parent Company. In the context of a resolution scenario, the Parent Company is also obligated under an amended and restated support agreement to contribute all of its contributable assets to its supported entities and/or the Funding IHC. The Funding IHC, in turn, would be obligated to provide capital and liquidity to its supported entities. These mechanisms are interconnected, as the guarantee of Morgan Stanley Finance LLC's securities represents one of the Parent Company's financial commitments that could be called upon during a resolution event, and the support agreement formalizes the process for distributing capital and liquidity across the organization during such a scenario.",
      "llm_answer": "The Parent Company’s unconditional guarantee of Morgan Stanley Finance LLC’s securities is a key component of its broader resolution‑planning framework. Under the amended and restated support agreement, the Parent is required to contribute all of its contributable assets (and, through the Funding IHC, to provide additional capital and liquidity) to its material entities in a resolution scenario, with these obligations secured by the Parent’s assets. This guarantee therefore ensures that, if a resolution event occurs, the Parent’s pledged support will be available to meet the debt‑service and other obligations of Morgan Stanley Finance LLC, reinforcing the overall financial resilience of the Firm’s resolution plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) All factual components are correct: the Parent Company's unconditional guarantee of Morgan Stanley Finance LLC's securities, the existence of the amended and restated support agreement, the obligation to contribute contributable assets, and the role of the Funding IHC in providing capital and liquidity during a resolution scenario. There are no numeric values in the question or answers, so quantitative accuracy is not applicable in terms of calculations, but no numbers are misstated. (2) The LLM correctly identifies all relevant entities: Parent Company, Morgan Stanley Finance LLC, Funding IHC, and supported entities. (3) The multi-hop reasoning is sound: it connects the guarantee of securities with the broader resolution framework and the support agreement, explaining how the guarantee fits within the Firm's systemic obligations during a resolution event. (4) The only minor shortcoming is that the LLM answer does not explicitly state that the support agreement obligates the Parent to contribute assets to the Funding IHC, which then provides capital to supported entities—the flow is implied but less clearly articulated than in the original. However, the semantic meaning and intent are preserved, and the answer remains contextually precise and factually aligned. Thus, the answer earns a 9 for correctness and qualitative accuracy due to this slight omission in structural clarity, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 425,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does the Bipartisan Budget Act of 2015's partnership tax audit rules potentially affect Simon Property Group's (SPG) financial obligations through its joint venture investments, including those managed by third parties such as Klépierre and The Taubman Realty Group, LLC?",
      "original_answer": "The Bipartisan Budget Act of 2015 introduced partnership tax audit rules that assess taxes, interest, or penalties at the partnership level for audit adjustments to income, gain, loss, deduction, or credit items. Simon Property Group (SPG), through its investments in 84 joint venture properties and entities like Klépierre and The Taubman Realty Group, LLC, could be required to bear the economic burden of these taxes, interest, and penalties even though SPG and its subsidiary REITs may not otherwise have been subject to additional corporate-level taxes had they owned the assets directly. This financial exposure arises because SPG applies the equity method of accounting to these joint ventures, and as a direct or indirect partner, SPG may be liable for partnership-level assessments without the ability to opt out of the rules, potentially resulting in material adverse effects on SPG's financial position.",
      "llm_answer": "The Bipartisan Budget Act of 2015 subjects partnership audit adjustments to partnership‑level tax liability, meaning that if a joint‑venture entity in which Simon Property Group holds an interest (including those managed by third parties such as Klépierre or The Taubman Realty Group, LLC) incurs additional taxes, interest or penalties from an IRS audit, the partnership may be required to pay those amounts and Simon, as a partner, could bear the economic burden even though the REITs themselves would not face the same corporate‑level tax consequences. This risk is highlighted in the “Partnership tax audit rules could have a material adverse effect on us” section of the filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the Bipartisan Budget Act of 2015, partnership-level tax liability, the applicability to joint ventures involving SPG (including Klépierre and The Taubman Realty Group, LLC), and the risk that SPG could bear economic burden despite its REIT status. The mention of the specific risk section in the filing adds contextual support. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, or property counts like '84 joint venture properties') in the LLM answer, but it does not misstate any numbers—only omits the specific count of joint ventures mentioned in the original. This omission is minor and does not affect the overall correctness. (3) The multi-hop reasoning is sound: the model correctly links the 2015 Act’s rules to partnership audits, applies them to SPG’s joint venture structure, identifies third-party-managed entities, and explains the financial exposure under equity method accounting. It correctly infers that SPG cannot opt out and may face material financial impact. (4) Semantic equivalence is strong—wording differs but meaning aligns closely with the original. The only minor gap is the absence of explicit mention of 'equity method of accounting' and 'inability to opt out of the rules,' though the economic burden implication is clearly stated. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 430,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Lockheed Martin's investment impairment in AMMROC in 2020 and restructuring charges in RMS in 2021 collectively impact net earnings and per-share results in those respective years?",
      "original_answer": "Lockheed Martin's noncash impairment charge of $128 million in 2020 on its investment in AMMROC decreased net earnings from continuing operations by $96 million, or $0.34 per share after tax. In 2021, Lockheed recorded a $36 million severance and restructuring charge ($28 million, or $0.10 per share after tax) associated with plans to close and consolidate facilities and reduce the workforce within the RMS business segment. Together, these events reduced net earnings by $96 million in 2020 and $28 million in 2021, with per-share impacts of $0.34 and $0.10, respectively.",
      "llm_answer": "The 2020 investment impairment in AMMROC and the 2021 restructuring charges together reduced net earnings and diluted earnings per share in the respective years. Specifically, the $128 million noncash impairment of AMMROC recorded in 2020 lowered 2020 net earnings by $96 million (or $0.34 per share after tax), and the $36 million severance and restructuring charge recorded in 2021 reduced 2021 net earnings by $28 million (or $0.10 per share after tax). These items are reflected in the “Other, net” and “Severance and restructuring charges” line items of the consolidated results and contributed to the decline in diluted earnings per share from $24.50 in 2020 to $22.76 in 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $128 million noncash impairment in AMMROC in 2020, which reduced net earnings by $96 million ($0.34 per share after tax), and the $36 million restructuring charge in RMS in 2021, which reduced net earnings by $28 million ($0.10 per share after tax). All numeric values match the ground truth exactly, including after-tax impacts and per-share effects. (2) Quantitative accuracy is perfect: the pre-tax and after-tax figures are correctly reported, and the per-share impacts are accurate. The answer correctly distinguishes between pre-tax charges and after-tax impacts on net earnings. (3) The multi-hop reasoning is sound—information from two different years and business segments (AMMROC in 2020 and RMS in 2021) is correctly synthesized. However, the addition of diluted EPS figures ($24.50 in 2020 to $22.76 in 2021) is extraneous and not part of the original answer; while not incorrect, it introduces data not requested or verified in the ground truth, slightly weakening qualitative precision. (4) The answer is contextually fully relevant, directly addressing the impact on net earnings and per-share results in the respective years. The only reason for not scoring a 10 is the inclusion of unrequested EPS trend data, which, while plausible, goes beyond the scope of the original answer and could imply unsupported causality. Otherwise, factual correctness and semantic equivalence are excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 404,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What was the year-over-year change in the balance of channel partner financing subject to guarantees, and how does this relate to Cisco's overall liquidity and capital resource requirements as stated in the MD&A section?",
      "original_answer": "The balance of channel partner financing subject to guarantees decreased from $1.7 billion in fiscal 2023 to $1.2 billion in fiscal 2024, representing a year-over-year decrease of $0.5 billion. Cisco states in its MD&A that it believes its cash and cash equivalents, investments, and cash generated from operations will satisfy its liquidity requirements, including working capital needs, capital expenditures, investment requirements, and commitments such as financing guarantees. This indicates that despite the decrease in guaranteed financing balances, Cisco remains confident in its ability to support such obligations through existing resources.",
      "llm_answer": "The year‑over‑year change in the balance of channel‑partner financing subject to guarantees was a decrease of $0.5 billion (from $1.7 billion at the end of fiscal 2023 to $1.2 billion at the end of fiscal 2024).  In the MD&A, Cisco notes that this reduction is part of its overall liquidity and capital‑resource management, indicating that lower guaranteed financing balances lessen the company’s contingent cash‑outflows and support its ability to meet working‑capital, capital‑expenditure and dividend‑payment requirements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the year-over-year change in channel partner financing subject to guarantees as a $0.5 billion decrease, from $1.7 billion in fiscal 2023 to $1.2 billion in fiscal 2024, matching the ground truth exactly. All numeric values and fiscal years are accurate. (2) The calculation of the $0.5 billion decrease is correct: $1.7B - $1.2B = $0.5B. Number formats are consistent and acceptable. (3) The multi-hop reasoning is sound: the LLM correctly links the quantitative change to Cisco's liquidity and capital resource management as discussed in the MD&A. While the original answer emphasizes Cisco’s confidence in meeting obligations through existing resources (cash, investments, operations), the LLM reinterprets this as reduced contingent outflows supporting capital requirements. This is a reasonable and logically consistent inference, though it slightly reframes rather than directly quotes Cisco’s stated position. (4) The answer is fully contextually relevant, addressing both the quantitative change and its implication for liquidity. The only minor deviation is in the precise emphasis of Cisco’s MD&A statement—original focuses on sufficiency of resources, while LLM emphasizes risk reduction from lower guarantees. This does not make the answer factually incorrect but introduces a subtle shift in nuance. Hence, full marks for quantitative accuracy and contextual relevance, near-perfect for qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 413,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the difference in the total value of 'Investments measured at NAV' between the two disclosed asset categories in the 2024 10-K filing of VZ, and which category has the higher value?",
      "original_answer": "The difference in the total value of 'Investments measured at NAV' between the two disclosed asset categories is $2,653 million. The first asset category reports 'Investments measured at NAV' at $2,656 million, while the second reports it at $3 million. Therefore, the first category has the higher value.",
      "llm_answer": "The 2024 10‑K filing does not disclose a line‑item titled “Investments measured at NAV” for any specific asset categories, and no quantitative values for such investments are provided in the pages supplied. Consequently, the difference in total value between two disclosed asset categories cannot be calculated, and it cannot be determined which category has the higher value.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is completely incorrect and contradicts the ground truth. The original answer confirms that 'Investments measured at NAV' are disclosed in the 2024 10-K filing of VZ (Verizon Communications), with specific values of $2,656 million and $3 million in two asset categories, resulting in a difference of $2,653 million. The LLM falsely claims these values are not disclosed at all. (2) Quantitative accuracy is extremely low because the LLM fails to report any of the correct figures—$2,656 million, $3 million, or the $2,653 million difference—despite their presence in the source data. (3) The reasoning is flawed: this is a multi-hop question requiring identification of two asset categories and comparison of their NAV-measured investments, but the LLM incorrectly concludes no data exists, failing both synthesis and retrieval steps. (4) Contextual relevance is low because the response denies the existence of key data rather than answering the question. The LLM may have had a retrieval failure (e.g., missing the relevant section of the 10-K), but based on the ground truth, the answer is factually wrong on all levels.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 327,
        "total_tokens": 1508
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does Abbott's production focus on Diabetes Care Devices, as stated in its 2024 10-K filing, relate to the 18.1% revenue increase in its Diabetes Care business, and what accounting policy supports the recognition of this revenue?",
      "original_answer": "Abbott's Diabetes Care business generated $6.805 billion in revenue in 2024, representing an 18.1% increase from the prior year. This growth aligns with Abbott's core business of producing health care products, including Diabetes Care Devices. The revenue from these devices is recognized upon the transfer of control, which occurs upon shipment or delivery, depending on the customer contract terms. This revenue recognition policy ensures that sales from Diabetes Care Devices are recorded in the period when control is transferred to the customer, supporting the reported increase in revenue.",
      "llm_answer": "Abbott's Diabetes Care segment generated $6,805 million in revenue in 2024, a 18.1 % increase over 2023, driven by strong growth in continuous glucose monitoring (CGM) systems. This revenue is recognized under Abbott's revenue‑recognition policy, which records product sales when control transfers—generally upon shipment or delivery—while also allocating the transaction price to multiple performance obligations (e.g., instruments, reagents, procedures, and service agreements) in its diagnostic businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly states that Abbott's Diabetes Care segment generated $6,805 million (i.e., $6.805 billion) in revenue in 2024, representing an 18.1% increase over the prior year—this matches the ground truth exactly in value and percentage, with acceptable formatting variation (e.g., $6,805 million vs $6.805 billion). The mention of continuous glucose monitoring (CGM) systems as a growth driver, while not in the original answer, is contextually plausible and does not contradict the ground truth; it adds detail without introducing inaccuracy. 2) Quantitatively, all numbers are accurate: the dollar amount, percentage increase, and year (2024) are correct. There are no calculation errors. 3) The accounting policy for revenue recognition is correctly described: revenue is recognized upon transfer of control, generally at shipment or delivery, which aligns with the ground truth. The LLM adds detail about allocation of transaction price to multiple performance obligations, which is consistent with ASC 606 and Abbott’s broader revenue policy, though this level of detail was not in the original answer. While this addition is accurate, it slightly shifts focus toward diagnostic businesses, which are not the core of the Diabetes Care Devices segment. This could introduce minor ambiguity, but does not invalidate the correctness. 4) The answer fully addresses the three-part question: (a) production focus on Diabetes Care Devices (implied through revenue from the segment), (b) the 18.1% revenue increase, and (c) the accounting policy for revenue recognition. The multi-hop reasoning—linking Abbott’s product focus to revenue growth and supporting it with accounting policy—is sound and logically structured. The only minor shortcoming is the slight overextension into diagnostic business performance obligations, which is not directly relevant to Diabetes Care Devices. Overall, the answer is factually correct, complete, and semantically equivalent to the ground truth with minor elaboration.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 541,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does The Home Depot's emphasis on project planning tools influence its competitive positioning with Pros, based on the specific customer expectations outlined in both sections of the 2024 10-K filing?",
      "original_answer": "The Home Depot's emphasis on project planning tools directly supports its competitive positioning with Pros by addressing their specific needs for dedicated sales support, product depth, and job-lot quantities for complex purchase needs, as outlined in both sections of the 2024 10-K. This focus enhances the interconnected shopping experience, which is critical for retaining and attracting Pros who require tailored solutions and streamlined purchasing processes.",
      "llm_answer": "The Home Depot’s 2024 10‑K shows that Pros value “project planning tools” as a key differentiator when choosing a supplier, and the company’s own disclosures stress that such tools are essential to winning and retaining professional customers. By embedding advanced planning and project‑management capabilities into its digital experience, Home Depot can meet Pros’ expectations for dedicated sales support, competitive credit/pricing, and seamless delivery options—strengthening its competitive positioning against other trade distributors.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies The Home Depot's emphasis on project planning tools and their importance to Pros, aligning with the 2024 10-K. It accurately reflects that Pros value these tools and that they help in winning and retaining professional customers. However, it introduces 'competitive credit/pricing' and 'seamless delivery options' as expectations met by the tools, which are not explicitly tied to project planning tools in the ground truth. The original answer emphasizes 'dedicated sales support, product depth, and job-lot quantities' as the key Pro needs addressed by project planning tools—this specific linkage is partially missed. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable; the score of 10 reflects no errors in this dimension. (3) The multi-hop reasoning is partially sound: the model connects project planning tools to Pro customer expectations and competitive positioning, but it does not fully synthesize the specific expectations (product depth, job-lot quantities) outlined in both sections of the 10-K. Instead, it substitutes related but unverified elements (credit/pricing, delivery). (4) The answer is contextually relevant and captures the general thrust of the original, but lacks precision in mapping tools to the exact customer expectations cited in the ground truth, warranting a 7 for qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 404,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the total number of shares available for award under the 2003 Incentive Program, the 2004 Non-Employee Director Restricted Stock Plan, and the Pioneer Natural Resources Company Amended and Restated 2006 Long Term Incentive Plan as of the end of 2024?",
      "original_answer": "The total number of shares available for award under the three plans is 56,689,904. This includes 47,088,821 shares under the 2003 Incentive Program, 238,700 shares under the 2004 Non-Employee Director Restricted Stock Plan, and 9,362,383 shares under the Pioneer LTIP.",
      "llm_answer": "Based on the provided document pages, the total number of shares available for award under the specified plans as of the end of 2024 is calculated as follows:  \n- 2003 Incentive Program: 47 million shares remaining  \n- 2004 Non-Employee Director Restricted Stock Plan: 47,088,821 shares available (explicitly stated in page 106)  \n- Pioneer Natural Resources Company Amended and Restated 2006 Long Term Incentive Plan: 9,362 thousand shares remaining (explicitly stated in page 106)  \n\nSumming these values: 47 million + 47,088,821 + 9,362,000 ≈ 103,450,821 shares. However, the document clarifies that the \"remaining shares available for award\" under each plan are explicitly listed, and the total is not directly summed in the text. The key figures are:  \n- 2003 Incentive Program: 47 million shares remaining  \n- Pioneer LTIP: 9,362 thousand shares remaining (9.362 million)  \n- The 2004 Director Plan's \"remaining available\" is not explicitly stated as a standalone number, but the total available shares under all plans (including the 2004 Director Plan) is referenced as part of the 56,689,904 shares in the Equity Compensation Plan table (page 111), but this includes all plans.  \n\nThe question asks for the **total number of shares available for award** across all three plans. The document provides the remaining shares for each plan:  \n- 2003 Incentive Program: 47 million shares  \n- Pioneer LTIP: 9,362 thousand shares (9.362 million)  \n- 2004 Non-Employee Director Plan: The text states \"available for award under the Pioneer LTIP were 9,362 thousand\" but does not give a separate number for the 2004 Director Plan. However, the Equity Compensation Plan table (page 111) states: \"Available shares can be granted in the form of restricted stock or other stock-based awards. Includes 47,088,821 shares available for award under the 2003 Incentive Program, 238,700 shares available for award under the 2004 Non-Employee Director Restricted Stock Plan, and 9,362,383 shares available for award under the Pioneer Natural Resources Company Amended and Restated 2006 Long Term Incentive Plan.\"  \n\nThus, the total shares available for award across all three plans is:  \n47,088,821 (2003 Incentive Program) + 238,700 (2004 Director Plan) + 9,362,383 (Pioneer LTIP) = **56,689,904 shares**.  \n\nThis matches the figure explicitly stated in the Equity Compensation Plan table on page 111. Therefore, the total number of shares available for award under the three plans as of the end of 2024 is 56,689,904.  \n\n**Answer**: 56,689,904 shares.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All key numbers are accurate: 47,088,821 shares for the 2003 Incentive Program, 238,700 for the 2004 Non-Employee Director Restricted Stock Plan, and 9,362,383 for the Pioneer LTIP. The final sum is correctly calculated as 56,689,904. (2) The LLM initially presents a confusion in the second bullet point by incorrectly stating 47,088,821 shares for the 2004 Director Plan, but it quickly identifies and corrects this error by referencing the correct table on page 111, where the accurate breakdown is cited. This shows self-correction and reliance on the authoritative source. (3) The multi-hop reasoning is sound: the model synthesizes data from different parts of the document (pages 106 and 111), distinguishes between approximate figures (e.g., '47 million') and exact values, and correctly identifies that the total must come from the consolidated table. (4) The final answer is semantically equivalent to the ground truth, with the exact total and component shares matching. Despite a minor initial misattribution, the LLM resolves it correctly, demonstrating strong reasoning and attention to detail. All scores are high due to factual accuracy, correct calculation, proper entity mapping, and contextual fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1730,
        "completion_tokens": 359,
        "total_tokens": 2089
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the impact of the reclassification of Customer receivables in 2023 on both interest income and interest expense in the Institutional Securities segment, and which specific financial adjustment amount is explicitly tied to this change?",
      "original_answer": "The reclassification of Customer receivables in 2023 resulted in a $4,432 million decrease to both interest income and interest expense in the Institutional Securities segment. This adjustment had no effect on net interest income but was entirely recorded within the Institutional Securities segment as part of aligning prior-year amounts to the current presentation.",
      "llm_answer": "The 2023 reclassification of Customer receivables reduced both interest income and interest expense by $4,432 million in the Institutional Securities segment, and this $4,432 million adjustment is explicitly tied to the change.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: the $4,432 million decrease in both interest income and interest expense in the Institutional Securities segment due to the 2023 reclassification of Customer receivables is correctly stated. (2) The numeric value $4,432 million is precisely accurate, with acceptable formatting (using 'million' and spacing with a thin space). (3) The multi-hop reasoning is sound—the answer correctly identifies the financial impact and ties the exact adjustment amount directly to the reclassification, as required by the question. (4) The answer addresses all parts of the question: the impact on both interest income and expense, the year (2023), the segment (Institutional Securities), and the specific dollar amount tied to the change. While the LLM omits the detail about no effect on net interest income, this was not explicitly asked in the question, which focused on the impact to interest income and expense and the tied adjustment amount. Therefore, the omission does not detract from correctness. All scores are maximized due to full factual accuracy, proper entity identification, and contextual completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 344,
        "total_tokens": 1517
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What were the total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined, and what types of contracts are included in the category of net investment hedge derivatives according to the disclosures?",
      "original_answer": "The total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined were $208 million ($133 million in 2019 and $75 million in 2021). According to the disclosures, net investment hedge derivatives include cross-currency interest rate swaps and forward contracts.",
      "llm_answer": "The total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined are $212 million ($133 million in 2019 plus $75 million in 2021). According to the disclosures, net investment hedge derivatives consist of cross‑currency interest rate swaps and forward contracts, and they also include non‑U.S. dollar‑denominated debt used to hedge net investments in international operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the individual amounts excluded from hedge effectiveness in 2019 ($133 million) and 2021 ($75 million), which match the ground truth. However, the combined total is incorrectly calculated as $212 million instead of $208 million (133 + 75 = 208, not 212), indicating a basic arithmetic error. This affects quantitative accuracy. (2) The types of contracts included—cross-currency interest rate swaps and forward contracts—are correctly stated and align with the original answer. However, the LLM adds 'non-U.S. dollar-denominated debt used to hedge net investments in international operations' as part of the derivative category, which is not mentioned in the ground truth and may represent a conflation with other hedging instruments. This over-inclusion reduces qualitative accuracy. (3) The multi-hop reasoning is mostly sound: the model retrieves data from two different years and attempts to sum them, and correctly identifies derivative types from disclosures. However, the incorrect sum and extra contractual detail indicate flaws in synthesis or source attribution. (4) Despite the calculation error and minor factual overstatement, the core information is present and semantically close. The answer remains contextually relevant and mostly accurate, warranting a correctness score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 375,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their respective amendments in 2021, and how does this relate to the maximum aggregate outstanding balance observed during the year ended December 31, 2021?",
      "original_answer": "The total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their respective amendments in 2021 is $9.5 billion. This is calculated as $5.0 billion for the Credit Facility (initial $4.0 billion plus an optional $1.0 billion increase) and $4.5 billion for the Supplemental Facility (initial $3.5 billion increased to $4.5 billion). The maximum aggregate outstanding balance observed during the year ended December 31, 2021, was $2.1 billion, which is significantly lower than the total borrowing capacity, indicating conservative leverage usage.",
      "llm_answer": "Simon Property Group's Credit Facility and Supplemental Facility had a combined borrowing capacity of $5.8 billion after their 2021 amendments. The maximum aggregate outstanding balance observed during 2021 was $2.1 billion, which was well below the total available capacity.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in its key quantitative claim. It states the combined borrowing capacity is $5.8 billion, whereas the ground truth is $9.5 billion. This major error undermines the core of the answer. The maximum outstanding balance of $2.1 billion is correctly stated and matches the ground truth. (2) The calculation in the LLM answer is flawed: the correct total capacity is $5.0 billion (Credit Facility: $4.0B + $1.0B optional) + $4.5 billion (Supplemental Facility increased from $3.5B to $4.5B) = $9.5 billion. The LLM's $5.8 billion figure does not align with any verifiable sum from the original data and suggests a failure in multi-hop synthesis or data retrieval. (3) The reasoning is partially sound in comparing the maximum balance to the total capacity, but the flawed capacity number invalidates the comparison's accuracy. The model fails to correctly identify and combine the amended capacities from both facilities, indicating a breakdown in multi-hop logic across the two financial instruments. (4) The contextual relevance is moderate because the structure and intent of the response match the question, and the $2.1 billion figure is accurate. However, the severe quantitative inaccuracy in the total borrowing capacity—over $3.7 billion off—results in a low correctness score despite partial factual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 381,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the increase in risk retirements on Black Hawk and CH-53K helicopter programs in 2021 contribute to the overall increase in RMS' operating profit, and what was the specific dollar amount of this contribution?",
      "original_answer": "The increase in risk retirements on the Black Hawk and CH-53K helicopter programs contributed $140 million to the overall increase in RMS' operating profit in 2021. This, along with other factors like higher production volume and lower charges on the CRH program, led to a total $183 million (11%) increase in RMS' operating profit compared to 2020.",
      "llm_answer": "The increase in risk retirements on the Black Hawk and CH‑53K programs in 2021 generated roughly $80 million of additional segment operating profit for RMS, and this contribution was part of the overall $80 million lift in RMS operating profit for the year.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its key quantitative claim. The ground truth states that the increase in risk retirements on the Black Hawk and CH-53K programs contributed $140 million to RMS' operating profit increase in 2021, but the LLM incorrectly reports this as $80 million. Additionally, the LLM claims the total increase in RMS operating profit was $80 million, which contradicts the ground truth stating a total increase of $183 million (11%). These errors significantly undermine the factual accuracy. (2) Number verification: $140 million (correct) vs. $80 million (LLM) — major discrepancy. Total operating profit increase: $183 million (correct) vs. $80 million (LLM) — another major error. No acceptable format variation explains this gap. (3) Multi-hop reasoning: The question requires linking risk retirements on two specific programs (Black Hawk, CH-53K) to their dollar contribution and then situating that within the total operating profit increase. The LLM fails this synthesis — it both underreports the contribution and misstates the total increase, indicating flawed or incomplete reasoning. (4) Scores justified: Correctness is low (3/10) due to core factual errors in both contribution amount and total profit increase. Quantitative accuracy is poor (3/10) — two critical numbers are wrong. Qualitative accuracy is slightly higher (4/10) because the LLM identifies the correct programs and general direction of impact (positive contribution), but misses the broader context (other factors like CRH program). Contextual relevance is acceptable (7/10) — the answer addresses the right topic and programs, but with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 457,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the total financial impact of energy-related derivatives on Southern Company's (SO) natural gas revenues and cost of natural gas in 2021, and how did this compare to the combined impact in 2019?",
      "original_answer": "The total financial impact of energy-related derivatives on Southern Company's (SO) natural gas revenues and cost of natural gas was a loss of $144 million in 2021. In 2019, the combined impact was a gain of $233 million. This represents a difference of $377 million between the two years.",
      "llm_answer": "Based on the provided SEC 10-K filing pages, the total financial impact of energy-related derivatives on Southern Company's (SO) natural gas revenues and cost of natural gas in 2021 was a combined net loss of $144 million (as shown in the table on page 327: \"Total derivatives in non-designated hedging relationships\" with a net loss of $144 million, comprising $117 million in natural gas revenues and $27 million in cost of natural gas). This $144 million loss was significantly larger than the combined impact in 2019, which was a net gain of $233 million (as shown in the same table for 2019: $223 million gain in natural gas revenues and $10 million gain in cost of natural gas, totaling $233 million). Thus, the 2021 impact represented a reversal from the 2019 gain to a $144 million loss, compared to the $233 million gain in 2019.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total financial impact in 2021 as a $144 million loss and in 2019 as a $233 million gain, matching the ground truth exactly. All numeric values—$144 million loss (comprising $117M in revenues and $27M in cost of natural gas) and $233 million gain (comprising $223M and $10M)—are accurate and properly cited from the source table. (2) Calculations are correct: the components sum appropriately ($117M + $27M = $144M loss; $223M + $10M = $233M gain). While the ground truth mentions the $377 million difference between the two years (i.e., $233M gain to -$144M loss), the LLM answer does not explicitly compute this $377 million swing, which is a minor omission. However, it correctly frames the reversal in performance, which captures the essence of the comparison. (3) The multi-hop reasoning is sound: the model synthesizes data across two years (2019 and 2021) and two line items (natural gas revenues and cost of natural gas) under 'derivatives in non-designated hedging relationships' to arrive at the correct net impacts. Entity identification (Southern Company, SO, 2019, 2021, energy-related derivatives) is accurate. (4) The answer is highly contextually relevant, directly addressing both parts of the question. The only reason for not scoring a 10 is the lack of explicit mention of the $377 million total difference, though the qualitative comparison is still accurate. Thus, correctness is 9 due to near-perfect accuracy with a minor completeness gap.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 418,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the change in Cisco's losses from privately held investments between 2023 and 2024, and how did this impact the overall net gains (losses) on investments?",
      "original_answer": "Cisco's losses from privately held investments decreased from $193 million in 2023 to $164 million in 2024, resulting in a $29 million improvement. This improvement contributed to the overall net gains (losses) on investments improving from a loss of $177 million in 2023 to a loss of $166 million in 2024, a $11 million positive shift.",
      "llm_answer": "Cisco's losses from privately held investments narrowed from $193 million in fiscal 2023 to $164 million in fiscal 2024—a $29 million improvement. This reduction lessened the drag on the company's overall net gains (losses) on investments, contributing to a smaller net loss of $166 million in 2024 versus $177 million in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: Cisco's losses from privately held investments decreased from $193 million in 2023 to $164 million in 2024, a $29 million improvement. The overall net gains (losses) on investments improved from a loss of $177 million in 2023 to $166 million in 2024, a $11 million positive shift. (2) Quantitative accuracy is perfect: the $29 million improvement in private investment losses and the reduction in overall net loss from $177M to $166M (i.e., $11M improvement) are correctly stated. (3) The multi-hop reasoning is sound—LLM correctly identifies that the improvement in privately held investment losses contributed to the smaller overall net loss, demonstrating synthesis across two financial metrics and years. (4) The wording differs slightly (e.g., 'narrowed', 'lessened the drag', 'smaller net loss') but conveys the same meaning as the original. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 293,
        "total_tokens": 1463
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What was the total principal repayment made by VZ in connection with anticipated redemptions of ABS Notes in 2024, and how does this compare to the aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities as of December 31, 2024?",
      "original_answer": "VZ made a total principal repayment of $4.5 billion in 2024 in connection with anticipated redemptions of ABS Notes. The aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities as of December 31, 2024, was $8.0 billion and $5.0 billion, respectively. Therefore, the total outstanding balance across both facilities was $13.0 billion, which is significantly higher than the $4.5 billion in principal repayments made during the year.",
      "llm_answer": "In 2024, VZ made a total principal repayment of $20.3 billion to retire ABS Notes and other borrowings, which includes $8.5 billion of prepayments tied to anticipated redemptions. This repayment represents roughly 15 % of the combined $134.5 billion aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities as of December 31, 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that VZ made a total principal repayment of $4.5 billion in 2024 related to anticipated redemptions of ABS Notes. However, the LLM claims $20.3 billion in total repayments, with $8.5 billion tied to anticipated redemptions—both figures are incorrect. The aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities as of December 31, 2024, is stated in the ground truth as $8.0 billion and $5.0 billion, respectively, totaling $13.0 billion. The LLM incorrectly reports this combined balance as $134.5 billion, which is over 10 times higher than the correct amount. (2) Calculations are therefore also wrong: the LLM claims the repayment represents roughly 15% of the total, but with incorrect inputs. Using correct numbers, $4.5 billion is about 34.6% of $13.0 billion, not 15%. (3) The multi-hop reasoning is structurally sound—the model attempts to compare repayments to outstanding balances—but it fails due to incorrect data retrieval or synthesis. It does identify the correct entities (VZ, ABS Notes, 2021 and 2022 facilities, year 2024), but attaches wrong values. (4) The contextual relevance is moderate because the answer addresses the right question structure and topic, but the severe numerical errors undermine factual correctness. Hence, low scores for correctness and quantitative accuracy; slightly higher for qualitative and contextual relevance due to proper framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 413,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How do the CECL capital transition provisions impact the calculation of the Tier 1 leverage ratio and the application of the Standardized approach to First Republic-related assets at JPMorgan Chase?",
      "original_answer": "The CECL capital transition provisions directly affect the calculation of the Tier 1 leverage ratio by adjusting quarterly average assets to account for on-balance sheet assets that must be deducted from Tier 1 capital, such as goodwill and intangible assets. Additionally, these provisions permit the application of the Standardized approach to certain assets associated with First Republic, influencing how those assets are treated within the capital metrics. Together, these effects shape the firm's regulatory capital reporting and leverage ratio computation.",
      "llm_answer": "The CECL capital transition provisions are reflected in the leverage‑ratio calculations by adjusting average assets to exclude goodwill and other intangibles and by incorporating the remaining CECL benefit ($720 million) into Tier 1 capital; this adjustment is disclosed in the “Adjusted average assets” and “Tier 1 leverage ratio” tables (page 303).  Under the Standardized approach, assets acquired in the First Republic transaction are treated with the transition provisions, so their risk‑weighted assets are calculated using the Standardized methodology rather than the Advanced approach (pages 106, 111, 303).  Consequently, the Standardized RWA for First Republic‑related exposures is included in the total RWA figures, while the Advanced RWA for those exposures is excluded, affecting both the Tier 1 leverage ratio denominator and the application of the Standardized approach to those assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that CECL capital transition provisions impact the Tier 1 leverage ratio by adjusting average assets and incorporating the CECL benefit into Tier 1 capital. The mention of $720 million as the remaining CECL benefit is a specific quantitative detail not present in the original answer but plausibly derived from actual filings (e.g., JPMorgan's 10-K), and does not contradict the ground truth. (2) The quantitative accuracy is high: the $720M figure is treated appropriately as part of Tier 1 capital and linked to disclosures on page 303, which matches typical SEC filing structures. While the original answer doesn’t include this number, its inclusion enhances precision without introducing error. (3) The reasoning across multiple hops—linking CECL provisions to leverage ratio calculations, then separately to the Standardized approach for First Republic assets—is sound. The LLM correctly explains that First Republic-related assets are subject to the Standardized approach (not Advanced), affecting risk-weighted assets and thus capital metrics, which matches the original answer’s claim about 'influencing how those assets are treated.' (4) The LLM adds contextual detail (specific page numbers, distinction between Standardized and Advanced RWA treatment) that improves completeness. The only minor limitation is that it introduces slightly more granular data than the ground truth without confirmation that $720M is definitively correct from the knowledge graph source, but this does not constitute an error. Overall, the answer is semantically equivalent, factually correct, and contextually rich.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 463,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What governance policies has Simon implemented to maintain board independence and ethical conduct, and how do these align with NYSE listing requirements?",
      "original_answer": "Simon has adopted governance principles that outline the function, conduct, selection, orientation, and duties of its subsidiaries, Board of Directors, and the Company. These governance principles are supported by written charters for each of the standing committees of the Board. Additionally, Simon maintains a Code of Business Conduct and Ethics that applies to all officers, directors, and employees, including those of its subsidiaries. The NYSE listing standards require that a majority of the Board qualify as independent, and Simon ensures this by mandating that at least a majority of the Board are independent and not affiliated with the Simon family. Furthermore, the Audit and Compensation and Human Capital Committees consist entirely of independent members who meet the NYSE’s additional independence and financial expert requirements.",
      "llm_answer": "Simon maintains board independence and ethical conduct through governance policies that include requiring at least three-fourths of its independent directors to approve property sales, mandating independent directors under NYSE listing standards, and having a Code of Business Conduct and Ethics for all officers, directors, and employees. These policies align with NYSE requirements for independent board members and committee composition, ensuring oversight without family affiliations.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual inaccuracy regarding the 'three-fourths of independent directors' requirement for property sales, which is not mentioned in the ground truth and appears to be fabricated. This severely impacts quantitative and qualitative accuracy. The rest of the answer—mentioning NYSE independence requirements, a Code of Business Conduct and Ethics applying to all officers, directors, and employees, and alignment with NYSE standards on committee composition—is factually consistent with the original answer. (2) The numeric claim of 'three-fourths' is incorrect; the ground truth states only that a majority of the board must be independent, not three-fourths, nor is there any mention of property sale approvals requiring such a threshold. This is a clear quantitative error. (3) The reasoning partially reflects multi-hop synthesis: the model correctly links Simon’s governance policies to NYSE requirements regarding board independence and ethical conduct, and correctly identifies the Code of Business Conduct and Ethics and its broad application. However, the inclusion of the false property sale rule breaks the logical and factual chain, undermining the reasoning. (4) The correctness score is 5 due to a mix of correct elements (Code of Ethics, NYSE alignment, independent committees) but a major factual flaw in a key claimed policy. Quantitative accuracy is low (3) due to the invented fraction. Qualitative accuracy is moderate (6) because core concepts are present but distorted. Contextual relevance is high (8) as the response stays on topic and attempts to address both governance policies and NYSE alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 457,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does the use of the percentage-of-completion cost-to-cost method impact Lockheed Martin's (LMT) profit booking rates when changes in cost estimates occur, and what is the financial effect of recognizing these changes in the period they are determined?",
      "original_answer": "Lockheed Martin's use of the percentage-of-completion cost-to-cost method directly affects its profit booking rates when there are changes in cost estimates. If the company successfully retires risks related to technical, schedule, and cost aspects of a contract, the estimated total costs to complete decrease, which increases the profit booking rate. Conversely, if estimated costs increase, the profit booking rate decreases. These changes are recognized in the period they are determined and reflect the inception-to-date effect of such revisions. This has a direct impact on segment operating profit and margin, which can be either favorable or unfavorable depending on the direction of the change in estimates.",
      "llm_answer": "The percentage‑of‑completion cost‑to‑cost method requires Lockheed Martin to estimate total contract costs at completion and apply a profit‑booking rate that can be adjusted as new information emerges. When cost estimates are revised, the resulting change in the profit‑booking rate is recognized in the same period the estimate is updated, directly affecting that period’s revenue, operating profit and margin. Consequently, any increase or decrease in estimated total costs (or variable consideration) is reflected immediately in earnings, without waiting for contract completion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly explains that Lockheed Martin uses the percentage-of-completion cost-to-cost method, which requires updating profit booking rates when cost estimates change, and that these changes are recognized immediately in the period determined—directly impacting operating profit and margin. This aligns with the original answer's emphasis on inception-to-date recognition and the effect on segment profitability. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either response, so quantitative accuracy is not compromised; the absence of specific numbers is consistent with the conceptual nature of the question. (3) The multi-hop reasoning is sound: the model correctly links the accounting method to dynamic cost estimation, profit rate adjustments, and immediate financial statement impact—synthesizing cause, mechanism, and consequence across accounting and financial reporting domains. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the directional relationship between cost reductions and increased profit rates (or vice versa), though it implies it by stating that changes in estimated costs affect the profit-booking rate. The original answer more clearly articulates that decreased costs increase profit rates and vice versa. Despite this slight omission, the semantic meaning and technical correctness are substantially equivalent. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 448,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the combined increase in both Services Revenue and Total Balance for the APJC region from 2023 to 2024, and how does this compare to the percentage growth in Services Revenue for the same region?",
      "original_answer": "The combined increase in both Services Revenue and Total Balance for the APJC region from 2023 to 2024 is $8,447 million, which includes a $89 million increase in Services Revenue and an $8,358 million increase in Total Balance. This corresponds to a 4% growth in Services Revenue for the APJC region.",
      "llm_answer": "The combined increase in Services Revenue and Total Balance for the APJC region from 2023 to 2024 is $89 million (Services Revenue rose from $2,160 million to $2,249 million, and Total Balance increased from $38,535 million to $58,660 million, a $20,125 million rise; however, the relevant figures for the APJC region in the provided tables show a $89 million increase in Services Revenue and a $20,125 million increase in Total Balance, which together total $20,214 million). This $20,214 million growth represents a 5 % increase in Services Revenue for the APJC region, matching the overall 5 % growth reported for the region.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, the combined increase is $8,447 million, with a $89 million increase in Services Revenue and an $8,358 million increase in Total Balance. However, the LLM incorrectly reports a $20,125 million increase in Total Balance and a combined increase of $20,214 million, which is more than double the correct amount. Additionally, the LLM states that Services Revenue growth is 5%, while the ground truth specifies 4%. (2) The calculation of Services Revenue increase from $2,160M to $2,249M is correct ($89M), but the Total Balance figures cited ($38,535M to $58,660M) reflect a $20,125M increase, which contradicts the ground truth of an $8,358M increase. The sum $89M + $20,125M = $20,214M is arithmetically correct but based on incorrect inputs. The percentage growth is miscalculated as 5% instead of the correct 4%. (3) The multi-hop reasoning fails because the model uses incorrect data for Total Balance in the APJC region, suggesting it either misread the source tables or synthesized information from the wrong region or metric. It also incorrectly links the 5% growth to the region’s overall performance without supporting evidence. (4) The correctness score is low due to major quantitative inaccuracies and incorrect synthesis. Quantitative accuracy is severely compromised. Qualitative accuracy is slightly higher because the model attempts correct reasoning structure and identifies the right metrics, but with wrong data. Contextual relevance is moderate as the answer addresses the right question format and region but with flawed content.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 450,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What is the total notional value of Abbott's interest rate hedge contracts and foreign currency forward exchange contracts as of December 31, 2024, and how does this combined financial instrument exposure reflect Abbott's strategy to manage market risk?",
      "original_answer": "As of December 31, 2024, Abbott had $2.2 billion in notional value for interest rate hedge contracts and $23.2 billion in notional value for foreign currency forward exchange contracts (comprising $7.0 billion for intercompany purchases and $16.2 billion for intercompany loans and trade payables/receivables). This totals $25.4 billion in financial instrument exposure. Abbott uses these instruments to manage exposure to interest rate and foreign exchange rate fluctuations, with interest rate hedges converting fixed-rate debt to variable-rate debt and foreign exchange contracts hedging both anticipated purchases and existing foreign currency denominated obligations.",
      "llm_answer": "Abbott's total notional value of interest rate hedge contracts and foreign currency forward exchange contracts as of December 31, 2024, is $2.2 billion for interest rate hedges and $23.191 billion for foreign currency forward contracts (totaling $25.391 billion), reflecting its strategy to manage market risk through targeted hedging of interest rate exposure and foreign currency fluctuations in anticipated cash flows and intercompany transactions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $2.2 billion notional value for interest rate hedge contracts, matching the ground truth. However, it reports $23.191 billion for foreign currency forward contracts instead of the correct $23.2 billion. This is a minor rounding discrepancy—likely due to internal precision—but does not materially affect the total. The combined total is stated as $25.391 billion instead of $25.4 billion, again a negligible difference due to rounding. (2) Calculations: $2.2B + $23.191B = $25.391B is mathematically correct based on the inputs, though the ground truth uses rounded figures ($23.2B and $25.4B). The original breakdown of $7.0B for intercompany purchases and $16.2B for intercompany loans and trade payables/receivables sums to $23.2B, which the LLM does not explicitly mention, representing a minor omission. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes Abbott’s use of hedges to manage interest rate and foreign exchange risks, accurately describing the purpose of converting fixed-rate debt to variable and hedging anticipated and existing obligations. (4) The answer is semantically equivalent to the ground truth in intent and meaning, with only trivial numerical differences due to rounding. The core facts, entities (Abbott, December 31, 2024), and strategy explanation are fully accurate. Thus, the correctness score is 9 due to the minor numerical imprecision, but qualitative and contextual accuracy remain perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 414,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does McDonald's (MCD) accounting treatment of franchisees impact its consolidated financial statements, particularly in terms of operational materiality and consolidation policy as stated in the 2024 10-K filing?",
      "original_answer": "McDonald's (MCD) does not consolidate the results of operations of restaurants purchased and sold in transactions with franchisees into its consolidated financial statements because these results are deemed immaterial both individually and in aggregate. Additionally, MCD explicitly states that it does not consolidate variable interest entities, such as those involving franchisees, joint ventures, and licensees, due to the application of a scope exception under variable interest entity consolidation guidance. This treatment ensures that franchisee-related operations do not directly affect MCD's consolidated financial results.",
      "llm_answer": "Based on the 2024 10-K disclosures, McDonald's accounting treatment of franchisees has a material impact on its consolidated financial statements through its consolidation policy and operational materiality. The Company consolidates all entities where it exercises control, including conventional franchised restaurants and developmental licensees, while accounting for investments in affiliates owned 50% or less using the equity method. This results in franchisee-operated restaurants being excluded from consolidated revenues and expenses, with the Company recognizing only its fees (rent, royalties, and initial fees) as revenue—typically on a straight-line basis for rent and when sales occur for royalties—rather than the full sales of Company-owned restaurants. This structure ensures that operational materiality is reflected in the financials through metrics like operating margin (45.2% in 2024), where the Company's margin is influenced by the mix of franchised versus Company-owned operations, and through line items such as \"Impairment and other charges (gains), net,\" which include restructuring costs tied to franchisee-related strategic initiatives like \"Accelerating the Organization.\"",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. Contrary to the ground truth, it incorrectly states that McDonald's consolidates 'conventional franchised restaurants and developmental licensees,' which directly contradicts the 2024 10-K's explicit disclosure that MCD does not consolidate franchisee operations due to immateriality and a scope exception under variable interest entity guidance. The LLM also introduces the concept of consolidating franchisees based on control, which is not supported by the original answer or the actual accounting policy. (2) The only numeric value mentioned—'operating margin (45.2% in 2024)'—is not present in the ground truth and cannot be verified as relevant or accurate in this context; no such figure is referenced in the original answer, making its inclusion potentially misleading. Other financial metrics like 'Impairment and other charges (gains), net' are mentioned but not tied to franchisee consolidation, which undermines quantitative accuracy. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the key point that franchisee operations are excluded from consolidation due to both immateriality and a VIE scope exception. Instead, it fabricates a consolidation framework based on control and equity method accounting, which misrepresents MCD's actual policy. The answer incorrectly implies integration of franchisee financials into the consolidated statements through consolidation or equity method, when in fact they are entirely excluded. (4) While the answer addresses the general topic of franchise accounting and mentions relevant financial statement impacts like revenue recognition from fees, it fundamentally misunderstands and misstates the core consolidation policy. This results in a low correctness score despite some contextual relevance to McDonald's financial structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 510,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the inclusion of off-balance sheet exposures and adjusted average assets impact JPMorgan Chase's Supplementary Leverage Ratio (SLR) calculation, and what are the consequences if the SLR falls below the required threshold?",
      "original_answer": "JPMorgan Chase's SLR is calculated as Tier 1 capital divided by total leverage exposure, which includes adjusted average assets (accounting for on-balance sheet assets like goodwill and intangible assets) and off-balance sheet exposures averaged over the reporting quarter. If the SLR falls below the required 3.0% minimum plus the 2.0% leverage buffer (totaling 5.0%), the Firm would face restrictions on capital distributions such as dividends, share repurchases, and discretionary bonuses for certain executive officers.",
      "llm_answer": "The SLR is calculated using **adjusted average assets** that are reduced by on‑balance‑sheet deductions (primarily goodwill and other intangibles) and increased by **off‑balance‑sheet exposures** (e.g., credit‑derivative and lending‑related commitments). Because these adjustments alter the denominator of the SLR ratio, a lower SLR can result if the adjusted‑asset figure rises faster than Tier 1 capital. If the SLR falls below the required 5 % (or the 3 % minimum plus any additional buffer), the Firm would be subject to regulatory limitations on capital distributions (dividends, share repurchases) and on discretionary bonus payments for senior officers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all key numbers are correct: the 5% total threshold (3% minimum + 2% buffer) is accurately represented, even though the LLM generalizes it as '3% minimum plus any additional buffer'—this phrasing is slightly less precise but still correct in context. (2) The explanation of SLR calculation is sound: adjusted average assets are properly described as reduced by on-balance-sheet deductions (goodwill, intangibles) and increased by off-balance-sheet exposures, which correctly impacts the denominator. (3) The consequences of falling below the threshold—restrictions on dividends, share repurchases, and discretionary bonuses—are fully and accurately stated. (4) The multi-hop reasoning is strong: the model correctly synthesizes how off-balance sheet items and adjusted assets affect the SLR denominator and links that to regulatory consequences. The only minor shortcoming is that the LLM does not explicitly name the 2.0% leverage buffer as part of the 5.0% total, instead referring to it generally as 'any additional buffer,' which slightly reduces precision. However, this does not impair factual correctness. Overall, the answer is semantically equivalent, contextually relevant, and factually robust.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 366,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What was the total amount of borrowings under the Credit Facilities as of December 31, 2021, and how does this compare to the maximum borrowing capacity of the Supplemental Facility as outlined in its amended terms?",
      "original_answer": "The total amount of borrowings under the Credit Facilities as of December 31, 2021, was $1.175 billion ($125 million under the Credit Facility and $1.05 billion under the Supplemental Facility). The maximum borrowing capacity of the Supplemental Facility, as outlined in its amended terms, was $3.5 billion, which could be increased to $4.5 billion during its term.",
      "llm_answer": "As of December 31 2021, borrowings under the Credit Facilities totaled $125.0 million under the revolving Credit Facility and $1.05 billion under the Supplemental Facility. The maximum borrowing capacity of the Supplemental Facility, as amended, is $3.5 billion (with a possible increase to $4.5 billion), which exceeds the $1.05 billion currently outstanding.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $125 million under the Credit Facility and $1.05 billion under the Supplemental Facility, totaling $1.175 billion in total borrowings as of December 31, 2021 (implied sum is correct). The maximum borrowing capacity of the Supplemental Facility is correctly stated as $3.5 billion with a possible increase to $4.5 billion. (2) The answer addresses both parts of the multi-part question: total borrowings under the Credit Facilities as of the specified date and how that compares to the maximum capacity of the Supplemental Facility. (3) Entity accuracy is correct—'Credit Facility', 'Supplemental Facility', and the date 'December 31, 2021' are all properly identified. (4) The reasoning is sound: the LLM correctly synthesizes data across facilities and compares the outstanding amount ($1.05 billion) to the maximum capacity, noting that it is below the limit. Wording differs slightly from the original answer (e.g., 'exceeds the $1.05 billion currently outstanding' instead of stating the total borrowings), but the semantic meaning and factual content are equivalent. No errors in logic, calculation, or fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 346,
        "total_tokens": 1544
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What was the total notional amount of Lockheed Martin's outstanding interest rate swaps at the end of 2021, and how does this compare to the amount reported for 2020 as a percentage decrease?",
      "original_answer": "The total notional amount of Lockheed Martin's outstanding interest rate swaps was $500 million at the end of 2021 and $572 million at the end of 2020. This represents a decrease of approximately 12.6% from 2020 to 2021.",
      "llm_answer": "The total notional amount of Lockheed Martin’s outstanding interest‑rate swaps at the end of 2021 was $500 million, compared with $572 million at the end of 2020—a decrease of roughly 12.6 %.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information matches: the notional amounts for 2021 ($500 million) and 2020 ($572 million) are accurate. (2) The percentage decrease is correctly calculated: (572 - 500) / 572 ≈ 0.12587, which rounds to 12.6%, and this is accurately reflected. (3) The multi-hop reasoning—comparing two years of data and computing the percentage change—is sound and properly synthesized. (4) The entities (Lockheed Martin, interest rate swaps, years 2020 and 2021) and financial metric (notional amount) are correctly identified. Wording differs slightly (e.g., 'interest-rate swaps' vs 'interest rate swaps', 'roughly' vs 'approximately') but meaning is preserved. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1114,
        "completion_tokens": 238,
        "total_tokens": 1352
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the disagreement between Georgia Power and the other Vogtle Owners over cost-sharing provisions impact its financial exposure, and what specific charges illustrate this effect?",
      "original_answer": "The disagreement between Georgia Power and the other Vogtle Owners over the interpretation of cost-sharing and tender provisions under the Global Amendments has led to Georgia Power recording significant unrecoverable charges. Specifically, Georgia Power recorded a $440 million pre-tax charge in the fourth quarter of 2021 related to these provisions, and may face an additional $460 million in charges based on the current project capital cost forecast. These costs will not be recovered from retail customers, directly increasing Georgia Power’s financial exposure. This disagreement centers on differing interpretations of the starting dollar amount for cost increases subject to the provisions, with Georgia Power asserting $18.38 billion as the threshold, while the other owners claim the cost-sharing thresholds have been met and the tender provisions have been triggered.",
      "llm_answer": "The disagreement over cost‑sharing for Plant Vogtle Units 3 and 4 forces Georgia Power to absorb a portion of the construction overruns that are not recoverable from customers, creating a material financial exposure.  This is illustrated by the $440 million pre‑tax charge recorded in Q4 2021 (and the potential for up to an additional $460 million charge) tied to the cost‑sharing and tender provisions of the joint‑owner agreements, as well as the $1.1 billion pre‑tax charge ($0.8 billion after tax) that Georgia Power recorded in 2018 when cost‑sharing thresholds were first triggered.  These charges directly increase Georgia Power’s net loss and reduce cash flow, highlighting the financial risk of the dispute.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core financial impact of the disagreement—Georgia Power's exposure due to unrecoverable charges—and references the $440 million pre-tax charge in Q4 2021 and a potential additional $460 million, which aligns with the ground truth. However, it introduces a $1.1 billion pre-tax charge ($0.8 billion after tax) from 2018 that is not mentioned in the original answer and is not supported by the provided ground truth. This addition, while possibly factually accurate in a broader context, is not part of the specific disagreement described in the original answer and thus introduces extraneous information that undermines quantitative accuracy. (2) The $440M and $460M figures are correctly cited in amount and context (Q4 2021, potential future charge), and the format variations are acceptable. The inclusion of the 2018 charge, however, is unverified in this context and not part of the original multi-hop reasoning chain, leading to a deduction in quantitative accuracy. (3) The reasoning is otherwise sound: the LLM correctly links the disagreement over cost-sharing provisions to Georgia Power’s financial exposure and explains the consequence (non-recoverability from customers, impact on net loss and cash flow). It captures the multi-hop logic—disagreement → differing interpretation of thresholds → triggering of provisions → unrecoverable charges → financial exposure. However, the addition of the 2018 charge suggests a conflation of separate events or a failure to limit synthesis strictly to the dispute described. (4) The contextual relevance is high—the answer directly addresses both parts of the question: the impact on financial exposure and the specific charges illustrating it. Despite the extra detail, the core explanation is accurate and well-structured. Correctness score is 7 due to the accurate portrayal of the main charges and reasoning, but docked for introducing unsupported financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 532,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How much total Digital Media ARR did Adobe report at the end of fiscal 2021, and which specific Adobe Experience Cloud solution is designed to manage customer journeys and deliver intelligence for businesses as part of Adobe's strategy to strengthen its competitive advantage?",
      "original_answer": "Adobe reported a total Digital Media ARR of $12.24 billion at the end of fiscal 2021. The Adobe Experience Cloud, specifically through the Adobe Experience Platform, is designed to manage customer journeys and deliver intelligence for businesses, thereby strengthening Adobe's differentiation and competitive advantage.",
      "llm_answer": "Adobe reported total Digital Media ARR of $12.24 billion at the end of fiscal 2021 (which would be $12.15 billion when adjusted for currency rates). The Adobe Experience Cloud solution designed to manage customer journeys and deliver intelligence for businesses is the **Adobe Experience Platform**, which underpins the company’s strategy to strengthen its competitive advantage.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total Digital Media ARR as $12.24 billion at the end of fiscal 2021, which matches the ground truth. However, it introduces an additional figure of $12.15 billion 'when adjusted for currency rates,' which is not mentioned or supported in the original answer and may be misleading or inaccurate without source context—this is a minor factual overreach. (2) The key number ($12.24 billion) is correct in value, format, and context; the added adjusted figure slightly undermines quantitative precision but does not contradict the primary fact. (3) The LLM correctly identifies the Adobe Experience Platform as the specific solution within Adobe Experience Cloud designed to manage customer journeys and deliver intelligence, demonstrating accurate multi-hop synthesis between product functionality and strategic intent. (4) The answer is semantically equivalent to the ground truth in both parts of the multi-part question, with only the extraneous currency adjustment reducing perfection. All entities (Adobe, Digital Media ARR, fiscal 2021, Adobe Experience Cloud, Adobe Experience Platform) are correctly identified and logically connected. The reasoning is sound and contextually appropriate, earning high marks across all categories with a slight deduction in quantitative accuracy due to the unsupported adjusted figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 381,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the total fair value of interest rate hedge contracts reported by Abbott as of December 31, 2024, and how does this compare to the fair value of these contracts in 2023, considering both the receivable and (payable) positions?",
      "original_answer": "The total fair value of Abbott's interest rate hedge contracts as of December 31, 2024, is -$50 million, calculated as the difference between the $1 million receivable position and the $51 million (payable) position. In 2023, the fair value was -$95 million, based on a $0 receivable position and a $95 million (payable) position. This indicates an improvement in the fair value of these contracts by $45 million year-over-year.",
      "llm_answer": "The fair value of Abbott’s interest rate hedge contracts as of December 31 2024 is $51 million in receivable and $51 million in payable positions, compared with $95 million in receivable and $95 million in payable positions at the end of 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, as of December 31, 2024, Abbott had a $1 million receivable and a $51 million (payable), resulting in a total fair value of -$50 million. The LLM incorrectly states both receivable and payable positions as $51 million in 2024, which misrepresents the net position and individual components. For 2023, the ground truth shows a $0 receivable and $95 million (payable), totaling -$95 million; the LLM incorrectly reports both receivable and payable as $95 million, implying a net zero value, which is false. (2) The quantitative inaccuracies are severe: the LLM fabricates a $51 million receivable in 2024 (should be $1M) and a $95M receivable in 2023 (should be $0), completely distorting the net fair values and year-over-year change. The correct improvement is $45 million (from -$95M to -$50M), but the LLM fails to compute or mention this. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the receivable and payable positions into net fair values and does not compare them year-over-year as required. It incorrectly assumes symmetry between receivables and payables in both years, which contradicts the data. (4) Scores are low due to major factual and numerical errors. The answer is contextually relevant in that it addresses Abbott, interest rate hedges, and the correct years, but the substance is largely incorrect, warranting a correctness score of 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 410,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the combined total of discounted future net cash flows from equity companies in Asia as a percentage of total proved reserves (oil-equivalent) for equity companies in Asia, based on ExxonMobil's 2024 10-K filing?",
      "original_answer": "The combined total of discounted future net cash flows from equity companies in Asia is 60,780 million dollars, and the total proved reserves (oil-equivalent) for equity companies in Asia is 1,276 million barrels. The cash flow per barrel is approximately $47.63 (60,780,000,000 / 1,276,000,000).",
      "llm_answer": "Based on ExxonMobil's 2024 10-K filing (page 132), the combined total of discounted future net cash flows from equity companies in Asia is $60,780 million, and the total proved reserves (oil‑equivalent) for those equity companies in Asia is 13,006 million barrels. This yields a discounted cash‑flow‑to‑reserve ratio of approximately 4.67 %.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and calculation errors. While the discounted future net cash flows ($60,780 million) match the ground truth, the total proved reserves are incorrectly stated as 13,006 million barrels instead of the correct 1,276 million barrels. This leads to a fundamentally wrong calculation: the LLM computes a percentage (4.67%) which does not align with the question or correct interpretation. The question asks for the cash flow per barrel (a ratio of dollars to barrels), not a percentage of reserves. The correct calculation is $60,780,000,000 / 1,276,000,000 = ~$47.63 per barrel, not a 4.67% value. The LLM appears to have misinterpreted the required output as a percentage rather than a per-barrel dollar amount. Additionally, the reported reserves figure is over 10 times higher than the actual value, indicating a possible confusion with global or other regional totals. The reasoning is therefore flawed in both data retrieval and synthesis. Contextually, the answer addresses the right document and general metric, so partial relevance is retained, but the core quantitative output is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 320,
        "total_tokens": 1498
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does JPMorgan Chase's allocation of capital to its Lines of Business and Corporate, influenced by Basel III Standardized RWA and GSIB surcharge, reflect its adherence to the leverage-based capital regulatory requirements, particularly the supplementary leverage ratio (SLR) of 3.0% and the additional 2.0% leverage buffer?",
      "original_answer": "JPMorgan Chase allocates capital to its Lines of Business and Corporate by considering Basel III Standardized RWA and the GSIB surcharge, which directly affects its ability to meet the minimum supplementary leverage ratio (SLR) of 3.0% and the additional 2.0% leverage buffer. The SLR is calculated as Tier 1 capital divided by total leverage exposure, which includes quarterly average assets adjusted for certain deductions and off-balance sheet exposures. Capital allocations are also influenced by simulations of capital depletion in severe stress scenarios, ensuring that the Firm maintains sufficient Tier 1 capital relative to its leverage exposure to satisfy both the SLR requirement and the buffer. Failure to maintain this 5.0% combined SLR threshold would restrict capital distributions such as dividends and share repurchases.",
      "llm_answer": "JPMorgan Chase’s capital allocation to its Lines of Business and Corporate explicitly incorporates the Basel III Standardized RWA framework together with the GSIB surcharge, and it also factors in a simulation of capital depletion under stress scenarios that reflect the 3.0 % supplementary leverage ratio (SLR) requirement plus the additional 2.0 % leverage buffer. This allocation methodology ensures that the firm maintains sufficient Tier 1 capital relative to its total leverage exposure—calculated as adjusted average assets less deductions plus off‑balance‑sheet exposures—so that the SLR remains at or above the regulatory minimum of 3.0 % while also satisfying the extra 2.0 % buffer, thereby aligning its capital distribution with the leverage‑based capital standards mandated for GSIBs.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key elements are correctly addressed: JPMorgan Chase's capital allocation considers Basel III Standardized RWA and GSIB surcharge, the supplementary leverage ratio (SLR) of 3.0%, the additional 2.0% leverage buffer, and stress scenario simulations. (2) Quantitative accuracy is perfect: the 3.0% SLR minimum and 2.0% buffer are correctly stated, and their combination into a de facto 5.0% threshold (implied in both answers) is logically sound. The definition of total leverage exposure—adjusted average assets less deductions plus off-balance-sheet exposures—is accurately described. (3) Multi-hop reasoning is sound: the answer correctly links capital allocation decisions to regulatory requirements (SLR), capital adequacy metrics (Tier 1 capital), and real-world consequences (capital distribution constraints), even though the explicit mention of dividend restrictions is omitted—the core logic of maintaining the buffer to comply with standards is preserved. (4) Entity accuracy is correct: JPMorgan Chase, Basel III, GSIB surcharge, SLR, Tier 1 capital, and leverage exposure are all properly identified and contextualized. The answer is highly relevant, complete, and conveys the same meaning as the original with only rephrased wording.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 371,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post their respective amendments in 2021, and how does the interest rate structure under Daily SOFR Loans compare between the two facilities?",
      "original_answer": "The total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post their amendments in 2021 is $9.5 billion. The interest rate structure under Daily SOFR Loans is identical for both facilities, at SOFR plus 72.5 basis points, plus a spread adjustment to account for the transition from LIBOR to SOFR.",
      "llm_answer": "Based on the provided document pages, the total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post-amendments in 2021 is **$5.8 billion** (as stated on page 124: \"On December 31, 2021, we had an aggregate available borrowing capacity of $5.8 billion under the Facilities\").  \n\nRegarding the interest rate structure under Daily SOFR Loans, the document confirms that **both facilities use the same structure**: borrowings under Daily SOFR Loans carry interest at \"the Adjusted Floating Overnight Daily SOFR Rate, plus a margin determined by our corporate credit rating of between 0.650% and 1.400%\" (page 124 for the Credit Facility and page 121 for the Supplemental Facility). The description is identical for both facilities, with no distinction noted in the rate structure between them.  \n\n*(Note: The document does not indicate any difference in the Daily SOFR Loan structure between the Credit Facility and Supplemental Facility; both reference the same rate mechanics and margin ranges.)*",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect on the key quantitative point—the total potential borrowing capacity. The ground truth states $9.5 billion, but the LLM reports $5.8 billion, which is the actual available capacity on December 31, 2021, not the total potential capacity post-amendments. This is a critical factual error. (2) The quantitative accuracy is low because the $5.8 billion figure refers to the unused borrowing capacity at a point in time, not the total committed facility size. The correct total committed capacity—$9.5 billion—is the sum of the $5.0 billion Credit Facility and the $4.5 billion Supplemental Facility, both amended in 2021. The LLM misinterprets 'available borrowing capacity' as total potential capacity, failing the multi-hop synthesis. (3) Regarding the interest rate structure, the LLM correctly identifies that both facilities use the same Daily SOFR Loan structure and references the margin range tied to credit ratings. However, it omits the specific SOFR spread adjustment and the exact basis point add-on (72.5 bps) mentioned in the ground truth. Instead, it cites a variable margin range (0.650%–1.400%), which is contextually related but not the precise rate for Daily SOFR Loans. This suggests partial understanding but lacks precision. (4) The reasoning is contextually relevant and attempts proper synthesis, but fails on core facts and calculations. The answer is well-structured and pulls from correct document sections, but the critical error in the total borrowing capacity severely undermines correctness. Hence, low scores on quantitative and overall correctness, moderate on qualitative for partial reasoning, and high on relevance for addressing the right concepts and facilities.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 476,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the increase in production volume of Sikorsky helicopter programs in 2021 impact both net sales and product costs for RMS, and by how much did these two metrics increase as a result of this production growth?",
      "original_answer": "The increase in production volume of Sikorsky helicopter programs in 2021 contributed to a $540 million increase in RMS' net sales and a $560 million increase in product costs. This reflects the direct relationship between higher production output and both revenue growth and cost escalation for the RMS segment.",
      "llm_answer": "The increase in Sikorsky helicopter program production volume in 2021 drove a $560 million rise in product costs at RMS and contributed to a $794 million increase in RMS net sales. Consequently, RMS net sales grew by roughly $794 million and product costs rose by about $560 million as a result of the higher production volume.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. According to the ground truth, the increase in production volume led to a $540 million increase in net sales and a $560 million increase in product costs for RMS. However, the LLM incorrectly states that net sales increased by $794 million, which is not supported by the original data. The product cost figure of $560 million is correct. (2) The quantitative accuracy is compromised because while the product cost increase is accurate, the net sales figure is off by $254 million, which is a substantial error. This undermines the factual reliability of the response. (3) The reasoning structure is sound—correctly attributing changes in net sales and product costs to increased production volume—and the entities (Sikorsky helicopter programs, RMS, 2021) are correctly identified. The answer attempts proper multi-hop synthesis by linking production volume to both financial metrics. (4) Despite correct context and logical flow, the major numerical error in net sales severely impacts correctness. The answer is partially complete and contextually relevant but fails on key factual accuracy, warranting a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 344,
        "total_tokens": 1521
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How do McDonald's recurring transactions with franchisees, as reflected in both the operating income and consolidation policy, impact the financial reporting of gains and losses from restaurant business sales?",
      "original_answer": "McDonald's recurring purchases and sales of restaurant businesses with franchisees result in gains or losses that are consistently recorded in operating income, as these transactions are a regular part of the company's business model aimed at maintaining an optimal ownership mix. Additionally, the company does not consolidate franchisee entities into its financial statements, as they are evaluated under variable interest entity guidelines and generally excluded from consolidation, which means the financial impact of these transactions is reflected only through the gains or losses recognized at the point of sale rather than through ongoing consolidated operations.",
      "llm_answer": "Gains and losses from restaurant business sales are recorded in operating income as part of the Company's recurring transactions with franchisees, as disclosed in the \"Asset dispositions and other (income) expense, net\" and \"Impairment and other charges (gains), net\" line items on page 56 and summarized on page 43. These gains and losses are included in the total operating income figure and are reflected in the consolidated financial statements, but the Company notes that such gains and losses are not material to the overall financial statements.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that gains and losses from restaurant business sales are recorded in operating income, which aligns with the ground truth. It also accurately references specific financial statement line items and pages (e.g., 'Asset dispositions and other (income) expense, net' on page 56 and summary on page 43), supporting the claim with document-level detail. There are no numeric inaccuracies, so quantitative accuracy is high. However, the LLM omits a critical part of the original answer regarding McDonald's consolidation policy: specifically, that franchisee entities are not consolidated due to variable interest entity evaluations. This is a key multi-hop component of the question linking recurring transactions, financial reporting, and consolidation policy. The LLM mentions that gains are reflected in consolidated financial statements but fails to explain that franchisees themselves are not consolidated, which fundamentally affects how these transactions are reported. Additionally, the LLM introduces a claim that these gains and losses are 'not material,' which is not present in the original answer and cannot be verified from the provided ground truth. This addition may misrepresent the significance of the transactions. While the core idea about operating income is correct, the absence of the consolidation rationale and the introduction of unverified materiality weaken the qualitative accuracy. Contextual relevance remains strong as the response addresses the financial reporting impact, but the missing synthesis on consolidation results in a partially correct, incomplete answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 443,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What was the impact on Chevron's (CVX) financial position in 2023 from its use of derivative commodity instruments, and how does this relate to the company's risk management practices and fair value measurements as monitored by its internal Risk Control group?",
      "original_answer": "Chevron's use of derivative commodity instruments in 2023 had no material impact on its financial position, results of operations, or liquidity. This conclusion is supported by both the fair value measurements and the company's internal risk management practices. Specifically, the fair value of derivative commodity instruments was not material to Chevron's Consolidated Balance Sheet or Consolidated Statement of Income. Additionally, the company's internal Risk Control group monitored market exposure on a daily basis, and the Audit Committee reviewed compliance with risk management policies, ensuring that derivative activities remained within acceptable risk thresholds.",
      "llm_answer": "Chevron's 2023 financial position was not materially affected by its use of derivative commodity instruments, as stated in Note 10: \"The company's derivatives are not material to the company's financial position, results of operations or liquidity.\" The Risk Control group monitors derivative market exposures daily, and the fair value changes of these instruments ($159 in assets and $262 in liabilities at December 31, 2023) were not material to operations. This aligns with the company's risk management practices, which integrate environmental and regulatory considerations into strategic planning and risk assessment tools, as noted in the Environmental Matters section. The derivative instruments are measured at fair value with gains/losses reflected in income, but their impact on the 2023 financial position was negligible.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly conveys that Chevron's use of derivative commodity instruments had no material impact on its financial position in 2023, aligning with the ground truth. It accurately references internal monitoring by the Risk Control group and fair value measurement practices. However, the LLM introduces specific dollar amounts—$159 in assets and $262 in liabilities—which are not present in the original answer or implied in the ground truth. While these figures may appear in actual filings, they were not part of the verified knowledge graph answer, making their inclusion a deviation that affects quantitative accuracy. (2) The numbers $159 and $262 are likely misstated or taken out of context—without units (e.g., thousands or millions), they are misleading. The ground truth explicitly states that fair values were not material, so citing raw numbers without context risks implying materiality. This is a significant issue in quantitative accuracy. (3) The multi-hop reasoning is sound: the model connects derivative usage to risk management practices, cites internal controls (Risk Control group), links to fair value accounting, and ties it to financial impact. It even references Note 10 and the Audit Committee implicitly through compliance language. However, the mention of 'environmental and regulatory considerations' from the Environmental Matters section is extraneous and not directly tied to derivative risk management, slightly diluting focus. (4) Despite minor inaccuracies and the introduction of unverified numbers, the core conclusion—that derivatives had no material impact—is correct, and the reasoning structure matches the ground truth. Hence, correctness is high but not perfect due to unsupported specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 479,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What is the total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, considering both the net benefit from AOCI and the allowance for credit losses included in Tier 2 capital?",
      "original_answer": "The total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, is $1.261 billion. This includes a $720 million benefit from AOCI related to the CECL capital transition provisions and a $541 million incremental allowance for credit losses on certain assets associated with First Republic, which is included in Tier 2 capital and impacts CET1 capital through regulatory capital calculations.",
      "llm_answer": "The CECL capital transition provisions added a $720 million benefit to CET1 capital as of December 31 2024, and the allowance for credit losses that is eligible for inclusion in Tier 2 capital (including the $541 million allowance on First Republic assets) is also reflected in the capital calculations. Consequently, the net impact of the CECL transition provisions on JPMorgan’s Basel III CET1 capital and the allowance for credit losses included in Tier 2 capital is captured by the $720 million CET1 benefit and the corresponding Tier 2 allowance adjustments shown in the capital reconciliations.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $720 million AOCI benefit and the $541 million allowance related to First Republic assets, both of which are accurate per the ground truth. However, it fails to explicitly state the total combined impact of $1.261 billion, which is the key quantitative answer required. While the components are present, the synthesis into a total figure is missing. (2) Quantitatively, both $720 million and $541 million are correct and match the ground truth; the sum ($720M + $541M = $1,261M) is mathematically accurate, but the LLM does not perform or state this calculation. The date (December 31, 2024) and entities (JPMorgan, CECL, Basel III CET1, Tier 2 capital, First Republic) are all correctly identified. (3) The multi-hop reasoning is partially sound — the model recognizes that both the AOCI benefit and the Tier 2 allowance affect CET1 capital through regulatory calculations — but it does not fully synthesize the two figures into a net total impact, which is the core of the question. Instead, it describes the components without concluding the aggregate effect. (4) The contextual relevance is high because the response stays focused on the CECL transition provisions and their capital impacts. However, the absence of the final summed value significantly reduces correctness, as the question explicitly asks for the 'total impact.' Thus, while the inputs are correct, the output is incomplete, warranting a moderate score of 6 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 414,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What was the total financial impact on GE from its AerCap-related transactions in 2023, considering both the net income contribution and the realized/unrealized gains or losses during that year?",
      "original_answer": "The total financial impact on GE from its AerCap-related transactions in 2023 was $2,654 million, combining the net income attributable to GE of $2,525 million and the realized/unrealized gain of $129 million in 2023.",
      "llm_answer": "The total financial impact of GE's AerCap-related transactions in 2023 was a net gain of $38 million from the realized and unrealized gains/losses on its AerCap investment, as disclosed in Note 19 of the 10-K (page 65), which states: \"Investment in and note with AerCap realized and unrealized gain (loss) $38 (2024) / $129 (2023) / $(865) (2022).\" This $38 million gain is part of the broader $2,264 million total other income (loss) for 2024, but specifically reflects the AerCap-related activity. The document does not provide a separate net income contribution figure for AerCap in 2023, only the realized/unrealized gain/loss amount.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but misses the core of the ground truth. It correctly identifies the $129 million realized/unrealized gain from AerCap in 2023, which matches the ground truth. However, it fails to mention the $2,525 million net income contribution from AerCap to GE in 2023, which is a critical component of the total financial impact. Instead, the LLM incorrectly states that 'the document does not provide a separate net income contribution figure for AerCap in 2023,' which contradicts the ground truth and indicates a failure in information retrieval or synthesis. (2) The quantitative accuracy is partially correct: the $129 million gain is accurate, but the total impact is wrong because the $2,525 million net income portion is omitted. The LLM also mistakenly references $38 million, which is the 2024 gain (as noted in the quote), not 2023, indicating confusion in time periods. While it quotes the correct $129 million for 2023, it incorrectly emphasizes $38 million as the 2023 figure in the summary, creating contradiction. (3) The multi-hop reasoning is flawed: the question requires combining two pieces of information — net income attributable to GE and the gain/loss from investment — but the model only retrieves one and incorrectly asserts the other is missing. This shows a failure in synthesizing across sections of the filing or misunderstanding the structure of GE's disclosures. (4) Contextual relevance is moderate: the answer discusses AerCap-related gains and cites a relevant note in the 10-K, showing it is on the right track, but it ultimately fails to answer the full scope of the question. The correctness score is low due to the omission of a major component ($2,525M) and introduction of incorrect emphasis on $38M for 2023, leading to a materially incorrect total financial impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 505,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much total consideration did Merck transfer in its acquisition of Immune Design, and what portion of this amount was allocated to goodwill, based on the fair value of net assets acquired?",
      "original_answer": "Merck transferred a total consideration of $301 million in its acquisition of Immune Design. Out of this, $20 million was allocated to goodwill, as it represented the excess of the consideration transferred over the fair value of net assets acquired.",
      "llm_answer": "Based on the information in the provided document pages, Merck transferred **$301 million** in consideration for its acquisition of Immune Design. Of this amount, **$20 million** was allocated to goodwill, as stated in the fair value of net assets acquired description on page 135: \"The excess of the consideration transferred over the fair value of net assets acquired of $20 million was recorded as goodwill.\" This allocation represents the portion of the total consideration attributable to goodwill.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total consideration transferred ($301 million) and the amount allocated to goodwill ($20 million), matching the ground truth exactly. (2) All numeric values are accurate and presented in a standard financial format; no calculations are required beyond what is explicitly stated in the source, and the LLM correctly interprets the $20 million as the excess of consideration over fair value of net assets, which is the definition of goodwill. (3) The reasoning is sound and reflects proper multi-hop understanding: it connects the total consideration with the allocation to goodwill based on the fair value of net assets, citing the correct logic from the document. (4) The answer is fully relevant, directly addressing both parts of the question with precise, semantically equivalent information. Minor wording differences (e.g., quoting the document) do not affect factual accuracy. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 285,
        "total_tokens": 1484
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What specific financial contributions do franchisees make to McDonald's revenue, and how does the co-investment by McDonald's in franchisee restaurant improvements impact the depreciation expense recorded by the Company?",
      "original_answer": "Franchisees contribute to McDonald's revenue primarily through the payment of rent (including minimum rent payments) and royalties based on a percentage of sales, along with initial fees upon the opening of a new restaurant or grant of a new franchise. McDonald's may co-invest with franchisees to fund restaurant improvements, where it generally manages the project and provides upfront funding. During these co-investment projects, McDonald's estimates which costs are its responsibility and which belong to the franchisee, allocating costs between Property and equipment and Accounts Receivable. Upon project completion, final cost allocations may result in immaterial adjustments to balances and associated depreciation expense, directly impacting the Company's financial statements.",
      "llm_answer": "Franchisees contribute to McDonald's revenue primarily through rent and royalties based on a percentage of sales, with specified minimum rent payments and initial fees paid upon opening new restaurants. McDonald's co-invests with franchisees to fund restaurant improvements, and these investments are capitalized as property and equipment; the associated costs are depreciated over the useful lives of the improvements, thereby increasing the Company's depreciation expense.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core financial contributions of franchisees to McDonald's revenue: rent (including minimum rent), royalties based on sales percentage, and initial fees. It also correctly identifies that McDonald's co-invests in franchisee restaurant improvements and that these investments are capitalized as property and equipment, leading to increased depreciation expense over time. There are no numeric inaccuracies (quantitative accuracy is perfect), and all entities and financial concepts are correctly used. However, the LLM omits a key nuance present in the ground truth: during co-investment projects, McDonald's allocates costs between itself and the franchisee, recording its share in Property and equipment and potentially an amount in Accounts Receivable for franchisee obligations. Furthermore, the ground truth notes that final cost allocations after project completion may lead to immaterial adjustments to depreciation expense, which the LLM does not mention. This missing detail slightly weakens the qualitative accuracy, as it overlooks the dynamic and potentially adjusting nature of cost allocation and its impact on depreciation. Nonetheless, the overall reasoning is sound, logically connects co-investment to capitalization and depreciation, and fully addresses both parts of the multi-hop question. The answer is semantically close and contextually fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 392,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "By how much did the value of Goldman Sachs' securities backed by real estate decrease from December 2023 to December 2024, and what was a primary cause of unrealized losses on Level 3 investments in 2023 related to this category?",
      "original_answer": "The value of Goldman Sachs' securities backed by real estate decreased by $120 million, from $689 million in December 2023 to $569 million in December 2024. A primary cause of unrealized losses on Level 3 investments in 2023 was weakness in the commercial real estate market, which specifically affected securities backed by real estate.",
      "llm_answer": "The value of Goldman Sachs’ securities backed by real estate fell from $687 million at the end of 2023 to $562 million at the end of 2024—a decline of $125 million. The primary driver of the unrealized losses on Level 3 investments in 2023 was weakness in the commercial real‑estate market, which caused losses on securities backed by real estate.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the primary cause of unrealized losses on Level 3 investments in 2023 as weakness in the commercial real estate market, which aligns with the ground truth and addresses the qualitative part of the question accurately. However, there are discrepancies in the quantitative values: the original answer states the value decreased from $689 million to $569 million, a $120 million decrease, while the LLM reports $687 million to $562 million, a $125 million decrease. These differences, though minor in magnitude, are factually incorrect. (2) The calculation of the decline is internally consistent in the LLM answer ($687M - $562M = $125M), but the source numbers do not match the ground truth. The correct decline is $120M ($689M - $569M), so the LLM's $125M is off by $5M. (3) The multi-hop reasoning is sound—the model correctly links the decrease in value over the specified time period and connects the cause of unrealized losses to the commercial real estate market, synthesizing information across time and categories appropriately. (4) The contextual relevance is perfect, as the answer directly addresses both parts of the question. The qualitative accuracy is high due to correct reasoning and entity identification (Goldman Sachs, Level 3 investments, real estate-backed securities, 2023–2024 timeframe). However, the quantitative accuracy is reduced due to incorrect base figures and resulting miscalculation of the decline, warranting a 6. Overall, the answer is mostly correct with minor but notable factual inaccuracies in the numbers, justifying a correctness score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 447,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much additional cost did American Tower incur beyond the principal amount when repaying the CoreSite Debt, and how does this compare to the previously reported outstanding balance as of December 31, 2021?",
      "original_answer": "American Tower incurred an additional $87.9 million beyond the principal amount when repaying the CoreSite Debt, which includes $80.1 million in prepayment consideration and $7.8 million in accrued interest. This repayment was based on the $875 million principal amount outstanding as of December 31, 2021, which had increased to a total redemption price of $962.9 million due to these additional costs.",
      "llm_answer": "The Company repaid the entire CoreSite Debt on January 7 2022 for an aggregate redemption price of $962.9 million, which included $80.1 million of prepayment consideration and $7.8 million of accrued interest. This amount exceeded the $955.1 million carrying value of the CoreSite Debt reported as of December 31 2021, resulting in an additional cost of approximately $7.8 million beyond the principal amount. This $7.8 million of extra cost is consistent with the $7.8 million of accrued and unpaid interest noted in the January 7 2022 repayment description and is comparable to the previously reported outstanding balance of $955.1 million as of December 31 2021.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numbers. While it correctly states the total redemption price ($962.9 million), prepayment consideration ($80.1 million), and accrued interest ($7.8 million), it incorrectly claims the outstanding balance as of December 31, 2021, was $955.1 million. The ground truth states the principal amount was $875 million, not $955.1 million. The LLM confuses the carrying value with the principal amount and misrepresents the additional cost as $7.8 million instead of $87.9 million. (2) Calculation verification: $80.1M + $7.8M = $87.9M in additional costs — this is correct in the LLM’s input data but not synthesized properly. The LLM incorrectly computes the additional cost as $962.9M - $955.1M = $7.8M, which is mathematically correct but based on a false premise. The correct calculation is $962.9M - $875M = $87.9M. (3) Multi-hop reasoning failure: The model fails to correctly link the repayment details to the correct prior-period principal balance. It uses an incorrect carrying value figure (possibly from a different context) and does not recognize that the $875M principal increased to $962.9M due to $87.9M in costs. This breaks the core multi-hop logic required. (4) Scores justified: Correctness is low (4) due to major factual and calculation errors despite some correct inputs. Quantitative accuracy is poor because the central figures (outstanding balance, additional cost) are wrong. Qualitative accuracy is moderate as the structure and terms are appropriate, but reasoning is flawed. Contextual relevance is high — the answer addresses the right event and timeframe with relevant financial components.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 460,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much did GE's collections from CFM International contribute to the change in cash impacts from current receivables in 2024, and what was the nature of GE's business relationship with CFM International that supported this financial interaction?",
      "original_answer": "GE reported that increased collections from CFM International partially offset a $(0.9) billion impact from current receivables in 2024. CFM International is a non-consolidated equity method investee jointly owned by GE and Safran Aircraft Engines, and GE makes substantial sales of parts and services to CFM International, which explains the significant receivables relationship.",
      "llm_answer": "The cash impact from current receivables improved by roughly $1 billion in 2024, driven largely by higher collections from CFM International. This increase stems from the long‑standing, equity‑method relationship between GE and CFM International, under which GE sells a substantial volume of parts and services to the joint venture.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that increased collections from CFM International had a significant positive impact on cash flows related to current receivables in 2024 and attributes this to the equity-method relationship and sales of parts and services, which aligns with the ground truth. However, the quantitative claim is inaccurate: the original answer states that collections 'partially offset a $(0.9) billion impact'—meaning the effect was positive but less than $0.9 billion—whereas the LLM claims an improvement of 'roughly $1 billion', which overstates both the magnitude and direction of the net impact. This is a significant error in financial interpretation. (2) The dollar amount is incorrect: '$1 billion improvement' contradicts the ground truth of a '$0.9 billion negative impact partially offset'—the net effect was still negative or at best a much smaller positive. While $1 billion is close numerically to $0.9 billion, the direction and context of the cash flow impact are misrepresented. (3) The multi-hop reasoning is sound: the model correctly links GE’s sales to CFM International, the equity-method investee status, and the resulting receivables and collections, showing good synthesis across business relationship and financial impact. (4) Scores reflect that core qualitative and relational understanding is accurate (hence high qualitative and contextual scores), but the quantitative inaccuracy—especially in magnitude and implied net effect—prevents a higher correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 421,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What was the total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case, combining prior year deferrals and current year pricing adjustments?",
      "original_answer": "The total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case was $276 million, as stated in the detailed variance drivers for the year ended December 31, 2023.",
      "llm_answer": "The total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case, combining prior year deferrals and current year pricing adjustments, was a $6 million increase, as indicated by the $6 million increase due to Ohio tax reform deferrals mentioned in the document.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its quantitative claim. The ground truth states the total financial impact was $276 million, but the LLM reports only a $6 million increase, which is a significant underreporting. The $6 million figure may correspond to a partial component (e.g., only tax reform deferrals), but the LLM fails to include the full combined impact from both the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case. (2) The calculation and numeric values are inaccurate. The correct total of $276 million is explicitly stated in the original answer as derived from the variance drivers for 2023. The LLM incorrectly isolates a $6 million item, suggesting it is the total impact, when it is likely just a subset. There is no indication that the LLM performed proper synthesis or summation across components. (3) The multi-hop reasoning is flawed. The question requires combining prior year deferrals and current year pricing adjustments from two sources—Ohio tax reform and the rate case. The LLM only references one element (Ohio tax reform deferrals) and omits the rate case adjustments entirely, failing the multi-hop synthesis requirement. (4) Contextual relevance is high because the answer addresses the correct company (Duke Energy), the correct year (2023), and the correct general topic (Ohio regulatory impacts on operating revenues). However, due to major quantitative and completeness failures, the overall correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 413,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much total revenue did Adobe's Digital Media segment generate in fiscal 2021, and what percentage of this revenue came from Creative Cloud and Document Cloud individually, based on the specific figures disclosed in the 10-K filing?",
      "original_answer": "Adobe's Digital Media segment generated $11.52 billion in revenue in fiscal 2021. Of this, Creative Cloud contributed $9.55 billion (83%) and Document Cloud contributed $1.97 billion (17%).",
      "llm_answer": "Adobe's Digital Media segment generated $11.52 billion in total revenue for fiscal 2021. Of this amount, Creative Cloud contributed $9.55 billion (approximately 83 % of the segment’s revenue) and Document Cloud contributed $1.97 billion (approximately 17 % of the segment’s revenue).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $11.52 billion total revenue, $9.55 billion from Creative Cloud, and $1.97 billion from Document Cloud. The percentages (83% and 17%) are correctly calculated and match the original answer. Minor wording differences such as 'approximately' do not affect accuracy, as the values are standard rounded figures. (2) The calculations are sound: $9.55B / $11.52B ≈ 82.9% (rounded to 83%) and $1.97B / $11.52B ≈ 17.1% (rounded to 17%), confirming the percentages are correctly derived. (3) The reasoning is logically sound and demonstrates proper synthesis of multi-hop information by correctly attributing segment revenue to its components as disclosed in the 10-K. (4) All entities—Adobe, Digital Media segment, Creative Cloud, Document Cloud, and fiscal 2021—are correctly identified and contextualized. The answer is complete, addressing both total revenue and the individual percentage contributions. Semantic equivalence is maintained with the original answer, with only minor, acceptable rewording (e.g., 'approximately').",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 323,
        "total_tokens": 1463
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the total increase in combined advertising and personnel-related costs for NFLX in 2021, specifically attributed to advertising expenses and headcount growth in both marketing and technology departments?",
      "original_answer": "The total increase in combined advertising and personnel-related costs for NFLX in 2021 was $722 million. This includes a $222 million increase in advertising expenses from the marketing department and a combined $500 million increase in personnel-related costs, with $116 million from marketing and $384 million from technology departments.",
      "llm_answer": "The total increase in combined advertising and personnel-related costs for NFLX in 2021 was $538 million, driven by a $222 million rise in advertising expenses and a $116 million increase in personnel-related costs, primarily due to headcount growth in both marketing and technology departments.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but has significant factual and calculation errors. The $222 million increase in advertising expenses is correct, as is the $116 million personnel-related cost increase for marketing. However, the LLM omits the $384 million personnel cost increase from the technology department, which is a critical component of the multi-hop synthesis required. Instead, it reports a total increase of $538 million, which is incorrect—the correct total is $722 million ($222M + $116M + $384M). (2) Quantitative accuracy is compromised: while $222M and $116M are accurate, the missing $384M leads to an incorrect total. The calculation of the combined increase is therefore flawed. (3) The reasoning is partially sound in linking advertising and personnel costs to headcount growth in marketing and technology, but fails to incorporate the full scope of personnel-related cost increases, especially in technology, indicating incomplete multi-hop synthesis across departments. (4) Contextual relevance is high as the answer addresses the right company (NFLX), year (2021), and cost categories. However, due to the omission of a major cost component and the resulting incorrect total, the overall correctness score is limited to 4, reflecting partial accuracy with significant gaps in completeness and quantitative precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 382,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does General Motors' equity earnings from Ultium Cells Holdings LLC influence its Automotive and other cost of sales, and what does this indicate about the financial treatment of this stake in relation to its electric vehicle production strategy?",
      "original_answer": "General Motors reports equity earnings from Ultium Cells Holdings LLC within its Automotive and other cost of sales, indicating that the entity is integral to its electric vehicle (EV) production strategy. This financial treatment shows that GM views its stake in Ultium Cells as a core operational component rather than a separate investment, aligning its battery cell supply directly with its automotive cost structure to support EV manufacturing.",
      "llm_answer": "General Motors records its equity earnings from Ultium Cells Holdings LLC in the “Automotive and other cost of sales” line of its consolidated income statement, reflecting the company’s view that the joint venture is integral to its EV battery supply chain. This treatment underscores that the stake is being accounted for as a core component of GM’s electric‑vehicle production strategy rather than as a peripheral investment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It accurately states that General Motors records equity earnings from Ultium Cells Holdings LLC within 'Automotive and other cost of sales,' which matches the original answer's claim about financial reporting treatment. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the answer correctly infers that this accounting treatment indicates GM views the joint venture as a core operational component of its EV strategy, not a peripheral investment, which aligns with the original answer’s interpretation. (4) The only minor difference is that the LLM answer does not explicitly use the phrase 'integral to its electric vehicle (EV) production strategy' or mention 'battery cell supply' being aligned with cost structure, but it effectively conveys the same meaning by stating the JV is 'integral to its EV battery supply chain' and a 'core component' of EV production. This constitutes a negligible difference in wording without loss of factual or conceptual accuracy. Thus, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 353,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the percentage decrease in the average price of U.S. Henry Hub natural gas in 2023 compared to 2022, and how did this price trend compare to Chevron's international natural gas realizations during the same period?",
      "original_answer": "The average price of U.S. Henry Hub natural gas decreased by 59.8% from $6.36 per MCF in 2022 to $2.56 per MCF in 2023. Chevron's international natural gas realizations also declined, but at a more moderate rate of 21.1%, from $9.75 per MCF in 2022 to $7.69 per MCF in 2023. This indicates that the drop in U.S. natural gas prices was significantly steeper than the decline in international prices, which are often linked to crude oil benchmarks.",
      "llm_answer": "The average price of U.S. Henry Hub natural gas fell 59.7% from 2022 ($6.36 per MCF) to 2023 ($2.56 per MCF), while Chevron's international natural gas realizations declined only 21.2% from $9.75 per MCF in 2022 to $7.69 per MCF in 2023, reflecting the steeper U.S. price drop due to high storage and production versus relatively stable global LNG pricing linked to oil.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects, with only negligible rounding differences in percentages. The ground truth reports a 59.8% decrease for Henry Hub and a 21.1% decline for Chevron's international realizations, while the LLM reports 59.7% and 21.2%, respectively. These minor discrepancies are within acceptable rounding tolerance and do not affect the overall accuracy. (2) Calculations verified: (6.36 - 2.56) / 6.36 = 59.75% ≈ 59.8% (ground truth), LLM says 59.7% — acceptable rounding. For Chevron: (9.75 - 7.69) / 9.75 = 21.13% ≈ 21.1% (ground truth), LLM says 21.2% — slight over-rounding but still reasonable. All dollar amounts ($6.36, $2.56, $9.75, $7.69) are exactly correct. (3) Multi-hop reasoning is sound: the model correctly synthesizes data across U.S. Henry Hub prices and Chevron’s international realizations, compares the two trends, and draws the correct conclusion about the steeper U.S. decline. It adds relevant context about high U.S. storage/production and oil-linked global LNG pricing, which aligns with typical market dynamics and enhances understanding without introducing inaccuracies. (4) Scores justified: correctness is 9 due to minor percentage rounding; quantitative accuracy is 9 for same reason; qualitative and contextual scores are 10 as reasoning, entity identification, and relevance are excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 383,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does Goldman Sachs' sensitivity of fair value measurements to changes in credit spreads impact the valuation of its level 3 credit derivatives, given the range of credit spreads and recovery rates used as significant unobservable inputs?",
      "original_answer": "Goldman Sachs' fair value of level 3 credit derivatives is directly impacted by changes in credit spreads and recovery rates. Specifically, the fair value of purchased credit protection increases when credit spreads or upfront credit points increase or when recovery rates decrease. This directional sensitivity is compounded by the broad variability in the underlying risk factors across different reference obligations, such as leverage, volatility, industry, borrowing costs, and macroeconomic conditions, which contribute to the wide range of credit spreads and recovery rates used as inputs in the valuation models.",
      "llm_answer": "Goldman Sachs’ fair‑value measurements for its Level 3 credit derivatives are highly sensitive to the credit‑spread inputs used in the valuation models. The document notes that credit‑spread ranges of 8 bps to 1,328 bps (with an average/median of 134 bps/91 bps in 2024 and 3 bps to 1,750 bps (average/median of 130 bps/85 bps in 2023) were applied, and that the fair value of purchased credit protection increases as credit spreads rise (or recovery rates fall). Consequently, variations in these unobservable credit‑spread inputs directly affect the reported fair‑value amounts of the Level 3 credit‑derivative assets and liabilities.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the directional sensitivity of Goldman Sachs' Level 3 credit derivatives to credit spreads and recovery rates, aligning with the ground truth: fair value of purchased credit protection increases with higher credit spreads and lower recovery rates. It also appropriately notes that these inputs are significant unobservable inputs affecting fair value measurements. However, the LLM introduces specific numeric ranges (e.g., 8 bps to 1,328 bps in 2024, 3 bps to 1,750 bps in 2023) and average/median values (134/91 bps in 2024, 130/85 bps in 2023) that are not present in the original answer. Since the ground truth does not include any specific numerical ranges or statistics for credit spreads or recovery rates, these figures cannot be verified and appear to be fabricated or hallucinated. This significantly impacts quantitative accuracy. While the qualitative reasoning about sensitivity and model inputs is sound and contextually relevant, the inclusion of unsupported numeric data undermines factual correctness. The answer is semantically aligned in direction and logic but fails on precise quantitative fidelity, warranting a score of 7 for correctness—core facts are right, but key numbers are unverified and likely incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 353,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the repayment of CoreSite Debt in January 2022 impact AMT's capital structure, and what does the alignment between the repayment amount and the carrying value of $955.1 million indicate about the valuation of this debt on AMT's balance sheet?",
      "original_answer": "The repayment of CoreSite Debt in January 2022, which totaled $955.1 million, directly reduced AMT's long-term obligations, thereby improving its debt-to-equity ratio and overall capital structure by eliminating a significant portion of its liabilities. The fact that the repayment amount matches the carrying value of $955.1 million, as disclosed in the detailed debt schedule, indicates that the debt was carried at its fair value or close to its redemption value on the balance sheet, suggesting minimal unamortized discounts or premiums on this debt at the time of repayment.",
      "llm_answer": "The repayment of CoreSite Debt in January 2022 eliminated the $955.1 million of CoreSite‑related borrowings from AMT’s balance sheet, reducing its total debt and improving leverage ratios. Because the repayment amount ($955.1 million) matched the carrying value of the CoreSite Debt, the transaction resulted in no gain or loss on debt extinguishment, confirming that the debt was recorded at its fair‑value carrying amount on the balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the repayment amount ($955.1 million) and date (January 2022), matching the ground truth. It accurately states that the debt was eliminated from the balance sheet, improving leverage ratios—consistent with the original answer's claim about improving the debt-to-equity ratio and capital structure. The key qualitative point—that the repayment amount matching the carrying value implies the debt was carried at fair value with no gain or loss on extinguishment—is correctly inferred and aligns with the ground truth's assertion about minimal unamortized discounts or premiums. (2) All numeric values—$955.1 million and January 2022—are factually correct and precisely match the ground truth. No calculations are required, but the comparison between repayment amount and carrying value is correctly interpreted. (3) The multi-hop reasoning is sound: the model connects the repayment event to its impact on capital structure and infers the accounting implication (no gain/loss) from the equality of repayment and carrying value, which requires synthesis across financial reporting concepts and balance sheet valuation principles. (4) The only minor omission is that the LLM answer does not explicitly mention 'long-term obligations' or 'detailed debt schedule' as in the original, but it conveys the same core financial implication. Wording differs slightly (e.g., 'fair-value carrying amount' vs 'fair value or close to redemption value'), but the semantic meaning is equivalent. Thus, the answer is highly accurate with only negligible contextual trimming, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 455,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How might the potential adjustments from ongoing tax examinations focusing on intercompany transfer pricing practices impact Adobe's financial position, given the range of estimated potential decreases in unrecognized tax benefits and the company's established reserves?",
      "original_answer": "The potential adjustments from ongoing tax examinations focusing on Adobe's intercompany transfer pricing practices could have an adverse effect on Adobe's financial position. Adobe has estimated a range of potential decreases in unrecognized tax benefits of up to $5 million over the next 12 months. These adjustments could result in increased tax liabilities, which would directly impact Adobe's consolidated financial statements. Adobe has established reserves to address potential exposures from tax audits, but due to the high uncertainty surrounding the timing and outcome of these examinations, the actual adjustments could exceed these reserves, leading to significant fluctuations in tax assets and liabilities on the balance sheet.",
      "llm_answer": "The ongoing tax examinations, which are expected to focus on intercompany transfer‑pricing practices, could lead to adjustments in Adobe’s unrecognized tax benefits. The company has reserved for potential decreases in those benefits, estimating that the range of possible reductions over the next 12 months is from $0 up to approximately $5 million. These reserves reflect the uncertainty of audit outcomes but indicate that any material impact on Adobe’s financial position is likely to be limited to this modest range.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key quantitative figure — a potential decrease in unrecognized tax benefits of up to $5 million over the next 12 months — which matches the ground truth exactly. It also accurately notes that reserves have been established, and that adjustments could arise from ongoing transfer pricing examinations. However, the LLM understates the potential financial impact by characterizing it as 'likely to be limited to this modest range,' which contradicts the original answer's emphasis on high uncertainty and the risk that actual adjustments could exceed reserves, leading to significant fluctuations in tax assets and liabilities. This misrepresents the severity and uncertainty of the potential impact. (2) All numbers are accurate: '$0 up to approximately $5 million' is consistent with 'up to $5 million' in the ground truth (the inclusion of $0 as a lower bound is a reasonable interpretation of a range with uncertainty). (3) The multi-hop reasoning is partially sound — the model correctly links tax examinations, transfer pricing, unrecognized tax benefits, and reserves — but fails to fully synthesize the implication that reserves may be insufficient, which is a critical part of the original answer's reasoning. (4) Scores reflect high factual accuracy in numbers (10), solid but incomplete qualitative reasoning due to downplaying of risk (7), and strong relevance to the question (9). The correctness score is 7 because while core facts and numbers are correct, the answer omits a key qualitative risk element, altering the overall interpretation of financial impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 446,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What was the combined growth percentage of alliance revenue related to Lenvima in 2021 and 2020, and how does this growth relate to Merck's broader oncology strategy as exemplified by Keytruda's combination therapies?",
      "original_answer": "The alliance revenue related to Lenvima grew by 21% in 2021 and 44% in 2020, resulting in a combined growth of 65% over the two years. This growth is aligned with Merck's broader oncology strategy, which emphasizes combination therapies to expand indications and improve patient outcomes. For instance, Keytruda is approved in combination with Lenvima for the treatment of certain patients with endometrial carcinoma and renal cell carcinoma (RCC), demonstrating Merck's focus on leveraging synergies between its oncology assets to drive revenue and therapeutic innovation.",
      "llm_answer": "The combined growth percentage of alliance revenue related to Lenvima in 2021 and 2020 was 21% in 2021 and 44% in 2020. This growth aligns with Merck's broader oncology strategy of leveraging combination therapies, exemplified by Keytruda's partnerships—such as its combination with Lenvima for treating advanced endometrial carcinoma and renal cell carcinoma—which has driven alliance revenue expansion and reinforced Merck's focus on targeted, synergistic cancer treatments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the alliance revenue growth percentages for Lenvima as 21% in 2021 and 44% in 2020, matching the ground truth. However, it did not explicitly state the combined growth of 65% over the two years, which is a required part of the question. While the individual yearly growth figures are accurate, the omission of the summed 65% reduces completeness. (2) All numeric values (21%, 44%) are correct and properly attributed to the right years. The calculation of combined growth (21 + 44 = 65%) is straightforward, and though the model provided the components, it failed to perform or report the final sum, which is a minor but notable gap in quantitative synthesis. (3) The reasoning is sound: the LLM correctly links Lenvima's revenue growth to Merck’s oncology strategy centered on combination therapies, specifically citing Keytruda + Lenvima approvals for endometrial carcinoma and renal cell carcinoma. This demonstrates accurate multi-hop synthesis across financial performance and strategic context. (4) The answer is semantically very close to the original, with only the missing explicit '65% combined growth' preventing a perfect score. Contextual relevance is excellent, as all information provided directly addresses the question’s focus on revenue trends and strategic alignment. Thus, high scores across all dimensions with a slight deduction in correctness and qualitative accuracy for incomplete synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 404,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did GM's investment in Ultium Cells Holdings LLC in 2024 directly impact its EBIT-adjusted performance, and by how much was this contribution quantified?",
      "original_answer": "GM's investment in Ultium Cells Holdings LLC contributed $0.7 billion in equity earnings, which directly increased GM's EBIT-adjusted performance in 2024. This favorable cost impact was explicitly noted as part of the EBIT-adjusted improvement due to increased equity earnings from Ultium Cells Holdings LLC.",
      "llm_answer": "GM’s 2024 investment in Ultium Cells Holdings LLC was recorded as a cash outflow of **$0.7 billion** in the consolidated cash‑flow statement (page 39).  Management & Analysis notes that this investment contributed positively to the company’s adjusted automotive free‑cash‑flow and to EBIT‑adjusted results, adding roughly **$0.7 billion** to the EBIT‑adjusted performance for the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that GM's investment in Ultium Cells Holdings LLC contributed $0.7 billion to EBIT-adjusted performance in 2024, which matches the ground truth. The dollar amount is accurate and correctly attributed to equity earnings impacting EBIT-adjusted results. (2) Quantitatively, the $0.7 billion figure is reported correctly in both the investment outflow and the contribution to EBIT-adjusted performance. Although the original answer specifies this as 'equity earnings,' the LLM correctly links the investment to a $0.7 billion positive impact on EBIT-adjusted, which is factually consistent. Format variations (e.g., $0.7 billion) are acceptable and correctly used. (3) The reasoning is sound: the LLM recognizes that the investment led to a direct contribution to EBIT-adjusted performance, demonstrating correct multi-hop synthesis between the investment and its income statement impact. It references management commentary supporting this, aligning with the original answer’s emphasis on explicit recognition of the impact. The only minor shortcoming is that it does not explicitly label the $0.7 billion as 'equity earnings,' though the functional impact is correctly described. (4) Scores reflect near-perfect factual accuracy, with full quantitative precision and high qualitative reasoning. The omission of the specific term 'equity earnings' prevents a perfect 10, but the semantic meaning and financial impact are correctly conveyed, warranting a 9 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 417,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the SEC's monthly short position reporting requirement for institutional investment managers, effective January 2025, interact with Goldman Sachs' regulatory obligations as a registered security-based swap dealer to influence its derivatives reporting practices?",
      "original_answer": "The SEC's monthly short position reporting requirement, applicable to institutional investment managers meeting specified thresholds starting in January 2025, complements Goldman Sachs' existing obligations as a registered security-based swap dealer. As a registered dealer, Goldman Sachs must comply with SEC rules on capital, margin, record-keeping, business conduct, and regulatory trade reporting. The new short position reporting rule adds another layer of transparency and accountability, requiring Goldman Sachs to ensure that its short position data in equity securities is accurately reported monthly. This enhances the firm's existing reporting practices by aligning them with broader SEC oversight goals, particularly in monitoring large positions and short-selling activity in the market.",
      "llm_answer": "The SEC’s new monthly short‑position reporting rule for institutional managers (effective January 2025) obligates Goldman Sachs’ registered security‑based swap dealer entities to incorporate short‑position disclosures into their public derivatives reporting, increasing the granularity of their regulatory filings and requiring them to track and report short‑position data alongside their existing security‑based swap disclosures.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key elements: the SEC's monthly short-position reporting requirement effective January 2025 and Goldman Sachs' status as a registered security-based swap dealer. The date (January 2025) is accurate, and the entities (SEC, Goldman Sachs, institutional investment managers) are correctly referenced, satisfying quantitative and entity accuracy. However, the LLM mischaracterizes the interaction between the two regulatory regimes. The original answer clarifies that the short-position reporting rule applies to 'institutional investment managers,' not security-based swap dealers per se. While Goldman Sachs may have entities that qualify as institutional managers, the rule does not directly obligate its swap dealer entities to report short positions unless they meet the threshold as managers. The LLM incorrectly implies that the swap dealer registration triggers the short-position reporting obligation, conflating two distinct regulatory categories. Additionally, the claim that short-position disclosures must be included in 'public derivatives reporting' is misleading—Form SHO filings for short positions are not public in the same way as SBS derivatives data reported under Title VII. The reasoning thus fails a key multi-hop logic test: correctly distinguishing between entity types (dealers vs. managers) and their respective reporting duties. While the general direction of increased transparency is correct, the mechanism and applicability are inaccurately portrayed, leading to a moderate correctness score. Contextual relevance is high as the response addresses the core topic of regulatory reporting interaction.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 453,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What was the financial impact on PepsiCo from the remeasurement of its 39% noncontrolling interest in TBG at fair value following the sale of its juice brands, and how does this reflect the structure of the transaction involving both cash and retained equity?",
      "original_answer": "PepsiCo recorded a $520 million gain from the remeasurement of its 39% ownership in TBG at fair value following the sale of its Tropicana, Naked, and other select juice brands to PAI Partners for approximately $3.5 billion in cash. This gain reflects the combination of the cash proceeds from the divestiture and the retained economic interest through the 39% noncontrolling stake, which was valued using a combination of the transaction price, discounted cash flows, and an option pricing model. The structure of the transaction allowed PepsiCo to realize immediate value while maintaining a financial stake in TBG’s future performance.",
      "llm_answer": "The remeasurement of PepsiCo’s 39% noncontrolling interest in TBG to fair value resulted in a $520 million gain recorded in 2022, which contributed to the overall $3.3 billion gain from the juice‑brand divestiture. This gain reflects the transaction’s structure—cash proceeds of about $3.5 billion were received while PepsiCo retained a 39% equity stake in the newly formed joint venture, allowing the fair‑value adjustment to capture both the cash received and the ongoing equity interest.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $520 million gain from the remeasurement of PepsiCo’s 39% noncontrolling interest in TBG and the $3.5 billion cash proceeds from the sale, which aligns with the ground truth. However, it introduces a new figure—'overall $3.3 billion gain from the juice-brand divestiture'—that is not present in the original answer and lacks verification from the provided ground truth. This number may be accurate contextually but cannot be confirmed and was not requested in the question, thus introducing unverified information. (2) All other numeric values—$520 million gain, 39% retained stake, $3.5 billion cash—are quantitatively accurate and properly formatted. The year '2022' is a reasonable inference but not explicitly stated in the ground truth, so minor deduction in precision. (3) The multi-hop reasoning is sound: the model correctly links the remeasurement gain to the transaction structure involving both cash proceeds and retained equity, and explains how fair value accounting applies to the retained interest. It captures the economic rationale that PepsiCo realized immediate value while maintaining exposure to future performance. (4) The answer is contextually relevant and addresses both parts of the question: the financial impact (the $520M gain) and how it reflects the transaction structure (cash + retained equity). The only significant issue is the unsupported claim about a $3.3 billion total gain, which slightly undermines quantitative and qualitative accuracy. Otherwise, entity names (PepsiCo, TBG, PAI Partners implied), percentages, and financial concepts are correct and well-synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 455,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How much did GE's financial performance from its retained ownership interests, including its stake in Baker Hughes, contribute to its total other income in 2023, and how does this compare to 2024?",
      "original_answer": "In 2023, GE's retained and sold ownership interests contributed $5,778 million to its total other income, which included a $10 million realized and unrealized gain from its investment in Baker Hughes. In 2024, this contribution dropped significantly to $518 million, with no gain recorded from Baker Hughes. This represents a decrease of $5,260 million in contributions from these ownership interests year-over-year.",
      "llm_answer": "In 2023, GE’s retained ownership interests—including its stake in Baker Hughes—generated $518 million of gains (losses) on those interests, which was reported as part of “Other income (loss)” and contributed to the $6.7 billion total other income for the year. By contrast, in 2024 the same source contributed only $399 million of gains (losses) on retained and sold ownership interests, amounting to a much smaller share of the $2.264 billion total other income reported for 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, GE's retained and sold ownership interests contributed $5,778 million (not $518 million) to total other income, with a $10 million gain from Baker Hughes. The LLM incorrectly states this figure as $518 million, which is actually the 2024 contribution in the ground truth. Furthermore, the LLM claims that in 2024 the contribution was $399 million, but the correct amount is $518 million—reversing and distorting both years' figures. The total other income values ($6.7 billion in 2023 and $2.264 billion in 2024) are not present in the original answer and appear to be fabricated or misattributed. (2) The quantitative errors are severe: the LLM swaps the correct 2023 and 2024 values, misreports the Baker Hughes gain (omitting it entirely in both years despite its mention in 2023), and introduces unverified total other income figures. The year-over-year decrease should be $5,260 million, but the LLM implies a much smaller drop based on incorrect inputs. (3) The multi-hop reasoning is flawed—the model fails to correctly identify and synthesize the contributions from retained/sold ownership interests across years and misattributes the role of Baker Hughes. It also conflates subcomponents with totals without proper support. (4) Despite these issues, the answer is contextually relevant—it addresses the right topic (GE’s income from ownership interests including Baker Hughes) and attempts a year-over-year comparison, which aligns with the question. However, due to major factual and numerical errors, the correctness and accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 457,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What is the total fair value of Mortgage-Backed Obligations held by the company as of January 31, 2024, based on the two separate disclosures in the 10-K filing, and what percentage of the total assets measured at fair value do they represent?",
      "original_answer": "The total fair value of Mortgage-Backed Obligations is $358 million ($236 million from the first disclosure and $122 million from the second). These obligations represent approximately 2.97% of the total assets measured at fair value, calculated as $358 million divided by the combined total assets of $12,079 million and $12,010 million from the two disclosures.",
      "llm_answer": "The total fair value of Mortgage-Backed Obligations held by the company as of January 31, 2024, is $122 million, representing 1% of the total assets measured at fair value ($12,079 million) as disclosed in the Level 2 fair value hierarchy on page 77. This is consistent with the $122 million reported for January 31, 2024, in the fair value table.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in both total fair value and percentage. The ground truth states the total fair value is $358 million ($236M + $122M from two disclosures), but the LLM only reports $122 million, missing the $236 million from the first disclosure. This leads to a major factual error. (2) The percentage reported by the LLM is 1%, but the correct percentage is approximately 2.97%, calculated as $358M / ((12,079M + 12,010M)/2) or based on combined total assets of $12,079M and $12,010M from the two disclosures. The LLM uses only one total asset figure ($12,079M), leading to incorrect context and calculation. (3) The multi-hop reasoning is flawed: the question requires aggregating two separate disclosures, but the LLM only uses one. It fails to synthesize information across both sources, which is essential for correctness. (4) While the LLM correctly identifies $122 million as one component and references a plausible page and fair value hierarchy level, it omits critical data and miscalculates the overall impact. The answer is contextually relevant to the topic and date but fails on completeness and accuracy, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 338,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Netflix's strategy of offering varied membership plans across different countries contribute to the 7% increase in average monthly revenue per paying membership in 2021, and how did this impact the overall 19% revenue growth for the year?",
      "original_answer": "Netflix's strategy of offering varied membership plans tailored to different countries allowed for pricing flexibility based on regional market conditions. This approach enabled the company to implement price changes that contributed to a 7% increase in average monthly revenue per paying membership. As a result of this pricing strategy and the expansion of paying memberships by 11%, consolidated revenues grew by 19% in 2021. The ability to adjust pricing models across different regions directly supported the overall revenue growth, demonstrating how localized membership plan strategies can drive global financial performance.",
      "llm_answer": "Netflix’s varied membership plans across countries allowed it to tailor pricing and features to local markets, which drove a 7% rise in average monthly revenue per paying member in 2021. This increase, combined with an 11% growth in the number of paying members, contributed to the overall 19% revenue growth for the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 7% increase in average monthly revenue per paying membership and links it to Netflix's strategy of offering varied membership plans across countries. It also accurately states the 11% growth in paying memberships and the resulting 19% overall revenue growth, which aligns with the ground truth. All key numerical values (7%, 11%, 19%) and the year (2021) are correct. (2) Quantitative accuracy is perfect: the percentages match the original answer, and the implied calculation (revenue growth ≈ membership growth + price/revenue per member growth) is logically sound and consistent with the data. (3) The multi-hop reasoning is mostly sound—connecting localized pricing strategies to average revenue per user, then combining that with membership volume growth to explain total revenue growth. The only minor omission is that the LLM answer does not explicitly mention 'pricing flexibility based on regional market conditions' or 'consolidated revenues,' which slightly reduces qualitative depth compared to the original. However, the core causal chain is preserved. (4) The answer is contextually fully relevant, directly addressing both parts of the question: how the strategy contributed to the 7% increase and how that impacted the 19% revenue growth. The wording differs but the semantic meaning and factual content are equivalent. A score of 9 is justified due to high accuracy with only minor contextual omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 408,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does Merck's collaboration with Eisai on Lenvima, specifically through the LEAP clinical program, influence Merck's pharmaceutical segment revenue, given the current status of key trials and alliance revenue model?",
      "original_answer": "Merck's collaboration with Eisai on Lenvima through the LEAP clinical program influences its pharmaceutical segment revenue by shaping the future commercial potential of the Keytruda plus Lenvima combination across multiple tumor types. Although the FDA issued a CRL for the first-line treatment of unresectable HCC based on the KEYNOTE-524/Study 116 trial, Merck and Eisai are conducting the Phase 3 LEAP-002 trial to demonstrate substantial evidence of effectiveness. The discontinuation of LEAP-007 and LEAP-011 due to futility assessments negatively impacts near-term revenue potential for Lenvima combinations in NSCLC and urothelial carcinoma. However, Merck's alliance revenue model, which includes shared profits from product sales net of costs, means that if any Lenvima-based combinations gain approval and succeed commercially, Merck will receive a portion of the revenue generated. This revenue stream is integral to the Pharmaceutical segment, which includes oncology products like Keytruda and its combinations, such as with Lenvima in approved indications like endometrial carcinoma and RCC.",
      "llm_answer": "Merck's collaboration with Eisai on Lenvima, driven by the LEAP clinical program, directly contributes to its Pharmaceutical segment revenue through alliance revenue sharing—Merck earns a portion of Lenvima sales, which reached $704 million in 2021, reflecting growth from $580 million in 2020 and $404 million in 2019. The partnership’s pipeline, including ongoing Phase 3 trials across multiple tumor types, supports continued revenue potential, though recent setbacks such as the CRL for HCC and trial discontinuations highlight execution risks that could affect future alliance earnings.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies, particularly in quantitative details. It states that Lenvima sales were $704 million in 2021, $580 million in 2020, and $404 million in 2019. However, these figures are not supported by the ground truth and likely misrepresent the actual sales data—Lenvima is an Eisai product, and while Merck shares in profits via the alliance, the answer incorrectly presents these as direct revenue figures attributable to Merck without clarifying the profit-sharing structure or the fact that these numbers may not reflect Merck's actual revenue contribution. The ground truth does not provide specific sales figures, so including them without verification introduces factual errors. (2) The mention of specific dollar amounts without sourcing or contextualization (e.g., whether these are global sales, Merck’s share, or net profits) undermines quantitative accuracy. There is no confirmation in the original answer that these numbers are correct, making their inclusion misleading. (3) Qualitatively, the LLM captures the general structure of the collaboration and references key events like the CRL for HCC and trial discontinuations (LEAP-007 and LEAP-011), which aligns with the ground truth. It acknowledges the alliance revenue model and the impact of clinical trial outcomes on future revenue potential, showing correct multi-hop reasoning between clinical results and financial impact. However, it omits critical details such as the ongoing LEAP-002 trial as a pivotal next step for HCC and fails to mention approved indications like endometrial carcinoma and RCC, which are currently contributing to revenue. (4) Contextually, the answer stays focused on the question, discussing how the collaboration affects revenue through clinical development and profit sharing. Despite missing some key elements and introducing unverified numbers, it maintains relevance and logical flow. Overall, the answer is partially correct but significantly weakened by unsupported quantitative claims, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 556,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How much did Chevron's total cost incurred by consolidated companies in 2023 exceed the combined total of expensed exploration costs and the PDC Energy, Inc. acquisition cost?",
      "original_answer": "Chevron's total cost incurred by consolidated companies in 2023 was $24.6 billion. The combined total of expensed exploration costs ($0.5 billion) and the PDC Energy, Inc. acquisition cost ($10.5 billion) was $11.0 billion. Therefore, the total cost exceeded this combined amount by $13.6 billion.",
      "llm_answer": "Based on the provided financial data, Chevron's total cost incurred by consolidated companies in 2023 was $24,559 million. The combined total of expensed exploration costs ($0.5 million) and the PDC Energy acquisition cost ($10.5 million) equals $11.0 million. Therefore, Chevron's total cost exceeded this combined amount by $13,468 million.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative errors despite correct reasoning structure. While it correctly identifies Chevron's total cost incurred as $24,559 million (~$24.6 billion, which is accurate), it incorrectly reports expensed exploration costs and the PDC acquisition cost as $0.5 million and $10.5 million respectively—these are off by a factor of 1,000. The correct values are $0.5 billion and $10.5 billion, or $500 million and $10,500 million. This leads to a grossly incorrect combined total of $11.0 million instead of $11.0 billion. The final difference is calculated as $13,468 million (~$13.5 billion), which is close to the correct $13.6 billion but still inaccurate due to the earlier unit error. (2) The calculation logic is sound—subtracting the sum of two costs from the total—but the inputs are wrong due to unit confusion (millions vs. billions). (3) The multi-hop reasoning is structurally correct: identifying Chevron’s total cost, isolating exploration and acquisition costs, summing them, and computing the difference. However, the failure to use consistent and correct units undermines the entire quantitative conclusion. (4) Contextual and qualitative aspects are mostly accurate: entities (Chevron, PDC Energy, Inc.), metric names, and year (2023) are correct, and the answer attempts the right synthesis. The core issue is numerical precision, leading to a low quantitative accuracy score and moderate correctness score due to partial credit for structure and entity identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 422,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does American Tower determine the fair value of its 2024 performance-based restricted stock units (PSUs) that include a market condition component, and what specific market metric is used in this valuation?",
      "original_answer": "American Tower determines the fair value of its 2024 PSUs with a market condition component using a Monte Carlo simulation model. This model evaluates the probability of satisfying the market condition requirements, which for the 2024 PSUs is based on relative total shareholder return measured against the REIT constituents included in the S&P 500 Index.",
      "llm_answer": "American Tower determines the fair value of its 2024 performance-based restricted stock units (PSUs) that include a market condition component using a Monte Carlo simulation model. The specific market metric used is the relative total shareholder return measured against the S&P 500 REIT constituents. The grant‑date fair value of this market‑condition component of the 2024 PSUs is $216.11 per share.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that American Tower uses a Monte Carlo simulation model to determine the fair value of its 2024 PSUs with a market condition component and correctly states that the market metric is relative total shareholder return against the S&P 500 REIT constituents, which aligns with the ground truth. However, the LLM introduces a specific dollar amount—$216.11 per share—for the grant-date fair value of the market-condition component, which is not present in the original answer and cannot be verified from the provided ground truth. This addition introduces a factual claim that cannot be confirmed and thus undermines quantitative accuracy. (2) There are no calculations in the question or answer, but the inclusion of an unverified dollar figure ($216.11) is a critical issue. The ground truth does not provide any numerical valuation, so this number appears to be hallucinated or sourced from outside the knowledge base. (3) The multi-hop reasoning is otherwise sound: the model correctly synthesizes the valuation method (Monte Carlo simulation) and the specific market metric (relative TSR vs. S&P 500 REITs), which requires linking the PSU structure to the performance metric. (4) The contextual relevance is perfect—the answer directly addresses both parts of the question. Qualitative accuracy is high due to correct entities, method, and metric. However, the correctness score is reduced due to the unsupported numerical claim, which could mislead users despite otherwise accurate reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 423,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How many amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan are documented across the disclosed filings, and what is the effective date of the fourth amendment?",
      "original_answer": "There are four documented amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan, with the fourth amendment effective as of July 1, 2022.",
      "llm_answer": "The disclosed filings document **four amendments** to the Caterpillar Inc. Supplemental Employees' Investment Plan. The **fourth amendment** became **effective on July 1, 2022**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately states that there are four documented amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan, which aligns with the original answer. (2) The effective date of the fourth amendment is correctly identified as July 1, 2022, with no discrepancy in formatting or content. (3) The question requires a multi-hop synthesis of both a count of amendments and the effective date of a specific amendment; the LLM correctly retrieves and combines both pieces of information from the disclosed filings. (4) The wording differs slightly (e.g., 'became effective on' vs 'effective as of'), but the semantic meaning is identical. All evaluation dimensions—factual accuracy, completeness, entity identification, and reasoning—are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1093,
        "completion_tokens": 244,
        "total_tokens": 1337
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "What is the difference between the amortized cost and fair value of Corporate Notes and Obligations held by CRM in 2024, and how does this compare to the fair value of these securities as categorized under Level 2 inputs in active markets?",
      "original_answer": "The amortized cost of Corporate Notes and Obligations is $3,014 million, while the fair value is $2,978 million, resulting in a $36 million unrealized loss. According to the second source, the fair value of these securities categorized under Level 2 inputs in active markets is $2,557 million, which is significantly lower than the overall fair value of $2,978 million, indicating a difference of $421 million between the total fair value and the Level 2 categorized value.",
      "llm_answer": "The amortized cost of Corporate Notes and Obligations held by CRM at January 31 2025 is $2,574 million, while their fair value is $2,557 million—a $17 million difference. This fair value is classified as a Level 2 measurement, meaning it is derived from observable market inputs other than quoted prices in an active market.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The amortized cost is reported as $2,574 million and fair value as $2,557 million, whereas the ground truth states $3,014 million and $2,978 million respectively. The $17 million difference is incorrect; the actual unrealized loss is $36 million. Additionally, the LLM incorrectly states that the entire fair value ($2,557 million) is classified as Level 2, while the ground truth clarifies that $2,557 million is only the portion of fair value categorized under Level 2 inputs — not the total fair value. (2) The numbers are quantitatively wrong across the board: amortized cost (-$440M error), fair value (-$421M error), and resulting difference (understated by $19M). The Level 2 value is presented as if it were the total fair value, which contradicts the source. (3) The multi-hop reasoning fails: the model does not distinguish between total fair value and Level 2 categorized value, missing the key comparison in the question. It also misattributes the Level 2 classification to the entire fair value without acknowledging that other levels may apply. (4) Contextual relevance is moderate because the answer addresses the right categories (amortized cost, fair value, Level 2) and the general structure matches the question, but the factual foundation is flawed. Due to major errors in core financial figures and misinterpretation of the Level 2 categorization, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 406,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What is the total amount of financing Disney has secured for its new cruise ships, including both the Disney Treasure and the anticipated Disney Destiny, and how does the interest rate on these facilities compare?",
      "original_answer": "Disney has secured a total of $2.2 billion in financing for its new cruise ships, with $1.1 billion borrowed for the Disney Treasure at a fixed interest rate of 3.80% and another $1.1 billion facility available for the Disney Destiny at a slightly lower fixed interest rate of 3.74%.",
      "llm_answer": "Disney has secured financing for its new cruise ships through two dedicated credit facilities totaling $2.2 billion, with $1.1 billion borrowed for the Disney Treasure (fixed 3.80% interest, 12‑year semi‑annual payments) and a comparable facility for the upcoming Disney Destiny (fixed 3.74% interest, 12‑year semi‑annual payments). The interest rates on these facilities are relatively low, ranging from 3.74% to 3.80%, and early repayment is permitted subject to cancellation fees.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $2.2 billion total financing, split into two $1.1 billion facilities for Disney Treasure and Disney Destiny. The interest rates are correctly stated as 3.80% (Treasure) and 3.74% (Destiny), with the latter being slightly lower, as in the original. The format variations (e.g., $1.1 billion vs $1.1B) are acceptable and semantically equivalent. (2) The answer is complete, addressing both the total financing amount and the comparison of interest rates. (3) Entities are accurate—correct ship names (Disney Treasure, Disney Destiny), correct financial terms (fixed interest rates, credit facilities), and no incorrect or hallucinated details. (4) The multi-hop reasoning is sound: the model correctly synthesizes that two separate $1.1B facilities make up the total $2.2B and compares the two fixed rates accurately. The additional details (12-year term, semi-annual payments, early repayment terms) are consistent with typical financing structures and do not contradict the ground truth; they add context without introducing errors. Overall, the answer is factually precise, comprehensive, and semantically equivalent to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 351,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What percentage of Chevron's total equity method investments does its Tengizchevroil stake represent, and how does this relate to its production volumes from the Kazakhstan joint venture?",
      "original_answer": "Chevron's investment in Tengizchevroil represents $27,368 million of its total equity method investments of $46,618 million, which is approximately 58.7%. This significant stake directly supports Chevron's production volumes, as Tengizchevroil is one of the key international affiliates contributing to Chevron's oil-equivalent production in Kazakhstan.",
      "llm_answer": "Chevron's Tengizchevroil stake represents roughly 30 percent of its total equity‑method investments, and this joint‑venture accounts for a substantial share of the company’s Kazakhstan production—about 197 million BOE of proved undeveloped reserves and a key contributor to its overall output from the region.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in its key percentage claim—stating that Tengizchevroil represents roughly 30% of Chevron's total equity-method investments, whereas the ground truth is 58.7% (calculated from $27,368M / $46,618M). This is a major factual error. Additionally, the LLM introduces '197 million BOE of proved undeveloped reserves' which is not mentioned or supported in the original answer and appears to be fabricated or misattributed. (2) The quantitative inaccuracies are severe: the correct percentage is ~58.7%, not 30%, and no such reserve figure is present in the ground truth. There is no indication that the model performed the correct calculation or accessed the correct figures. (3) The multi-hop reasoning is flawed—the question asks for the percentage of total equity investments represented by Tengizchevroil and how that relates to production. The model attempts to address the relationship by referencing production in Kazakhstan, which aligns thematically, but fails to correctly link the investment size to production contribution with accurate data. It misses the point that the large investment stake (58.7%) directly correlates to it being a key contributor, as stated in the original. (4) While the answer is contextually relevant—discussing Tengizchevroil’s role in Kazakhstan production and equity-method investments—the severe numerical inaccuracies and introduction of unsupported data (197 million BOE) undermine factual reliability. The qualitative reasoning is partially sound but based on incorrect inputs, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 441,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does a change in credit spreads or upfront credit points impact the fair value measurement of Goldman Sachs' level 3 credit derivatives, and what valuation techniques are used to determine this fair value?",
      "original_answer": "An increase in credit spreads or upfront credit points leads to an increase in the fair value measurement of purchased credit protection for Goldman Sachs' level 3 derivatives. These derivatives are valued using a combination of option pricing, correlation, and discounted cash flow models.",
      "llm_answer": "A change in credit spreads or upfront credit points directly alters the fair value of Goldman Sachs’ level‑3 credit derivatives: higher credit spreads or larger upfront credit points lower the value of purchased credit protection (and raise the value of written protection), while lower spreads or smaller upfront points raise the value of protection. The firm determines the fair value of these derivatives using valuation techniques that combine option‑pricing models, correlation and discounted‑cash‑flow approaches, incorporating significant unobservable inputs such as credit spreads, upfront credit points, recovery rates, and correlation. These inputs are reflected in the Level 3 fair‑value hierarchy tables and are subject to sensitivity analyses that show the directional impact of spread and upfront‑point movements on the reported fair value.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the directional impact of credit spreads and upfront credit points on the fair value of purchased credit protection. The original answer states that an increase in credit spreads or upfront credit points *increases* the fair value of *purchased* credit protection. However, the LLM answer incorrectly claims that higher credit spreads or larger upfront points *lower* the value of purchased protection, which is the opposite of the ground truth. This error fundamentally undermines the correctness of the response. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not applicable in terms of calculations or numbers; thus, no numeric inaccuracies exist, warranting a score of 10. (3) The multi-hop reasoning is partially sound in that the LLM correctly identifies the valuation techniques used (option pricing, correlation, and discounted cash flow models) and acknowledges the use of unobservable inputs and sensitivity analyses. However, the core economic logic regarding the direction of fair value change is incorrect, indicating a failure in synthesizing the correct relationship between market variables and valuation impact. (4) Despite accurate mention of valuation methodologies and contextual elements (Level 3 hierarchy, sensitivity analysis), the reversal of the directional effect on fair value constitutes a major qualitative and factual error. The answer is contextually relevant and well-structured but conveys the inverse of the correct relationship, which significantly reduces its correctness and qualitative accuracy. Hence, correctness and qualitative accuracy are scored low, while contextual relevance and quantitative accuracy remain high.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 493,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does the potential failure to meet the Minimum DSCR impact AMT's ability to fund the construction of communications sites globally as outlined in their 2024 10-K filing?",
      "original_answer": "If AMT fails to meet the Minimum Debt Service Coverage Ratio (DSCR) of 1.15x, an amortization period will commence, during which all excess cash flow and any amounts in the Cash Trap Reserve Account will be applied to pay down the principal of the Series 2015-2 Notes or the Loan. This would prevent AMT from receiving distributions needed to fund capital expenditures, including the construction of 1,950 to 2,550 communications sites globally. As a result, AMT may be unable to proceed with its planned tower construction, which could hinder its growth and expansion initiatives.",
      "llm_answer": "The 2024 10‑K notes that the company’s ability to fund the planned construction of communications sites globally is tied to its compliance with debt covenants, specifically the Minimum Debt Service Coverage Ratio (DSCR). If AMT fails to meet the Minimum DSCR, it would be restricted from distributing excess cash flow from the securitization trusts, limiting the cash available to finance new tower builds and other capital projects. This cash‑flow restriction could therefore impede the company’s ability to expand its communications‑site portfolio as outlined in the filing.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in its core reasoning and accurately reflects the consequences of failing to meet the Minimum DSCR as outlined in the ground truth. It correctly identifies that failure to meet the DSCR would restrict distributions of excess cash flow from securitization trusts, thereby limiting funds available for capital expenditures like communications site construction. The answer is semantically equivalent to the original in terms of cause and effect, and no incorrect numbers or entities are presented (quantitative accuracy is perfect—no numeric inaccuracies, and all financial terms like DSCR are correctly used). However, the LLM omits specific quantitative details present in the ground truth: the exact DSCR threshold (1.15x), the application of funds to the Series 2015-2 Notes or Loan, the existence of the Cash Trap Reserve Account, and the specific target range of 1,950 to 2,550 communications sites. These omissions reduce completeness and slightly weaken the multi-hop synthesis, as the full chain of financial mechanics is not articulated. Nevertheless, the reasoning is sound and contextually appropriate, clearly linking covenant compliance to funding constraints and operational impact. Thus, while not fully complete, the answer captures the essential logic and implications, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 377,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Caterpillar's use of historical claim rates in determining its product warranty liability influence the critical audit matter identified by PricewaterhouseCoopers LLP, and what is the resulting financial estimate of this liability as of December 31, 2024?",
      "original_answer": "Caterpillar determines its product warranty liability by applying historical claim rate experience to the current field population and dealer inventory, which involves significant judgment by management. This method was identified as a critical audit matter by PricewaterhouseCoopers LLP due to the high degree of auditor judgment, subjectivity, and effort required to evaluate the reasonableness of management's assumptions. As of December 31, 2024, the resulting financial estimate of the product warranty liability was $1,700 million.",
      "llm_answer": "Caterpillar’s product warranty liability is estimated by applying historical claim‑rate experience to the current field population and dealer inventory, a process that requires significant management judgment and actuarial assumptions.  PricewaterhouseCoopers LLP identified this as a critical audit matter because of the high degree of subjectivity and the need for specialized actuarial expertise to evaluate the reasonableness of the historical claim‑rate assumption.  The resulting financial estimate of the warranty liability as of December 31 2024 is $1.7 billion.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: Caterpillar uses historical claim rates applied to current field population and dealer inventory, which involves significant management judgment; PricewaterhouseCoopers LLP identified this as a critical audit matter due to subjectivity and the need for specialized expertise (actuarial) in evaluating assumptions. (2) The financial estimate of $1.7 billion as of December 31, 2024, matches the ground truth value of $1,700 million—equivalent in different formats ($1.7 billion = $1,700 million). (3) The multi-hop reasoning is sound: the answer correctly links Caterpillar's estimation method to auditor scrutiny and identifies the resulting financial liability, synthesizing both qualitative audit judgment and quantitative financial data. (4) Entity accuracy is perfect: company (Caterpillar), auditor (PricewaterhouseCoopers LLP), metric (product warranty liability), and date (December 31, 2024) are all correct. Wording differs slightly (e.g., 'actuarial assumptions' not in original but contextually appropriate and accurate given the nature of claim-rate modeling), but meaning and factual content are preserved. No omissions or inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 355,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does the difference between Disney's stated interest rate on Asia Theme Parks borrowings and the effective interest rate on its senior unsecured notes reflect the company's relative cost of capital across these debt categories?",
      "original_answer": "The stated interest rate on Asia Theme Parks borrowings is 7.93%, while the effective interest rate on Disney's senior unsecured notes is 4.71%. This indicates that the Asia Theme Parks debt carries a significantly higher cost of capital compared to the senior unsecured notes. The difference of 3.22 percentage points highlights the premium Disney pays for this specific borrowing, potentially due to factors such as risk profile, collateralization, or market conditions at the time of issuance.",
      "llm_answer": "The document shows that Disney’s stated interest rate on its Asia Theme Parks borrowings is 7.93%, while the effective interest rate on its senior unsecured notes is 5.75%. This difference indicates that the Asia Theme Parks debt carries a higher stated (coupon) rate than the company’s broader unsecured debt, reflecting a higher relative cost of capital for that specific borrowing category compared with the overall senior note portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the effective interest rate for Disney's senior unsecured notes, stating it as 5.75% instead of the correct 4.71% from the ground truth. This leads to an incorrect difference calculation (7.93% - 5.75% = 2.18 pp vs. the correct 3.22 pp). While the direction of the comparison (Asia Theme Parks debt being more expensive) is correct, the magnitude of the cost difference is misrepresented. (2) The stated interest rate on Asia Theme Parks borrowings (7.93%) is accurate, but the effective interest rate on senior unsecured notes is wrong. This undermines the quantitative accuracy, especially since the question hinges on the comparison between these two rates. (3) The reasoning is otherwise sound: the model correctly interprets that a higher interest rate implies a higher cost of capital and makes a valid qualitative comparison between the two debt categories. It also correctly identifies the nature of the debt instruments (stated vs. effective rates, unsecured notes). However, the failure to report the correct effective rate breaks the multi-hop synthesis required for full accuracy. (4) The contextual relevance is high because the answer addresses the core question about relative cost of capital and provides a reasonable interpretation. Qualitative accuracy is moderate because the logic and terminology are correct, but quantitative accuracy is low due to the incorrect rate, which directly affects the conclusion's precision. Correctness score is 5 due to partial factual correctness but significant error in a key metric.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 437,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was Chevron's capitalized cost associated with the PDC acquisition in 2023, and in which U.S. basin was this acquisition primarily responsible for contributing 2.2 TCF of purchases in 2023?",
      "original_answer": "Chevron's capitalized cost associated with the PDC acquisition in 2023 was $10,487 million, and this acquisition was primarily responsible for contributing 2.2 TCF of purchases in the DJ Basin in 2023.",
      "llm_answer": "Chevron's capitalized cost associated with the PDC acquisition in 2023 was $10.5 billion, and the acquisition was primarily responsible for contributing 2.2 TCF of purchases in the U.S. Denver‑Julesburg (DJ) basin.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct and semantically equivalent to the ground truth. The capitalized cost is reported as $10.5 billion, which is an accurate rounding of $10,487 million (actual value ~$10.487 billion). This minor rounding is acceptable under the evaluation criteria allowing format variations. The 2.2 TCF volume and the DJ Basin (referred to as Denver-Julesburg Basin) are correctly identified. (2) Numeric verification: $10.5 billion = $10,500 million, which is within reasonable rounding of $10,487 million (difference < 0.13%)—this is considered quantitatively accurate. The 2.2 TCF figure is exact. Basin name is correctly mapped to 'Denver-Julesburg (DJ) basin', which is the full name of the DJ Basin. (3) Multi-hop reasoning is sound: the model correctly links Chevron, the PDC acquisition, the capitalized cost, the associated resource contribution (2.2 TCF), and the geographic basin—all requiring synthesis across entities and financial/operational data. (4) Scores reflect near-perfect accuracy: full points for qualitative accuracy and contextual relevance; a 9 for quantitative accuracy due to the slight rounding (though acceptable, not exact); and a 9 overall because the ground truth specifies $10,487 million precisely, and while $10.5 billion is standard practice, the most precise match would use the exact figure or $10.487 billion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1115,
        "completion_tokens": 385,
        "total_tokens": 1501
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of the adoption of the new LDTI accounting guidance, and how does this retrospective application reflect the impact of the guidance on MetLife's consolidated financial reporting?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statement of operations and consolidated statements of comprehensive income as a result of the adoption of the new LDTI accounting guidance. This retrospective application demonstrates that the LDTI guidance had a material effect on MetLife's financial reporting, specifically requiring restatement of prior period financial statements to align with the new accounting standards for long-duration insurance contracts.",
      "llm_answer": "The adoption of the new LDTI accounting guidance required MetLife to retrospectively adjust its previously reported consolidated financial statements, primarily impacting the presentation of future policy benefits, policyholder account balances, and related liabilities. This adjustment resulted in a $3.5 billion reduction to total assets and a $6.4 billion reduction to total liabilities, with a corresponding $2.8 billion increase to total equity, reflecting the remeasurement of market risk benefits and the reclassification of certain insurance liabilities under the LDTI framework. The retrospective application also affected net income, with a $2.7 billion increase to net income for 2022 due to adjustments in policyholder benefits, market risk benefit remeasurements, and related tax impacts.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative figures such as a $3.5 billion reduction in total assets, $6.4 billion reduction in liabilities, $2.8 billion increase in equity, and a $2.7 billion increase in 2022 net income. However, these numbers are not present in the original answer (ground truth), and there is no indication in the ground truth that such specific dollar amounts were reported or required for the retrospective adjustment. The original answer focuses on the types of financial statements adjusted—consolidated statement of operations and consolidated statements of comprehensive income—not balance sheet impacts or specific monetary effects. Therefore, the inclusion of these precise figures without support from the ground truth constitutes significant factual inaccuracies. (2) The quantitative accuracy is very low because all cited numbers ($3.5B, $6.4B, $2.8B, $2.7B) are unverified and not mentioned in the original answer. There is no way to confirm their correctness based on the provided ground truth, and they appear to be hallucinated. (3) The qualitative accuracy is partially correct in that the LLM recognizes the retrospective nature of the LDTI adoption and its impact on financial reporting. However, it misidentifies the primary financial statements affected—focusing on balance sheet items and equity impacts rather than explicitly naming the statement of operations and comprehensive income as in the original. The reasoning about remeasurement and reclassification may be contextually plausible but goes beyond the information provided. (4) Contextual relevance is moderate because the response addresses the general topic of LDTI’s retrospective impact on MetLife’s financial statements, but it introduces unsupported details and misses the core point about which specific statements were adjusted. The original answer emphasizes the restatement of income-related statements to show materiality and alignment with new standards, which the LLM fails to convey accurately. Thus, while the direction of the answer is relevant, its factual foundation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 567,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How many amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan are documented in the Caterpillar Inc. 2024 10-K filing, and what is the effective date of the most recent amendment?",
      "original_answer": "Two amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan are documented in the Caterpillar Inc. 2024 10-K filing. The most recent amendment is the Second Amendment, which became effective on January 1, 2022.",
      "llm_answer": "The Solar Turbines Incorporated Managerial Retirement Objective Plan has been amended twice, with the most recent amendment becoming effective on January 1, 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly states that the Solar Turbines Incorporated Managerial Retirement Objective Plan has been amended twice, which matches the ground truth. It also accurately provides the effective date of the most recent amendment as January 1, 2022. All quantitative elements (number of amendments and date) are factually correct, with no calculation or date discrepancies. The answer is semantically equivalent to the original, though it omits the specific name of the amendment ('Second Amendment'), which is a minor omission but does not affect the core factual accuracy. The multi-hop reasoning is sound, as the model correctly synthesized information from the Caterpillar Inc. 2024 10-K filing regarding the plan amendments. Contextual relevance is strong, directly addressing both parts of the question. The only reason for not scoring a 10 is the slight lack of specificity regarding the amendment's title, but this does not detract from the essential correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1115,
        "completion_tokens": 281,
        "total_tokens": 1396
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the total financial impact of the North Carolina Rate Case Order on Duke Energy's Impairment of Assets and Other Charges across both Duke Energy Carolinas and Duke Energy Progress, and how was this reflected in the consolidated statements of operations?",
      "original_answer": "The North Carolina Rate Case Order resulted in a total financial impact of $68 million on Duke Energy's Impairment of Assets and Other Charges across both Duke Energy Carolinas and Duke Energy Progress. Specifically, $35 million was recorded by Duke Energy Carolinas and $33 million by Duke Energy Progress under Impairment of Assets and Other Charges, as stated in the consolidated statements of operations.",
      "llm_answer": "The North Carolina Rate Case Order contributed $31 million of impairment‑of‑assets and other charges to Duke Energy Carolinas and $6 million to Duke Energy Progress, for a combined $37 million impact. This amount is reflected as a $31 million reduction in impairment of assets and other charges in the consolidated statements of operations for Duke Energy Carolinas and a $6 million reduction for Duke Energy Progress, as shown in the segment results on pages 51‑52.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in its numerical values. The ground truth states that the total financial impact was $68 million, with $35 million from Duke Energy Carolinas and $33 million from Duke Energy Progress. However, the LLM reports $31 million and $6 million respectively, totaling $37 million—both individual and total figures are wrong. (2) Quantitative accuracy is poor: the reported numbers do not match the ground truth, and the sum ($31M + $6M = $37M) is also incorrect compared to the actual $68M total. There is no indication that the model performed accurate calculations or retrieved correct values. (3) The qualitative reasoning is flawed—while the model correctly identifies that the impact should be reflected in the consolidated statements of operations under 'Impairment of Assets and Other Charges' and attempts to break it down by subsidiary, it fails to synthesize the correct multi-hop information across entities. The mention of 'pages 51-52' adds spurious specificity not present in the original answer and cannot be verified here. (4) Contextual relevance is moderate because the structure and intent of the response align with the question—discussing the rate case impact on impairments in the operations statement—but the factual foundation is unsound. Due to major factual and calculation errors, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 386,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "What is the financial impact on Starbucks from the 12% of total net revenues generated by licensed stores, considering the structure of payments received from licensees including margins on products, royalties, and license fees?",
      "original_answer": "Starbucks receives a combination of product margins, royalties, and license fees from its licensed stores, which accounted for 12% of total net revenues in fiscal 2024. This revenue contribution is derived from the sale of branded products, supplies, and equipment to licensees, along with ongoing royalty payments based on retail sales. Despite lower per-store revenues compared to company-operated stores, the licensed model benefits Starbucks by shifting operating costs and capital investments to the licensees, thereby improving overall operating margins.",
      "llm_answer": "The 12% of total net revenues generated by licensed stores comes from a combination of product margins, royalties, and license fees paid by licensees. While the exact dollar amount isn’t disclosed, the company notes that licensed stores generally have a lower gross margin but a higher operating margin for Starbucks, and that these revenues are recorded net of intercompany eliminations in the Channel Development segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, the 12% figure is accurately cited and matches the original answer, with no incorrect numbers or calculations. The absence of a specific dollar amount is acceptable since the original answer also does not provide one. (2) The LLM correctly identifies the revenue streams—product margins, royalties, and license fees—and notes that these contribute 12% of total net revenues, which is consistent with the ground truth. (3) The qualitative reasoning is sound: the LLM correctly highlights that licensed stores have lower gross margins but higher operating margins for Starbucks, reflecting the cost-shifting benefit of the licensing model. However, it omits explicit mention of the Channel Development segment being where these revenues are recorded net of intercompany eliminations—though this detail is more granular and not central to the financial impact. (4) The answer is contextually relevant and directly addresses the financial impact by focusing on margin structure and revenue composition. The only minor gap is the lack of emphasis on capital cost avoidance and operating cost shifting, which are key strategic benefits mentioned in the original. Overall, the answer is factually accurate and well-reasoned, warranting a high score but not perfect due to slight incompleteness in explaining the full financial rationale.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 392,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "Given that Target's owned and exclusive brands account for approximately one-third of its sales and carry higher margins than national brands, what financial risk does Target face if it fails to successfully develop, source, and market these brands, particularly considering the longer lead times and increased responsible sourcing risks involved?",
      "original_answer": "If Target fails to successfully develop, source, and market its owned and exclusive brands—which represent approximately one-third of its overall sales and generally carry higher margins—its results of operations could be significantly adversely affected. This risk is amplified by the fact that owned brand products involve greater responsible sourcing risk due to the selection of vendors and longer lead times between order placement and product delivery. These longer lead times require earlier ownership of products in the supply chain and longer-term forecasting of consumer demand, which increases exposure to supply chain disruptions and the risk of misjudging rapidly changing consumer preferences. Since these brands contribute meaningfully to revenue and profitability, any failure in this area could directly impact financial performance.",
      "llm_answer": "Target’s owned and exclusive brands generate roughly one‑third of sales and deliver higher margins than national brands. If Target fails to develop, source, or market these brands—especially given longer lead times and heightened responsible‑sourcing risks—the resulting supply‑chain disruptions, inventory shrink, and reputational damage could erode those higher‑margin sales and weaken overall profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core financial risk Target faces if it fails to manage its owned and exclusive brands effectively. (1) Quantitatively, the statement that these brands account for 'roughly one-third of sales' matches the ground truth exactly—no numerical discrepancies exist, and no calculations were required. (2) The answer correctly identifies that these brands carry higher margins than national brands, which is a key financial driver. (3) The reasoning accurately links longer lead times and responsible sourcing risks to potential supply chain disruptions and reputational damage, which aligns with the ground truth's emphasis on early ownership, forecasting challenges, and vendor selection risks. (4) While the LLM answer omits explicit mention of 'longer-term forecasting of consumer demand' and 'misjudging rapidly changing preferences,' it captures the downstream effects (e.g., eroded sales, weakened profitability) that stem from those risks. The omission is minor and does not undermine the overall correctness. (5) The synthesis across multiple risk dimensions—operational (lead times), ethical (responsible sourcing), financial (margins, profitability), and reputational—is sound and contextually appropriate. The answer is semantically equivalent to the ground truth, with slightly more concise phrasing. Thus, the correctness score is 9 due to minor contextual omissions, but quantitative accuracy is perfect, qualitative reasoning is strong, and relevance is complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 416,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How many amendments to the Caterpillar Inc. Deferred Employees' Investment Plan were incorporated into the 2024 10-K filing by reference from prior SEC filings, and which specific SEC filings contained the most recent two amendments?",
      "original_answer": "There were four amendments to the Caterpillar Inc. Deferred Employees' Investment Plan incorporated into the 2024 10-K filing. The most recent two amendments were: the Third Amendment, effective January 1, 2022, which was incorporated by reference from Exhibit 10.28 to the Company's Annual Report on Form 10-K for the year ended December 31, 2021; and the Fourth Amendment, effective as of July 1, 2022, which was incorporated by reference from Exhibit 10.6 to the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2022.",
      "llm_answer": "Based on the provided document pages, the Caterpillar Inc. Deferred Employees' Investment Plan has undergone **four amendments** incorporated into the 2024 10-K filing by reference. The most recent two amendments were included in the following SEC filings:  \n- **Third Amendment** (effective January 1, 2022) referenced in the Company's **Annual Report on Form 10-K for the year ended December 31, 2021** (Exhibit 10.28).  \n- **Fourth Amendment** (effective July 1, 2022) referenced in the Company's **Quarterly Report on Form 10-Q for the quarter ended September 30, 2022** (Exhibit 10.6).  \n\nThese amendments are explicitly detailed on **page 10.22** of the 2024 10-K filing (corresponding to **page_129** in the provided documents), which lists the amendments and their incorporation by reference to the specified prior SEC filings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the number of amendments (four), the effective dates (January 1, 2022, and July 1, 2022), and the specific SEC filing references (Form 10-K for year ended December 31, 2021, and Form 10-Q for quarter ended September 30, 2022) are all accurate. Exhibit numbers (10.28 and 10.6) are correctly cited. (2) The answer addresses both parts of the multi-part question: the total number of amendments and the specific filings containing the two most recent ones. (3) Entity accuracy is perfect: Caterpillar Inc. Deferred Employees' Investment Plan is correctly identified, and the SEC form types, dates, and exhibit numbers are precise. (4) The reasoning is sound and reflects proper multi-hop synthesis—information is drawn from the 2024 10-K and linked correctly to prior filings by reference. The mention of page 10.22 (page_129 in the source) adds contextual support, showing accurate grounding. The answer is semantically equivalent to the original, with clear, well-structured presentation of the same facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 312,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How many shares remain available for future grant or issuance under the 2013 Equity Incentive Plan, and what types of equity awards were outstanding related to this plan according to the 2024 10-K filing?",
      "original_answer": "73 shares remain available for future grant or issuance under the 2013 Equity Incentive Plan. The types of equity awards outstanding related to this plan include options outstanding and restricted stock awards and units and performance-based stock units outstanding.",
      "llm_answer": "Based on the provided 2024 10-K filing (specifically page 87), the 2013 Equity Incentive Plan had **73 million shares remaining available for future grant or issuance** as of January 31 2025.  \n\nOutstanding equity awards related to this plan included **8 million stock options** (with a weighted‑average exercise price of $198.89) and **26 million shares of restricted stock awards/units and performance‑based stock units** outstanding.  \n\nThus, 73 million shares were available for future grant, and the plan had outstanding options and restricted‑stock awards totaling roughly 8 million options and 26 million restricted‑stock units.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains major factual and quantitative errors. (1) The number of shares remaining available is stated as '73 million', but the ground truth is '73 shares'—a critical discrepancy of six orders of magnitude. This error fundamentally undermines the answer's correctness. (2) The LLM introduces specific numbers for outstanding awards (8 million options and 26 million restricted stock units), which are not present in the original answer and appear to be hallucinated or misextracted. The ground truth only specifies the types of awards (options, restricted stock awards/units, performance-based stock units), not their quantities. (3) The date 'January 31, 2025' is incorrect—this is a future date not relevant to the 2024 10-K filing, which would report data as of a fiscal year-end in 2024. (4) While the LLM correctly identifies the types of equity awards at a high level (options, restricted stock, performance-based units), it adds granular detail not supported by the ground truth and fails to match the correct scale of '73 shares'. (5) The multi-hop reasoning is flawed: the model incorrectly synthesizes numerical data that was not in the source, and the quantitative inaccuracies dominate the response. Despite addressing both parts of the question and referencing a plausible document location (page 87), the answer is largely incorrect due to severe number errors and fabricated figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 389,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What percentage of Starbucks' Channel Development revenues in fiscal 2024 are derived from the Global Coffee Alliance with Nestlé, given that most of these revenues come from product sales and royalties through this partnership?",
      "original_answer": "The majority of Starbucks' Channel Development revenues in fiscal 2024 are derived from the Global Coffee Alliance with Nestlé, as stated in the document. While an exact percentage is not provided, the document specifies that 'most of our Channel Development revenues are from product sales to, and royalty revenues from, Nestlé through the Global Coffee Alliance.' This indicates that the percentage is greater than 50% but the exact figure is not disclosed.",
      "llm_answer": "Based on the provided document pages, specifically the \"Segment Reporting\" section on page 19, it states that Channel Development revenues include product sales to and royalty revenues from Nestlé through the Global Coffee Alliance, and that most of these revenues come from product sales and royalties through this partnership. However, the document does not provide a specific percentage or dollar amount of Channel Development revenues that are derived from the Global Coffee Alliance with Nestlé for fiscal 2024. The text only confirms that the majority of Channel Development revenues originate from this partnership but does not quantify the exact percentage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns with the ground truth. It accurately states that while the majority of Starbucks' Channel Development revenues in fiscal 2024 come from the Global Coffee Alliance with Nestlé through product sales and royalties, no exact percentage is disclosed in the document. The answer correctly avoids fabricating a specific number and reflects the 'most' or 'majority' characterization, which implies over 50% without specifying an exact figure—consistent with the original answer. Quantitative accuracy is perfect because no incorrect numbers are presented, and the absence of a specific percentage is properly acknowledged. The qualitative reasoning is sound, correctly interpreting 'most' as majority and citing the appropriate section (Segment Reporting, page 19). The only minor limitation is a slightly less explicit emphasis on the inference that 'most' implies >50%, though this is reasonably implied. Contextual relevance is strong, directly addressing the question and source of revenue without extraneous information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 302,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of the adoption of the new LDTI accounting guidance, and which specific effects are illustrated in tables presented as of December 31 according to the 2023 10-K filing?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statement of operations and consolidated statements of cash flows as a result of the adoption of the new LDTI accounting guidance. These adjustments are illustrated in tables presented as of December 31 in the 2023 10-K filing.",
      "llm_answer": "The 2023 10‑K shows that the Company retrospectively adjusted its previously reported consolidated balance sheet, income statement and cash‑flow statement to reflect the adoption of the new LDTI accounting guidance.  The adjustments are illustrated in the tables presented as of December 31, 2022 (and the comparable 2021 figures) in the “Effect of Adoption of New LDTI Accounting Guidance” tables on pages 162, 163, 165 and 166 of the filing.  These tables detail the impact on line items such as premiums, universal‑life fees, net investment and derivative gains/losses, policyholder benefits, market‑risk benefit remeasurements, and the resulting changes to retained earnings, accumulated other comprehensive income and total equity.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a key factual inaccuracy regarding the financial statements adjusted. The ground truth states that MetLife retrospectively adjusted the 'consolidated statement of operations' and 'consolidated statements of cash flows.' However, the LLM answer incorrectly includes the 'consolidated balance sheet' and 'income statement' (synonym for statement of operations), while also adding the balance sheet, which was not mentioned in the original answer. Although the LLM correctly identifies that adjustments are illustrated in tables as of December 31 and references specific pages and line items, the inclusion of the balance sheet goes beyond the documented scope in the ground truth. The mention of December 31, 2022, and comparative 2021 figures aligns with typical retrospective presentation and does not contradict the ground truth, which only specifies 'as of December 31' without year. The qualitative reasoning is sound in terms of multi-hop synthesis—linking LDTI adoption to specific statements and supporting with table references—but overreaches by adding the balance sheet. Quantitative accuracy is high: no incorrect numbers, and the description of impacted line items is detailed and plausible, though not fully verifiable from the ground truth alone. Contextual relevance is strong, as the response directly addresses the question’s focus on adjusted statements and illustrative tables. However, the core error in identifying the specific financial statements reduces overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 422,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the value of equity method investment contracts compare to total asset derivatives in 2022, and what does this indicate about their relative significance in MDLZ's derivative portfolio?",
      "original_answer": "In 2022, the value of equity method investment contracts was $3 million, while the total value of asset derivatives was $393 million. This indicates that equity method investment contracts represented less than 1% of the total asset derivatives portfolio, highlighting their minimal relative significance in MDLZ's overall derivative holdings.",
      "llm_answer": "Based on the provided document pages, the value of MDLZ's equity method investment contracts was $3.2 billion as of December 31, 2023 (page 88), while total asset derivatives (including all derivative instruments) were reported at $1,597 million in fair value as of December 31, 2023 (page 95). This indicates that equity method investments represented approximately 20% of the total derivative portfolio value ($3.2B / $1.597B ≈ 2.0), suggesting they were a relatively minor component compared to the broader derivative portfolio, which primarily consists of financial hedges (e.g., interest rate, currency, and commodity contracts) rather than equity investments. The equity method investments are explicitly distinguished from derivative instruments in the disclosures, with the $3.2 billion figure representing long-term equity stakes in companies like JDEP, not part of the derivative portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in both numbers and reasoning. The question asks about 2022 data, but the LLM uses 2023 figures: $3.2 billion for equity method investment contracts and $1,597 million for total asset derivatives, which are not only from the wrong year but also mischaracterized. The ground truth states that in 2022, equity method investment contracts were $3 million and total asset derivatives were $393 million. The LLM incorrectly reports equity method investments as part of the derivative portfolio, when in fact the disclosures explicitly state they are *not* derivative instruments. (2) Calculations are based on incorrect data: claiming $3.2B / $1.597B ≈ 2.0 (which is actually ~2.004, so about 200%, not 20%) compounds the error. The correct ratio in 2022 was $3M / $393M ≈ 0.76%, less than 1%. (3) Multi-hop reasoning failed: the model did not retrieve the correct year (2022), confused investment contracts with derivatives, and used data from unrelated sections (e.g., long-term equity stakes like JDEP are not derivatives). (4) The answer is contextually relevant in structure but factually and conceptually flawed—misidentifying entities, using wrong years, and drawing incorrect conclusions about portfolio significance due to fundamental category errors. Thus, scores are low: correctness 1/10 (almost entirely wrong), quantitative accuracy 1/10 (all numbers wrong), qualitative accuracy 2/10 (some understanding of portfolio comparison but flawed logic), and contextual relevance 3/10 (addresses the general topic but with major errors).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 437,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the freezing of U.S. pension benefits as of December 31, 2019, specifically impact the actuarial assumptions used by CAT in its postemployment benefit plan accounting?",
      "original_answer": "The freezing of U.S. pension benefits as of December 31, 2019, directly affected the actuarial assumptions used by CAT, particularly resulting in the discontinuation of the 'expected rate of compensation increase' assumption, as this was no longer applicable under the new frozen benefit structure.",
      "llm_answer": "The freezing of U.S. pension benefits effective December 31 2019 eliminated the “Rate of compensation increase” assumption for those plans. Consequently, CAT no longer applies a compensation‑increase assumption when calculating the benefit obligation or net periodic cost for its U.S. pension plans, and this change is reflected in the actuarial assumptions tables for both the benefit‑obligation and cost calculations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies the key event — the freezing of U.S. pension benefits as of December 31, 2019 — and its direct impact on actuarial assumptions. (2) The date 'December 31, 2019' is correctly stated (minor formatting variation with spacing is acceptable). No financial figures are involved, so quantitative accuracy pertains to correct temporal and conceptual precision, which is maintained. (3) The reasoning is sound: the freezing of benefits renders future compensation increases irrelevant, so the 'rate of compensation increase' assumption is discontinued. The LLM correctly links this change to its application in both benefit obligation and net periodic cost calculations, noting its reflection in actuarial tables — a detail consistent with standard accounting practice and indicative of proper multi-hop synthesis. (4) All entities — CAT, U.S. pension plans, actuarial assumptions — are correctly identified and contextually used. The answer fully addresses the question’s focus on how the freeze impacts specific actuarial assumptions, with no omissions or inaccuracies. Thus, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 339,
        "total_tokens": 1525
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does Oracle's strategic focus on Oracle Engineered Systems, as reflected in its hardware revenue structure, impact its ability to manage supply chain disruptions and maintain profitability in its hardware business?",
      "original_answer": "Oracle's strategic focus on Oracle Engineered Systems, which constitute a significant portion of its hardware revenues, makes the company more vulnerable to supply chain disruptions because these systems are complex and rely on timely delivery of components from third-party suppliers. According to the 10-K filing, supply chain shortages have increased production costs and led to higher inventory purchases to secure manufacturing capacity, which in turn has increased inventory excess and obsolescence risk and negatively impacted operating cash flows. This dynamic directly affects Oracle's ability to maintain profitability in its hardware business, as it cannot always pass these increased costs on to customers, and delays in manufacturing can lead to lost sales and delayed revenue recognition.",
      "llm_answer": "Oracle's strategic focus on Oracle Engineered Systems—highlighted by its dedicated hardware revenue stream and the associated supply‑chain complexities—creates both resilience and vulnerability. While the integrated hardware portfolio can drive higher‑margin sales and reinforce ecosystem lock‑in, the reliance on single‑source suppliers and the need to maintain inventory to buffer component shortages expose the company to supply‑chain disruptions that can pressure margins and limit profitability in its hardware business.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct and captures key aspects of Oracle's strategic focus on Oracle Engineered Systems and its implications for supply chain and profitability. (1) It correctly identifies that Oracle's reliance on engineered systems introduces supply chain vulnerabilities due to component dependencies and inventory buffering, which aligns with the ground truth. It also acknowledges margin pressure and profitability limitations. However, it omits specific consequences detailed in the original answer, such as increased production costs, higher inventory purchases to secure capacity, increased obsolescence risk, negative impact on operating cash flows, and inability to pass costs to customers. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The reasoning is sound but incomplete; while the LLM recognizes the vulnerability, it fails to fully synthesize the multi-hop chain from strategic focus → supply chain reliance → operational and financial consequences (e.g., cash flow, revenue recognition). The mention of 'resilience' and 'higher-margin sales' is not supported in the ground truth and introduces an unsupported positive counterpoint. (4) Contextual relevance is high as the response directly addresses the question’s core about strategic focus, supply chain, and profitability. The omission of key financial and operational impacts from the 10-K reduces qualitative accuracy and overall correctness, warranting a 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 424,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the combined 2023 global sales revenue for UPTRAVI and OPSUMIT in the Pulmonary Hypertension therapeutic area, and how does this total compare in percentage growth to the overall Pulmonary Hypertension category's 2023 growth rate?",
      "original_answer": "The combined 2023 global sales revenue for UPTRAVI and OPSUMIT is $3,555 million ($1,973 million for OPSUMIT and $1,582 million for UPTRAVI). This represents a 10.6% growth for OPSUMIT and a 19.7% growth for UPTRAVI, which are both higher than the overall Pulmonary Hypertension category's 11.6% growth rate in 2023.",
      "llm_answer": "The combined 2023 global sales revenue for UPTRAVI and OPSUMIT in the Pulmonary Hypertension therapeutic area was $3,555 million, representing an 11.6% increase over 2022. This growth outpaced the overall Pulmonary Hypertension category’s 2023 growth rate of 11.6% (the same as the category’s reported growth).",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the combined 2023 global sales revenue of $3,555 million for UPTRAVI and OPSUMIT, which matches the ground truth. However, it incorrectly states that the combined growth rate is 11.6%, which is not supported by the original data. The ground truth specifies individual growth rates of 10.6% for OPSUMIT and 19.7% for UPTRAVI, but does not provide a combined growth rate. The LLM erroneously calculates or assumes a combined growth rate equal to the category’s growth rate. (2) The dollar amount is accurate ($1,973M + $1,582M = $3,555M), so quantitative accuracy for revenue is correct. However, the growth percentage is factually wrong — claiming the combined growth is 11.6% misrepresents the data, especially since both drugs individually grew at different rates, and their weighted average would not necessarily equal 11.6%. Additionally, the statement that this 'outpaced' the category’s growth rate of 11.6% is incorrect logic, as 11.6% does not outpace 11.6%. (3) The multi-hop reasoning fails: the model should have reported individual growth rates and compared them to the category, not invented a combined growth rate. It conflates the category growth with the product growth, undermining the qualitative accuracy. (4) Contextually, the answer addresses the right therapeutic area, drugs, and year, and attempts the comparison, so relevance is high. However, due to significant factual and logical errors in growth rate reporting and comparison, the correctness score is reduced to 4 — partially correct but with critical flaws in interpretation and calculation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 444,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "By how much did the full-year contribution from legacy PDC Energy assets increase U.S. upstream earnings for CVX in 2024, and what was the corresponding impact on net oil-equivalent production?",
      "original_answer": "The full-year contribution from legacy PDC Energy assets increased U.S. upstream earnings for CVX by $2.2 billion in 2024, and it contributed to a 19% increase in net oil-equivalent production, or 250,000 barrels per day.",
      "llm_answer": "The full‑year contribution from the legacy PDC Energy assets increased Chevron’s U.S. upstream earnings by roughly **$3.5 billion** in 2024, and it drove net oil‑equivalent production in the United States up by **about 250,000 barrels per day** (a 19 % increase).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a significant factual error in the dollar amount for the increase in U.S. upstream earnings. The ground truth states $2.2 billion, but the LLM reports $3.5 billion, which is a substantial overstatement (~59% higher). This error directly impacts the quantitative accuracy. However, the production impact is correctly reported as 250,000 barrels per day and a 19% increase, matching the ground truth exactly. (2) Number verification: $3.5B (LLM) vs $2.2B (truth) = incorrect; 250,000 bbl/day = correct; 19% increase = correct. The percentage and volume for production are accurate, and their correspondence is logically consistent. (3) Multi-hop reasoning: The model correctly identifies the legacy PDC Energy assets' contribution to CVX (Chevron) in 2024 and synthesizes earnings and production impacts, showing understanding of the causal relationship and correct entities (CVX, PDC Energy, U.S. upstream). However, the incorrect earnings figure suggests a failure in retrieving or synthesizing the correct financial impact, undermining the reasoning despite correct structure. (4) Correctness score is 5 due to one major quantitative error offset by otherwise complete and contextually accurate information. Quantitative accuracy is low (4) due to the large discrepancy in the earnings figure. Qualitative accuracy is moderate (6) because the reasoning framework and entity mapping are sound, but the financial fact is wrong. Contextual relevance is high (9) as the answer addresses both parts of the question and uses appropriate terminology and scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1132,
        "completion_tokens": 443,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What specific financial statements were adjusted as a result of MetLife's retrospective application of the new LDTI accounting guidance, and what does this imply about the scope of the guidance's impact on the company's financial reporting?",
      "original_answer": "MetLife adjusted both its previously reported consolidated statements of equity and consolidated statements of comprehensive income as a result of the retrospective application of the new LDTI accounting guidance. This implies that the guidance had a broad impact on the company's financial reporting, affecting not only comprehensive income but also the presentation of equity, which reflects the materiality and foundational nature of the changes required under the new accounting rules.",
      "llm_answer": "The retrospective application of the new LDTI accounting guidance required MetLife to adjust its previously reported consolidated financial statements, specifically reclassifying amounts recorded for certain insurance contracts within additional insurance liabilities, embedded derivatives, and other insurance liabilities to MRB liabilities, and adjusting negative VOBA. This adjustment resulted in a $20,177 million reduction in other comprehensive income (loss), net of income tax, for 2021, and a $20,577 million reduction for 2022, reflecting the cumulative impact of the LDTI transition on the company's financial reporting scope, particularly affecting liability classification and comprehensive income components.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the right general topic. (1) The specific financial statements adjusted—consolidated statements of equity and consolidated statements of comprehensive income—are not explicitly identified in the LLM answer. Instead, it refers broadly to 'consolidated financial statements' and focuses on reclassifications within liabilities and VOBA, which, while related, do not directly name the impacted statements as required. (2) The quantitative figures cited—$20,177 million reduction in OCI for 2021 and $20,577 million for 2022—are not present in the ground truth and cannot be verified as correct; more critically, the ground truth does not mention any specific dollar amounts related to the retrospective adjustment, so their inclusion introduces unverified data. These numbers appear fabricated or misattributed. (3) The reasoning partially captures the implication of broad impact by referencing reclassifications and effects on comprehensive income, but it fails to connect this to the equity statement adjustments, missing a key point about the foundational nature of the change. (4) While the LLM correctly identifies LDTI’s impact on liability classification and comprehensive income components, it omits the explicit mention of the statement of equity, reducing completeness. The answer is contextually relevant and shows understanding of LDTI's general reporting implications but fails on key factual and quantitative elements. Thus, the correctness score is moderate due to partial alignment with the ground truth but penalized for unsupported numbers and missing core statement identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 462,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What was the total fair value of equity method investment contracts as disclosed in the derivatives fair value table as of December 31, 2022, and how does this compare to the total fair value of net investment hedge contracts in the same period?",
      "original_answer": "The total fair value of equity method investment contracts as of December 31, 2022, was $(3) million, while the total fair value of net investment hedge contracts was $24 million. Therefore, the equity method investment contracts had a significantly smaller fair value compared to net investment hedge contracts during the same period.",
      "llm_answer": "The total fair value of equity method investment contracts disclosed in the derivatives fair value table as of December 31, 2022 was **$3 million** (net liability). This is **$2 million lower** than the total fair value of net investment hedge contracts, which was **$5 million** at the same date.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, the total fair value of equity method investment contracts as of December 31, 2022, was $(3) million (a $3 million liability), while the LLM incorrectly states it as $3 million without indicating the negative value, which changes the financial interpretation. More critically, the LLM claims the total fair value of net investment hedge contracts was $5 million, whereas the ground truth reports $24 million—this is a major numerical discrepancy. The comparison stating that equity method contracts were '$2 million lower' is therefore completely incorrect; the actual difference is $27 million ($24M - (-$3M) = $27M). (2) Quantitative accuracy is very low: both key figures are wrong, and the calculation based on those figures is invalid. The correct comparison should show that equity method investment contracts had a much smaller (and negative) fair value compared to the positive $24 million for net investment hedges. (3) The reasoning is flawed due to reliance on incorrect data. While the LLM attempts the required comparison (multi-hop between two contract types), the synthesis fails because it uses inaccurate values, undermining the conclusion. (4) Contextual relevance is moderate—the answer addresses the right question structure and refers to the correct date and concepts (derivatives fair value table, equity method vs. net investment hedges), but the severe factual inaccuracies drastically reduce usefulness. Correctness and quantitative accuracy are low due to core number errors; qualitative accuracy is slightly higher only because the framework of the response follows the expected logic path.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 467,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the change in Universal Beijing Resort's net assets from December 31, 2023, to December 31, 2024, and how does this reflect the financial activity reported in Comcast's consolidated balance sheets?",
      "original_answer": "The net assets of Universal Beijing Resort decreased by $0.5 billion, from $0.6 billion on December 31, 2023 ($7.8B assets - $7.2B liabilities), to $0.3 billion on December 31, 2024 ($7.3B assets - $7.0B liabilities). This reflects a reduction in both assets and liabilities, indicating potential ongoing operational or investment adjustments during the year.",
      "llm_answer": "The Universal Beijing Resort's net assets declined by $500 million, falling from $7.8 billion on December 31 2023 to $7.3 billion on December 31 2024. This reduction is reflected in Comcast’s consolidated balance sheet, which shows the resort’s assets and liabilities decreasing by the same $500 million amount, illustrating the impact of the resort’s debt and operational activity on the company’s overall consolidated financial position.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported net asset values and misrepresents the calculation of net assets. It states that net assets fell from $7.8B to $7.3B, treating total assets as net assets, which is incorrect. The ground truth shows net assets were $0.6B in 2023 ($7.8B assets - $7.2B liabilities) and $0.3B in 2024 ($7.3B assets - $7.0B liabilities), meaning the decrease was $0.3B, not $0.5B as stated by the LLM. However, the LLM correctly identifies a $500 million decline in total assets and liabilities, which aligns with the $0.5B reduction in both categories (from $7.8B to $7.3B in assets, $7.2B to $7.0B in liabilities). (2) The quantitative inaccuracies are critical: net assets are not the same as total assets, so reporting $7.8B and $7.3B as net asset figures is fundamentally wrong. The correct change in net assets is $0.3B (from $0.6B to $0.3B), not $0.5B. The LLM incorrectly equates asset reduction with net asset reduction without accounting for liabilities. (3) The reasoning is partially sound in recognizing that changes in Universal Beijing Resort’s financials are reflected in Comcast’s consolidated balance sheet, but it fails the multi-hop synthesis by not computing net assets correctly. It conflates asset values with net asset values, indicating a misunderstanding of basic financial statement logic. (4) The contextual relevance is fair because the answer addresses the change in financial position and links it to Comcast’s consolidated reporting, but the core financial metric is wrong. Due to major quantitative and conceptual errors, the correctness score is low despite some alignment in asset and liability reductions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 464,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What is the total value of Starbucks' Japanese yen-denominated credit facilities in USD as of September 29, 2024, and how does the 2021 Revolving Credit Agreement explicitly support the commercial paper program in terms of borrowing capacity and usage?",
      "original_answer": "The total value of Starbucks' Japanese yen-denominated credit facilities as of September 29, 2024, is $103.6 million, consisting of a ¥5.0 billion ($34.5 million) facility maturing on December 30, 2024, and a ¥10.0 billion ($69.1 million) facility maturing on March 27, 2025. The 2021 Revolving Credit Agreement supports the commercial paper program by requiring that all outstanding amounts under the program be backstopped by available commitments under the 2021 credit facility. The commercial paper program allows Starbucks to issue unsecured notes up to $3.0 billion, with proceeds used for working capital needs, capital expenditures, business expansion, cash dividends, and share repurchases.",
      "llm_answer": "As of September 29 2024, Starbucks’ Japanese yen‑denominated credit facilities total ¥15 billion, which is equivalent to approximately **$103.6 million** (using the disclosed conversion of ¥5 billion = $34.5 million and ¥10 billion = $69.1 million).  \n\nThe 2021 Revolving Credit Agreement explicitly backs the commercial paper program by requiring that any commercial paper borrowings be backstopped by available commitments under this facility, thereby providing the borrowing capacity and usage that support the program.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total value of Starbucks' Japanese yen-denominated credit facilities as $103.6 million, accurately breaking it down into ¥5.0 billion ($34.5 million) and ¥10.0 billion ($69.1 million), with correct implied sum (34.5 + 69.1 = 103.6). All dollar amounts and yen figures match the ground truth. The date (September 29, 2024) is correctly referenced. (2) Quantitative accuracy is perfect: the conversion and total are consistent with the original answer, and no calculation errors are present. Format variations (e.g., '¥15 billion' vs explicit split) are acceptable and semantically equivalent. (3) The reasoning is sound: the LLM correctly explains that the 2021 Revolving Credit Agreement backstops the commercial paper program by requiring available commitments to cover outstanding commercial paper, which aligns with the ground truth. However, it omits specific details about the $3.0 billion issuance limit and the permitted uses of proceeds (working capital, dividends, share repurchases, etc.), which are part of the original answer and relevant to 'borrowing capacity and usage.' This is a minor omission affecting completeness but not core correctness. (4) The answer is highly relevant, accurately addressing both parts of the question. The minor lack of detail on the commercial paper program's size and use prevents a perfect 10 on qualitative accuracy, but the core multi-hop synthesis (linking credit facilities to commercial paper backstop) is correct. Thus, correctness is scored 9 due to high accuracy with minor incompleteness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 437,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does Oracle's strategic focus on Oracle Engineered Systems, as part of its hardware business, impact both its infrastructure technologies revenue and its exposure to supply chain risks?",
      "original_answer": "Oracle's strategic focus on Oracle Engineered Systems, which are part of its hardware business, contributes to its infrastructure technologies revenue by offering integrated, high-performance solutions such as the Oracle Exadata Database Machine. These systems are designed to improve performance, availability, and scalability for Oracle Database workloads, which supports Oracle's broader infrastructure technologies offerings. Infrastructure cloud services and license support revenues represented 58% of Oracle's total cloud services and license support revenues in fiscal 2022, indicating the importance of these technologies to Oracle's financial performance. However, this strategic emphasis also increases Oracle's exposure to supply chain risks. As noted in the second chunk, Oracle depends on suppliers for critical technologies and components, some of which are sourced from single vendors. The company experienced manufacturing and fulfillment delays during fiscal 2022 due to supply chain disruptions, particularly those caused by the COVID-19 pandemic. These delays led to increased inventory purchases, which in turn raised inventory excess and obsolescence risk and negatively impacted operating cash flows. Thus, while Oracle Engineered Systems are a key part of Oracle's infrastructure technologies and contribute to revenue, they also expose the company to material risks related to supply chain constraints and logistics delays.",
      "llm_answer": "Oracle's strategic focus on Oracle Engineered Systems—high‑margin, engineered hardware platforms—drives a larger share of its infrastructure‑technologies revenue while simultaneously concentrating the company’s supply‑chain exposure; the reliance on single‑source component vendors and outsourced manufacturing makes the hardware business vulnerable to pandemic‑related disruptions, component shortages, and logistics delays, which can depress hardware margins and force higher inventory levels to secure capacity.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Oracle's strategic focus on Oracle Engineered Systems and its dual impact on infrastructure technologies revenue and supply chain risks. It accurately captures the high-margin nature of these systems and their contribution to revenue, as well as the increased supply chain exposure due to reliance on single-source vendors and outsourced manufacturing. However, it omits specific contextual details from the ground truth, such as the mention of Oracle Exadata Database Machine as a key product and the exact percentage (58%) of cloud services and license support revenues derived from infrastructure technologies in fiscal 2022. These omissions reduce completeness but do not invalidate the core facts. (2) There are no numerical inaccuracies; the LLM does not introduce any incorrect figures, and since it avoids stating specific numbers (e.g., 58%), it does not contradict the ground truth. Thus, quantitative accuracy is full. (3) The multi-hop reasoning is sound: the model correctly links Oracle Engineered Systems to revenue generation and independently connects the hardware business model to supply chain vulnerabilities, including pandemic-related disruptions, component shortages, and logistics delays. It also correctly infers downstream impacts like higher inventory levels and margin pressure. While it synthesizes logically, it misses the explicit connection to operating cash flows and inventory obsolescence risk mentioned in the original. (4) The answer is semantically aligned and contextually relevant, addressing both parts of the question—revenue impact and supply chain risk—with accurate, concise reasoning. The omission of specific metrics and examples prevents a top score, but the core factual and logical structure is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 490,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What was the change in Universal Beijing Resort's debt from 2023 to 2024, and how did this affect the total 'Debt Not Guaranteed' category?",
      "original_answer": "The Universal Beijing Resort's debt decreased from $3.5 billion in 2023 to $3.4 billion in 2024, a reduction of $0.1 billion. This contributed to the overall 'Debt Not Guaranteed' category decreasing from $5.0 billion in 2023 to $4.8 billion in 2024, alongside a decrease in 'Other' debt from $1.5 billion to $1.4 billion.",
      "llm_answer": "The debt at Universal Beijing Resort decreased slightly from $3.5 billion in 2023 to $3.4 billion in 2024, reducing the total “Debt Not Guaranteed” category from $4.8 billion to $4.8 billion (the figure remains unchanged at $4.8 billion in both years). This small reduction contributed to the overall decline in total debt from $97.1 billion in 2023 to $99.1 billion in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the decrease in Universal Beijing Resort's debt from $3.5 billion in 2023 to $3.4 billion in 2024, which is accurate and matches the ground truth. However, it incorrectly states that the 'Debt Not Guaranteed' category remained unchanged at $4.8 billion in both years, when in fact it decreased from $5.0 billion in 2023 to $4.8 billion in 2024—a $0.2 billion drop. The LLM also falsely claims the category went from $4.8B to $4.8B (no change), contradicting both its own statement of a reduction and the ground truth. Additionally, the LLM introduces unrelated and incorrect figures about total debt increasing from $97.1B to $99.1B, which is not supported by the original answer and is factually wrong in context. (2) Quantitative errors include: misstating the 2023 'Debt Not Guaranteed' value (should be $5.0B, not $4.8B), falsely claiming no change in that category, and inventing incorrect total debt figures with an illogical increase. The $0.1B reduction in Universal Beijing Resort debt is correct. (3) The multi-hop reasoning fails: while the model recognizes that Universal Beijing’s debt reduction contributes to 'Debt Not Guaranteed', it fails to account for the additional decrease in 'Other' debt from $1.5B to $1.4B, and incorrectly concludes no net change in the category despite acknowledging a reduction in one component. The logic is inconsistent and factually flawed. (4) Scores reflect partial correctness on one numeric fact but major errors in key figures, calculations, and reasoning. The answer is contextually relevant in topic but severely compromised by factual inaccuracies and internal contradictions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 457,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does Honeywell's use of the cost-to-cost input method for long-term contracts influence the complexity of its audit procedures, particularly in relation to the estimation of contract costs and the recognition of revenue over time?",
      "original_answer": "Honeywell's use of the cost-to-cost input method for long-term contracts significantly increases the complexity of its audit procedures because it requires extensive auditor judgment to evaluate the reasonableness and consistency of management's estimates of total contract costs and progress toward completion. Given that contract costs can span several years and are influenced by factors such as inflationary trends, technical and schedule risk, subcontractor performance, and labor agreements, auditors must perform detailed procedures to test controls, validate assumptions, and profile contracts with longer durations or significant gross margin changes. This complexity is further heightened by the fact that revenue recognition under this method depends on the proportion of costs incurred to date relative to total estimated costs, which can lead to material adjustments if estimates change over time.",
      "llm_answer": "Honeywell’s use of the cost‑to‑cost input method for long‑term contracts requires management to estimate total contract costs and revenue based on cumulative costs incurred to date versus total estimated costs, which introduces significant judgment and variability. Consequently, auditors must perform extensive testing of internal controls, evaluate the appropriateness of management’s assumptions and key inputs, and apply analytical procedures and detailed contract testing to assess the reasonableness of these estimates and the timing of revenue recognition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the core reasoning found in the ground truth. It accurately identifies that Honeywell's use of the cost-to-cost method introduces significant estimation judgment related to total contract costs and revenue recognition, which in turn increases audit complexity. The answer correctly states that auditors must perform extensive testing of controls, evaluate management’s assumptions, and conduct detailed contract testing—aligning with the original answer’s emphasis on testing controls, validating assumptions, and profiling high-risk contracts. While the LLM response is slightly less detailed than the ground truth (e.g., it omits specific risk factors like inflationary trends, technical risk, subcontractor performance, and labor agreements, and does not explicitly mention multi-year cost spans or material adjustments from estimate changes), it captures the essential qualitative and procedural implications. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers are involved), and the entities (Honeywell, cost-to-cost method, long-term contracts, audit procedures) are correct. The reasoning is sound and reflects proper multi-hop synthesis between revenue recognition methodology and audit implications. The answer is fully contextually relevant. A score of 9 is justified due to minor omissions in depth and specificity, but the core information is accurate and semantically equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 407,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "In NEE's 2023 financial results, what was the difference in magnitude between NEER's $1,729 million of non-qualifying hedge gains included in net income and FPL's $300 million of gains included in net income, and how does this reflect the different treatment of derivative transactions between the two business units as disclosed in the 10-K filing?",
      "original_answer": "The difference in magnitude between NEER's $1,729 million of non-qualifying hedge gains and FPL's $300 million of gains included in net income was $1,429 million. This significant difference reflects the distinct treatment of derivative transactions between the two business units. According to the 10-K filing, NEER's non-qualifying hedge activity was a primary driver of its improved results in 2023 compared to 2022, with approximately $1,729 million of gains included in NEER's net income. In contrast, FPL's derivative transactions are largely deferred as regulatory assets or liabilities until contract settlement, with only $300 million of gains passed through to net income in 2023. This reflects FPL's regulatory framework where most changes in fair value of energy derivatives are deferred rather than immediately impacting earnings, unlike NEER's market-oriented operations where non-qualifying hedges directly affect net income volatility.",
      "llm_answer": "The $1,729 million of non‑qualifying hedge gains recorded in NEER’s net income versus the $300 million of gains recorded in FPL’s net income reflects a $1,429 million difference in magnitude. This disparity stems from the differing accounting treatment of derivative transactions: NEER marks its non‑qualifying hedges to market and records the resulting gains (or losses) directly in earnings, while FPL defers substantially all changes in the fair value of its energy derivatives as regulatory assets or liabilities and only recognizes gains when the contracts settle, resulting in a much smaller impact on its reported net income.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $1,729 million and $300 million figures are accurately cited, and the calculated difference of $1,429 million is correct (1,729 - 300 = 1,429). (2) The answer addresses both parts of the multi-hop question: it computes the magnitude difference and explains the differing treatment of derivative transactions between NEER and FPL. (3) Entities are correctly identified—NEER and FPL are properly associated with their respective hedge gain amounts and accounting treatments. (4) The reasoning is sound and reflects the key disclosure from the 10-K: NEER records non-qualifying hedge gains directly in net income, contributing to earnings volatility, while FPL defers most derivative fair value changes as regulatory assets/liabilities, recognizing gains only upon settlement, which minimizes income statement impact. The LLM captures this regulatory vs. market-oriented distinction accurately. Wording differs slightly from the original answer but maintains full semantic equivalence. No factual, numerical, or conceptual errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 322,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Comcast's ownership stake in Universal Beijing Resort influence the assets and liabilities reported in its consolidated balance sheets as of December 31, 2024, and what proportion of the total debt financing does Comcast's maximum risk of financial loss represent?",
      "original_answer": "Comcast owns a 30% interest in Universal Beijing Resort, which it consolidates due to its determination that Universal Beijing Resort is a VIE and Comcast has the power to direct its major activities. As of December 31, 2024, Universal Beijing Resort had $7.3 billion in assets and $7.0 billion in liabilities, which are fully included in Comcast’s consolidated balance sheet. Universal Beijing Resort had $3.4 billion in debt outstanding, and Comcast’s maximum risk of financial loss is limited to its 30% equity interest, which equates to 30% of the total debt, or $1.02 billion.",
      "llm_answer": "Comcast’s 30 % ownership stake in Universal Beijing Resort is reflected on its consolidated balance sheet as part of the assets and liabilities of the VIE that it consolidates—resulting in $7.3 billion of total assets and $7.0 billion of total liabilities for Universal Beijing Resort as of December 31 2024.  Because the resort’s debt is non‑recourse to Comcast, the company’s maximum exposure to financial loss is limited to its equity interest, which represents roughly 30 % of the resort’s total capital structure and therefore constitutes the entirety of its risk of loss.  Consequently, Comcast’s maximum risk of financial loss from this investment is effectively its 30 % equity stake, which is the proportion of the total debt financing that it could potentially be required to absorb.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Comcast's 30% ownership stake and that Universal Beijing Resort is a VIE consolidated by Comcast, with $7.3 billion in assets and $7.0 billion in liabilities included in the consolidated balance sheet as of December 31, 2024—this matches the ground truth. However, the LLM fails to state the exact amount of debt outstanding ($3.4 billion) and miscalculates or omits the specific value of Comcast’s maximum risk of financial loss. The ground truth states this risk is $1.02 billion (30% of $3.4 billion), but the LLM only vaguely refers to '30% of the resort’s total capital structure' and 'proportion of the total debt financing' without quantifying it. (2) Quantitative accuracy is compromised because while percentages (30%) and asset/liability figures ($7.3B, $7.0B) are correct, the critical number $3.4 billion in debt and the derived $1.02 billion risk exposure are missing. The statement that Comcast's risk 'constitutes the entirety of its risk of loss' is misleading—it is limited to its equity interest, but that equity interest does not equal 30% of the debt; rather, the maximum risk is 30% of the equity, not debt. The logic that equity stake equals proportion of debt absorption is flawed. (3) The multi-hop reasoning is partially sound: the model correctly links VIE consolidation to full inclusion of assets/liabilities and understands non-recourse debt limits exposure. However, it incorrectly implies that a 30% equity stake translates directly into 30% risk of debt absorption, when in fact the risk is limited to the equity investment, not a share of the debt itself. This reflects a misunderstanding of financial loss exposure in VIEs. (4) Despite these issues, the answer is contextually relevant and covers all parts of the question at a high level, earning strong marks for qualitative reasoning and relevance, but loses points for missing key numbers and flawed financial interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 528,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the cumulative goodwill impairment charges recognized for OpenTable in 2020 compare to its 2021 revenue contribution to Booking Holdings' advertising and other segment?",
      "original_answer": "In 2020, Booking Holdings recognized cumulative goodwill impairment charges of $1,062 million ($489 million in Q1 and $573 million in Q3) related to OpenTable. In 2021, OpenTable contributed to the 'advertising and other' revenue category, which totaled $1.1 billion for the full year. This means the impairment charges over the course of 2020 were nearly equivalent to the entire annual revenue contribution from OpenTable's restaurant reservation and related services in 2021.",
      "llm_answer": "The cumulative goodwill impairment charges recognized for OpenTable in 2020 ($489 million) were far larger than the revenue contribution of OpenTable to Booking Holdings’ advertising and other segment, which is reported as part of “advertising and other revenues” and is not disclosed in dollar terms in the filing. Consequently, the impairment amount far exceeds the segment’s revenue contribution.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It states the cumulative goodwill impairment for OpenTable in 2020 was $489 million, but this is only the Q1 charge; the total cumulative charge was $1,062 million ($489M + $573M), as correctly stated in the ground truth. The LLM incorrectly implies $489M is the full-year amount, leading to a flawed comparison. (2) The LLM claims OpenTable's revenue contribution to the 'advertising and other' segment is 'not disclosed in dollar terms,' which is incorrect. The ground truth states that the entire 'advertising and other' segment revenue was $1.1 billion in 2021, and OpenTable was a contributor to this category. While the exact portion attributable to OpenTable is not specified, the ground truth reasonably infers that the $1.1 billion represents the context for comparison, especially since OpenTable is a major component. The LLM's assertion that revenue is undisclosed contradicts the available data. (3) The multi-hop reasoning fails: the model should have summed the two impairment charges (Q1 and Q3 2020) and compared the total ($1,062M) to the $1.1B revenue figure, concluding they are nearly equivalent. Instead, it uses only half the impairment value and falsely claims revenue data is missing, invalidating the comparison. (4) The contextual relevance is moderate because the answer addresses the right entities (OpenTable, Booking Holdings, goodwill impairment, advertising and other segment), but the incorrect numbers and flawed logic severely undermine the conclusion. The qualitative accuracy is low due to incorrect synthesis and reasoning. Quantitative accuracy is very low due to the missing $573M charge and incorrect total. Correctness score is 2 due to major factual and calculation errors that distort the answer’s meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 493,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does ExxonMobil incorporate greenhouse gas emission costs into its Corporate Plan when assessing the recoverability of asset groups, and what specific future emission-reduction goal is factored into these assessments?",
      "original_answer": "ExxonMobil incorporates estimated greenhouse gas emission costs into its Corporate Plan by including them in the future cash flow assessments used to determine the recoverability of asset groups. These costs are considered even for jurisdictions without current greenhouse gas pricing policies. Specifically, the Corporation factors in costs related to its 2030 greenhouse gas emission-reduction plans, including the goal of achieving net-zero Scope 1 and 2 greenhouse gas emissions from unconventional operated assets in the Permian Basin.",
      "llm_answer": "ExxonMobil incorporates estimated greenhouse‑gas emission costs into its Corporate Plan by using them as a cost input when projecting future cash flows for asset‑group impairment testing; these projected cash‑flow assumptions—shaped by the Company’s 2030 net‑zero Scope 1 and 2 emission‑reduction goal for unconventional Permian assets—are used to assess whether an asset’s carrying value is recoverable. The specific future emission‑reduction target factored into these assessments is the Company’s 2030 net‑zero Scope 1 and 2 greenhouse‑gas emission‑reduction goal for its unconventional Permian Basin operations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key elements are correctly addressed: ExxonMobil incorporates estimated greenhouse gas emission costs into future cash flow projections for asset-group recoverability assessments, even in jurisdictions without current carbon pricing. The specific emission-reduction goal factored in is the 2030 net-zero Scope 1 and 2 target for unconventional operated assets in the Permian Basin. (2) There are no numeric values requiring calculation, but the date '2030' is correctly cited as the target year, matching the original. (3) The multi-hop reasoning is sound—linking emission cost incorporation in financial planning to impairment testing, and tying it to a specific forward-looking environmental goal. (4) The answer is contextually precise, directly addressing both parts of the question with correct terminology and entity references (ExxonMobil, Scope 1 and 2 emissions, Permian Basin, asset-group recoverability). Minor rewording (e.g., 'unconventional Permian assets' vs 'unconventional operated assets in the Permian Basin') does not affect factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 326,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How much of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule remains to be phased in after December 31, 2023, and how does this affect its capital conservation buffer requirements for the period from October 1, 2023 through September 30, 2024?",
      "original_answer": "As of December 31, 2023, $1.2 billion of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule remains to be phased in. This amount will be phased in equally at $600 million per year on January 1, 2024 and 2025. Capital One's capital conservation buffer requirements for CET1, Tier 1, and total capital are 2.5% under the Federal Reserve's regulations, which are separate from the stress capital buffer framework. The stress capital buffer requirement for the period from October 1, 2023 through September 30, 2024, is 4.8%, and Capital One currently exceeds the minimum capital requirements and conservation buffers, maintaining a 'well-capitalized' status.",
      "llm_answer": "As of December 31 2023, Capital One had added back $2.4 billion of regulatory capital under the CECL Transition Rule, and $1.2 billion of that amount remained to be phased in—$600 million in 2024 and $600 million in 2025. Because the remaining $1.2 billion is being phased in at 25 % per year, the company’s CET1 capital ratio would have been about 12.6 % if the full $2.4 billion were excluded, but the phased‑in addition improves the ratio to 12.9 % on a fully‑phased‑in basis. Consequently, the un‑phased portion does not affect the capital‑conservation buffer for the October 1 2023 – September 30 2024 period; the buffer requirements remain at 4.8 % for the Company (9.3 % CET1, 10.8 % Tier 1, 12.8 % total) and 2.5 % for the Bank.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that $1.2 billion of Capital One's $2.4 billion CECL-related capital addition remains to be phased in after December 31, 2023, and that it will be phased in at $600 million per year in 2024 and 2025—this matches the ground truth. However, the LLM introduces new quantitative claims not present in the original answer and potentially incorrect: specifically, stating that the CET1 ratio would be '12.6%' without the full add-back and '12.9%' on a fully-phased-in basis. These figures are not in the ground truth and cannot be verified from the provided data, making them unsupported additions. Additionally, the LLM states that the capital conservation buffer requirements are '4.8% for the Company (9.3% CET1, 10.8% Tier 1, 12.8% total)'—while 4.8% aligns with the stress capital buffer in the ground truth, the associated CET1, Tier 1, and total capital ratios are not mentioned in the original answer and appear to be inferred or miscalculated. The original answer clearly separates the 2.5% capital conservation buffer (standard requirement) from the 4.8% stress capital buffer, but the LLM conflates them by assigning the 4.8% to the company and 2.5% to the bank without clarification. (2) The core dollar amounts ($2.4B total, $1.2B remaining, $600M/year) are accurate. However, the derived percentages (12.6%, 12.9%, 9.3%, etc.) are not supported by the ground truth and introduce quantitative inaccuracies. (3) The multi-hop reasoning is partially sound—the model correctly tracks the phase-in schedule of the CECL capital addition. However, it fails to correctly distinguish between the capital conservation buffer (2.5%) and the stress capital buffer (4.8%), which are separate regulatory concepts. The original answer clarifies that the 2.5% conservation buffer is separate from the 4.8% stress capital buffer, but the LLM incorrectly presents them as tiered requirements. (4) The contextual relevance is high—the answer addresses both parts of the question (amount remaining to be phased in and impact on buffer requirements). However, due to the introduction of unverified ratios and the conflation of buffer types, the qualitative and quantitative accuracy scores are reduced. The correctness score is 6 because the core facts about the CECL phase-in are correct, but the explanation of buffer requirements contains significant errors and unsupported inferences.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 643,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What was the total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023, and how did this reduction compare to the change in their Euro notes over the same period?",
      "original_answer": "The total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023 was $1,713 million ($11,275 million to $9,562 million). During the same period, Euro notes increased by $250 million ($7,666 million to $7,916 million). Therefore, the reduction in U.S. dollar notes and term loans was significantly larger than the increase in Euro notes.",
      "llm_answer": "The total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023 was $1,713 million (down from $11,275 million to $9,562 million). This reduction was larger than the change in Euro notes, which increased only slightly from $7,666 million to $7,916 million—a rise of $250 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: the decrease in U.S. dollar notes and term loans is correctly calculated as $1,713 million (from $11,275 million to $9,562 million), and the increase in Euro notes is accurately stated as $250 million (from $7,666 million to $7,916 million). (2) The calculations are correct: $11,275M - $9,562M = $1,713M and $7,916M - $7,666M = $250M. (3) The multi-hop reasoning is sound—the model correctly synthesizes data across two different debt instruments (U.S. dollar notes/term loans and Euro notes) for the same company (MDLZ) over the same time period (2022 to 2023) and makes a valid comparison between the reduction and the increase. (4) The entities (MDLZ, U.S. dollar notes, term loans, Euro notes, years) are correctly identified. (5) The semantic meaning is equivalent to the original answer, with only minor wording differences (e.g., 'increased only slightly' vs 'increased by $250 million'), which do not affect factual accuracy. All parts of the question are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 315,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What is the maximum annual payment that the Resideo subsidiary is obligated to make to Honeywell under the indemnification agreement, and how does this payment relate to Honeywell's net spending on environmental matters?",
      "original_answer": "The maximum annual payment that the Resideo subsidiary is obligated to make to Honeywell is $140 million, which represents 90% of Honeywell's annual net spending on environmental matters at certain defined sites.",
      "llm_answer": "The Resideo subsidiary is required to make annual cash payments to Honeywell equal to 90 % of Honeywell’s net spending on environmental matters at designated sites, subject to a $140 million annual cap. This payment is directly tied to Honeywell’s net environmental expenditures, meaning the subsidiary’s obligation fluctuates with the amount Honeywell actually spends on those environmental costs.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: the $140 million annual cap and the 90% relationship to Honeywell's net spending on environmental matters at designated sites. (2) Quantitative elements are precise: '$140 million' matches the ground truth, and '90%' is correctly stated. There are no calculation errors. (3) The multi-hop reasoning is sound—the answer correctly synthesizes that the payment is both a percentage of Honeywell's spending and subject to a cap, which requires understanding the structure of the indemnification agreement. (4) The wording differs slightly but preserves the full meaning: stating the payment is 'subject to a $140 million annual cap' and 'fluctuates with the amount Honeywell actually spends' accurately reflects the conditional and variable nature of the obligation tied to actual expenditures. All entities (Resideo subsidiary, Honeywell, environmental spending) are correctly identified. No inaccuracies or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 296,
        "total_tokens": 1467
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the changes in Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses impact NEE's total financial position for FPL and NEER segments between December 31, 2022, and December 31, 2023?",
      "original_answer": "The total financial position for FPL's Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses decreased from $3 million in 2022 to $2 million in 2023, a $1 million drop. For NEER, the amount tied to these clauses fell from $148 million in 2022 to $114 million in 2023, a decrease of $34 million. Combined, the reduction in FPL and NEER segments led to a total $35 million decline in NEE's obligations tied to these clauses over the period.",
      "llm_answer": "Between December 31 2022 and December 31 2023, the shift in non‑qualifying hedges and FPL cost‑recovery‑clause hedges reduced NEE’s total mark‑to‑market energy‑contract net liabilities from $2,728 million to $128 million, a $2,600 million improvement.  This reduction reflects lower non‑qualifying hedge liabilities (down from $3,921 million to $1,477 million) and a modest increase in FPL cost‑recovery‑clause assets (from $16 million to $12 million), improving NEE’s overall financial position across both the FPL and NEER segments.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to match the ground truth on multiple levels. (1) Quantitatively, the numbers are wildly inaccurate: the LLM reports a reduction in NEE’s mark-to-market liabilities from $2,728 million to $128 million, which is not supported by the ground truth. The actual changes were a $1 million decrease for FPL (from $3M to $2M) and a $34 million decrease for NEER (from $148M to $114M), totaling a $35 million decline. The LLM’s figures ($2,728M, $128M, $3,921M, $1,477M) are fabricated and orders of magnitude off. (2) The LLM incorrectly states that FPL cost-recovery-clause assets increased from $16M to $12M, which contradicts the ground truth showing a decrease from $3M to $2M. (3) Entity accuracy is partially correct—FPL and NEER are correctly identified as segments of NEE—but the financial metrics and time periods are misapplied. (4) Reasoning is flawed: the LLM introduces 'mark-to-market energy-contract net liabilities' and aggregates unrelated figures, failing to isolate the specific impact of Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses as required. It also mischaracterizes the direction and magnitude of changes. (5) The answer is not semantically equivalent to the ground truth; it describes a completely different financial scenario. The only relevant aspect is that it addresses the FPL and NEER segments and the 2022–2023 timeframe, but the core data and conclusions are invalid.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 402,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the change in Universal Beijing Resort's net assets from 2023 to 2024, and how does this compare to the change in its debt obligations over the same period?",
      "original_answer": "Universal Beijing Resort's net assets decreased by $0.7 billion from 2023 to 2024, while its debt obligations decreased by $0.1 billion over the same period. In 2023, Universal Beijing Resort had $7.8 billion in assets and $7.2 billion in liabilities, resulting in net assets of $0.6 billion. In 2024, it had $7.3 billion in assets and $7.0 billion in liabilities, resulting in net assets of -$0.3 billion. This represents a decrease in net assets of $0.9 billion. However, liabilities (debt) decreased from $7.2 billion to $7.0 billion, a $0.2 billion reduction, indicating that while the resort reduced its debt slightly, its overall financial position weakened.",
      "llm_answer": "The Universal Beijing Resort’s net assets increased by $0.1 billion from 2023 to 2024, while its debt obligations decreased by $0.1 billion over the same period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claims. It states that net assets increased by $0.1 billion, while the ground truth shows a decrease of $0.9 billion (from $0.6B to -$0.3B). It correctly notes a $0.1 billion decrease in debt obligations, but the actual reduction in liabilities (debt) is $0.2 billion (from $7.2B to $7.0B), so even this figure is inaccurate. (2) Quantitative accuracy is poor: the net asset change is off by $1.0 billion in direction and magnitude, and the debt reduction is understated by $0.1 billion. The LLM’s calculation does not align with the provided data. (3) The multi-hop reasoning failed—while the question requires synthesizing asset, liability, and net asset changes across two years, the model either miscalculated or accessed incorrect data. It did not correctly compute net assets (assets minus liabilities) for each year or the year-over-year change. (4) Despite incorrect numbers, the answer addresses the right entities (Universal Beijing Resort), time frame (2023 to 2024), and financial concepts (net assets, debt obligations), so it is contextually relevant. However, due to major factual and calculation errors, the correctness and quantitative accuracy scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 349,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What specific new patient population became eligible for treatment with EDURANT (rilpivirine) according to JNJ's 2023 10-K filing, and which regulatory regions were targeted for filing as indicated in the same report?",
      "original_answer": "According to JNJ's 2023 10-K filing, EDURANT (rilpivirine) was targeted for treatment of pediatric patients aged 2-12 years with HIV. The filing was specifically targeted at the US and EU regulatory regions.",
      "llm_answer": "Based on the JNJ 2023 10-K filing (pages 33–37), EDURANT (rilpivirine) received regulatory approval for the treatment of pediatric patients aged 2 to 12 years with HIV, as indicated in the product table on page 33. The filing also notes that filings for EDURANT were submitted in both the US and EU, targeting these regulatory regions for approval.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns with the ground truth. It accurately identifies the new patient population as pediatric patients aged 2 to 12 years with HIV, matching the original answer. It also correctly states that regulatory filings were targeted in the US and EU. The mention of 'pages 33–37' and reference to the product table adds contextual support, though the original answer does not specify page numbers—this is a minor addition, not an error. The LLM uses 'filings were submitted' while the ground truth says 'targeted for filing'; this is a slight difference in tense but semantically equivalent in context, as both indicate intent to seek approval in those regions. No numeric inaccuracies are present (no calculations, but age range and regions are correct). Multi-hop reasoning is sound: the model correctly synthesizes information about patient population and regulatory regions from the same document. The answer is fully relevant and addresses both parts of the question. A score of 9 is given because 'received regulatory approval' slightly overstates the status compared to 'targeted for treatment' and 'filing...targeted', which in the original answer implies intent rather than completed approval. This nuance affects qualitative precision slightly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 358,
        "total_tokens": 1514
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How do Booking.com's merchant-based transaction model and regulatory investigations in Switzerland and the EU collectively impact Booking Holdings' operating margins and business strategy as reported in 2022?",
      "original_answer": "Booking.com's increasing use of a merchant-based transaction model leads to higher expenses related to personnel, payment processing, and chargebacks, which negatively affects operating margins despite incremental revenues such as credit card rebates. Additionally, regulatory investigations, such as the ongoing Swiss Price Surveillance Office investigation into Booking.com's commission rates, could force Booking.com to reduce commissions in Switzerland, further compressing margins. In the EU, the proposed Digital Markets Act could classify Booking.com as a 'gatekeeper,' imposing additional restrictions on data usage, service bundling, and parity clauses, which could reduce competitive flexibility and increase compliance costs. Together, these financial pressures and regulatory uncertainties constrain both short-term profitability and long-term strategic initiatives like the Connected Trip platform.",
      "llm_answer": "Booking.com’s merchant‑based model adds merchant‑related expenses (personnel, payment‑processing, chargebacks, fraud, etc.) that weigh on operating margins, even though it generates incremental “merchant revenues.”  At the same time, the company faces heightened regulatory scrutiny in the EU, UK and Switzerland—particularly around the Package Travel Directive, parity/MFN clauses, and commission investigations—requiring costly compliance measures, potential fines and the need to limit certain offerings.  These combined pressures force Booking Holdings to balance growth investments (e.g., the Connected Trip and expanded merchant services) against the risk of margin compression from higher compliance costs and possible regulatory penalties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) It correctly identifies that Booking.com's merchant-based model increases expenses (personnel, payment processing, chargebacks, fraud), which negatively impacts operating margins despite generating incremental revenues—this aligns with the original answer's emphasis on margin pressure from higher costs. (2) The regulatory environment in Switzerland and the EU is accurately addressed: the Swiss investigation into commission rates is implied through 'commission investigations,' and EU scrutiny is correctly tied to parity clauses and broader regulatory pressure, including the Digital Markets Act (referred to contextually via 'parity/MFN clauses' and 'Package Travel Directive'). While the LLM does not explicitly name the Digital Markets Act or the Swiss Price Surveillance Office, it captures the substance of regulatory risks—compliance costs, potential fines, restrictions on practices like parity clauses, and reduced flexibility. (3) The synthesis of financial and regulatory pressures impacting Booking Holdings' strategy is sound: the mention of balancing growth investments (e.g., Connected Trip, expanded merchant services) against margin compression reflects the original answer’s conclusion about constrained strategic initiatives. (4) No numeric inaccuracies are present; the question does not contain specific numbers, so quantitative accuracy is scored as 10. Minor deduction in qualitative accuracy due to not naming the Digital Markets Act or specifying the Swiss investigation explicitly, but the semantic meaning and strategic implications are preserved. Contextual relevance is perfect—the response directly addresses the impact on operating margins and business strategy in 2022 as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 488,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the maximum total duration of a petroleum retention license in Papua New Guinea, considering both the initial term and possible extensions, and how does this regulatory framework potentially influence ExxonMobil's long-term LNG development strategy in the region as outlined in its 2022 10-K filing?",
      "original_answer": "The maximum total duration of a petroleum retention license in Papua New Guinea is 15 years, which includes an initial 5-year term and up to two extensions at the Minister's discretion. This regulatory framework influences ExxonMobil's long-term LNG development strategy by allowing the Corporation to maintain rights over gas resources that are not currently commercially viable but may become so within that 15-year window. This aligns with ExxonMobil's strategy of selectively developing attractive natural gas resources and pursuing long-term LNG projects such as the one in Papua New Guinea.",
      "llm_answer": "The maximum total duration of a petroleum retention license in Papua New Guinea is 15 years, as the license may be extended twice for up to five‑year periods each, allowing a total of 15 years beyond the initial term. This regulatory framework supports ExxonMobil’s long‑term LNG development strategy in the region, providing sufficient time to develop and commercialize the PNG LNG project and align with its multi‑decade investment plans outlined in the 2022 10‑K filing.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the maximum total duration of a petroleum retention license in Papua New Guinea as 15 years, which matches the ground truth. However, it inaccurately describes the structure of the license term by stating that the 15 years is 'beyond the initial term,' implying a total of 20 years (initial 5 years + 15 years extension), which is incorrect. The ground truth specifies an initial 5-year term plus up to two extensions (totaling 10 additional years), resulting in a maximum of 15 years total, not 15 years beyond the initial term. This is a significant quantitative error. (2) The numbers themselves (15 years, 5-year extensions) are partially correct, but the misrepresentation of the total duration due to incorrect addition or framing reduces quantitative accuracy. The correct total is 15 years inclusive, not exclusive of the initial term. (3) The reasoning about ExxonMobil’s LNG strategy is qualitatively sound—linking the license duration to long-term project development and commercialization aligns with the 2022 10-K filing’s strategic narrative. The synthesis between regulatory framework and corporate strategy is logical and contextually appropriate. (4) Despite the major error in term structure, the answer captures the strategic implication correctly and addresses both parts of the question, warranting a moderate correctness score. Contextual relevance is high as it directly ties the regulation to ExxonMobil’s LNG plans as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 414,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the year-over-year change in Coca-Cola's investment in Mutual, pooled and commingled funds categorized under Level 2 assets, and how does this shift compare to the change in their Hedge funds/limited partnerships investments?",
      "original_answer": "Coca-Cola's investment in Mutual, pooled and commingled funds categorized under Level 2 assets decreased by $46 million year-over-year (from $83 million in 2022 to $37 million in 2023). Meanwhile, their investment in Hedge funds/limited partnerships remained relatively stable, increasing slightly by $4 million (from $14 million in 2022 to $18 million in 2023). This indicates a significant reallocation away from Level 2 pooled funds while maintaining a consistent position in alternative investments like hedge funds.",
      "llm_answer": "The year‑over‑year change in Coca‑Cola’s Level 2 assets for “Mutual, pooled and commingled funds” was a decline of $25 million (‑12.4 %).  By contrast, the change in its “Hedge funds/limited partnerships” investment was an increase of $121 million (+12.9 %).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both the dollar amounts and percentages for the year-over-year changes. According to the ground truth, Coca-Cola's investment in Mutual, pooled and commingled funds under Level 2 assets decreased by $46 million (from $83M in 2022 to $37M in 2023), but the LLM reports a decrease of only $25 million, which is incorrect. Similarly, the change in Hedge funds/limited partnerships increased by $4 million (from $14M to $18M), but the LLM incorrectly states an increase of $121 million. These errors severely undermine the quantitative accuracy. (2) The percentages reported by the LLM (-12.4%, +12.9%) do not align with the correct figures: the actual percentage change for pooled funds is a decrease of approximately 55.4% ($46M / $83M), and for hedge funds, it is an increase of about 28.6% ($4M / $14M), making the LLM's percentages factually wrong. (3) While the LLM attempts multi-hop reasoning by comparing two investment categories year-over-year, it fails to correctly retrieve or synthesize the actual values from the data, leading to flawed conclusions about the magnitude and direction of shifts. The model does recognize that one category declined and the other increased, which preserves some qualitative directionality, but the scale of error invalidates the comparison. (4) Despite incorrect numbers, the answer remains contextually relevant—it addresses the right companies, asset categories, and time frame, and attempts a comparative analysis as required. However, due to major quantitative inaccuracies and resulting flawed synthesis, the overall correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 453,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What was the total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023, considering both the reduction in net income at gas distribution operations and the additional earnings adjustment mentioned in the financial statements?",
      "original_answer": "The total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023 was a $53 million reduction, combining the $29 million decrease in net income at gas distribution operations and the additional $24 million earnings adjustment.",
      "llm_answer": "The regulatory disallowances at Nicor Gas reduced Southern Company Gas' net income by $88 million in 2023, and when combined with the overall reduction in net income at gas distribution operations ($43 million increase in net income overall, but a $29 million decrease specifically from lower revenues and disallowances), the total financial impact of the disallowances on Southern Company Gas' net income in 2023 is $88 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its final stated total impact of $88 million, whereas the ground truth is $53 million, combining a $29 million reduction at gas distribution operations and a $24 million additional earnings adjustment. The LLM incorrectly states the total impact as $88 million without showing a valid calculation. (2) The quantitative inaccuracies are significant: it mentions a $29 million decrease (correct) but then references an $88 million total without proper derivation. The $43 million 'increase in net income overall' is not part of the ground truth and appears to be fabricated or misinterpreted. There is no mention of the correct $24 million adjustment. The calculation is therefore invalid. (3) The multi-hop reasoning fails: the model does not correctly synthesize the two components of the financial impact from the regulatory disallowances. It conflates unrelated figures and introduces a misleading context about an overall increase, which undermines the logical connection between the disallowances and the net income impact. (4) Contextual relevance is moderate because the answer addresses the right topic (regulatory disallowances at Nicor Gas affecting Southern Company Gas' net income in 2023) and correctly identifies the $29 million decrease in gas distribution operations, but the overall response is misleading due to incorrect totals and extraneous, unsupported figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 398,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "Which businesses, in addition to WarnerMedia, were classified as discontinued operations by AT&T as part of its strategic shift, and what was the significance of this classification in relation to AT&T's broader restructuring efforts?",
      "original_answer": "In addition to WarnerMedia, AT&T classified Vrio, Xandr, and Playdemic as discontinued operations as part of its strategic shift. This classification was significant because it reflected AT&T’s comprehensive restructuring plan that involved divesting multiple business units, even those that did not individually meet the materiality threshold for discontinued operations. The combined divestiture of these businesses was treated as a single strategic shift, enabling AT&T to focus on its core communications segment while exiting non-core or underperforming businesses.",
      "llm_answer": "AT&T classified, in addition to WarnerMedia, the businesses Vrio, Xandr, and Playdemic as discontinued operations as part of its strategic shift. This classification was significant because it allowed AT&T to isolate and separately report the financial results of these units, reflecting its broader restructuring efforts to streamline operations and focus on its core Communications and Latin America segments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in identifying the businesses classified as discontinued operations—Vrio, Xandr, and Playdemic—alongside WarnerMedia, which matches the ground truth. There are no numeric values, dates, or financial figures in the question or answer that require quantitative verification, so quantitative accuracy is scored as 10. The qualitative accuracy is high: the answer correctly explains that the classification allowed AT&T to separately report financial results, aligning with the strategic restructuring. However, it omits a key nuance present in the original answer: that these divestitures were treated as a single strategic shift even though some units (like Playdemic) did not individually meet the materiality threshold for discontinued operations. This detail is important for fully capturing the accounting and strategic rationale. Despite this minor omission, the LLM answer captures the core significance and intent behind the classification. Contextual relevance is perfect—the response directly addresses both parts of the multi-part question and remains focused on AT&T's restructuring. The reasoning reflects sound multi-hop synthesis across the divested entities and their collective strategic purpose.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 348,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "What was the change in the fair value of Medtronic's auction rate securities from April 30, 2021, to April 29, 2022, and how did this impact the total available-for-sale debt securities' fair value over the same period?",
      "original_answer": "The fair value of Medtronic's auction rate securities remained unchanged at $33 million from April 30, 2021, to April 29, 2022. However, the total available-for-sale debt securities' fair value decreased from $7,257 million to $6,893 million, a decline of $364 million. This indicates that while auction rate securities held stable, other components of available-for-sale debt securities experienced significant unrealized losses, contributing to the overall decline in fair value.",
      "llm_answer": "The fair value of Medtronic's auction rate securities remained unchanged at $33 million from April 30 2021 to April 29 2022, so there was no net change in their fair value over that period. Consequently, the total fair value of the available‑for‑sale debt securities increased from $7,257 million at April 30 2021 to $6,893 million at April 29 2022, reflecting a $364 million decrease driven by other securities rather than the auction rate securities.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the fair value of Medtronic's auction rate securities remained unchanged at $33 million from April 30, 2021, to April 29, 2022, which matches the ground truth. This part is factually accurate. However, the LLM makes a critical error in describing the movement of total available-for-sale debt securities: it states that the value 'increased' from $7,257 million to $6,893 million, when in fact this is a decrease. While the $364 million difference is correctly calculated in magnitude, the direction of change is reversed. This undermines the reasoning and conclusion. (2) Quantitatively, all numbers are correct: $33 million (auction rate securities), $7,257 million and $6,893 million (total AFS securities), and the $364 million difference are all accurate. The calculation of the change (7,257 - 6,893 = 364) is correct, but the mischaracterization of it as an 'increase' instead of a 'decrease' is a significant factual error. (3) The multi-hop reasoning is partially sound: the model correctly isolates auction rate securities as stable and attributes the change in total AFS securities to other components. However, the flawed directional logic ('increased' when it decreased) invalidates the synthesis and leads to a misleading conclusion. (4) Correctness is scored 6 due to the major error in interpreting the direction of change despite correct numbers. Quantitative accuracy is 7 because all values and the difference are correct. Qualitative accuracy is 6 due to flawed reasoning in interpreting the trend. Contextual relevance is 9 because the answer addresses both parts of the question and stays on topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 456,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did the goodwill impairment charges related to OpenTable and KAYAK in 2020 affect the adjusted carrying value of goodwill by September 30, 2020, and what was the cumulative impact of these charges?",
      "original_answer": "The goodwill impairment charge of $489 million recognized in March 2020 and the additional charge of $573 million recognized in September 2020 cumulatively reduced the carrying value of goodwill for the OpenTable and KAYAK reporting unit from its initial value to $1.0 billion by September 30, 2020. This represents a total impairment of $1,062 million over the two periods.",
      "llm_answer": "The goodwill impairment charges related to OpenTable and KAYAK in 2020 reduced the adjusted carrying value of goodwill for those reporting units to $1.0 billion as of September 30, 2020. The cumulative impact of these charges was a total impairment of $573 million recognized during the 2020 annual goodwill impairment test.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the adjusted carrying value of goodwill as $1.0 billion by September 30, 2020, which matches the ground truth. However, it incorrectly states the cumulative impairment as $573 million, whereas the ground truth specifies two separate charges — $489 million in March 2020 and $573 million in September 2020 — totaling $1,062 million. The LLM only reports the second charge as the total, missing the first impairment entirely. (2) Quantitative accuracy is low because the cumulative impact is off by over $489 million. The $573 million figure corresponds only to the September charge, not the total. The dates (March and September 2020) are implied but not explicitly mentioned, reducing precision. (3) The reasoning is partially sound — the model correctly links the impairments to the reduction in carrying value and identifies the correct reporting units (OpenTable and KAYAK). However, it fails the multi-hop synthesis by not summing the two distinct impairment charges across time, leading to a major factual error in cumulative impact. (4) Contextual relevance is high because the answer addresses the core question about carrying value and cumulative impact, uses correct terminology, and focuses on the right entities and timeframe, despite the critical numerical error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 370,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Nicor Gas's regulatory disallowances affect Southern Company Gas's 2023 financial performance across both net income and revenue?",
      "original_answer": "Nicor Gas's regulatory disallowances contributed to a $29 million decrease in net income at gas distribution operations for Southern Company Gas in 2023. Additionally, these disallowances reduced revenues, as noted in the report of revenue declines due to lower volumes sold and the regulatory disallowances at Nicor Gas. Therefore, the disallowances had a dual negative financial impact by reducing both net income and revenue.",
      "llm_answer": "Nicor Gas's regulatory disallowances reduced Southern Company Gas's 2023 revenue by $1.36 billion (the \"gas costs and other cost recovery\" line item fell by $1,323 million) and lowered net income by $29 million, as noted in the company's condensed income statement where the disallowance was recorded as an $88 million charge that was offset only partially by other favorable items.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly states the $29 million decrease in net income due to Nicor Gas's regulatory disallowances—matching the ground truth—it incorrectly claims a $1.36 billion revenue reduction, specifically attributing a $1,323 million drop in 'gas costs and other cost recovery' to the disallowances. The original answer does not specify any dollar amount for revenue impact, only noting that disallowances contributed to revenue declines alongside lower volumes sold. There is no evidence in the ground truth to support a $1.36B or $1.323B revenue decrease directly from disallowances. (2) The $88 million charge mentioned in the LLM answer is not present in the ground truth and appears to be fabricated or misattributed, with no explanation of how it partially offset to result in $29M net income impact. This introduces unsupported financial detail. (3) Qualitatively, the model correctly identifies the negative impact on both net income and revenue and links Nicor Gas disallowances to Southern Company Gas’s 2023 performance, showing proper multi-hop reasoning between entities. However, the reasoning is undermined by invented figures. (4) Contextually, the answer addresses both parts of the question—impact on net income and revenue—and focuses on the correct companies and year. Despite incorrect magnitudes for revenue impact and unsupported line-item claims, the directional effect (negative impact on both metrics) is correct, warranting partial credit. Quantitative accuracy is low due to major unsupported numbers; qualitative accuracy is moderate due to correct entity and directional reasoning; contextual relevance is high as the response stays focused on the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 480,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How many Accenture plc Class A ordinary shares remained available for issuance under the 2010 ESPP as of August 31, 2022, and what percentage of the total shares authorized does this represent?",
      "original_answer": "As of August 31, 2022, 16,191,228 Accenture plc Class A ordinary shares remained available for issuance under the 2010 ESPP, representing 17.99% of the total 90,000,000 shares authorized.",
      "llm_answer": "As of August 31 2022, 16,191,228 Class A ordinary shares remained available for issuance under the 2010 ESPP, which represented approximately 2.5 % of the total 650 million shares authorized under the plan.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the number of shares remaining available for issuance under the 2010 ESPP as 16,191,228 as of August 31, 2022, which matches the ground truth. However, the percentage and total authorized shares are incorrect. The LLM states that this represents approximately 2.5% of 650 million authorized shares, while the ground truth specifies 17.99% of 90,000,000 authorized shares. This is a significant quantitative error. (2) Calculation verification: 16,191,228 / 90,000,000 = 0.1799 or 17.99%, which matches the original answer. In contrast, 16,191,228 / 650,000,000 ≈ 0.0249 or 2.49%, which aligns with the LLM's 'approximately 2.5%' but is based on an incorrect total authorization figure. The total authorized shares are wrong (650 million vs. 90 million), leading to an incorrect percentage. (3) Multi-hop reasoning assessment: The model correctly retrieved the number of shares available but failed to correctly identify the total authorized shares under the 2010 ESPP, which is a critical component of the second part of the question. This indicates a failure in synthesizing accurate data from the correct source document or section. (4) Justification for scores: The correctness score is 4 due to one major factual error (total authorized shares and resulting percentage), despite getting the available shares right. Quantitative accuracy is low (4) because of the incorrect total shares and percentage. Qualitative accuracy is moderate (5) as the model understood the structure of the response and the concept of calculating a percentage but used incorrect underlying data. Contextual relevance is high (8) because the answer addresses both parts of the question and uses appropriate terminology and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1110,
        "completion_tokens": 479,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does AT&T's collaboration with Ericsson for commercial-scale Open RAN deployment, as outlined in its 2023 10-K, influence its 2024 expense trends and longer-term operational efficiency goals?",
      "original_answer": "AT&T's collaboration with Ericsson for commercial-scale Open RAN deployment will pressure 2024 expense trends due to the spending required to support growth and efficiency initiatives, including the deployment of Open RAN and associated accelerated depreciation. However, the software benefits of 5G wireless technology, enabled by Open RAN, are expected to result in a more efficient use of capital and lower network-related expenses in the coming years. This aligns with AT&T's longer-term operational efficiency goals by fostering lower network costs and improved operational efficiencies through a more robust ecosystem of network infrastructure providers and suppliers.",
      "llm_answer": "The 2023 10-K notes that AT&T is collaborating with Ericsson to lead U.S. commercial-scale Open RAN deployment, aiming to build a more robust ecosystem of network infrastructure providers. This initiative is expected to lower network costs and improve operational efficiencies, supporting the company's long-term goal of enhancing efficiency through cost transformation and strategic investments in fiber and 5G infrastructure.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AT&T's collaboration with Ericsson on commercial-scale Open RAN deployment and links it to long-term operational efficiency goals such as lower network costs and improved efficiencies. It accurately references the 2023 10-K and the strategic intent behind the initiative. However, it omits a key part of the original answer: the near-term negative impact on 2024 expense trends due to spending on deployment and accelerated depreciation. This is a significant omission because the question specifically asks about both 2024 expense trends and longer-term efficiency goals. (2) There are no numeric values, dates, or calculations in either the original or LLM answer beyond '2023' and '2024', which are used correctly—thus quantitative accuracy is perfect. (3) The multi-hop reasoning is partially sound: the model correctly connects AT&T, Ericsson, Open RAN, and efficiency goals. However, it fails to synthesize the full cause-effect chain: increased short-term expenses leading to long-term savings. This weakens the qualitative reasoning. (4) The answer is contextually relevant and well-phrased but lacks completeness in addressing both the short-term cost pressures and the longer-term benefits, making it only partially aligned with the ground truth. Correctness is reduced due to this critical omission, though core facts are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 387,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What was the total proved developed bitumen reserves in Canada/Other Americas for XOM's consolidated subsidiaries as of December 31, 2021, and how did this compare to the discounted future net cash flows from this region in the same year?",
      "original_answer": "The total proved developed bitumen reserves in Canada/Other Americas for XOM's consolidated subsidiaries as of December 31, 2021, were 2,635 million barrels. This corresponds to a discounted future net cash flow of $28,710 million from Canada/Other Americas in 2021. The reserves represent a significant portion of XOM's future cash flow projections from the region.",
      "llm_answer": "The total proved developed bitumen reserves in Canada/Other Americas for XOM's consolidated subsidiaries as of December 31, 2021 was **268 million barrels** (as shown in the “Proved developed reserves, as of December 31, 2021” table on page 137). This reserve base generated discounted future net cash flows of **approximately $28.7 billion** (the discounted future net cash‑flow figure for Canada/Other Americas in the “Standardized Measure of Discounted Future Cash Flows” table on page 141). In other words, the 268 million barrels of bitumen corresponded to a present‑value of roughly $28.7 billion of cash flows under the standardized 10 % discounting methodology.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the proved developed bitumen reserves value. The ground truth states 2,635 million barrels, but the LLM reports 268 million barrels—a significant underreporting by over 90%. This error severely undermines the answer's correctness. However, the discounted future net cash flow of $28.7 billion (or $28,710 million) is accurately reported and matches the ground truth, with acceptable format variation ($28.7 billion ≈ $28,710 million). (2) The quantitative accuracy is low due to the reserves number being grossly incorrect. Even though the cash flow figure is correct, the reserves figure is central to the question and its inaccuracy invalidates much of the response. (3) The reasoning structure is sound—LLM correctly identifies the need to pull reserves and cash flow data from two different tables and links them appropriately. It also correctly identifies the region (Canada/Other Americas), company (XOM), and time period (December 31, 2021). However, the failure to extract the correct reserves number suggests a data retrieval or misreading error, breaking the multi-hop synthesis. (4) Contextual relevance is high—the answer addresses both parts of the question, cites appropriate tables, and uses correct terminology. Despite structural and contextual strengths, the major numerical error in a core metric results in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 393,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the adoption of ASU No. 2022-02 impact Capital One's allowance for credit losses and loan modification reporting practices as of December 31, 2023?",
      "original_answer": "The adoption of ASU No. 2022-02 led to a $2.1 billion increase in Capital One's allowance for credit losses, bringing the total to $15.3 billion as of December 31, 2023. Additionally, the standard eliminated the classification of loan modifications as Troubled Debt Restructurings (TDRs), replacing them with a new framework for reporting modified loans, which affects how loan modifications are disclosed and managed under the new accounting guidance.",
      "llm_answer": "The adoption of ASU No. 2022-02 eliminated the prior troubled debt restructuring (TDR) accounting guidance and required Capital One to report loan modifications for borrowers experiencing financial difficulty as Financial Difficulty Modifications (FDMs) rather than TDRs. As a result, the company now accounts for these modifications as a continuation of the existing loan, and the allowance for credit losses reflects the updated methodology under the new ASU, which impacts the allowance for credit losses and loan modification reporting practices as of December 31, 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the qualitative impact of ASU No. 2022-02 on Capital One's loan modification reporting practices, specifically the elimination of Troubled Debt Restructurings (TDRs) and the shift to a new framework (referred to as Financial Difficulty Modifications, or FDMs, though the exact acronym may not be officially used). It also correctly notes that the allowance for credit losses is affected under the new methodology. However, it fails to include the key quantitative impact specified in the ground truth: the $2.1 billion increase in the allowance, bringing the total to $15.3 billion as of December 31, 2023. This omission is significant because the question explicitly asks about the impact on the allowance, which includes a material numerical change. (2) The absence of any dollar amounts or numerical changes results in a low quantitative accuracy score. The ground truth includes two precise figures ($2.1B increase and $15.3B total) that are completely missing in the LLM response. (3) The multi-hop reasoning is partially sound—the model connects the adoption of the ASU to changes in both allowance methodology and loan modification classification, which shows understanding of the dual aspects of the question. However, it does not synthesize the numerical outcome of this adoption, which is a critical component of the original answer. (4) The contextual relevance and qualitative accuracy are high because the response stays on topic, uses correct terminology, and accurately describes the accounting change. However, the lack of quantitative details reduces the overall correctness score to 6, as the answer is partially correct but missing essential data required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 474,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does the potential increase in contingent liabilities from Bank BPH's ongoing litigation in Poland impact GE's liquidity position as reported in its 2023 10-K filing?",
      "original_answer": "The potential increase in contingent liabilities from Bank BPH's ongoing litigation in Poland could negatively impact GE's liquidity position. GE reported total cash, cash equivalents, and restricted cash of $17.0 billion at December 31, 2023. However, $14.2 billion of this amount was held outside the U.S., with $1.7 billion in countries with currency control restrictions. If additional contingent liabilities from Bank BPH become payable, GE may face challenges in accessing sufficient liquidity without incurring substantial costs or repatriation taxes. This could constrain its ability to meet business needs and financial obligations, especially under stressed conditions.",
      "llm_answer": "The 2023 10‑K notes that ongoing litigation involving Bank BPH in Poland could generate additional contingent liabilities and loss estimates that may need to be recognized, potentially affecting GE’s liquidity position. While the filing does not quantify the impact, it warns that any increase in these liabilities could materially affect GE’s cash flows and overall financial condition.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the ongoing litigation at Bank BPH in Poland could lead to additional contingent liabilities that may affect GE's liquidity, which aligns with the ground truth. However, it fails to include any of the specific quantitative data provided in the original answer, such as GE's total cash position of $17.0 billion, the $14.2 billion held outside the U.S., or the $1.7 billion in countries with currency controls. These omissions significantly reduce factual completeness and accuracy. (2) The ground truth includes precise figures critical to assessing liquidity constraints, especially under stress, but the LLM answer states that 'the filing does not quantify the impact,' which is incorrect—GE’s 2023 10-K does provide specific cash location and restriction data relevant to liquidity risk. This misstatement undermines quantitative accuracy. (3) The reasoning is partially sound: the LLM recognizes the multi-hop connection between Bank BPH litigation and GE’s liquidity, and understands that contingent liabilities could affect cash flows and financial condition. However, it fails to synthesize the key link that foreign cash holdings (especially in restricted jurisdictions) limit GE’s ability to access liquidity if liabilities become payable, which is central to the original answer’s logic. (4) While the LLM answer is contextually relevant and captures the general risk, it lacks the detailed financial data and nuanced reasoning about repatriation costs and geographic cash constraints that are essential to fully answering the multi-hop question. Hence, correctness is partially accurate but significantly incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 459,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How many total shares were both issued upon exercise of outstanding options and still available for future issuance under the Amended and Restated 2010 Share Incentive Plan as disclosed in the 2022 10-K filing?",
      "original_answer": "The Amended and Restated 2010 Share Incentive Plan had 14,830,623 shares issued upon exercise of outstanding options and 27,381,461 shares still available for future issuance, totaling 42,212,084 shares.",
      "llm_answer": "Based on the disclosed information in the 2022 10-K filing (specifically the table in Part IV, Item 12 on page 51), the total shares available for future issuance under the Amended and Restated 2010 Share Incentive Plan, after accounting for shares reserved for outstanding options and other awards, is **27,381,461 shares**. This figure represents the remaining available shares under the plan as of August 31, 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 27,381,461 shares still available for future issuance, which matches the ground truth. However, it completely omits the 14,830,623 shares issued upon exercise of outstanding options, which is a critical part of the question. The question asks for the *total* shares that were both issued upon exercise *and* still available, requiring a sum of these two components. (2) The quantitative accuracy is partially correct—27,381,461 is accurate, but the missing 14,830,623 prevents the correct total of 42,212,084 from being computed. The LLM does not attempt the sum, so the total is absent. (3) The reasoning is flawed in that it fails the multi-hop requirement: it retrieves one piece of data (shares available) but ignores the second required component (shares issued upon exercise). There is no synthesis between the two data points as required by the question. (4) Contextual relevance is fair because the answer discusses the correct plan and cites the correct document and location, but it does not address the full scope of the question. The omission of a major component results in a low correctness score despite partial factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 338,
        "total_tokens": 1509
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the total amount of the 2025 Term Loan that AT&T paid off in 2023, and on what date was this loan terminated according to the disclosures?",
      "original_answer": "AT&T paid off the $2,500 million 2025 Term Loan in full and terminated it on March 30, 2023.",
      "llm_answer": "The 2025 Term Loan was paid off in full on March 30, 2023, and the termination of that loan was disclosed in the financing activities section of the filing.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the date of termination as March 30, 2023, which matches the ground truth. However, it failed to specify the amount of the 2025 Term Loan, which was $2,500 million (or $2.5 billion), a key part of the question. This omission affects completeness and quantitative accuracy. (2) The date is accurate, but the dollar amount is missing entirely—this is a significant quantitative gap, though no incorrect numbers were provided. (3) The reasoning is partially sound: the model correctly linked the loan payoff to its termination date and referenced the appropriate section of the filing (financing activities), indicating correct synthesis of information related to the event. However, it did not fully synthesize all disclosed details, particularly the loan amount, which was required. (4) The answer is contextually relevant and well-phrased, but the missing loan amount prevents a higher score. While the termination date is correct, the question explicitly asked for both the total amount and the date, so the answer is incomplete. Hence, correctness is reduced to 7 due to missing critical data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1062,
        "completion_tokens": 323,
        "total_tokens": 1386
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the change in KO's investment in mutual, pooled and commingled funds from 2022 to 2023, and how much of the 2023 investment was categorized under Level 2 valuation inputs?",
      "original_answer": "KO's investment in mutual, pooled and commingled funds decreased by $47 million from 2022 to 2023. In 2023, $37 million of the $39 million investment was categorized under Level 2 valuation inputs.",
      "llm_answer": "The change in KO's investment in mutual, pooled and commingled funds from 2022 to 2023 was a decrease of $61 million (from $304 million in 2022 to $243 million in 2023). Of the 2023 investment, $257 million was categorized under Level 2 valuation inputs.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect. (1) Quantitatively: The ground truth states that KO's investment decreased by $47 million from 2022 to 2023, with a 2023 investment of $39 million, of which $37 million was categorized under Level 2. The LLM claims a decrease of $61 million (from $304M to $243M), which is factually wrong, and states that $257 million of the 2023 investment was Level 2—this exceeds the total investment claimed ($243M), which is logically impossible. (2) Calculations are incorrect: a drop from $304M to $243M is indeed $61M, but these base numbers do not match the ground truth. The Level 2 amount cannot exceed the total investment. (3) Multi-hop reasoning failed: the model did not correctly identify the actual values for KO’s investments in the relevant years or their valuation levels. (4) Entity accuracy is correct—KO refers to The Coca-Cola Company, and the years 2022 and 2023 are properly targeted—but all financial data is wrong. The answer is off by orders of magnitude. Thus, only minimal relevance is given for addressing the right company and time frame.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1121,
        "completion_tokens": 311,
        "total_tokens": 1432
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, and how much net cash did GE pay to AerCap related to continuing involvement with the company during the same period?",
      "original_answer": "The total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, was $1,189 million. Additionally, GE paid $203 million in net cash to AerCap related to continuing involvement activities.",
      "llm_answer": "The total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, was $1,189 million, as disclosed in Note 3 of the 10-K for the earnings (loss) of discontinued operations. Additionally, GE paid $203 million in net cash to AerCap related to continuing involvement during the same period, as stated in the same note.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, both key figures are accurate: $1,189 million for the pre-tax charge and $203 million in net cash paid to AerCap, with no calculation or formatting issues. Minor elaboration on the source (Note 3 of the 10-K) adds context without introducing error. (2) The answer is complete, addressing both parts of the multi-part question: the pre-tax litigation charge and the net cash payment to AerCap. (3) Entity accuracy is correct—GE and AerCap are properly identified, the time period (year ended December 31, 2023) is accurate, and the financial metrics (pre-tax charge, net cash) are correctly used. (4) The reasoning is sound and reflects proper multi-hop synthesis, as both pieces of information likely come from different sections of the 10-K (e.g., discontinued operations and continuing involvement disclosures), and the model correctly links them. The added reference to 'Note 3' enhances credibility and shows appropriate contextual grounding. Overall, the answer is factually precise, semantically equivalent to the ground truth, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 324,
        "total_tokens": 1488
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Accenture's investment in research and development and its focus on delivering 360° value contribute to its competitive positioning in the global IT services market, especially when compared to its competitors' offerings?",
      "original_answer": "Accenture invested $1.1 billion in research and development during fiscal 2022, which supports its ability to innovate and deliver advanced solutions. This investment underpins its strategy of delivering 360° value—defined as providing financial business cases, inclusion and diversity progress, employee reskilling, and sustainability support to clients. This differentiates Accenture in a competitive market where competitors include multinational IT providers, offshore firms, consultancies, and in-house corporate departments. Accenture claims no other firm offers the same breadth of services at scale, and its 360° value approach, backed by R&D and global ecosystem partnerships, enables it to deliver outcomes across strategy, execution, and transformation, giving it a unique competitive edge.",
      "llm_answer": "Accenture’s heavy investment in research and development—$1.1 billion in fiscal 2022—combined with its broader 360° value strategy, differentiates it from competitors by embedding innovation, sustainability and talent development into every client engagement. This focus enables Accenture to deliver differentiated industry‑specific solutions, accelerate digital transformation, and create measurable financial and societal outcomes that clients value, reinforcing its position as a trusted, high‑growth partner in the global IT services market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states Accenture's $1.1 billion R&D investment in fiscal 2022, matching the ground truth exactly. This satisfies the quantitative accuracy requirement with no discrepancies in number, year, or entity. (2) The answer captures the core elements of Accenture’s 360° value proposition—innovation, sustainability, talent development (reskilling), and societal outcomes—aligning with the ground truth’s definition involving financial business cases, inclusion and diversity, employee reskilling, and sustainability. While the LLM does not explicitly list all four components verbatim, it semantically conveys the breadth of the 360° value approach. (3) The reasoning is sound: it connects R&D investment to innovation and advanced solution delivery, links the 360° value model to client outcomes, and positions Accenture competitively in the global IT services market. It correctly implies a multi-hop synthesis between R&D spending, value delivery, and competitive differentiation. (4) The only minor shortcoming is the omission of explicit mention that Accenture claims no other firm offers the same breadth of services at scale, and less emphasis on ecosystem partnerships. However, the essence of competitive differentiation is preserved. The answer is highly relevant, factually accurate, and conveys the same strategic narrative as the ground truth, warranting a high score with only slight deduction for minor completeness gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 406,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What specific entities, in addition to WarnerMedia, were classified as discontinued operations by AT&T in 2023, and how does this classification affect the presentation of their financial results?",
      "original_answer": "In addition to WarnerMedia, AT&T classified Vrio, Xandr, and Playdemic as discontinued operations in 2023. This classification means that the financial results of these entities are excluded from ongoing operations and are instead reported separately as discontinued operations, including for periods prior to the consummation of the WarnerMedia/Discovery transaction.",
      "llm_answer": "AT&T classified WarnerMedia, Vrio, Xandr, and Playdemic as discontinued operations in 2023, as explicitly stated in Note 24 of the financial statements. This classification requires these businesses to be presented separately in the financial results, with their operating results and assets/liabilities shown as discontinued operations, while the remaining operations (primarily Communications and Latin America segments) are reported as continuing. Consequently, the company's consolidated financial results reflect only the performance of continuing operations, with discontinued operations' results isolated in a dedicated table showing net losses of $181 million in 2023, $2.297 billion in 2022, and $2.297 billion in 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies all entities classified as discontinued operations by AT&T in 2023: WarnerMedia, Vrio, Xandr, and Playdemic, matching the ground truth. The explanation of the financial presentation impact is accurate and more detailed than the original answer, correctly stating that results are separated and reported for prior periods as well. The LLM provides additional context from Note 24 and specifies net losses for 2023 ($181 million), 2022 ($2.297 billion), and 2021 ($2.297 billion), which are plausible figures consistent with typical financial disclosures. While these specific numbers are not in the ground truth (which focuses on the classification and reporting treatment), they do not contradict it and appear to be correctly cited from the actual filing. There is no indication of calculation errors or misstatements. The multi-hop reasoning is sound—correctly synthesizing the list of entities and the accounting treatment. The only reason for not giving a perfect 10 is that the original answer did not include the numerical loss amounts, so we cannot fully verify their presence in the source knowledge graph; however, they are contextually appropriate and do not detract from accuracy. The answer is semantically equivalent and exceeds the original in detail without introducing errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 368,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What is the total unrealized loss attributed to Auction Rate Securities held by MDT as of April 29, 2022, and how does this loss distribute across the maturity periods according to the 2022 10-K filing?",
      "original_answer": "The total unrealized loss attributed to Auction Rate Securities held by MDT as of April 29, 2022, is $3 million. This loss is entirely associated with securities having maturity periods of more than 12 months, as no unrealized loss is reported for securities with maturity periods of less than 12 months.",
      "llm_answer": "The 2022 10‑K filing shows that the unrealized loss on auction‑rate securities held by Medtronic (MDT) was $3 million as of April 29, 2022. This loss is disclosed in the “available‑for‑sale debt securities” tables (page 70) under the “Auction rate securities” line, which reports a fair value of $33 million and an unrealized loss of $3 million. The loss is not broken out by maturity period in the filing; it is simply aggregated under the auction‑rate securities category.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total unrealized loss of $3 million as of April 29, 2022, which matches the ground truth and is quantitatively accurate. However, it incorrectly states that the loss is not broken out by maturity period in the filing, which directly contradicts the ground truth that specifies the entire $3 million loss is attributed to securities with maturities of more than 12 months, with no loss for those under 12 months. This omission or misrepresentation of the maturity distribution significantly undermines the qualitative accuracy. (2) All numeric values—$3 million loss, correct date, correct company (MDT/ Medtronic), and correct reference to the 2022 10-K—are factually correct. (3) The multi-hop reasoning fails because while the model locates the correct total loss, it does not synthesize the additional information about maturity periods that is required by the question. The ground truth confirms such a breakdown exists in the filing, so claiming it does not shows either a misreading or failure to retrieve that detail. (4) The correctness score is 4 due to one major factual omission in the qualitative reasoning—despite correct numbers, the answer fails a core part of the question. Quantitative accuracy is 10 because all numbers are correct. Qualitative accuracy is low (4) due to incorrect reasoning about the availability of maturity breakdown. Contextual relevance is high (8) because the answer addresses the right document, company, and metric, and provides a plausible citation, even if incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 429,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How many shares of Class B-2 common stock were issued during the Class B-1 common stock exchange offer in May 2024, and what percentage of the total shares issued in that exchange consisted of Class B-2 common stock?",
      "original_answer": "In May 2024, 120 million shares of Class B-2 common stock were issued during the exchange offer for Class B-1 common stock. A total of 168 million shares were issued in that exchange (120 million Class B-2 and 48 million Class C). Therefore, Class B-2 shares accounted for approximately 71.4% of the total shares issued.",
      "llm_answer": "During the May 2024 Class B‑1 exchange offer, Visa accepted 241 million shares of Class B‑1 common stock and issued approximately 120 million shares of Class B‑2 common stock (and 48 million shares of Class C common stock). Thus, Class B‑2 shares represented roughly 33 % of the total shares issued in that exchange.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 120 million shares of Class B-2 common stock issued, which matches the ground truth. It also correctly notes the issuance of 48 million Class C shares. However, it incorrectly calculates the percentage of Class B-2 shares in the total issuance. The total shares issued were 168 million (120M B-2 + 48M C), so Class B-2 should represent 120/168 ≈ 71.4%, not 33%. The LLM’s 33% figure is factually wrong and suggests a major calculation or reasoning error. (2) The date (May 2024) is correct. The numbers for Class B-2 and Class C shares are accurate, but the percentage is not. The incorrect percentage severely undermines the quantitative accuracy. (3) The multi-hop reasoning fails at the synthesis step: while the model retrieves the correct component numbers, it does not correctly compute the proportion. The mention of 241 million shares of Class B-1 accepted is extraneous and not part of the original question or answer, suggesting possible confusion or hallucination. (4) Correctness score is 4 due to partial factual accuracy (correct share counts) but major error in the key derived metric (percentage). Quantitative accuracy is 5 because half the numbers are right but the calculation is wrong. Qualitative accuracy is 4 due to flawed reasoning and potential hallucination of irrelevant data. Contextual relevance is 8 because the answer addresses the right event and exchange, despite errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 401,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What is the total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 to 2023, and how does this reflect in the change in the number of Wind Turbines sold during the same period?",
      "original_answer": "The total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 (11.7 GW) to 2023 (8.5 GW) is 3.2 GW. During the same period, the number of Wind Turbines sold decreased from 3,590 units in 2021 to 2,225 units in 2023, a reduction of 1,365 units. This indicates a decline in both the volume of turbines sold and the overall capacity of wind energy systems delivered by GE.",
      "llm_answer": "The total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 to 2023 was 3.2 GW (from 11.7 GW in 2021 to 8.5 GW in 2023). This decline is reflected in the reduction of Wind Turbines sold from 3,590 units in 2021 to 2,225 units in 2023, a decrease of 1,365 units.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: the decrease in capacity is correctly calculated as 3.2 GW (11.7 GW - 8.5 GW), and the reduction in units sold is correctly stated as 1,365 units (3,590 - 2,225). (2) The answer addresses both parts of the question: the total decrease in GW capacity and the corresponding change in the number of turbines sold. (3) Entity accuracy is perfect—GE is correctly identified, and the years 2021 and 2023 are accurately referenced with correct metrics (GW capacity and unit counts). (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects the decline in capacity to the decline in unit volume, showing understanding of the relationship between the two metrics. The answer is semantically equivalent to the original, with no omissions or inaccuracies. All scores are maximized accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 269,
        "total_tokens": 1444
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "What was the total amount paid by AT&T for C-Band licenses, including all incentive and relocation costs through 2023, and how does this reflect in the company's cash flow classification?",
      "original_answer": "AT&T paid a total of $26,477 million for C-Band licenses, including $23,406 million in auction deposits and payments, $3,067 million in incentive and relocation costs ($955 million for Phase I, $2,112 million for Phase II, and $1,100 million in compensable relocation costs over several years, of which $650 million was paid in 2021, $98 million in 2022, and $109 million in 2023). These payments are classified under 'Acquisitions, net of cash acquired' on AT&T's consolidated statements of cash flows.",
      "llm_answer": "The total amount paid by AT&T for C-Band licenses, including all incentive and relocation costs through 2023, was $23,406 (comprising a $550 upfront deposit paid in 2020 and $22,856 in cash payments made in the first quarter of 2021, plus $955 in incentive payments cleared in December 2021 and $2,112 in Phase II incentive payments cleared in 2023, with additional relocation costs of $650 in 2021, $98 in 2022, and $109 in 2023). This expenditure is classified as \"Acquisitions, net of cash acquired\" on AT&T's consolidated statements of cash flows, where cash paid for spectrum deposits (net of refunds), capitalized interest, and any payments for incentive and relocation costs are aggregated.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states the total amount paid as $23,406 million, but this figure only includes auction deposits and payments, not the full total including incentive and relocation costs. The ground truth total is $26,477 million ($23,406M auction payments + $3,067M incentive and relocation costs). The LLM incorrectly presents $23,406 as the total, omitting the explicit summation and misrepresenting the scope. (2) While the LLM correctly breaks down some components—$955M Phase I incentives, $2,112M Phase II, and annual relocation costs of $650M (2021), $98M (2022), $109M (2023)—it fails to sum these properly into the total incentive and relocation cost of $3,067M or the overall $26,477M. Additionally, the LLM omits the $1,100M in compensable relocation costs as a category, only listing annual payments without connecting them to the larger bucket. (3) The qualitative reasoning is partially sound: it identifies the correct cash flow classification—'Acquisitions, net of cash acquired'—and correctly associates spectrum deposits, incentive, and relocation costs with this line item. It also reflects multi-hop synthesis by pulling together payments across years and types, though the synthesis is incomplete due to the missing total. (4) Contextual relevance is strong—the answer addresses both parts of the question (total cost and cash flow classification), uses correct entities (AT&T, C-Band, correct years), and maintains focus. However, the critical error in the total amount paid—understating it by ~$3 billion—severely impacts factual correctness. Hence, correctness and quantitative accuracy are penalized heavily, while qualitative reasoning and relevance remain acceptable.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 478,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Medtronic's decision to discontinue the HVAD System impact its financial performance in fiscal year 2022, and what other product lines were highlighted as growth drivers in the same period?",
      "original_answer": "Medtronic's decision to discontinue the HVAD System in June 2021 removed a product that had generated $141 million in net sales during fiscal year 2021. This discontinuation likely contributed to the company's focus on other growth drivers in fiscal year 2022, such as the Symplicity Spyral Multi-Electrode Renal Denervation Catheter, Pulse Field Ablation, Aurora Extravascular ICD, and transcatheter mitral and tricuspid therapy products led by the Intrepid system. Despite the loss of HVAD revenue, Medical Surgical's net sales increased to $9.1 billion in fiscal year 2022, up 5% compared to the prior year, driven by recovery in global procedure volumes and strong performance in Surgical Innovations, partially offset by supply chain disruptions.",
      "llm_answer": "Medtronic's discontinuation of the HVAD System in June 2021 generated a $515 million non‑cash impairment charge (including $409 million of intangible‑asset write‑downs) and $366 million of commitments and restructuring costs in fiscal 2022, but the company offset this head‑wind with strong growth in other divisions—particularly Cardiovascular (up 6 % to $11.4 billion) and Surgical Innovations (up 11 %). These product lines, along with continued expansion of the Micra pacing platform, Azure XT/S SureScan systems, and the Evolut TAVR portfolio, were highlighted as the primary growth drivers for fiscal 2022.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in financial figures. The ground truth states that HVAD generated $141 million in net sales in fiscal year 2021, but the LLM incorrectly claims a $515 million non-cash impairment charge and $366 million in restructuring costs in fiscal 2022—these figures are not present in the original answer and contradict the provided knowledge. Additionally, the LLM states Cardiovascular grew to $11.4 billion (up 6%), but the original answer refers to Medical Surgical (not Cardiovascular) increasing to $9.1 billion (up 5%). (2) The product lines mentioned as growth drivers partially overlap: Symplicity Spyral, Pulse Field Ablation, Aurora ICD, and transcatheter mitral/tricuspid therapies (Intrepid) are missing from the LLM answer, while Micra, Azure XT/S, and Evolut TAVR are mentioned but not in the original. This indicates incorrect entity mapping. (3) The multi-hop reasoning is flawed—the LLM correctly links HVAD discontinuation to financial impact and identifies other growth drivers, but uses incorrect financial data and misattributes revenue growth to the wrong segment. (4) Despite incorrect numbers and misidentified product lines, the answer remains contextually relevant by addressing both parts of the question: financial impact of HVAD discontinuation and alternative growth drivers. However, due to major quantitative and qualitative errors, the correctness score is low. Minor formatting variations in numbers are accepted, but here the values are entirely inconsistent with ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 435,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How much total cash did Walmart pay to acquire additional shares from Flipkart noncontrolling interest holders and settle the liability to former noncontrolling interest holders of PhonePe during fiscal 2024, and what was the impact on Walmart's ownership percentage in Flipkart?",
      "original_answer": "Walmart paid $3.5 billion to acquire additional shares from Flipkart noncontrolling interest holders and settle the liability to former noncontrolling interest holders of PhonePe during fiscal 2024. This increased Walmart's ownership in Flipkart from approximately 75% as of January 31, 2023, to approximately 85% as of January 31, 2024.",
      "llm_answer": "Walmart paid $3.5 billion in cash during fiscal 2024 to acquire additional Flipkart shares from non‑controlling interest holders and to settle the liability to former non‑controlling interest holders of PhonePe. This transaction increased Walmart’s ownership stake in Flipkart from roughly 75 % (as of January 31 2023) to approximately 85 % (as of January 31 2024).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $3.5 billion cash payment is accurately reported, along with the correct ownership percentages (75% to 85%) and corresponding dates (January 31, 2023, and January 31, 2024). Minor formatting differences (e.g., ' ' thin spaces, 'approximately' vs 'roughly') do not affect meaning. (2) The answer addresses both parts of the multi-part question: the total cash paid and the impact on Walmart's ownership in Flipkart. (3) All entities—Walmart, Flipkart, PhonePe, noncontrolling interest holders—are correctly identified and contextually accurate. (4) The multi-hop reasoning is sound: the answer correctly synthesizes the cash outflow for two related purposes (acquiring shares and settling liabilities) and links it to the change in ownership percentage over the fiscal year. Semantically, the LLM response conveys the same information as the original answer with equivalent precision and clarity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 286,
        "total_tokens": 1494
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Microsoft's treatment of unearned revenue from volume licensing programs, including the timing of invoicing and revenue recognition, impact the presentation and auditability of its financial statements, given the complexity in determining standalone selling prices (SSP) and the auditor's focus on revenue recognition?",
      "original_answer": "Microsoft recognizes unearned revenue from volume licensing programs, which include Software Assurance (SA) and cloud services, by invoicing annually at the beginning of each contract period and recognizing revenue ratably over the coverage period. This creates contract balances such as receivables or unearned revenue, depending on the timing mismatch between invoicing and revenue recognition. Due to the complexity in determining standalone selling prices (SSP) for on-premises licenses sold with SA or software updates, Microsoft must use judgment and estimates based on customer size and geographic region, which affects the allocation of discounts and the pattern of revenue recognition. This complexity was a critical audit matter for Microsoft’s independent auditors, who focused on the application of revenue recognition principles, especially around transfer of control and variable consideration. Therefore, the structure and accounting treatment of volume licensing programs directly influence both the presentation of financial statements and the nature of the audit procedures performed.",
      "llm_answer": "Microsoft’s volume‑licensing contracts often involve multiple performance obligations (e.g., on‑premises licenses bundled with Software Assurance or cloud services). Because the standalone selling prices (SSP) of these bundled items are not directly observable, the company must estimate SSP using market conditions, customer size, geography, or ranges of amounts, and allocate revenue accordingly. This estimation creates significant judgment and estimation risk, which auditors address by testing controls over performance‑obligation identification, evaluating the reasonableness of SSP estimates, and performing detailed substantive procedures on a sample of agreements. Consequently, the complexity of determining SSP and the timing of invoicing versus revenue recognition affects both the presentation of revenue and the auditability of Microsoft’s financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Microsoft's use of judgment in estimating standalone selling prices (SSP) due to unobservable market prices, reliance on customer size and geography, allocation of revenue in bundled arrangements, and the resulting audit focus on controls, SSP reasonableness, and substantive testing are all consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly links volume licensing complexity → SSP estimation challenges → need for judgment → impact on revenue allocation and timing → consequences for audit procedures. It captures the cause-effect chain between accounting treatment and auditability. (4) Minor omission: the LLM does not explicitly mention that invoicing occurs annually at the beginning of the contract period and that revenue is recognized ratably, which is a key point in the original answer explaining the creation of unearned revenue and timing mismatches. However, the implication of timing differences is covered through the discussion of performance obligations and revenue recognition patterns. This small gap prevents a perfect 10 but does not undermine the overall correctness. The answer remains semantically equivalent in intent and substance, with strong contextual relevance to the question about financial statement presentation and auditability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 436,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What were the total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan over the three fiscal years ended May 31, 2022, and why were no profit sharing contributions included in this total?",
      "original_answer": "The total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan over the three fiscal years ended May 31, 2022, were $343 million ($126 million in 2022, $110 million in 2021, and $107 million in 2020). No profit sharing contributions were included in this total because the company did not make any discretionary profit sharing contributions for the fiscal years 2022, 2021, or 2020, as stated in the plan terms.",
      "llm_answer": "The total company contributions to Nike's 401(k) Savings and Profit Sharing Plan for the three fiscal years ended May 31, 2022, were $126 million in 2022, $110 million in 2021, and $107 million in 2020, as disclosed in Note 13. No profit‑sharing contributions were made in any of those years because the plan’s profit‑sharing feature was not exercised; the Company determined that the fair value of any such discretionary profit‑sharing contributions was not material to its financial position or results of operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reported all company contributions: $126 million in 2022, $110 million in 2021, and $107 million in 2020, matching the ground truth exactly. The total of $343 million is accurate (126 + 110 + 107 = 343), though the LLM did not explicitly state the sum, it provided all components, allowing for easy derivation. (2) All numeric values, years, and financial amounts are correct and match the ground truth. Format variations (e.g., using 'million' vs '$343 million') are acceptable and semantically equivalent. (3) The reasoning for no profit sharing contributions is mostly accurate: the LLM correctly states that no profit-sharing contributions were made in 2020–2022. However, it adds a justification not present in the ground truth — that the fair value was 'not material' — whereas the original answer states simply that no discretionary contributions were made as per plan terms. This introduces a plausible but unverified rationale, slightly reducing qualitative accuracy. (4) The answer is contextually fully relevant, addresses both parts of the multi-hop question, and synthesizes data correctly across three fiscal years. The only minor shortcoming is the inferred reason for no profit sharing, which, while reasonable, is not directly supported by the provided ground truth. Hence, correctness is high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 379,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What is the total change in Chevron's (COP) consolidated natural gas reserves in the Asia Pacific/Middle East region from the end of 2023 to the end of 2024, and how does this compare to the change in natural gas reserves in Africa over the same period?",
      "original_answer": "Chevron's consolidated natural gas reserves in the Asia Pacific/Middle East region decreased by 16 billion cubic feet from 312 (2023) to 296 (2024). In contrast, natural gas reserves in Africa increased by 297 billion cubic feet from 172 (2023) to 468 (2024). Therefore, while reserves declined slightly in the Asia Pacific/Middle East, they significantly increased in Africa.",
      "llm_answer": "The total change in Chevron's (COP) consolidated natural gas reserves in the Asia Pacific/Middle East region from the end of 2023 to the end of 2024 was an increase of 257 billion cubic feet (from 2,890 BCF to 3,147 BCF). In contrast, natural gas reserves in Africa decreased by 13 billion cubic feet over the same period (from 468 BCF to 455 BCF).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. According to the ground truth, Chevron's natural gas reserves in the Asia Pacific/Middle East region decreased by 16 billion cubic feet (from 312 to 296 BCF), but the LLM claims an increase of 257 BCF (from 2,890 to 3,147 BCF), which is both directionally and numerically wrong. Similarly, in Africa, reserves increased by 297 BCF (from 172 to 468 BCF), but the LLM incorrectly states a decrease of 13 BCF (from 468 to 455 BCF), again reversing the direction and misstating the values. (2) All numerical values are incorrect—there is no overlap with the ground truth numbers. The LLM uses completely different base figures (e.g., 2,890 BCF vs. 312 BCF), suggesting a confusion with another dataset or region. Calculations based on these wrong numbers are also invalid. (3) The multi-hop reasoning fails entirely: the model does not correctly identify the relevant data points for Chevron’s reserves in the specified regions and years, nor does it accurately compare the changes. Instead, it presents fabricated or misattributed data. (4) The contextual relevance is low but not zero because the answer attempts to address the question structure (change in reserves in two regions over 2023–2024), so partial credit is given for relevance. However, due to pervasive factual and quantitative errors, the correctness and accuracy scores are near minimum.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 398,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How much total cash did Walmart receive from equity funding related to PhonePe during fiscal 2024, and how did this compare to the amount paid to acquire shares from noncontrolling interest holders of PhonePe in the same fiscal year?",
      "original_answer": "Walmart received $0.7 billion from equity funding related to PhonePe during fiscal 2024 and paid $3.5 billion to acquire shares from noncontrolling interest holders of PhonePe in the same fiscal year. Therefore, Walmart spent $2.8 billion more than it received in net cash related to PhonePe equity transactions during fiscal 2024.",
      "llm_answer": "Walmart received $700 million in cash from equity funding related to PhonePe during fiscal 2024, while it paid $3.5 billion to acquire shares from noncontrolling interest holders of PhonePe in the same fiscal year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Walmart received $700 million (equivalent to $0.7 billion) from equity funding and paid $3.5 billion to acquire shares from noncontrolling interest holders in fiscal 2024, matching the ground truth. All numeric values are accurate with acceptable format variation ($700 million vs $0.7 billion). (2) Quantitative accuracy is perfect: both amounts are correct, and though the LLM does not explicitly compute the net difference of $2.8 billion, it provides the necessary figures for correct inference. (3) The reasoning is sound and entities are accurately identified—Walmart, PhonePe, fiscal 2024, equity funding, and noncontrolling interest transactions are all correctly referenced. The only minor omission is the explicit comparison stating Walmart spent $2.8 billion more than it received, which was part of the original answer. However, the core multi-hop synthesis—linking inflows and outflows related to PhonePe equity—is present. (4) Scores reflect near-perfect factual accuracy, with a small deduction in qualitative accuracy due to the missing explicit comparison, though the data needed to derive it is fully provided. Contextual relevance is complete as all parts of the question are substantively addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 357,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What is the total pre-tax charge recorded by RTX in 2024 as a result of resolving the SEC Administrative Order and related legal matters, and how long will the compliance monitor oversee RTX's obligations under these agreements?",
      "original_answer": "RTX recorded a total pre-tax charge of $918 million in 2024 related to the SEC Administrative Order and other legal resolutions. The compliance monitor will oversee RTX's obligations for a period ending three years from the date on which the monitor is engaged.",
      "llm_answer": "The total pre‑tax charge recorded by RTX in 2024 for resolving the SEC administrative order and related legal matters was **$918 million**, and the compliance monitor will oversee RTX’s obligations for **three years** from the date the monitor is engaged.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the pre-tax charge of $918 million in 2024 is accurately reported, with correct dollar amount and year. The duration of the compliance monitor's oversight is correctly stated as three years from the engagement date, which aligns with the original answer. Format variations (e.g., 'million' vs 'M') are acceptable and do not affect accuracy. (2) The answer is complete, addressing both parts of the multi-part question: the financial impact (pre-tax charge) and the duration of monitoring. (3) Entity accuracy is correct—RTX is the proper company, 2024 is the correct fiscal year, and the SEC Administrative Order is accurately referenced. (4) The reasoning is sound and reflects proper synthesis of multi-hop information: linking the financial charge to the resolution of legal matters and correctly interpreting the time-bound nature of the compliance monitor’s role. (5) The semantic meaning is equivalent to the original answer, with clear, concise phrasing that preserves all key facts. No errors in logic, calculation, or fact retrieval.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 321,
        "total_tokens": 1471
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What was the total Microsoft Cloud revenue in fiscal year 2023, and which specific cloud-based offerings, including Dynamics 365, contributed to this revenue?",
      "original_answer": "The total Microsoft Cloud revenue in fiscal year 2023 was $111.6 billion. This revenue was generated from offerings such as Azure and other cloud services, Office 365 Commercial, the commercial portion of LinkedIn, Dynamics 365, and other commercial cloud properties.",
      "llm_answer": "Microsoft's fiscal year 2023 total Cloud revenue was $111.6 billion. This figure includes revenue from Dynamics 365 and other cloud‑based offerings such as Azure, Office 365 Commercial, LinkedIn’s commercial business, and additional Microsoft Cloud services.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitative accuracy: The total Microsoft Cloud revenue of $111.6 billion for fiscal year 2023 is correctly stated, matching the original answer exactly. (2) Completeness: The answer addresses both parts of the question—total revenue and the contributing cloud offerings. All key offerings listed in the ground truth—Dynamics 365, Azure, Office 365 Commercial, LinkedIn’s commercial business, and other cloud services—are included, with only minor rephrasing (e.g., 'additional Microsoft Cloud services' corresponds to 'other commercial cloud properties'). (3) Entity accuracy: All entities (Microsoft, fiscal year 2023, Dynamics 365, Azure, Office 365 Commercial, LinkedIn) are correctly identified and appropriately scoped (e.g., 'commercial portion' of LinkedIn is implied in 'LinkedIn’s commercial business'). (4) Reasoning: The multi-hop synthesis is sound—revenue figure and component services are accurately aggregated from the knowledge base. (5) Semantic equivalence: Despite slight wording differences, the meaning and factual content are identical. No errors in logic, calculation, or fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1134,
        "completion_tokens": 333,
        "total_tokens": 1468
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does Universal Beijing Resort's $3.5 billion debt position as of December 31, 2023, reflect both its direct financing arrangements and its position within Comcast's consolidated debt structure?",
      "original_answer": "Universal Beijing Resort's $3.5 billion debt position reflects both its direct financing arrangements and its consolidated position within Comcast's debt structure. As stated in the evidence, Universal Beijing Resort secured its financing through a debt facility with a maximum borrowing limit of ¥29.7 billion RMB (approximately $4.2 billion), funded by a syndicate of Chinese financial institutions and secured by the resort's assets and investor equity interests. As of December 31, 2023, the resort had $3.5 billion of debt outstanding under this arrangement, including $3.1 billion in term loans. Despite this secured debt structure, Comcast consolidates Universal Beijing Resort as a Variable Interest Entity (VIE) due to its governance structure and its ability to direct major economic activities. However, Comcast explicitly states that there are no liquidity arrangements, guarantees, or financial commitments between itself and the resort, meaning Comcast's risk exposure is limited to its 30% equity interest. In the consolidated debt disclosures, Universal Beijing Resort's $3.5 billion debt is categorized under 'Debt Not Guaranteed,' appearing separately from Comcast's other major debt segments like NBCUniversal and Comcast Cable, which are subject to cross-guarantees.",
      "llm_answer": "Universal Beijing Resort's $3.5 billion debt is recorded in Comcast’s consolidated balance sheet as part of the “Debt Subject to Cross‑Guarantees” and “Debt Not Guaranteed” categories (see Note 8 and the debt‑guarantee table on page 96). Although the resort’s borrowing is structured as a separate, non‑guaranteed loan secured by the resort’s assets, it is ultimately reflected in Comcast’s overall debt position, contributing to the $97.1 billion total debt reported for Comcast as of December 31 2023. This illustrates how the resort’s financing both represents direct borrowing by the joint venture and adds to Comcast’s consolidated leverage, even though the debt is not cross‑guaranteed by Comcast’s other subsidiaries.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several critical factual inaccuracies that significantly undermine its correctness. (1) Quantitative Accuracy: The $3.5 billion debt figure and December 31, 2023 date are correct, and the reference to Comcast's $97.1 billion total debt may be accurate in context, but the LLM incorrectly states that Universal Beijing Resort's debt is recorded under 'Debt Subject to Cross-Guarantees'—this directly contradicts the ground truth, which explicitly states it is categorized under 'Debt Not Guaranteed' and is not cross-guaranteed. This misclassification is a major error. (2) Completeness: The answer fails to mention key elements such as the ¥29.7 billion RMB financing facility, the syndicate of Chinese banks, the asset and equity security structure, and Comcast's 30% equity interest with no guarantees or liquidity support. These omissions omit essential context about the resort’s direct financing and Comcast’s limited exposure. (3) Entity Accuracy: While the entities (Universal Beijing Resort, Comcast) and date are correct, the misattribution of the debt category ('Subject to Cross-Guarantees') misrepresents the financial structure. (4) Reasoning: The multi-hop synthesis is flawed—the model incorrectly infers that because the debt appears on the consolidated balance sheet, it contributes to Comcast’s leverage in a guaranteed way, when the ground truth emphasizes that this debt is non-guaranteed and legally separate. The reasoning fails to distinguish between consolidation for accounting purposes (VIE) and actual financial risk exposure. (5) Semantic Equivalence: The overall message—that the debt is both direct and consolidated—is partially aligned, but the critical distinction about lack of cross-guarantees and Comcast’s limited liability is misrepresented, leading to a misleading conclusion. The answer suggests Comcast bears broader risk than it does. Thus, while some numbers are correct and the topic relevance is fair, the core financial classification error and missing details result in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 552,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "What was the change in Nike's investment in commercial paper and bonds from May 31, 2021, to May 31, 2022, and how did this shift affect the composition of their short-term investments?",
      "original_answer": "Nike's investment in commercial paper and bonds decreased from $748 million on May 31, 2021, to $660 million on May 31, 2022, representing a decline of $88 million. This reduction was part of a broader reallocation in their short-term investments, where total Level 2 short-term investments dropped from $695 million to $630 million, indicating a strategic shift toward more liquid or alternative short-term instruments such as U.S. Treasury securities and money market funds.",
      "llm_answer": "From the provided pages, the Company's short-term investments at May 31 2022 consisted of $660 million in commercial paper and bonds (classified as Level 2) and $37 million in cash and equivalents, while at May 31 2021 the corresponding amounts were $748 million in commercial paper and bonds and $57 million in cash and equivalents. This represents a decrease of $88 million in the commercial‑paper‑and‑bond component, shifting the composition of short‑term investments toward a larger proportion of cash and money‑market funds and away from longer‑term debt securities. Consequently, the overall mix of short‑term investments moved from a higher allocation to commercial paper and bonds in 2021 to a lower allocation in 2022, with the remainder increasingly held in cash and money‑market instruments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key numbers: $748 million in commercial paper and bonds on May 31, 2021, and $660 million on May 31, 2022, with a correct $88 million decrease. These match the ground truth exactly. The mention of $37 million and $57 million in cash and equivalents aligns with the broader context of short-term investment composition, though this detail was not emphasized in the original answer. (2) All calculations are accurate: the $88 million decline is correctly computed. Number formats are consistent and acceptable. (3) The reasoning is sound: the LLM correctly infers a shift in composition toward more liquid instruments like cash and money market funds, even though the exact term 'Level 2 short-term investments' is not fully reconciled—minor discrepancy in that the original answer notes total Level 2 investments dropped from $695M to $630M, which the LLM does not mention. This is a small omission in completeness but does not invalidate the overall conclusion. (4) The answer is contextually relevant, directly addressing both parts of the question: the change in investment and its impact on short-term investment composition. The synthesis across years and asset classes is logical and semantically equivalent to the ground truth. The score is 9 instead of 10 because the LLM does not reference the broader Level 2 investment totals from the original, which adds slight contextual depth, but the core facts, numbers, and reasoning are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 414,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the introduction of Class B-2 common stock impact the diluted earnings per share calculation for fiscal 2023, given that no Class B-2 shares were outstanding prior to the Class B-1 exchange offer?",
      "original_answer": "The introduction of Class B-2 common stock affects the diluted earnings per share calculation by increasing the weighted-average number of as-converted Class A common stock outstanding. Since Class B-2 shares were not outstanding prior to the Class B-1 exchange offer, their assumed conversion into Class A stock in the diluted EPS calculation contributes to the as-converted equity structure, thereby potentially lowering the diluted earnings per share compared to the basic earnings per share, which does not include these conversions.",
      "llm_answer": "The introduction of Class B‑2 common stock does not affect the diluted earnings‑per‑share calculation for fiscal 2023 because no Class B‑2 shares were outstanding before the Class B‑1 exchange offer; consequently, there were no Class B‑2 shares to include in the diluted‑share calculations for that year. (The only impact is reflected in fiscal 2024, where the newly issued Class B‑2 shares are shown with a diluted EPS of $15.43.)",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both reasoning and factual content. (1) The claim that Class B-2 shares do not affect diluted EPS for fiscal 2023 because they were not outstanding prior to the exchange is misleading—diluted EPS calculations include potential dilution from convertible securities and assumed conversions, even if issued partway through the year. The timing of the exchange offer does not preclude inclusion in the same fiscal year's diluted EPS if the conversion is assumed to occur. (2) There are no numeric values in the original answer to verify quantitatively, but the LLM introduces a specific diluted EPS figure of $15.43 for fiscal 2024, which is not present in the ground truth and cannot be verified—this is hallucinated data. (3) The multi-hop reasoning fails: the correct logic requires understanding that Class B-2 shares, upon issuance, are treated as convertible into Class A stock and thus included in the as-converted share count for diluted EPS in the year of issuance (2023), increasing the denominator and potentially lowering diluted EPS. The LLM incorrectly concludes no impact in 2023 and invents a future impact in 2024 not supported by the question or ground truth. (4) Contextual relevance is moderate because it addresses the right topic (diluted EPS and Class B-2 stock), but the conclusion and reasoning are factually wrong, making the response misleading overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 391,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the difference in pension cost recognition patterns under U.S. government Cost Accounting Standards (CAS) specifically impact the Raytheon segment's financial reporting compared to Collins and Pratt & Whitney?",
      "original_answer": "The Raytheon segment recognizes pension and PRB expenses under U.S. government Cost Accounting Standards (CAS), which differ in cost recognition patterns compared to Financial Accounting Standards (FAS) used by Collins and Pratt & Whitney. While the ultimate liability for pension and PRB costs under FAS and CAS is similar, the Raytheon segment adjusts its financial reporting to reflect CAS-based expenses, impacting its operating profit. Over time, Raytheon expects to recover these pension and PRB liabilities through the pricing of its products and services to the U.S. government, which is not a factor for Collins and Pratt & Whitney.",
      "llm_answer": "The Raytheon segment’s pension and post‑retirement benefit (PRB) expense is presented using a Cost Accounting Standards (CAS) basis that differs from the Financial Accounting Standards (FAS) basis used by Collins and Pratt & Whitney; this CAS‑based expense is adjusted out of segment operating profit because the timing of cost recognition under CAS does not align with the segment’s profit measurement, whereas Collins and Pratt & Whitney record pension and PRB expense on a FAS basis. Consequently, the pension‑related cost pattern under CAS impacts the reported profitability of the Raytheon segment by shifting expense timing relative to the other two segments.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Raytheon uses CAS for pension and PRB expense recognition while Collins and Pratt & Whitney use FAS, and that this leads to different cost recognition patterns affecting reported profitability—this aligns with the ground truth. However, it incorrectly states that the CAS-based expense is 'adjusted out of segment operating profit,' which contradicts the original answer; the truth is that Raytheon *does* include CAS-based expenses in its operating profit, but expects recovery through government pricing. This is a significant qualitative error in reasoning. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is partially sound: the model correctly contrasts CAS vs FAS usage across segments and links it to financial reporting differences. But it fails to mention the key point about expected recovery through U.S. government pricing, which is central to the impact on Raytheon’s financial reporting and absent in the LLM response. This omission affects completeness and reasoning. (4) Contextual relevance is high—the answer addresses the core issue of differing recognition patterns and their impact on financial reporting. However, due to the mischaracterization of how CAS expenses are treated in segment profit and the missing recovery mechanism, the qualitative accuracy and overall correctness are reduced. The answer captures the structural difference but misses the economic implication emphasized in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 448,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How many separate Supplemental Indentures related to the 1.850% Notes due 2020 are documented across the provided excerpts, and which trustees were involved in these agreements?",
      "original_answer": "There are two Supplemental Indentures related to the 1.850% Notes due 2020 documented across the provided excerpts. The first was part of the Ninth Supplemental Indenture dated February 12, 2015, with U.S. Bank National Association as Trustee. The second was part of the Twelfth Supplemental Indenture dated February 6, 2017, with The Bank of New York Mellon Trust Company, N.A. as Trustee.",
      "llm_answer": "Based on the provided excerpts, there are **two** separate Supplemental Indentures documented for the 1.850% Notes due 2020:  \n1. The **Ninth Supplemental Indenture** (dated February 12, 2015), filed as Exhibit 4.12 on page 105.  \n2. The **Twelfth Supplemental Indenture** (dated February 6, 2017), filed as Exhibit 4.15 on page 106.  \n\nBoth agreements involve **The Bank of New York Mellon Trust Company, N.A.** as Trustee. The Ninth Supplemental Indenture references the 1.850% Notes due 2020 among other notes, while the Twelfth Supplemental Indenture specifically governs the 1.850% Notes due 2020 and other series.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM correctly identifies that there are two Supplemental Indentures related to the 1.850% Notes due 2020, with accurate dates (February 12, 2015, and February 6, 2017) and correct indenture numbers (Ninth and Twelfth). The filing details (Exhibit 4.12, 4.15, page numbers) are also accurately reported, showing strong quantitative accuracy. However, there is a critical error in the trustee identification: the LLM states that both agreements involve The Bank of New York Mellon Trust Company, N.A. as Trustee, which contradicts the ground truth. According to the original answer, the Ninth Supplemental Indenture (2015) had U.S. Bank National Association as Trustee, while the Twelfth (2017) had The Bank of New York Mellon Trust Company, N.A. This is a significant qualitative inaccuracy in entity attribution, affecting the correctness of the multi-hop synthesis. The reasoning is partially sound in linking the indentures to the notes, but fails in correctly associating trustees across documents. Contextual relevance is excellent—the answer directly addresses the question and includes supporting detail. Due to the trustee error, the answer is not fully factually correct, warranting a score of 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 344,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What was the net gain (or loss) recognized in income from foreign exchange forwards and options in fiscal year 2022, and how did this compare to the fair value of foreign exchange forwards and options assets as of May 31, 2021?",
      "original_answer": "The net gain recognized in income from foreign exchange forwards and options in fiscal year 2022 was $40 million. As of May 31, 2021, the fair value of foreign exchange forwards and options assets was $92 million. This indicates that while Nike held a significant fair value in these instruments at the end of fiscal 2021, the net impact on income in the following year was a relatively smaller gain of $40 million.",
      "llm_answer": "The net gain recognized in income from foreign exchange forwards and options in fiscal 2022 was $40 million, which was a gain compared with the $150 million loss recorded in fiscal 2021. This gain contributed to the $45 million of gains reclassified from accumulated other comprehensive income into income for the year. The fair value of the foreign exchange forwards and options assets as of May 31, 2021 was $92 million.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the net gain in income from foreign exchange forwards and options in fiscal year 2022 as $40 million and the fair value of these instruments as of May 31, 2021 as $92 million, both of which match the ground truth. However, the LLM introduces additional information not present in the original answer — specifically, a '$150 million loss in fiscal 2021' and '$45 million of gains reclassified from AOCI' — which, while potentially true, are not part of the verified ground truth and could mislead if unverified. (2) Quantitative accuracy is high: $40 million and $92 million are correct; no calculations are required in the question, but the introduced numbers cannot be validated against the ground truth and thus reduce confidence. (3) The multi-hop reasoning is partially sound — the model correctly links fiscal 2022 income impact and the prior-year fair value — but adds unverified comparative data, indicating potential overreach in synthesis. (4) Contextual relevance is perfect: the answer addresses the core question directly and includes the correct entities (foreign exchange forwards/options, fiscal years, correct metrics). The correctness score is 7 because core facts are accurate, but unverified additions reduce precision and trustworthiness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 364,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does AIG's use of loss development methods in U.S. Personal Insurance and U.S. Property differ in terms of reserving approach and what impact did prior year developments have on each segment during 2021?",
      "original_answer": "In U.S. Personal Insurance, AIG uses loss development methods in combination with frequency/severity methods, particularly for domestic personal auto, where claim counts emerge quickly, allowing for immediate analysis of loss trends. In 2021, this segment experienced $412 million of favorable prior year development, mainly due to favorable development and subrogation recoveries from the 2017 and 2018 catastrophe years. In contrast, for U.S. Property, AIG uses loss development methods along with IBNR factor methods, especially for short-tail classes, and relies on expected loss ratio methods for the latest accident year. The U.S. Property segment does not have a specific 2021 prior year development figure mentioned in the provided text, but the reserving methodology reflects a need to adjust for loss trends including inflation. The difference in methodology reflects the distinct claim emergence patterns and severity profiles between the two segments.",
      "llm_answer": "During 2021, AIG’s U.S. Personal Insurance segment recorded $412 million of favorable prior‑year development, whereas its U.S. Property segment experienced $118 million of favorable prior‑year development. The favorable development in each line was driven primarily by better‑than‑expected emergence of losses and subrogation recoveries in the Personal Insurance book, and by favorable emergence across several specialty classes in the Property book.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the quantitative claim about U.S. Property's prior year development. The ground truth states that no specific 2021 prior year development figure is mentioned for U.S. Property, but the LLM incorrectly asserts $118 million of favorable development, which is not supported by the original data. The $412 million favorable development for U.S. Personal Insurance is correct. (2) The quantitative accuracy is low because the inclusion of the $118 million figure is entirely fabricated or misattributed, undermining the factual integrity of the response. There is no indication in the ground truth that such a number exists for U.S. Property in 2021. (3) The reasoning is partially sound in that it correctly identifies favorable loss emergence and subrogation recoveries for Personal Insurance, aligning with the ground truth. However, the claim about 'several specialty classes' in Property is not mentioned in the original and reflects unsupported inference. Crucially, the LLM fails to address the core part of the question about differences in reserving approaches: it omits any discussion of the use of frequency/severity methods in Personal Insurance versus IBNR factor and expected loss ratio methods in Property. This missing methodological comparison represents a major gap in multi-hop synthesis. (4) While the answer touches on the impact of prior year developments and correctly identifies the Personal Insurance figure, it fails to explain the differing reserving methodologies, which is a central component of the question. Thus, despite some correct elements, the answer is significantly flawed in both quantitative accuracy and completeness of reasoning, warranting a correctness score of 4.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 482,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does Walmart's majority stake in Flipkart, acquired in 2018, expose Walmart to potential financial risks based on ongoing regulatory proceedings initiated by India's Directorate of Enforcement, and how does this relate to Walmart's broader international investment strategy as described in its 2023 10-K filing?",
      "original_answer": "Walmart's majority stake in Flipkart, acquired in 2018, exposes it to potential financial risks due to ongoing regulatory proceedings initiated by India's Directorate of Enforcement. These proceedings investigate alleged violations of India's Foreign Direct Investment (FDI) rules by Flipkart and its subsidiaries during 2009–2015, prior to Walmart's acquisition. If the regulatory authority determines that violations occurred, it could impose monetary penalties. Walmart is unable to predict the final outcome or scope of the proceedings, and while it does not currently believe the matter will have a material adverse effect, it cannot provide assurance. This situation highlights the risks inherent in Walmart's broader international investment strategy, which includes expanding through acquisitions such as Flipkart to strengthen its global retail ecosystem and omni-channel capabilities.",
      "llm_answer": "Walmart’s 2018 acquisition of a majority stake in Flipkart subjects the company to India’s Directorate of Enforcement investigations into alleged foreign‑direct‑investment violations dating back to 2009‑2015, which could result in monetary penalties or other remedies and therefore pose a material financial risk to Walmart. This exposure is highlighted in the 2023 10‑K under “Certain Other Matters,” where the company notes that the notice is an early stage of proceedings that it cannot predict the outcome of, and it could materially affect its business, financial condition, or cash flows. The filing also underscores Walmart’s broader international‑investment strategy of acquiring strategic stakes in high‑growth e‑commerce platforms (e.g., Flipkart, PhonePe) to expand its omni‑channel ecosystem, making such regulatory risks an inherent component of its global expansion approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Walmart acquired a majority stake in Flipkart in 2018; the Directorate of Enforcement initiated proceedings over alleged FDI violations from 2009–2015, prior to acquisition; potential outcomes include monetary penalties; Walmart cannot predict the outcome or scope. The mention of 'materially affect its business, financial condition, or cash flows' is consistent with the cautious tone in the original. (2) Quantitative accuracy is perfect: dates (2018 acquisition, 2009–2015 period) are correct, no numerical calculations required. (3) Multi-hop reasoning is sound—correctly links Walmart’s acquisition to regulatory risk in India and ties it to Walmart’s broader international strategy of acquiring e-commerce platforms like Flipkart and PhonePe to expand its omni-channel ecosystem. The reference to the 2023 10-K and the 'Certain Other Matters' section adds contextual fidelity. (4) Minor deduction in qualitative accuracy because the original answer clarifies Walmart 'does not currently believe the matter will have a material adverse effect,' a nuance slightly softened in the LLM version which emphasizes risk without balancing it with Walmart’s current assessment. However, the LLM does state the proceedings are in an 'early stage' and outcome 'cannot be predicted,' preserving reasonable equivalence. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 414,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What was the total dollar value of Class A ordinary shares issued in the 2023 fiscal year, and how did this issuance impact the total Accenture plc shareholders' equity by August 31, 2024?",
      "original_answer": "The total dollar value of Class A ordinary shares issued in the 2023 fiscal year was $7,970. This issuance, along with other changes, contributed to an increase in total Accenture plc shareholders' equity from $25,692,839 (as of August 31, 2023) to $28,288,646 (as of August 31, 2024), an increase of $2,595,807.",
      "llm_answer": "The total dollar value of Class A ordinary shares issued during fiscal 2023 was $3,954 million. This issuance reduced Accenture plc shareholders’ equity by $4,111 million, as reflected by the net decrease in treasury‑share balances and the corresponding impact on total shareholders’ equity in the Consolidated Shareholders’ Equity Statement.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. The total dollar value of Class A ordinary shares issued in fiscal 2023 is stated as $3,954 million ($3.954 billion), whereas the ground truth is $7,970 (approximately $7.97 million). This is off by three orders of magnitude and fundamentally incorrect. Additionally, the LLM claims the issuance reduced shareholders’ equity by $4,111 million, while the ground truth states that shareholders’ equity increased by $2,595,807—from $25,692,839 to $28,288,646—indicating a substantial increase, not a decrease. (2) Quantitative accuracy is extremely low: both key numbers (issuance value and equity impact) are incorrect. The calculation of the change in shareholders’ equity in the ground truth is accurate ($28,288,646 - $25,692,839 = $2,595,807), but the LLM invents a reduction of $4,111 million with no supporting evidence from the truth data. (3) The reasoning is flawed: the LLM incorrectly infers that share issuance reduced equity, when in reality, issuing shares typically increases equity (unless offset by large buybacks or losses, which is not the case here). The answer references treasury-share balances but misinterprets their impact. It fails to correctly synthesize the multi-hop elements—linking share issuance to equity changes over time—leading to an invalid conclusion. (4) Contextual relevance is moderate because the answer addresses the right topic (share issuance and equity impact) and mentions relevant financial statements, but the incorrect figures and reversed directional impact (decrease vs. actual increase) severely undermine its usefulness. Overall, the answer is mostly incorrect with major factual and logical flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 468,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does AIG's use of loss development methods for excess casualty lines, particularly those with attachment points above $10 million, influence its reserving methodology for U.S. Property and aerospace exposures, and what role do expected loss ratios play in both analyses?",
      "original_answer": "AIG uses a layered approach in its excess casualty reserving, where losses capped at $10 million are analyzed using traditional loss development and expected loss ratio methods, and this estimate is then used to derive the expected loss estimate for losses above $10 million, reflecting the expected relationships between the layers. In U.S. Property and aerospace exposures, AIG also employs a combination of loss development methods and expected loss ratio methods, especially for aviation claims where severity drives reserving. Expected loss ratios are critical in both cases, particularly for recent accident years where reported loss data is insufficient, and projections are adjusted for inflation, rate changes, and market conditions. This shows that AIG relies heavily on expected loss ratios to bridge early uncertainty across both excess casualty and aviation lines, while layer-specific development patterns guide the ultimate loss estimation process.",
      "llm_answer": "AIG applies loss development methods—particularly for excess‑casualty lines with attachment points above $10 million—to shape its reserving for U.S. Property and aerospace exposures, using expected loss ratios to set the ultimate loss estimates for the most recent accident years. These expected loss ratios, derived from projected ultimate loss ratios adjusted for rate changes, inflation and market trends, are incorporated into the reserve models and drive the selection of the best‑estimate reserves.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct and captures key elements of AIG's reserving methodology, particularly the use of loss development methods and expected loss ratios for recent accident years. Quantitatively, there are no specific numbers (e.g., dollar amounts, percentages) that are incorrect—none are mentioned, which matches the original answer's lack of precise figures beyond the $10 million attachment point, correctly included. Thus, quantitative accuracy is high. Contextual relevance is strong, as the response directly addresses how excess casualty methods influence reserving in U.S. Property and aerospace lines and the role of expected loss ratios. However, the LLM omits a critical multi-hop element: the layered approach where losses below $10 million are first estimated using development and expected loss ratio methods, and that estimate is then used to derive the expected losses above $10 million based on inter-layer relationships. This synthesis is explicitly stated in the ground truth and central to AIG’s methodology, but the LLM only implies a general influence without detailing the mechanistic, layer-dependent derivation. Additionally, while the LLM mentions expected loss ratios are adjusted for inflation, rate changes, and market trends, it does not specify their particular importance in aviation due to severity or in early accident years where data is sparse—details emphasized in the original. The reasoning is sound but incomplete, missing the structural connection between layers and the dual application across casualty and aviation. Hence, qualitative accuracy and overall correctness are reduced due to missing synthesis, though core concepts are correctly conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 462,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What was the total dollar value of Accenture plc Class A ordinary shares repurchased during the period covered by the financial statements ending August 31, 2022, and how does this compare to the remaining share purchase authorization as of August 31, 2024?",
      "original_answer": "The total dollar value of Accenture plc Class A ordinary shares repurchased during the period ending August 31, 2022, was $4,111,266. As of August 31, 2024, the remaining share purchase authorization was $2,694,281. This indicates that a significant portion of the available authorization had already been utilized prior to 2024.",
      "llm_answer": "The total dollar value of Accenture plc Class A ordinary shares repurchased during the period covered by the financial statements ending August 31, 2022 was $4.1 billion, as shown by the $4,107,312 reduction in Treasury Shares in the Consolidated Shareholders’ Equity Statement for fiscal 2022.  \n\nAs of August 31, 2024, the remaining share purchase authorization for publicly announced open‑market share purchases and related programs was $2,694,281 million, meaning the authorization that remained after the 2022 repurchases was roughly $2.7 billion.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the remaining share purchase authorization value as of August 31, 2024. It states '$2,694,281 million', which equals approximately $2.7 trillion, but the correct value is $2,694,281 (about $2.7 million). This is a massive overstatement by a factor of 1,000 due to the erroneous addition of 'million' after the number. The repurchase amount in 2022 is approximately correct: LLM reports $4.1 billion based on $4,107,312, while the ground truth is $4,111,266—a minor difference of about $4,000, which is acceptable under format variation. (2) Quantitative accuracy is compromised primarily by the 'million' error. The 2022 repurchase figure is close and can be considered accurate within rounding or reporting differences. However, the 2024 remaining authorization is catastrophically misrepresented. (3) The multi-hop reasoning is partially sound: the model correctly identifies the need to report both the 2022 repurchase value and the 2024 remaining authorization. It attempts to cite a source (Treasury Shares reduction) for the 2022 figure and correctly names the company and fiscal periods. However, the synthesis fails due to the unit error in the second value, undermining the comparison. (4) Correctness is scored at 5 due to one major factual error despite mostly correct structure and intent. Quantitative accuracy is 5 because half of the key numbers (the 2024 authorization) is severely wrong. Qualitative accuracy is 6 because reasoning and entity identification are correct, but the error suggests flawed data extraction. Contextual relevance is 9 because the answer addresses both parts of the question and stays focused on the required financial metrics and timeline.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 474,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How do changes in META's advertising policies to comply with regulatory developments in Europe impact both user engagement and advertising revenue, particularly in relation to the shift from 'legitimate interests' to 'consent' for behavioral advertising?",
      "original_answer": "META's shift from 'legitimate interests' to 'consent' for behavioral advertising in Europe has led to the introduction of a 'subscription for no ads' alternative and an option for users to see less personalized ads, which are less relevant and effective than premium ad offerings. This change has reduced META's ability to effectively target and measure ads, which has adversely affected advertising revenue. Additionally, the implementation of these advertising policies has contributed to reduced user engagement, particularly in features like Feed and Stories that monetize at higher rates, further impacting revenue. These policy changes were made to comply with European regulations, but they have had a material adverse effect on both user engagement and advertising revenue.",
      "llm_answer": "The shift from “legitimate interests” to “consent” for behavioral advertising in Europe forces Meta to rely on user‑granted consent, which reduces the precision of its targeting and leads to less relevant ads. Consequently, advertisers see lower ad effectiveness, causing reduced ad spend and a decline in advertising revenue, while users who opt for a “subscription for no ads” or see less‑personalized ads experience lower engagement with the platform.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and captures the core causal chain described in the ground truth: the shift from 'legitimate interests' to 'consent' reduces targeting precision, leading to less relevant ads, lower ad effectiveness, reduced ad spend, and lower user engagement. It correctly identifies the introduction of the 'subscription for no ads' option and less-personalized ads as outcomes. The answer also accurately links reduced ad relevance to lower advertiser spending and user engagement, which aligns with the original answer's claim of adverse effects on advertising revenue and engagement in high-monetization features. While the LLM answer does not explicitly mention 'Feed and Stories' or use the phrase 'material adverse effect,' these omissions are minor and do not detract from the overall accuracy. There are no numerical values in the question or ground truth, so quantitative accuracy is scored as 10 by default. The reasoning is sound and synthesizes the multi-hop logic correctly: regulatory change → policy change → reduced targeting → lower engagement and revenue. The semantic meaning is equivalent to the original answer, with only slight differences in emphasis. Thus, the answer earns a 9 in correctness and qualitative accuracy for near-perfect alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 359,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does the redemption policy of Accenture plc Class X ordinary shares directly affect the total number of shares outstanding and what specific mechanism ensures this relationship remains aligned with the number of Accenture Canada Holdings Inc. exchangeable shares?",
      "original_answer": "The redemption policy of Accenture plc Class X ordinary shares ensures that the number of Class X ordinary shares outstanding never exceeds the number of Accenture Canada Holdings Inc. exchangeable shares. This is achieved through a mechanism where Accenture plc redeems Class X ordinary shares upon the redemption or exchange of Accenture Canada Holdings Inc. exchangeable shares on a one-for-one basis, maintaining alignment between the two share classes.",
      "llm_answer": "The redemption of Accenture plc Class X ordinary shares directly reduces the total number of shares outstanding because each redeemed share is cancelled and removed from issue. This relationship is kept in sync with the number of Accenture Canada Holdings Inc. exchangeable shares through a contractual redemption mechanism: Accenture may redeem Class X shares only to the extent that the aggregate number of Class X shares outstanding never exceeds the aggregate number of exchangeable shares still held, and any redemption of exchangeable shares is matched by a corresponding redemption of the corresponding Class X shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the same core information as the ground truth. (1) It correctly states that redemption of Class X ordinary shares reduces the total number of shares outstanding through cancellation, which aligns with the mechanism described in the original answer. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, or counts), so quantitative accuracy is not compromised—no numbers are misstated. (3) The multi-hop reasoning is sound: the answer correctly links the redemption of Accenture Canada Holdings Inc. exchangeable shares to the corresponding redemption of Accenture plc Class X shares on a one-for-one basis, even if it doesn't explicitly use the phrase 'one-for-one basis.' The contractual mechanism ensuring alignment is accurately described. (4) The only minor shortcoming is that the LLM answer does not explicitly emphasize the 'never exceeds' condition as a forward-looking constraint, instead framing it as a matching process during redemption. However, the substance—that the number of Class X shares never exceeds the number of exchangeable shares—is implied through the described mechanism. Wording differs slightly but semantic equivalence is maintained. All entities (Accenture plc, Class X ordinary shares, Accenture Canada Holdings Inc., exchangeable shares) are correctly identified and logically connected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 387,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What was the change in net milestone capitalization for Jardiance between 2020 and 2021, and how does this trend reflect the amortization practices described in the filing?",
      "original_answer": "The net milestone capitalization for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, representing a $20.1 million decline. This decrease reflects the amortization of capitalized milestones over time, as described in the filing. These milestone payments were capitalized as intangible assets and are being amortized to cost of sales through their respective terms under the collaboration, based on factors such as the latest of the launch date, patent expiration, or supplementary protection certificates. The reduction from 2020 to 2021 illustrates the ongoing amortization of this intangible asset over its useful life.",
      "llm_answer": "The net milestone capitalization for Jardiance decreased from $156.2 million at the end of 2020 to $136.1 million at the end of 2021, reflecting a $20.1 million reduction that is amortized into cost of sales over the collaboration term. This decline illustrates the ongoing amortization of capitalized milestones—recorded as intangible assets and expensed gradually—consistent with the filing’s description of milestone payments being capitalized and then amortized through cost of sales as the related products generate revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the net milestone capitalization values for Jardiance in 2020 ($156.2 million) and 2021 ($136.1 million), and accurately calculates the $20.1 million decline. These figures match the ground truth exactly, with acceptable formatting (e.g., 'million' vs 'M'). (2) All numeric values and the difference between years are correct. The calculation of the $20.1 million reduction is accurate: 156.2 - 136.1 = 20.1. (3) The reasoning correctly links the decrease to amortization practices described in the filing. It accurately reflects that milestone payments are capitalized as intangible assets and amortized to cost of sales over time, particularly tied to the collaboration term and product revenue generation. While the LLM answer omits specific details about amortization being based on the latest of launch date, patent expiration, or supplementary protection certificates, it captures the core concept of gradual amortization aligned with revenue, which is semantically close. (4) The answer is highly relevant, directly addressing both parts of the question: the quantitative change and its relation to amortization practices. The only minor shortcoming is the lack of granular detail on the specific factors governing amortization timing, which slightly reduces qualitative accuracy but does not impair overall correctness. Thus, the answer is factually sound, complete in key aspects, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 406,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How does the use of IBNR factor methods in U.S. Property and UK/Europe Property insurance lines differ in terms of claim frequency and severity characteristics, and what impact does this have on the reserving process for each region?",
      "original_answer": "The IBNR factor methods are used in both U.S. Property and UK/Europe Property insurance lines, but the reserving process reflects differences in claim frequency and severity. In the UK/Europe Property segment, IBNR factor methods are applied due to low frequency/high severity losses, where IBNR factors are applied to earned premium to estimate ultimate expected losses based on prior accident quarters adjusted for current cost levels and historical emergence patterns. In the U.S. Property segment, similar IBNR factor methods are used, but the reserving process also accounts for a shift toward non-admitted coverages that have altered the customer profile to be less severe in the aggregate. This difference in severity and customer base influences how IBNR factors are continually reevaluated and applied in each region to ensure reserve adequacy.",
      "llm_answer": "The reserving approach for U.S. Property relies more heavily on frequency/severity and ground‑up claim projections, while UK/Europe Property uses loss development and IBNR factor methods that are applied to earned premium to estimate future losses. Consequently, U.S. Property reserves are adjusted with more granular claim‑by‑claim severity modeling, whereas UK/Europe reserves depend on longer‑tail development trends and are subject to greater volatility from external judicial and underwriting cycle factors, leading to a generally more stable but less granular reserving process in the UK/Europe segment.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the use of IBNR factor methods in U.S. Property and UK/Europe Property lines. The ground truth states that IBNR factor methods are used in both regions, but the LLM incorrectly claims that U.S. Property relies more on frequency/severity and ground-up claim projections, implying a departure from IBNR methods, which contradicts the original answer. This misrepresents the core reserving methodology in the U.S. segment. Additionally, the original answer highlights that both regions use IBNR factor methods applied to earned premium, with differences arising from claim severity and customer profile shifts (e.g., non-admitted coverages in the U.S.), but the LLM fails to mention this key point. Instead, it introduces unsupported claims about granular claim-by-claim modeling in the U.S. and greater volatility from judicial factors in the UK/Europe, which are not present in the ground truth. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable; however, the absence of numbers does not excuse the factual divergence. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the commonality of IBNR methods across both regions and misattributes differences in reserving processes to incorrect causes (e.g., granularity vs. development trends), rather than the actual drivers—differences in severity and customer base due to non-admitted coverages. (4) While the response is contextually relevant and addresses the general topic of reserving differences, the qualitative inaccuracies severely undermine the correctness. The answer fabricates methodological distinctions not present in the source, leading to a low correctness and qualitative accuracy score despite good structure and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 499,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What is the combined global market share of Procter & Gamble's Grooming segment for blades and razors, and how does this compare to their global market share in male electric shavers?",
      "original_answer": "Procter & Gamble holds more than 60% global market share in blades and razors and over 25% global market share in male electric shavers, resulting in a difference of more than 35 percentage points.",
      "llm_answer": "Based on the provided document pages, Procter & Gamble's Grooming segment holds a combined global market share of **more than 60% in blades and razors** (as stated in the \"Organization Design\" section on page 18: \"Our global blades and razors market share is more than 60%, primarily behind our Gillette and Venus brands\"). Additionally, the Grooming segment holds **over 25% of the male electric shavers market** (also noted on page 18). The document does not provide a separate, specific global market share figure for male electric shavers beyond this 25% share, but confirms the Grooming segment's leadership position across all grooming categories, including electric shavers. The combined market share for blades/razors (60%+) and the male electric shavers share (25%+) are distinct metrics, with the former being explicitly stated as \"more than 60%\" for blades/razors and the latter as \"over 25%\" for male electric shavers. The document does not quantify a direct comparison between these two specific market shares (e.g., \"the blades/razors share is X% higher than electric shavers\"), but confirms both are significant leadership positions within the Grooming segment.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key market shares: 'more than 60%' for blades and razors and 'over 25%' for male electric shavers, which matches the ground truth. These percentages are accurately extracted and reported. (2) However, the LLM fails to make the explicit comparison stated in the ground truth — that the difference is 'more than 35 percentage points' — which is a direct inference from the two figures (60% - 25% = 35%). While the numbers themselves are correct, the answer omits this calculated difference, which is a core part of the original answer. (3) The multi-hop reasoning is partially sound: the model correctly identifies both market shares from the same source (page 18) and associates them with the correct segment and product categories. However, it does not synthesize the two figures into a comparative statement, instead noting that 'the document does not quantify a direct comparison,' which contradicts the ground truth that such a comparison is implied and calculable. (4) The contextual relevance is high because the response stays focused on the question and cites the correct document section. Quantitative accuracy is high due to correct percentages, but qualitative accuracy and overall correctness are reduced due to the failure to compute or acknowledge the implied difference, which is essential to fully answering the comparative aspect of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 391,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How much did General Dynamics invest in Aerospace segment product development in 2023, and what mechanism do they use with suppliers to offset a portion of these costs?",
      "original_answer": "General Dynamics invested $510 million in Aerospace segment product development in 2023. They use cost-sharing arrangements with suppliers to offset a portion of these financial costs, where supplier contributions are explicitly for reimbursement of development costs and are recorded as a reduction of R&D expenses.",
      "llm_answer": "General Dynamics invested $510 million in Aerospace segment product development in 2023. The company offsets a portion of these costs through cost‑sharing agreements with suppliers, which provide reimbursements of development expenses and are recognized as a reduction of R&D expenses.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that General Dynamics invested $510 million in Aerospace segment product development in 2023, matching the ground truth exactly in both amount and year. The mechanism used to offset costs—cost-sharing agreements with suppliers—is accurately described, including the key detail that supplier contributions serve as reimbursement for development expenses and are recorded as a reduction of R&D expenses. (2) The numeric value ($510 million) is correct and presented in an equivalent format (using a narrow space, which is typographically acceptable). No calculations are required beyond accurate reporting, which is fulfilled. (3) The multi-hop reasoning is sound: the answer synthesizes information about a specific company (General Dynamics), a specific segment (Aerospace), a specific year (2023), a financial figure, and a contractual mechanism with suppliers—all required elements. (4) The LLM answer is semantically equivalent to the original, using slightly different phrasing (e.g., 'cost-sharing agreements' vs 'cost-sharing arrangements') without altering meaning. All components are factually accurate, complete, and contextually appropriate, warranting top scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 350,
        "total_tokens": 1506
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How much did Accenture spend on Class A Ordinary Share purchases during fiscal 2024, and how did this affect the total value of treasury shares held by the company?",
      "original_answer": "Accenture spent $4,111,266 on Class A Ordinary Share purchases during fiscal 2024, which increased the total value of treasury shares held by the company by the same amount.",
      "llm_answer": "Accenture spent $4,509,392 on Class A Ordinary Share purchases during fiscal 2024, which increased the total value of treasury shares held by the company. This amount is reflected in the \"Total\" row of the share purchase activity table on page 101, where the cumulative treasury share purchases for Accenture plc Class A Ordinary Shares reached $4,509,392. The open-market share purchases (11,753,807 shares for $3,780,519) and other purchases (2,159,586 shares for $728,873) contributed to this total, resulting in a net increase in treasury shares. The company holds these shares as treasury stock, which can be used for employee benefits and equity awards.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its key numeric claim. The original answer states that Accenture spent $4,111,266 on Class A Ordinary Share purchases during fiscal 2024, but the LLM claims $4,509,392, which is a significant discrepancy. This error undermines the entire response. (2) The quantitative accuracy is very low: the correct amount is $4,111,266, not $4,509,392. The LLM appears to have misread or misinterpreted the data, possibly confusing cumulative totals from different periods or including incorrect line items. The breakdown of open-market purchases ($3,780,519) and other purchases ($728,873) sums to $4,509,392, but this total does not match the ground truth, indicating either a source error or incorrect aggregation. (3) While the LLM demonstrates an understanding of multi-hop concepts—linking share purchases to treasury stock impact and explaining usage of treasury shares—the reasoning is based on incorrect data, so the synthesis fails. The model correctly identifies that share purchases increase treasury share value, which shows sound qualitative logic, but the foundation is flawed. (4) Contextual relevance is high because the answer addresses both parts of the question (amount spent and effect on treasury shares) and provides additional relevant context about share types and usage. However, due to the critical numerical inaccuracy, the correctness and quantitative accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 402,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What was the year-over-year dollar increase in the value of META's Servers and Network Assets from December 31, 2023, to December 31, 2024, and how does this relate to META's depreciation policy for assets placed in service?",
      "original_answer": "The value of META's Servers and Network Assets increased by $21.559 billion year-over-year, from $46.838 billion on December 31, 2023, to $68.397 billion on December 31, 2024. According to META's depreciation policy, assets placed in service are depreciated over their estimated useful life, while assets still in construction in progress (CIP) are not depreciated until they are placed in service. This significant increase in asset value suggests that a large amount of previously unplaced CIP assets were placed into service during 2024 and are now being depreciated prospectively over their revised estimated useful lives.",
      "llm_answer": "The year‑over‑year dollar increase in the value of META’s Servers and Network Assets is **$21.56 billion** (from $46.838 billion on 12/31/2023 to $68.397 billion on 12/31/2024). This growth aligns with META’s depreciation policy, which states that servers and network assets are depreciated over a useful life of four to five years (effective January 2025 extended to 5.5 years), so the rising asset base will be depreciated over these extended periods.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly calculated the year-over-year dollar increase in META's Servers and Network Assets as $21.56 billion (from $46.838B to $68.397B), which matches the ground truth of $21.559 billion—this minor rounding difference is acceptable. All numeric values and dates are accurate. (2) Quantitatively, the answer is fully correct: the starting and ending asset values are accurate, and the difference is properly computed. (3) However, the qualitative reasoning is partially incorrect. The LLM references META’s depreciation policy of 4–5 years (extended to 5.5 years in 2025), but this misses the key point in the ground truth: the increase reflects a shift from construction-in-progress (CIP) assets to placed-in-service assets, which then begin depreciation. The LLM fails to mention that CIP assets are not depreciated until placed in service—a core part of the multi-hop reasoning. Instead, it focuses on useful life duration, which, while related, does not explain the significance of the asset value increase in relation to depreciation policy. (4) The answer is contextually relevant and addresses both parts of the question, but the reasoning component lacks the correct synthesis between CIP, placement into service, and the initiation of depreciation. Hence, while numbers are perfect, the conceptual explanation is incomplete, warranting a correctness score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 387,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How many drug indications for which Eli Lilly received FDA Breakthrough Therapy designation in 2022 are currently in the submitted status versus discontinued development, and what are the specific compounds and therapeutic areas associated with each status?",
      "original_answer": "Eli Lilly had two drug indications with FDA Breakthrough Therapy designation in 2022 that were in the submitted status: Empagliflozin (Jardiance®) for heart failure with preserved ejection fraction and Baricitinib (Olumiant®) for alopecia areata. No indications with FDA Breakthrough Therapy designation were in the discontinued status in 2022.",
      "llm_answer": "In 2022, Eli Lilly received FDA Breakthrough Therapy designation for several drug indications, but the company’s disclosures do not specify how many of those designations are currently in “submitted” versus “discontinued” development. The only indication that was explicitly noted as discontinued is baricitinib for systemic lupus erythematosus, which was stopped in January 2022 after top‑line Phase III results. All other Breakthrough‑designated programs listed (e.g., empagliflozin for chronic kidney disease, baricitinib for alopecia areata, donanemab for early Alzheimer’s disease, selpercatinib for lung and thyroid cancer, pirtobrutinib for mantle‑cell lymphoma, etc.) are described as either “Submitted,” “Phase III,” “Phase II,” or “Approved,” with no indication that any of them have been formally discontinued. Consequently, the available information does not provide a clear count of submitted versus discontinued Breakthrough‑designated indications, nor does it list specific compounds and therapeutic areas for each status beyond the discontinued lupus program.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is largely incorrect in its core claims and contradicts the ground truth. (1) Quantitatively, the original answer states that Eli Lilly had two Breakthrough Therapy designations in 2022 with indications in 'submitted' status and zero in 'discontinued' status. The LLM incorrectly claims that baricitinib for systemic lupus erythematosus was discontinued in 2022 and implies uncertainty about the submitted vs. discontinued counts, which contradicts the definitive ground truth. This is a major factual error. (2) The LLM lists multiple indications (e.g., donanemab, selpercatinib, pirtobrutinib) that were not part of the 2022 Breakthrough Therapy designations in the ground truth, introducing hallucinated or misattributed programs. (3) While the LLM correctly identifies baricitinib for alopecia areata and mentions empagliflozin, it misattributes empagliflozin’s indication to chronic kidney disease instead of heart failure with preserved ejection fraction, which is a key error in therapeutic area. (4) The reasoning fails on multi-hop synthesis: the question asks for a count and specific compounds by status, but the LLM evades giving a clear answer, citing lack of disclosure, whereas the ground truth confirms two submitted and zero discontinued. (5) Contextually, the answer is relevant and structured appropriately, showing awareness of Eli Lilly’s pipeline and Breakthrough Therapy designations, but the factual inaccuracies severely undermine correctness. Minor point: the LLM correctly notes baricitinib was discontinued for lupus, but this was not part of the 2022 Breakthrough Therapy cohort in question, so its inclusion misleads the synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 455,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does AIG's reliance on loss development methods differ between U.S. Other Casualty lines and U.S. Property lines, and what specific reserving adjustments were made in 2021 for U.S. Personal Insurance due to prior year catastrophe recoveries?",
      "original_answer": "AIG uses a combination of loss development methods, frequency/severity, and expected loss ratio methods for U.S. Other Casualty lines, particularly for long-tail general liability or products liability lines, while giving more weight to expected loss ratio methods for recent accident years due to the long-tail nature and less credible reported losses. In contrast, for U.S. Property lines, which are short-tail, AIG primarily uses frequency/severity methods, loss development methods, and IBNR factor methods, with IBNR factors applied to earned premiums for low frequency/high severity losses. In 2021, AIG recognized $412 million of favorable prior year development in U.S. Personal Insurance due to subrogation recoveries from the 2017 and 2018 catastrophe years.",
      "llm_answer": "AIG applies loss development methods to its long‑tail U.S. Other Casualty lines, which rely heavily on development and frequency/severity techniques, whereas for its shorter‑tail U.S. Property lines it uses a mix of frequency/severity, loss development and IBNR factor methods, often giving more weight to expected loss ratios for the most recent years. In 2021 the company recorded $412 million of favorable prior‑year development in U.S. Personal Insurance, largely driven by subrogation recoveries and favorable development from the 2017‑2018 catastrophe years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the $412 million favorable prior year development in 2021 for U.S. Personal Insurance is correctly reported, and the reference to 2017-2018 catastrophe years aligns with the original answer (which specifies 2017 and 2018). (2) The reserving methodology comparison between U.S. Other Casualty and U.S. Property lines is accurately summarized: long-tail casualty lines use loss development and frequency/severity methods, with expected loss ratio methods emphasized for recent years due to less credible data; property lines, being short-tail, use frequency/severity, loss development, and IBNR factor methods. The LLM slightly simplifies the emphasis on expected loss ratio methods—original answer specifies they are more heavily weighted in recent accident years for casualty lines, while the LLM implies this applies to property lines, which is a minor inaccuracy. (3) Multi-hop reasoning is sound: the model correctly synthesizes methodological differences across two lines of business and links 2021 adjustments to prior catastrophe recoveries via subrogation. (4) Semantic equivalence is strong—wording differs but meaning is preserved. The only minor issue is the slight misplacement of emphasis on expected loss ratio methods, which slightly affects qualitative accuracy. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 404,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What proportion of Procter & Gamble's fiscal year 2024 net sales was contributed by the Baby, Feminine & Family Care segment, and approximately what portion of that can be attributed to the Charmin brand given its North American toilet paper market position?",
      "original_answer": "The Baby, Feminine & Family Care segment contributed 24% of Procter & Gamble's net sales in fiscal year 2024. Within this segment, Charmin holds approximately 25% North American market share in toilet paper, which is a key component of the family care business that is predominantly concentrated in North America.",
      "llm_answer": "The Baby, Feminine & Family Care segment contributed roughly 24% of Procter & Gamble’s fiscal 2024 net sales, and within that segment Charmin accounts for about one‑third of the segment’s sales, reflecting its leading North American toilet‑paper market position.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the Baby, Feminine & Family Care segment contributed 24% of Procter & Gamble’s fiscal 2024 net sales, which matches the ground truth. However, it incorrectly states that Charmin accounts for 'about one-third' of the segment’s sales, while the ground truth does not provide a direct percentage of segment sales attributable to Charmin. Instead, it states that Charmin holds approximately 25% market share in the North American toilet paper market—a related but distinct metric. The LLM conflates brand market share in a product category with revenue contribution within a business segment, which is a significant factual error. (2) The 24% figure is accurate, but the 'one-third' (approx. 33%) claim lacks support in the original answer and introduces a number not present in the ground truth. The ground truth only specifies 25% North American market share for Charmin in toilet paper, not its proportion of segment sales. (3) The multi-hop reasoning is partially sound—linking Charmin to the Family Care sub-segment and referencing its market position—but fails in accurately synthesizing how that market position translates to financial contribution. The leap from '25% market share in North American toilet paper' to 'one-third of segment sales' is unsupported and incorrect. (4) Scores reflect partial correctness: the first part is fully accurate (24%), but the second part introduces a false quantitative claim. Contextual relevance is high as the answer addresses both parts of the question and stays focused on the relevant segment and brand.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 438,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "Given General Dynamics' $510 million R&D investment in 2023, how does the Combat Systems segment leverage this spending to support the development and modernization of platforms like the M1E3 Abrams tank, and what financial or strategic outcomes are tied to this investment?",
      "original_answer": "General Dynamics' Combat Systems segment leverages its $510 million R&D investment in 2023 to modernize existing platforms and develop next-generation capabilities, such as the M1E3 Abrams main battle tank. This investment supports the development of advanced systems architecture, improved communications, power generation, fuel efficiency, optics, and armor for the Abrams fleet. The M1E3 Abrams program is an engineering change that incorporates significant capability improvements to counter future threats, including quicker technology upgrades, reduced sustainment footprint, and increased tactical mobility. These R&D-driven enhancements aim to maintain General Dynamics' market-leading position in land combat systems and ensure long-term value creation through innovation, affordability, and speed-to-market. The financial outcome of this investment is reflected in the company’s ability to secure long-term contracts, support modernization programs, and drive sustained revenue from both U.S. and international defense customers.",
      "llm_answer": "General Dynamics' $510 million R&D investment is channeled through its Combat Systems segment to modernize key platforms such as the Abrams tank.  In 2023 the Army announced the development of the M1E3 Abrams—an engineering‑change upgrade that adds next‑generation communications, power generation, fuel‑efficiency, optics and armor—leveraging the segment’s expertise and the $510 million spend to accelerate technology upgrades, reduce sustainment footprint and improve tactical mobility.  The investment also funds upgrades to the Stryker vehicle and related autonomous‑system programs, delivering higher lethality, survivability and export‑market growth, which supports long‑term revenue and margin expansion for the segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: the $510 million R&D investment in 2023 is correctly attributed to General Dynamics' Combat Systems segment and linked to the M1E3 Abrams development. The description of the M1E3 as an engineering-change upgrade with improvements in communications, power generation, fuel efficiency, optics, and armor matches the original. The strategic outcomes—accelerated tech upgrades, reduced sustainment footprint, improved tactical mobility—are accurately reflected. (2) Quantitative accuracy is perfect: the $510 million figure is correctly cited with acceptable formatting ($510 million). No calculations were required. (3) Multi-hop reasoning is sound: the model correctly connects R&D spending to platform modernization (M1E3), identifies specific technical enhancements, and infers strategic outcomes like export growth and long-term revenue—consistent with the original’s emphasis on sustained revenue and market leadership. (4) The only minor omission is that the LLM mentions Stryker and autonomous systems, which, while plausible, are not in the ground truth and slightly extend beyond the provided context. However, this does not contradict the original and adds reasonable context. The core financial and strategic outcomes (long-term contracts, revenue from U.S. and international customers) are adequately captured in the reference to 'long-term revenue and margin expansion.' Overall, the answer is factually correct, contextually relevant, and semantically equivalent with only slight expansion beyond the source.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 444,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What was the total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024, combining both purchases under the publicly announced open-market share purchase program and those unrelated to such programs?",
      "original_answer": "The total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024 was $609.1 million. This includes $605 million from purchases under the publicly announced open-market share purchase program and $4.1 million from purchases unrelated to publicly announced programs.",
      "llm_answer": "During fiscal 2024 Accenture repurchased a total of 2,072,563 Class A ordinary shares, of which 2,000,308 shares were bought under its publicly announced open‑market share‑purchase program and the remaining 72,255 shares were acquired in transactions unrelated to that program (e.g., employee‑share‑plan withholdings). The aggregate dollar value of all Class A shares purchased in the fiscal year was approximately $628 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in dollar amounts. The ground truth states the total dollar value of Class A Ordinary Shares purchased was $609.1 million ($605 million under the program and $4.1 million unrelated), but the LLM claims approximately $628 million, which is off by $18.9 million (overstated by ~3%). This is a major quantitative error. Additionally, while the LLM provides share counts (2,072,563 total, split between program and non-program), these are not requested in the question and do not compensate for the incorrect total dollar value. (2) The calculation implied by the LLM—$628 million total—is not supported by the ground truth data. Even if share counts were accurate, the aggregate dollar value must match; minor rounding does not justify an $18.9 million discrepancy. The original answer specifies exact figures ($605M + $4.1M = $609.1M), and the LLM’s figure fails to align. (3) The reasoning shows partial multi-hop synthesis—distinguishing between purchases under the program and those unrelated (e.g., withholdings)—which reflects understanding of the two components. However, the failure to report the correct total dollar value undermines the core of the multi-hop requirement. (4) Contextually, the answer addresses the right entities (Accenture, Class A Ordinary Shares, fiscal 2024, open-market program vs. unrelated purchases) and time period, so relevance is high. But due to the critical error in the key metric (total dollar value), the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the structure and intent of the response are sound, but facts are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 460,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does AT&T's 2021 payment to Crown Castle under their sublease arrangement compare to the initial cash proceeds received from Crown Castle in the 2013 tower transaction?",
      "original_answer": "AT&T made $253 in payments to Crown Castle in 2021 under the sublease arrangement, while the initial cash proceeds received from Crown Castle in the 2013 tower transaction were $4,827. This indicates that the 2021 payment represents a small fraction of the original transaction value.",
      "llm_answer": "AT&T's 2021 payment to Crown Castle under its sublease arrangement ($253) is significantly lower than the initial $4,827 cash proceeds it received from Crown Castle in the 2013 tower transaction. The 2013 deal involved an upfront cash payment for tower sales and exclusive lease rights, while the 2021 payment was a routine sublease payment for continued tower space usage under a 10-year agreement.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: AT&T's 2021 payment to Crown Castle was $253, and the initial cash proceeds from the 2013 tower transaction were $4,827. These values match the ground truth exactly. (2) Quantitative accuracy is perfect—both dollar amounts are correct, and the comparison (2021 payment being significantly lower) is factually sound. There are no calculation errors. (3) The multi-hop reasoning is strong: the model correctly synthesizes information across two different time points (2013 and 2021), two different financial events (initial tower sale proceeds vs. sublease payment), and provides context for each transaction. It distinguishes between the upfront cash payment in 2013 and the routine sublease payment in 2021, demonstrating accurate understanding of the nature of the transactions. (4) The answer is semantically equivalent to the ground truth and adds contextual clarity by explaining the nature of the 2013 deal and the 2021 payment, enhancing completeness without introducing errors. All entities—AT&T, Crown Castle, years (2013, 2021), and financial terms—are accurate. Therefore, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 333,
        "total_tokens": 1510
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does General Motors' valuation methodology for Stellantis warrants and their sensitivity to equity price risk inform the potential financial impact of a 10% adverse change in Stellantis stock price on GM's equity investments in 2021?",
      "original_answer": "General Motors estimates the fair value of its Stellantis warrants using the Black-Scholes formula, which incorporates inputs such as the Stellantis stock price and estimated dividend yield. At the end of 2021, GM's investment in Stellantis warrants had a fair value of $1.5 billion. GM also assessed that a 10% adverse change in quoted security prices for Stellantis would have had an insignificant effect on its financial statements. This suggests that even though the valuation methodology is sensitive to stock price changes, the overall financial impact of a 10% adverse movement in Stellantis stock would not have been material to GM’s equity investments in 2021.",
      "llm_answer": "Based on the document, GM's valuation methodology for Stellantis warrants indicates that a 10% adverse change in Stellantis stock price would have had an \"insignificant effect\" on GM's equity investments at December 31, 2021 and 2020. This is explicitly stated in the Equity Price Risk section on page 50: \"Our investment in Stellantis warrants is valued based on a Black-Scholes formula. We estimate that a 10% adverse change in quoted security prices in Stellantis would have had an insignificant effect at December 31, 2021 and 2020.\" Therefore, GM's equity investments in Stellantis would not have been materially impacted by a 10% adverse change in Stellantis stock price in 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GM used the Black-Scholes model to value Stellantis warrants, the fair value was $1.5 billion at the end of 2021 (implied in original answer, not contradicted here), and a 10% adverse change in Stellantis stock price would have had an 'insignificant effect' on GM's financial statements as of December 31, 2021. The LLM correctly cites the source (Equity Price Risk section, page 50) and quotes the exact language from the filing. (2) Quantitative accuracy is perfect: no incorrect numbers, percentages, or dates are presented. The omission of the $1.5 billion fair value figure is a minor gap but does not detract from the core conclusion about materiality. (3) Reasoning is sound: the LLM correctly links the valuation methodology (Black-Scholes) to sensitivity to stock price changes, then correctly infers that despite this sensitivity, the financial impact would be immaterial—demonstrating proper multi-hop synthesis. (4) The answer is fully contextually relevant, directly addressing how the valuation methodology and risk assessment inform the potential financial impact. The only reason for not scoring a 10 is the omission of the $1.5 billion fair value, which provides useful context but does not alter the conclusion about insignificance of impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 378,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "What percentage of P&G's total global market share in the Baby, Feminine & Family Care segment is attributed to the adult incontinence sub-category, specifically through the Always Discreet brand?",
      "original_answer": "The adult incontinence sub-category, represented by the Always Discreet brand, contributes approximately 15% to P&G's total global market share in the Baby, Feminine & Family Care segment. This is derived from the stated 20% global market share of the overall Baby, Feminine & Family Care segment, where Always Discreet holds a 15% market share within its specific sub-category of adult incontinence.",
      "llm_answer": "Based on the provided document pages, specifically the \"Baby, Feminine & Family Care\" segment details on page 18, the adult incontinence sub-category within this segment is attributed to the Always Discreet brand. The document states: \"We compete in the menstrual care sub-category primarily behind our Always and Tampax brands with over 25% global market share. We also compete in the adult incontinence sub-category behind Always Discreet, with about 15% market share in the markets in which we compete.\" This indicates that the adult incontinence sub-category, represented by Always Discreet, holds approximately 15% market share within the Baby, Feminine & Family Care segment. However, the question asks for the percentage of P&G's *total global market share* in this segment attributed to the adult incontinence sub-category specifically through Always Discreet. The document does not provide a specific percentage of the segment's total market share that is attributable to the adult incontinence sub-category (e.g., it does not state that adult incontinence constitutes X% of the segment's total market share). It only states that Always Discreet has about 15% market share *in the markets in which it competes*, which is a subset of the segment's overall market. Therefore, the exact percentage of the segment's total global market share attributed to the adult incontinence sub-category via Always Discreet is not explicitly provided in the document. The 15% figure refers to market share within the adult incontinence category, not the proportion of the Baby, Feminine & Family Care segment's total market share. \n\n(Note: The document does not contain a specific numerical value for the adult incontinence sub-category's contribution to the segment's total market share as a percentage of the segment's overall market share. The 15% is the market share of Always Discreet *within the adult incontinence category*, not the segment's total market share.)",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer misinterprets the ground truth. The original answer states that Always Discreet contributes approximately 15% to P&G's total global market share in the Baby, Feminine & Family Care segment, derived from the brand's 15% market share within the adult incontinence sub-category and its positioning within the broader segment. However, the LLM incorrectly asserts that the 15% figure refers only to market share within the adult incontinence category in the markets in which P&G competes, and claims this does not equate to 15% of the total segment market share—directly contradicting the ground truth which explicitly states it *does* represent 15% of the total segment's market share. (2) Quantitatively, the LLM correctly identifies the 15% figure but fails to apply it correctly in context. The ground truth treats this 15% as the contribution to the total segment market share, while the LLM treats it as a sub-category share and concludes the requested percentage is not provided—this is factually incorrect per the knowledge graph. (3) The reasoning is partially sound in that the LLM attempts to trace the source of the data and distinguish between market share within a sub-category versus the total segment, but it fails the multi-hop synthesis: it should have recognized from the ground truth that the 15% is already framed as the contribution to the total segment share, not just within the sub-category. (4) Contextual relevance is high—the LLM cites the correct document section and brand, and addresses the right segment and sub-category. However, due to the fundamental misinterpretation of how the 15% is defined, the core factual claim is incorrect, warranting a low correctness score despite accurate sourcing and partial understanding.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1603,
        "completion_tokens": 484,
        "total_tokens": 2087
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "What was the average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024, based on the total cash outlay and the number of shares acquired through both the publicly announced open-market share purchase program and transactions unrelated to publicly announced share plans?",
      "original_answer": "The average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024 was approximately $299.48.",
      "llm_answer": "Based on the provided document pages, the average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024 was $303.05. This figure is derived from the total cash outlay of $605 million for 2,000,308 shares purchased under the publicly announced open-market share purchase program during the quarter, as reported in the \"Purchases of Accenture plc Class A Ordinary Shares\" table on page 39. The document specifies that this average price \"reflects the total cash outlay for the period, divided by the number of shares acquired,\" and explicitly states the average price as $303.05 for the quarter. The calculation is based on the total shares purchased (2,000,308) and the total cash outlay ($605 million) for the open-market program, which is the relevant purchase program referenced in the question. The document also clarifies that other share purchases (e.g., for employee tax withholding) are separate and do not affect the average price calculation for the publicly announced program.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual error in the average price per share. The ground truth states the average price was approximately $299.48, while the LLM reports $303.05, which is incorrect. The LLM bases its calculation on $605 million for 2,000,308 shares, but this leads to an average price of approximately $302.48 ($605,000,000 / 2,000,308 ≈ $302.48), not $303.05, indicating a calculation inconsistency. More importantly, the question asks for the average price based on *both* the publicly announced open-market program *and* transactions unrelated to publicly announced plans. The LLM explicitly excludes non-publicly announced transactions (e.g., employee tax withholding), stating they 'do not affect the average price calculation,' which contradicts the question's requirement to include all share acquisitions. This omission represents a failure in multi-hop reasoning and synthesis across all relevant purchase types. While the LLM correctly identifies the source document and references the right table, it misinterprets the scope of the required calculation. The entity (Accenture plc Class A shares), time period (Q4 fiscal 2024), and general context are accurate, supporting a moderate qualitative and relevance score. However, the quantitative inaccuracy and incomplete synthesis significantly reduce correctness and quantitative accuracy scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 385,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the difference in net milestones capitalized for Jardiance between 2020 and 2021, and how does this compare to the collaboration revenue reported for Jardiance in 2021?",
      "original_answer": "The net milestones capitalized for Jardiance decreased by $20.1 million from 2020 ($156.2 million) to 2021 ($136.1 million). This $136.1 million in 2021 net milestones capitalized for Jardiance was part of the broader collaboration and other revenue, which totaled $175.0 million for the year ended December 31, 2021.",
      "llm_answer": "The net milestones capitalized for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, a reduction of $20.1 million. This decline is reflected in the amortization of those milestones to cost of sales, and the $1,490.8 million of collaboration and other revenue reported for Jardiance in 2021 includes the amortization of the remaining capitalized milestones.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the net milestones capitalized for Jardiance in 2020 ($156.2 million) and 2021 ($136.1 million), and accurately calculates the difference as $20.1 million decrease—this quantitative information matches the ground truth exactly. However, the LLM incorrectly states that collaboration and other revenue for Jardiance in 2021 was $1,490.8 million, which is a significant error; the ground truth reports this figure as $175.0 million. This major factual discrepancy undermines the validity of the comparison. (2) Number verification: $156.2M - $136.1M = $20.1M (correct). But $1,490.8M vs $175.0M is off by over $1.3 billion—clearly incorrect and likely due to confusion with another figure or entity. (3) Multi-hop reasoning: The model correctly synthesizes the change in capitalized milestones across years, but fails in the second hop—comparing 2021 milestones to collaboration revenue—because it uses an incorrect revenue figure. It also introduces the concept of amortization to cost of sales, which, while potentially contextually relevant, is not part of the original answer and distracts from the requested comparison. (4) The correctness score is 6 due to mostly accurate numbers but a critical error in the collaboration revenue figure, which breaks the core comparison. Quantitative accuracy is 8 because most numbers are correct except the key revenue metric. Qualitative accuracy is 5 due to flawed reasoning and introduction of unsupported details. Contextual relevance is 7 because the response addresses the right topic and structure but misrepresents a key financial figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 446,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How much in gains did GM record from its Stellantis warrants in 2021, and what ongoing business relationship with Stellantis affects GM's post-sale operations?",
      "original_answer": "General Motors recorded $316 million in gains from its Stellantis warrants in 2021. Additionally, GM continues to have an operational relationship with Stellantis, involving the purchase and supply of certain vehicles, parts, and engineering services following the sale of the Opel/Vauxhall Business.",
      "llm_answer": "GM recorded a $1.4 billion gain from the Stellantis warrants in 2021, and the ongoing business relationship with Stellantis—specifically the guarantee it provides to ensure the Seller’s indemnification obligations and the continued supply of vehicles, parts and engineering services—affects GM’s post‑sale operations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that GM recorded a $1.4 billion gain from Stellantis warrants in 2021, whereas the ground truth is $316 million — a significant factual error. This undermines the core of the quantitative response. (2) The number is off by over $1 billion, which is not a formatting or rounding difference but a major inaccuracy. No acceptable variation explains this discrepancy (e.g., $1.4B vs $316M). (3) On qualitative aspects, the LLM correctly identifies an ongoing business relationship involving the supply of vehicles, parts, and engineering services, which aligns with the ground truth. However, it introduces the concept of a 'guarantee... for Seller’s indemnification obligations' — information not present in the original answer and potentially extraneous or incorrect without supporting evidence. This suggests partial but flawed multi-hop reasoning: while it captures the operational continuity, it adds unverified detail. (4) The answer addresses both parts of the question (gain amount and ongoing relationship), so it is contextually relevant and attempts the required synthesis. However, the massive numerical error severely compromises factual correctness, warranting a low overall score despite some accurate qualitative elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 359,
        "total_tokens": 1517
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the pre-tax loss recognized by AIG from the deconsolidation of AIG Financial Products Corp. (AIGFP), and how does this reflect the financial impact of AIGFP's Chapter 11 reorganization on AIG's consolidated financial statements?",
      "original_answer": "AIG recognized a pre-tax loss of $114 million from the deconsolidation of AIG Financial Products Corp. (AIGFP) as a result of its Chapter 11 reorganization filing on December 14, 2022. This loss was reported in the line item 'Net gain (loss) on divestitures and other' in AIG’s consolidated financial statements. Despite the deconsolidation of AIGFP and the reclassification of its $37.6 billion loan receivable to a third-party asset with a full allowance for credit losses, AIG stated that the reorganization would not have a material impact on its consolidated balance sheets or respective businesses. Therefore, while the $114 million loss reflects a direct financial consequence of the reorganization, AIG assessed that the broader financial position of the company remained largely unaffected.",
      "llm_answer": "The deconsolidation of AIG Financial Products Corp. (AIGFP) resulted in a **pre-tax loss of $114 million**, which was reported in \"Net gain (loss) on divestitures and other\" in AIG's financial statements. This loss reflects the financial impact of AIGFP's Chapter 11 reorganization, as the subsidiary was deconsolidated from AIG's results, eliminating its assets and liabilities (including the $37.6 billion loan receivable) and requiring adjustments to reflect the deconsolidation in AIG's consolidated financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the pre-tax loss of $114 million and the reporting line item 'Net gain (loss) on divestitures and other,' which matches the ground truth. It also accurately references the $37.6 billion loan receivable and the deconsolidation impact. However, it omits the specific date of the Chapter 11 filing (December 14, 2022), which is part of the original answer and relevant context. Additionally, the LLM answer does not mention AIG's explicit statement that the reorganization would not have a material impact on its consolidated balance sheets or businesses—a key qualitative assessment in the ground truth. (2) All numeric values—$114 million and $37.6 billion—are correct and properly contextualized. No calculations are required, and the figures match the original answer exactly. (3) The reasoning is sound: the LLM correctly links the Chapter 11 reorganization to the deconsolidation, explains the removal of AIGFP’s assets and liabilities, and notes the financial statement impact. It synthesizes the cause (reorganization), event (deconsolidation), and effect (loss recognition) accurately. The only gap is the missing materiality assessment, which weakens the completeness of the multi-hop synthesis. (4) The answer is highly relevant, directly addressing both parts of the question—quantifying the loss and explaining its financial impact. The omission of the materiality statement and filing date prevents a perfect score, but the core facts and logic are fully aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 426,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What is the total net value of Acquired Franchise Rights in 2024, and how does this compare to the reported gross value of the same asset category in the prior year?",
      "original_answer": "The total net value of Acquired Franchise Rights in 2024 is $598 million. This net value is derived from the gross value of $821 million in 2024 after subtracting accumulated amortization of $223 million. In 2023, the gross value of Acquired Franchise Rights was $840 million. Therefore, the gross value of Acquired Franchise Rights decreased by $19 million from 2023 to 2024.",
      "llm_answer": "The total net value of Acquired Franchise Rights in 2024 is $1,858 million, compared with $1,891 million reported in the prior year.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. The total net value of Acquired Franchise Rights in 2024 is stated as $1,858 million, which is grossly inaccurate compared to the ground truth of $598 million. Similarly, the prior year value is reported as $1,891 million, which does not match the actual 2023 gross value of $840 million or the implied 2023 net value. (2) Quantitative accuracy fails completely: the correct 2024 net value is $598M (from $821M gross - $223M amortization), and the 2023 gross value was $840M, showing a $19M decrease. The LLM provides no correct numbers. (3) The multi-hop reasoning is absent: the model fails to break down net vs. gross values, does not reference amortization, and does not correctly compare 2024 net to 2023 gross as required. It incorrectly compares net to net rather than addressing the net-to-gross comparison across years. (4) Contextual relevance is low but not zero because the answer addresses the general topic (Acquired Franchise Rights) and time frame (2024 vs prior year), but with entirely wrong data and flawed logic. Hence, correctness is scored as 1 due to complete factual inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1131,
        "completion_tokens": 329,
        "total_tokens": 1461
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the total financial commitment made by AT&T for the C-Band licenses, including both the auction payment and the estimated future costs for spectrum clearing and relocation, as disclosed in the 10-K filing?",
      "original_answer": "AT&T's total financial commitment for the C-Band licenses was $26,478, which includes $23,406 for the auction payment, $2,112 for future spectrum clearing costs, and $1,000 for compensable relocation costs.",
      "llm_answer": "The 10‑K discloses that AT&T’s total financial commitment for the C‑Band licenses is the $23,406 it paid to win the auction (the $550 deposit plus $22,856 cash payment in 2021) plus the $3,112 it expects to incur for clearing and relocation – $955 already paid for Phase I clearing, an estimated $2,112 for Phase II clearing and about $1,000 of compensable relocation costs.  In sum, AT&T’s total commitment for the C‑Band licenses, including the auction payment and the estimated future clearing and relocation costs, is $23,406 + $3,112 ≈ $26,518.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a minor quantitative discrepancy in the total sum. The ground truth states the total financial commitment is $26,478, composed of $23,406 (auction), $2,112 (spectrum clearing), and $1,000 (relocation). The LLM correctly identifies the auction payment ($23,406) and breaks down the future costs as $2,112 for Phase II clearing and $1,000 for relocation, which aligns with the ground truth. However, the LLM adds an additional $955 already paid for Phase I clearing to the future costs, totaling $3,112 for clearing and relocation, which results in a calculated total of $26,518 instead of $26,478. This suggests a misinterpretation of what constitutes 'future' costs—the $955 for Phase I was likely already incurred and not part of the estimated future commitment. While the components are largely accurate and the reasoning is sound, the inclusion of $955 in future costs inflates the total. The multi-hop synthesis across auction payment and future obligations is well-executed, and all entities (AT&T, C-Band, 10-K) are correct. The answer is contextually complete and relevant, with only a small calculation/interpretation error affecting precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 335,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the change in net milestones capitalized for Jardiance between 2020 and 2021, and how does this reflect in the financial performance of Lilly's diabetes product portfolio?",
      "original_answer": "The net milestones capitalized for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, representing a decline of $20.1 million. This reduction indicates a lower recognition of milestone-related revenue or a deferral of payments tied to Jardiance's performance metrics during this period. As Jardiance is a key diabetes product in Lilly's portfolio, this decline could signal a slowdown in the product's developmental or commercial milestone achievements, potentially affecting the overall financial performance of Lilly’s diabetes segment.",
      "llm_answer": "The net milestones capitalized for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, reflecting a $20.1 million reduction. This decline contributed to the $337 million increase in Jardiance net product revenue in 2021 (from $1,153.8 million to $1,490.8 million), indicating that the lower capitalized milestones were offset by higher product sales and royalty adjustments within Lilly’s diabetes portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the net milestones capitalized for Jardiance in 2020 ($156.2 million) and 2021 ($136.1 million), and accurately calculates the $20.1 million decrease. These quantitative elements are factually correct and match the ground truth. However, the LLM introduces new financial data—Jardiance net product revenue increasing from $1,153.8 million to $1,490.8 million (a $337 million increase)—that is not present in the original answer or implied by the ground truth. More critically, the reasoning that the decline in capitalized milestones 'contributed to' higher revenue is logically flawed and unsupported. Capitalized milestones are accounting entries related to asset recognition (often tied to collaboration agreements or development milestones), not direct drivers of product revenue. The original answer interprets the decline as a signal of slower milestone achievement, which may affect financial performance, while the LLM incorrectly frames the reduction as a positive contributor to revenue growth, which misrepresents the financial logic. (2) All provided numbers are accurate in format and calculation, earning high marks for quantitative accuracy. (3) The multi-hop reasoning fails: while the model synthesizes a narrative, it invents a causal relationship between capitalized milestones and product revenue without evidence, and adds external data not in the ground truth. This undermines the qualitative accuracy. (4) Contextual relevance is moderate—the response addresses the question's topic and attempts to link milestones to financial performance—but the incorrect causal inference and fabricated data reduce its reliability. Correctness score is low due to significant reasoning errors despite numerical accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 482,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the total financial benefit recognized by General Motors in 2021 from its relationship with Stellantis, including both pension income and gains from Stellantis warrants?",
      "original_answer": "General Motors recognized a total financial benefit of $1.0 billion in 2021 from its relationship with Stellantis, which included $0.8 billion in non-service pension income and $0.2 billion in gains related to Stellantis N.V. warrants.",
      "llm_answer": "Based on the provided financial statements, GM recognized a total financial benefit of $1.0 billion in 2021 from its relationship with Stellantis, consisting of $0.8 billion in non-service pension income and $0.2 billion in gains from Stellantis warrants. This is explicitly stated in the \"Interest income and other non-operating income, net\" discussion on page 36, which notes the $0.8 billion increase in non-service pension income and $0.2 billion increase in gains related to Stellantis warrants for the year ended December 31, 2021.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $1.0 billion total benefit, broken down into $0.8 billion in non-service pension income and $0.2 billion in gains from Stellantis warrants. These values exactly match the original answer, with acceptable formatting variations (e.g., $0.8 billion = $800 million). The total sum ($0.8B + $0.2B = $1.0B) is mathematically correct. (2) The answer is complete, addressing both components of the financial benefit (pension income and warrant gains) and correctly attributing them to the year 2021. (3) Entity accuracy is perfect: General Motors, Stellantis, and the specific financial instruments (non-service pension income and Stellantis N.V. warrants) are correctly identified. (4) The reasoning is sound and demonstrates multi-hop synthesis by referencing a specific section of the financial statements (page 36, 'Interest income and other non-operating income, net') to justify the figures, showing proper grounding in the source material. (5) The semantic meaning is equivalent to the original answer, with slightly more detail (page reference) that enhances credibility without introducing error. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 352,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the impact of changes in Corebridge's stock price on AIG's financial statements for the period following the initial equity method investment, and how does this reflect AIG's ownership interest?",
      "original_answer": "The changes in Corebridge's stock price directly impacted AIG's financial statements by affecting the value of AIG's ownership interest in Corebridge and resulting in a gain on the sale of Corebridge shares. This is explicitly stated in the Consolidated Statements of Income under the fair value option, where the impact of changes in Corebridge's stock price is recognized. Additionally, AIG's equity method income from Corebridge, which includes changes in the stock price since the initial investment, contributes to AIG's overall financial position.",
      "llm_answer": "The impact of Corebridge’s stock‑price movements on AIG’s financial statements after the equity‑method investment is reflected in the discontinued‑operations loss on deconsolidation.  AIG recorded an $8.5 billion retained investment in Corebridge (294.2 million shares × $28.90 per share on June 9 2024) and, when combined with other retained assets, resulted in a $4.754 billion after‑tax loss on the sale of its remaining stake—an amount that directly ties AIG’s post‑investment earnings to fluctuations in Corebridge’s quoted market price.  This loss underscores that AIG’s residual ownership interest in Corebridge is now measured at fair value, so changes in the stock price flow through AIG’s income (as seen in the $601 million equity‑method gain/loss reported for the period) and ultimately affect the net income attributable to AIG from discontinued operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several specific quantitative figures such as an $8.5 billion retained investment (294.2 million shares × $28.90), a $4.754 billion after-tax loss, and a $601 million equity-method gain/loss. However, these numbers are not present in the original answer (ground truth), which does not specify any dollar amounts, dates (e.g., June 9, 2024), or share counts. There is no mention in the ground truth of a deconsolidation loss, retained investment calculation, or after-tax loss amount, making these additions factually unsupported by the provided truth. The original answer only states that changes in Corebridge’s stock price affect AIG’s financial statements via fair value recognition and equity method income, without citing specific line items like 'discontinued operations' or exact gains/losses. (2) The quantitative values in the LLM response appear internally consistent (e.g., 294.2M × $28.90 ≈ $8.5B), but since they are not found in the ground truth and cannot be verified from the question context, they represent hallucinated precision. The $601 million equity-method gain/loss is also not mentioned in the original answer, which only generally references equity method income being affected by stock price changes. (3) The reasoning partially aligns with the multi-hop logic: the LLM correctly infers that AIG’s ownership interest is measured at fair value and that stock price changes impact income, which is consistent with the original answer’s reference to fair value option and equity method accounting. However, it overreaches by anchoring this to discontinued operations and deconsolidation, which are not mentioned in the ground truth. The synthesis goes beyond the provided information, introducing new financial line items and events not validated by the original answer. (4) Despite the hallucinated numbers and over-specificity, the core qualitative idea—that stock price changes affect AIG’s income through fair value and equity method accounting—is correct and relevant. The contextual relevance is high because it addresses the impact on financial statements and links it to ownership interest. However, the correctness score is reduced due to unsupported specifics, and quantitative accuracy is low because the numbers, while plausible, are not grounded in the truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 622,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What is the total net value of Other Identifiable Intangibles for PEP in 2024, and by how much did this value decrease from 2023 to 2024 according to the amortization data provided?",
      "original_answer": "The total net value of Other Identifiable Intangibles for PEP in 2024 is $144. This value decreased by $30 from 2023 ($174) to 2024 ($144) due to amortization.",
      "llm_answer": "The total net value of Other Identifiable Intangibles for PepsiCo (PEP) in 2024 is $144 million, and it decreased by $30 million from 2023 to 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total net value of Other Identifiable Intangibles for PEP in 2024 as $144 million and the decrease from 2023 to 2024 as $30 million, which matches the ground truth in both value and calculation. The ground truth states the 2023 value was $174, and $174 - $30 = $144, confirming the accuracy of the decrease. (2) Quantitative accuracy is perfect: the numbers $144 million and $30 million are correct, and the format variation (adding 'million') is acceptable and common in financial reporting. The original answer uses bare numbers ($144, $174), but the LLM's addition of 'million' does not contradict the ground truth and aligns with typical SEC filing conventions. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly inferred the decrease by comparing two time points and attributed it to amortization, though it omitted explicit mention of amortization. However, the question asks for the amount of decrease 'according to the amortization data,' and while the LLM implies this by stating the decrease, it does not explicitly reference amortization. This is a minor omission in qualitative reasoning. (4) Contextual relevance is high—the answer directly addresses both parts of the question with precise, relevant financial data. The slight omission of 'amortization' in the explanation prevents a perfect qualitative score, but the core facts and calculations are fully accurate, warranting a 9/10 overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1085,
        "completion_tokens": 418,
        "total_tokens": 1503
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What is the total revenue generated from nuclear-powered submarines in 2023, and how does this compare to the revenue from surface ships, given the strategic importance of submarine programs like the Columbia-class and Virginia-class?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment generated $8,631 million in revenue from nuclear-powered submarines, compared to $2,698 million from surface ships. This results in a ratio of approximately 3.2:1 in favor of nuclear-powered submarine revenue over surface ship revenue. This significant revenue disparity reflects the strategic importance and high demand for submarine programs like the Columbia-class and Virginia-class, which are central to the U.S. Navy's long-term defense strategy and have received top acquisition priority and substantial investment.",
      "llm_answer": "Based on the revenue breakdown in the document, nuclear-powered submarines generated $8,631 million in revenue for 2023, while surface ships generated $2,698 million. This represents a significant revenue contribution from submarine programs like the Columbia-class and Virginia-class, which are highlighted as strategic priorities in the Marine Systems segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the revenue from nuclear-powered submarines ($8,631 million) and surface ships ($2,698 million) in 2023, matching the ground truth exactly. These figures are critical and accurately reported with correct units and year. (2) All numeric values are correct and properly formatted; the comparison between submarine and surface ship revenue is factually sound, though the LLM does not explicitly compute the 3.2:1 ratio mentioned in the ground truth. However, stating the two figures conveys sufficient information for the comparison to be derived, so this omission is minor. (3) The reasoning is logically sound: the LLM correctly attributes the high submarine revenue to strategic programs like Columbia-class and Virginia-class, aligning with the multi-hop synthesis required (linking financial data to strategic importance). It references the Marine Systems segment appropriately, showing correct entity and context mapping. (4) The answer is contextually fully relevant, addressing both parts of the question—revenue figures and their strategic implication. The only minor shortcoming is the lack of explicit ratio calculation, which slightly reduces qualitative accuracy, but since the raw data allows for accurate inference, the correctness score remains high. Overall, the answer is factually complete, precise, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 385,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What was the change in the fair value of GM's investment in Stellantis warrants between December 31, 2020, and December 31, 2021, and how does this compare to the change in the fair value of marketable debt securities over the same period?",
      "original_answer": "The fair value of GM's investment in Stellantis warrants increased by $0.3 billion (from $1.2 billion in 2020 to $1.5 billion in 2021). The fair value of marketable debt securities decreased by $0.4 billion (from $9.0 billion in 2020 to $8.6 billion in 2021). Therefore, the increase in equity investment was $0.3 billion, while the decrease in debt securities was $0.4 billion, showing contrasting trends in the valuation of these two asset classes.",
      "llm_answer": "The fair value of GM’s investment in Stellantis warrants increased by $0.3 billion from $1.2 billion at December 31 2020 to $1.5 billion at December 31 2021. Over the same period, the fair value of marketable debt securities (available‑for‑sale) rose modestly from $9.0 billion to $8.6 billion, a decrease of $0.4 billion. Thus, the warrant fair‑value change was a $0.3 billion gain, whereas the debt‑security fair‑value change was a $0.4 billion loss.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the change in fair value of GM's investment in Stellantis warrants as a $0.3 billion increase from $1.2 billion (2020) to $1.5 billion (2021), matching the ground truth. It also correctly states the decrease in marketable debt securities as $0.4 billion from $9.0 billion to $8.6 billion. (2) All numeric values and calculations are accurate: $1.5B - $1.2B = +$0.3B; $9.0B - $8.6B = -$0.4B. The dollar amounts, years, and directions of change are all factually correct. (3) The multi-hop reasoning is sound—information is synthesized across two different asset classes (equity warrants and debt securities) over the same time period. The comparison between the two changes is logically presented. (4) There is a minor wording issue: the phrase 'rose modestly from $9.0 billion to $8.6 billion' is contradictory because a rise should not accompany a decrease in value. However, the subsequent clarification that it is a 'decrease of $0.4 billion' corrects this misstatement. This does not affect factual correctness but slightly impacts clarity. Overall, the answer conveys the same information as the original with high accuracy and appropriate context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 338,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What is the net decrease in the value of Acquired Franchise Rights for PEP from 2023 to 2024, and how does this reflect in the company's amortization expense over the same period?",
      "original_answer": "The net value of Acquired Franchise Rights for PEP decreased from $626 in 2023 to $598 in 2024, resulting in a $28 decrease. This decrease is partially attributable to the amortization expense of $74 in 2024, which contributes to the reduction in net value of the franchise rights.",
      "llm_answer": "The net decrease in the value of Acquired Franchise Rights for PepsiCo (PEP) from 2023 to 2024 was $22 million (from $840 million to $598 million), and this reduction is reflected in the amortization expense, which declined slightly to $74 million in 2024 from $75 million in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numbers. According to the ground truth, the Acquired Franchise Rights value decreased from $626 in 2023 to $598 in 2024, a $28 decrease. However, the LLM incorrectly states the 2023 value as $840 million, leading to a wrong decrease of $22 million. This misrepresents the core financial data. The amortization expense of $74 million in 2024 is correctly stated, but the LLM adds unsupported information that it declined from $75 million in 2023, which is not present in the original answer and cannot be verified from the given truth. (2) Calculation verification: The correct decrease is $626 - $598 = $28; the LLM calculates $840 - $598 = $242, but incorrectly reports $22 million, which is mathematically inconsistent and factually wrong. (3) Multi-hop reasoning is partially sound in linking amortization expense to the decrease in franchise rights, but the reasoning is undermined by incorrect base values. The original answer notes that the $74 million amortization contributes to the $28 decrease, implying other factors may be involved; the LLM fails to reflect this nuance and incorrectly suggests a direct or proportional relationship. (4) Scores justified: Correctness is low (3/10) due to major factual and numerical errors. Quantitative accuracy is very poor (2/10) due to wrong values and miscalculations. Qualitative accuracy is moderate (4/10) as the model identifies the right metric and general direction of change but with flawed details. Contextual relevance is acceptable (7/10) because the answer addresses the right topic and structure, despite inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 452,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "By how much did the increase in service costs related to F-35 sustainment contracts at Aeronautics affect the overall service costs increase in 2023, and how does this compare to the corresponding increase in service sales for the same business unit and reason?",
      "original_answer": "The increase in service costs related to F-35 sustainment contracts at Aeronautics was approximately $570 million, which accounted for the majority of the overall $775 million (8%) increase in service costs in 2023. This corresponds to an increase in service sales of approximately $600 million at Aeronautics due to higher volume on F-35 sustainment contracts. Therefore, the cost increase was $30 million less than the sales increase, indicating a potential improvement in margin or profitability on these contracts.",
      "llm_answer": "The increase in service costs related to F‑35 sustainment contracts at Aeronautics contributed approximately $600 million of the $788 million (7 %) rise in total service sales in 2023. This service‑cost increase was partially offset by higher operating profit from Aeronautics’ F‑35 sustainment work, whereas the overall service‑sales growth was driven by that same $600 million uplift, contrasting with the modest $91 million (1 %) rise in net sales for the Rotary and Mission Systems segment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the increase in service costs related to F-35 sustainment was $570 million, accounting for the majority of a $775 million (8%) increase in overall service costs. However, the LLM incorrectly states that the $600 million cost increase contributed to a $788 million (7%) rise in *service sales*, conflating costs with sales and misrepresenting both the metric and the total. Additionally, the LLM claims the $600 million is an uplift in service costs contributing to service sales growth, which is logically inconsistent. (2) Key numbers are wrong: cost increase is reported as $600M (vs. $570M), total increase as $788M (vs. $775M), and percentage as 7% (vs. 8%). The LLM correctly identifies the $600 million figure but misattributes it as both the cost and sales increase without noting the $30 million difference (cost being less than sales), which is a key insight in the original answer regarding margin improvement. (3) The multi-hop reasoning is flawed: the model fails to correctly link the cost increase to the overall service cost increase and instead incorrectly ties it to service sales growth. It also introduces unrelated information about Rotary and Mission Systems’ $91 million (1%) net sales rise, which is not asked for and distracts from the core comparison between Aeronautics’ service costs and sales. (4) The contextual relevance is moderate because the answer discusses F-35 sustainment at Aeronautics in 2023 and attempts to compare costs and sales, but the incorrect use of metrics and numbers severely undermines accuracy. Due to major quantitative and qualitative errors, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 472,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How much total share repurchase authority did Accenture plc have as of September 25, 2024, and how does this reflect the company's financial strategy regarding Class A Ordinary Shares?",
      "original_answer": "As of September 25, 2024, Accenture plc had a total outstanding share repurchase authority of $6,694 million. This reflects the company's ongoing financial strategy to actively manage its equity structure by repurchasing Class A Ordinary Shares, as demonstrated by the additional $4,000 million in authority approved by the Board of Directors, bringing the total from $2,694 million to $6,694 million. This strategy includes both open-market purchases and other share purchase programs.",
      "llm_answer": "As of September 25 2024, Accenture plc’s board had authorized a total of **$6.694 billion** of share‑repurchase authority—comprising the pre‑existing $2.694 billion plus an additional $4 billion approved on that date. This expanded authority reflects the company’s strategy of returning capital to shareholders while maintaining flexibility to fund acquisitions, growth initiatives, and other strategic investments, underscoring its confidence in generating strong cash flows from its global professional‑services business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the total share repurchase authority as $6.694 billion (equivalent to $6,694 million), matching the ground truth. It accurately breaks this down into the pre-existing $2.694 billion and the newly approved $4 billion (matching the $4,000 million in the original), confirming quantitative accuracy. The date (September 25, 2024) is correctly cited. 2) All numbers are correct and consistent with the ground truth, allowing for format variation (billion vs million). The calculation ($2.694B + $4B = $6.694B) is accurate. 3) The reasoning is sound: the LLM correctly infers that the increase reflects a strategic capital return initiative and ties it to shareholder value, confidence in cash flows, and strategic flexibility—consistent with the original's emphasis on active equity management. It adds context about funding acquisitions and growth, which is plausible and aligns with typical financial strategy, though not explicitly stated in the ground truth. 4) The answer is semantically equivalent and highly relevant. The only minor gap is that the LLM does not explicitly mention 'Class A Ordinary Shares' in the strategy explanation, though it is implied. It also omits mention of 'open-market purchases and other share purchase programs'—a small completeness shortfall. Overall, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a high score with only slight deduction for minor omissions in qualitative detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 410,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "Given Netflix's expansion into live programming and the fixed nature of its content costs, how might a failure to meet membership growth expectations directly impact its financial flexibility and profitability?",
      "original_answer": "Netflix's expansion into live programming introduces additional fixed content costs, which are largely non-adjustable regardless of membership growth rates. If Netflix fails to meet membership growth expectations, it may not be able to proportionally increase per-member revenue or adjust expenditures, thereby negatively impacting margins, liquidity, and overall profitability.",
      "llm_answer": "A failure to meet membership growth expectations would directly constrain Netflix’s financial flexibility and profitability because its content costs are fixed and cannot be easily reduced. With limited ability to adjust expenditures or raise per‑membership revenue quickly, slower membership growth would pressure margins, limit cash flow for new investments, and increase the risk of declining profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies that Netflix's content costs are fixed and non-adjustable, which directly impacts financial flexibility and profitability if membership growth falls short. The reasoning accurately reflects the cause-effect chain: failure to meet membership growth expectations → inability to offset fixed costs → margin pressure, reduced cash flow, and lower profitability. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The only minor difference is that the LLM answer mentions 'limited ability to raise per-membership revenue quickly,' which is a slight expansion beyond the original answer but still reasonable and not factually incorrect. This does not detract from the core accuracy but prevents a perfect qualitative score. Contextual relevance is full—every part of the question is addressed, including live programming implications, fixed costs, and financial outcomes. Multi-hop reasoning is sound: linking business strategy (live programming) to cost structure (fixed costs) to financial performance (profitability and liquidity).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 335,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What is the total carrying value of the 5.15% 2041 Notes as a percentage of the total carrying value of all debt reported by AMGN in 2022, and how much principal of these notes was exchanged according to the debt exchange table?",
      "original_answer": "The total carrying value of the 5.15% 2041 Notes was $729 million, which represents approximately 2.19% of the total carrying value of all debt ($33,309 million) reported by AMGN in 2022. Additionally, $245 million in principal amount of these notes was exchanged.",
      "llm_answer": "The total carrying value of the 5.15% 2041 Notes was $729 million, which represented roughly 2.2 % of AMGN’s total debt carrying value of $33,309 million in 2022. In the 2020 debt‑exchange, $245 million principal of the 5.15% 2041 Notes was tendered and exchanged for the newly issued 2.77% 2053 Notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key factual elements: the carrying value of the 5.15% 2041 Notes ($729 million), the total carrying value of AMGN's debt ($33,309 million), the resulting percentage (~2.19%, reported as 2.2% which is a rounded but acceptable approximation), and the exchanged principal amount ($245 million). These values match the ground truth exactly or with acceptable rounding. (2) Quantitative accuracy is perfect: $729M / $33,309M = 0.02188, which rounds to 2.2% when reported to one decimal place. The principal exchanged is correctly stated as $245 million. (3) The multi-hop reasoning is sound—information about debt carrying values and exchange activity is synthesized correctly. The only minor issue is the mention of the 2020 debt exchange, which, while factually accurate based on typical filings, slightly extends beyond the scope of the question, which only asked for how much principal was exchanged (not when or for what). However, this addition does not detract from correctness. (4) The answer is contextually fully relevant and semantically equivalent to the ground truth. The slight rounding of 2.19% to 2.2% is acceptable and common in financial reporting. Thus, the answer is highly accurate with only negligible deviation in precision, warranting a 9/10 on correctness and qualitative accuracy, but full marks on quantitative and contextual dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 392,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does McDonald's acquisition and subsequent sale of franchised restaurants impact its financial reporting of goodwill, specifically when sold within 24 months versus beyond 24 months from acquisition?",
      "original_answer": "When McDonald's acquires franchised restaurants, it records goodwill as the excess cost over the net tangible and identifiable intangible assets. If a Company-operated restaurant is sold within 24 months of acquisition, the goodwill associated with the acquisition is written off in its entirety. However, if a Company-operated restaurant is sold beyond 24 months from acquisition, the amount of goodwill written off is based on the relative fair value of the business sold compared to the reporting unit. This distinction directly affects how goodwill impacts financial reporting depending on the time of sale.",
      "llm_answer": "The Company's accounting policy requires that goodwill associated with a Company‑operated restaurant sold within 24 months of acquisition be written off in its entirety, whereas goodwill sold after 24 months is written off only to the extent of the relative fair value of the business sold versus the reporting unit. This treatment is disclosed in the “Goodwill” section of the filing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It accurately states the 24-month threshold for goodwill write-off treatment, matching the original answer's key criterion. (2) The quantitative accuracy is perfect: the 24-month period is correctly cited, and the distinction between full versus partial goodwill write-off based on timing is precisely described. No calculations are involved, but the time-based condition and financial treatment are correctly reported. (3) The multi-hop reasoning is sound—McDonald's acquisition of franchised restaurants leads to goodwill recognition, and the subsequent sale timing determines the financial reporting impact, which the model correctly synthesizes. The answer reflects proper understanding of accounting policy application over time. (4) The response is fully contextually relevant, directly addressing how the timing of sale (within vs. beyond 24 months) affects goodwill treatment in financial reporting. Minor wording differences (e.g., 'Company-operated restaurant' vs. 'franchised restaurants acquired') do not affect meaning, as the context implies acquired restaurants become company-operated. The mention of disclosure in the 'Goodwill' section adds contextual fidelity without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 360,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What was AIG's equity method income from Corebridge after the deconsolidation date in 2024, and how was this income calculated based on the post-deconsolidation period?",
      "original_answer": "AIG's equity method income from Corebridge after the deconsolidation date (June 9, 2024) was calculated as the sum of dividends received and changes in Corebridge's stock price from June 9, 2024, to December 31, 2024. This income reflects AIG's retained 48.4% ownership stake and the financial performance of Corebridge during the post-deconsolidation period.",
      "llm_answer": "Based on the provided document pages, AIG's equity method income from Corebridge after the deconsolidation date in 2024 was $601 million. This amount was calculated as the sum of dividends received and changes in Corebridge's stock price since June 9, 2024 (the deconsolidation date), as explicitly stated in the \"ITEM 8 | Notes to Consolidated Financial Statements | 4. Discontinued Operations Presentation\" section on page 111. The document specifies: \"Equity method income (loss) related to Corebridge (based on fair value) $ 601\" for the period following deconsolidation.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that AIG's equity method income was $601 million, which is not supported by the original answer (ground truth). The ground truth does not provide a specific dollar amount for the income, only the method of calculation. Therefore, the inclusion of $601 million is a factual error. (2) The date of deconsolidation (June 9, 2024) is correctly identified, and the post-deconsolidation period up to December 31, 2024, aligns with the ground truth. However, the numerical value of $601 million is not mentioned in the original answer and appears to be hallucinated or extracted from a source not aligned with the provided ground truth. (3) The reasoning about how the income was calculated—'the sum of dividends received and changes in Corebridge's stock price'—is consistent with the original answer and reflects correct multi-hop understanding of equity method accounting post-deconsolidation. The reference to fair value and the retained 48.4% ownership is implied in the method, though not explicitly restated. (4) While the conceptual framework is accurate and contextually relevant, the incorrect assignment of a specific dollar figure significantly undermines factual correctness. Thus, the quantitative accuracy is low due to the unsupported number, but qualitative and contextual accuracy remain moderate to high.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 380,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "Given that McDonald's heavily franchised business model relies on franchisee contributions to revenue and considers franchisees as a critical component of its business, by what percentage do franchisees contribute to McDonald's global workforce, and how does the company's recruitment initiative for diverse franchisees aim to influence this demographic composition?",
      "original_answer": "Franchisees contribute to over 93% of McDonald's global workforce, as over two million individuals work in franchised restaurants compared to over 150,000 company employees. McDonald's recruitment initiative for diverse franchisees aims to influence this demographic composition by reducing upfront equity requirements for eligible candidates and providing ongoing learning and development, specifically targeting underrepresented groups in both the U.S. and International Operated Markets to increase diversity among franchisees.",
      "llm_answer": "Franchisees contribute approximately 95 % of McDonald’s workforce, as the company’s heavily franchised model relies on franchisees to operate the majority of its restaurants worldwide.  To accelerate diversity, McDonald’s has launched a recruitment initiative that lowers upfront equity requirements and provides ongoing learning and development for eligible franchisee candidates from under‑represented groups, aiming to increase the share of diverse franchisees in its U.S. and international operated markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that franchisees contribute approximately 95% to McDonald's global workforce, which is very close to the ground truth of 'over 93%' (based on over 2 million in franchised restaurants vs. over 150,000 company employees). The slight discrepancy in percentage (95% vs. ~93%) is minor and within acceptable rounding or estimation variance, especially given that the exact figure may vary slightly by year. The core quantitative claim is factually sound. (2) The recruitment initiative is accurately described: lowering upfront equity requirements and providing ongoing learning and development for underrepresented groups is correctly reported. The target scope—U.S. and international operated markets—is also correctly included. (3) Multi-hop reasoning is strong: the model connects the franchised business model to workforce composition and then links the diversity initiative to demographic influence, synthesizing workforce data with strategic HR/franchise policy. (4) All entities (McDonald’s, franchisees, underrepresented groups) and initiatives are correctly identified. The answer is semantically equivalent to the ground truth, with slightly more concise wording but no material omissions. The 9/10 score reflects the minor overstatement of the percentage, though not enough to undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 378,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the unfavorable profit adjustment on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume in 2023 collectively impact the operating profit of RMS, and how does this compare to the contribution from Sikorsky programs to the backlog increase?",
      "original_answer": "The unfavorable profit adjustment of $100 million on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume together caused a significant decrease in RMS' operating profit for Sikorsky helicopter programs in 2023. This decrease was partially offset by higher operating profit from IWSS programs, including a favorable adjustment of $65 million and increased volume on the Aegis program, resulting in an overall $41 million decrease in RMS' operating profit compared to 2022. Despite this profit decline, Sikorsky programs contributed to an increase in backlog during 2023 due to higher orders, indicating future revenue potential.",
      "llm_answer": "The $100 million unfavorable profit adjustment on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume together shaved $41 million (2 %) off RMS’s 2023 operating profit, while the backlog growth was driven by higher Sikorsky orders. In contrast, Sikorsky programs contributed positively to the backlog increase, offsetting part of the profit decline.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $100 million unfavorable adjustment and lower Black Hawk production as key factors reducing RMS's operating profit, and notes the net $41 million decrease in operating profit, which aligns with the ground truth. However, it incorrectly implies that the $41 million reduction is solely due to these two factors, whereas the ground truth clarifies that this net decrease already reflects partial offset from gains in IWSS programs (e.g., $65 million favorable adjustment and Aegis volume). Thus, the LLM misattributes the $41 million as a direct sum of the $100 million hit minus unspecified offsets, rather than presenting it as a net result after positive contributions from other programs. (2) The quantitative values—$100 million, $41 million, and 2%—are all factually present in the LLM answer. While the 2% figure is not in the original answer and cannot be verified from the provided data, its inclusion introduces an unconfirmed detail, slightly undermining quantitative accuracy. The core calculation (net $41M drop) is accurate, even if the breakdown is oversimplified. (3) The multi-hop reasoning is partially sound: the model connects the Canadian Maritime Helicopter adjustment and Black Hawk volume to profit impact and separately links Sikorsky programs to backlog growth. However, it fails to fully synthesize the contrast between current profit decline and future revenue potential via backlog, which is a key nuance in the original answer. (4) Despite minor inaccuracies in causal attribution and the addition of an unverified percentage, the LLM captures the essential facts and overall trajectory. The answer remains contextually relevant and conveys the main takeaway: profit declined due to specific Sikorsky issues, while backlog grew due to Sikorsky orders. Hence, correctness is high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 506,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What was the total value of Broadcom's acquisition of VMware, and how does this acquisition align with Broadcom's strategic focus on infrastructure software solutions?",
      "original_answer": "Broadcom acquired VMware for a total value of $84,186 million, which includes $30,788 million in cash and $53,398 million in Broadcom common stock. This acquisition aligns with Broadcom's strategic focus on infrastructure software solutions by enhancing its capabilities in multi-cloud services and enabling digital innovation with enterprise control, as stated in the overview of Broadcom's business segments and strategic priorities.",
      "llm_answer": "Broadcom's acquisition of VMware was valued at approximately $61 billion, as reflected by the $3,642 million of net deferred tax liabilities recorded on the excess of book basis over tax basis of acquired assets and the $53.4 billion fair value of VMware stock issued in the transaction. This acquisition directly aligns with Broadcom's strategic focus on expanding its infrastructure software solutions, particularly in hybrid cloud, virtualization, and enterprise workloads, to complement its semiconductor business and create a more comprehensive portfolio for enterprise IT infrastructure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the total acquisition value as approximately $61 billion, whereas the ground truth is $84,186 million ($84.186 billion). The LLM appears to have added $3.642 billion (net deferred tax liabilities) to $53.4 billion (fair value of stock issued), but these figures do not represent the full cash and stock consideration. The correct components are $30,788 million in cash and $53,398 million in stock, which sum to $84,186 million. The $3.642 billion tax liability is a post-acquisition accounting item, not part of the purchase price, so its inclusion as a component of value is factually incorrect. (2) The qualitative aspects are partially correct: the acquisition does align with Broadcom's strategic focus on infrastructure software, particularly in hybrid cloud and enterprise workloads, which is consistent with the ground truth mentioning multi-cloud services and digital innovation. However, the LLM omits specific strategic language from the source about 'enterprise control' and 'business segment priorities'. (3) The multi-hop reasoning is flawed because the model misinterprets financial data from the acquisition accounting (tax liabilities and fair value of stock) as components of the total deal value, failing to correctly synthesize the actual cash and stock consideration reported. (4) Despite the major quantitative error, the answer is contextually relevant and captures the general strategic rationale, warranting moderate scores in qualitative accuracy and contextual relevance. The correctness score is low due to the significant miscalculation of the total deal value, a core fact in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 455,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the introduction of the $6.99 ad-supported tier relate to Netflix's reported 18% year-over-year increase in global paid memberships, considering the company's stated strategy of balancing average revenue per user (ARPU) with broader market penetration?",
      "original_answer": "The introduction of the $6.99 ad-supported tier contributed to Netflix's 18% year-over-year increase in global paid memberships by making the service more accessible to price-sensitive consumers, aligning with the company's strategy to prioritize broader market penetration even at the expense of lower ARPU. This pricing decision reflects Netflix's explicit acknowledgment in its filings of the tradeoff between subscriber growth and per-user revenue, as the lower price point likely accelerated membership expansion while moderating average revenue per user growth.",
      "llm_answer": "The $6.99 ad‑supported tier is part of Netflix’s strategy to grow its subscriber base while managing ARPU, which is reflected in the 18% year‑over‑year rise in global paid memberships reported in the 10‑K. By offering a lower‑priced, ad‑supported option, Netflix can attract price‑sensitive users and expand market penetration without significantly diluting overall revenue per user, thereby supporting both revenue growth and subscriber‑count expansion.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all numbers are accurate: the $6.99 price point and 18% year-over-year increase in global paid memberships are correctly cited, with no calculation errors. (2) The answer addresses the core relationship between the ad-supported tier and subscriber growth, correctly identifying Netflix's strategy of balancing ARPU with market penetration. (3) The reasoning is sound but slightly less precise than the original answer: while it correctly notes that the lower-priced tier supports subscriber growth, it downplays the acknowledged tradeoff by stating the tier avoids 'significantly diluting' ARPU, whereas the ground truth explicitly acknowledges that lower ARPU is an accepted consequence. The original answer more accurately reflects Netflix's strategic acceptance of lower per-user revenue in exchange for faster membership growth. (4) Despite this nuance, the LLM answer captures the essential multi-hop logic—linking pricing strategy, subscriber growth, and ARPU implications—and remains contextually accurate and relevant. Minor deduction in qualitative accuracy due to softened portrayal of the ARPU tradeoff.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 338,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What is the total number of individuals working in McDonald's restaurants globally, including both Company-owned and franchised restaurants, and how does this workforce contribute to the company's stated purpose and mission?",
      "original_answer": "The total number of individuals working in McDonald's restaurants globally is over 2,150,000, which includes over 150,000 Company employees and over two million individuals working in franchised restaurants. This extensive workforce contributes to the company's purpose of feeding and fostering communities and its mission to make delicious feel-good moments easy for everyone by delivering consistent, high-quality service across the global restaurant network.",
      "llm_answer": "Based on the document, McDonald's employs over 150,000 Company employees globally (including corporate and restaurant staff), with approximately 70% based outside the U.S., and relies on over two million individuals working in franchised restaurants worldwide. This combined workforce is central to McDonald's purpose of \"feeding and fostering communities\" and its mission to \"make delicious feel-good moments easy for everyone,\" as emphasized in its \"Our People\" and \"Human Capital Management\" sections, which highlight that \"people are at the cornerstone of the Company's business\" and that its values—including inclusion and community—are brought to life by its global workforce.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key quantitative figures: over 150,000 Company employees and over two million individuals working in franchised restaurants, which aligns with the ground truth total of over 2,150,000. The percentage of Company employees outside the U.S. (~70%) is an additional detail not in the ground truth but does not contradict it and may be contextually accurate; it does not affect the core numerical accuracy. (2) Quantitative accuracy is perfect: the sum of over 150,000 and over two million logically supports the total of over 2,150,000. No calculation errors. Format variations (e.g., 'over two million') are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound—correctly synthesizing workforce data from both Company and franchise operations and linking it to McDonald's purpose and mission. The LLM cites relevant sections ('Our People', 'Human Capital Management') and accurately reflects the company's stated values, including community, inclusion, and service delivery. (4) The answer is contextually excellent, directly addressing both parts of the question: total workforce size and its contribution to purpose and mission. The only minor gap is the lack of explicitly stating the total (over 2,150,000) as a single sum, though it is clearly implied by the components. This omission prevents a perfect 10 but does not undermine correctness. Overall, the answer is factually accurate, well-reasoned, and highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 414,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the total fair value of the VMware acquisition by Broadcom, and how does this acquisition enhance Broadcom's infrastructure software capabilities?",
      "original_answer": "The total fair value of the VMware acquisition by Broadcom was $84,186 million, which includes $30,788 million in cash and $53,398 million in Broadcom common stock. This acquisition enhances Broadcom's infrastructure software capabilities by adding VMware's multi-cloud services, which enable digital innovation with enterprise control, thereby strengthening Broadcom’s portfolio of infrastructure and security software solutions.",
      "llm_answer": "The total fair value of the VMware acquisition was approximately $53.4 billion, consisting of about $30.8 billion in cash and 544 million shares of Broadcom common stock (split‑adjusted). This acquisition enhances Broadcom’s infrastructure software capabilities by adding VMware’s leading multi‑cloud services and expanding its portfolio of enterprise‑grade cloud, virtualization and security solutions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is partially correct on quantitative details: it states the cash portion as $30.8 billion (close to the ground truth $30,788 million), but reports the stock portion as '544 million shares' instead of the $53,398 million fair value. It also gives the total fair value as $53.4 billion, which is significantly lower than the correct total of $84,186 million (~$84.2 billion). This major discrepancy in total value and failure to report the stock component in dollar terms reduces quantitative accuracy. 2) The calculation of the total is incorrect: $30.8B + value of 544M shares should equal ~$84.2B, but the LLM implies $53.4B total, suggesting a fundamental error in aggregation or data sourcing. 3) Qualitatively, the answer correctly identifies that the acquisition enhances Broadcom's infrastructure software capabilities through VMware's multi-cloud services and expands its portfolio in cloud, virtualization, and security—this aligns with the ground truth and shows sound reasoning and entity accuracy. 4) Contextually, the response is fully relevant, addressing both parts of the question. However, the severe quantitative inaccuracies—especially the total value being off by over $30 billion—prevent a higher correctness score despite accurate qualitative synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 359,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Netflix's pricing strategy for its membership plans, as outlined in the 2024 10-K, potentially conflict with its need to retain existing members amid rising macroeconomic pressures also mentioned in the filing?",
      "original_answer": "Netflix's pricing strategy, which includes a range of membership plans priced between $1 and $32 per month as of December 31, 2024, could conflict with its ability to retain existing members if price increases or plan adjustments are not favorably received. The 2024 10-K highlights that adverse macroeconomic conditions, such as inflation, may impact consumers' willingness or ability to continue paying for the service. If Netflix adjusts pricing or modifies membership plans in a way that is not perceived as valuable by members, it could lead to increased cancellations and negatively affect revenue and results of operations, especially since content costs are largely fixed and may not be adjusted in line with reduced growth.",
      "llm_answer": "The 2024 10‑K notes that Netflix continually tests and adjusts its membership pricing—including the newer ad‑supported tier—to boost revenue per subscriber, but it also warns that any price change or shift in plan mix could be poorly received by members, especially as macro‑economic pressures tighten household budgets.  This creates a tension: while pricing moves are meant to offset rising content costs and preserve margins, they risk alienating price‑sensitive subscribers and could accelerate churn, jeopardizing the company’s ability to retain its existing member base amid intensifying competition and economic headwinds.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, while the exact price range ($1 to $32 per month) is not explicitly mentioned in the LLM response, this is a minor omission since the focus is on the strategic tension rather than specific pricing tiers. All other temporal references (2024 10-K) and contextual details are correct. (2) The answer correctly identifies Netflix's pricing adjustments, including the ad-supported tier, and links them to macroeconomic pressures like inflation and household budget constraints—consistent with the filing. (3) The multi-hop reasoning is sound: it synthesizes Netflix’s pricing strategy, the risk of member churn, fixed content costs, and external economic pressures into a coherent conflict, even if it doesn't explicitly state that content costs are 'largely fixed' as in the original. (4) The semantic meaning fully captures the core risk described in the ground truth: that pricing actions intended to grow revenue may backfire under economic stress, threatening retention and financial performance. The answer is slightly less specific on the structural cost issue but otherwise matches the original in substance and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 341,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does McDonald's financial exposure from franchisee performance impact its goodwill accounting when acquiring and subsequently selling restaurants, based on the risks described in the franchise business model and the goodwill valuation methodology?",
      "original_answer": "McDonald's financial exposure from franchisee performance impacts its goodwill accounting significantly when acquiring and selling restaurants. According to the franchise business model, McDonald's relies heavily on franchisee sales growth to drive its revenues, as franchisees contribute through rent and royalties. If franchisee sales trends worsen, it could lead to financial distress for franchisees, increasing the likelihood of restaurant closures or sales. When McDonald's acquires restaurants from franchisees, it assigns goodwill based on expected profitability and cash flows using a discounted cash flow methodology. However, if a restaurant is sold within 24 months of acquisition, the associated goodwill is written off entirely. If sold after 24 months, goodwill is written off based on the relative fair value of the business sold. Therefore, poor franchisee performance that leads to acquisition and early resale directly affects McDonald's goodwill balances and may result in material write-offs.",
      "llm_answer": "McDonald's goodwill accounting is directly tied to its franchise business model risks: when acquiring restaurants from franchisees, goodwill is assigned to reporting units and valued using discounted cash flow (Level 3) inputs based on expected profitability, but if a Company-operated restaurant is sold within 24 months, the associated goodwill is fully written off, and beyond 24 months, it is written off proportionally based on relative fair value. This creates financial exposure where poor franchisee performance—driven by risks like supply chain disruptions, labor shortages, or operational failures—can depress restaurant profitability, potentially triggering goodwill impairments or accelerated write-offs that materially impact the Company's financial results, as highlighted in the \"Our franchise business model presents a number of risks\" section and the goodwill impairment testing methodology.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: goodwill is assigned using discounted cash flow (Level 3 inputs), written off fully if sold within 24 months, and proportionally based on relative fair value after 24 months. These timeframes and accounting treatments match the original answer exactly. (2) Quantitative accuracy is perfect: the 24-month threshold is correctly cited, and there are no numerical errors or miscalculations. Format variations (e.g., 'proportionally' vs 'based on relative fair value') are semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly links franchisee performance risks (e.g., supply chain, labor) to reduced profitability, which can lead to acquisitions and early resale, triggering goodwill write-offs. It also ties this to the goodwill valuation methodology and impairment testing, showing synthesis across the franchise model and accounting policy. (4) The only minor shortcoming is that the LLM slightly generalizes the cause of write-offs by mentioning 'goodwill impairments'—which are distinct from disposal-related write-offs—though in context, it refers correctly to write-offs upon sale. The original answer more precisely limits the impact to sales within or after 24 months. Despite this nuance, the core logic and factual content are correct. Contextual relevance is excellent, directly addressing the interplay between franchisee performance, acquisition, resale, and goodwill accounting.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 417,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How do Lockheed Martin's hypersonics programs align with its Space segment's strategic priorities and contribute to its anticipated growth through 2026?",
      "original_answer": "Lockheed Martin's hypersonics programs are a key part of its Space segment's strategic priorities, as they are explicitly mentioned among major programs such as those with the U.S. Army and U.S. Navy to design, develop, and build hypersonic strike weapons. These programs align with the Space segment's focus on advanced strike capabilities and are expected to enter early production phases through 2026. This anticipated production transition directly supports Lockheed Martin's strategic growth objective, as outlined in its 2023 10-K filing, which highlights hypersonics as one of four key growth areas in the near-to-mid-term alongside current programs of record, classified programs, and new awards.",
      "llm_answer": "Lockheed Martin's hypersonics programs are a key growth driver aligned with its Space segment's strategic priorities of advancing next‑generation missile defense and classified systems, with multiple hypersonic strike weapons expected to enter early production through 2026. This aligns with the company's broader growth outlook, as highlighted by its focus on classified programs, hypersonics, and new awards within its 21st‑Century Security strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth. (1) All factual elements are correct: Lockheed Martin's hypersonics programs are indeed a key part of its Space segment's strategic priorities, with expected entry into early production through 2026. The mention of classified programs, hypersonics, and new awards as growth drivers aligns with the 2023 10-K filing. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no dates or numbers are incorrect. (3) The multi-hop reasoning is sound: the answer correctly links hypersonics to the Space segment, ties them to strategic growth priorities, and references the 2026 timeline and broader strategic framework (implied 21st-Century Security strategy). (4) Minor omission: the original answer specifies U.S. Army and U.S. Navy programs as key hypersonics efforts, which the LLM omits, and it does not explicitly name 'advanced strike capabilities' as the strategic focus (instead saying 'missile defense and classified systems,' which is slightly different—hypersonics are more about offensive strike than defense). However, 'classified systems' and 'new awards' are correctly identified as parallel growth areas. The LLM answer remains semantically equivalent in intent and substance, with only slight imprecision in emphasis. Thus, correctness is high but not perfect due to minor contextual omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 405,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Broadcom's valuation methodology for VMware Cloud Foundation-related developed technology reflect its projected financial contribution, and what specific technique was used to estimate its economic benefit over time?",
      "original_answer": "Broadcom used the multi-period excess earnings method under the income approach to value the developed technology related to VMware Cloud Foundation. This method estimates the present value of projected cash flows generated by the technology, subtracting charges that represent the contribution of other assets to those cash flows. The economic useful life of the technology was determined based on the technology cycle and forecasted cash flows, directly linking its expected financial contribution over time to its valuation.",
      "llm_answer": "Broadcom's valuation methodology for VMware Cloud Foundation-related developed technology reflects its projected financial contribution through the use of the multi-period excess earnings method under the income approach, which isolates the cash flows attributable to the developed technology after accounting for contributions from other assets. The economic benefit of this technology is estimated by projecting future cash flows over its useful life—determined by technology cycles and forecasted revenue patterns—and discounting them to present value, with specific allocations detailed in the fair value breakdown on page 68. This approach ensures the developed technology's value is measured by the incremental revenue it generates, net of other asset contributions, and is amortized over an 8-year weighted-average period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. It correctly identifies the multi-period excess earnings method under the income approach as the valuation technique used by Broadcom for VMware Cloud Foundation-related developed technology, which is factually correct. The explanation of how this method isolates cash flows attributable to the technology after subtracting contributions from other assets matches the ground truth's description. The answer adds specific detail about an 8-year weighted-average amortization period and a reference to 'page 68' of a filing for fair value breakdown, which are plausible contextual details consistent with SEC disclosures and do not contradict the ground truth. While the original answer does not mention the 8-year period or page number, these are likely accurate in context and enhance completeness without introducing error. The economic benefit estimation through projected cash flows, consideration of technology cycles, and discounting to present value are all correctly described and semantically equivalent to the ground truth. The reasoning is sound, multi-hop synthesis is appropriate (linking valuation method to financial contribution and useful life), and all key entities (Broadcom, VMware Cloud Foundation, developed technology) are correct. The only reason for not scoring a 10 is the inclusion of minor specifics (page 68, 8-year amortization) that, while likely accurate, are not confirmed in the ground truth and slightly extend beyond the provided information. However, they do not detract from factual correctness. Quantitative accuracy is high—no numerical errors—and contextual relevance is perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 460,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the launch of Sky Glass influence Comcast's Corporate and Other segment expenses in 2021 and what strategic expectation did the company have regarding costs for 2022?",
      "original_answer": "The launch of Sky Glass contributed to increased costs in the Corporate and Other segment in 2021, as noted by the mention of 'costs related to Sky Glass and XClass TV' partially offsetting prior-year cost savings. The company expected to incur further increased costs in 2022 related to the continued rollout of Sky Glass and XClass TV, indicating a strategic anticipation of ongoing investment in these new product launches.",
      "llm_answer": "The launch of Sky Glass was expected to increase Corporate and Other segment expenses in 2021, and the company anticipated incurring higher costs in 2022 related to the continued rollout of Sky Glass and the launch of XClass TV.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the launch of Sky Glass increased Corporate and Other segment expenses in 2021 and that higher costs were expected in 2022 due to the continued rollout of Sky Glass and the launch of XClass TV. This aligns with the ground truth, which notes increased costs in 2021 from Sky Glass and XClass TV partially offsetting prior savings, and expectations of further cost increases in 2022. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the model correctly links the product launch (Sky Glass) to segment-level cost impacts across two fiscal years and incorporates the strategic expectation for 2022. The only minor shortcoming is that the LLM answer does not explicitly mention that these costs were 'partially offsetting prior-year cost savings,' a nuance present in the original. However, this omission does not distort the core factual claim. (4) The answer is contextually fully relevant, directly addressing both parts of the question—impact in 2021 and strategic expectation for 2022. Overall, the LLM response is factually accurate and semantically equivalent to the ground truth with only slight reduction in detail, justifying a correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 383,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does McDonald's (MCD) valuation methodology for acquiring restaurants from franchisees impact the treatment of goodwill when those restaurants are sold within or beyond 24 months of acquisition, and what is the financial implication of this policy on goodwill write-offs?",
      "original_answer": "McDonald's uses a discounted cash flow methodology (Level 3 inputs) to determine the fair value of restaurants acquired from franchisees. If a restaurant is sold within 24 months of acquisition, the entire goodwill associated with that acquisition is written off. If sold beyond 24 months, only a portion of the goodwill is written off, based on the relative fair value of the business sold compared to the reporting unit. This policy directly affects the magnitude and timing of goodwill write-offs, potentially increasing write-off amounts for recently acquired restaurants.",
      "llm_answer": "The Company's valuation methodology for acquiring restaurants from franchisees uses a discounted cash flow (Level 3) approach to determine fair value, and it includes a specific goodwill policy: if a Company‑operated restaurant is sold within 24 months of acquisition, the entire associated goodwill is written off; if sold after 24 months, the goodwill write‑off is proportional to the relative fair value of the business sold versus the reporting unit. This policy results in goodwill write‑offs that can be significant when restaurants are sold shortly after acquisition, directly reducing earnings in the period of sale.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key elements are correct: McDonald's uses a discounted cash flow methodology with Level 3 inputs for valuing restaurants acquired from franchisees. The policy on goodwill write-offs—full write-off if sold within 24 months, proportional write-off based on relative fair value if sold after 24 months—is accurately described. (2) There are no numeric values requiring calculation (e.g., dollar amounts or percentages), but the 24-month threshold is correctly stated and matches the original. Format and terminology (e.g., 'proportional', 'relative fair value', 'reporting unit') are used appropriately. (3) The multi-hop reasoning is sound: the answer connects the valuation methodology to the goodwill treatment and explains the financial implication—namely, that early sales lead to larger, immediate write-offs that impact earnings. (4) The answer is complete, addressing both the 'how' of valuation, the timing-based treatment of goodwill, and the financial impact on write-offs and earnings. Wording differs slightly (e.g., 'directly reducing earnings' vs. 'affects magnitude and timing') but conveys the same meaning. No factual errors, omissions, or misstatements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 352,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the concentration risk in Boeing's customer financing portfolio, particularly in 717 and 747-8 aircraft, compound the financial vulnerability caused by the $1.8 billion portfolio defaults linked to the impact of the COVID-19 pandemic on airline revenues and cash flows?",
      "original_answer": "The concentration risk in Boeing's customer financing portfolio, especially in 717 and 747-8 aircraft, increases the financial exposure because a significant portion of the portfolio is tied to fewer customers and specific aircraft types. If these customers face financial difficulties or defaults, Boeing could suffer significant losses. This risk is compounded by the impact of the COVID-19 pandemic, which has already caused a dramatic decline in commercial air traffic, reducing airline revenues and cash flows. As a result, some airlines may not be able to make timely payments, increasing the likelihood of defaults within the $1.8 billion customer financing portfolio. This dual exposure heightens Boeing's risk of material adverse effects on its financial position, results of operations, and cash flows.",
      "llm_answer": "The $1.8 billion customer‑financing portfolio is heavily weighted toward 717 and 747‑8 aircraft and toward customers with weaker credit, so when the pandemic crushed airline cash flows and drove defaults, those concentrated exposures amplified the financial strain; the resulting defaults not only eroded cash and earnings but also limited Boeing’s ability to refinance or sell the aircraft, deepening the company’s liquidity and credit‑rating pressures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $1.8 billion portfolio figure is correctly stated and matches the original answer. No other numerical values (e.g., dates, percentages) are present, so no calculation errors exist. Format is consistent and acceptable. (2) The LLM correctly identifies the concentration risk in Boeing’s customer financing portfolio, specifically naming the 717 and 747-8 aircraft types, which matches the entities in the ground truth. It also correctly links this risk to the impact of the COVID-19 pandemic on airline cash flows and defaults. (3) The reasoning is sound and captures the multi-hop logic: concentration risk + pandemic-induced financial stress → amplified defaults → broader financial consequences for Boeing. The LLM adds value by noting downstream effects such as reduced ability to refinance or sell aircraft and impacts on liquidity and credit ratings, which are reasonable inferences consistent with the original answer’s mention of 'material adverse effects.' (4) While the original answer emphasizes the structural risk of concentration and pandemic-driven defaults, the LLM answer goes slightly further in implications but remains factually and semantically aligned. The only minor gap is that the original explicitly mentions 'fewer customers and specific aircraft types' as the source of concentration, while the LLM focuses on 'weaker credit' customers—this is a nuance but not incorrect. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 438,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the launch of Sky Glass in the fourth quarter of 2021 impact the financial performance of CMCSA's Corporate and Other segment in 2021, and what specific cost and revenue effects were tied to this product introduction?",
      "original_answer": "The launch of Sky Glass in the fourth quarter of 2021 contributed to increased revenue in the Corporate and Other segment in 2021 due to sales of the new televisions. However, it also led to higher expenses tied to the product's introduction, partially offsetting the financial benefit. This dual impact reflects both the revenue generation from hardware sales and the cost investment required for launching a new product line.",
      "llm_answer": "The launch of Sky Glass in Q4 2021 generated a modest revenue boost for the Corporate and Other segment, adding roughly $461 million of revenue in 2021 (up from $248 million in 2020).  However, the product’s rollout also incurred higher operating costs – the segment’s expenses fell only slightly to $1,819 million in 2021 from $2,033 million in 2020, reflecting the additional hardware‑sales and marketing outlays tied to Sky Glass.  Consequently, the segment posted a smaller loss of $1.358 billion in Adjusted EBITDA for 2021, an improvement from the $1.785 billion loss the prior year.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific financial figures—$461 million revenue in 2021 (vs $248 million in 2020), expenses of $1,819 million (vs $2,033 million in 2020), and Adjusted EBITDA losses of $1.358 billion and $1.785 billion—for the Corporate and Other segment. However, the ground truth contains no such numbers, and there is no indication in the original answer that these figures are available or were part of the knowledge graph. This suggests the LLM fabricated detailed quantitative data not present in the source material. (2) The calculations implied—such as the year-over-year change in revenue and expenses—are mathematically accurate based on the numbers provided (e.g., $2,033M to $1,819M is a small decrease), but since the numbers themselves are not in the ground truth and cannot be verified as correct from the provided context, they represent hallucinated precision. (3) The qualitative reasoning—linking Sky Glass to increased revenue and higher costs in the Corporate and Other segment—is consistent with the ground truth and shows correct multi-hop understanding: the product launch drives both revenue (from TV sales) and costs (from marketing and rollout), leading to a net partial offset. This synthesis aligns with the original answer’s logic. (4) Contextually, the response addresses both parts of the question: financial impact on the segment and specific cost/revenue effects. However, the inclusion of fabricated metrics severely undermines factual correctness. While the directionality (revenue up, costs up, loss narrowed) may be plausible, the absence of such data in the ground truth means the answer cannot be considered factually accurate. Thus, the correctness score is low due to hallucinated numbers, despite sound reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 487,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What is the total fair value of commercial mortgage-backed securities held by CVS as of December 31, 2023, and how much unrealized loss does this category represent compared to its total debt securities portfolio?",
      "original_answer": "CVS held commercial mortgage-backed securities with a fair value of $675 million as of December 31, 2023, which represented $100 million in unrealized losses. This unrealized loss accounts for approximately 12% of the total unrealized losses across all debt securities, which stood at $836 million.",
      "llm_answer": "As of December 31 2023, the fair value of the commercial mortgage‑backed securities held by CVS was $675 million, and this category represented $100 million of the total unrealized loss within its overall debt‑securities portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the fair value of commercial mortgage-backed securities ($675 million) and the associated unrealized loss ($100 million) as of December 31, 2023, matching the ground truth exactly. All numeric values and dates are accurate, and formatting variations (e.g., $675 million) are acceptable. The answer addresses both parts of the question: the fair value and the unrealized loss within the total debt securities portfolio. However, it omits the contextual detail that the $100 million unrealized loss represents approximately 12% of the total $836 million in unrealized losses across all debt securities. While this percentage is not strictly required to answer the question, it adds completeness to the comparison with the total debt securities portfolio. The entity (CVS), metric (fair value, unrealized loss), and time period (December 31, 2023) are all correct. The reasoning is sound and semantically equivalent to the original answer, though slightly less detailed in the comparative aspect. Hence, full marks for quantitative accuracy and contextual relevance, a 9 for qualitative accuracy due to minor omission, and a 9 overall for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 332,
        "total_tokens": 1481
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the growth in third-party seller unit sales contribute to Amazon's overall sales increase in 2023, and what international risk related to third-party sellers could potentially impact Amazon's international expansion strategy?",
      "original_answer": "The growth in third-party seller unit sales was a key contributor to Amazon's 12% overall sales increase in 2023, particularly in both North America and International segments. However, Amazon faces international risks such as regulatory restrictions in countries like India, where foreign ownership rules limit control over online retail platforms, potentially complicating Amazon's expansion and reliance on third-party sellers in such markets.",
      "llm_answer": "In 2023, growth in third‑party seller unit sales was a primary driver of Amazon’s overall sales increase, contributing to the 12 % year‑over‑year rise in consolidated net sales and accounting for much of the 11 % growth in International sales. A key international risk tied to this reliance on third‑party sellers is the potential for regulatory or geopolitical changes—such as stricter foreign‑investment rules, data‑localization mandates, or trade restrictions in major markets like China and India—that could limit Amazon’s ability to expand or sustain its marketplace operations abroad.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the 12% overall sales increase and 11% International sales growth (a close proxy to the North America and International segment growth mentioned in the original) are accurately reported. The 12% year-over-year rise in consolidated net sales matches the ground truth's 12% overall sales increase. (2) The LLM correctly identifies third-party seller growth as a primary driver of Amazon’s sales growth, addressing the first part of the question. (3) For the international risk, while the original specifically cites India’s foreign ownership rules, the LLM generalizes to 'stricter foreign-investment rules' in 'major markets like China and India,' which includes the correct jurisdiction (India) and plausible risks (foreign-investment rules, data localization). This is a minor generalization but remains factually sound and contextually appropriate. (4) Multi-hop reasoning is strong: the model connects third-party seller growth to overall and international sales, then links reliance on such sellers to regulatory risks abroad. The only slight shortfall is that the original emphasizes India as a specific example with binding ownership rules, while the LLM broadens to China and India without specifying the exact nature of India’s restrictions. However, the core entities (Amazon, third-party sellers, 2023, international expansion), metrics, and causal logic are correct. Wording differs but semantic meaning is equivalent. No calculation errors. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 464,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What is the difference in the number of shares remaining available for future issuance between the Deferred Compensation Plan and the Non-Qualified Deferred Compensation Plan for Independent Contractors at Wells Fargo in 2023?",
      "original_answer": "The difference in the number of shares remaining available for future issuance between the Deferred Compensation Plan and the Non-Qualified Deferred Compensation Plan for Independent Contractors is 1,712,810 shares.",
      "llm_answer": "The Deferred Compensation Plan has 1,853,363 shares remaining available for future issuance, while the Non-Qualified Deferred Compensation Plan for Independent Contractors has 140,553 shares remaining available for future issuance. This results in a difference of 1,712,810 shares between the two plans.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the number of shares remaining available for future issuance under both the Deferred Compensation Plan (1,853,363 shares) and the Non-Qualified Deferred Compensation Plan for Independent Contractors (140,553 shares), which aligns with the ground truth data. (2) The difference is calculated as 1,853,363 - 140,553 = 1,712,810 shares, which matches the original answer exactly. All numeric values and the final calculation are accurate. (3) The reasoning is sound and demonstrates proper multi-hop synthesis by retrieving share availability from two distinct plans and computing the difference. (4) The answer is fully relevant, complete, and semantically equivalent to the ground truth, with no factual or computational errors. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 249,
        "total_tokens": 1399
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What specific categories of products are included in PMI's reduced-risk product line, and how do heated tobacco units contribute to this classification based on the company's 2022 10-K filing?",
      "original_answer": "PMI's reduced-risk product line includes heated tobacco units, heat-not-burn devices and related accessories, and other nicotine-containing products such as e-vapor and oral nicotine products. Heated tobacco units are a core component of this category, as explicitly stated in both sections of the 10-K filing, which specifically name them as part of the reduced-risk offerings.",
      "llm_answer": "Based on the 2022 10-K filing (pages 31, 32, 33, 36, 37, 61, 67, 96, 97, 100), PMI’s reduced‑risk product line is defined as comprising “heated tobacco units, heat‑not‑burn devices and related accessories, and other nicotine‑containing products” such as e‑vapor and oral‑nicotine items. The filing reports that net revenues from reduced‑risk products totaled **$9.1 billion in 2021**, driven largely by sales of heated‑tobacco units (e.g., Platform 1, KT & G heat‑not‑burn products) and associated accessories. Thus, within the reduced‑risk category, heated‑tobacco units are a distinct sub‑segment that contributes a substantial portion of the overall reduced‑risk revenue.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the product categories in PMI's reduced-risk line—specifically heated tobacco units, heat-not-burn devices and accessories, and other nicotine-containing products like e-vapor and oral nicotine products—matching the ground truth. It also correctly positions heated tobacco units as a core component of this category. However, the LLM introduces a specific financial figure—$9.1 billion in net revenues for reduced-risk products in 2021—which is not mentioned in the original answer and is potentially inaccurate or misattributed. Since the ground truth does not include any revenue figures, the inclusion of this number introduces unverified quantitative data, reducing factual accuracy. (2) The quantitative claim of $9.1 billion in 2021 is not corroborated by the ground truth and may be incorrect or taken from a different context; no such number appears in the original answer, and the question does not ask for financial performance. This constitutes a significant issue in quantitative accuracy despite being internally consistent in the LLM's response. (3) The reasoning is sound in terms of categorization and classification, correctly synthesizing that heated tobacco units are a key part of the reduced-risk product line. The multi-hop logic is appropriate—linking product types to their role in the category—but the addition of unsolicited financial data distracts from the core question. (4) The contextual relevance is high because the answer directly addresses the product categories and the role of heated tobacco units. The qualitative accuracy is strong in entity identification and conceptual understanding, but the quantitative inaccuracy lowers the overall correctness score to 7 due to the introduction of potentially false financial data not present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 498,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What percentage of NVDA's revenue came from DirectCustomerA in fiscal year 2025, and how does this compare to the previous year for which data is available?",
      "original_answer": "In fiscal year 2025, DirectCustomerA accounted for 12% of NVDA's revenue. For the previous year with available data (fiscal year 2024), DirectCustomerA's contribution was not disclosed (marked as '*'). Therefore, a direct numerical comparison cannot be made, but we observe that DirectCustomerA became a named top customer in 2025 after not being reported in 2024.",
      "llm_answer": "Based on the provided document pages, **NVIDIA did not disclose any customer representing 10% or more of total revenue in fiscal year 2025**. The table on page 80 explicitly states: \"DirectCustomerA: 12% (Jan26,2025) | * Less than 10% of total revenue.\" The asterisk confirms that DirectCustomerA's 12% share **exceeded 10%**, but the document clarifies this was an exception—no customer represented 10% or more of total revenue for fiscal year 2025, as the 12% figure is labeled with an asterisk indicating it was *not* considered \"10% or more\" per the company's reporting convention (likely due to rounding or specific exclusion criteria). However, the question asks for the *percentage of revenue from DirectCustomerA*, which the document confirms as **12%** for fiscal year 2025 (Jan26,2025).  \n\nFor comparison to the prior year (fiscal 2024), the same table shows DirectCustomerA accounted for **11%** of revenue in fiscal 2024 (Jan28,2024). Thus, DirectCustomerA's revenue share increased from **11% in fiscal 2024 to 12% in fiscal 2025**.  \n\n**Answer**:  \nDirectCustomerA contributed 12% of NVIDIA's revenue in fiscal year 2025, up from 11% in fiscal year 2024. The document confirms no customer represented 10% or more of total revenue for fiscal 2025, but DirectCustomerA's share was explicitly reported as 12% (with the asterisk clarifying it was not classified as \"10% or more\" per the company's threshold).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its quantitative and qualitative claims. (1) According to the ground truth, DirectCustomerA accounted for 12% of NVDA's revenue in fiscal year 2025, which matches the LLM's claim. However, the ground truth explicitly states that for fiscal year 2024, the contribution was *not disclosed* (marked as '*'), meaning no percentage should be reported. The LLM incorrectly asserts that DirectCustomerA contributed 11% in fiscal 2024, which directly contradicts the ground truth. (2) The LLM fabricates a comparison (11% to 12%) based on a non-disclosed value, introducing a false calculation. There is no evidence in the ground truth that 11% was reported for 2024. (3) The reasoning is flawed: the LLM misinterprets the asterisk, claiming it indicates the 12% was 'not considered 10% or more' due to rounding or exclusion criteria—this is unsupported by the ground truth, which uses the asterisk simply to denote non-disclosure in the prior year. (4) The LLM also introduces a contradictory narrative that 'no customer represented 10% or more' while simultaneously citing 12%, creating confusion. The correct interpretation per the ground truth is that DirectCustomerA became a named top customer in 2025 after not being reported (i.e., below threshold or not individually disclosed) in 2024. Thus, the core factual error (inventing a 11% figure) severely undermines correctness, despite getting the 2025 percentage right.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 401,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How many distinct versions of the Restricted Share Rights Award Agreement were filed or incorporated by reference for grants occurring on or after January 24, 2023, and January 23, 2024, respectively, in Wells Fargo's 2023 10-K filing?",
      "original_answer": "There are two distinct versions of the Restricted Share Rights Award Agreement: one for grants on or after January 24, 2023, which was incorporated by reference, and another for grants on or after January 23, 2024, which was filed herewith.",
      "llm_answer": "Based on the provided pages from Wells Fargo's 2023 10-K filing, **two distinct versions of the Restricted Share Rights Award Agreement were filed or incorporated by reference** for grants occurring on or after the specified dates:  \n- **One version** was incorporated by reference for grants **on or after January 24, 2023** (referenced in Exhibit 10(a) to the 2022 Annual Report on Form 10-K).  \n- **Another version** was incorporated by reference for grants **on or after January 23, 2024** (referenced in the same Exhibit 10(a) to the 2022 Annual Report on Form 10-K).  \n\nThus, **two distinct versions** were filed/incorporated for these grant date ranges.  \n\n*(Answer derived from Exhibit 10(a) descriptions on pages 13–14, which list the award agreements for grants \"on or after January 24, 2023\" and \"on or after January 23, 2024\" as separate incorporated references.)*",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that there are two distinct versions of the Restricted Share Rights Award Agreement, which matches the ground truth. The dates (January 24, 2023, and January 23, 2024) are accurately reported, and the conclusion that two versions were filed or incorporated is correct. However, there is a factual error in the method of inclusion: the LLM states that both versions were 'incorporated by reference,' while the ground truth specifies that the version for grants on or after January 23, 2024, was 'filed herewith,' not incorporated by reference. This is a significant qualitative distinction in SEC filing terminology and affects the accuracy of the synthesis. (2) Quantitatively, all dates and counts are correct—two versions, correct grant date thresholds—so quantitative accuracy is high. (3) The multi-hop reasoning is mostly sound: the model correctly links the two agreements to their respective dates and identifies them as distinct. However, it fails to differentiate the filing method (incorporated by reference vs. filed herewith), indicating a lapse in precise document characterization, which is critical in SEC contexts. (4) Contextual relevance is perfect—the answer directly addresses the question, cites the correct exhibit and pages, and maintains focus. The error is in nuance of filing status, not relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 381,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the continued uncertainty in FAA approval timelines for the 787 Program in 2022 impact Boeing's cost of sales and margin forecasting, given the reach-forward loss and contractual termination risks described in the critical audit matter?",
      "original_answer": "The continued uncertainty in the FAA approval timeline to resume 787 deliveries significantly increased estimation uncertainty in Boeing's revenue forecasts, particularly for aircraft nearing contractual termination rights. This uncertainty led to potential additional customer considerations and could result in lower margins or further material reach-forward losses. This is reflected in the 2021 cost of sales, which saw a $4,574 million decrease compared to 2020, partly due to the reach-forward loss on the 787 program, highlighting the financial impact of delayed deliveries and increased risk in forecasting.",
      "llm_answer": "The continued uncertainty surrounding FAA approval timelines for the 787 program created significant estimation risk for Boeing’s revenue forecasts under program accounting, directly affecting cost‑of‑sales calculations and margin projections. Because the timing of FAA clearance determines when delayed aircraft can be delivered—and whether customers can invoke contractual termination rights—Boeing recorded a reach‑forward loss and faced potential additional consideration to customers, which pressured margins and required extensive audit scrutiny of the revenue estimates.",
      "correctness_score": 7,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the impact of FAA approval uncertainty on Boeing's revenue forecasts, cost of sales, and margin projections, and accurately references the reach-forward loss and contractual termination risks. It also correctly links these factors to audit scrutiny and margin pressure. However, it omits the key quantitative detail from the ground truth: the $4,574 million decrease in cost of sales in 2021 compared to 2020, which is central to the financial impact. While the qualitative reasoning is sound and contextually relevant, the absence of this specific figure significantly affects quantitative accuracy. (2) No numeric values are mentioned in the LLM answer, despite the ground truth including a precise dollar amount ($4,574 million) and a year-over-year comparison between 2020 and 2021. This omission fails the quantitative accuracy check, even though format variations would be acceptable—no number at all is provided. (3) The multi-hop reasoning is well-executed: the model connects FAA delays → delivery uncertainty → customer termination rights → potential concessions → reach-forward losses → impact on cost of sales and margins → audit implications. This demonstrates strong synthesis across cause-effect链条. (4) The correctness score is 7 because the core financial mechanism and risk factors are accurately described, but the missing dollar figure and year comparison prevent a higher score. Quantitative accuracy is penalized heavily (5/10) for omitting the key number. Qualitative accuracy is high (8/10) due to correct logic and terminology. Contextual relevance is excellent (9/10) as the response directly addresses the question’s focus on cost of sales and margin forecasting impacts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 475,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the role of third-party sellers contribute to Amazon's North America and International sales growth in 2023, and what was the net effect of foreign exchange rate changes on these sales increases?",
      "original_answer": "Third-party sellers were a key driver of unit sales growth in both North America and International segments in 2023. In North America, sales increased by 12%, primarily due to increased unit sales by third-party sellers, advertising sales, and subscription services. Similarly, International sales increased by 11%, also largely driven by increased unit sales by third-party sellers. Foreign exchange rate changes had a mixed impact: they reduced North America net sales by $71 million but increased International net sales by $88 million, resulting in a net positive impact of $17 million on total sales growth.",
      "llm_answer": "In 2023, third‑party sellers drove growth in both North America and International segments, contributing to the 12% rise in North America net sales and the 11% rise in International net sales, as highlighted by the increase in unit sales from those sellers. Currency movements had a modest net effect: a weaker U.S. dollar added $88 million to International sales, while overall foreign‑exchange changes reduced consolidated net sales by about $71 million, partially offsetting the growth from third‑party sellers.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that third-party sellers contributed to the 12% growth in North America and 11% growth in International sales, which matches the ground truth. However, it misrepresents the net effect of foreign exchange rate changes. The ground truth states that FX changes reduced North America sales by $71 million and increased International sales by $88 million, resulting in a net positive impact of $17 million. The LLM incorrectly states that foreign exchange changes reduced 'consolidated net sales by about $71 million,' which contradicts the net positive effect and misattributes the $71 million as a consolidated reduction rather than a regional impact. (2) The percentages (12%, 11%) and the $88 million FX benefit to International are correct. The $71 million FX headwind to North America is mentioned but mischaracterized in scope and direction at the consolidated level. The net effect should be +$17 million, but the LLM implies a $71 million reduction, which is factually incorrect. (3) The multi-hop reasoning is partially sound—linking third-party seller growth to regional sales increases is accurate and reflects synthesis across segments. However, the foreign exchange synthesis fails: it does not correctly combine the opposing regional FX impacts into the correct net effect, indicating a breakdown in multi-hop logic for the second part. (4) Scores reflect mostly correct qualitative understanding and contextual relevance, but quantitative accuracy is reduced due to the significant error in the FX impact calculation and characterization, which affects the overall correctness despite strong performance on the first part of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 462,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "Given Wells Fargo's obligations under the USA PATRIOT Act, how might deficiencies in its anti-money laundering program constrain its ability to pursue future bank acquisitions, and which regulatory body would assess these deficiencies during the approval process?",
      "original_answer": "Deficiencies in Wells Fargo's anti-money laundering (AML) program could constrain its ability to pursue future bank acquisitions because the Federal Reserve Board (FRB), along with other federal banking regulators, is required to evaluate the effectiveness of a financial institution's AML compliance program when determining whether to approve a proposed bank acquisition. If the FRB finds that Wells Fargo's AML program is ineffective or non-compliant, it may deny the acquisition proposal, citing risks to financial integrity and national security under the provisions of the USA PATRIOT Act.",
      "llm_answer": "Deficiencies in Wells Fargo’s anti‑money‑laundering program could trigger heightened scrutiny by federal banking regulators, potentially limiting its ability to meet capital‑distribution requirements and thereby restricting future bank acquisitions. Such deficiencies would be evaluated by the Federal Reserve Board (FRB) during the regulatory approval process for any proposed acquisition.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the Federal Reserve Board (FRB) as the regulatory body that would assess deficiencies during the acquisition approval process, which aligns with the ground truth. This is a key entity and regulatory point, and it is accurately stated. However, the LLM introduces the idea that AML deficiencies could affect 'capital-distribution requirements,' which is not mentioned or implied in the original answer and is not directly tied to the USA PATRIOT Act or acquisition constraints in this context. The ground truth emphasizes that AML deficiencies pose risks to financial integrity and national security, which are grounds for denial under the PATRIOT Act—this reasoning is missing in the LLM response. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable; the score of 10 reflects no errors in this dimension. (3) The multi-hop reasoning is partially sound: the LLM connects AML deficiencies to regulatory scrutiny and links the FRB to the approval process, which is correct. However, it fails to fully synthesize the legal basis (USA PATRIOT Act) and the rationale for denial (risk to financial integrity/national security), weakening the qualitative accuracy. (4) The answer is contextually relevant and addresses the core question about constraints on acquisitions and the responsible regulator, but omits key explanatory elements from the ground truth, justifying a moderate deduction in correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 422,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What was the percentage increase in PMI's total international industry cigarette and heated tobacco unit volume in 2021 compared to 2020, and which product category does heated tobacco units fall under in PMI's financial reporting?",
      "original_answer": "The total international industry cigarette and heated tobacco unit volume increased by 2.4% in 2021 compared to 2020. Heated tobacco units fall under the 'reduced-risk products' category in PMI's financial reporting.",
      "llm_answer": "The percentage increase in PMI's total international industry cigarette and heated tobacco unit volume in 2021 compared to 2020 was 2.4%, and heated tobacco units fall under the \"Reduced-risk products\" category in PMI's financial reporting.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the 2.4% percentage increase in PMI's total international industry cigarette and heated tobacco unit volume from 2020 to 2021, matching the ground truth exactly. It also accurately identifies that heated tobacco units fall under the 'Reduced-risk products' category in PMI's financial reporting, which aligns with the original answer. (2) The numeric value (2.4%) is correct and precisely matches the ground truth; no calculations were required beyond what was reported, and the percentage is accurately presented. (3) The reasoning is sound and reflects proper synthesis of multi-hop information: the answer combines volume trends with product categorization from PMI's reporting structure, correctly linking two distinct pieces of information from the knowledge base. (4) All aspects of the question are addressed completely and accurately, with no omissions or errors. The wording differs slightly (e.g., capitalization of 'Reduced-risk products') but maintains semantic equivalence. Therefore, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1135,
        "completion_tokens": 307,
        "total_tokens": 1442
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "Given the $1.8 billion customer financing portfolio and the 24.2% default rate applied to CCC-rated receivables, by how much could Boeing's potential losses increase if the ongoing impacts of the COVID-19 pandemic cause all CCC-rated receivables within this portfolio to default?",
      "original_answer": "Boeing's potential losses could increase by $435.6 million if all CCC-rated receivables within the $1.8 billion customer financing portfolio were to default, based on the 24.2% default rate applied to CCC-rated receivables.",
      "llm_answer": "Based on the provided pages, Boeing's $1.8 billion customer‑financing portfolio includes receivables rated CCC, to which it applies a default rate of 24.2 %. If every CCC‑rated receivable in that portfolio were to default, the exposure would be roughly $445 million (the total carrying value of CCC‑rated financing receivables). Applying the 24.2 % default rate yields an expected loss of about **$108 million**. Thus, the potential increase in losses from a full CCC default would be approximately **$108 million**.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core calculation and conclusion. The question asks by how much Boeing's potential losses could increase if *all* CCC-rated receivables default, which implies a 100% default scenario on the CCC portion, not applying the 24.2% rate to an estimated exposure. The ground truth correctly calculates 24.2% of $1.8 billion = $435.6 million as the potential loss, treating the 24.2% as the *proportion* of the portfolio that is CCC-rated and thus exposed. However, the LLM misinterprets the 24.2% as a *probability of default* to be applied to a separate CCC exposure of $445 million (which exceeds the total portfolio size of $1.8 billion, making it incoherent), yielding $108 million — a figure that does not align with the ground truth or logical interpretation. (2) Quantitatively, the numbers are inconsistent: $445 million cannot be the 'carrying value' of CCC receivables within a $1.8 billion portfolio if 24.2% is the share of CCC assets (which would be ~$435.6 million). Then applying 24.2% again as a default rate compounds the error. The correct approach is a single multiplication: 24.2% of $1.8 billion = $435.6 million. The LLM’s $108 million is off by over 75%. (3) The multi-hop reasoning fails: the model does not recognize that the 24.2% serves as the *proportion* of the portfolio rated CCC, and a full default of those would mean 100% loss on that segment. Instead, it incorrectly treats 24.2% as a loss-given-default rate on a larger CCC subset, showing flawed financial logic. (4) Contextual relevance is fair — the answer addresses Boeing, the $1.8 billion portfolio, CCC ratings, and default risk — but the incorrect reasoning and numbers severely undermine accuracy. Hence, low scores on correctness and quantitative accuracy, moderate on qualitative, and acceptable on relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 503,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What percentage of NVDA's revenue came from DirectCustomerC in the fiscal year ending January 26, 2025, and how does this compare to the previous year's data for the same customer?",
      "original_answer": "In the fiscal year ending January 26, 2025, DirectCustomerC accounted for 11% of NVDA's revenue. This is unchanged from the prior year, as DirectCustomerC also represented 11% of NVDA's revenue in the fiscal year ending January 28, 2024.",
      "llm_answer": "Based on the provided financial data, DirectCustomerC accounted for 11% of NVIDIA's total revenue in the fiscal year ending January 26, 2025. This represents an increase from the prior year (fiscal year ending January 28, 2024), where DirectCustomerC contributed 0% of total revenue (as indicated by the asterisk \"*\" denoting less than 10% and no specific percentage reported for that year). Thus, the percentage rose from 0% to 11% year-over-year.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its comparison between fiscal years. While it correctly states that DirectCustomerC accounted for 11% of NVDA's revenue in the fiscal year ending January 26, 2025, it falsely claims that the prior year (ending January 28, 2024) showed 0% contribution. The ground truth explicitly states that DirectCustomerC also represented 11% in the prior year, meaning there was no change. The LLM incorrectly interprets an asterisk ('*') denoting 'less than 10%' as 0%, which is a significant misreading. (2) The percentage values are thus wrong: 11% → 11% is accurate; 11% → 0% is not. The calculation of a year-over-year increase from 0% to 11% is therefore invalid. (3) The multi-hop reasoning fails because the model did not correctly retrieve or interpret the prior year's data point. It should have recognized that '11%' was reported for both years, but instead assumed absence of a specific number (due to '<10%' notation) meant 0%, which is not supported by the ground truth. (4) Scores reflect major factual error in quantitative and qualitative accuracy, though the answer is contextually relevant and addresses the right entities and time periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 339,
        "total_tokens": 1519
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "What is the total fair value of Commercial Mortgage-Backed Securities (CMBS) held by CVS Health Corporation as of December 31, 2023, and how does this compare to the unrealized losses associated with these securities according to the investment maturity breakdown?",
      "original_answer": "CVS Health Corporation held a total fair value of $675 million in Commercial Mortgage-Backed Securities (CMBS) as of December 31, 2023. The unrealized losses associated with these CMBS were $100 million, representing a significant portion (approximately 14.8%) of the total unrealized losses across all investment categories.",
      "llm_answer": "As of December 31 2023, the Company held $675 million of fair‑value Commercial Mortgage‑Backed Securities (CMBS), and the unrealized loss associated with these securities was $100 million. This loss represents the unrealized loss for the “Greater than ten years” maturity bucket, where the CMBS fair value was $660 million with $98 million of unrealized losses, plus the smaller amounts in the other buckets, resulting in a total unrealized loss of $100 million for the CMBS portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total fair value of CMBS as $675 million and the total unrealized losses as $100 million, matching the ground truth exactly. These figures are reported with accurate formatting ($675 million, $100 million), and the date (December 31, 2023) is correct. (2) All numeric values are accurate: $675 million fair value and $100 million unrealized loss align with the original answer. The LLM adds granular detail about the maturity breakdown—$660 million in the 'Greater than ten years' bucket with $98 million in unrealized losses—information not contradicted by the ground truth and consistent with a plausible multi-hop synthesis from maturity buckets. The sum of $98 million plus 'smaller amounts in other buckets' to reach $100 million is logically sound and does not introduce error. (3) The reasoning is strong: the LLM correctly synthesizes data across maturity categories to arrive at the total unrealized loss, demonstrating valid multi-hop logic. While the ground truth does not include the maturity bucket details, the LLM’s inclusion of them enhances the answer without inaccuracy. (4) The only reason for not scoring a 10 is that the original answer emphasizes that the $100 million loss represents ~14.8% of total unrealized losses across all investments—a contextual comparison the LLM omits. This is a minor omission in completeness, but the core quantitative and entity accuracy remains flawless. All entities (CVS Health Corporation, CMBS, December 31, 2023) are correct. The answer is highly relevant and factually aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 441,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the treatment of changes in estimated fair value of Unit-linked securities differ between net investment income and net derivative gains (losses) based on the disclosed components of MetLife's financial statements?",
      "original_answer": "Changes in the estimated fair value of Unit-linked securities are included in net investment income, while lapses associated with net embedded derivatives, which may arise from these securities, are included in net derivative gains (losses). This distinction reflects different accounting treatments for valuation changes versus derivative-related outcomes.",
      "llm_answer": "Based on the disclosed components of MetLife's financial statements, changes in the estimated fair value of Unit-linked securities are treated differently in net investment income versus net derivative gains (losses). Specifically, for Unit-linked and FVO securities (including mutual fund interests without readily determinable fair values), changes in estimated fair value are included in **net investment income**, while changes in estimated fair value of embedded derivatives related to these securities (e.g., those tied to policy guarantees) are reported in **net derivative gains (losses)**. This distinction is highlighted in Note 13 (Fair Value) and Note 11 (Investments), where the Company explicitly states that \"substantially all realized/unrealized gains (losses) included in net income (loss) for net derivatives and net embedded derivatives are reported in net derivative gains (losses)\" and that \"changes in estimated fair value of Unit-linked and FVO securities are included in net investment income.\"",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that changes in the estimated fair value of Unit-linked securities are included in net investment income, while derivative-related components (specifically embedded derivatives tied to policy guarantees) are reported in net derivative gains (losses). This matches the core distinction in the original answer. (2) There are no numeric values, dates, or calculations in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes accounting treatments from different notes (Note 13 and Note 11) to explain the differential treatment, demonstrating proper cross-document understanding. (4) The LLM adds contextual detail not in the ground truth (e.g., reference to FVO securities and mutual fund interests, specific note citations), which enhances accuracy without introducing error. The only minor shortcoming is that it frames the derivative component as 'changes in estimated fair value of embedded derivatives' whereas the original emphasizes 'lapses associated with net embedded derivatives' as the item in net derivative gains. While related, 'lapses' and 'fair value changes' are not identical triggers—this subtle distinction prevents a perfect 10, but the overall accounting logic remains correct. Semantic equivalence is strong, and the answer is fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 407,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How much financial loss did Boeing record on the 787 Program in the fourth quarter of 2021, and how does the uncertainty around FAA approval for resuming deliveries potentially affect future revenue estimates for the program, based on the accounting methodology described?",
      "original_answer": "Boeing recorded a $3.5 billion loss on the 787 Program in the fourth quarter of 2021. The uncertainty around FAA approval for resuming deliveries affects future revenue estimates because Boeing uses program accounting, which requires estimating the revenue expected upon delivery of each aircraft. The timing of FAA approval is a key factor in determining which aircraft will reach contractual termination rights, and changes in the expected delivery resumption date could lead to additional customer considerations, lower margins, or further material reach-forward losses.",
      "llm_answer": "Boeing recorded a $3.5 billion loss on the 787 program in Q4 2021, driven by rework‑related delays and customer considerations. The company notes that uncertainty around the FAA’s approval to resume deliveries introduces significant risk to future revenue estimates, as delayed deliveries could lower forecasted revenue and increase costs, potentially prompting additional losses.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $3.5 billion loss in Q4 2021, matching the ground truth exactly in amount and time period. This satisfies quantitative accuracy. (2) The mention of 'rework-related delays and customer considerations' as drivers is consistent with known context from Boeing's filings, though not explicitly part of the ground truth answer; it adds plausible detail without contradicting facts. (3) On the second part of the question—how FAA approval uncertainty affects future revenue estimates—the LLM captures the general risk to revenue and costs due to delivery delays, which aligns with the ground truth. However, it omits the specific accounting methodology (program accounting) and key nuances such as the impact on contractual termination rights, customer considerations, and reach-forward losses that are central to the multi-hop reasoning required. (4) While the answer is factually correct and contextually relevant, the lack of precise linkage to program accounting and its implications reduces qualitative accuracy. The core facts are right, but the depth of financial reasoning is incomplete. Hence, correctness is high but not full.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 333,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "What percentage of revenue did NVDA derive from DirectCustomerA in the fiscal year ending January 26, 2025, and how does this compare to the availability of data for the same customer in the prior fiscal year?",
      "original_answer": "NVDA derived 12% of its revenue from DirectCustomerA in the fiscal year ending January 26, 2025. The data for DirectCustomerA in the prior fiscal year (January 28, 2024) is marked as unavailable (denoted by '*'), indicating no disclosed percentage for that year.",
      "llm_answer": "Based on the provided document pages, NVDA derived **12% of its revenue from DirectCustomerA in the fiscal year ending January 26, 2025** (as shown in the \"Direct Customers\" table on page 41 and reiterated on page 16). This contrasts with the prior fiscal year (January 28, 2024), where DirectCustomerA contributed **less than 10% of total revenue** (indicated by an asterisk \"*\" in the same table), confirming no customer represented 10% or more of revenue in fiscal 2024. Thus, the percentage increased from below 10% to 12% year-over-year.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 12% revenue contribution from DirectCustomerA in the fiscal year ending January 26, 2025, which matches the ground truth. However, it incorrectly interprets the asterisk ('*') in the prior fiscal year (January 28, 2024) as meaning 'less than 10%,' whereas the ground truth explicitly states that the data is 'unavailable' and marked with '*'. This is a critical factual error, as 'unavailable' does not imply 'less than 10%'—it means no data was disclosed. (2) The quantitative accuracy is partially correct: the 12% figure is accurate, but the inference of '<10%' for the prior year is unsupported by the ground truth and introduces a false data point. (3) The multi-hop reasoning fails because the model assumes a comparison (increase from below 10% to 12%) that cannot be made due to missing prior-year data. The original answer correctly refrains from making any comparison due to unavailability. (4) Contextual relevance is high—the answer addresses both parts of the question and references appropriate document locations. However, the incorrect interpretation of the asterisk undermines factual correctness, warranting a moderate score of 4 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 343,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "What was the total financial impact on Amgen from its equity investment and collaboration with BeiGene in 2023, combining the fair value of the investment and the net cost recoveries, product sales, and profit/loss sharing expenses related to the collaboration?",
      "original_answer": "The total financial impact on Amgen from its relationship with BeiGene in 2023 was $4.374 billion, combining the fair value of the investment ($4.2 billion), net cost recoveries ($109 million), product sales ($125 million), and profit/loss sharing expenses ($40 million).",
      "llm_answer": "The total financial impact of Amgen’s 2023 equity investment and collaboration with BeiGene—combining the fair‑value of the investment and the net cost recoveries, product sales, and profit/loss‑sharing expenses—was approximately **$4.2 billion** (the fair value of the BeiGene equity investment as of December 31 2023) plus the net cost recoveries and profit‑sharing expenses that are recorded in the income statement.  According to the 10‑K, the fair‑value of the investment was $4.2 billion, while net cost recoveries from BeiGene were $109 million in 2023 and product sales to BeiGene were $125 million; profit‑sharing expenses related to the collaboration were $40 million.  Together, these components represent the total financial impact of the arrangement for 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all individual financial components from the ground truth: fair value of investment ($4.2 billion), net cost recoveries ($109 million), product sales ($125 million), and profit/loss sharing expenses ($40 million). However, it fails to compute the total financial impact of $4.374 billion, which is the key requirement of the question. Instead, it lists the components and implies they should be summed but does not perform or state the sum. This omission significantly affects correctness. (2) All numeric values are accurate and match the ground truth, with acceptable formatting (e.g., $4.2 billion, $109 million). The calculation needed is straightforward: 4,200 + 109 + 125 + 40 = 4,474 million = $4.374 billion. The LLM does not make any arithmetic errors because it avoids performing the calculation. (3) The multi-hop reasoning is mostly sound—the model synthesizes data from the collaboration across multiple financial line items and correctly attributes them to the Amgen-BeiGene relationship. However, it falls short in fully synthesizing the final answer by combining all elements into a single total impact figure, which is the core of the question. (4) Contextual relevance is perfect—the response stays focused on the 2023 financial impact of the Amgen-BeiGene collaboration and includes all relevant components. The qualitative accuracy is reduced due to the lack of final synthesis. Quantitative accuracy is high because all numbers are correct, but the total is missing. Correctness score is 7 because while all inputs are correct, the failure to provide the final computed total—a central requirement—constitutes a significant but not fatal error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 466,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does MetLife's use of different forecast periods for commercial/agricultural versus residential mortgage loans affect the duration over which estimated lifetime loss rates are applied before reverting to historical loss experience?",
      "original_answer": "MetLife applies estimated lifetime loss rates over a two-year forecast period for commercial and agricultural mortgage loans before reverting to historical loss experience, whereas for residential mortgage loans, the forecast period is two years but reverts to industry historical loss experience over a one-year period. This means the duration before reverting to historical data is longer for commercial and agricultural loans (two-year forecast + two-year reversion = 4 years total) compared to residential loans (two-year forecast + one-year reversion = 3 years total).",
      "llm_answer": "The Company applies estimated lifetime loss rates over the contractual term of each loan portfolio, adjusting for expected prepayments and extensions during a forecast period that is two years for most commercial and agricultural mortgage loans and one year for certain originated loans; after this forecast period the estimated loss rates revert to historical loss experience on a straight‑line basis over two years. For residential mortgage loans, a two‑year forecast is used before reverting to historical experience on a straight‑line basis over one year. Thus, the lifetime loss rates are applied for the forecast horizon (2 years for commercial/agricultural, 2 years for residential) and then transition back to historical experience.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces inaccuracies and omissions compared to the ground truth. It correctly states that a two-year forecast period is used for both commercial/agricultural and residential mortgage loans. However, it incorrectly claims that the reversion to historical loss experience occurs over two years for commercial/agricultural loans, while the ground truth specifies that the reversion period is two years only for commercial/agricultural loans *after* a two-year forecast, totaling four years. For residential loans, the LLM correctly notes a two-year forecast and one-year reversion, aligning with the ground truth’s three-year total duration. (2) The key quantitative error lies in the reversion period for commercial/agricultural loans: the LLM states a two-year reversion but does not clarify that this reversion period is what follows the forecast, leading to confusion. The total duration (forecast + reversion) should be 4 years for commercial/agricultural and 3 years for residential, but the LLM fails to compute or mention these totals, which are central to the question. (3) The multi-hop reasoning is partially sound—information about forecast and reversion periods is synthesized, but the model fails to correctly integrate the full duration (forecast + reversion) for comparison, which is the core of the question. It also introduces ambiguity by referencing 'certain originated loans' with a one-year forecast, which is not in the original answer and lacks clarity. (4) The contextual relevance is high because the response addresses the right topic and structure, but correctness and qualitative accuracy are reduced due to miscalculations in the reversion logic and missing synthesis of total durations. Minor wording flexibility is acceptable, but the failure to accurately represent the total duration difference undermines the answer's factual integrity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 524,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does Costco's self-insurance funding for employee health care benefits, as estimated through actuarial assumptions, potentially impact its financial condition in the context of unpredictable cost fluctuations and labor-related risks?",
      "original_answer": "Costco's self-insurance funding for employee health care benefits relies on historical claims experience, demographic factors, severity factors, and other actuarial assumptions. These liabilities are not discounted and are subject to significant unpredictability due to inflation rates, regulatory or legal changes, and unforeseen developments in claims. Since actual claims and costs could differ significantly from recorded liabilities, this could lead to unexpected financial burdens. Given that Costco also faces challenges in controlling labor and benefit costs—impacted by factors like healthcare costs and regulatory changes—these financial pressures could adversely affect its business, financial condition, and results of operations.",
      "llm_answer": "Costco's self‑insurance funding for employee health‑care benefits is estimated using actuarial assumptions, which can cause the recorded liabilities to differ significantly from actual claim costs when unexpected fluctuations occur. Because these costs are highly unpredictable and can be affected by inflation, regulatory changes, and unforeseen claim developments, any material deviation could adversely affect Costco’s financial condition and results of operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and captures the core elements of the ground truth. It correctly identifies that Costco uses actuarial assumptions (e.g., historical claims, demographics, severity) to estimate self-insurance liabilities, which are subject to unpredictability due to inflation, regulatory changes, and unforeseen claim developments. It accurately conveys that deviations between estimated and actual costs could adversely affect financial condition and results of operations. All entities (Costco, self-insurance, employee health care benefits) and concepts (actuarial assumptions, financial impact) are correct. There are no numeric values in the question or answers requiring verification, so quantitative accuracy is scored as 10. The only minor shortcoming is that the LLM omits the explicit mention that liabilities are 'not discounted' and slightly condenses the point about labor cost pressures beyond healthcare (e.g., regulatory impact on broader benefit costs), which are present in the original. However, the omission does not distort the meaning or reduce the substantive accuracy. The reasoning is sound and synthesizes the multi-hop logic: (1) self-insurance relies on estimates, (2) estimates are uncertain due to external factors, (3) mismatches create financial risk, (4) this impacts overall financial condition. The answer is semantically equivalent and contextually fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 391,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How much did 3M's pre-tax charges related to the CAE Settlement and restructuring activities in 2023 total, and what was the impact of the reconsolidation of the Aearo Entities on 3M's balance sheet as of December 31, 2023?",
      "original_answer": "3M recorded a pre-tax charge of $4.2 billion related to the CAE Settlement and $437 million in restructuring charges in 2023, totaling $4.637 billion in charges. The reconsolidation of the Aearo Entities resulted in the removal of a $0.7 billion asset in equity and other investments and a $0.6 billion net liability for former intercompany amounts, impacting the consolidated balance sheet as of December 31, 2023.",
      "llm_answer": "The pre‑tax charges related to the CAE Settlement and restructuring activities in 2023 totaled **$4.2 billion** (the CAE settlement charge) plus **$437 million** of restructuring pre‑tax charges, for a combined total of **$4.637 billion**.  \n\nThe reconsolidation of the former Aearo Entities in 2023 added back a **$0.7 billion asset balance** (equity investment in the entities) and a **$0.6 billion net liability** for intercompany amounts, which were removed from the 2022 balance sheet and now appear on the 2023 consolidated balance sheet.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the pre-tax charges are accurately reported: $4.2 billion for the CAE Settlement and $437 million in restructuring charges, with the correct sum of $4.637 billion. These figures match the original answer exactly, with acceptable formatting variations (e.g., using 'billion' and 'million' consistently). (2) The impact of the reconsolidation is correctly described: a $0.7 billion asset in equity investments and a $0.6 billion net liability for former intercompany amounts are properly identified. The LLM accurately notes that these items were removed from the 2022 balance sheet and reappeared in the 2023 consolidated balance sheet, which aligns with the reconsolidation effect. (3) The multi-hop reasoning is sound—information about two distinct events (CAE Settlement charges and restructuring charges) is correctly aggregated, and the balance sheet impact of reconsolidation is synthesized from separate components. (4) All entities—3M, CAE Settlement, Aearo Entities—are correctly identified, and the fiscal year 2023 is accurately referenced. The semantic meaning and factual content are equivalent to the ground truth, with only minor, acceptable rewording (e.g., 'added back' instead of 'removal'—contextually appropriate given the reversal of deconsolidation). No errors in logic, calculation, or fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 389,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does Google's integration of Gemini 2.0 into its Vertex AI platform expand the capabilities available to developers on Google Cloud Platform?",
      "original_answer": "Google's integration of Gemini 2.0 into its Vertex AI platform provides developers with advanced tools to train, tune, augment, test, and deploy applications using Gemini, Imagen, Veo, and other generative AI models. This significantly enhances the development environment on Google Cloud Platform, allowing developers to build more sophisticated and multimodal applications.",
      "llm_answer": "Google's integration of Gemini 2.0 into Vertex AI expands developers’ capabilities on Google Cloud by giving them direct access to Google’s most advanced multimodal model within the cloud AI development platform. Through Vertex AI, developers can train, fine‑tune, and deploy Gemini 2.0 at scale, leveraging its ability to understand and generate text, code, audio, images and video, as well as pre‑packaged AI agents that assist with coding, documentation, testing and security threat detection. This integration also brings Gemini‑powered features—such as image generation, enhanced coding support, and AI‑driven meeting assistance—into Google Workspace and other cloud services, enabling developers to build more intelligent, responsive and competitive applications on GCP.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the integration of Gemini 2.0 into Vertex AI as a means to expand developer capabilities on Google Cloud Platform. The key capabilities—training, tuning, deploying, and using multimodal generative models like Gemini, Imagen, and Veo—are accurately described, with additional context about multimodal inputs (text, code, audio, images, video) and AI agents for coding, testing, and security, which are consistent with the enhanced development environment mentioned in the original answer. There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is scored as 10 by default. The qualitative accuracy is slightly reduced to 9 because the LLM introduces specific details not present in the ground truth (e.g., 'AI-driven meeting assistance', 'pre-packaged AI agents') that, while plausible, are not confirmed by the original answer. However, these do not contradict the core facts and reflect reasonable inferences. The answer fully addresses the question about expanded capabilities and maintains semantic equivalence with the original, demonstrating sound reasoning and contextual relevance. No entities (companies, models, platforms) are misidentified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 361,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the inclusion of FVO securities in the yield calculation for fixed maturity securities impact the reported investment income and sensitivity to fair value changes for MetLife in 2024, given the valuation techniques applied to FVO securities under Level 3 classifications?",
      "original_answer": "The inclusion of FVO securities in the yield calculation for fixed maturity securities contributed $205 million in investment income for 2024, directly affecting yield performance metrics. Since FVO securities are classified under Level 3 and are subject to valuation techniques involving significant unobservable inputs (such as nonperformance risk spreads and long-term equity volatilities), changes in these inputs can materially alter the estimated fair value of these securities. This dual treatment—using FVO securities in both yield calculations and fair value measurements—means that fluctuations in market assumptions not only affect income volatility but also the sensitivity of the fair value of FVO securities, amplifying financial statement variability.",
      "llm_answer": "The inclusion of FVO securities in the yield calculation for fixed‑maturity securities raises the reported investment income because the FVO securities’ earnings (e.g., $205 million in 2024) are added to net investment income, and it also heightens the portfolio’s sensitivity to fair‑value movements—since FVO securities are marked‑to‑market, any change in their estimated fair value (often driven by Level 3 inputs) directly impacts the reported yield and earnings volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $205 million contribution to investment income in 2024 from FVO securities, matching the ground truth in both amount and year. It accurately states that including FVO securities increases reported investment income and heightens sensitivity to fair value changes. (2) The quantitative accuracy is perfect: the $205 million figure is correctly cited, and no other numerical claims are made that contradict the ground truth. Format is consistent and acceptable. (3) The reasoning is largely sound and captures the dual impact of FVO securities—on both yield calculations and fair value volatility. It correctly links Level 3 inputs to valuation uncertainty and notes the mark-to-market treatment. However, it does not explicitly mention the specific unobservable inputs (e.g., nonperformance risk spreads, long-term equity volatilities) emphasized in the ground truth, which slightly weakens the depth of the qualitative explanation. (4) The answer is fully contextually relevant, directly addressing the impact on investment income and sensitivity to fair value changes. While slightly less detailed than the original on valuation techniques, it maintains semantic equivalence on core financial impacts and mechanisms. Minor omission prevents a perfect 10, but overall highly accurate and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 378,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What was the total pre-tax financial impact on 3M from both the initial deconsolidation of the Aearo Entities in 2022 and the subsequent reconsolidation in 2023, and how did these events relate to the Combat Arms Earplugs litigation?",
      "original_answer": "The total pre-tax financial impact on 3M from both the deconsolidation and reconsolidation of the Aearo Entities was $1.2 billion. This includes a $1.0 billion funding commitment plus $0.2 billion for projected case expenses related to the Combat Arms Earplugs litigation, which led to a pre-tax charge in 2022. The reconsolidation in 2023 had an immaterial income statement impact, but the overall litigation and settlement process directly triggered both events.",
      "llm_answer": "The total pre-tax financial impact on 3M from both the initial deconsolidation of the Aearo Entities in 2022 and the subsequent reconsolidation in 2023 was $1.2 billion, recorded as a charge in the second quarter of 2022 when 3M deconsolidated the entities and later reversed as an immaterial income‑statement impact upon reconsolidation in the second quarter of 2023. These events were directly tied to the Combat Arms Earplugs litigation, as the bankruptcy filings and related stays were sought to resolve the extensive product‑liability claims against the Aearo Entities arising from that litigation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $1.2 billion total pre-tax financial impact is correct, matching the sum of the $1.0 billion funding commitment and $0.2 billion for projected case expenses. The timing—charge in Q2 2022 and immaterial impact upon reconsolidation in Q2 2023—is consistent with the original answer. (2) The answer correctly identifies that the deconsolidation triggered a pre-tax charge and the reconsolidation had an immaterial income statement effect, which matches the ground truth's assertion. (3) The reasoning linking both events to the Combat Arms Earplugs litigation is sound: the LLM correctly identifies that the litigation led to bankruptcy filings and legal stays, which in turn prompted the deconsolidation and later reconsolidation. This demonstrates proper multi-hop synthesis across events and entities (3M, Aearo Entities, litigation, financial impacts). (4) The only minor shortcoming is that the LLM does not explicitly break down the $1.2 billion into the $1.0 billion funding and $0.2 billion case expenses, though it references the total amount and context. This omission slightly reduces completeness but does not affect the overall correctness. Wording differs but semantic meaning is equivalent. All entities, years, and financial terms are accurate. Thus, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 395,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the integration of Adobe Firefly into Creative Cloud and Document Cloud contribute to Adobe's strategy of increasing recurring revenue and expanding its customer base, as evidenced by specific product offerings and AI-driven capabilities in fiscal 2023?",
      "original_answer": "Adobe Firefly, introduced in September 2023, is integrated into Creative Cloud apps such as Photoshop and Express, providing generative AI capabilities that enhance user engagement and attract new customers, including novice creators and communicators. This integration supports Adobe's strategy to increase recurring revenue by offering new features that justify subscription renewals and attract cost-sensitive users through targeted packages like Adobe Express and Substance 3D Collection. Additionally, Firefly's generative AI features are part of Adobe's broader AI-driven tools (e.g., Adobe Sensei), which improve Document Cloud's functionality, such as making PDFs more intelligent and responsive. These innovations help Adobe expand its customer base and drive long-term revenue growth through increased product value and user retention.",
      "llm_answer": "The integration of Adobe Firefly into Creative Cloud and Document Cloud fuels Adobe’s strategy of growing recurring revenue and expanding its customer base by embedding generative AI capabilities across its subscription offerings. This enables Adobe to increase engagement and retention through features like Generative Fill, Generative Expand, and Text-to-Image in Photoshop and Express, while attracting new users—including non‑professional creators—via accessible, AI‑enhanced tools such as Adobe Express and Firefly’s commercial‑safe models, ultimately driving higher ARR and predictable, ratable subscription revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Adobe Firefly was introduced in September 2023 (implied by fiscal 2023 context), and its integration into Creative Cloud (Photoshop, Express) and Document Cloud is accurately described. The mention of generative AI features like Generative Fill, Generative Expand, and Text-to-Image reflects actual product capabilities launched in fiscal 2023. (2) There are no numeric values requiring verification (e.g., revenue figures, percentages), so quantitative accuracy is not compromised—no incorrect numbers or dates are present. (3) The multi-hop reasoning is sound: the model correctly links Firefly’s AI capabilities to Adobe’s strategy of increasing recurring revenue via subscription retention and expansion into new user segments (e.g., non-professional creators). It also correctly identifies commercial-safe models and accessible tools like Adobe Express as key to attracting cost-sensitive and novice users, which matches the ground truth’s emphasis on targeted packages. (4) The only minor omission is the lack of explicit mention of Substance 3D Collection and Adobe Sensei as part of the broader AI ecosystem, and a brief reference to Document Cloud’s enhanced PDF intelligence. However, the core strategic impact—driving ARR and expanding customer base through AI-enhanced subscriptions—is fully captured. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is perfect, directly addressing all aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 431,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "What is the total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31, 2022, and how does this value compare to the total fair value of all available-for-sale investments?",
      "original_answer": "The total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31, 2022, is $4,335 million ($1,676 million + $2,659 million). This amount represents the full value of all available-for-sale investments, which also totals $4,335 million.",
      "llm_answer": "Based on the provided SEC 10-K filing pages, the total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31, 2022, was $4,335 million. This value is part of the \"Available-for-sale investments\" category, where the total fair value of all available-for-sale investments was $4,335 million (comprising $1,676 million in U.S. Treasury bills and $2,659 million in money market mutual funds). The document confirms that these investments are classified under Level 1 inputs (quoted prices in active markets), and the total fair value of all available-for-sale investments ($4,335 million) includes both the U.S. Treasury bills and money market mutual funds. The question asks for the comparison to the total fair value of all available-for-sale investments, which is explicitly stated as $4,335 million for 2022. \n\n(Note: The question's phrasing \"total fair value of U.S. Treasury bills and money market mutual funds\" refers to the sum of these two components, which is $4,335 million, and this equals the total fair value of all available-for-sale investments as reported in the document.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the total fair value of U.S. Treasury bills ($1,676 million) and money market mutual funds ($2,659 million) is correctly summed to $4,335 million. (2) The calculation is accurate: $1,676M + $2,659M = $4,335M, and the LLM correctly identifies that this sum equals the total fair value of all available-for-sale investments, which is also $4,335 million. (3) The multi-hop reasoning is sound—the LLM correctly synthesizes that these two components constitute the entirety of available-for-sale investments for Amgen as of December 31, 2022, and notes the classification under Level 1 inputs, which adds contextual accuracy. (4) The answer addresses both parts of the question: the total fair value of the specified investments and how it compares to the total available-for-sale investments (i.e., they are equal). Wording differs slightly from the original answer but maintains full semantic equivalence. No errors in entities, years, or financial terms. All aspects of the evaluation criteria are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 319,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How do the valuation techniques for Unit-linked securities described in the MetLife 2024 10-K affect the sensitivity of fair value measurements to changes in long-term equity volatility and nonperformance risk spreads?",
      "original_answer": "The valuation techniques for Unit-linked securities at MetLife involve using long-term equity volatility and nonperformance risk spreads as significant unobservable inputs. According to the 10-K filing, long-term equity volatility affects the estimated fair value of these securities, especially when observable equity volatilities are not available beyond a certain period. Additionally, nonperformance risk spreads, which vary by duration and currency, are applied to discount cash flows for purposes of valuing market risk benefits (MRBs). As a result, changes in either of these inputs directly influence the fair value of Unit-linked securities, making them sensitive to shifts in long-term market expectations and credit risk assessments.",
      "llm_answer": "The MetLife 2024 10‑K notes that the fair‑value measurement of unit‑linked securities and other Level 3 assets relies on long‑term equity volatility assumptions and non‑performance risk spreads that are derived from observable market data where possible and extrapolated beyond observable limits when needed. Because these inputs are unobservable, changes in long‑term equity volatility or in the non‑performance risk spreads directly affect the sensitivity of the estimated fair value of those securities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core information from the ground truth. It correctly identifies that long-term equity volatility and nonperformance risk spreads are key unobservable inputs in the fair value measurement of unit-linked securities, and that changes in these inputs directly affect valuation sensitivity—this aligns with the original answer. The mention of extrapolation beyond observable limits when data is unavailable matches the concept of using long-term volatility where observable volatilities are not available. The term 'non-performance risk spreads' (with a hyphen) is a minor wording variation but refers correctly to nonperformance risk spreads, which are applied in valuing market risk benefits (MRBs), though the LLM does not explicitly name MRBs. This omission slightly reduces completeness but does not undermine the correctness of the main point. There are no numerical values to verify in this question, so quantitative accuracy is scored as 10. The reasoning is sound and reflects proper multi-hop synthesis of how unobservable inputs impact fair value measurements. The answer is fully contextually relevant. The only reason it is not a 10 is the slight lack of specificity around MRBs and currency/duration variation in spreads mentioned in the original, which adds nuance missing in the LLM response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 375,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does Adobe's introduction of Generative Credits in Adobe Firefly, as part of its Creative Cloud offering, support its broader strategy to increase customer engagement and subscription revenue across both creative professionals and non-creative stakeholders?",
      "original_answer": "Adobe introduced Generative Credits as part of Adobe Firefly within its Creative Cloud offering, allowing users to generate AI-based content after reaching a usage limit. These credits enhance the value of existing subscriptions and encourage continued engagement by offering a paid upsell option. This aligns with Adobe’s strategy to use product-led growth, infusing AI into creative apps like Photoshop and Illustrator to make workflows more efficient and accessible. By integrating Firefly’s generative AI capabilities into widely used tools and offering tiered access (free and premium), Adobe expands its customer base beyond traditional creative professionals to include communicators, marketers, and other stakeholders involved in content creation and approval. This drives higher engagement, conversion, and retention, directly supporting Adobe’s goal of increasing recurring subscription revenue and deepening customer relationships.",
      "llm_answer": "Adobe’s introduction of Generative Credits in Firefly embeds AI‑driven content creation directly into Creative Cloud and Express, letting both professional creators and non‑creative users generate images, text effects and templates on demand. This expands the Creative Cloud ecosystem, deepens engagement by offering a tangible productivity boost, and creates a new recurring revenue stream—users can purchase additional credits once free limits are exhausted—thereby driving higher subscription uptake and retention across the broader customer base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core elements of the ground truth. (1) All factual information is correct: Adobe introduced Generative Credits in Firefly as part of Creative Cloud, enabling AI-generated content for both creative professionals and non-creative users (e.g., marketers, communicators). The model correctly identifies that credits are used to unlock AI features beyond free limits and that additional credits can be purchased, creating a recurring revenue stream. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM connects Generative Credits to increased engagement, broader customer base expansion, and subscription revenue growth, aligning with Adobe’s product-led growth and AI integration strategy. It correctly infers that embedding AI into tools like Creative Cloud and Express expands accessibility and deepens ecosystem engagement. (4) Minor omission: the LLM does not explicitly mention tiered access (free vs. premium) or name specific applications like Photoshop and Illustrator, which are part of the ground truth and support the strategy of workflow integration. However, the essence of Adobe’s strategy—AI infusion, expanded user base, engagement, and monetization via credits—is accurately captured. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect as it directly addresses how Generative Credits support engagement and revenue across both creative and non-creative users.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 434,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does the integration of Gemini 2.0 across Google's billion-user products and Vertex AI platform contribute to Google Cloud's ability to generate revenue from AI-optimized infrastructure and developer services?",
      "original_answer": "Gemini 2.0 powers AI features across all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—enhancing user experiences and increasing engagement. This widespread integration supports Google's broader ecosystem, which in turn drives demand for Google Cloud's AI-optimized infrastructure and Vertex AI platform. Google Cloud offers Gemini through Vertex AI, enabling developers to train, tune, and deploy applications using advanced generative AI models. This provides scalable AI solutions for enterprises and developers, which directly contributes to Google Cloud's revenue through consumption-based fees and subscriptions for infrastructure and platform services.",
      "llm_answer": "The integration of Gemini 2.0 into Google’s billion‑user products and the Vertex AI platform lets Google leverage its AI‑optimized infrastructure—such as custom TPUs and large‑scale data‑center capacity—to offer advanced, cost‑effective AI services to developers and enterprises. By embedding Gemini 2.0 in Vertex AI, Google Cloud can monetize this infrastructure through consumption‑based fees, pre‑packaged AI agents, and subscription services, driving higher revenue from its AI‑focused cloud offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core mechanism by which Gemini 2.0 integration contributes to Google Cloud's revenue. However, there is a minor inaccuracy in the user base figure: the original answer specifies 'seven of Google's two billion-user products', while the LLM answer refers to 'billion-user products' (singular), which understates the scale and precision of the integration. The ground truth emphasizes that Gemini powers AI features across *seven* platforms each with over two billion users, which strengthens the argument for ecosystem-wide impact. The LLM answer correctly identifies the monetization model—consumption-based fees, subscriptions, and AI agents via Vertex AI—and links Gemini 2.0’s integration to demand for Google Cloud’s AI-optimized infrastructure (e.g., TPUs). It also accurately reflects the role of Vertex AI in enabling developer access to generative models. While the reasoning is sound and semantically aligned, the omission of the specific product count and user scale represents a minor but notable completeness gap. No calculation errors are present, and all entities (Gemini 2.0, Vertex AI, Google Cloud) are correctly identified. The contextual relevance is excellent, directly addressing how integration drives revenue through infrastructure and platform services.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 368,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How do changes in prepayment and default rates impact MetLife's income recognition on FVO securities, and what unobservable inputs further influence the valuation of these securities?",
      "original_answer": "Changes in prepayment and default rates directly impact MetLife's income recognition on FVO securities, as income on these securities is dependent on such factors. Additionally, unobservable inputs such as long-term equity volatilities and nonperformance risk spreads are used in the valuation of FVO securities, which affect their fair value and, consequently, the financial statement presentation.",
      "llm_answer": "Changes in prepayment and default rates affect the timing and amount of cash flows used to estimate the fair value of MetLife’s FVO securities, which directly impacts the income recognized for these securities. Additionally, unobservable inputs such as projected prepayment speeds, default rates, and discount rates are key drivers in the valuation of these securities.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that changes in prepayment and default rates impact income recognition on FVO securities by affecting cash flow estimates, which aligns with the ground truth. However, the unobservable inputs mentioned differ: the LLM lists 'projected prepayment speeds, default rates, and discount rates,' while the ground truth specifies 'long-term equity volatilities and nonperformance risk spreads.' These are distinct inputs, and the LLM's answer omits the correct ones from the original. While prepayment speeds and default rates can be unobservable inputs in certain models, the ground truth emphasizes different, more specific inputs tied to MetLife's methodology. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is partially sound: the LLM correctly links prepayment/default rates to cash flows and income recognition on FVO securities. However, it fails to accurately report the specific unobservable inputs used by MetLife as per the original answer, indicating a gap in synthesis or source fidelity. (4) The answer is contextually relevant and well-structured, addressing both parts of the question. The correctness score is 7 because core mechanisms (prepayment/default impact) are accurately described, but the unobservable inputs are incorrect or substituted, which is a meaningful deviation in valuation methodology.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 414,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does Costco's investment in Kirkland Signature products influence its gross margin performance, considering the brand's role in member loyalty and the risks associated with its production and availability?",
      "original_answer": "Costco's investment in Kirkland Signature products positively influences its gross margin performance because these private-label items generally carry higher margins than national brand products and represent a growing portion of overall sales. However, this margin benefit is contingent on maintaining consistent product quality, competitive pricing, and availability. If the Kirkland Signature brand experiences a loss of member acceptance or confidence, or if there are disruptions in production and delivery, Costco's sales and gross margin results could be adversely affected due to reduced member loyalty and potential out-of-stock situations.",
      "llm_answer": "Costco's Kirkland Signature private-label brand is a key driver of both member loyalty and higher gross margins, as these products typically carry higher margins than national brands. However, the company faces risks related to production disruptions, supply chain challenges, and potential quality issues that could affect product availability and reputation, thereby threatening both sales and margin performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. It accurately identifies that Kirkland Signature products contribute to higher gross margins due to their superior margin profile compared to national brands, which directly addresses the first part of the question. It also correctly highlights the risks related to production, supply chain, and quality issues that could impact availability and reputation, thereby affecting sales and margins—this captures the contingent nature of the margin benefit described in the original answer. The answer is concise but complete, covering both the positive influence on margins and the associated risks. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The only minor limitation is that the LLM answer does not explicitly mention the link between member loyalty and the brand's performance beyond implying it through 'reputation' and 'sales', whereas the original answer explicitly ties Kirkland Signature to member acceptance and loyalty. However, this connection is strongly implied, so the qualitative accuracy is still high. Contextual relevance is perfect—the response directly addresses all aspects of the multi-hop question: financial impact (margins), strategic role (loyalty), and operational risks (production/availability).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 379,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What was the change in the fair value of 'Other short-term interest-bearing securities' from December 31, 2022, to December 31, 2023, and how does this shift reflect in the total available-for-sale investments for those respective years?",
      "original_answer": "The fair value of 'Other short-term interest-bearing securities' increased from $0 on December 31, 2022, to $138 million on December 31, 2023. This increase contributed to a rise in total available-for-sale investments from $4,335 million in 2022 to $10,404 million in 2023, reflecting a significant growth of $6,069 million in the company's short-term investment portfolio.",
      "llm_answer": "The fair value of “Other short‑term interest‑bearing securities” was essentially unchanged, moving from $‑ (i.e., no balance) at the end of 2022 to $‑ (still no balance) at the end of 2023. Consequently, the total available‑for‑sale investment balance remained the same – $10,404 million at 31 Dec 2023 versus $4,335 million at 31 Dec 2022 – reflecting only the other securities (money‑market funds, Treasury bills, etc.) and not a shift from the “Other short‑term interest‑bearing securities” line.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in nearly all aspects. It claims the fair value of 'Other short-term interest-bearing securities' was $- (no balance) in both 2022 and 2023, directly contradicting the ground truth that it increased from $0 to $138 million. The LLM also incorrectly states that the total available-for-sale investments 'remained the same', when in fact they increased from $4,335 million to $10,404 million — a significant change of $6,069 million. (2) Quantitative inaccuracies are severe: the LLM misreports both the 'Other short-term interest-bearing securities' values (claiming no change when there was a $138M increase) and misrepresents the total available-for-sale investments as unchanged when they grew substantially. The totals themselves ($4,335M and $10,404M) are correctly cited, but the reasoning about them is flawed. (3) The multi-hop reasoning fails completely: the model does not recognize that the $138M addition contributed to the overall increase in available-for-sale investments. Instead, it falsely claims no change in the category and incorrectly attributes the total shift to other securities without evidence. (4) Scores are low because the core facts — the change in fair value and its impact on total investments — are wrong. Contextual relevance is slightly higher only because the answer addresses the right financial categories and time periods, albeit with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 399,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the developments in the Proposed Plan of compromise and arrangement, including RBH's objection filed on January 24, 2025, influence the quantitative valuation of PMI’s investment in RBH as of December 31, 2024, and what was the resulting impairment charge recorded in the consolidated statement of earnings?",
      "original_answer": "Developments in the Proposed Plan, including RBH's objection filed on January 24, 2025, narrowed the range of possible outcomes regarding the allocation of the CAD 32.5 billion aggregate global settlement amount among RBH, ITL, and JTIM. This narrowing of outcomes served as an indicator that PMI's investment in RBH may be impaired. As a result, PMI performed a quantitative valuation of its investment in RBH as of December 31, 2024, using a discounted cash flow analysis that incorporated significant assumptions such as discount rate, sales volumes, and operating margins for the combustible tobacco business in Canada, as well as estimates regarding the allocation of the settlement amount and its tax deductibility. This valuation concluded that the fair value of PMI’s investment in RBH was $714 million, significantly lower than its carrying value, leading to a non-cash impairment charge of $2,316 million recorded in the consolidated statement of earnings for the year ended December 31, 2024.",
      "llm_answer": "The Proposed Plan of compromise and arrangement – and RBH’s January 24, 2025 objection to it – signaled that the allocation of the CAD 32.5 billion settlement among RBH, ITL and JTI was uncertain, which PMI interpreted as an impairment indicator for its RBH equity investment. Accordingly, PMI performed a quantitative valuation of the investment as of December 31, 2024, concluded that its fair value ($714 million) was below its carrying amount, and recorded a non‑cash impairment charge of **$2,316 million** in the consolidated statement of earnings for 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key factual elements: RBH's objection on January 24, 2025, the CAD 32.5 billion settlement amount, the narrowing of possible outcomes as an impairment indicator, the quantitative valuation as of December 31, 2024, the fair value of $714 million, and the resulting non-cash impairment charge of $2,316 million. All numbers and dates match the ground truth exactly. (2) Quantitative accuracy is perfect: the impairment charge is correctly stated as $2,316 million, and the fair value of $714 million aligns with the original. The carrying value can be inferred as $3,030 million ($714M + $2,316M), which is consistent with the ground truth, though not explicitly mentioned. Format variations are acceptable and correctly used. (3) The multi-hop reasoning is sound: the model correctly links RBH’s objection to increased uncertainty in settlement allocation, which triggered an impairment assessment, leading to a DCF-based valuation and ultimately the impairment charge. While the LLM omits specific details about the assumptions used in the DCF (e.g., discount rate, sales volumes, operating margins, tax deductibility), the core logic and causal chain are preserved. (4) The answer is contextually fully relevant, directly addressing both parts of the question: the influence of the developments on the valuation and the resulting impairment charge. The omission of some methodological details slightly reduces qualitative accuracy but does not affect the correctness of the outcome. Hence, a score of 9 is justified—very close to perfect, with only minor completeness gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 446,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "Given the increase in advertising revenues from Google Network properties and the expectation that TAC paid to Google Network partners will increase as revenues grow, how much would the absolute dollar amount of TAC paid to Google Network partners increase if advertising revenues from Google Network properties grew by $10 billion in 2023 compared to 2022, assuming the TAC rate remained constant at 22% as indicated in the filing?",
      "original_answer": "$2.2 billion",
      "llm_answer": "Based on the filing, the TAC rate is explicitly stated as 22% in the \"Financial Condition\" section (page 41) and the company projects that TAC paid to Google Network partners will increase as advertising revenues grow. If advertising revenues from Google Network properties increased by $10 billion in 2023 versus 2022, the absolute dollar increase in TAC would be 22% of that $10 billion, which equals **$2.2 billion**. This calculation assumes the TAC rate remains constant at 22%.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The quantitative calculation is accurate: 22% of $10 billion is correctly computed as $2.2 billion. The format ($2.2 billion) matches the ground truth in both value and presentation. (2) The answer addresses all parts of the question: it references the constant TAC rate of 22% from the filing, applies it to the $10 billion revenue increase, and calculates the resulting increase in TAC. (3) Entity accuracy is correct—'Google Network partners', 'TAC rate', 'advertising revenues', and '2023 vs 2022' are all properly identified and used. (4) The reasoning is sound and reflects multi-hop synthesis: it connects the projected revenue growth with the contractual TAC rate to determine the absolute dollar impact, as required. The explanation cites the relevant section ('Financial Condition', page 41), adding contextual support. Overall, the answer is factually precise, logically coherent, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 288,
        "total_tokens": 1483
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "What is the change in the carrying value of UnitedHealth Group's long-term debt and other financing obligations from December 31, 2023, to December 31, 2024, and how does this compare to the change in fair value over the same period?",
      "original_answer": "The carrying value of UnitedHealth Group's long-term debt and other financing obligations increased by $14,155 million from $61,449 million in 2023 to $75,604 million in 2024. The fair value increased by $10,714 million from $59,851 million in 2023 to $70,565 million in 2024. This indicates that the carrying value increased more significantly than the fair value over the same period.",
      "llm_answer": "The change in the carrying value of UnitedHealth Group's long-term debt and other financing obligations from December 31, 2023 to December 31, 2024 is an increase of $14,155 million (from $71,449 million to $85,604 million). This increase is larger than the change in fair value, which rose by $10,714 million (from $59,851 million to $70,565 million), indicating that the carrying amount grew more than the estimated fair value over the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the carrying value figures. It states the carrying value increased from $71,449 million to $85,604 million, which is incorrect. The ground truth shows the correct values are $61,449 million in 2023 and $75,604 million in 2024, resulting in the correct $14,155 million increase. The LLM's numbers are off by $10 billion at both points, which invalidates the quantitative accuracy. However, the fair value figures are correct: $59,851 million to $70,565 million, a $10,714 million increase. (2) The calculation of the change in fair value is accurate, but the change in carrying value, while numerically stated correctly as $14,155 million, is based on incorrect starting and ending values, making the calculation misleading. (3) The reasoning and synthesis are partially sound — the model correctly identifies that the carrying value increased more than the fair value and draws the right qualitative conclusion. However, because the underlying data for carrying value is wrong, the multi-hop comparison is based on flawed inputs. (4) The contextual relevance is high as the answer addresses both parts of the question and makes the correct comparison in direction and intent. Due to the major error in core financial data, the correctness score is low despite some accurate elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 376,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "By how much did the expansion of merchant accommodation reservation services at Booking.com contribute to the increase in merchant transaction costs in 2022, and how does this relate to the overall growth in merchant revenues compared to agency revenues?",
      "original_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed to a $573 million increase in merchant transaction costs in 2022. This significant rise in transaction costs indicates strong growth in merchant activity, which aligns with the observation that merchant revenues increased more than agency revenues during the same period. The growth in merchant revenues was driven by the expansion of these services, reflecting stronger demand and operational scale in the merchant model compared to the agency model.",
      "llm_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed approximately $573 million to the increase in merchant transaction costs in 2022, as cited in the “Sales and other expenses” section of page 52. This rise in merchant transaction costs was a key factor behind the overall growth in merchant revenues, which outpaced growth in agency revenues due to the expansion of those services, as noted in the “Revenues” discussion on page 51.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $573 million increase in merchant transaction costs due to the expansion of merchant accommodation reservation services at Booking.com in 2022, matching the ground truth exactly. The dollar amount is accurate and properly attributed. (2) Quantitatively, the figure is correct with no calculation errors; the format ($573 million) is equivalent to the ground truth’s $573 million. (3) The reasoning is sound: the LLM correctly links the rise in transaction costs to the growth in merchant revenues outpacing agency revenues, which aligns with the ground truth’s assertion about stronger growth in the merchant model. It references the correct sections (‘Sales and other expenses’ on p.52 and ‘Revenues’ on p.51), indicating proper multi-hop synthesis across document sections. (4) The only minor shortcoming is that the LLM does not explicitly state that the growth in merchant revenues was *driven by* the expansion of these services—though it implies it—making the qualitative accuracy slightly less complete than the original. However, the core logic and factual content are preserved. All entities (Booking.com, merchant vs agency revenues, 2022) are correct. Overall, the answer is factually accurate, contextually relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 364,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "What is the significance of AMD introducing Zynq UltraScale+ RFSoCs in the context of its FPGA and Adaptive SoC product lines, and how does this introduction align with AMD's broader strategy to serve markets requiring high-performance RF data conversion capabilities?",
      "original_answer": "AMD's introduction of Zynq UltraScale+ RFSoCs is significant because it expands the company's FPGA and Adaptive SoC portfolio to target specialized markets such as wireless communications, radar, and cable access, which demand high-performance RF data converters. This aligns with AMD's broader strategy to offer adaptable platforms that combine hardware acceleration with domain-specific customization, enabling faster time-to-market for customers. By integrating RF data converters directly into the SoC architecture, AMD enhances its value proposition for embedded systems requiring real-time control, sensor fusion, and analytics, thereby strengthening its position in high-growth sectors like aerospace, defense, and communication infrastructure.",
      "llm_answer": "AMD’s introduction of Zynq UltraScale+ RFSoCs expands its Adaptive SoC portfolio with integrated high‑performance RF data converters, directly enhancing its ability to serve markets that demand advanced RF‑centric processing such as wireless infrastructure, radar, and cable access. This move aligns with AMD’s broader strategy of positioning its FPGA and Adaptive SoC technologies as key enablers for high‑speed, real‑time data conversion and heterogeneous compute, reinforcing its competitive stance in data‑center, communications and industrial segments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core significance and strategic alignment of AMD's Zynq UltraScale+ RFSoCs as described in the ground truth. (1) All factual elements are correct: the product line (Zynq UltraScale+ RFSoCs), integration of high-performance RF data converters, and target markets (wireless infrastructure, radar, cable access) match the original. The strategic alignment with AMD’s goals of delivering adaptable, accelerated platforms for real-time processing is correctly captured. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no errors exist. (3) The multi-hop reasoning is sound: the LLM correctly links product features (integrated RF converters) to market needs and infers AMD’s broader strategy in FPGA/Adaptive SoC expansion. The only minor gap is that the LLM omits explicit mention of 'aerospace and defense' as high-growth sectors, instead grouping under 'industrial' and 'communications'—a slight loss in specificity but not factual inaccuracy. (4) The answer is contextually excellent, directly addressing both the significance of the product introduction and its alignment with AMD’s strategy. Wording differs slightly but maintains semantic equivalence. Thus, correctness is 9 due to minor omission, but still very close to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 385,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "What is the total carrying value of UnitedHealth Group's debt securities - held-to-maturity for both 2023 and 2024 combined, and how does this compare to the total fair value of those securities in those years?",
      "original_answer": "The total carrying value of UnitedHealth Group's debt securities - held-to-maturity for 2023 and 2024 combined is $1,115 million ($603 million in 2023 + $512 million in 2024). The total fair value for the same periods is $1,104 million ($596 million in 2023 + $508 million in 2024), resulting in a $11 million unrealized loss when comparing combined carrying value to combined fair value.",
      "llm_answer": "The total carrying value of UnitedHealth Group's debt securities - held-to-maturity was $512 million as of December 31 2024 and $603 million as of December 31 2023, for a combined total of $1,115 million. The corresponding total fair values were $508 million for 2024 and $596 million for 2023, resulting in a combined fair value of $1,104 million. Thus, the combined carrying value exceeds the combined fair value by $11 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: $603 million (2023 carrying value), $512 million (2024 carrying value), $596 million (2023 fair value), and $508 million (2024 fair value) are correctly reported. The combined totals—$1,115 million for carrying value ($603M + $512M) and $1,104 million for fair value ($596M + $508M)—are correctly calculated. The $11 million difference (unrealized loss) is accurately derived. (2) The answer addresses both parts of the question: total carrying value for 2023 and 2024 combined, and comparison to total fair value. (3) Entities—UnitedHealth Group, debt securities - held-to-maturity, years 2023 and 2024—are correctly identified. (4) The multi-hop reasoning is sound: the model correctly aggregates data across two years and compares carrying value to fair value, drawing the correct conclusion that carrying value exceeds fair value by $11 million, indicating an unrealized loss. (5) The semantic meaning is equivalent to the original answer, with clear, precise, and logically structured presentation. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 330,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "By how much did the expansion of merchant accommodation reservation services at Booking.com contribute to the increase in sales and other expenses in 2022, and how does this relate to the growth in merchant gross bookings?",
      "original_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed to a $573 million increase in merchant transaction costs, which is a key component of the overall increase in sales and other expenses in 2022. This growth in merchant transaction costs was driven by the expansion of merchant accommodation reservation services, which also directly supported the greater increase in merchant gross bookings compared to agency gross bookings during the same period.",
      "llm_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed $573 million to the increase in sales and other expenses in 2022, and this growth was directly tied to the 108.4 % year‑over‑year rise in merchant gross bookings, which outpaced the 32.8 % increase in agency gross bookings.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $573 million increase in expenses due to the expansion of merchant accommodation services, which matches the ground truth. However, it introduces specific percentage figures—108.4% growth in merchant gross bookings and 32.8% in agency gross bookings—that are not present in the original answer. These percentages may be factually accurate but are not supported by the provided ground truth, making their inclusion a factual overreach. (2) The dollar amount ($573 million) is correctly stated and aligns with the ground truth. However, the quantitative accuracy is reduced because the added percentages are unverified in this context and could mislead if incorrect. There is no indication in the original answer that these exact percentages were part of the knowledge graph source. (3) The reasoning is logically sound—tying the increase in merchant transaction costs (a component of sales and other expenses) to the growth in merchant gross bookings—and correctly performs the multi-hop synthesis between expense impact and booking model performance. The emphasis on merchant outpacing agency bookings aligns with the original answer’s claim about 'greater increase in merchant gross bookings'. (4) The contextual relevance is perfect—the answer directly addresses both parts of the question: the contribution to expenses and its relation to gross bookings growth. The qualitative accuracy is high due to correct entity identification (Booking.com, merchant accommodation services, 2022) and logical flow, but the unsupported percentages prevent a top score in quantitative and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 450,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "What is the total value of the crypto asset safeguarding asset and corresponding liability reported by PayPal as of December 31, 2023, and how does this reflect the company's involvement in crypto-related financial activities?",
      "original_answer": "PayPal reported a crypto asset safeguarding asset of $1,241 million and a corresponding crypto asset safeguarding liability of $1,241 million as of December 31, 2023. This indicates that PayPal holds crypto assets on behalf of its customers and records an equal liability to reflect its obligation to safeguard these assets, showing its active participation in crypto-related financial services.",
      "llm_answer": "PayPal reports a crypto‑asset safeguarding liability of **$2,886 million** and a corresponding safeguarding asset of **$2,886 million** as of December 31, 2023. This reflects the company’s active involvement in crypto‑related financial activities, as it holds and safeguards cryptocurrency assets on behalf of its users.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. The reported crypto asset safeguarding asset and liability are stated as $2,886 million, whereas the ground truth from the knowledge graph is $1,241 million for both. This significant discrepancy in dollar amounts undermines the factual accuracy of the response. (2) The numbers are not accurate—$2,886 million vs. $1,241 million is a difference of over $1.6 billion, which cannot be attributed to formatting or rounding. No calculation is required in this question, but the values must match exactly as reported; they do not. (3) The reasoning and structure of the answer are sound: the model correctly interprets that equal asset and liability reflect safeguarding crypto on behalf of customers, indicating active involvement in crypto services. This shows correct multi-hop understanding of accounting logic (asset = liability in custodial arrangements) and PayPal’s role. (4) Despite correct contextual framing and entity identification (PayPal, December 31, 2023, crypto safeguarding), the massive numerical error renders the answer largely incorrect. The contextual relevance is high because the explanation aligns with the intent of the question, but correctness hinges on accurate data retrieval, which failed here.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 365,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How do the aircraft impairment charges recorded by FedEx in 2023 and 2024 reflect the company's Network 2.0 optimization strategy, and what is the cumulative financial impact of these charges on the DRIVE transformation program through 2024?",
      "original_answer": "The aircraft impairment charges of $70 million in 2023 and $157 million in 2024 reflect FedEx's strategic decision to modernize its fleet and align air network capacity with current and anticipated shipment volumes, as part of the broader Network 2.0 optimization initiative. These charges resulted from the permanent retirement of older aircraft models, including Boeing MD-11F, Boeing 757-200, and Airbus A300-600 aircraft, to support more efficient operations under the DRIVE program. The DRIVE program also includes $582 million in business optimization costs incurred in 2024 alone, bringing the total cumulative optimization-related costs (including impairment charges) to $839 million through 2024, demonstrating the significant financial investment FedEx is making to implement Network 2.0 and improve long-term profitability.",
      "llm_answer": "The 2024 aircraft impairment charge of $157 million reflects FedEx’s Network 2.0 optimization strategy, as the company retired 22 Boeing 757‑200 aircraft and related engines to modernize its air fleet and better align capacity with current and anticipated shipment volumes. Combined with the $70 million impairment recorded in 2023, these charges represent a cumulative financial impact of $227 million in pre‑tax aircraft impairment expenses through 2024 as part of the broader DRIVE transformation program.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the aircraft impairment charges of $70 million in 2023 and $157 million in 2024, and accurately calculates the cumulative impairment total of $227 million. These numbers match the ground truth exactly, and formatting is consistent. (2) Quantitatively, all figures are correct: $70M (2023), $157M (2024), and their sum $227M are accurate. However, the LLM fails to mention the additional $582 million in business optimization costs incurred in 2024 under the DRIVE program, which is critical to answering the second part of the question about the *cumulative financial impact* of the DRIVE transformation program. The ground truth states that total cumulative costs through 2024 are $839 million ($227M in impairments + $582M in other costs), a key point omitted in the LLM response. (3) The reasoning correctly links the impairment charges to the Network 2.0 strategy and fleet modernization, including the retirement of Boeing 757-200 aircraft, which aligns with the ground truth. However, it omits mention of other retired aircraft models (MD-11F, A300-600), and more importantly, fails to synthesize the full scope of DRIVE-related costs, indicating incomplete multi-hop reasoning across financial line items. (4) The answer is contextually relevant and well-structured, but the omission of the $582 million in business optimization costs significantly limits completeness. While the impairment charges are accurately reported, the cumulative financial impact on the DRIVE program is underreported, affecting the overall correctness. Hence, a score of 7 is justified: core facts are correct, but a major component of the multi-part question is inadequately addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 469,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "What is the total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, and how much did the gross unrealized losses on these obligations increase from December 31, 2023, to December 31, 2024?",
      "original_answer": "The total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, is $3,627 million. The gross unrealized losses on these obligations increased by $40 million, from $234 million in 2023 to $274 million in 2024.",
      "llm_answer": "As of December 31, 2024, the total fair value of U.S. government and agency obligations held by UNH was $3,627 million, and the gross unrealized losses on these obligations increased by $267 million from $234 million at December 31, 2023 to $274 million at December 31, 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the total fair value of U.S. government and agency obligations as $3,627 million as of December 31, 2024, which matches the ground truth. It also correctly stated the gross unrealized losses were $234 million as of December 31, 2023, and $274 million as of December 31, 2024. However, it incorrectly calculated the increase in gross unrealized losses as $267 million instead of the correct $40 million ($274M - $234M = $40M). This is a critical quantitative error. (2) The numbers themselves (3,627, 234, 274) are accurate, but the derived value (increase) is wrong, indicating a failure in basic arithmetic despite correct input data. (3) The multi-hop reasoning required—identifying the two time points, extracting the unrealized losses, and computing the difference—was partially sound in data retrieval but failed in the final calculation step. The model appears to have either misread the numbers or made a computational mistake. (4) The contextual relevance is perfect—the answer addresses both parts of the question and uses correct entities (UNH, U.S. government and agency obligations, correct dates). Due to the significant calculation error affecting a core part of the question, the correctness and quantitative accuracy scores are moderate. The qualitative accuracy is slightly higher because the model retrieved the correct data points but failed only in the final inference.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 397,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the 54% merchant basis transaction mix in 2023 and the associated increase in merchant-related expenses impact Booking.com's operating margins compared to 2022, and what were the key cost components contributing to this effect?",
      "original_answer": "The increase in merchant basis transaction mix from 44% in 2022 to 54% in 2023 led to higher merchant-related expenses, which negatively impacted Booking.com's operating margins despite associated incremental revenues. Key cost components included personnel expenses, payment processing fees, and chargebacks (including those related to fraud), all of which are recorded in 'Personnel' expenses and 'Sales and other expenses' in the Consolidated Statements of Operations. This shift toward a greater proportion of business conducted on a merchant basis resulted in additional costs that outweighed the benefits of increased revenues such as payment card rebates, thereby compressing operating margins.",
      "llm_answer": "The 54% merchant‑basis transaction mix in 2023 increased merchant‑related expenses (personnel, payment‑processing, chargebacks, and other incremental costs) that were recorded in “Personnel” and “Sales and other expenses,” thereby compressing Booking.com’s operating margins relative to 2022. These added costs offset the incremental revenue generated from the higher merchant share, leading to lower margin performance despite the rise in transaction volume.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 54% merchant basis transaction mix in 2023 and implicitly acknowledges the increase from 2022 (44% in ground truth), though it does not explicitly state the 2022 figure. All key cost components—personnel expenses, payment processing fees, and chargebacks—are accurately mentioned, and their classification in 'Personnel' and 'Sales and other expenses' is correctly noted. The conclusion that increased costs compressed operating margins despite incremental revenues aligns with the ground truth. (2) Quantitatively, the 54% figure is correct and matches the ground truth; the absence of the 44% 2022 mix is a minor omission but does not introduce inaccuracy—rather, it reduces completeness slightly. No calculations are required, and all referenced metrics are used appropriately. (3) The multi-hop reasoning is sound: the model correctly links the shift in transaction mix to higher expenses, identifies the relevant cost categories, and explains the net negative impact on operating margins. It captures the cause-effect chain across business model shift, cost structure, and profitability. (4) The answer is contextually fully relevant and semantically equivalent to the original, with only slight omission of the explicit 2022 comparison percentage. This does not detract significantly from the overall correctness, hence a 9/10. Quantitative accuracy is perfect, contextual relevance is complete, and qualitative reasoning is strong with only minor room for elaboration on fraud-related chargebacks specifically.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 432,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the reclassification of eligible consumer installment receivables to 'Loans and Interest Receivable, Held for Sale' and the subsequent change in fair value measurement methodology impact PayPal's financial statements in 2024, particularly in terms of asset valuation and income recognition?",
      "original_answer": "The reclassification of eligible consumer installment receivables to 'Loans and Interest Receivable, Held for Sale' led to a change in valuation methodology from an unobservable price-based model to one using observable inputs such as executed prices for comparable loans sold to the global investment firm. This reclassification caused these assets to be classified within Level 2 in the fair value hierarchy starting in Q1 2024, improving transparency and reliability of valuation. Additionally, any previously recorded allowance for credit losses was reversed, decreasing transaction and credit losses in 2023. In 2024, valuation changes and charge-offs for these held-for-sale loans were recorded in 'restructuring and other' on the consolidated statements of income (loss), directly impacting income recognition.",
      "llm_answer": "The reclassification of eligible consumer installment receivables to “Loans and interest receivable, held for sale” and the shift to fair‑value measurement (lower of cost or fair value, with changes recorded in restructuring and other) reduced transaction and credit losses by reversing prior allowances and required the portfolio to be valued at the lower of cost or fair value on an aggregate basis. This valuation approach lowered the recorded asset value to reflect market‑based prices and caused income‑statement impacts through restructuring charges and the recognition of fair‑value adjustments rather than interest income.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the reclassification of consumer installment receivables to 'Loans and interest receivable, held for sale' and the shift in valuation methodology, which aligns with the ground truth. It accurately notes the reversal of prior allowances reducing transaction and credit losses, and correctly states that fair value changes are recorded in 'restructuring and other' on the income statement—this matches the original answer’s claim about income recognition impact. There are no numeric values in the question or answer requiring quantitative verification, so quantitative accuracy is scored as 10 by default. However, the LLM omits key details: it does not mention the change in fair value hierarchy classification to Level 2, nor does it specify the use of observable inputs like executed prices from comparable loans sold to a global investment firm, which are critical aspects of the valuation methodology shift. Additionally, while it mentions 'lower of cost or fair value', the original answer clarifies the move to a more transparent, market-based observable input model—not just a lower-of-cost-or-market adjustment—so the reasoning is partially oversimplified. The answer is contextually relevant and captures the core financial statement impacts on asset valuation and income recognition, but lacks completeness in explaining the full scope of the methodology change and its implications for transparency and reliability. Thus, while factually aligned on major consequences, it misses nuanced but important multi-hop details from the original knowledge graph answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 438,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "What is the total combined borrowing capacity in USD from both the newly established €1.5 billion credit facility and the existing short-term credit arrangements as of December 31, 2024, and how does this compare to the borrowing capacity from short-term credit arrangements as of December 31, 2023?",
      "original_answer": "The total combined borrowing capacity as of December 31, 2024, from the newly established €1.5 billion (approximately $1.6 billion) credit facility and the existing short-term credit arrangements of $2.1 billion was $3.7 billion. This represents a decrease compared to the $2.7 billion in short-term credit arrangements available as of December 31, 2023.",
      "llm_answer": "As of December 31 2024, PMI’s total borrowing capacity was $6.2 billion under its committed revolving credit facilities (a €1.5 billion facility plus $2.5 billion of multi‑year facilities and a $1.7 billion 364‑day facility) and an additional $2.1 billion of short‑term credit arrangements, giving a combined capacity of roughly $8.3 billion. This compares with a borrowing capacity of about $2.7 billion from short‑term arrangements alone as of December 31 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the total combined borrowing capacity as of December 31, 2024, is $3.7 billion, composed of the €1.5 billion (~$1.6 billion) credit facility and $2.1 billion in short-term credit arrangements. However, the LLM claims a total combined capacity of $8.3 billion, incorrectly adding $6.2 billion in revolving credit facilities (including a $2.5 billion multi-year and $1.7 billion 364-day facility not mentioned in the ground truth) plus $2.1 billion in short-term arrangements. These additional facilities are not part of the original data and represent a major fabrication or misattribution. (2) The calculation in the LLM answer is therefore incorrect: $6.2B + $2.1B = $8.3B is not supported by the ground truth, which correctly calculates $1.6B + $2.1B = $3.7B. The comparison to the $2.7B available in 2023 is correctly referenced, but the conclusion about the direction of change is missing — the ground truth notes a decrease from $2.7B to $3.7B total capacity, while the LLM fails to make this comparison despite listing both figures. (3) Multi-hop reasoning is flawed: the model fails to correctly identify which facilities constitute the 'newly established' and 'existing' capacities, instead introducing unverified credit facilities. It does recognize the need to combine new and existing capacities and compare across years, but the synthesis is based on incorrect inputs. (4) The contextual relevance is moderate because the answer addresses the right time periods and types of credit facilities, and attempts the required comparison. However, due to severe quantitative and qualitative errors, the overall correctness score is low. The answer is not semantically equivalent to the ground truth and misrepresents key financial facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 499,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How much total revenue did NVIDIA's Compute & Networking segment contribute in fiscal year 2024, given that one direct customer accounted for 13% of total revenue and one estimated indirect customer accounted for 19% of total revenue, assuming total company revenue was $27 billion?",
      "original_answer": "$8.64 billion",
      "llm_answer": "Based on the provided document pages, the question asks for the total revenue contributed by NVIDIA's Compute & Networking segment in fiscal year 2024. The document states that one direct customer accounted for 13% of total revenue and one indirect customer accounted for 19% of total revenue, both attributable to the Compute & Networking segment. With total company revenue reported as $27 billion, the combined revenue from these two customers represents 32% of total revenue ($27 billion × 0.13 + $27 billion × 0.19 = $27 billion × 0.32 = $8.64 billion). However, the question specifically asks for the segment's total revenue contribution, not just the revenue from these customers. \n\nThe document does not provide the exact revenue figure for the Compute & Networking segment itself. It only mentions that these customers contributed 13% and 19% of total revenue, respectively, and that the segment's revenue is concentrated. Without additional data on the segment's total revenue (e.g., its percentage of overall revenue or specific dollar amount), the exact contribution cannot be determined from the provided information. The $8.64 billion figure represents the combined revenue from these two customers, not the segment's total revenue.\n\nTherefore, the question cannot be answered with the provided information, as the exact total revenue for the Compute & Networking segment is not disclosed in the document. The document only provides the revenue percentages of specific customers relative to total company revenue, not the segment's overall revenue. \n\nAnswer: The provided information does not contain the exact total revenue figure for NVIDIA's Compute & Networking segment in fiscal year 2024; it only states that one direct customer accounted for 13% and one indirect customer accounted for 19% of total revenue ($27 billion), but does not specify the segment's total revenue contribution.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its reasoning and conclusion. (1) The question asks for the total revenue of NVIDIA's Compute & Networking segment in FY2024, and the ground truth is $8.64 billion. The LLM incorrectly claims this cannot be determined, when in fact the knowledge graph confirms that the segment's total revenue is derived from the sum of the 13% (direct customer) and 19% (indirect customer) of total revenue, both attributed to the Compute & Networking segment. This implies the segment accounted for 32% of total revenue, which is $27 billion × 0.32 = $8.64 billion — a calculation the LLM performs correctly but then misinterprets as only representing two customers' contributions rather than the full segment revenue. (2) Quantitatively, the $8.64 billion figure is accurate and matches the ground truth exactly, but the LLM rejects it due to a flawed interpretation of the data. (3) The multi-hop reasoning fails: the model does not recognize that in the context of the knowledge graph, the Compute & Networking segment’s total revenue is defined by these two customer contributions (direct and indirect), which together constitute the segment's reported revenue. This is a known pattern in SEC filings where large customer concentrations equate to segment revenue disclosure. (4) Contextual relevance is low because the answer denies the possibility of an answer despite having all necessary data. The LLM overcomplicates the question and incorrectly asserts missing information. Thus, despite performing the correct math, it arrives at a wrong conclusion, warranting a correctness score of 0.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 442,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does AIG's Internal Capital Framework, as part of its Risk Appetite Framework, support the company's assessment of capital resources required to maintain consolidated target capitalization levels, particularly in relation to its stress testing framework and diversification benefits?",
      "original_answer": "AIG's Internal Capital Framework quantifies the company's aggregate economic risk at a given confidence interval by factoring in diversification benefits between risk factors and business lines. This quantification supports the assessment of resources needed at the AIG Parent level to support subsidiaries and determine the capital resources required to maintain consolidated company target capitalization levels. Additionally, AIG uses a stress testing framework to evaluate aggregate exposure to its most significant financial and insurance risks, which complements the Internal Capital Framework in guiding capital allocation decisions and ensuring financial resilience.",
      "llm_answer": "AIG's Internal Capital Framework quantifies aggregate economic risk and incorporates diversification benefits across risk factors and business lines, directly informing the capital resources needed to sustain consolidated target capitalization levels. This framework feeds into the stress testing methodology, which assesses exposure to significant financial and insurance risks, enabling AIG to evaluate whether its current capital structure—supported by reinsurance arrangements and collateralized recoveries—adequately withstands adverse scenarios while maintaining regulatory and strategic capital adequacy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) It correctly identifies that AIG's Internal Capital Framework quantifies aggregate economic risk and incorporates diversification benefits across risk factors and business lines, which directly supports the assessment of capital resources needed to maintain consolidated target capitalization levels—this matches the original answer exactly in substance. (2) There are no numeric values (e.g., percentages, dollar amounts, dates) in either answer, so quantitative accuracy is not compromised; all financial concepts (e.g., capital resources, diversification benefits) are used appropriately. (3) The multi-hop reasoning is sound: the LLM correctly links the Internal Capital Framework to stress testing and explains how both inform capital adequacy under adverse scenarios. It adds slight elaboration—'reinsurance arrangements and collateralized recoveries'—which is contextually plausible and consistent with AIG's risk management practices, though not explicitly mentioned in the ground truth. This does not introduce inaccuracy but adds detail beyond the source, slightly reducing qualitative accuracy by a minor degree. (4) The answer fully addresses all parts of the question: the role of the Internal Capital Framework, its relationship to capital assessment, integration with stress testing, and consideration of diversification. Contextual relevance is perfect, as all content directly responds to the query with appropriate financial and structural nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 424,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "Given that Target's owned brands represent approximately one-third of its merchandise sales and the associated risks of developing and sourcing these brands, how might supply chain disruptions or failure to meet consumer demand impact Target's financial performance, particularly in relation to inventory management and profitability?",
      "original_answer": "Target's owned brands represent approximately one-third of its merchandise sales and generally carry higher margins than equivalent national brand products. If Target is unable to accurately forecast consumer demand for these products, it could result in insufficient or excess inventory, increased inventory markdowns, and higher costs. Additionally, because owned brand products generally require longer lead times and earlier ownership in the supply chain, supply chain disruptions or failure to meet consumer demand could lead to inventory shrink, which has historically elevated in recent years. This inventory shrink has already adversely affected, and could continue to adversely affect, Target's results of operations and financial condition. Furthermore, these issues could limit Target's ability to drive net earnings growth, especially during key seasonal moments like the November and December holiday period, where a larger portion of sales traditionally occur.",
      "llm_answer": "Target’s owned and exclusive brands account for roughly one‑third of merchandise sales and carry higher margins, but they also require longer lead times, more accurate demand forecasting, and expose the company to heightened supply‑chain risk. If supply‑chain disruptions prevent timely delivery of these products—or if Target fails to meet consumer demand—the resulting inventory imbalances (excess or insufficient stock) would likely trigger markdowns, increase shrink, and depress profitability, directly eroding the margins that these brands are meant to enhance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) Quantitatively, the statement that Target's owned brands represent approximately one-third of merchandise sales is correctly reflected. No specific dates or dollar amounts are in the original, so no numerical discrepancies exist. (2) The LLM correctly identifies that owned brands carry higher margins, require longer lead times, and are subject to supply chain risks and demand forecasting challenges. It accurately links supply chain disruptions and demand misforecasting to inventory imbalances, markdowns, shrink, and reduced profitability—mirroring the causal chain in the original. (3) Multi-hop reasoning is sound: it connects the higher-margin nature of owned brands with the operational risks (longer lead times, early ownership), then synthesizes how disruptions impact inventory and ultimately erode profitability. The only minor omission is the specific mention of seasonal periods (e.g., November–December holidays) as critical times when these risks could limit net earnings growth, which is present in the original. (4) Despite this small contextual detail, the LLM answer is semantically equivalent in substance and fully relevant to the question. The reasoning is logical, entities (Target, owned brands, inventory, profitability) are correct, and the synthesis across cause-effect链条 is strong. A score of 9 is justified due to high accuracy with a slight deduction for incomplete completeness on seasonal impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 416,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "What is the difference in the 2024 carrying values of NVDA's 3.50% Notes Due 2050 and 3.50% Notes Due 2040?",
      "original_answer": "$397 million",
      "llm_answer": "The 2024 carrying values of NVIDIA's 3.50% Notes Due 2040 and 3.50% Notes Due 2050 are $1,000 million and $2,000 million, respectively, resulting in a difference of $1,000 million.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numbers and calculation. The ground truth states the difference is $397 million, but the LLM claims a difference of $1,000 million. Additionally, the LLM reports carrying values of $1,000 million and $2,000 million for the 2040 and 2050 notes respectively, which are not supported by the ground truth and significantly misstate the actual figures. (2) The calculation itself ($2,000M - $1,000M = $1,000M) is mathematically correct, but based on false inputs, rendering the output invalid. The correct difference of $397 million is not reflected. (3) The multi-hop reasoning fails because the model did not retrieve or synthesize the correct carrying values from the source documents. It incorrectly identifies the values for both notes, suggesting a failure in entity-metric alignment (i.e., associating the wrong carrying values with the respective debt instruments). (4) The contextual relevance is high because the answer addresses the right entities (NVDA, 3.50% Notes Due 2040 and 2050, 2024 carrying values) and performs the correct type of comparison (difference in carrying values). However, due to severe quantitative inaccuracies and flawed data retrieval, the correctness and qualitative accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1038,
        "completion_tokens": 362,
        "total_tokens": 1400
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How many total shares of common stock were available for future issuance under both the 2020 Stock Incentive Plan and the ESPP as of December 31, 2024, and what types of awards can be issued under the 2020 Stock Incentive Plan according to the UnitedHealth Group 2024 10-K filing?",
      "original_answer": "As of December 31, 2024, 64 million total shares of common stock were available for future issuance under both the 2020 Stock Incentive Plan and the ESPP. Specifically, 48 million shares were available under the 2020 Stock Incentive Plan, and 16 million shares were available under the ESPP. Under the 2020 Stock Incentive Plan, future awards may take the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards.",
      "llm_answer": "As of December 31 2024, the 2020 Stock Incentive Plan had approximately 48 million shares available for future issuance, and the Employee Stock Purchase Plan had about 16 million shares available. The 2020 Stock Incentive Plan may issue stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards and other stock‑based awards.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 48 million shares available under the 2020 Stock Incentive Plan and 16 million under the ESPP, which sum to 64 million total shares—though the total is not explicitly stated in the LLM answer, it is implied by the two components and the question only asks for the total 'under both' plans, which the provided numbers allow to be correctly inferred. (2) The types of awards listed—stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards—are identical in meaning and complete compared to the ground truth. (3) The entities are correct: UnitedHealth Group is implied by context, the 2020 Stock Incentive Plan and ESPP are correctly named, and the date (December 31, 2024) is accurately referenced. (4) The reasoning is sound and reflects proper synthesis of multi-hop information from the 10-K filing, correctly separating the two plans and their respective share availability while accurately describing award types. (5) The wording differs slightly (e.g., 'approximately' and 'about') but these are acceptable approximations and do not affect factual accuracy. Overall, the answer is factually correct, complete, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 377,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How does AIG's use of the Expected Loss Ratio Methods, specifically the Bornhuetter Ferguson approach, help address the challenges of loss emergence volatility in U.S. Workers' Compensation, which is characterized by extremely long-tail loss development patterns?",
      "original_answer": "AIG uses the Expected Loss Ratio Methods, including the Bornhuetter Ferguson approach, to address the challenges of volatility in loss emergence for U.S. Workers' Compensation, an extremely long-tail line of business. In cases where reported loss data lacks sufficient credibility—such as in long-tail lines at early stages of development—Expected Loss Ratio Methods provide a more stable estimate by applying an expected loss ratio to earned premiums. This method avoids overreacting to anomalous early-stage losses that could distort projections, unlike loss development methods that might extrapolate unusual activity onto the unreported portion of losses. This is particularly important for U.S. Workers' Compensation, where loss emergence can extend for decades and reporting patterns have slowed due to an increasing proportion of large deductible business.",
      "llm_answer": "AIG’s use of the Expected Loss Ratio Methods—particularly the Bornhuetter Ferguson approach—helps mitigate the volatility of loss emergence in U.S. Workers’ Compensation by providing a more stable, forward‑looking estimate of ultimate losses. This method leverages premiums and early‑reported loss data to project future loss ratios, allowing the company to adjust reserves quickly when loss development deviates from historical patterns, thereby reducing the uncertainty inherent in the long‑tail, slow‑emerging nature of workers’ compensation claims.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of AIG's use of the Expected Loss Ratio Methods and the Bornhuetter Ferguson approach, and correctly identifies the purpose of stabilizing loss estimates in the context of U.S. Workers' Compensation's long-tail nature. There are no numeric values in the question or answers that require verification, so quantitative accuracy is scored as 10. However, the LLM answer misses a key nuance present in the original answer: it does not explicitly state that the Expected Loss Ratio Method is used when reported loss data lacks credibility, particularly in early development stages, nor does it contrast the method with loss development techniques that might overextrapolate anomalous early losses. Additionally, the original answer highlights the impact of large deductible business slowing reporting patterns—a specific contextual factor that the LLM omits. While the LLM captures the general reasoning and intent of the method (stability, forward-looking estimates), it falls short in fully conveying the multi-hop synthesis of why this method is specifically suited to the challenges of U.S. Workers' Compensation. Thus, qualitative accuracy is reduced due to incomplete reasoning depth and missing contextual causality. Contextual relevance remains high as the response directly addresses the question’s core topic with appropriate terminology and logical flow.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 390,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "What is the total number of amendments made to the Credit Card Program Agreement between Target Corporation and TDBank USA, N.A., as documented in the 10-K filings referenced, and what does this indicate about the evolution of their financial partnership?",
      "original_answer": "The Credit Card Program Agreement between Target Corporation and TDBank USA, N.A. has undergone 2 amendments, as documented in the filings. This indicates that the financial partnership has evolved over time, with modifications made in 2015 and 2019 to adapt the agreement to changing business or regulatory conditions.",
      "llm_answer": "The 10‑K filing shows that the Credit Card Program Agreement with TDBank USA, N.A. has been amended three times – the original agreement was executed on October 22 2012, and subsequent amendments were filed on February 24 2015, November 19 2019, and September 20 2023 (the latter being an amendment to the 2021 credit agreement that also references the credit‑card program). Thus, four distinct amendments have been documented. This demonstrates that the financial partnership has been refined and expanded over time to accommodate evolving operational needs and regulatory requirements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. The ground truth states there are 2 amendments (in 2015 and 2019), but the LLM claims 3 or 4 amendments, citing dates including February 24, 2015, November 19, 2019, and September 20, 2023, with the latter tied to a 2021 credit agreement not mentioned in the original answer. This contradicts the documented truth. (2) The dates and number of amendments are not aligned with the ground truth: while 2015 and 2019 are correctly identified as amendment years, the inclusion of a 2023 amendment (and reference to a 2021 agreement) introduces unsupported information not present in the original answer. The count of 'three' or 'four' amendments is therefore incorrect. (3) The multi-hop reasoning fails because the LLM appears to conflate the Credit Card Program Agreement with a separate credit agreement (2021), introducing an erroneous linkage. The original answer does not reference any 2021 or 2023 amendments, so the LLM overextends its synthesis. (4) While the qualitative interpretation about the partnership evolving to meet operational and regulatory needs is semantically similar to the original's 'evolved over time... changing business or regulatory conditions,' the incorrect factual foundation undermines the reasoning. The contextual relevance is moderate because the answer addresses the right topic and draws a plausible conclusion, but the factual inaccuracies severely reduce correctness. Quantitative accuracy is very low due to wrong counts and dates; qualitative accuracy is low due to flawed entity linkage and reasoning; contextual relevance is acceptable as the response remains on-topic and interprets the implications reasonably, albeit based on incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 481,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How much did FedEx spend on business optimization activities related to Network 2.0 in 2023 and 2024 combined, and what was the primary purpose of these expenditures?",
      "original_answer": "FedEx spent $273 million in 2023 and $582 million in 2024 on business optimization activities related to Network 2.0, totaling $855 million. These expenditures were primarily used for professional services and severance to support the multi-year effort to improve the efficiency with which FedEx picks up, transports, and delivers packages in the U.S. and Canada.",
      "llm_answer": "FedEx spent $582 million in 2024 on business optimization activities related to Network 2.0, and $273 million in 2023, for a combined total of $855 million. The primary purpose of these expenditures was to drive efficiency across the transportation segments, lower overhead and support costs, and transform the company’s digital capabilities by consolidating sortation facilities, reducing pickup‑and‑delivery routes, and optimizing the enterprise line‑haul network through the Network 2.0 initiative.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures: $273 million in 2023 and $582 million in 2024, with a correct combined total of $855 million. These match the ground truth exactly, and the format variations (e.g., using thin spaces) are acceptable. (2) Quantitative accuracy is perfect—each dollar amount and the sum are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two years and links expenditures to the Network 2.0 initiative. The primary purpose is described with slightly different wording than the original answer but captures the core intent—improving efficiency in pickup, transport, and delivery—through specific actions like consolidating sortation facilities and optimizing the line-haul network. It adds detail about digital transformation and cost reduction, which are consistent with the initiative’s goals, though the original emphasizes 'professional services and severance' as the use of funds. This additional context does not contradict but expands slightly, possibly inferring from related disclosures. (4) The answer is fully contextually relevant and addresses both parts of the question: total spending and the purpose. The only minor deviation is that the LLM focuses more on operational outcomes (e.g., route reduction) rather than the direct use of funds (e.g., severance), but the overall qualitative meaning aligns closely. Thus, the answer is factually correct and comprehensive, warranting a 9/10 due to slight difference in emphasis on fund usage, but not in substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 431,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the introduction of the ad-supported subscription plan, as mentioned in the context of Netflix's competitive strategy, affect the financial forecasting risks highlighted in the 2023 10-K filing?",
      "original_answer": "The introduction of the ad-supported subscription plan increases financial forecasting risks because consumer adoption of new pricing strategies like this plan is inherently difficult to predict, which could lead to material discrepancies between forecasted and actual revenues, net income, and other financial metrics.",
      "llm_answer": "The ad‑supported subscription plan introduces a new revenue stream and pricing model that Netflix must forecast accurately, increasing uncertainty around subscriber adoption and revenue per member. This adds forecasting risk to the 2023 10‑K’s existing uncertainties about revenue growth, membership expansion, and the fixed‑cost nature of content commitments, as highlighted in Item 1A and Item 7 of the filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. It accurately identifies that the ad-supported subscription plan increases financial forecasting risks due to uncertainty in subscriber adoption and revenue per member, which aligns with the original answer's emphasis on difficulty predicting consumer adoption leading to discrepancies in financial metrics. While the original answer focuses on the inherent unpredictability of new pricing models affecting forecasts, the LLM expands slightly by referencing specific sections of the 10-K (Item 1A and Item 7) and tying the risk to existing uncertainties like revenue growth, membership expansion, and fixed content costs—details that are consistent with typical 10-K disclosures and add context without introducing error. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects proper multi-hop synthesis between Netflix’s strategic move (ad-supported plan) and its implications on financial forecasting risks disclosed in the 10-K. The answer is fully contextually relevant. The only reason for not scoring a perfect 10 is that the LLM slightly reframes the risk in broader terms rather than explicitly stating the potential for 'material discrepancies between forecasted and actual revenues, net income, and other financial metrics' as in the original, though this concept is implicitly covered.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 404,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the patent expiration timeline for Prevnar 13 in different regions, as listed in Pfizer's 2024 10-K, relate to the $964 million intangible asset impairment charge for Prevnar 13's developed technology rights recorded in 2023?",
      "original_answer": "The $964 million intangible asset impairment charge for Prevnar 13's developed technology rights in 2023 was driven by updated commercial forecasts reflecting a transition to vaccines with higher serotype coverage. This aligns with the patent expiration timeline showing that Prevnar 13's major Europe patent expired in 2029, while its U.S. patent expires in 2026. These expirations likely contribute to reduced long-term commercial viability, prompting the impairment charge as Pfizer transitions focus to next-generation vaccines like Prevnar 20.",
      "llm_answer": "The $964 million intangible‑asset impairment charge recorded in 2023 for Prevnar 13’s developed technology rights reflects the updated commercial forecasts that anticipate a transition to newer vaccines with broader serotype coverage, which shortens the effective commercial life of the Prevnar 13 patent portfolio. This accelerated depreciation aligns with the patent expiration timeline noted in the 10‑K, where Prevnar 13’s U.S. basic patent is set to expire in 2026 (with extensions possible), and the impairment was triggered as the projected cash flows from the product fell below its carrying value before that expiration. Consequently, the impairment charge is directly tied to the anticipated loss of exclusivity and the resulting reduction in the asset’s useful life.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $964 million impairment charge in 2023 related to Prevnar 13's developed technology rights and accurately links it to updated commercial forecasts driven by the transition to next-generation vaccines with broader serotype coverage. The U.S. patent expiration in 2026 is correctly stated, aligning with the ground truth. However, the LLM omits mention of the European patent expiration in 2029, which is included in the original answer and provides important regional context for the multi-hop reasoning. (2) All numeric values—$964 million, 2023 charge, 2026 U.S. patent expiry—are factually correct and match the ground truth. Format variations (e.g., '2026' vs '2026') are consistent. No calculations are required, but the causal link between reduced cash flows and impairment is correctly explained. (3) The reasoning is sound: the LLM correctly synthesizes the connection between patent life, loss of exclusivity, reduced cash flow projections, and the resulting impairment. It accurately reflects GAAP accounting principles for intangible asset impairment. The only gap is the missing Europe 2029 expiration, which weakens the completeness of the multi-regional analysis implied in the question. (4) Despite the omission of the European patent date, the answer remains highly accurate, relevant, and logically structured, conveying the core causal mechanism behind the impairment. The contextual relevance is strong as it directly addresses the relationship between patent timeline and financial impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 430,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does McDonald's reliance on franchisees for operational success connect with its decision not to consolidate franchisee-related entities in its financial statements, and what risk does this pose if franchisees fail to execute key customer experience initiatives?",
      "original_answer": "McDonald's explicitly states that it does not consolidate franchisee-related entities in its financial statements, as these businesses qualify for a scope exception under variable interest entity consolidation guidance. This means the financial performance of franchisee-operated restaurants is not directly reflected in McDonald's consolidated financial results. However, McDonald's acknowledges that its business success heavily depends on franchisees executing key initiatives such as digital engagement, mobile ordering, and delivery improvements. If franchisees fail to effectively implement these customer experience strategies, it could negatively impact McDonald's sales, guest counts, and market share, despite the franchisee-related entities not being consolidated in its financial statements.",
      "llm_answer": "McDonald's relies on franchisees to drive Systemwide sales and brand consistency, but it does not consolidate franchisee‑related entities in its financial statements. This means the company’s reported results exclude the financial performance of its franchisees, so if franchisees fail to execute key customer‑experience initiatives the impact on sales and profitability would not be reflected in the company’s consolidated earnings, potentially masking deteriorating performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core relationship between McDonald's reliance on franchisees and its non-consolidation of franchisee-related entities. It correctly states that franchisee financial performance is excluded from McDonald's consolidated results, which aligns with the ground truth regarding the scope exception under variable interest entity guidance (though this specific accounting detail is omitted). The answer accurately identifies the risk: if franchisees fail to execute customer experience initiatives, the negative impact on sales and profitability would not appear in McDonald's reported earnings, potentially masking performance issues. This reflects the ground truth's concern about impacts on sales, guest counts, and market share. All entities (McDonald's, franchisees) and financial concepts (consolidation, earnings) are used correctly. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The main shortcoming is the omission of specific examples of key initiatives mentioned in the original answer—digital engagement, mobile ordering, and delivery improvements—which slightly reduces completeness and qualitative accuracy. However, the LLM generalizes these appropriately as 'key customer-experience initiatives,' preserving semantic equivalence. The reasoning is sound and synthesizes the multi-hop connection between operational dependence and financial reporting treatment. Contextual relevance is strong as all content directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 426,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's adoption of the LDTI standard impact its equity as of January 1, 2021, and what specific adjustments were made to the consolidated financial statements for the years ended December 31, 2022 and 2021?",
      "original_answer": "AIG's adoption of the LDTI standard resulted in a net decrease to beginning total equity of $1,264 million as of January 1, 2021. Additionally, the adoption adjustments included a $2 million decrease and a $983 million increase to net income for the years ended December 31, 2022 and 2021, respectively. These adjustments also led to a $1,219 million increase in total equity as of December 31, 2022. The changes were primarily due to adjustments related to market risk benefits (MRBs) and the discount rate used to measure the liability for future policy benefits.",
      "llm_answer": "AIG adopted the LDTI standard on January 1 2021 (transition date) with a modified retrospective basis (full retrospective for MRBs), resulting in a $1.264 billion net decrease to beginning total equity as of January 1 2021. The adoption adjustments increased net income by $2 million for 2022 and $983 million for 2021, and increased total equity by $1.219 billion as of December 31 2022, primarily through changes to MRB fair‑value measurements and the discount‑rate assumption used for the liability for future policy benefits. These adjustments are reflected in the consolidated financial statements for the years ended December 31 2022 and 2021.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the $1,264 million net decrease to beginning equity as of January 1, 2021, the $2 million and $983 million increases to net income for 2022 and 2021 respectively, and the $1,219 million increase in total equity as of December 31, 2022. The dollar amounts are correctly presented using billion/million formats ($1.264 billion = $1,264 million; $1.219 billion = $1,219 million), which is acceptable per evaluation guidelines. (2) Quantitative accuracy is perfect: all numbers match the original answer exactly when normalized, and no calculation errors are present. (3) The qualitative reasoning is sound: the LLM correctly identifies the transition date, the modified retrospective adoption method, the full retrospective treatment of MRBs, and the primary drivers of the adjustments (MRB fair-value measurements and discount rate assumptions). It also correctly links these adjustments to the consolidated financial statements for the relevant years. (4) The answer addresses both parts of the multi-hop question: the impact on equity at adoption (January 1, 2021) and the specific adjustments in the financial statements for 2022 and 2021. The synthesis across time periods and financial statement impacts is accurate and complete. All entities (AIG, LDTI, MRBs, equity, net income) are correctly identified and contextualized. Therefore, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 409,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the increase in Gulfstream aircraft orders specifically impact General Dynamics' cash flow from operating activities in 2021, and what was the resulting percentage of this cash flow relative to net earnings?",
      "original_answer": "The increase in Gulfstream aircraft orders led to a rise in customer deposits, which positively affected General Dynamics' cash flow from operating activities in 2021, resulting in $4.3 billion in cash provided by operating activities. This amount represented 131% of net earnings for the year.",
      "llm_answer": "Based on the provided document pages, the increase in Gulfstream aircraft orders specifically impacted General Dynamics' cash flow from operating activities in 2021 by driving higher customer deposits and inventory reduction, which positively affected cash inflows. This contributed to cash provided by operating activities reaching $4.3 billion (131% of net earnings), with the document explicitly linking Gulfstream order activity to the cash flow improvement. The resulting cash flow from operating activities represented 131% of net earnings for 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the increase in Gulfstream aircraft orders led to higher customer deposits, positively impacting cash flow from operating activities, which reached $4.3 billion in 2021, representing 131% of net earnings. These numbers match the original answer exactly, and format is consistent. (2) Quantitative accuracy is perfect: $4.3 billion and 131% are correctly reported, and the percentage relationship to net earnings is accurately stated. (3) The reasoning is sound and reflects multi-hop synthesis: the model correctly links Gulfstream order increases → higher customer deposits → improved operating cash flow → percentage of net earnings. The addition of 'inventory reduction' as a contributing factor, while not in the original answer, is plausible and does not contradict the ground truth; it may reflect additional context from the source document, so it does not constitute a factual error. (4) The answer is fully relevant and addresses both parts of the question: the impact on cash flow and the resulting percentage relative to net earnings. The only minor deviation is the inclusion of an extra detail (inventory reduction), which slightly extends beyond the original answer but does not reduce accuracy. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 398,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does AIG's integrated bottom-up risk identification process at the product-line level, as part of its Risk Identification and Measurement framework, support the company's internal capital framework in quantifying aggregate economic risk at a given confidence interval?",
      "original_answer": "AIG's integrated bottom-up risk identification process, conducted down to the product-line level, captures material risks inherent in specific business operations. This granular risk data feeds into the internal capital framework, which quantifies AIG's aggregate economic risk at a given confidence interval. By incorporating detailed risk assessments from individual product lines, the internal capital framework can more accurately account for diversification benefits between risk factors and business lines, thereby enabling a more robust quantification of overall economic risk exposure.",
      "llm_answer": "AIG’s integrated bottom‑up risk identification process runs down to the product‑line level and feeds directly into its internal capital framework, which quantifies the company’s aggregate economic risk at a specified confidence interval by aggregating the economic capital required for each line of business and incorporating diversification benefits across lines. This framework underpins the stress‑testing approach that estimates the capital needed to support subsidiaries and maintain the consolidated target capital level.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies AIG's bottom-up risk identification process at the product-line level and its role in feeding the internal capital framework, which quantifies aggregate economic risk at a given confidence interval. The mention of aggregating economic capital across business lines and incorporating diversification benefits aligns with the original answer. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly links granular risk identification to internal capital modeling and explains how diversification and aggregation support economic risk quantification. The addition of 'stress-testing approach' and 'consolidated target capital level' provides extra context not in the original but does not contradict it and is plausibly related. (4) The only minor gap is that the LLM answer does not explicitly state that the granularity 'enables a more robust quantification' due to better diversification modeling, which is a key point in the original. However, the implication is present. Overall, the answer is semantically equivalent with high completeness, accuracy, and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 372,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does the introduction of the RTX 4080 GPU, as part of NVDA's product transitions, interact with supply chain risks and demand forecasting challenges to potentially impact NVDA's financial performance?",
      "original_answer": "The introduction of the RTX 4080 GPU is part of NVDA's broader product transitions, which are complex and may result in unanticipated quality or production issues, increasing inventory provisions, warranty costs, or causing product delays. These transitions are difficult to manage and may impair NVDA’s ability to predict demand and impact supply mix, potentially leading to additional costs. Furthermore, NVDA depends on foundries to manufacture its semiconductor wafers and faces risks such as lack of guaranteed supply, higher component prices, and low manufacturing yields. These supply chain risks reduce NVDA’s control over product quantity, quality, and delivery schedules. If demand for the RTX 4080 is underestimated, NVDA may not be able to secure enough supply to meet customer orders, damaging relationships and leading to lost revenue and market share. Conversely, if demand is overestimated, NVDA may be unable to reduce inventory or contractual commitments, leading to inventory write-downs, cancellation penalties, and impairments. These factors, combined with extended lead times and geopolitical tensions, may negatively impact NVDA’s gross margins and financial results.",
      "llm_answer": "The introduction of the RTX 4080 GPU creates additional supply‑chain complexity and demand‑forecasting uncertainty, which can strain inventory management and lead to pricing pressures, warranty costs, or write‑downs if demand is misestimated. These factors, combined with geopolitical export restrictions and reliance on third‑party suppliers, may erode gross margins and overall financial performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically aligned with the ground truth, with no numeric inaccuracies (quantitative accuracy is perfect, though no specific numbers were present in either answer). It correctly identifies the core risks associated with the RTX 4080 launch: supply-chain complexity, demand-forecasting uncertainty, inventory mismanagement risks (write-downs), warranty costs, reliance on third-party suppliers, and margin pressure. It also mentions geopolitical export restrictions, which are contextually relevant and consistent with broader supply chain risks in NVDA’s filings. However, the LLM answer omits several key details from the original: (1) the explicit link between product transitions and unanticipated quality/production issues, (2) the impact on supply mix and inventory provisions, (3) the risk of product delays, (4) lack of guaranteed supply and low manufacturing yields from foundries, (5) cancellation penalties, and (6) the bidirectional risk of demand misestimation (both under- and over-estimation consequences). While the answer captures the essence and major implications, these omissions reduce completeness and depth of multi-hop reasoning, particularly around NVDA’s contractual commitments and foundry dependencies. The reasoning is sound but less comprehensive than the original. Contextual relevance is excellent—every point raised directly addresses the question. Thus, correctness and qualitative accuracy are high but not full, due to missing nuances essential to the full financial risk profile.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 426,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the Starbucks Rewards loyalty program impact Starbucks' revenue recognition timing, and what was the company's total advertising expense in fiscal 2022?",
      "original_answer": "The Starbucks Rewards loyalty program causes a deferral in revenue recognition. As customers earn Stars, Starbucks defers revenue based on the estimated value of the product for which the reward is expected to be redeemed. Revenue is only recognized when the reward is actually redeemed. This deferral mechanism ensures that a portion of revenue from purchases that generate Stars is not recognized upfront but rather when the reward is used. In fiscal 2022, Starbucks incurred $416.7 million in advertising expenses.",
      "llm_answer": "The Starbucks Rewards loyalty program requires the company to defer revenue associated with earned Stars toward future free‑product redemptions, establishing a liability for unredeemed points; this deferral alters the timing of revenue recognition for those sales. In fiscal 2022, Starbucks recorded total advertising expense of $416.7 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately describes the impact of the Starbucks Rewards program on revenue recognition: revenue is deferred for earned Stars and recognized upon redemption, which aligns with the original answer's explanation of deferral based on estimated reward value. (2) The quantitative figure for advertising expense in fiscal 2022 is exactly correct at $416.7 million, matching the ground truth in both amount and fiscal year. (3) The reasoning correctly synthesizes the accounting treatment of loyalty programs—specifically the deferral of revenue and liability creation—which demonstrates sound multi-hop understanding of financial reporting implications. (4) All entities (Starbucks, Starbucks Rewards, fiscal 2022) and financial concepts (revenue deferral, advertising expense) are accurately identified and used. The answer is concise but complete, addressing both sub-questions with precise, factually correct information. Minor wording differences (e.g., 'defers revenue associated with earned Stars' vs 'defers revenue based on estimated value') do not affect meaning and are semantically equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 333,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What was the total change in the notional amount of intercompany loans and forecasted interest payments from 2023 to 2024, and how much in interest payments related to these loans was recognized in earnings in 2024?",
      "original_answer": "The notional amount of intercompany loans and forecasted interest payments increased by $1,546 million from 2023 to 2024 ($4,406 million in 2024 - $2,860 million in 2023). In 2024, $75 million in interest payments related to these loans was recognized in earnings under 'Interest and other expense, net.'",
      "llm_answer": "The total change in the notional amount of intercompany loans and forecasted interest payments from 2023 to 2024 was an increase of $1,546 million (from $2,860 million to $4,406 million), and $75 million in interest payments related to these loans was recognized in earnings in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the change in notional amount is accurately calculated as $1,546 million ($4,406M - $2,860M), and the interest recognized in 2024 is correctly stated as $75 million. These values match the original answer exactly, with acceptable format variation (e.g., writing out 'million' vs using 'M'). (2) The answer is complete, addressing both parts of the multi-part question: the total change in notional amount and the interest payments recognized in earnings in 2024. (3) Entity accuracy is correct—'intercompany loans and forecasted interest payments' are properly identified, and the years 2023 and 2024 are correctly referenced. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly inferred the change by computing the difference between two years' values and accurately reported the interest recognized in earnings. (5) The semantic meaning is equivalent to the original answer, with no loss of key details or contextual nuance. Minor wording differences (e.g., 'increase of $1,546 million (from $2,860 million to $4,406 million)' vs the original's parenthetical calculation) do not affect factual accuracy. All scoring categories warrant full marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 357,
        "total_tokens": 1521
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What is the dollar amount increase in Total Marine Systems revenue from 2020 to 2021, and how does this growth compare to the increase in revenue for Nuclear-powered submarines during the same period?",
      "original_answer": "The dollar amount increase in Total Marine Systems revenue from 2020 to 2021 is $547 million ($10,526 million in 2021 minus $9,979 million in 2020). During the same period, the revenue for Nuclear-powered submarines increased by $179 million ($7,117 million in 2021 minus $6,938 million in 2020). Therefore, the growth in Total Marine Systems revenue is significantly higher than the growth in Nuclear-powered submarines revenue, with a difference of $368 million.",
      "llm_answer": "The dollar amount increase in Total Marine Systems revenue from 2020 to 2021 was $547 million, and this growth was driven primarily by higher U.S. Navy ship construction volume on programs such as the Columbia‑class submarine, John Lewis‑class oiler and Arleigh Burke‑class destroyer, whereas the increase in revenue for Nuclear‑powered submarines over the same period was $179 million. Thus, the Marine Systems segment’s revenue growth ($547 million) was more than three times the $179 million rise seen in Nuclear‑powered submarine revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the dollar amount increase in Total Marine Systems revenue ($547 million) and Nuclear-powered submarines revenue ($179 million), matching the ground truth exactly. The calculations are accurate: $10,526M - $9,979M = $547M and $7,117M - $6,938M = $179M. (2) All numeric values, including the final comparison, are correct. The statement that Total Marine Systems' growth was 'more than three times' the growth in Nuclear-powered submarines is accurate (547 / 179 ≈ 3.05), which aligns with the ground truth's implication of significantly higher growth. (3) The multi-hop reasoning is sound: the model synthesized revenue figures across two segments (Total Marine Systems and Nuclear-powered submarines) and correctly compared their year-over-year increases. It also added context about drivers (e.g., Columbia-class, John Lewis-class), which, while not required, enhances the answer without introducing error. (4) The only minor deviation from the original answer is that the LLM did not explicitly state the $368 million difference in growth between the two segments, which was included in the ground truth. However, it conveyed the same comparative insight (significantly higher growth) through a different but valid metric (over three times). This omission is minor and does not affect factual correctness. Therefore, the answer is fully quantitatively accurate, highly qualitatively accurate, and contextually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 405,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What is the dollar amount change in Mac sales from 2023 to 2024, and how does this compare to the change in iPad sales over the same period?",
      "original_answer": "The dollar amount change in Mac sales from 2023 to 2024 is $627 million (from $29,357 million to $29,984 million). For iPad sales, the change from 2023 to 2024 is a decrease of $1,606 million (from $28,300 million to $26,694 million). This indicates that while Mac sales increased slightly, iPad sales experienced a more significant decline.",
      "llm_answer": "Mac sales increased by $630 million (2 %) from 2023 to 2024, while iPad sales fell by $1.6 billion (6 %) over the same period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with minor rounding differences. (1) Quantitatively: The Mac sales increase is reported as $630 million vs. the exact $627 million in the ground truth—a negligible rounding difference (within 0.5%). The iPad sales decrease is stated as $1.6 billion, which is equivalent to $1,600 million, very close to the actual $1,606 million—a difference of only 0.4%. Percentages (2% increase for Mac, 6% decrease for iPad) align with the ground truth when calculated: (29,984 - 29,357) / 29,357 ≈ 2.1%, rounded to 2%; (26,694 - 28,300) / 28,300 ≈ -5.66%, rounded to 6%. (2) Completeness: The answer addresses both parts of the question—change in Mac sales and change in iPad sales—with correct direction (increase/decrease), magnitude, and comparison context. (3) Entity accuracy: 'Mac' and 'iPad' are correct product lines, and the time period (2023 to 2024) is correctly implied. (4) Reasoning: The model correctly performs multi-hop reasoning by identifying sales figures for two products across two years and computing changes. The qualitative comparison (Mac up slightly, iPad down more significantly) is logically sound and consistent with the data. (5) Semantic equivalence: Despite rounding, the answer preserves the factual and comparative meaning of the original. Only a minor deduction in quantitative accuracy due to rounding beyond typical reporting precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1115,
        "completion_tokens": 398,
        "total_tokens": 1514
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the unfavorable volume/mix in the chocolate category in 2024 impact Mondelēz International's total net revenue growth, given the prior-year favorable volume/mix in chocolate and the company's overall net revenue increase of $452 million?",
      "original_answer": "The unfavorable volume/mix in the chocolate category in 2024 contributed to a drag on total net revenue growth, despite the company reporting an overall increase of $452 million. In 2023, chocolate contributed $10.619 billion to total net revenues, and the 2024 performance saw a decline in this category, which was explicitly cited as a driver of the unfavorable volume/mix. This contrasts with 2023, where chocolate experienced favorable volume/mix, contributing to a $1,437 million increase in net revenues. The 2024 decline in chocolate volume/mix offset some of the gains from net pricing and created headwinds that limited the overall revenue growth to 3.5% ($452 million), despite pricing actions aimed at countering input cost increases.",
      "llm_answer": "The unfavorable volume/mix in chocolate reduced total net revenue growth in 2024, contributing to a $452 million increase in net revenue (3.5%) despite higher net pricing; the prior year had shown a favorable volume/mix in chocolate, and the overall net revenue increase of $452 million was partially offset by this negative volume/mix effect.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the unfavorable volume/mix in chocolate as a drag on 2024 net revenue growth and notes the $452 million overall increase (3.5%), which aligns with the ground truth. It also correctly contrasts this with the prior year's favorable volume/mix. However, it omits key quantitative details present in the original answer: the $10.619 billion 2023 chocolate revenue contribution and the $1,437 million prior-year net revenue increase attributed to chocolate's favorable performance. These omissions reduce completeness and quantitative accuracy. (2) While the $452 million and 3.5% figures are accurate and correctly contextualized, the absence of the $1,437 million prior-year impact and the specific revenue figure for chocolate in 2023 means the answer fails to fully quantify the shift from favorable to unfavorable volume/mix. There are no calculation errors, but the synthesis is incomplete. (3) The multi-hop reasoning is partially sound—the model connects 2024's unfavorable chocolate performance to the overall revenue outcome and references prior-year conditions—but it does not fully synthesize the magnitude of the year-over-year change in chocolate's contribution, which is central to understanding the drag. (4) The answer is contextually relevant and conveys the general trend correctly, but lacks specificity in numbers and causal detail, warranting a score of 7 for correctness. Quantitative accuracy is slightly penalized for missing key figures, while qualitative reasoning and relevance remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 430,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How do initial capacity constraints related to custom components impact Apple's ability to manage supply chain risks and maintain product availability, given its reliance on single-source suppliers and outsourcing partners in Asia?",
      "original_answer": "Initial capacity constraints related to custom components directly impact Apple's ability to manage supply chain risks and maintain product availability because the company often relies on single-source suppliers for these components. As stated in the 10-K filing, when a component or product uses new technologies, initial capacity constraints may exist until suppliers' yields have matured or their manufacturing capacities have increased. This can delay the availability of components at acceptable prices, or at all, especially if suppliers choose to focus on producing more common components rather than custom ones tailored to Apple's needs. Additionally, Apple's reliance on outsourcing partners primarily located in Asia for final assembly means that any disruption in the supply of these custom components can lead to delays in finished product shipments. This combination of dependency on limited suppliers and initial capacity constraints increases the risk of supply shortages and affects Apple's ability to meet market demand, thereby impacting its business, results of operations, and financial condition.",
      "llm_answer": "Initial capacity constraints for custom components can delay new product launches and cause supply shortages, forcing Apple to rely on single-source suppliers in Asia. This limited flexibility amplifies supply chain risks and can materially affect product availability and financial performance.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually correct in its core claims and captures the essential relationship between initial capacity constraints, reliance on single-source suppliers in Asia, and the resulting supply chain risks and impact on product availability and financial performance. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. However, the LLM response is less complete compared to the original answer. It omits key explanatory details from the 10-K, such as the reason for capacity constraints (immature yields or limited manufacturing scale for new technologies), the risk that suppliers may prioritize common components over Apple’s custom ones, and the specific geographic concentration of outsourcing partners in Asia amplifying disruption risks. These omissions reduce completeness and weaken the depth of multi-hop reasoning, though the overall logic and entity identification (Apple, single-source suppliers, Asia-based manufacturing) are accurate. The answer is contextually relevant and correctly synthesizes the high-level implications, but lacks the detailed causal chain present in the ground truth. Thus, while the qualitative accuracy is good, it falls short of full accuracy due to missing nuances critical to a comprehensive understanding of the risk dynamics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 370,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How much revenue did Disney report from TV/SVOD distribution licensing in 2022 after factoring in the content license early termination fee, and how does this compare to the previous year's TV/SVOD distribution licensing revenue?",
      "original_answer": "Disney reported $3,429 million in TV/SVOD distribution licensing revenue in 2022 after factoring in the $1,023 million content license early termination fee, compared to $5,266 million in 2021. This represents a decrease of $1,837 million from the prior year.",
      "llm_answer": "Disney reported TV/SVOD distribution licensing revenue of $3.429 billion in fiscal 2022, after deducting the $1.023 billion early‑termination fee, compared with $5.266 billion in fiscal 2021. This reflects a decline due to the termination of certain licenses that were previously recognized as revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures: $3.429 billion (equivalent to $3,429 million) for 2022 TV/SVOD distribution licensing revenue after the $1.023 billion ($1,023 million) early termination fee, and $5.266 billion ($5,266 million) for 2021. These match the ground truth exactly, with acceptable format variation (billion vs million). (2) The quantitative accuracy is perfect—values are correct, and while the LLM does not explicitly state the $1,837 million decrease, it correctly implies a decline, which is consistent with the data. The omission of the exact dollar decrease is a minor completeness issue but does not affect factual correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes the impact of the early termination fee on 2022 revenue and compares it to the prior year. Entity accuracy is flawless—Disney, TV/SVOD distribution licensing, fiscal years 2021 and 2022, and the financial metric are all correctly identified. (4) The answer is semantically equivalent to the ground truth, with slightly less numerical detail in the comparison but no factual errors. The contextual relevance is perfect, directly addressing both parts of the question. The correctness score is 9 due to the missing explicit mention of the $1,837 million decrease, which was part of the original answer, but this does not undermine the core accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 390,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does Starbucks' integration of the Mobile App with the Starbucks Rewards loyalty program drive customer engagement and store visit frequency, based on the 2022 10-K disclosures?",
      "original_answer": "Starbucks' integration of the Mobile App with the Starbucks Rewards loyalty program drives customer engagement and store visit frequency by enabling customers to earn Stars through multiple payment methods—such as cash, credit or debit cards, or selected mobile wallets—and by offering Mobile Order and Pay functionality. This allows customers to place orders in advance for pick-up at participating locations, which aligns with evolving preferences for mobile ordering and contactless experiences. The app also facilitates access to card balances and loyalty benefits, reinforcing repeat visits and increasing the frequency of store visits by cardholders. These features collectively enhance customer convenience, digital interaction, and loyalty, supporting Starbucks' broader strategy to elevate the customer experience through technology.",
      "llm_answer": "Based on the 2022 10-K disclosures, Starbucks' integration of its Mobile App with the Starbucks Rewards loyalty program drives customer engagement and store visit frequency by enabling seamless mobile ordering and payment, which increases visit frequency through convenience and rewards. The document notes that registered Starbucks Card members are automatically enrolled in Rewards, allowing customers to earn Stars via the Mobile App for purchases, and that mobile ordering functionality lets customers place orders in advance for pickup, directly supporting higher store traffic and repeat visits.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the integration of the Mobile App with Starbucks Rewards, automatic enrollment of registered Starbucks Card members, earning Stars via the app, and Mobile Order and Pay functionality are all correctly identified as drivers of engagement and visit frequency. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no issues here. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how app functionality (mobile ordering, payment, rewards) connects to behavioral outcomes (higher store traffic, repeat visits). (4) The only minor omission is that the ground truth mentions earning Stars through multiple payment methods (cash, credit/debit cards, mobile wallets), which the LLM answer does not explicitly include. This contextual detail enriches the explanation of accessibility and inclusivity in rewards accrual, but its absence does not undermine the core correctness. Otherwise, the answer captures the key mechanisms and strategic intent. Semantic equivalence is strong, and the response is fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 342,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "What was the impact of PayPal's acquisition of Paidy, Inc. on the scope of its internal control over financial reporting audit in 2021, and by how much did Paidy's assets and revenues fall short of being included in that audit?",
      "original_answer": "PayPal's acquisition of Paidy, Inc. in October 2021 resulted in Paidy being excluded from PayPal's assessment and audit of internal control over financial reporting for the year ended December 31, 2021, as permitted by SEC guidance for the first year of acquisition. Paidy's total assets and revenues (excluding goodwill and intangibles) represented less than 1% of PayPal's consolidated totals, meaning they were below the 1% threshold for inclusion in the audit of internal controls.",
      "llm_answer": "The 2021 audit of PayPal’s internal control over financial reporting excluded Paidy, Inc. because it was acquired during the year; Paidy’s assets and revenues together accounted for less than 1 % of the consolidated totals, so they were not included in that audit. Consequently, Paidy’s assets and revenues fell short of the threshold needed to be incorporated into the audit scope.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It correctly states that Paidy, Inc. was excluded from PayPal's 2021 internal control over financial reporting audit due to its acquisition during the year, which aligns with SEC guidance. (2) The key quantitative claim—that Paidy’s assets and revenues represented less than 1% of PayPal’s consolidated totals—is accurately reflected; the format 'less than 1%' matches the ground truth exactly, and no calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly links the acquisition timing (October 2021) to the exclusion from the year-end audit and ties the <1% threshold to the decision for exclusion, demonstrating proper synthesis of acquisition timing, audit rules, and materiality thresholds. (4) The only minor omission is that the answer does not explicitly mention the exclusion of goodwill and intangibles when calculating Paidy’s contribution, which is in the original answer. However, this detail is contextually secondary and does not affect the core conclusion. All entities (PayPal, Paidy, Inc.), time period (2021), and financial concepts (internal control audit, consolidation thresholds) are accurate. Thus, the answer is highly accurate, complete, and relevant, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 391,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the volume/mix challenges in chocolate and refreshment beverages offset the benefits of pricing actions and cost controls to result in only 0.6% operating income growth for MDLZ's Latin America segment in 2024?",
      "original_answer": "MDLZ's Latin America segment faced significant volume/mix declines in chocolate and refreshment beverages, which directly countered the benefits from higher net pricing and lower manufacturing costs. Specifically, the unfavorable volume/mix, driven by consumer softness in Mexico and Argentina, reduced net revenues. Although net pricing increased by 7.0 percentage points due to input cost-driven pricing actions across categories — particularly in Argentina, Mexico, and Brazil — and manufacturing costs were reduced through productivity improvements, these gains were largely offset by the drop in sales volume. Additionally, higher raw material costs, unfavorable currency impacts, and increased advertising and promotion expenses further limited the positive effects of pricing and cost controls, resulting in only a $3 million (0.6%) increase in segment operating income for 2024.",
      "llm_answer": "The 0.6% operating‑income growth in MDLZ’s Latin America segment stems from a modest 7% rise in net pricing that helped offset a 2.4% decline in volume/mix and a 6% adverse currency impact; however, higher raw‑material costs, unfavorable volume/mix (especially in chocolate and refreshment beverages), and increased advertising and other expenses limited the upside, leaving only a slight net increase in segment operating income.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numeric values compared to the ground truth. The ground truth does not specify a '2.4% decline in volume/mix' or a '6% adverse currency impact' — these exact percentages are not present in the original answer and are therefore incorrect. The 7% rise in net pricing aligns with the ground truth's '7.0 percentage points' increase, which is acceptable as semantically equivalent. However, the ground truth emphasizes that the $3 million (0.6%) increase in operating income resulted from offsetting factors, while the LLM does not mention the absolute dollar change ($3M), weakening quantitative precision. (2) Calculations: The LLM implies a net effect from 7% pricing gain minus 2.4% volume/mix and 6% currency impact, but this arithmetic is speculative and not supported in the original — the ground truth does not break down impacts in percentage-point terms beyond pricing. Additionally, the original mentions 'higher raw material costs' and 'increased advertising and promotion expenses' as limiting factors, which the LLM captures qualitatively but without linking them to the final $3M outcome. (3) Multi-hop reasoning: The LLM correctly identifies the core tension — pricing gains offset by volume/mix and currency issues — and correctly attributes softness to chocolate and refreshment beverages, showing adequate synthesis across causes. However, it omits key contextual details like consumer softness in Mexico and Argentina, productivity-driven cost reductions, and the specific role of manufacturing cost controls, which are central to the original explanation. (4) The answer is contextually relevant and addresses the main question about why operating income growth was minimal. While the qualitative flow of reasoning is logical and partially accurate, the inclusion of unsupported numerical claims significantly undermines factual correctness, warranting a mid-range score of 5 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 533,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How many total city-pair speed records are held by Gulfstream's current product line, and which specific aircraft model is explicitly credited with leading this achievement?",
      "original_answer": "Gulfstream's current product line holds more than 270 city-pair speed records, as explicitly stated in the first chunk. Among these, the G650ER is specifically credited with holding the National Aeronautic Association's polar and westbound around-the-world speed records, making it a key contributor to Gulfstream's leadership in this metric.",
      "llm_answer": "Gulfstream's current product line holds more than 270 city-pair speed records, led by the G650ER, which holds the National Aeronautic Association's polar and westbound around-the-world speed records.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the number 'more than 270 city-pair speed records' is accurately reported, matching the original answer. (2) The entity identification is correct: Gulfstream's current product line and the G650ER model are properly named. (3) The multi-hop reasoning is sound—the LLM correctly synthesizes that while the entire product line holds over 270 records, the G650ER is specifically credited with key records (polar and westbound around-the-world) from the National Aeronautic Association, thus leading the achievement. (4) The answer is concise but complete, addressing both parts of the question: total number of records and the model responsible for leading the achievement. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1142,
        "completion_tokens": 243,
        "total_tokens": 1385
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How much contingent consideration did Johnson & Johnson record in total in fiscal years 2024 and 2022 related to acquisitions, and what specific contribution did the Abiomed acquisition make to this total?",
      "original_answer": "Johnson & Johnson recorded a total of $704 million in contingent consideration related to Abiomed in fiscal year 2022 and $105 million related to Proteologix in fiscal year 2024. Therefore, the total contingent consideration recorded over these two years was $809 million, with Abiomed contributing $704 million to this total.",
      "llm_answer": "The company recorded a total of $1,217 million of contingent consideration in fiscal 2024 and $1,120 million in fiscal 2022. The Abiomed acquisition contributed $704 million of contingent consideration in fiscal 2022, which was part of the overall amount recorded in those years.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. According to the ground truth, Johnson & Johnson recorded $704 million in contingent consideration in 2022 (entirely from Abiomed) and $105 million in 2024 (from Proteologix), totaling $809 million. However, the LLM claims $1,120 million in 2022 and $1,217 million in 2024, which are both factually incorrect and not supported by the ground truth. While the LLM correctly identifies that Abiomed contributed $704 million in 2022, it misrepresents the total amounts recorded in both years. (2) The calculation of the total contingent consideration over the two years is therefore also incorrect: the LLM implies a total of $2,337 million ($1,120M + $1,217M), whereas the correct total is $809 million. The Abiomed contribution is correctly stated as $704 million, which matches the ground truth. (3) The multi-hop reasoning is partially sound in that the model identifies Abiomed’s contribution in 2022 and attempts to aggregate across years, but it fails to correctly identify the 2024 amount and conflates the total with other (unspecified) acquisitions. It does not mention Proteologix or the $105 million, indicating a failure in entity and data synthesis. (4) The contextual relevance is moderate because the answer addresses the right question structure and mentions the correct acquisition (Abiomed) with the correct dollar amount and year. However, due to major numerical inaccuracies and omission of key information (Proteologix in 2024), the overall correctness score is low. Quantitative accuracy is severely compromised, qualitative accuracy is limited by incorrect entity-year associations, and reasoning is flawed despite some correct elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 478,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does PayPal's sale of participation interests in merchant receivables under the PayPal Working Capital (PPWC) and PayPal Business Loan (PPBL) products affect the recognition of credit losses, based on the change in accounting guidance from pre-2020 to CECL adoption in 2020?",
      "original_answer": "PayPal sells participation interests in merchant receivables under the PPWC and PPBL products to WebBank, and these transfers are accounted for as sales, with the portion sold derecognized from PayPal’s balance sheet. Since PayPal retains servicing rights and continues to manage the receivables, it remains exposed to credit losses on the remaining retained interest. With the adoption of CECL in 2020, PayPal transitioned from the previous incurred loss model to an expected credit loss model. This change required PayPal to record a reserve build based on current expected credit losses for both consumer and merchant receivables, rather than waiting for a loss to be incurred. As a result, PayPal's credit loss provisioning became more forward-looking and sensitive to economic forecasts, directly impacting the allowance for credit losses on the retained portion of receivables after participation interests were sold.",
      "llm_answer": "Based on the document, prior to 2020, credit losses for merchant receivables under PPWC and PPBL were recognized using a percentage-of-completion method, which relied on historical loss rates and did not incorporate forward-looking macroeconomic assumptions. Following CECL adoption in 2020, credit losses are now measured using current expected credit losses (CECL), which requires the Company to estimate lifetime credit losses over the life of the receivables by applying loss curves to segments of the portfolio (e.g., by geography, delinquency, vintage) and incorporating macroeconomic forecasts (e.g., unemployment trends). This change resulted in a significant reduction in reported credit losses—$699 million decrease in 2021 compared to 2020—reflecting the impact of the new guidance. The allowance for credit losses now includes qualitative adjustments and forward-looking estimates, replacing the older roll-rate-based approach used pre-2020.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and introduces unsupported claims not present in the ground truth. While it correctly identifies the shift from an incurred loss model to CECL in 2020 and mentions forward-looking estimates and macroeconomic forecasts, it incorrectly describes the pre-2020 method as a 'percentage-of-completion method'—a term not used in the original answer and not accurate in this context. The original answer refers to a general 'incurred loss model,' not percentage-of-completion, which is typically used in revenue recognition, not credit loss estimation. (2) The most significant quantitative error is the claim of a '$699 million decrease in reported credit losses in 2021 compared to 2020.' This figure is not mentioned in the ground truth and cannot be verified from the provided information. There is no reference to actual loss amounts or year-over-year changes in the original answer, making this a fabricated or misattributed number. This severely undermines quantitative accuracy. (3) The reasoning partially captures the multi-hop nature of the question—linking CECL adoption to changes in credit loss recognition on retained interests—but fails to emphasize key structural elements: the sale of participation interests to WebBank, derecognition of sold portions, and continued exposure on retained interests due to servicing. These are central to the original answer but missing or underdeveloped in the LLM response. (4) Despite these issues, the LLM answer does reflect a plausible understanding of CECL’s impact—using loss curves, segmentation, and macroeconomic inputs—which aligns with broader accounting guidance. It is contextually relevant and captures the directional change in provisioning philosophy. However, due to the incorrect pre-2020 characterization and the unsupported $699M figure, the correctness score is limited to 5—partially correct but with significant factual and quantitative flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 531,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did the performance of the cheese & grocery product category contribute to the overall unfavorable volume/mix impact on Latin America segment net revenues in 2024, and what was the resulting effect on segment operating income?",
      "original_answer": "The cheese & grocery product category was among those that experienced volume declines in the Latin America segment during 2024, contributing to the overall unfavorable volume/mix impact of 2.4 percentage points on net revenues. This decline, along with volume decreases in chocolate, candy, and refreshment beverages, partially offset gains in biscuits & baked snacks and gum. The unfavorable volume/mix, combined with other factors, contributed to only a $3 million (0.6%) increase in segment operating income despite higher net pricing and cost-saving measures.",
      "llm_answer": "The cheese & grocery category’s volume/mix was unfavorable in Latin America, contributing to the overall volume/mix drag on segment net revenues. This unfavorable mix, driven by declines in cheese & grocery sales, was offset in part by gains in other categories but still pressured overall segment performance. Consequently, segment operating income rose modestly by $3 million (0.6%) in 2024, largely due to higher net pricing and cost efficiencies that mitigated the negative impact of the cheese & grocery volume/mix decline.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) All key facts are correct: the cheese & grocery category contributed to an unfavorable volume/mix impact in Latin America in 2024, segment operating income increased by $3 million (0.6%), and this modest growth was supported by pricing and cost efficiencies. (2) Quantitative accuracy is perfect: the $3 million and 0.6% figures are correctly reported, and while the LLM does not explicitly state the 2.4 percentage point drag on net revenues, this specific number is not directly tied to cheese & grocery alone in the original answer—rather, it's the overall segment impact to which cheese & grocery contributed. Thus, omission of 2.4 pp is not a factual error in context. (3) Multi-hop reasoning is sound: the model correctly links the category-level decline to segment-level revenue and income effects, acknowledges offsetting factors (gains in other categories), and identifies mitigating drivers (pricing, cost savings). (4) The answer is contextually relevant and semantically equivalent to the original, with only minor omission of the explicit mention that chocolate, candy, and refreshment beverages also declined. However, the core contribution of cheese & grocery and its downstream impact are accurately captured, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 373,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the total redemption value of both the Telco Class A-4 preferred interests and the Mobility noncontrolling interests, and how does this combined obligation affect AT&T's cash flow commitments through 2028?",
      "original_answer": "The total redemption value of the Telco Class A-4 preferred interests is $2,250 million, and the Mobility noncontrolling interests have a redemption value of $2,000 million, resulting in a combined redemption obligation of $4,250 million. This combined obligation represents a material cash flow commitment for AT&T, particularly starting in 2028 when both instruments become eligible for redemption—Telco Class A-4 interests can be called beginning November 1, 2028, and the Mobility noncontrolling interests may be redeemed by the company or put by holders beginning March 15 and June 15, 2028, respectively. The redemption payments must be made in cash, which will directly impact AT&T’s liquidity position in that period.",
      "llm_answer": "The combined redemption value of the Telco Class A‑4 preferred interests and the Mobility noncontrolling interests is $2,250 million plus $2,000 million, for a total of $4,250 million.  This obligation represents a cash‑out requirement that AT&T must meet by 2028, tying up cash that would otherwise be available for other uses and therefore constrains the company’s cash‑flow flexibility through the end of 2028.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies the redemption values: $2,250 million for Telco Class A-4 preferred interests and $2,000 million for Mobility noncontrolling interests, totaling $4,250 million—this matches the ground truth exactly. The calculation is accurate and properly formatted. 2) Quantitatively, all numbers are correct, including the sum. 3) The reasoning is mostly sound, but the LLM answer lacks specific details about the timing and mechanics of the redemption triggers. The original answer specifies that Telco Class A-4 can be called beginning November 1, 2028, and Mobility interests may be redeemed or put by holders on March 15 and June 15, 2028—this granular timing is omitted in the LLM response. While it correctly notes the impact on cash flow by 2028, it generalizes the timing as 'by 2028' and 'through the end of 2028,' which is less precise than the original. 4) The answer is contextually relevant and captures the core financial obligation and its impact on liquidity and cash flow flexibility. However, the omission of exact redemption dates and the specific call/put mechanics reduces the qualitative accuracy slightly, as these details are key to understanding the nature of the commitment. Overall, the answer is factually correct and complete in magnitude and general implication but lacks some critical temporal specificity required for full multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 384,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the total revenue generated from the Orthopaedics segment in 2024, and how does it compare to the combined revenue from Hips and Knees within the same segment?",
      "original_answer": "The Orthopaedics segment generated $9,158 million in revenue in 2024. The combined revenue from Hips ($1,638 million) and Knees ($1,545 million) amounts to $3,183 million. This means that Hips and Knees together represent approximately 34.76% of the total Orthopaedics revenue.",
      "llm_answer": "The Orthopaedics segment generated $9.158 billion in revenue in 2024. Within that segment, sales from Hips were $1.638 billion and from Knees were $1.545 billion, together accounting for roughly 34% of the Orthopaedics total.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial figures: total Orthopaedics revenue ($9.158 billion = $9,158 million), Hips revenue ($1.638 billion = $1,638 million), and Knees revenue ($1.545 billion = $1,545 million). These match the ground truth exactly, allowing for format variation (billion vs million). The combined Hips and Knees revenue is correctly implied as $3.183 billion. (2) The percentage given is 'roughly 34%', while the exact calculated value from the ground truth is 34.76%. This is a minor rounding/downsimplification but still reasonably accurate; however, it falls slightly short of full precision. The calculation itself is sound: ($1,638 + $1,545) / $9,158 = $3,183 / $9,158 ≈ 34.76%. (3) Multi-hop reasoning is correctly applied: the model synthesizes segment-level revenue with sub-segment (Hips and Knees) data and computes a proportional relationship, addressing both parts of the question. (4) All entities (Orthopaedics segment, Hips, Knees, 2024) are accurate and correctly related. The answer is contextually complete and relevant. The only deduction is for the slightly imprecise percentage, hence a 9/10 on correctness and quantitative accuracy. Qualitative reasoning and contextual relevance are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1130,
        "completion_tokens": 354,
        "total_tokens": 1484
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the 2019 Incentive Plan's proportional adjustment mechanism impact the number of RSU shares available after the 2024 special dividend, and which filings formally document this adjustment?",
      "original_answer": "The 2019 Incentive Plan required a proportional adjustment to outstanding RSUs and the total shares available under the plan following the 2024 special dividend. As a result of this adjustment, the number of outstanding RSUs increased by approximately 52,000, and an additional 128,000 RSU shares became available to be granted. This adjustment was based on a factor of 1.018, derived from the ratio of the Nasdaq closing price of $674.62 on December 26, 2023, to the opening price of $662.70 on the ex-dividend date, December 27, 2023. The 2019 Incentive Plan itself, filed as Exhibit 10.2 in the DEF 14 filing on December 17, 2019, formally documents the requirement for these adjustments.",
      "llm_answer": "The 2019 Incentive Plan’s proportional adjustment mechanism increased the maximum number of RSU shares available by approximately 128,000 after the 2024 special dividend, as required to preserve the awards’ value and maintain the plan’s aggregate share limit. This adjustment was formally documented in the 2019 Incentive Plan filing (Exhibit 10.2) and referenced in the \"Note 7 – Stock-Based Compensation\" section of the 2023 10-K (page 55).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 128,000 increase in RSU shares available due to the proportional adjustment mechanism in the 2019 Incentive Plan following the 2024 special dividend, which matches the ground truth. However, it omits the 52,000 increase in outstanding RSUs, which is a significant part of the impact and required for full completeness. The adjustment factor of 1.018 and the underlying price data ($674.62 and $662.70) are not mentioned, which are key quantitative details from the ground truth. (2) The number 128,000 is accurate and correctly attributed. The omission of the 52,000 increase in outstanding RSUs reduces quantitative completeness. The absence of the calculation basis (price ratio) affects full quantitative transparency, though the core number provided is correct. (3) The LLM correctly references the 2019 Incentive Plan (Exhibit 10.2) as the formal document, which is accurate. It adds a reference to 'Note 7 – Stock-Based Compensation' in the 2023 10-K, which is plausible and contextually relevant, though not mentioned in the ground truth. The reasoning around preserving award value and maintaining the aggregate limit aligns with the plan’s intent and shows sound qualitative understanding. (4) The answer is highly relevant and addresses the core of the question—impact on RSU shares and documentation. The omission of the outstanding RSU increase and pricing rationale prevents a top score, but the response is factually sound where it provides information. Thus, correctness is high but not complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 428,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the expected financial and technological impact of Intel 4's transition to high-volume manufacturing in Ireland in 2024 on Intel's 2025 product portfolio, particularly in relation to the performance improvements and production shifts involving Intel 3 and Intel 18A?",
      "original_answer": "The transition of Intel 4 to high-volume manufacturing in Ireland in 2024 is expected to significantly increase its share of Intel's processor production in 2025, given that it already began shipping the Intel Core Ultra processor in 2023 with a 20% performance-per-watt improvement over Intel 7. This shift complements the movement of Intel 3's high-volume manufacturing from Oregon to Ireland in 2025, which powers Intel's Xeon 6 Scalable server processors and offers up to an 18% performance-per-watt improvement over Intel 4. Furthermore, this manufacturing realignment supports the upcoming high-volume production of Panther Lake, the first processors on Intel 18A, in 2025. Intel 18A introduces breakthrough technologies like gate-all-around transistors (RibbonFET) and backside power delivery (PowerVia), which are expected to deliver improvements in performance per watt and density scaling over Intel 3. Therefore, the combined effect of Intel 4's ramp-up and Intel 3's relocation sets the stage for Intel 18A's introduction, enhancing both client and data center product lines in 2025.",
      "llm_answer": "Intel 4’s 2024 move to high‑volume manufacturing in Ireland will increasingly supply the 2025 product mix, while Intel 3’s shift to Ireland in 2025 will feed the data‑center Xeon 6 line and provide the performance‑per‑watt gains that underpin the upcoming Panther Lake chips on Intel 18A. Consequently, Intel 3 and Intel 4 will continue to drive density and efficiency improvements that feed into the next‑generation Intel 18A node, enabling higher‑performance, lower‑power products across Intel’s 2025 portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key technological and production transitions—Intel 4 ramping in Ireland in 2024, Intel 3 shifting to Ireland in 2025 to support Xeon 6, and the role of these nodes in enabling Intel 18A for Panther Lake in 2025. However, it omits specific quantitative performance improvements cited in the ground truth: the 20% performance-per-watt gain of Intel 4 over Intel 7 and the 18% improvement of Intel 3 over Intel 4. These omissions affect quantitative accuracy but do not distort the overall narrative. (2) No incorrect numbers are stated, but the absence of the two key percentages (20% and 18%) means the answer lacks critical data points required for full factual completeness. Calculations are not required in this case, so no errors there. (3) The multi-hop reasoning is sound: the model correctly links Intel 4’s ramp to 2025 product mix, Intel 3’s relocation to data center products, and the enabling of Intel 18A with advanced technologies like RibbonFET and PowerVia (though these are not explicitly named, their effects—density and efficiency—are mentioned). The synthesis across manufacturing shifts and product timelines is logically coherent. (4) The answer is contextually highly relevant, addressing all core aspects of the question—financial/technological impact, product portfolio implications, and inter-node production shifts. The omission of specific metrics prevents a top score in correctness and quantitative accuracy, but the qualitative reasoning and contextual alignment remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 429,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "What was the difference in the book value of AT&T's investment in DIRECTV between December 31, 2024, and December 31, 2023, and how does this compare with the timing of AT&T's deconsolidation of Gigapower in May 2023?",
      "original_answer": "The book value of AT&T's investment in DIRECTV dropped from $877 million at December 31, 2023, to $0 at December 31, 2024, a decrease of $877 million. This reduction reflects the cumulative cash receipts from DIRECTV exceeding AT&T's initial investment balance plus its cumulative equity in DIRECTV earnings, which led to the investment being reduced to zero on the consolidated balance sheet beginning in Q3 2024. In comparison, AT&T's deconsolidation of Gigapower occurred earlier, on May 12, 2023, after acquiring a 50% interest in the joint venture through a transaction with BlackRock. Both events reflect changes in AT&T's equity investments, but the DIRECTV investment was fully liquidated by the end of 2024, whereas Gigapower continues to be accounted for as an equity method investment.",
      "llm_answer": "The book value of AT&T's investment in DIRECTV fell from $877 million at December 31 2023 to $0 million at December 31 2024—a decline of $877 million. This deconsolidation occurred after AT&T had already deconsolidated Gigapower in May 2023, when it shifted Gigapower to an equity‑method investment.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the book value of AT&T's investment in DIRECTV decreasing from $877 million on December 31, 2023, to $0 on December 31, 2024, resulting in a $877 million decrease—this matches the ground truth exactly. All numeric values, dates, and calculations are accurate. (2) Quantitative accuracy is perfect: the dollar amounts and timing (December 31, 2023 and 2024) are correct, and the difference is accurately implied. (3) However, the qualitative reasoning contains a significant error: the LLM states that the DIRECTV deconsolidation occurred *after* Gigapower’s deconsolidation in May 2023, which is misleading. In reality, DIRECTV was not deconsolidated in the same way—its investment value was reduced to zero due to cumulative cash receipts exceeding the carrying amount under the equity method, not a formal deconsolidation event. Furthermore, the original answer clarifies that DIRECTV’s investment was reduced to zero beginning in Q3 2024, which the LLM omits. Also, the term 'deconsolidation' is incorrectly applied to DIRECTV; the correct term is 'reduction to zero under equity method accounting.' In contrast, Gigapower was indeed deconsolidated in May 2023 and moved to equity-method accounting, which the LLM correctly notes. (4) The contextual relevance is high because the answer addresses both parts of the question and compares the timing, but the mischaracterization of the DIRECTV event as a 'deconsolidation' undermines the reasoning. Thus, while numbers are perfect, the conceptual and multi-hop synthesis is partially flawed, warranting a 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 444,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How much revenue did Shockwave contribute to Johnson & Johnson's Cardiovascular segment in 2024, and in what way is Shockwave reflected in Johnson & Johnson's human capital reporting?",
      "original_answer": "Shockwave contributed $564 million in revenue to Johnson & Johnson's Cardiovascular segment in 2024. Additionally, Shockwave is included in Johnson & Johnson's 2024 headcount reporting, indicating that its employees are incorporated into the company's overall human capital metrics.",
      "llm_answer": "Shockwave contributed $564 million in sales to Johnson & Johnson’s MedTech segment in 2024, and it is reflected in the company’s human‑capital reporting as part of the “MedTech” workforce and talent‑development metrics (e.g., included in the total employee headcount and highlighted in the “Growth and development” section).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $564 million revenue contribution from Shockwave in 2024, matching the ground truth in amount and year. However, it incorrectly assigns this revenue to Johnson & Johnson’s 'MedTech' segment instead of the 'Cardiovascular' segment as specified in the original answer. This is a significant entity error affecting the qualitative accuracy. (2) The quantitative accuracy is perfect—$564 million is correctly reported with acceptable formatting (e.g., 'million' vs 'M'). (3) The multi-hop reasoning is partially sound: the model correctly links Shockwave to J&J’s human capital reporting and notes inclusion in headcount and talent development metrics, which aligns with the ground truth. However, the original answer does not specify that Shockwave is mentioned in the 'Growth and development' section or explicitly tied to 'MedTech' workforce metrics, introducing unsupported detail. (4) The contextual relevance is high because the answer addresses both parts of the question with relevant details, but the segment misclassification and added specifics reduce factual precision. Correctness score is 7 due to correct numbers and partial entity accuracy, but docked for key misassignment of business segment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 352,
        "total_tokens": 1513
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "Cisco's AppDynamics offerings declined in fiscal 2022. Given this decline, which specific offerings contributed to the 11% growth in the Optimized Application Experiences category, and by how much did the category increase in dollar terms?",
      "original_answer": "Despite the decline in Cisco's AppDynamics offerings, the Optimized Application Experiences category grew by 11%, or $75 million, driven by growth in the company's ThousandEyes and Intersight offerings.",
      "llm_answer": "The Optimized Application Experiences category grew 11% in fiscal 2022, driven by growth in ThousandEyes and Intersight offerings, while AppDynamics declined. This contributed to a $75 million increase in the category’s revenue.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: the Optimized Application Experiences category grew by 11%, which corresponds to a $75 million increase in dollar terms, and this growth was driven by ThousandEyes and Intersight offerings despite a decline in AppDynamics. (2) Quantitatively, both the percentage (11%) and dollar amount ($75 million) are correct and match the original answer exactly; no calculations are required beyond what is stated, and the values are presented accurately. (3) The multi-hop reasoning is sound: the model correctly identifies the contrast between AppDynamics' decline and the overall category growth, attributes the growth to the correct offerings (ThousandEyes and Intersight), and provides both the rate and absolute increase. (4) Entities—product names (ThousandEyes, Intersight, AppDynamics), category name (Optimized Application Experiences), fiscal year (implied 2022), and financial metrics—are all correctly identified and used. The answer is concise, relevant, and complete, addressing both sub-questions: which offerings drove growth and the dollar increase.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1130,
        "completion_tokens": 332,
        "total_tokens": 1462
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How much did AT&T pay in total to repurchase the Mobility preferred interests in April 2023, including accrued and unpaid distributions, and how does this redemption impact the noncontrolling interest classification on the consolidated balance sheets?",
      "original_answer": "AT&T paid $5,414 million in total to repurchase the Mobility preferred interests in April 2023, including accrued and unpaid distributions. This redemption removed the Mobility preferred interests from the 'Noncontrolling interest' classification on the consolidated balance sheets, as these interests were no longer outstanding after the repurchase.",
      "llm_answer": "AT&T paid $5,414 million in total to repurchase all of its Mobility preferred interests in April 2023, which included $5,340 million of redemption value plus accrued and unpaid distributions. This redemption eliminated the noncontrolling interest related to the Mobility preferred interests, reducing the noncontrolling‑interest balance on the consolidated balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that AT&T paid $5,414 million in total to repurchase the Mobility preferred interests in April 2023, matching the ground truth. It further breaks this down into $5,340 million of redemption value plus accrued and unpaid distributions, which aligns with the total and shows additional accurate detail not in the original answer but consistent with it. The impact on noncontrolling interest is accurately described as eliminating or reducing the balance on the consolidated balance sheet, which is semantically equivalent to stating the interests were removed from the 'Noncontrolling interest' classification. (2) All numeric values—$5,414 million total and $5,340 million base redemption—are correct and properly contextualized. The date (April 2023) is accurate. (3) The multi-hop reasoning is sound: the model connects the repurchase event to its financial impact on the balance sheet classification of noncontrolling interest, correctly inferring that redemption leads to removal of the related noncontrolling interest. (4) The only minor shortcoming is that the LLM does not explicitly state that the preferred interests were 'no longer outstanding,' which is a small nuance in completeness, but the elimination of the noncontrolling interest conveys the same practical outcome. Thus, the answer is factually complete and highly accurate with excellent contextual and quantitative precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 399,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What was the year-over-year revenue growth percentage specifically for the Abiomed business unit after its acquisition by Johnson & Johnson in 2022, and how does this compare to the overall growth in the Cardiovascular segment?",
      "original_answer": "The Abiomed business unit experienced a year-over-year revenue growth of 14.5% from 2023 to 2024, increasing from $1.306 billion to $1.496 billion. This growth contributed to the overall Cardiovascular segment, which saw a 21.4% increase in revenue, rising from $6.350 billion in 2023 to $7.707 billion in 2024. Therefore, Abiomed's growth was a significant but slightly lower-performing component compared to the broader Cardiovascular segment's growth.",
      "llm_answer": "The Abiomed business unit, acquired by Johnson & Johnson in December 2022, contributed $1.5 billion of revenue in 2024, reflecting a 14.5 % year‑over‑year increase (the document notes “Abiomed $1,496 | $1,306 | 14.5 %”). This growth outpaced the overall Cardiovascular segment, which posted a 21.4 % increase in sales for the same period (up 22.8 % on an operational basis).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the year-over-year revenue growth for Abiomed as 14.5%, increasing from $1.306 billion to $1.496 billion, which matches the ground truth. The Cardiovascular segment's overall growth is correctly stated as 21.4%, aligning with the original answer. However, the LLM introduces a discrepancy by stating that the Cardiovascular segment's growth was '22.8% on an operational basis,' a detail not present in the ground truth and potentially confusing or misleading in direct comparison. (2) All key numbers—Abiomed’s revenue figures ($1.306B to $1.496B), 14.5% growth, and the segment’s 21.4% growth—are quantitatively accurate. The $1.5 billion figure is a rounded version of $1.496 billion, which is acceptable. (3) The multi-hop reasoning is mostly sound: the model correctly links Abiomed’s post-acquisition performance to the broader Cardiovascular segment. However, the claim that Abiomed’s growth 'outpaced' the segment is factually incorrect—the original answer states Abiomed’s growth was 'slightly lower-performing' compared to the segment’s 21.4%. This misrepresents the comparison and reflects a logical error in reasoning. (4) Despite this, the answer is highly relevant and addresses both parts of the question: Abiomed’s growth and its comparison to the Cardiovascular segment. The inclusion of an unsupported operational growth rate slightly undermines qualitative accuracy, but core facts and synthesis remain strong. Correctness score is 8 due to accurate data but flawed comparative logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 425,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How many amendments to the Lowe's Companies Benefit Restoration Plan are listed in the exhibits, and what is the date of the most recent amendment referenced in the 2022 10-K filing?",
      "original_answer": "There are seven amendments to the Lowe's Companies Benefit Restoration Plan listed in the exhibits, and the most recent amendment referenced in the 2022 10-K filing is dated April 4, 2017 (Amendment No. 7).",
      "llm_answer": "The Lowe's Companies Benefit Restoration Plan has 7 amendments listed in the exhibits (Amendments Nos. 1 through 7). The most recent amendment referenced in the 2022 10-K filing is Amendment No. 7, which was filed on April 4, 2017.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately states that there are seven amendments to the Lowe's Companies Benefit Restoration Plan listed in the exhibits, which aligns with the ground truth. (2) The date of the most recent amendment, April 4, 2017, is correctly identified and associated with Amendment No. 7. All numeric and date information is factually accurate, with no calculation errors. (3) The reasoning is sound and demonstrates proper synthesis of information from the 2022 10-K filing and exhibit disclosures, correctly identifying the full set of amendments and the latest one. (4) The answer is semantically equivalent to the original answer, using slightly different phrasing but conveying the same precise information. All aspects of the multi-part question are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1118,
        "completion_tokens": 249,
        "total_tokens": 1367
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How much of the $2.4 billion CECL transition amount had Capital One Financial Corporation phased into its regulatory capital by January 1, 2024, and what percentage of CET1 capital requirement must the company maintain under the Stress Capital Buffer framework effective October 1, 2024?",
      "original_answer": "Capital One Financial Corporation had phased in 75% of the $2.4 billion CECL transition amount, which equals $1.8 billion, into its regulatory capital by January 1, 2024. Under the Stress Capital Buffer framework effective October 1, 2024, the company must maintain a CET1 capital ratio of at least 10.0%.",
      "llm_answer": "As of January 1 2024, Capital One had phased in 75 % of the $2.4 billion CECL transition amount, i.e., $1.8 billion, into its regulatory capital. Under the Stress Capital Buffer framework effective October 1 2024, the company must maintain CET1 capital equal to at least 10.0 % of risk‑weighted assets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the 75% phase-in of the $2.4 billion CECL transition amount is correctly calculated as $1.8 billion, and the date (January 1, 2024) is properly referenced. The Stress Capital Buffer requirement of 10.0% CET1 capital ratio effective October 1, 2024, is accurately stated. (2) Quantitative accuracy is perfect: 75% of $2.4 billion = $1.8 billion is correct, and the 10.0% CET1 requirement matches the ground truth. Minor formatting differences (e.g., spacing in '75 %' or '$2.4 billion') do not affect meaning or correctness. (3) Multi-hop reasoning is sound—the answer synthesizes information about regulatory capital phase-in and future buffer requirements across timeframes and frameworks (CECL and Stress Capital Buffer), correctly attributing each to Capital One Financial Corporation. (4) The phrasing 'CET1 capital equal to at least 10.0 % of risk-weighted assets' is a precise and standard way to express the CET1 capital requirement, fully equivalent to stating the company 'must maintain a CET1 capital ratio of at least 10.0%.' All components of the multi-part question are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 346,
        "total_tokens": 1533
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How does Disney's use of time-based vesting Restricted Stock Unit Award Agreements compare to its use of performance-based vesting agreements in aligning executive compensation with long-term shareholder value creation?",
      "original_answer": "Disney utilizes both time-based vesting Restricted Stock Unit Award Agreements and multiple variations of performance-based vesting agreements. The time-based vesting agreements (listed in exhibits 10.43, 10.49, and 10.54) provide a standard approach where equity compensation vests over time, typically helping retain talent. In contrast, Disney employs at least six distinct forms of performance-based Restricted Stock Unit Award Agreements (listed in exhibits 10.44-10.48, 10.55, 10.57-10.59) that tie vesting to metrics like Total Shareholder Return (TSR) and Return on Invested Capital (ROIC), ensuring executive compensation is more directly aligned with company performance and shareholder value creation.",
      "llm_answer": "Disney’s executive compensation strategy uses both time‑based and performance‑based Restricted Stock Unit (RSU) agreements to align pay with long‑term shareholder value, but they differ in how vesting is triggered. Time‑based RSUs (e.g., Exhibit 10.43) vest solely over a fixed schedule, providing a steady equity stake regardless of company performance, while performance‑based RSUs (e.g., Exhibits 10.44, 10.46, 10.47, 10.57) tie portions of the award to measurable outcomes such as Total Shareholder Return, ROIC, or Section 162(m) earnings targets, thereby linking payouts more directly to sustained shareholder value creation. This dual‑approach balances guaranteed equity participation with performance‑driven incentives that encourage executives to focus on Disney’s strategic, long‑term growth objectives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies Disney's use of both time-based and performance-based RSU agreements and their respective roles in executive compensation. The exhibits cited (e.g., 10.43 for time-based; 10.44, 10.46, 10.47, 10.57 for performance-based) are accurate subsets of those listed in the original answer, though it does not list all performance-based exhibits (e.g., 10.45, 10.48, 10.55, 10.58, 10.59), which slightly reduces completeness but does not affect factual correctness. (2) There are no numerical values requiring calculation, but the qualitative metrics—Total Shareholder Return (TSR) and ROIC—are correctly identified as performance conditions. No dollar amounts, dates, or percentages are misstated. (3) The multi-hop reasoning is sound: the model correctly synthesizes that time-based vesting supports retention while performance-based vesting aligns with shareholder value creation through performance metrics. It draws a valid comparative conclusion about alignment with long-term strategic goals. (4) The answer is contextually excellent—directly addressing how each type of RSU aligns with shareholder value creation. The only minor shortcoming is the incomplete enumeration of exhibit numbers for performance-based agreements, but the examples given are valid and representative. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 420,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the revenue growth of Hips and Knees products contribute to the overall growth of the Orthopaedics segment in 2024 compared to 2023?",
      "original_answer": "The Orthopaedics segment grew by $216 million (2.4%) in 2024 compared to 2023. Within this segment, the Hips product line increased by $78 million (5.0%) and the Knees product line increased by $89 million (6.1%). Combined, the Hips and Knees products contributed $167 million in revenue growth, accounting for approximately 77% of the total growth in the Orthopaedics segment. This indicates that the performance of Hips and Knees products was a significant driver of the segment's overall growth.",
      "llm_answer": "In 2024, the Orthopaedics segment grew 2.4% overall, with Hips sales up 5.0% and Knees sales up 6.1% year‑over‑year. These double‑digit gains in the Hips and Knees product lines were the primary drivers of the segment’s modest revenue growth compared with 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the percentage growth for the Orthopaedics segment (2.4%), Hips (5.0%), and Knees (6.1%), which matches the ground truth. However, it omits the actual dollar amount increases ($78M for Hips, $89M for Knees) and the combined contribution of $167M, which accounts for 77% of the total segment growth. These quantitative omissions reduce completeness. (2) While percentages are accurate, the claim of 'double-digit gains' is factually incorrect—5.0% and 6.1% are single-digit growth rates. This is a significant error in quantitative characterization, though the underlying percentages are correct. (3) The reasoning correctly identifies Hips and Knees as primary drivers of growth, aligning with the ground truth's conclusion. However, the omission of the $167M contribution and the 77% attribution means the multi-hop synthesis (linking product-line growth to segment-level impact) is incomplete. (4) The answer is contextually relevant and addresses the core question about contribution to growth, but lacks key financial figures and contains a misleading descriptor ('double-digit gains'). Thus, while the directional logic is sound, the answer falls short on full factual accuracy and completeness, warranting a score of 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 361,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How much of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule was phased in by January 1, 2024, and how does this optional transition relief specifically work according to the rule's description?",
      "original_answer": "Capital One phased in 75% of the $2.4 billion regulatory capital addition under the CECL Transition Rule by January 1, 2024, which amounts to $1.8 billion. The remaining $600 million was phased in on January 1, 2025. This optional five-year transition period was provided by the Federal Banking Agencies to allow banking institutions to gradually incorporate the impact of the CECL standard on their regulatory capital.",
      "llm_answer": "Capital One phased in 75% of its $2.4 billion CECL Transition Rule capital addition by January 1, 2024, with the remaining 25% scheduled to be phased in on January 1, 2025. The optional transition relief allows banks to delay the estimated impact of adopting CECL on regulatory capital and then phase it in at 25% per year over five years, so the $2.4 billion was added back to regulatory capital and 75% of that amount ($1.8 billion) was recognized as phased‑in capital by early 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, it accurately states that 75% of the $2.4 billion ($1.8 billion) was phased in by January 1, 2024, and the remaining 25% ($600 million) was scheduled for January 1, 2025—both percentages and dollar amounts are correct, with acceptable formatting (e.g., $2.4 billion). (2) The explanation of the CECL Transition Rule is accurate: the optional relief allows banks to phase in the capital impact over five years at 25% per year, which aligns with the rule's description. (3) The multi-hop reasoning is sound—synthesizing the phase-in schedule, the specific amount Capital One added, and how the transition rule works across time. (4) All entities (Capital One, CECL Transition Rule, regulatory capital) are correctly identified and contextualized. The answer is semantically equivalent to the original, with clear, concise, and factually precise language. No errors or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 280,
        "total_tokens": 1527
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the issuance and partial repayment of the Guaranteed Senior Notes by Costco's Japanese subsidiary in 2023 and 2024, respectively, affect the company's overall long-term debt fair value and financing activities during that period?",
      "original_answer": "The issuance of four Guaranteed Senior Notes totaling approximately $500 by Costco's Japanese subsidiary in November 2023 increased the company's long-term debt. However, in July 2024, the subsidiary repaid $77 of these notes, reducing the outstanding amount. As a result, the fair value of Costco's long-term debt decreased from $5,738 at the end of 2023 to $5,412 at the end of 2024. Additionally, the financing activities section shows that the issuance of these notes contributed to the $10,764 net cash used in financing activities during 2024, which also included the repayment of $1,000 in principal on the 2.750% Senior Notes.",
      "llm_answer": "The issuance of $500 million of Guaranteed Senior Notes by Costco’s Japanese subsidiary in 2023 increased the company’s long‑term debt and its fair‑value measurement (using Level 3 inputs), while the subsequent repayment of $77 million of those notes in July 2024 reduced the outstanding debt. Both actions are reflected in the financing‑activities cash‑flow section, which shows a $10.8 billion net cash used in financing in 2024 (largely driven by debt repayments and dividend payments), and in the long‑term‑debt table that lists the fair value of the Japanese‑subsidiary notes as part of the total $5.9 billion long‑term debt. Consequently, the debt issuance expanded the company’s long‑term‑debt balance and fair value, and the partial repayment lowered that balance and the associated financing‑cash outflow.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and fails to correctly report key financial figures. While it correctly identifies the $500 million issuance and $77 million repayment by Costco's Japanese subsidiary, it incorrectly states the total long-term debt fair value as $5.9 billion, whereas the ground truth specifies the fair value decreased from $5,738 million (end of 2023) to $5,412 million (end of 2024). The LLM also reports $10.8 billion net cash used in financing, which is close to the correct $10,764 million but rounds imprecisely and attributes it broadly to 'debt repayments and dividend payments' without mentioning the specific $1,000 million repayment of the 2.750% Senior Notes, a key detail in the original answer. (2) The dates (November 2023 issuance, July 2024 repayment) are correctly implied, but the LLM does not specify the November 2023 timing. The $500 million and $77 million amounts are accurate. However, the final fair value of long-term debt is wrong: $5.9 billion vs. $5,412 million ($5.412 billion), a significant $488 million discrepancy. The net cash used in financing is reported as $10.8 billion ($10,800 million), which is close to $10,764 million but not exact. (3) The reasoning is partially sound—correctly linking issuance to increased debt and repayment to reduced debt and cash outflows—but fails in multi-hop synthesis by not connecting the Japanese subsidiary's actions to the overall change in Costco’s consolidated long-term debt fair value over the two years. It also omits the specific contribution of the $1,000 million principal repayment to the financing activities, which is a critical component of the original answer. (4) The contextual relevance is high—the answer addresses the question’s core about debt issuance, repayment, fair value, and financing activities—but the quantitative inaccuracies and missing specifics reduce correctness. The qualitative reasoning is logical but incomplete. Thus, the correctness score is 5 due to partial factual accuracy with significant numerical and synthesis errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 564,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What is the total estimated environmental remediation liability Caterpillar accrues for all sites, and how does its methodology for estimating these costs differ between individual sites and multi-party sites?",
      "original_answer": "Caterpillar estimates its total environmental remediation liability across all sites to be immaterial and includes this amount in 'Accrued expenses.' For individual sites, Caterpillar accrues costs based on available data, technologies, applicable laws, and prior remediation experience, and if no amount within a range is more likely, it accrues the minimum. When multiple potentially responsible parties are involved, Caterpillar considers its proportionate share of the probable costs rather than the full estimated liability.",
      "llm_answer": "The total estimated environmental remediation liability Caterpillar accrues for all sites is not material and is recorded in “Accrued expenses,” but the exact aggregate amount is not disclosed in the provided pages. Caterpillar estimates remediation costs for individual sites based on currently available data, applicable laws, technologies, and prior experience, using the most likely cost within a range (or the minimum if no single amount is more likely), while for multi‑party sites it considers its proportionate share of probable costs and does not factor in potential recoveries from insurers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, it correctly states that the total environmental remediation liability is 'not material' (synonymous with 'immaterial' in the original) and recorded in 'Accrued expenses,' which matches the ground truth. No specific dollar amount is provided in either answer, as it is considered immaterial and undisclosed—this is correctly reflected. (2) The methodology for individual sites is accurately described: Caterpillar uses available data, laws, technologies, and experience, and accrues the minimum amount if no point in the range is more likely. The LLM adds 'most likely cost within a range,' which is a reasonable elaboration consistent with accounting practices and does not contradict the original. (3) For multi-party sites, the LLM correctly notes that Caterpillar considers its proportionate share of probable costs and adds the detail about not factoring in recoveries from insurers. While this specific point isn't in the original answer, it is consistent with conservative liability estimation practices and does not introduce inaccuracy; it may reflect additional context from the filing not in the ground truth summary. (4) All parts of the question are addressed: total liability and the difference in methodology between site types. The reasoning is sound and synthesizes the required information correctly. The only minor deviation is the slight expansion on insurer recoveries, which doesn't detract from factual correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 455,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What was the percentage change in revenue for Cisco's 'Other Products' category between fiscal years 2021 and 2022, and how does the company's updated reporting structure introduced in fiscal 2022 reflect its strategic approach to this underperforming category?",
      "original_answer": "The revenue for Cisco's 'Other Products' category decreased by 29% between fiscal years 2021 and 2022, dropping from $15 million to $11 million. Despite this decline, Cisco introduced a new reporting structure in fiscal 2022 that explicitly included 'Other Products' as a distinct category, signaling that even underperforming segments are still considered relevant to the company's strategic priorities as they align with its broader portfolio and long-term goals.",
      "llm_answer": "The percentage change in revenue for Cisco's \"Other Products\" category between fiscal years 2021 and 2022 was a decline of 29% (from $15 million to $11 million). The updated reporting structure introduced in fiscal 2022, which consolidated \"Other Products\" into a distinct category alongside strategic segments like Secure, Agile Networks and Internet for the Future, reflects Cisco's effort to better align its financial disclosures with its strategic priorities and address the underperforming nature of this category by isolating its performance for clearer analysis.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 29% decline in revenue for Cisco's 'Other Products' category from $15 million in fiscal 2021 to $11 million in fiscal 2022, matching the ground truth exactly. All numeric values and the percentage change are accurate, with no calculation errors. (2) Quantitative accuracy is perfect—values are reported correctly, and the percentage change is consistent with the source data (approx. 26.67% actual drop, rounded to 29% as per original answer, so the LLM follows the ground truth's rounding). (3) The reasoning is sound: the LLM correctly notes that the updated reporting structure in fiscal 2022 maintained 'Other Products' as a distinct category, which aligns with the ground truth's interpretation that this reflects strategic relevance despite underperformance. It adds contextual detail about consolidation alongside 'Secure, Agile Networks' and 'Internet for the Future', which enhances clarity and reflects accurate synthesis. (4) The only minor deviation is that the LLM frames the reporting change as a way to 'address the underperforming nature' by isolating performance, while the ground truth emphasizes continued strategic relevance. This is a subtle interpretive difference but does not contradict the core message. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only slight deduction in qualitative accuracy due to nuanced emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 405,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the timing and frequency of amendments to executive employment agreements at Costco, including the agreement with Ron Vachris effective January 1, 2024, compare to the renewal pattern of W. Craig Jelinek's agreement over the past six years?",
      "original_answer": "Costco has consistently renewed W. Craig Jelinek's Executive Employment Agreement annually from 2017 through 2023, with extensions effective each January 1, as shown by filings dated from 2016 to 2022. The agreement with Ron Vachris, effective January 1, 2024, follows this same annual renewal pattern, indicating a continuation of Costco's executive employment practices.",
      "llm_answer": "The executive employment agreement with Ron Vachris, effective January 1 2024, is listed as Exhibit 10.9 in the Form 10‑Q (filed December 20, 2023), whereas W. Craig Jelinek’s agreement and its extensions are disclosed as Exhibits 10.5 through 10.5.5, all filed as quarterly reports in 2016‑2023. This reflects a newer, distinct agreement for Vachris, contrasting with the series of six extensions that have renewed Jelinek’s arrangement roughly each year since 2016.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct details but fundamentally misrepresents the comparison between Ron Vachris's agreement and W. Craig Jelinek's renewal pattern, leading to a significant error in reasoning and conclusion. (1) Correct elements: The effective date of Vachris's agreement (January 1, 2024) and the filing of Jelinek’s agreements between 2016–2023 are factually accurate. The exhibit numbers and filing types (Form 10-Q) are also correctly cited. (2) Quantitative accuracy: Dates and years are mostly correct, though the phrase '2016–2023' is vague but acceptable; however, the original answer specifies annual renewals from 2017 through 2023 with filings from 2016 to 2022, which is more precise. No calculations are involved, so numerical accuracy is not a major factor. (3) Multi-hop reasoning failure: The LLM incorrectly concludes that Vachris’s agreement represents a 'newer, distinct agreement' that 'contrasts' with Jelinek’s pattern. This contradicts the ground truth, which states that Vachris’s agreement follows the same annual renewal pattern, indicating continuity in executive employment practices. The model fails to recognize that the change in exhibit number does not imply a change in renewal pattern or policy. (4) The answer is contextually relevant and includes appropriate document references, but the core conclusion is factually wrong, undermining the qualitative and overall correctness scores. The answer should have affirmed the consistency in timing and frequency, not contrasted them.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 418,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What was the change in the net value of Customer Relationships from December 31, 2020, to December 31, 2021, and how does this compare to the change in the net value of Intellectual Property over the same period?",
      "original_answer": "The net value of Customer Relationships decreased by $181 million (from $893 million in 2020 to $712 million in 2021), while the net value of Intellectual Property decreased by $86 million (from $366 million in 2020 to $280 million in 2021).",
      "llm_answer": "The net value of Customer Relationships decreased by $181 million from $712 million at the end of 2020 to $531 million at the end of 2021. Over the same period, the net value of Intellectual Property fell by $86 million, from $366 million in 2020 to $280 million in 2021.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the starting and ending values for Customer Relationships, although the calculated change of $181 million is correct. According to the ground truth, the net value of Customer Relationships decreased from $893 million in 2020 to $712 million in 2021. However, the LLM states it decreased from $712 million in 2020 to $531 million in 2021, which is incorrect. This suggests the model may have misread or misaligned the years. (2) The Intellectual Property values and change are accurate: $366 million in 2020 to $280 million in 2021 is an $86 million decrease, correctly reported. (3) The multi-hop reasoning is partially sound — the model correctly identifies both assets and compares their changes over time, but fails in accurate data retrieval for Customer Relationships. (4) Despite correct calculation magnitude and direction (decrease), the wrong base values undermine factual reliability. The answer is contextually relevant and well-structured, but the quantitative inaccuracy in key financial figures significantly reduces correctness. Thus, correctness and quantitative accuracy are scored moderately, qualitative reasoning is acceptable, and relevance is high.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 346,
        "total_tokens": 1490
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What is the total revenue contribution from the 'Secure, Agile Networks' product category in fiscal 2022, and how does its revenue recognition model differ for hardware versus SaaS arrangements?",
      "original_answer": "The 'Secure, Agile Networks' product category contributes significantly to Cisco's revenue, with distinct revenue recognition models: hardware and perpetual software revenue is recognized upfront upon transfer of control, while SaaS arrangements recognize revenue ratably over the contract term.",
      "llm_answer": "The total revenue contribution from the 'Secure, Agile Networks' product category in fiscal 2022 was $23,829 million, as reported in the disaggregated revenue table under \"Revenue for Groups of Similar Products and Services\" (page 101) and \"Disaggregation of Revenue\" (page 72). Regarding revenue recognition, hardware and perpetual software licenses within this category are recognized upfront upon transfer of control (as stated in the revenue recognition policy on page 72), while SaaS arrangements are recognized ratably over the contract term as a single performance obligation (also detailed on page 72).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes a specific revenue figure of $23,829 million for the 'Secure, Agile Networks' category in fiscal 2022, which is not present in the original answer (ground truth). The ground truth does not provide any numerical revenue amount, only a qualitative description of the revenue recognition model. There is no way to verify the accuracy of $23,829 million from the provided ground truth, making the quantitative claim unsupported and likely incorrect or hallucinated. (2) The revenue recognition details—upfront recognition for hardware and perpetual software, and ratable recognition for SaaS—are accurately described and align semantically with the original answer. These qualitative aspects are correct and reflect proper synthesis of the multi-hop requirement regarding different models within the same product category. (3) The reasoning for the revenue recognition model is sound and correctly identifies the distinction between hardware/perpetual software and SaaS arrangements, demonstrating accurate multi-hop logic across product types and accounting policies. However, the inclusion of an unverified dollar amount undermines factual correctness. (4) The contextual relevance is high because the answer addresses both parts of the question and cites appropriate sections (e.g., page 72, 101), though these page references are not in the ground truth and may be fabricated. Overall, the qualitative and contextual accuracy is strong, but the unsupported numerical figure significantly reduces the correctness and quantitative accuracy scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 434,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What was Amazon's revenue from third-party seller fees in 2022, and how does this revenue stream align with Amazon's stated business model of enabling sellers to grow their businesses through its platform?",
      "original_answer": "Amazon's revenue from third-party seller fees in 2022 was $117,757 million. This revenue stream aligns with Amazon's business model of enabling sellers to grow their businesses by offering programs that allow them to sell products on Amazon's platform, leveraging Amazon's fulfillment and shipping services, and accessing a large customer base. The fees collected from sellers support Amazon's investment in infrastructure and services that facilitate this ecosystem.",
      "llm_answer": "Amazon's revenue from third-party seller fees was $117.1 billion in 2022, representing 12% of total net sales. This aligns with Amazon's business model of enabling sellers to grow their businesses through its platform by offering programs that allow sellers to sell products in Amazon's stores and fulfill orders through Amazon, for which Amazon earns fixed fees, a percentage of sales, per-unit activity fees, interest, or some combination thereof.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy: it reports third-party seller fees as $117.1 billion, while the ground truth is $117,757 million ($117.757 billion). This is a difference of $657 million, likely due to rounding or sourcing variation. The 12% of total net sales is not verifiable from the provided ground truth and introduces unconfirmed information. 2) The revenue figure is close but not exact—acceptable within typical reporting variations if approximate, but not fully accurate. The percentage breakdown was not in the original and cannot be confirmed, reducing quantitative accuracy. 3) The reasoning and qualitative content are strong: the answer correctly identifies that third-party seller fees come from programs enabling sellers to sell and fulfill through Amazon, and links this to Amazon’s business model of supporting seller growth via platform services. It accurately describes fee structures (fixed fees, percentage of sales, per-unit fees), demonstrating sound multi-hop synthesis between revenue data and business model context. 4) Contextual relevance is perfect—the answer directly addresses both parts of the question: the revenue amount and its alignment with Amazon’s business model. Despite the small numerical discrepancy and the addition of an unsupported percentage, the core facts and logic are correct, warranting a high but not top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 390,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What is the difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement for this metric as of December 31, 2024?",
      "original_answer": "The difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement is 9 percentage points.",
      "llm_answer": "Based on the provided document pages, Capital One Financial Corp's Common Equity Tier 1 (CET1) capital ratio as of December 31, 2024 is 13.5% (as stated in Table 12 of page 86), while the Minimum Capital Adequacy requirement for CET1 under the Basel III standardized approach is 4.5% (also from Table 12, column \"Minimum Capital Adequacy\" for December 31, 2024). The difference between these figures is 9.0 percentage points.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: Capital One's CET1 ratio is correctly stated as 13.5% and the Minimum Capital Adequacy requirement under Basel III as 4.5%, both as of December 31, 2024. (2) The calculation of the difference (13.5% - 4.5% = 9.0 percentage points) is precise and correctly expressed. The format '9.0 percentage points' is semantically equivalent to '9 percentage points' in the ground truth. (3) The multi-hop reasoning is sound—information is correctly extracted from Table 12 on page 86, synthesizing the company-specific metric and the regulatory requirement. (4) Entities (Capital One Financial Corp, CET1 ratio, Minimum Capital Adequacy requirement), metric definitions, and time period are all accurately identified and used. The answer is complete, contextually relevant, and conveys the same information as the original answer with no omissions or errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 274,
        "total_tokens": 1427
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What regulatory risks threaten Altria's $1.7 billion investment in JUUL as of 2021, and how could these risks financially impact Altria's strategic objectives?",
      "original_answer": "Altria faces significant regulatory risks regarding its $1.7 billion investment in JUUL, as outlined in the 2022 10-K filing. The Federal Trade Commission (FTC) has issued an administrative complaint alleging that Altria's 35% investment in JUUL and associated agreements violate antitrust laws by constituting an unreasonable restraint of trade and substantially lessening competition. The FTC is seeking remedies that include divestiture of the investment or rescission of the transaction, which could directly result in a loss of this asset. This risk is compounded by the fact that such regulatory actions could negatively impact Altria's credit ratings, increase financing costs, and hinder its ability to achieve strategic and financial objectives, including anticipated revenue improvements and cost savings from the investment.",
      "llm_answer": "Regulatory risks threatening Altria's $1.7 billion JUUL investment include ongoing FTC antitrust enforcement actions alleging that the investment and related agreements constitute an unreasonable restraint of trade and seeking remedies such as divestiture or rescission of the transaction, as well as potential adverse ESG investor sentiment and litigation from putative class actions that could force divestiture or impair the investment’s value. These risks could materially reduce the fair‑value of the JUUL stake, impair Altria’s ability to achieve its strategic objective of leveraging JUUL to accelerate growth in the e‑vapor category, and generate impairment charges or write‑downs that would negatively affect earnings and the company’s overall financial position.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions and additions that affect qualitative accuracy. (1) Quantitative accuracy is perfect: the $1.7 billion investment amount is correct, and no other numerical values (e.g., 35%) are misstated—though the LLM omits the specific 35% stake mentioned in the original. The year 2021 is referenced in the question, and while the 10-K cited is from 2022, it reflects the state of regulatory risk as of that time, which is appropriate. (2) The FTC antitrust complaint is accurately described, including the allegations of unreasonable restraint of trade and the potential remedies of divestiture or rescission. This matches the original answer. (3) However, the LLM introduces additional risks not present in the ground truth: 'adverse ESG investor sentiment' and 'putative class actions'—these are not mentioned in the original 10-K-based answer and represent speculative additions. While plausible, they are not supported by the provided ground truth. (4) The financial and strategic impacts are well-reasoned: the risk of impairment charges, negative effects on earnings, and failure to achieve strategic growth objectives via JUUL are semantically equivalent to the original’s concern about failing to meet revenue and cost-saving goals. The omission of credit rating and financing cost impacts—present in the original—is a minor but notable gap in completeness. (5) Multi-hop reasoning is sound: the model correctly links regulatory action to financial and strategic consequences. Overall, the answer is factually strong, contextually relevant, and accurately captures the core regulatory and financial risks, but loses points for minor overreach and omission of a key detail (35% stake, credit rating impact).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 486,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "Given NVIDIA's $500 million Notes Due 2060 as part of its long-term debt structure and the risks associated with maintaining indebtedness, how does the 2060 note specifically contribute to the potential adverse effects on NVIDIA's financial flexibility as outlined in the 10-K filing?",
      "original_answer": "NVIDIA's $500 million Notes Due 2060 is one of several long-term debt obligations that collectively total $11 billion. The 10-K filing highlights that as each series of senior notes matures, NVIDIA may face challenges in refinancing on favorable terms or at all, which could adversely affect its financial condition. Specifically, maintaining this level of indebtedness requires NVIDIA to dedicate a substantial portion of cash flows from operations toward debt service obligations and principal repayments. This allocation limits NVIDIA's flexibility in planning for or reacting to changes in its business and industry, impairs its ability to obtain future financing for working capital, capital expenditures, acquisitions, or other corporate purposes, and increases vulnerability to adverse changes in general economic conditions. Therefore, the $500 million Notes Due 2060 directly contribute to these constraints on financial flexibility as part of the broader debt structure.",
      "llm_answer": "The $500 million 2060 senior notes add to NVIDIA’s long‑term debt, increasing the total amount of outstanding notes to roughly $11 billion and requiring future principal repayments or refinancing. This larger debt burden limits the company’s financial flexibility by tying up cash that could otherwise be used for operations, investments, or strategic initiatives, and it heightens exposure to covenant breaches, interest‑rate fluctuations, and potential downgrades that could raise borrowing costs. Consequently, the 2060 notes amplify the risks associated with maintaining indebtedness and can constrain NVIDIA’s ability to respond to market changes or fund growth opportunities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $500 million 2060 notes and the $11 billion total long-term debt are accurately reported, with acceptable formatting ($500 million = $500 million). (2) The answer correctly identifies that the 2060 notes are part of a larger debt structure and contribute to refinancing risk and cash flow constraints. (3) Multi-hop reasoning is sound: it synthesizes the impact of long-term debt on financial flexibility, including cash flow allocation, refinancing challenges, and vulnerability to economic and interest rate changes. (4) While the LLM omits explicit mention of 'debt service obligations' and 'covenant breaches' is slightly overemphasized (not explicitly mentioned in the original), it captures the core risks—reduced flexibility, constrained growth funding, and heightened vulnerability. The answer is semantically equivalent in key aspects and fully relevant to the question. One minor point deducted for slight underrepresentation of 'cash flow dedication to debt service' as emphasized in the original, but overall reasoning and factual accuracy are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 335,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How does the expanded FDA approval of Vemlidy for younger pediatric patients impact Gilead's market potential in the treatment of chronic HBV, given its existing product portfolio for liver disease?",
      "original_answer": "The expanded FDA approval of Vemlidy for chronic HBV treatment in pediatric patients aged six years and older, who weigh at least 25 kg, significantly broadens Gilead's market reach in liver disease. Previously, Vemlidy was approved for adults and pediatric patients 12 years and older. This expansion allows Gilead to now treat a younger demographic, enhancing its position in the HBV market. Additionally, Vemlidy complements Gilead’s existing liver disease portfolio, which includes Viread (approved for patients 2 years and older) and Epclusa and Harvoni (approved for HCV in patients 3 years and older). This strategic regulatory expansion increases Gilead's commercial opportunity by extending treatment access across a wider age range of HBV patients.",
      "llm_answer": "The expanded FDA approval of Vemlidy for pediatric patients 6 years and older with chronic hepatitis B (CHB) broadens Gilead’s addressable market in the pediatric HBV space, adding a new, younger indication to its existing liver‑disease portfolio that already includes Epclusa, Harvoni, Viread and Livdelzi. This diversification strengthens Gilead’s growth prospects in chronic HBV by tapping a pediatric segment that previously was not covered, complementing its established hepatitis C and oncology products and enhancing overall market potential for its liver‑disease franchise.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core impact of the expanded FDA approval of Vemlidy for pediatric patients aged 6 years and older, correctly identifying the broadening of Gilead's market potential in chronic HBV. The quantitative details—specifically the age group (6 years and older)—are correct and match the ground truth. The mention of Vemlidy's complementarity to Gilead’s existing liver disease portfolio is accurate, and the listed products (Epclusa, Harvoni, Viread) align with the original answer. However, the LLM incorrectly includes 'Livdelzi' in the liver disease portfolio in this context—Livdelzi (selgantolimod) is being developed for NASH, not HBV or HCV, and is not approved for pediatric use or chronic HBV treatment. This is a minor factual inaccuracy affecting entity accuracy but does not undermine the central reasoning. The answer successfully performs multi-hop reasoning by linking the expanded indication to broader market reach and portfolio synergy. It omits the detail that prior approval was for ages 12 and older and that weight (≥25 kg) is also a criterion, but these are secondary details. Overall, the answer is semantically equivalent in intent and meaning, with high contextual relevance and strong reasoning, warranting a high score with a minor deduction for the inclusion of an irrelevant product.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 376,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What percentage of Lowe's total sales in fiscal 2023 came from installed sales categories that are also covered by Lowe's extended protection plans, and which specific product category among these is explicitly mentioned in both contexts?",
      "original_answer": "The installed sales categories that are also covered by Lowe's extended protection plans contributed approximately 5% of total sales in fiscal 2023. The specific product category explicitly mentioned in both contexts is Appliances.",
      "llm_answer": "Based on the provided document pages, Lowe's fiscal 2023 installed sales accounted for approximately 5 % of total sales, and the specific product category explicitly mentioned in both the installed‑sales context and the extended protection‑plan context is **Appliances**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The percentage of Lowe's total sales from installed sales categories covered by extended protection plans in fiscal 2023 is accurately stated as 5%, which aligns with the original answer. (2) The specific product category explicitly mentioned in both contexts—installed sales and extended protection plans—is correctly identified as Appliances. (3) The multi-hop reasoning is sound: the model correctly synthesized information linking installed sales, extended protection plans, their contribution to total sales, and the overlapping product category. (4) All entities (Lowe's, fiscal 2023, installed sales, extended protection plans, Appliances) are accurate and contextually appropriate. The answer is concise, factually precise, and semantically equivalent to the ground truth, warranting top scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 259,
        "total_tokens": 1408
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the cumulative impact on Capital One's regulatory capital from the CECL Transition Election from 2020 through 2024, considering the phase-in schedule and the 25% scaling factor applied to the 'day 2' ongoing impact?",
      "original_answer": "The cumulative impact on Capital One's regulatory capital from the CECL Transition Election from 2020 through 2024 includes a 25% scaling factor applied to the 'day 2' ongoing impact of CECL during the initial two years (2020–2021), and a 25% annual phase-in of both the after-tax 'day 1' CECL adoption impact and the cumulative 'day 2' ongoing impact from 2022 through 2024. This structured phase-in delays and gradually integrates the full capital impact of CECL adoption into regulatory capital.",
      "llm_answer": "The CECL Transition Election allowed Capital One to add back $2.4 billion (after‑tax) of capital through 2021 and then phase in the remaining impact at 25 % per year from 2022‑2024; consequently, the “day‑2” ongoing impact is being added back at 25 % of the estimated increase each year, resulting in a cumulative capital boost of roughly $2.4 billion that is fully reflected in the 2021 CET1 ratio (13.1 % vs. 12.4 % on a fully‑phased‑in basis).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar amounts ($2.4 billion after-tax) and CET1 ratio figures (13.1% vs 12.4%) that are not present in the original answer (ground truth), and there is no verification that these numbers are accurate based on the provided knowledge graph. The original answer does not include any quantitative figures, so the introduction of $2.4 billion and specific ratios represents unsupported precision. (2) The quantitative accuracy is low because the LLM fabricates exact numbers not present in the ground truth. While the phase-in schedule (25% per year from 2022–2024) is correctly referenced, the 'day 2' ongoing impact being added back at 25% annually is only partially accurate—the original specifies a 25% scaling factor applied to 'day 2' in 2020–2021, not a full phase-in of the ongoing impact from 2022–2024. The LLM conflates the treatment of 'day 1' and 'day 2' impacts. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies the two-phase structure (initial relief through 2021, then phase-in from 2022–2024), but mischaracterizes the mechanics. The original specifies that from 2022–2024, there is a 25% annual phase-in of *both* the after-tax 'day 1' impact *and* the cumulative 'day 2' ongoing impact, whereas the LLM implies only the 'day 2' impact is being phased in. This is a significant error in regulatory capital treatment. (4) Contextual relevance is high because the answer addresses the CECL transition, phase-in periods, and capital impact. However, the correctness score is low due to factual inaccuracies and unsupported numerical claims, despite capturing some structural elements of the policy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 460,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What was the net financial impact of Altria's 2021 tobacco settlement obligations and NPM adjustment recoveries on its cost of sales?",
      "original_answer": "Altria recorded $4.6 billion in charges to cost of sales for the year ended December 31, 2021, related to the State Settlement Agreements and FDA user fees. During the same period, Altria received $21 million as a reduction to cost of sales from the 2004 NPM adjustment. This resulted in a net cost of $4.579 billion for 2021 after accounting for the NPM adjustment recovery.",
      "llm_answer": "The net financial impact of Altria’s 2021 tobacco settlement obligations and NPM‑adjustment recoveries was reflected as a **$21 million reduction to cost of sales** in the third quarter of 2021, representing the minimum amount of the 2004 NPM adjustment that Altria expected to receive. This reduction offset part of the ongoing settlement and FDA user‑fee costs recorded in cost of sales.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is significantly incorrect in both quantitative and qualitative aspects. (1) Quantitatively, it states a $21 million reduction to cost of sales as the net financial impact, but the ground truth specifies a net cost of $4.579 billion after combining $4.6 billion in charges and a $21 million recovery. The $21 million figure is only the NPM adjustment recovery, not the net impact. The LLM incorrectly presents this recovery as the net effect, omitting the much larger $4.6 billion charge. (2) The time frame is also wrong: the $21 million reduction was for the full year 2021, not just the third quarter. (3) Qualitatively, the reasoning fails to synthesize the two components of the net impact—settlement obligations and NPM recovery—required by the multi-hop question. Instead, it focuses only on the NPM adjustment and ignores the dominant cost component. (4) Contextually, the answer is partially relevant as it discusses the correct company (Altria), the correct year (2021), and the correct type of adjustment (2004 NPM), but it fundamentally misrepresents the net financial impact. The answer suggests a net benefit of $21 million when in fact there was a net cost of $4.579 billion. This is a major factual error that severely undermines the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 354,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "Following the freeze of U.S. pension benefits in 2019, by how much did Caterpillar Inc.'s total liabilities for non-qualified deferred compensation plans and other postemployment benefits increase from 2020 to 2021?",
      "original_answer": "Caterpillar Inc.'s total liabilities for non-qualified deferred compensation plans and other postemployment benefits increased by $91 million from 2020 to 2021. In 2020, the total liability was $554 million ($63 million for other postemployment benefits + $491 million for non-qualified deferred compensation). In 2021, the total liability was $645 million ($67 million for other postemployment benefits + $538 million for non-qualified deferred compensation). The increase occurred after the pension freeze in December 2019, which eliminated service cost and shifted focus to other benefit liabilities.",
      "llm_answer": "Based on the information in the provided pages, the liability for postemployment benefits (which includes non‑qualified deferred compensation plans and other postemployment benefits) was $67 million for 2021 and $63 million for 2020. This represents an increase of **$4 million** from 2020 to 2021.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both magnitude and composition of the liability increase. The ground truth states that the total liabilities for non-qualified deferred compensation plans and other postemployment benefits increased from $554 million in 2020 to $645 million in 2021, a $91 million increase. The LLM incorrectly reports only the 'other postemployment benefits' component ($63M in 2020, $67M in 2021) and ignores the much larger non-qualified deferred compensation liabilities ($491M in 2020, $538M in 2021), which are explicitly part of the question. (2) The calculation is based on wrong data: the LLM computes a $4M increase by comparing only the 'other postemployment benefits' line items, failing to sum both components as required. The correct calculation is ($538M + $67M) - ($491M + $63M) = $645M - $554M = $91M. (3) The multi-hop reasoning is flawed: the question requires aggregating two distinct liability categories across two years and computing the difference. The LLM fails to recognize that 'non-qualified deferred compensation plans' are a major part of the total and must be included. It also does not mention the context of the 2019 pension freeze, which is central to the explanation in the ground truth. (4) The contextual relevance is moderate because the answer addresses postemployment benefits and the correct time frame, but it omits a key component of the liability, leading to a grossly inaccurate conclusion. Hence, the correctness and quantitative accuracy scores are low; qualitative accuracy is slightly higher due to correct identification of years and partial metric recognition, but reasoning is fundamentally flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 461,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028, and how does this relate to the $630 million indefinite-lived intangible asset recorded for Mellanox's in-process research and development project?",
      "original_answer": "The total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028 is $1.889 billion. This includes $585 million in 2023, $461 million in 2024, $405 million in 2025, $121 million in 2026, $16 million in 2027, and $121 million in 2028 and thereafter. The $630 million indefinite-lived intangible asset for Mellanox's in-process research and development (IPR&D) project is not included in these estimates because it had not yet reached technological feasibility as of January 30, 2022, and therefore was not yet amortized. Instead, it was subject to annual impairment testing.",
      "llm_answer": "The total estimated amortization expense for acquisition‑related intangible assets from fiscal 2023 through 2028 is $585 million in 2023, $461 million in 2024, $405 million in 2025, $121 million in 2026, $16 million in 2027 and $121 million thereafter, amounting to roughly $1.3 billion over the six‑year horizon. This expense excludes the $630 million indefinite‑lived in‑process R&D asset recorded for Mellanox’s IPR&D, which will not be amortized until the project reaches technological feasibility and is then amortized over its estimated useful life.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly lists the annual amortization expenses for each fiscal year from 2023 to 2028 and thereafter: $585M, $461M, $405M, $121M, $16M, and $121M. However, it incorrectly calculates the total as 'roughly $1.3 billion', which is inaccurate. The correct sum is $585 + $461 + $405 + $121 + $16 + $121 = $1.889 billion. This significant miscalculation undermines the quantitative accuracy. (2) The exclusion of the $630 million indefinite-lived intangible asset related to Mellanox's IPR&D is correctly explained: it is not amortized until technological feasibility is reached, and instead is subject to annual impairment testing. This reasoning aligns with the ground truth and shows proper understanding of accounting treatment for IPR&D. (3) The multi-hop reasoning is sound—linking NVIDIA's acquisition-related amortization schedule with the separate treatment of the Mellanox IPR&D asset demonstrates correct synthesis across financial concepts and entities. (4) While the qualitative and contextual aspects are strong—correct entities (NVIDIA, Mellanox, IPR&D), correct years, and correct conceptual explanation—the major error in summing the amortization amounts reduces the correctness and quantitative accuracy scores. A correct total was essential to fully answer the first part of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 372,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What is the combined U.S. and EU patent expiration year for Biktarvy, and how does the expanded FDA approval of Biktarvy for people with HIV who have M184V/I resistance influence its market exclusivity timeline?",
      "original_answer": "Biktarvy has a U.S. patent expiration year of 2033 and an EU patent expiration year of 2033. The FDA-approved expanded indication for Biktarvy to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance reinforces its market exclusivity by broadening its therapeutic application, thereby supporting continued revenue generation potential through 2033 in both regions.",
      "llm_answer": "The combined U.S. and EU patent expiration for Biktarvy is 2033. The FDA’s expanded approval for Biktarvy to treat people with HIV who have M184V/I resistance does not alter the patent expiration timeline, as the exclusivity remains anchored to the 2033 patent expiry.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the U.S. and EU patent expiration year for Biktarvy as 2033, which matches the ground truth. This satisfies the quantitative requirement accurately. (2) All numeric values—specifically the year 2033—are correct and consistent with the original answer. There are no calculation errors. (3) The reasoning regarding the FDA's expanded approval is mostly sound: it correctly notes that the expanded indication does not change the patent expiration timeline. However, the LLM answer omits the positive impact of the expanded approval on market exclusivity in terms of broadening therapeutic use and supporting revenue generation, which is a key qualitative point in the ground truth. While it doesn't misstate anything, it provides a less complete explanation of how expanded approvals reinforce market exclusivity indirectly, even if they don’t extend the patent term. (4) The answer is contextually relevant and factually accurate, with only a minor omission in depth of reasoning. Thus, full marks for quantitative accuracy and contextual relevance, a 9 for qualitative accuracy due to incomplete synthesis of the exclusivity implication, and a 9 overall for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 342,
        "total_tokens": 1527
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the Federal Reserve's supervisory stress testing modeling impact Capital One Financial Corporation's (COF) ability to return capital to stockholders, and what specific regulatory requirement from the Dodd-Frank Act reinforces this limitation?",
      "original_answer": "The Federal Reserve's supervisory stress testing modeling may indicate a lower capacity for Capital One Financial Corporation (COF) to return capital to stockholders than internal projections suggest, potentially leading to restrictions on dividends and share repurchases. This limitation is reinforced by the Dodd-Frank Act's codification of the 'source of strength doctrine,' which requires COF to maintain sufficient capital to support its subsidiary banks, further constraining capital returns.",
      "llm_answer": "The Federal Reserve’s supervisory stress‑testing models can require Capital One to hold more capital than its own projections indicate, limiting the amount of capital it can actually deploy for dividends or share‑repurchases. This limitation is reinforced by the Dodd‑Frank Act’s “source‑of‑strength” provision, which obligates a bank holding company to act as a source of financial strength for its subsidiaries and subjects it to the Federal Reserve’s capital adequacy requirements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) It correctly explains that the Federal Reserve's stress testing may require Capital One to hold more capital than internally projected, thereby limiting dividends and share repurchases—this aligns with the original answer's point about lower capacity for capital returns. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense; however, the absence of any incorrect numbers or miscalculations supports a perfect score. (3) The multi-hop reasoning is sound: the LLM connects supervisory stress testing → capital constraints → limits on capital returns, and correctly identifies the Dodd-Frank Act's 'source-of-strength' doctrine as the reinforcing regulatory requirement. The term is accurately quoted and its purpose—ensuring the holding company supports its subsidiaries—is correctly described. (4) The only minor difference is that the LLM answer does not explicitly mention the 'codification' of the doctrine or use the exact phrase 'source of strength doctrine' without hyphens, but this is a stylistic variation and does not affect meaning. The substance and legal reference are correct. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 389,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What was the total amount of payments made by PM USA under the State Settlement Agreements for the years 2019, 2020, and 2021 combined, and how does this compare to the maximum potential NPM Adjustment for 2020 alone?",
      "original_answer": "PM USA paid a total of $12.8 billion under the State Settlement Agreements for the years 2019 ($4.2 billion), 2020 ($4.4 billion), and 2021 ($4.3 billion). This total is significantly higher than the maximum potential NPM Adjustment for 2020 alone, which was $572 million.",
      "llm_answer": "The total payments made by PM USA under the State Settlement Agreements for 2019, 2020, and 2021 combined were $13.4 billion, and the maximum potential NPM Adjustment for 2020 alone was $572 million.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant error in the total combined payments: it reports $13.4 billion, whereas the ground truth is $12.8 billion (sum of $4.2B + $4.4B + $4.3B = $12.9B, with minor rounding possibly explaining the $12.8B figure). The LLM's total is off by $0.6 billion, indicating a major quantitative inaccuracy. However, the maximum potential NPM Adjustment for 2020 is correctly stated as $572 million. (2) The individual yearly breakdowns are missing in the LLM answer, which reduces completeness, though the question does not explicitly require them. The core error lies in the incorrect sum—either due to wrong inputs or miscalculation. (3) The multi-hop reasoning is partially sound: the model identifies the need to sum payments across three years and compare to the 2020 NPM Adjustment. However, the incorrect total undermines the validity of the comparison. (4) Despite the numerical error, the answer addresses both parts of the question and uses correct entities (PM USA, State Settlement Agreements, NPM Adjustment, correct years), earning points for qualitative accuracy and contextual relevance. The conclusion that the total payments far exceed the NPM Adjustment would still hold even with the inflated total, but the magnitude of error reduces confidence in the result.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1135,
        "completion_tokens": 367,
        "total_tokens": 1503
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What is the difference between the fair value of the 2.85% Notes Due 2030 as reported in the first table and the net carrying amount of the same notes as disclosed in the second table for the fiscal year ending January 30, 2022?",
      "original_answer": "The fair value of the 2.85% Notes Due 2030 is $1,542 million according to the first table, while the net carrying amount is $1,500 million according to the second table. The difference between the two values is $42 million.",
      "llm_answer": "The fair value of the 2.85% Notes Due 2030 is $1,542 million, while the net carrying amount of those notes is $1,500 million, resulting in a $42 million difference.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: the fair value of the 2.85% Notes Due 2030 is correctly stated as $1,542 million, and the net carrying amount is correctly given as $1,500 million. The difference is accurately calculated as $42 million. (2) Quantitative accuracy is perfect—numbers match the original answer exactly, with only a typographic variation in spacing (using a non-breaking space) that does not affect meaning or correctness. The calculation (1,542 - 1,500 = 42) is mathematically sound. (3) The multi-hop reasoning is correctly executed: the model synthesizes data from two different tables (fair value from the first, carrying amount from the second) for the same financial instrument and fiscal year (ending January 30, 2022), demonstrating proper cross-reference. (4) The answer is semantically equivalent to the original, conveying the same information concisely and clearly. All evaluation dimensions—factual correctness, completeness, entity accuracy, and logical reasoning—are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1117,
        "completion_tokens": 311,
        "total_tokens": 1428
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the application of the Tailoring Rules impact the capital requirements for Capital One Financial Corporation (COF) as a Category III institution, particularly in relation to the Stress Capital Buffer Rule and the exclusion of certain elements of AOCI?",
      "original_answer": "As a Category III institution under the Tailoring Rules, Capital One Financial Corporation (COF) is no longer subject to the Basel III Advanced Approaches framework and certain associated capital requirements. Additionally, COF has elected to exclude certain elements of Accumulated Other Comprehensive Income (AOCI) from its regulatory capital. This exclusion, combined with the recalibration of the Stress Capital Buffer Rule—based on supervisory stress test results—reduces the complexity and burden of capital calculations for COF while maintaining a CET1 capital ratio buffer that is institution-specific and annually adjusted.",
      "llm_answer": "The Tailoring Rules classify Capital One as a Category III institution, allowing it to exclude certain elements of AOCI from its regulatory capital. This exclusion, together with the CECL Transition Rule’s phasing‑in of CECL impacts, reduces the amount of capital that must be held to satisfy the Stress Capital Buffer Rule. Consequently, Capital One’s stress‑capital buffer requirement for 2021‑2022 was 2.5 %, translating to minimum capital ratios of 7.0 % CET1, 8.5 % Tier 1 and 10.5 % total capital, which it comfortably exceeded as of December 31 2021.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly around quantitative details. While it correctly identifies that Capital One (COF), as a Category III institution, can exclude certain AOCI elements from regulatory capital under the Tailoring Rules, it introduces the CECL Transition Rule—which is not mentioned in the ground truth and is not directly tied to the Stress Capital Buffer (SCB) reduction in the provided context. The specific SCB percentage of 2.5% and the resulting minimum capital ratios (7.0% CET1, 8.5% Tier 1, 10.5% total) for 2021–2022 are not supported by the original answer and appear to be fabricated or misattributed. The ground truth does not provide any specific numerical capital requirements or time-bound percentages, nor does it mention CECL. (2) The dates (2021–2022) and capital ratio figures are unsupported by the original answer, which focuses on structural and methodological impacts rather than specific annual buffer values. These numbers may be factually correct in another context, but they are not derivable from the provided ground truth and thus represent a mismatch. (3) The multi-hop reasoning is partially sound—linking Category III status, AOCI exclusion, and the SCB—but incorrectly adds CECL phasing-in as a contributing factor, which distorts the causal logic. The original answer emphasizes reduced complexity and burden with an annually adjusted, institution-specific CET1 buffer, not fixed percentages. (4) The contextual relevance is high because the LLM addresses the core topic: how Tailoring Rules affect COF’s capital requirements via AOCI exclusion and SCB. However, the addition of unsupported specifics and the misattribution of effects reduce correctness. The qualitative accuracy is moderate due to correct entity identification (COF, AOCI, SCB, Category III) and general direction of impact, but flawed reasoning integration. Quantitative accuracy is low due to unverified percentages and dates not present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 544,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What was the total change in fair value of Altria's JUUL investment from 2020 to 2021, and how was this change reflected in Altria's consolidated financial statements?",
      "original_answer": "The fair value of Altria's JUUL investment remained unchanged at $1,705 million from 2020 to 2021. This amount was included in 'investments in equity securities' on Altria's consolidated balance sheets at December 31, 2021, and was accounted for under the fair value option following the Share Conversion in the fourth quarter of 2020. Changes in the fair value of the JUUL investment, calculated quarterly using level 3 fair value measurements, were included in 'income (losses) from equity investments' in Altria's consolidated statements of earnings (losses).",
      "llm_answer": "The total change in fair value of Altria's JUUL investment from 2020 to 2021 was a $100 million increase, which was recognized in the consolidated statements of earnings (losses) as part of \"income (losses) from equity investments.\" This gain was reflected in the fair‑value option accounting for the JUUL equity investment and was included in the overall fair‑value adjustments reported in the company's financial statements.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that there was a $100 million increase in the fair value of Altria's JUUL investment from 2020 to 2021. The ground truth states that the fair value remained unchanged at $1,705 million during this period, meaning the change was $0. This major quantitative error undermines the core of the answer. (2) The calculation of a $100 million increase is not supported by the data and contradicts the original answer, which explicitly notes no change in fair value. Even allowing for format variations, the numbers are fundamentally wrong. (3) While the LLM correctly identifies that changes in fair value (had they occurred) would be reflected under the fair value option and reported in 'income (losses) from equity investments' in the consolidated statements of earnings, it fails to accurately represent the key fact that no change occurred. This reflects a failure in multi-hop reasoning—while the accounting treatment is correctly described, the model incorrectly assumes a change took place. (4) The contextual relevance is moderate because the answer addresses the correct financial statement line items and accounting method, but the incorrect change in value severely compromises factual accuracy. The qualitative accuracy is low due to the incorrect synthesis of financial data, despite some correct contextual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 385,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What percentage of Union Pacific's total locomotives are leased rather than owned, and how does this compare to the total number of switching locomotives in their fleet?",
      "original_answer": "Union Pacific leases 1,037 out of 7,154 total locomotives, which represents approximately 14.5% of their fleet. This number is significantly higher than the 132 switching locomotives in their fleet.",
      "llm_answer": "Union Pacific reports total owned and leased locomotives of 7,154, with 1,037 leased (representing approximately 14.5% of the total fleet). Switching locomotives number 132, which is included within the total fleet but represents a much smaller portion of the overall equipment count.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numbers: 7,154 total locomotives, 1,037 leased (14.5% of the fleet), and 132 switching locomotives. These match the ground truth exactly, and the percentage calculation (1,037 / 7,154 ≈ 14.5%) is accurate. (2) Quantitative accuracy is perfect—no errors in numbers, percentages, or formatting. (3) The reasoning is sound: the LLM correctly notes that leased locomotives make up 14.5% of the total fleet and appropriately compares this to the 132 switching locomotives, acknowledging they are a subset of the total fleet. While the original answer explicitly states that the leased number is 'significantly higher' than the switching locomotive count, the LLM implies this by noting switching locomotives are a 'much smaller portion,' which is semantically equivalent but slightly less direct. (4) The answer is fully contextually relevant, addressing both parts of the question: the percentage of leased locomotives and the comparison to switching locomotives. The only minor shortcoming is the slightly less explicit comparison between 1,037 leased and 132 switching units, but the contrast is still clearly conveyed. Thus, the answer is factually complete and accurate with only a slight nuance difference in emphasis, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 373,
        "total_tokens": 1499
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What was the change in fair value of the 2.20% Notes Due 2021 from January 31, 2021, to January 30, 2022, and how does this reflect in both the fair value disclosures and the debt-specific maturity and interest rate table?",
      "original_answer": "The fair value of the 2.20% Notes Due 2021 decreased from $1,011 million on January 31, 2021, to $0 million on January 30, 2022, as shown in the fair value disclosures. This aligns with the debt-specific maturity and interest rate table, which indicates that the notes had an effective interest rate of 2.38% and a remaining term of 0 years by January 30, 2022, meaning the notes had matured and were no longer outstanding.",
      "llm_answer": "The fair‑value disclosures show that the $1,000 million carrying amount of the 2.20% Notes Due 2021 was reduced to $0 on the balance sheet as of January 30 2022, reflecting a $1,000 million decrease from the $1,000 million reported on January 31 2021. This reduction is captured in the “Debt‑specific maturity and interest‑rate” table, which lists the 2.20% Notes Due 2021 with a $0 fair value as of January 30 2022 and a $1,000 million carrying amount as of January 31 2021.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decrease in fair value from $1,000 million to $0, which aligns with the maturity of the notes. However, the ground truth specifies the fair value on January 31, 2021, as $1,011 million, while the LLM states $1,000 million—this is a factual discrepancy affecting quantitative accuracy. The carrying amount may be $1,000 million, but the question asks about fair value, and the LLM conflates the two. (2) The calculation of a $1,000 million decrease is based on incorrect input values; the actual decrease should be $1,011 million to $0, or a $1,011 million reduction. The dates (January 31, 2021, and January 30, 2022) are correct. The interest rate (2.38%) and remaining term (0 years) from the debt-specific table are omitted in the LLM answer, which reduces completeness. (3) The reasoning is logically sound—recognizing that the drop to $0 reflects maturity—and correctly ties the fair value disclosure to the debt table. However, it fails to fully synthesize the multi-hop elements by not referencing the effective interest rate or remaining term, which are key to explaining why the fair value is zero (i.e., maturity). (4) Despite missing some details and having a minor but material numerical inaccuracy, the answer is contextually relevant and captures the core trend: the notes matured, fair value dropped to zero. Hence, correctness is reduced to 7 due to the incorrect fair value figure and missing synthesis points, though the overall direction and logic are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 422,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does the temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks impact the calculation of Capital One's supplementary leverage ratio, and what specific regulatory framework influenced this adjustment?",
      "original_answer": "The temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks from the denominator of the supplementary leverage ratio, as permitted under an interim final rule issued by the Federal Reserve, increased Capital One's supplementary leverage ratio. This adjustment was made under the Basel III Standardized Approach framework, which governs the company's capital ratios and regulatory requirements.",
      "llm_answer": "The temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks from the denominator of the supplementary leverage ratio was required by an interim final rule issued by the Federal Reserve, which adjusted the calculation of Capital One’s supplementary leverage ratio. This adjustment was made in accordance with the regulatory framework governing the supplementary leverage ratio under Basel III and U.S. capital rules.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It correctly identifies that the temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks affects the denominator of the supplementary leverage ratio, thereby increasing Capital One's ratio, though it does not explicitly state the directional impact ('increased') as in the original answer. However, this is implied by the context of regulatory adjustments under Basel III. (2) There are no numeric values, dates, or calculations in the question or answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the answer correctly links the interim final rule by the Federal Reserve to the adjustment in the supplementary leverage ratio and correctly identifies the Basel III Standardized Approach (referred to as 'Basel III and U.S. capital rules') as the governing framework. The phrasing is slightly less precise than the original (e.g., 'U.S. capital rules' is broader than 'Basel III Standardized Approach'), but still accurate. (4) The answer is fully contextually relevant, addressing both the regulatory mechanism (interim final rule) and the broader framework (Basel III). The only minor shortcoming is the slightly less specific reference to the exact Basel III framework, warranting a 9 in qualitative accuracy and 9 overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 389,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What was the total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023, and how were these assets valued?",
      "original_answer": "The total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023 was $3,209 million. These assets, which include Federal Government Securities valued at $1,508 million and Bonds and Debentures valued at $1,696 million, were valued using a bid evaluation process with bid data provided by independent pricing sources.",
      "llm_answer": "Based on the provided document pages, Union Pacific's pension plan assets classified as Level 2 investments totaled **$3,209 million** as of December 31, 2023. These assets were valued using observable inputs other than quoted prices in active markets, specifically including Federal government securities ($1,508 million), bonds and debentures ($1,696 million), and corporate stock ($5 million), as detailed in the fair value hierarchy on page 58.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key aspects. (1) Quantitatively, the total Level 2 investment value of $3,209 million is correct, and the breakdown into Federal Government Securities ($1,508 million) and Bonds and Debentures ($1,696 million) is accurate. The sum of these components is $3,204 million, with the $5 million difference reasonably attributed to corporate stock, bringing the total to $3,209 million—this minor detail was not in the original answer but does not contradict it and may reflect additional data from the source document. (2) The valuation method is correctly described as using observable inputs from independent pricing sources, consistent with a bid evaluation process, though the LLM uses more general terminology ('observable inputs other than quoted prices in active markets') rather than the specific 'bid evaluation process' mentioned in the ground truth. This is a slight omission but still semantically aligned with Level 2 valuation under fair value accounting. (3) The multi-hop reasoning is sound: the model correctly identifies Union Pacific, the 2023 fiscal year, the pension plan's Level 2 assets, and synthesizes values across asset categories. (4) All entities (company, year, financial items) are correct. The answer is fully relevant and addresses both parts of the question: total value and valuation method. The slight rewording of the valuation methodology prevents a perfect 10, but the core information is preserved and factually correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 417,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What specific automotive applications of NVIDIA Omniverse are mentioned in the 10-K filing, and how does its integration with the DRIVE platform support NVIDIA's end-to-end AI computing strategy?",
      "original_answer": "The 10-K filing specifically mentions that NVIDIA Omniverse Avatar software is used for real-time conversational AI capability in automotive applications, particularly as part of the DRIVE Chauffeur and DRIVE Concierge systems. This integration with the DRIVE platform supports NVIDIA's end-to-end AI computing strategy by combining Omniverse's real-time 3D simulation and collaboration capabilities with DRIVE's autonomous driving and in-vehicle experience solutions. This strategic integration allows NVIDIA to provide a comprehensive, software-defined approach to automotive computing—from training deep neural networks using GPUs to deploying AI-driven cockpit experiences and autonomous driving features, enabling continuous innovation through over-the-air updates.",
      "llm_answer": "NVIDIA cites its Omniverse platform as a real‑time 3D design and collaboration tool that “empowers artists, designers and creators to connect and collaborate in leading design applications” and notes that it is being used in automotive contexts such as virtual car showrooms and simulation‑based development.  The filing explains that this automotive work is delivered through the DRIVE platform, which couples Omniverse‑enabled simulation (e.g., DRIVE Sim) with the DRIVE AGX hardware and software stack to train, validate and continuously update autonomous‑driving neural networks, thereby supporting NVIDIA’s end‑to‑end AI computing strategy from training in the data center to inference in the vehicle.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of NVIDIA Omniverse and DRIVE platform integration and correctly identifies key applications such as simulation-based development and DRIVE Sim. It accurately reflects that Omniverse supports NVIDIA's end-to-end AI strategy by enabling training, validation, and over-the-air updates through a pipeline from data center to vehicle. However, it misses the specific mention of 'Omniverse Avatar' and its role in real-time conversational AI for DRIVE Chauffeur and DRIVE Concierge systems, which are explicitly highlighted in the ground truth. While the LLM captures the broader integration with DRIVE AGX and simulation use cases, it omits the specific application of conversational AI in the cockpit experience, a key detail in the original answer. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning is logically sound, though incomplete in synthesizing all specified applications. The answer remains contextually relevant and conveys a high-level understanding of the strategic integration, warranting a solid but not full score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 317,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "What was the percentage change in Converse's contribution to NIKE, Inc.'s total revenues from 2022 to 2023, and how did this compare to the percentage change in Converse's operating income over the same period?",
      "original_answer": "Converse's contribution to NIKE, Inc.'s total revenues increased by 3.4% from 2022 to 2023, while its operating income decreased by 30.0% over the same period.",
      "llm_answer": "The percentage change in Converse's contribution to NIKE, Inc.'s total revenues from 2022 to 2023 was a decrease of approximately 1.8% (from $2,346 million in 2022 to $2,427 million in 2023, representing a decline from 5.0% to 4.7% of total revenues). Converse's operating income increased by 13.1% over the same period (from $669 million in 2022 to $758 million in 2023, based on the provided operating income figures of $669 million for 2022 and $758 million for 2023, though the exact 2023 operating income is not explicitly stated in the documents—using the provided data, the calculation is derived from the context of the operating income figures referenced in the financial statements).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both direction and magnitude compared to the ground truth. The original answer states that Converse's contribution to NIKE's total revenues increased by 3.4% from 2022 to 2023, while the LLM claims a decrease of 1.8%, which is factually wrong. Additionally, the original answer states that Converse's operating income decreased by 30.0%, but the LLM claims an increase of 13.1%, which is the opposite direction and grossly inaccurate. (2) The dollar amounts cited by the LLM ($2,346M to $2,427M for revenue, $669M to $758M for operating income) are inconsistent with the ground truth data and appear fabricated. The calculation from $2,346M to $2,427M actually reflects an increase (~3.4%), not a decrease, so even the arithmetic is flawed. The LLM incorrectly interprets this as a decline in percentage contribution due to a supposed drop from 5.0% to 4.7%, which contradicts the stated revenue increase. (3) The multi-hop reasoning failed completely: the model did not correctly extract or synthesize the actual percentage change in Converse's revenue contribution or operating income. It misrepresented both trends (direction of change) and magnitudes. (4) The correctness score is 1 due to major factual and directional errors. Quantitative accuracy is 1 because all key numbers and calculations are wrong. Qualitative accuracy is 1 due to flawed logic and entity/metric misalignment. Contextual relevance is 2 because the answer addresses the right entities (Converse, NIKE, revenue, operating income) and time frame (2022–2023), but with completely incorrect data and conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 450,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the changes to the TDR accounting guidance impact the classification of trial modifications in both the residential real estate and credit card loan portfolios for the year ended December 31, 2023?",
      "original_answer": "The changes to the TDR accounting guidance eliminated the 'reasonably expected' and 'concession' assessment criteria, which resulted in trial modifications being classified as TDRs but not FDMs in both the residential real estate and credit card loan portfolios. For residential real estate, this meant $69 million of loans under trial modification were considered TDRs but not FDMs. Similarly, for credit card loans, $27 million of loans under trial modification were classified as TDRs but not FDMs.",
      "llm_answer": "The changes to the TDR accounting guidance eliminated the “reasonably expected” and “concession” assessment criteria, causing trial modifications in both residential real estate and credit card portfolios to be classified as TDRs (rather than permanent modifications or FDMs). For the year ended December 31 2023, this resulted in $69 million of trial‑modified residential real estate loans and $27 million of trial‑modified credit‑card loans being recorded as TDRs, reflecting the impact of the revised guidance on classification.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: the elimination of the 'reasonably expected' and 'concession' criteria under the revised TDR guidance led to trial modifications being classified as TDRs but not FDMs in both the residential real estate and credit card loan portfolios. (2) Quantitative accuracy is perfect: $69 million for residential real estate and $27 million for credit card loans under trial modification are correctly reported, matching the ground truth exactly. Minor formatting differences (e.g., 'credit-card loans' vs 'credit card loans') do not affect meaning. (3) Multi-hop reasoning is sound—the model correctly synthesizes the impact of accounting guidance changes on classification outcomes across two loan types and ties it to specific financial amounts. (4) The answer addresses all parts of the question: the nature of the guidance change, its impact on classification (TDRs vs FDMs), and the financial magnitude for both portfolios for the correct period (year ended December 31, 2023). No omissions or inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 318,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How many total retention shares and retention units were outstanding under Union Pacific's stock incentive plans as of December 31, 2023, and how does this compare to the number of restricted shares outstanding under the Directors Plan on the same date?",
      "original_answer": "As of December 31, 2023, Union Pacific had 954,405 retention shares and 366,046 retention units outstanding under its stock incentive plans, totaling 1,320,451. This compares to 16,000 restricted shares outstanding under the Directors Plan on the same date.",
      "llm_answer": "As of December 31 2023, Union Pacific’s stock incentive plans had **2,438,300** total retention shares and retention units outstanding (including 366,046 retention units that lack an exercise price).  \nThe number of restricted shares outstanding under the Directors Plan on that same date was **16,000**.  \nThus, the retention‑share/unit total is roughly **152 times larger** than the restricted‑share count under the Directors Plan.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. According to the ground truth, Union Pacific had 954,405 retention shares and 366,046 retention units outstanding, totaling 1,320,451. However, the LLM reports a total of 2,438,300 retention shares and units, which is nearly double the correct amount. While the 366,046 retention units figure is correctly cited, the retention shares number is missing and the total is wrong. The 16,000 restricted shares under the Directors Plan is correctly reported. (2) The calculation of the total (954,405 + 366,046 = 1,320,451) is incorrect in the LLM response, as it reports 2,438,300—this suggests either a data error or misattribution. The comparison ratio of ~152x is based on the incorrect total and thus also wrong; the correct ratio is approximately 82.5x (1,320,451 / 16,000). (3) The multi-hop reasoning is partially sound—the model identifies the need to sum retention instruments and compare them to Directors Plan shares—but fails due to incorrect input data. It correctly distinguishes between stock incentive plans and the Directors Plan, showing awareness of structural differences. (4) The contextual relevance is high as the answer addresses both parts of the question and attempts a meaningful comparison. However, the quantitative accuracy is low due to the major error in the total retention shares/units figure, which undermines the correctness score. The qualitative accuracy is moderate because the reasoning framework is logical but built on incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 431,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "What was the total amount of AMD's investment in the ATMP JV as of December 28, 2024, including both the carrying value of its equity investment and the secured loan it provided to the JV?",
      "original_answer": "AMD's total investment in the ATMP JV as of December 28, 2024, was $249 million. This includes the carrying value of its equity investment, which was $149 million, and a secured term loan of $100 million provided to the JV.",
      "llm_answer": "Based on the provided document pages, AMD's investment in the ATMP JV as of December 28 2024 consisted of a carrying value of its equity investment of approximately $149 million and a secured loan of $100 million that it had extended to the JV. Consequently, the total amount of AMD's investment in the ATMP JV, combining both components, was about $249 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All key facts are accurately reported: the carrying value of AMD's equity investment is correctly stated as $149 million, the secured loan is accurately given as $100 million, and the total investment is correctly calculated as $249 million. (2) Quantitative accuracy is perfect: all dollar amounts match the original answer exactly, and the sum ($149M + $100M = $249M) is mathematically correct. Format variations (e.g., $249 million vs $249M) are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound—while the information appears to come from a single source, the model correctly synthesizes two components (equity investment and loan) into a total investment figure, which is the core of the multi-part question. (4) The answer is contextually relevant, directly addressing the question with precise, complete, and well-structured information. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 288,
        "total_tokens": 1444
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What was the total financial impact on Danaher from the disposition of Envista Holdings Corporation, including the gain on disposition, the foreign currency translation adjustment loss, and the IPO and Separation-related costs?",
      "original_answer": "The total financial impact on Danaher from the disposition of Envista Holdings Corporation was $387 million. This includes a $451 million gain on disposition, reduced by $109 million in reclassified foreign currency translation adjustment losses and $69 million in IPO and Separation-related costs.",
      "llm_answer": "The total financial impact of the Envista Holdings Corporation disposition was a net gain of $451 million on disposition, offset by a $109 million foreign‑currency translation adjustment loss that was re‑classified from accumulated other comprehensive income, and $69 million of IPO and separation‑related costs—all of which were recorded in earnings from discontinued operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all three financial components: $451 million gain on disposition, $109 million foreign currency translation adjustment loss, and $69 million in IPO and separation-related costs. These values match the ground truth exactly. However, the LLM answer fails to compute or state the net total financial impact of $387 million, which is the sum of these components ($451M - $109M - $69M = $387M), as explicitly required by the question. (2) All numeric values are accurate and correctly formatted; the calculation itself is straightforward and verifiable, but the final result is omitted. (3) The reasoning is mostly sound—the model correctly attributes each component to the disposition event and notes they are recorded in discontinued operations, showing proper synthesis across the financial impacts. However, it does not complete the multi-hop step of aggregating the individual figures into the total impact, which is central to the question. (4) The answer is contextually complete and relevant, with precise terminology and correct entity (Envista Holdings Corporation, Danaher implications) and metric identification. The omission of the final net figure reduces completeness and thus lowers the correctness and qualitative accuracy scores, despite perfect quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 370,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did the 15% currency-neutral revenue decline in Converse, driven by North America and Western Europe, impact the overall EBIT performance of the Converse segment, considering the 130 basis point gross margin contraction linked to unfavorable foreign currency exchange rates?",
      "original_answer": "The 15% currency-neutral revenue decline in Converse, primarily due to drops in North America and Western Europe, contributed to a 30% decrease in reported EBIT. This was exacerbated by a 130 basis point gross margin contraction caused in part by unfavorable changes in standard foreign currency exchange rates, which further reduced profitability.",
      "llm_answer": "The 15% currency-neutral revenue decline in Converse, driven by North America and Western Europe, reduced reported EBIT by 30% due to a 130 basis point gross margin contraction from unfavorable foreign currency exchange rates, partially offset by a 2% decrease in selling and administrative expenses.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 15% currency-neutral revenue decline in Converse driven by North America and Western Europe, the 130 basis point gross margin contraction due to unfavorable foreign currency exchange rates, and the 30% decrease in reported EBIT—all of which match the ground truth. However, the LLM introduces new information not present in the original answer: 'partially offset by a 2% decrease in selling and administrative expenses.' This detail is absent from the ground truth and cannot be verified from the provided context, making it an unsupported addition. (2) Quantitatively, all percentages (15%, 130 bps, 30%) are accurate and correctly applied. There are no calculation errors, and the numbers align with the original answer. The 2% reduction in expenses, while specific, lacks corroboration and slightly undermines quantitative reliability. (3) The multi-hop reasoning is mostly sound—the model correctly links revenue decline and margin pressure to EBIT performance. However, the inclusion of unverified cost reductions weakens the logical synthesis, as it implies a counterbalancing factor not mentioned in the ground truth. (4) The answer is contextually relevant and captures the core causal chain. Due to the factual correctness of key metrics and the central conclusion (30% EBIT decline due to revenue and margin pressures), a score of 7 is justified, with minor deductions for the unsupported claim about expense reductions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 408,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did the adoption of the new TDR accounting guidance on January 1, 2023, specifically impact JPMorgan Chase's allowance for credit losses in 2023, and what was the resulting effect on the Firm's financial position given the changes in trial modifications and Chapter 7 loans?",
      "original_answer": "The adoption of the new TDR accounting guidance on January 1, 2023, resulted in a $587 million reduction in JPMorgan Chase's allowance for credit losses. This change was driven by the elimination of the TDR 'reasonably expected' and 'concession assessment' criteria, which reclassified $69 million of loans subject to trial modification and $9 million of loans subject to discharge under Chapter 7 bankruptcy proceedings as non-FDMs (Financial Disincentive Modifications), although they were still considered TDRs. This reclassification reduced the allowance requirement, reflecting a change in how credit losses were estimated for these categories of loans, thereby improving the Firm's reported financial position by lowering the required reserves.",
      "llm_answer": "The adoption of the new TDR accounting guidance on January 1 2023 required that trial‑modification and Chapter 7 loan modifications be treated as TDRs, eliminating the “reasonably expected” and “concession” assessments. Consequently, the Firm’s allowance for credit losses reflected a $587 million reduction attributable to this change, and the allowance as of December 31 2023 was $24.8 billion—a net addition of $3.1 billion from the prior year, which included $1.2 billion to cover First Republic loans and related commitments. This adjustment improved the Firm’s credit‑loss provision outlook while the allowance now incorporates the heightened risk from downgraded wholesale exposures and the elevated macro‑economic stress scenarios.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the direction of the accounting change. The ground truth states that the elimination of the 'reasonably expected' and 'concession assessment' criteria led to reclassifying certain trial modifications and Chapter 7 loans as *non-FDMs*, thereby *reducing* the allowance. However, the LLM incorrectly states that these modifications are now *required to be treated as TDRs*, which implies an increase in allowance, contradicting the $587 million reduction. This misrepresents the core logic of the accounting change. (2) The $587 million reduction is correctly stated, which matches the ground truth. However, the additional figures—$24.8 billion allowance and $3.1 billion net addition—are not in the original answer and introduce unverified data. The mention of $1.2 billion for First Republic is contextually relevant but extraneous and not part of the original multi-hop focus. (3) The multi-hop reasoning fails because the LLM inverts the cause-effect relationship: it suggests the new guidance increased TDR classifications, when in fact it reduced the scope of FDMs despite retaining TDR status. This undermines the qualitative accuracy of the synthesis between the guidance change and its impact on reserves. (4) Despite the major reasoning error, the answer includes the correct dollar impact ($587M reduction) and references the relevant loan types (trial modifications, Chapter 7), maintaining partial relevance. Hence, a moderate score is given for contextual relevance, but correctness and qualitative accuracy are significantly penalized due to the fundamental misinterpretation of the accounting rule change.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 460,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What is the total amount invested in Level 2 assets by UNP's pension plan, and which specific investment categories use bid evaluation with independent pricing sources as their valuation methodology?",
      "original_answer": "The total amount invested in Level 2 assets by UNP's pension plan is $1,111 million. These Level 2 assets are specifically composed of investments in Corporate Stock, Federal Government Securities, and Bonds and Debentures, all of which use bid evaluation processes with independent pricing sources as their valuation methodology.",
      "llm_answer": "The total amount invested in Level 2 assets by UNP's pension plan was $3,209 million as of December 31, 2023. The specific investment categories that use bid evaluation with independent pricing sources as their valuation methodology are Federal government securities and bonds and debentures.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in its quantitative claim, stating $3,209 million invested in Level 2 assets, whereas the ground truth is $1,111 million—a major discrepancy. This error alone severely undermines the answer's correctness. (2) The specific investment categories partially match: the LLM correctly identifies 'Federal Government Securities' and 'Bonds and Debentures' as using bid evaluation with independent pricing sources, but it omits 'Corporate Stock', which is explicitly included in the ground truth. Thus, the answer is incomplete in identifying all relevant categories. (3) The multi-hop reasoning appears flawed—either the model retrieved data from an incorrect year (e.g., 2023 vs. the implied reporting period in the knowledge graph) or conflated Level 2 assets with total plan assets or another classification level (e.g., Level 1 or 3). The failure to align the correct amount with the correct categories indicates a breakdown in synthesizing accurate, cross-referenced data. (4) Despite the factual inaccuracies, the answer is contextually relevant—it addresses the right company (UNP), the right financial concept (Level 2 assets), and valuation methodology, and uses appropriate terminology. Hence, contextual relevance is moderate. However, due to the large numerical error and omission of a key category, the correctness, quantitative, and qualitative accuracy scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 397,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did the growth rate of DHR's research and medical products segment revenue between 2019 and 2021 compare to the company's total revenue growth over the same period, and what does this suggest about the segment's role in DHR's overall financial performance?",
      "original_answer": "DHR's research and medical products segment grew from $13,512 million in 2019 to $24,802 million in 2021, representing a 83.5% increase over two years. Meanwhile, DHR's total revenue increased from $17,911 million in 2019 to $29,453 million in 2021, a 64.4% increase. This indicates that the research and medical products segment outperformed the company's overall growth, suggesting it was a key driver of DHR's financial performance during this period.",
      "llm_answer": "The research and medical products segment revenue grew from $13.512 billion in 2019 to $24.802 billion in 2021, a compound annual growth rate of roughly 45 % over the two‑year span, whereas total company revenue increased from $17.911 billion to $29.453 billion, a compound annual growth rate of about 27 %. This indicates that the segment’s revenue expansion outpaced the company’s overall revenue growth, underscoring its pivotal role in driving DHR’s total financial performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial figures: research and medical products segment revenue of $13.512 billion in 2019 and $24.802 billion in 2021, and total revenue of $17.911 billion in 2019 and $29.453 billion in 2021. These match the ground truth exactly when converted from millions to billions. (2) The LLM calculates compound annual growth rates (CAGR) of approximately 45% for the segment and 27% for total revenue. While the ground truth uses a two-year percentage change (83.5% and 64.4%), the CAGR values provided by the LLM are mathematically accurate: CAGR = (24.802/13.512)^(1/2) - 1 ≈ 45%, and (29.453/17.911)^(1/2) - 1 ≈ 27%. Although the original answer uses total growth over two years instead of CAGR, the LLM’s use of CAGR is a valid and more precise way to express growth over multiple periods, and the comparison remains factually sound. (3) The multi-hop reasoning is correct: the model synthesizes segment and total revenue data across 2019 and 2021, compares their growth, and draws the logical conclusion that the segment outpaced overall company growth and played a pivotal role. (4) All entities (DHR, research and medical products segment, correct years) are accurate. The answer is semantically equivalent to the ground truth, with slightly more sophisticated presentation using CAGR. The only minor deviation is the choice of growth metric (CAGR vs. total growth), but this does not reduce factual accuracy—rather, it enhances analytical depth. Hence, correctness is scored 9 (not 10) because the original answer used total growth percentages, and while CAGR is valid, strict alignment with the ground truth’s calculation method would have been preferable for full parity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 473,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did the adoption of the revised TDR accounting guidance on January 1, 2023, specifically affect JPMorgan's allowance for credit losses and the classification of trial modifications for credit card loans during the year ended December 31, 2023?",
      "original_answer": "The adoption of the revised TDR accounting guidance on January 1, 2023, resulted in a $587 million reduction in JPMorgan's allowance for credit losses. Additionally, the changes eliminated the TDR reasonably expected and concession assessment criteria, which affected the classification of credit card loan modifications. As a result, trial modifications were considered TDRs but not FDMs (formally distressed modifications), whereas in the prior year, credit card TDRs totaled $418 million. For the year ended December 31, 2023, credit card FDMs were $648 million, and there were $27 million of loans subject to trial modifications.",
      "llm_answer": "The adoption of the revised TDR accounting guidance on January 1 2023 eliminated the “reasonably expected” and “concession” criteria, causing trial modifications to be treated as TDRs while still not being classified as formal debt‑modifications (FDMs). Consequently, the allowance for credit losses grew by $1.9 billion in 2023, with $675 million of that increase driven by wholesale loan and lending‑related commitment downgrades, and a $587 million reduction was recorded specifically as a result of the new TDR guidance. This resulted in a total allowance for credit losses of $24.8 billion as of December 31 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies that the revised TDR guidance eliminated the 'reasonably expected' and 'concession' criteria and that trial modifications are now treated as TDRs but not FDMs. It also correctly states the $587 million reduction in the allowance for credit losses due to the new TDR guidance, which matches the ground truth. However, it incorrectly claims the allowance 'grew by $1.9 billion' overall in 2023, which contradicts the implication of a $587 million reduction from the TDR change — the ground truth does not mention any increase in the allowance due to TDR adoption, only a reduction. The $1.9 billion increase and $675 million wholesale downgrades are not supported by the original answer and appear to be fabricated or misattributed. Additionally, the LLM fails to report key data from the ground truth: the prior year's credit card TDRs ($418 million), the 2023 credit card FDMs ($648 million), and the $27 million in loans under trial modifications. (2) Quantitative accuracy is partially correct: the $587 million reduction is accurate, but the $1.9 billion increase and $675 million wholesale component are not in the ground truth and introduce significant errors. The total allowance of $24.8 billion is not mentioned in the original and cannot be verified. (3) The multi-hop reasoning is partially sound — the model correctly links the change in criteria to the reclassification of trial modifications. However, it fails to synthesize the full impact on classification metrics (FDMs, trial mods) and introduces unrelated or incorrect financial movements. (4) Correctness is scored 5 due to a critical contradiction (reduction vs. increase in allowance) and missing key figures. Quantitative accuracy is 5 due to one correct major number but several incorrect ones. Qualitative accuracy is 6 because reasoning about the criteria change is correct, but synthesis is incomplete. Contextual relevance is 9 — the answer stays on topic and addresses the core issue, despite factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 563,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did 3M's adoption and subsequent introduction of a new accounting principle for determining net periodic pension and postretirement plan cost impact the presentation of its pension-related financial metrics across reporting periods?",
      "original_answer": "3M adopted a new accounting principle in the first quarter of 2021 that changed how it calculates the market-related value of fixed income securities in its pension and postretirement plans. Previously, the company used a calculated value approach that deferred asset gains or losses over three years, but it switched to a fair value approach that immediately reflects changes in asset values. This change was applied retrospectively, impacting the expected return on plan assets and the amortization of net unamortized actuarial gains or losses. As a result, the presentation of pension-related financial metrics such as net periodic benefit cost, non-operating other expense (income), net income, and earnings per share was altered. Additionally, this change affected consolidated other comprehensive income, retained earnings, and accumulated other comprehensive income (loss). The fair value approach aligns the expected return on plan assets more closely with the plans' funded status and liability-driven investment strategy, resulting in a more current reflection of asset value changes in financial reporting.",
      "llm_answer": "The adoption of a new accounting principle for determining net periodic pension and postretirement plan cost—changing from the calculated‑value approach to a fair‑value approach for the fixed‑income portion of plan assets—was applied retrospectively to all periods presented. This change altered the components of net periodic benefit cost (specifically the expected return on plan assets and the amortization of unamortized actuarial gains/losses) and therefore modified the presentation of pension‑related financial metrics across reporting periods, though it did not affect consolidated operating income or cash provided by operating activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth. (1) It correctly identifies the key change: 3M's switch from a calculated-value to a fair-value approach for fixed-income securities in pension and postretirement plans, applied retrospectively. This aligns with the original answer's description of the accounting change and its impact on the expected return on plan assets and amortization of actuarial gains/losses. (2) There are no numeric values, dates, or financial figures in the LLM answer, but the ground truth mentions the change occurred in Q1 2021—this specific date is missing in the LLM response, which slightly reduces completeness. However, since the question does not explicitly ask for the timing, and the retrospective application is noted, this is a minor omission. (3) The reasoning is sound: the LLM correctly links the accounting change to the altered presentation of pension-related metrics (e.g., net periodic benefit cost) and notes that operating income and cash flows are unaffected, which is consistent with the ground truth. (4) The answer is contextually relevant and semantically equivalent in substance, though it omits mention of specific impacted items like net income, earnings per share, retained earnings, and accumulated other comprehensive income. It also does not mention the alignment with liability-driven investment strategy, which is a qualitative nuance but not central to the core impact on financial metric presentation. Overall, the answer is factually correct, logically structured, and highly relevant—just slightly less comprehensive than the full ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 449,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did the adoption of the new TDR accounting guidance impact JPMorgan's allowance for credit losses in 2023, and what was the specific dollar amount of this impact?",
      "original_answer": "The adoption of the changes to the TDR accounting guidance on January 1, 2023, resulted in a reduction of $587 million in JPMorgan's allowance for credit losses. This reduction occurred because the new guidance eliminated the TDR 'reasonably expected' and 'concession' assessment criteria, which affected how trial modifications were classified. Previously, trial modifications were considered TDRs (Troubled Debt Restructurings), but under the new guidance, they are no longer classified as FDMs (Financial Difficulty Modifications), leading to a lower allowance requirement.",
      "llm_answer": "The adoption of the new TDR accounting guidance on January 1 2023 reduced the Firm’s allowance for credit losses by $587 million. This reduction is explicitly noted in the allowance‑for‑credit‑losses discussion, which states that the allowance as of December 31 2023 reflected a $587 million decrease resulting from the TDR guidance change.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the dollar amount of $587 million and the effective date of January 1, 2023, are accurately reported. The format '$587 million' is equivalent to '$587 million' used in the LLM answer. (2) The answer addresses both parts of the question: the impact (a reduction in allowance for credit losses) and the specific dollar amount ($587 million). (3) Entity accuracy is correct—JPMorgan (referred to as 'the Firm', which is consistent with JPMorgan's 10-K terminology), the TDR accounting guidance, and the year 2023 are all correctly identified. (4) The reasoning, while more concise than the original answer, correctly identifies the outcome of the guidance change and ties it to the allowance reduction. Although it omits the detailed explanation about the removal of 'reasonably expected' and 'concession' criteria and the reclassification of trial modifications, it still accurately reflects the net impact and source of the change, which is sufficient for correctness. The answer is semantically equivalent and factually sound, with no errors in multi-hop synthesis or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 332,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the combined impact on goodwill and operating profit specifically in the Africa/Eurasia region for Colgate-Palmolive in 2023, and how does this compare to the capital expenditures made in the same region during the year?",
      "original_answer": "In 2023, Colgate-Palmolive experienced a decrease in goodwill of $19 million due to foreign currency translation in the Africa/Eurasia region, bringing the ending goodwill balance to $88 million from $107 million. At the same time, the company reported an operating profit of $254 million for the region. Capital expenditures in Africa/Eurasia totaled $10 million in 2023. Therefore, the combined impact of the goodwill decrease and capital expenditures was $29 million, which is significantly lower than the region's operating profit of $254 million.",
      "llm_answer": "The combined impact of goodwill and operating profit in the Africa/Eurasia region for Colgate-Palmolive in 2023 was $254 million in operating profit, while capital expenditures for the same region totaled $10 million. This indicates that the region generated substantially higher operating profit than the capital invested there during the year.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the operating profit of $254 million and capital expenditures of $10 million for the Africa/Eurasia region in 2023, which matches the ground truth. However, it completely omits the $19 million decrease in goodwill due to foreign currency translation, a key component of the 'combined impact on goodwill and operating profit' asked in the question. The answer incorrectly frames the 'combined impact' as just operating profit, when the question specifically asks for the combined effect of goodwill change and operating profit — which in the ground truth is interpreted as the sum of the $19M goodwill decrease and $10M capex ($29M total), compared to operating profit. (2) While $254M operating profit and $10M capex are quantitatively accurate, the failure to include the $19M goodwill decrease results in a significant factual omission. The calculation of 'combined impact' is not performed at all, and the answer misrepresents the nature of the combined impact. (3) The multi-hop reasoning is flawed: the model fails to synthesize the goodwill change (from the balance sheet impact) with operating profit and capex. It also misunderstands the question’s requirement to assess the combined impact of goodwill and capex relative to operating profit. (4) The answer is contextually relevant — it discusses the right company, region, year, and financial metrics — but lacks completeness and correct synthesis, leading to a partially correct response with significant gaps in reasoning and factual content.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 427,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the impact on 3M's goodwill reporting structure as a result of the 2021 business segment reporting changes, and how was this evaluated in terms of impairment risk?",
      "original_answer": "As a result of the 2021 business segment reporting changes, 3M applied the relative fair value method to determine the impact on goodwill for any reporting unit changes, and these changes were found to be immaterial. Despite these changes, the Company completed its annual goodwill impairment test in the fourth quarter of 2021 and determined that no impairment existed. This indicates that the restructuring did not negatively affect the fair value of reporting units to the extent that impairment would occur.",
      "llm_answer": "The 2021 business‑segment reporting change required 3M to re‑assign goodwill to new reporting units using the relative‑fair‑value method, which resulted in immaterial adjustments to goodwill balances. 3M performed its annual goodwill impairment test in Q4 2021 and concluded that no impairment existed; the change did not create any additional impairment risk beyond the normal annual test. 3M also evaluated the impact of the restructuring actions and the revised pension assumptions, but these did not affect the goodwill impairment assessment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the use of the relative fair value method for reassigning goodwill due to 2021 reporting changes, the immateriality of adjustments, and the conclusion of no impairment from the Q4 2021 annual test. (2) There are no numeric values requiring calculation, but dates (2021, Q4) and qualitative financial terms (immaterial, no impairment) are correctly used and consistent with the original. (3) The multi-hop reasoning is sound—linking segment changes to goodwill reallocation, then to impairment testing and risk assessment. The LLM adds minor extra detail (pension assumptions), which is not in the ground truth but does not contradict it and may reflect broader context from the filing. (4) The answer is semantically equivalent to the original, with only slight expansion. The correctness score is 9 because while all critical information is accurate and complete, the mention of 'revised pension assumptions' introduces an element not directly tied to the goodwill impact or impairment test in the ground truth, slightly exceeding the scope. Quantitative accuracy is 10 as there are no numerical errors. Qualitative accuracy is 9 due to this minor extraneous detail. Contextual relevance is 10—every part of the question is addressed directly and appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 378,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the strategic rationale behind AMD's investment in Silo AI, and how does it connect to AMD's goals for AI model deployment and software development?",
      "original_answer": "AMD's investment in Silo AI was strategically aimed at leveraging Silo AI's workforce to accelerate the deployment and development of AI models and software solutions on AMD hardware. This partnership aligns with AMD's broader objective to strengthen its capabilities in the AI space, particularly within its Data Center segment, by integrating Silo AI's expertise in AI research and development.",
      "llm_answer": "AMD's strategic rationale for investing in Silo AI centers on accelerating the deployment and development of AI models and software solutions on AMD hardware by leveraging Silo AI's workforce and expertise. This acquisition aligns with AMD's broader goals of expanding its AI software ecosystem, enhancing model optimization tools, and strengthening its competitive position in the AI infrastructure market. By integrating Silo AI, AMD aims to streamline AI workflows and improve the efficiency of deploying models on its hardware platforms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: AMD's investment in Silo AI is correctly framed as a strategic move to accelerate AI model deployment and software development on AMD hardware by leveraging Silo AI's workforce and expertise. The connection to AMD's broader AI goals, particularly in the Data Center segment and AI infrastructure, is accurately reflected. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the rationale (workforce leverage) with AMD's strategic objectives (AI software ecosystem, model optimization, competitive positioning). The only minor discrepancy is that the LLM refers to the transaction as an 'acquisition' rather than an 'investment,' which slightly overstates the nature of the deal, though this does not materially distort the strategic intent. (4) The answer is contextually excellent—fully relevant, comprehensive, and semantically equivalent to the original answer, with slightly enhanced detail (e.g., 'streamline AI workflows') that is consistent with the ground truth. Thus, the correctness score is 9 due to the minor terminology issue, but all other dimensions are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 376,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How many amendments were made to the Amended and Restated Agreement For Research & Development Alliance on Triex Module Technology between September 2, 2014, and September 1, 2015?",
      "original_answer": "6 amendments were made to the agreement during the specified period.",
      "llm_answer": "Three amendments were made to the Amended and Restated Agreement for Research & Development Alliance on Triex Module Technology between September 2, 2014, and September 1, 2015.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states that three amendments were made, while the ground truth specifies six amendments during the period from September 2, 2014, to September 1, 2015. This is a significant factual error in the quantitative claim. (2) The number of amendments is incorrect—3 vs. the correct count of 6. There are no calculations involved, but the core numeric fact is wrong. Number format is not an issue here, but the count is materially off. (3) The reasoning appears to follow the question structure and references the correct agreement and time period, indicating proper entity identification and contextual understanding. However, the failure to report the correct number of amendments suggests either a data retrieval error or incorrect synthesis across filings. This is a multi-hop requirement involving tracking amendments over time, and the model undercounted by half. (4) The contextual relevance is high because the answer addresses the exact agreement and correct date range. Qualitative accuracy is moderate due to correct entity and time framing but flawed conclusion. Quantitative accuracy is low due to the incorrect count. Correctness score is low because the answer provides a number that is factually wrong despite correct context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1069,
        "completion_tokens": 354,
        "total_tokens": 1424
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did the timing of PM's acquisition of Swedish Match impact its operational reporting scope in the 2023 10-K, and what does the separate shipment volume commentary suggest about the integration timeline?",
      "original_answer": "PMI acquired a majority position in Swedish Match on November 11, 2022, which resulted in Swedish Match's results being included in PM's financials only from that date through December 31, 2022. This limited inclusion period affected the operational reporting scope in the 2023 10-K, as Swedish Match's business operations were managed and evaluated separately from PM's geographical segments. Additionally, the separate shipment volume commentary for Swedish Match indicates that integration efforts had not yet reached a stage where its operations were fully consolidated with PM’s existing business units, suggesting a phased or ongoing integration process.",
      "llm_answer": "The timing of PM's acquisition of Swedish Match (closing November 11 2022) shifted the company’s reporting structure so that the Swedish Match operating segment—covering its smoke‑free and oral‑product businesses—was presented separately in the 2023 10‑K financial tables (e.g., pages 65‑66). This separate segment disclosure reflects that the acquisition was integrated only late in 2022, with full‑year 2023 results now reported as a distinct “Swedish Match” segment rather than being folded into other geographic segments.  \n\nThe accompanying shipment‑volume commentary, which notes “excluding snuff, snuff leaf and U.S. chew” and references “the inclusion of Swedish Match’s 2022 shipment volume for the full year” to achieve comparability, indicates that the integration timeline was still being aligned; PMI is using the 2022 full‑year volume figures as a baseline to compare 2023 performance, suggesting that the business had not yet been fully harmonized into PMI’s regular reporting cycles at the time of the filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the acquisition date of November 11, 2022, is accurately stated, and the implication that Swedish Match was included only from that date forward in 2022 is consistent with the original answer. There are no numerical values (e.g., dollar amounts, shipment volumes) in the question or ground truth that are misstated. (2) The LLM correctly identifies that Swedish Match was reported as a separate operating segment in the 2023 10-K (e.g., pages 65–66), which reflects the limited integration and supports the claim about reporting scope. This matches the ground truth’s point about Swedish Match being managed separately from geographic segments. (3) The reasoning is sound: the LLM infers from the separate shipment volume commentary—particularly the exclusion of certain products and the use of full-year 2022 Swedish Match data for comparability—that integration was still in progress. This correctly interprets the implication of the commentary, though the original answer frames it slightly more generally as a 'phased or ongoing integration process,' while the LLM provides more specific evidence from the filing. (4) The LLM adds contextual detail (e.g., reference to specific 10-K pages and product lines excluded) not in the ground truth but plausibly derived from the source, enhancing relevance and precision. The only minor gap is that the original answer emphasizes that 2022 inclusion was partial (Nov–Dec), which the LLM implies but does not explicitly state in the context of financial reporting for that year. However, this does not detract significantly from correctness. Overall, the answer demonstrates strong multi-hop reasoning—linking acquisition timing to reporting structure and using shipment commentary to infer integration status—and is semantically equivalent to the ground truth with enhanced detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 523,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "What was the total notional amount of interest rate swaps entered into by 3M in 2021, and how does this compare to the combined principal amount of the fixed-rate notes due in 2049 and 2050 that these swaps were designed to hedge?",
      "original_answer": "The total notional amount of interest rate swaps entered into by 3M in 2021 was $800 million. These swaps were applied to a combined principal amount of $1.65 billion of fixed-rate notes due in 2049 and 2050, meaning the swaps covered approximately 48.5% of the total principal for those notes.",
      "llm_answer": "Based on the document, 3M entered into interest rate swaps with an aggregate notional amount of $800 million in 2021. These swaps were designed to hedge a portion of the fixed‑rate notes due in 2049 ($500 million) and 2050 ($300 million), which together have a combined principal amount of $800 million. Thus, the notional amount of the swaps matches the combined principal of the 2049 and 2050 notes being hedged.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $800 million notional amount of interest rate swaps entered into by 3M in 2021, which matches the ground truth. However, it incorrectly states that the combined principal amount of fixed-rate notes due in 2049 and 2050 is $800 million (comprising $500M in 2049 and $300M in 2050), whereas the ground truth specifies a combined principal of $1.65 billion. This is a critical factual error. (2) The calculation in the LLM answer is internally consistent (i.e., $500M + $300M = $800M), but these input numbers are incorrect. The correct comparison should be $800M swaps against $1.65B notes, resulting in ~48.5% coverage, which the LLM fails to report. Instead, it claims the swap amount 'matches' the principal, which is false. (3) The multi-hop reasoning is partially sound—linking the swaps to the notes they hedge—but fails at data retrieval: the principal amounts for the 2049 and 2050 notes are wrong. The model appears to have hallucinated or misread the note amounts. (4) Due to the significant error in financial figures and the resulting incorrect conclusion about hedge coverage, the correctness and quantitative accuracy scores are low. Qualitative accuracy is moderate because the structure and intent of reasoning are correct. Contextual relevance is high as the answer addresses the right entities and question framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 384,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What was the total consideration transferred by AbbVie for both the acquisition of Allergan and Soliton, Inc., and how much of this combined amount was attributed to cash payments?",
      "original_answer": "The total consideration transferred by AbbVie for the acquisitions of Allergan and Soliton, Inc. was $64,619 million, of which $40,210 million was attributed to cash payments.",
      "llm_answer": "The total consideration transferred by AbbVie for both the Allergan and Soliton, Inc. acquisitions was $64.1 billion for Allergan and $535 million for Soliton, with $39.7 billion of that amount attributed to cash payments for Allergan (the cash component of the Allergan purchase price).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but has significant factual inaccuracies. It states that the total consideration for Allergan was $64.1 billion and $535 million for Soliton, which implies a combined total of $64,635 million—close to the ground truth total of $64,619 million. However, the individual figures are inaccurate: the actual consideration for Allergan was $63,884 million and for Soliton $735 million (summing to $64,619 million), so both component values are incorrect. Additionally, the cash payment is reported as $39.7 billion, whereas the ground truth is $40,210 million ($40.21 billion), making the cash figure inaccurate by over $500 million. (2) The quantitative inaccuracies in both acquisition values and cash component undermine the precision. While the total sum is nearly correct due to offsetting errors, the individual components do not match the source data. (3) The reasoning shows an attempt at multi-hop synthesis—combining two acquisitions and extracting cash payments—but fails to accurately retrieve or compute the correct figures. The model references only the cash component for Allergan and omits any mention of cash paid for Soliton, suggesting incomplete synthesis. (4) Contextual relevance is high because the answer addresses the right companies, transaction types, and payment components. However, due to key numerical errors and incomplete cash attribution, the correctness and accuracy scores are significantly reduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 410,
        "total_tokens": 1534
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does Bank of America's adherence to Basel 3 capital requirements influence its ability to execute its $25 billion stock repurchase program authorized in 2024?",
      "original_answer": "Bank of America's adherence to Basel 3 capital requirements directly influences its ability to execute its $25 billion stock repurchase program because the program is subject to the Corporation's capital position and regulatory requirements. As of December 31, 2024, the Corporation's Common Equity Tier 1 (CET1) capital ratio under the Standardized approach was 11.9 percent, exceeding the minimum requirement of 10.7 percent, which includes a capital conservation buffer and G-SIB surcharge. This capital adequacy allows the Corporation to proceed with repurchasing $13.1 billion of common stock in 2024, as it remains above the thresholds that would trigger restrictions on capital distributions.",
      "llm_answer": "Bank of America's Basel 3 capital ratios—particularly its Common Equity Tier 1 ratio of 13.5 % (Standardized) and 16.9 % (Advanced)—exceed the regulatory minimums and the well‑capitalized thresholds, providing sufficient capital buffers to support its $25 billion stock‑repurchase program. This strong capital position, underpinned by Basel 3‑compliant capital composition and the ability to meet Total Loss‑Absorbing Capacity requirements, enables the bank to safely execute the repurchase program without breaching capital‑distribution restrictions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative metrics. The ground truth states that Bank of America's CET1 ratio under the Standardized approach was 11.9% as of December 31, 2024, while the LLM incorrectly reports it as 13.5% (Standardized) and 16.9% (Advanced), which are not supported by the original answer. These inflated figures misrepresent the bank's actual capital position. Additionally, the original answer specifies that the bank repurchased $13.1 billion of stock in 2024 under the $25 billion authorized program, but the LLM omits this critical detail and implies full execution capability without reference to actual repurchase volume. (2) The calculation of capital buffers and compliance thresholds is not verifiable due to incorrect input numbers. The LLM introduces 'Advanced approach' and 'Total Loss-Absorbing Capacity' requirements, which are not mentioned in the original answer and go beyond the provided context. (3) While the LLM correctly identifies the multi-hop relationship between Basel 3 compliance and stock repurchase capacity, it fails to accurately synthesize the specific data points from the knowledge graph. The reasoning is conceptually sound but built on incorrect data, undermining the conclusion. (4) Despite the strong conceptual framing and relevance to the question, the answer scores low on correctness due to major quantitative errors. The contextual relevance is high because it addresses the core mechanism linking capital requirements to repurchase ability, but the factual foundation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 436,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What is the total carrying value in millions of the Medium-term note ($650 million) with maturity dates in 2023 and 2048 as reported in the MMM 2022 10-K filing?",
      "original_answer": "The total carrying value of the Medium-term note ($650 million) with maturity dates in 2023 and 2048 is $1,287 million.",
      "llm_answer": "The carrying value of the Medium-term note due in 2023 with a $650 million principal amount is $649 million (in millions), as shown in the long‑term debt table on page 87.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but significantly incomplete and factually inaccurate in key aspects. It only reports the carrying value of the 2023 maturity tranche ($649 million) and omits the 2048 tranche entirely. The ground truth states the total carrying value is $1,287 million, which implies the 2048 tranche must be around $638 million ($1,287M - $649M), but this is not mentioned. (2) Quantitatively, the $649 million figure for the 2023 note appears accurate (consistent with ground truth), but the total carrying value is wrong because it fails to include both tranches. The question explicitly asks for the 'total carrying value' of a $650 million note with maturities in both 2023 and 2048, implying two components. The LLM does not sum or even acknowledge the second component. (3) The reasoning is flawed in multi-hop synthesis: the model should have identified that a single $650M note was split into two maturities (2023 and 2048), located both carrying values, and summed them. It only found one part. This indicates failure in entity linkage and aggregation across maturities. (4) Contextual relevance is moderate because the answer addresses the correct company (MMM), correct filing (2022 10-K), and correct metric (carrying value), but fails to answer the core quantitative total. The response is relevant but incomplete and thus substantially incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1076,
        "completion_tokens": 387,
        "total_tokens": 1464
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What is the difference in interest rates between IBM's 2.900% Notes due 2030 and the highest-yielding debt instrument listed in IBM's 2024 10-K filing?",
      "original_answer": "The highest-yielding debt instrument listed in IBM's 2024 10-K filing is the 7.125% Debentures due 2096. The difference in interest rates between these instruments and the 2.900% Notes due 2030 is 4.225 percentage points.",
      "llm_answer": "The 2.900% Notes due 2030 have an interest rate of 2.900%, while the highest‑yielding debt instrument listed in IBM’s 2024 10‑K filing is the 7.125% Debentures due 2096, which carries a 7.125% coupon. Therefore, the interest‑rate difference is 7.125% − 2.900% = 4.225 percentage points.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: the 2.900% Notes due 2030 and the 7.125% Debentures due 2096 are correctly identified, with their respective interest rates and maturities. (2) The calculation of the interest rate difference is precise: 7.125% - 2.900% = 4.225 percentage points, which is numerically and semantically correct. (3) The multi-hop reasoning is sound—correctly identifying the highest-yielding debt instrument from IBM's 2024 10-K and comparing it to the specified note, which requires synthesis across multiple entries in the debt schedule. (4) The answer is contextually relevant, complete, and conveys the same information as the original answer with equivalent wording. No errors in entities, numbers, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1128,
        "completion_tokens": 240,
        "total_tokens": 1368
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "What was the total financial value of AbbVie's acquisition of Allergan, and how much in right-of-use assets did AbbVie acquire as part of the lease obligations assumed during the acquisition?",
      "original_answer": "The total financial value of AbbVie's acquisition of Allergan was $64,084 million, which included $453 million in right-of-use assets acquired in the transaction as of December 31, 2020.",
      "llm_answer": "The acquisition of Allergan was valued at a total consideration of $64,084 million, comprising $39,675 million in cash paid to Allergan shareholders, $23,979 million in fair‑value of AbbVie common stock issued, and $430 million in fair‑value of equity awards granted to former Allergan award holders.  \n\nAs part of the lease obligations assumed in the transaction, AbbVie acquired right‑of‑use assets with a recorded value of $66 million, reflecting the right‑of‑use assets obtained in exchange for new operating lease liabilities during the acquisition.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total financial value of AbbVie's acquisition of Allergan as $64,084 million, which matches the ground truth and is a key correct element. However, it incorrectly states the right-of-use assets acquired as $66 million, whereas the ground truth specifies $453 million — a significant factual error. Additionally, the LLM provides a detailed breakdown of the acquisition consideration ($39,675M cash, $23,979M stock, $430M equity awards), which sum to $64,084M and are internally consistent, but this breakdown is not part of the original question or ground truth answer, suggesting potential hallucination or use of incorrect source data. (2) Quantitative accuracy is partially correct: the total value is accurate, but the right-of-use asset figure is off by a large margin (66 vs 453 million), indicating a major error in a core data point. The breakdown numbers, while summing correctly, are not verifiable against the ground truth and appear extraneous. (3) The multi-hop reasoning is flawed: while the model recognizes that the acquisition value and lease-related right-of-use assets are two components of the transaction, it fails to correctly extract or synthesize the correct value for the latter. The mention of 'new operating lease liabilities' introduces context not present in the ground truth and may reflect misinterpretation of lease accounting. (4) Contextual relevance is high — the answer addresses both parts of the question and stays on topic. However, the inclusion of unverified breakdowns reduces qualitative accuracy. Correctness score is low due to the critical error in the right-of-use asset value, which is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 467,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How many shares of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan according to the 2024 10-K filing, and why are no future awards or deferrals possible under this plan?",
      "original_answer": "According to the 2024 10-K filing, 391 shares of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan. No future awards or deferrals are possible under this plan because it has been closed to new deferrals and awards, as explicitly stated in the filing.",
      "llm_answer": "According to the 2024 10-K filing, 391 shares of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan. No future awards or deferrals are possible under this plan because the plan has been fully utilized and no further awards or deferrals will be made, as explicitly stated in the document.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the number of shares issuable—391—as stated in the 2024 10-K filing, matching the ground truth exactly. This satisfies the quantitative requirement with full accuracy. (2) The explanation for why no future awards or deferrals are possible differs slightly in wording: the LLM states the plan 'has been fully utilized and no further awards or deferrals will be made,' while the ground truth specifies it 'has been closed to new deferrals and awards.' Although the core idea—that no future activity is allowed—is preserved, the phrase 'fully utilized' may imply the plan ended due to exhaustion of allocated shares, which is not confirmed in the ground truth. The actual reason per the filing is administrative closure, not resource depletion. This is a minor but notable nuance in qualitative reasoning. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information about a specific stock award plan from the 2024 10-K, linking the number of shares to the plan status. (4) Despite the slight rewording in rationale, the answer conveys functionally equivalent information and remains factually aligned with the original. Thus, the correctness score is 9 due to perfect numbers and relevance, with a minor deduction in qualitative accuracy for imprecise reasoning phrasing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 372,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did the amortization of intangible assets associated with the Allergan acquisition impact AbbVie's gross margin in 2021, and what was the total amortization expense for definite-lived intangible assets in that same year?",
      "original_answer": "The amortization of intangible assets associated with the Allergan acquisition negatively impacted AbbVie's gross margin in 2021, as noted in the 10-K filing. Although lower amortization of inventory fair value step-up adjustments and favorable product mix contributed to an increase in gross margin, the expense from amortizing intangible assets related to the Allergan acquisition partially offset these gains. In 2021, the total amortization expense for definite-lived intangible assets was $7.7 billion.",
      "llm_answer": "The amortization of intangible assets related to the Allergan acquisition reduced AbbVie's gross margin in 2021, as noted in the \"Gross Margin\" discussion stating that the increase in gross margin percentage was \"partially offset by higher amortization of intangible assets associated with the Allergan acquisition.\" The total amortization expense for definite-lived intangible assets in 2021 was $7.7 billion, as reported in Note 7 (page 100) which states \"Amortization expense was $7.7 billion in 2021.\"",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total amortization expense for definite-lived intangible assets in 2021 is accurately reported as $7.7 billion, which aligns with the original answer and is correctly attributed to Note 7, page 100 of the 10-K. (2) The answer addresses both parts of the question: it explains that the amortization of intangible assets from the Allergan acquisition negatively impacted gross margin in 2021, using direct language from the filing ('partially offset by higher amortization'), and correctly identifies the total amortization expense. (3) The reasoning is sound and reflects proper multi-hop synthesis: it connects the impact on gross margin with the broader context of offsetting factors (e.g., inventory step-up adjustments and product mix, though not required in the LLM answer) while focusing on the specific negative effect of Allergan-related amortization. (4) All entities—AbbVie, Allergan acquisition, 2021 fiscal year, definite-lived intangible assets—are correctly identified and contextualized. The answer is semantically equivalent to the ground truth, with slightly more precise citation (Note 7, page 100), enhancing credibility without introducing error. No factual, numerical, or logical inaccuracies are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 368,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What is the specific purpose of the Restoration Plans as it relates to the Benefit Plans, and how does The Home Depot fund these Restoration Plans according to the 2023 10-K filing?",
      "original_answer": "The Restoration Plans are designed to provide certain associates with deferred compensation that they would have received as a matching contribution under the Benefit Plans if not for the maximum compensation limits set by the Internal Revenue Code. The Home Depot funds these Restoration Plans through contributions made to grantor trusts, which are then used to purchase shares of the company's common stock in the open market.",
      "llm_answer": "The Restoration Plans are designed to provide certain associates with deferred compensation that they would have received under the Benefit Plans as a matching contribution, but only if not for the maximum compensation limits under the Internal Revenue Code. According to the 2023 10-K filing, The Home Depot funds these Restoration Plans through contributions made to grantor trusts, which are then used to purchase shares of the company's common stock in the open market.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually and semantically equivalent to the original (ground truth) answer. (1) All components are correct: the purpose of the Restoration Plans is accurately described as providing deferred compensation in the form of matching contributions that would have been made under the Benefit Plans but for the IRS compensation limits. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, or dates), so quantitative accuracy is not compromised. (3) The funding mechanism is correctly identified: The Home Depot funds the Restoration Plans through contributions to grantor trusts, which then purchase company stock in the open market—this multi-hop synthesis of purpose and funding method is accurate and complete. (4) Entities (The Home Depot, Restoration Plans, Benefit Plans, Internal Revenue Code, grantor trusts) are correctly referenced. (5) The reasoning is sound and directly responsive to both parts of the question. Wording differs slightly but preserves full meaning. No omissions or inaccuracies. All evaluation dimensions are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 313,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What is the percentage change in the value of Variable Rate Notes from December 31, 2023, to December 31, 2024, and how does this reflect in the overall change in total borrowings over the same period?",
      "original_answer": "The value of Variable Rate Notes remained unchanged at $22 million from December 31, 2023, to December 31, 2024. However, total borrowings increased from $20,443 million to $31,099 million, representing a $10,656 million increase. Therefore, the percentage change in Variable Rate Notes is 0%, while the overall percentage increase in total borrowings is approximately 52.1%.",
      "llm_answer": "The Variable Rate Notes balance remained unchanged at $22 million as of both December 31 2023 and December 31 2024, resulting in a 0% change. This stability contributed to the overall increase in total borrowings, which rose from $20.4 billion at the end of 2023 to $31.1 billion at the end of 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the Variable Rate Notes remained unchanged at $22 million, resulting in a 0% change, which matches the ground truth. The total borrowings are reported as rising from $20.4 billion to $31.1 billion, which are rounded versions of the exact figures ($20,443 million to $31,099 million). While these rounded values are reasonable and commonly used in reporting, they slightly reduce precision. The LLM omits the exact dollar increase ($10,656 million) and the precise overall percentage increase (approximately 52.1%), which were part of the original answer. (2) Number verification: $22 million for Variable Rate Notes is correct. $20.4 billion is a rounded version of $20,443 million (difference of $43 million), and $31.1 billion is a rounded version of $31,099 million (difference of $9 million). These approximations are acceptable in context but introduce minor inaccuracies. The exact percentage increase (52.1%) is not mentioned, which is a notable omission. (3) Multi-hop reasoning: The model correctly synthesizes that stable Variable Rate Notes coexisted with a significant increase in total borrowings, implying other debt components drove the increase. This logical inference is sound and reflects proper multi-hop understanding. (4) The correctness score is 8 due to accurate core facts and reasoning, but with minor omissions in precise figures and the overall percentage change. Quantitative accuracy is 8 due to acceptable rounding but missing exact values. Qualitative accuracy is 8 due to sound reasoning and correct entity identification. Contextual relevance is 10 as the answer directly addresses the question with relevant information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 464,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total carrying amount of HD's 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, according to the provided financial data?",
      "original_answer": "The total carrying amount of HD's 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, is $1,726 million.",
      "llm_answer": "Based on the provided financial data, the total carrying amount of HD's 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, is $980 million for each tranche, totaling $1,960 million combined. This is confirmed by the \"Senior notes\" fair value and carrying value table on page 66, which lists \"4.95% Senior notes due September 2026\" with a carrying value of $744 million (though this appears to be a typo in the table as the context indicates $980 million for the 2052 notes, and the 2026 notes are listed separately with $744 million; however, the 2052 notes are explicitly stated as $980 million in the table's final row). The 2026 notes are also referenced in the long-term debt table on page 59 with a carrying amount of $750 million principal, but the carrying value (net of discount) is $744 million, while the 2052 notes are clearly listed as $980 million carrying value. The question asks for the total carrying amount of both tranches, which sums to $744 million + $980 million = $1,724 million. However, the document's \"Senior notes\" table on page 66 explicitly states \"4.95% Senior notes due September 2052\" with a carrying value of $980 million, and the 2026 notes are listed as $744 million, but the question specifies \"September 2026 and September 2052,\" so the total carrying amount is $744 million (2026) + $980 million (2052) = $1,724 million. \n\n**Correction based on precise data**: The document's \"Senior notes\" table (page 66) lists \"4.95% Senior notes due September 2026\" with a carrying value of $744 million and \"4.95% Senior notes due September 2052\" with a carrying value of $980 million. Therefore, the total carrying amount is $744 million + $980 million = $1,724 million. The initial interpretation of $980 million per tranche was incorrect; each tranche has its own carrying value, and the total is $1,724 million. \n\n**Final Answer**: The total carrying amount of the 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, is $1,724 million.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the two tranches of HD's 4.95% Senior Notes due in September 2026 and September 2052 and aims to compute their total carrying amount as of January 28, 2024. It accurately retrieves the carrying values: $744 million for the 2026 notes and $980 million for the 2052 notes from the 'Senior notes' fair value and carrying value table on page 66. The final calculated sum is $1,724 million, which is off by $2 million from the ground truth of $1,726 million. This minor discrepancy may stem from rounding differences not visible in the source data or a small transcription error, but the individual components are correctly cited from the document. (2) The numbers are nearly exact: $744M and $980M are both correctly referenced, and the arithmetic $744M + $980M = $1,724M is correct. The ground truth is $1,726M, so the error is minimal but non-zero. (3) The multi-hop reasoning is sound—LLM synthesizes data from two different tables (page 59 and page 66), recognizes a potential typo, and cross-validates entries. It corrects its initial misinterpretation (assuming both tranches were $980M), demonstrating strong qualitative reasoning and attention to detail. (4) The answer is highly contextually relevant, directly addressing the question with proper entity and time period alignment. The minor $2M difference prevents a perfect score, but the reasoning, sourcing, and near-perfect accuracy justify a 9/10 on correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 407,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What percentage decrease did PM experience in its net derivative asset position from 2022 to 2023, and how does this align with the changes in its total gross amount of derivative contracts?",
      "original_answer": "PM experienced a 45.7% decrease in its net derivative asset position from $186 million in 2022 to $101 million in 2023. This aligns with a reduction in the total gross amount of derivative contracts from $873 million in 2022 to $584 million in 2023, indicating a strategic reduction in overall derivative exposure.",
      "llm_answer": "The net derivative asset position decreased by 93% from $186 million in 2022 to $101 million in 2023, a decline of approximately 93%. This reduction occurred alongside a 7% increase in the total gross notional amount of derivative contracts, which rose from $40,401 million in 2022 to $43,265 million in 2023.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple critical factual errors. The percentage decrease in PM's net derivative asset position is incorrectly stated as 93%, whereas the correct decrease is 45.7% (from $186M to $101M). The calculation of (186 - 101) / 186 ≈ 0.457 or 45.7% is straightforward, but the LLM's 93% is grossly inaccurate. Additionally, the LLM claims a 7% increase in total gross derivative contracts, but the ground truth shows a reduction from $873M to $584M (a 33% decrease), not an increase. The LLM cites implausibly large figures of $40,401M and $43,265M, which are off by an order of magnitude and completely incorrect. (2) All key numeric values are wrong: the percentage change, the gross notional amounts, and the implied direction of change (increase vs. decrease). Even allowing for format variations, these numbers do not align with the ground truth in any way. (3) The multi-hop reasoning is fundamentally flawed. The LLM fails to correctly synthesize the relationship between net asset position and gross contracts. Instead of noting alignment in reduction (both decreasing, indicating reduced exposure), it incorrectly asserts gross contracts increased, leading to a false conclusion about PM's derivative strategy. (4) Due to pervasive factual inaccuracies, incorrect calculations, and reversal of trends, the answer is almost entirely incorrect. The only correct element is the mention of PM and the correct years (2022 to 2023), but all substantive content is wrong, warranting a correctness score of 1.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 424,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total number of shares available for future issuance under both the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non-Employee Directors as of December 31, 2024, and how does this compare to the number of shares of Common Stock to be issued for options and RSUs under these plans?",
      "original_answer": "The total number of shares available for future issuance under both the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non-Employee Directors as of December 31, 2024, is 27.9 million (27.1 million from the 2016 Stock Incentive Plan and 0.8 million from the 2016 Stock Plan for Non-Employee Directors). This is in addition to 10,221,113 shares of Common Stock to be issued for options and 2,005,555 RSUs subject to continued employment under the 2016 Stock Incentive Plan, as well as 129,854 shares of Common Stock to be issued for options under the 2016 Stock Plan for Non-Employee Directors.",
      "llm_answer": "As of December 31 2024, the 2016 Stock Incentive Plan has 27.1 million shares available for future issuance and the 2016 Stock Plan for Non‑Employee Directors has 0.8 million shares available. In total, 29.3 million shares may be issued under these plans, which exceeds the 12.9 million options and RSUs that are currently outstanding and would be issued if all such awards were exercised.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 27.1 million shares available under the 2016 Stock Incentive Plan and 0.8 million under the 2016 Stock Plan for Non-Employee Directors, matching the ground truth. However, it incorrectly calculates the total available for future issuance as 29.3 million (27.1M + 0.8M = 27.9M, not 29.3M). This is a critical error in basic arithmetic. (2) The LLM states that 12.9 million options and RSUs are 'currently outstanding', but the ground truth specifies 10,221,113 shares for options, 2,005,555 RSUs, and 129,854 shares under the directors' plan, totaling ~12,356,522 shares (not 12.9M). The LLM overestimates this figure and fails to break down the components. (3) The multi-hop reasoning is partially sound—correctly identifying both plans and their respective available shares—but fails in accurate summation and misrepresents the outstanding obligations. The comparison claim that available shares 'exceed' outstanding awards is directionally correct (27.9M > ~12.36M), but the magnitude is misrepresented due to incorrect totals. (4) The contextual relevance is high as the answer addresses both parts of the question and uses correct entity names and timeframes. However, the quantitative inaccuracies in both the total available shares and the outstanding awards significantly reduce correctness. The qualitative reasoning is logical but based on flawed numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 391,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What was the growth in Dynamics 365 revenue in fiscal year 2022, and how does this contribute to the overall Dynamics products and cloud services revenue growth of 25%?",
      "original_answer": "Dynamics 365 revenue grew by 39% in fiscal year 2022, which significantly contributed to the overall Dynamics products and cloud services revenue growth of 25%. This indicates that Dynamics 365 was a key driver behind the broader Dynamics suite's performance, suggesting strong adoption and demand for Microsoft's integrated business applications platform.",
      "llm_answer": "The Dynamics 365 revenue grew by **39 %** in fiscal 2022, and this strong growth helped lift the overall Dynamics products and cloud services revenue up **25 %** for the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Dynamics 365 revenue grew by 39% in fiscal year 2022 and that this contributed to the overall Dynamics products and cloud services revenue growth of 25%, which matches the ground truth exactly in terms of key facts. (2) All numeric values—39% and 25%—are accurate and correctly attributed to the right fiscal year (2022) and financial metrics. There are no calculation errors, and the percentages align with the original answer. (3) The multi-hop reasoning is sound: the model correctly infers that the strong growth in Dynamics 365 helped drive the broader Dynamics suite’s growth, even if it doesn’t explicitly state that Dynamics 365 was a 'key driver' or mention 'strong adoption and demand' as in the original. However, the causal contribution is logically conveyed. (4) The answer is semantically equivalent to the ground truth in factual content, though slightly less detailed in qualitative interpretation. It omits the explanatory phrase about 'strong adoption and demand for Microsoft's integrated business applications platform,' but this does not detract from core correctness. Hence, full marks for quantitative accuracy and contextual relevance, a 9 for qualitative accuracy due to minor omission in reasoning elaboration, and a 9 overall for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1138,
        "completion_tokens": 369,
        "total_tokens": 1507
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "By how much did Tesla's Energy Generation and Storage revenue increase specifically due to the deployment of Megapack in 2021 compared to 2020, and what role does Megapack play in Tesla's broader energy storage product portfolio?",
      "original_answer": "Tesla's Energy Generation and Storage revenue increased by $795 million, or 40%, in 2021 compared to 2020, primarily driven by the deployment of Megapack along with growth in solar cash and loan jobs, Powerwall, and Solar Roof. Megapack is a key component of Tesla's energy storage product lineup, designed for commercial, industrial, utility, and energy generation customers, and can be grouped to form large-scale installations of gigawatt hours or greater capacity.",
      "llm_answer": "Tesla's Energy Generation and Storage revenue increased by $795 million (a 40% rise) in 2021 versus 2020, driven primarily by higher deployments of Megapack, solar cash and loan projects, Powerwall and Solar Roof, while Powerpack deployments declined as the product was phased out. Megapack serves as the flagship utility‑scale battery offering within Tesla's broader energy‑storage portfolio, complementing smaller residential solutions like Powerwall and the company's solar generation products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the $795 million increase and 40% growth in Tesla's Energy Generation and Storage revenue from 2020 to 2021, matching the ground truth exactly. These figures are accurate and properly contextualized as being driven primarily by Megapack deployments, along with solar cash and loan jobs, Powerwall, and Solar Roof. (2) Quantitatively, all numbers are correct—$795 million and 40%—and the comparison between 2021 and 2020 is valid. There are no calculation errors. (3) The reasoning is sound and reflects multi-hop synthesis: the model correctly identifies Megapack as a primary growth driver and appropriately situates it within Tesla’s broader energy storage portfolio. It adds a relevant detail not in the original answer—namely that Powerpack was being phased out—which is factually accurate and enhances the explanation without contradicting the ground truth. (4) The only minor deviation from the original answer is that the LLM emphasizes Megapack as the 'flagship utility-scale' product and mentions Powerpack's phaseout, which, while accurate, slightly shifts focus from the original answer’s broader list of contributing factors. However, this does not reduce factual accuracy. The core information—revenue increase amount, percentage, key drivers including Megapack, and Megapack’s role in the product lineup—is fully aligned. Semantic equivalence is maintained, and the answer is contextually complete and highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 409,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What was the total pre-tax loss recognized by Walmart in fiscal 2021 and 2022 related to the divestiture of Asda, including both the initial loss estimate and the additional adjustments upon closing, and how does this reflect the financial impact of pension-related obligations tied to the disposal group?",
      "original_answer": "Walmart recognized a total pre-tax loss of $5.7 billion related to the divestiture of Asda. This includes the $5.5 billion estimated pre-tax loss recognized in the fourth quarter of fiscal 2021, which incorporated $2.3 billion of accumulated pension components, and an additional $0.2 billion loss recorded in the first quarter of fiscal 2022 upon closing, primarily due to changes in net assets, currency exchange rate fluctuations, and purchase price adjustments. The pension-related obligations significantly contributed to the overall loss, illustrating the financial impact of legacy liabilities in international divestitures.",
      "llm_answer": "Walmart recognized a total pre‑tax loss of about **$5.5 billion** on the Asda divestiture in fiscal 2021 (the estimated loss recorded when Asda was classified as held‑for‑sale), and then incurred an additional **$0.2 billion** pre‑tax loss in fiscal 2022 related to post‑closing adjustments and indemnity liabilities.  \n\nThe loss reflects the financial impact of pension obligations tied to the disposal group: the company had to derecognize the Asda pension plan, which required a **$2.3 billion** pension‑related charge that was included in the $5.5 billion loss, and subsequent adjustments to pension‑related liabilities (e.g., indemnity and tax reserves) contributed to the later $0.2 billion loss.  \n\nThus, the total pre‑tax loss from the Asda disposal—combining the initial estimated loss and the later adjustments—was roughly **$5.7 billion**, with a substantial portion driven by pension‑related obligations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $5.5 billion initial pre-tax loss in fiscal 2021, the $0.2 billion additional loss in fiscal 2022, and the total $5.7 billion sum are correctly reported. The $2.3 billion pension-related charge is accurately cited as part of the initial loss. (2) The answer is complete, addressing both the total pre-tax loss over two fiscal years and the role of pension-related obligations. (3) Entity accuracy is correct: Walmart, Asda, fiscal 2021 and 2022, and the financial metrics (pre-tax loss, pension charge, post-closing adjustments) are all properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: the answer correctly links the initial loss recognition upon classification as held-for-sale, the pension derecognition impact, and the subsequent adjustments at closing (including indemnity and currency effects), demonstrating a clear understanding of the financial mechanics. (5) Semantic equivalence is achieved: while the wording differs slightly (e.g., 'indemnity liabilities' vs 'purchase price adjustments'), the core facts, calculations, and causal relationships are preserved and accurately conveyed. The total loss of $5.7 billion is correctly calculated as $5.5B + $0.2B, and the significant role of pension obligations is properly emphasized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 387,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What percentage of Microsoft's More Personal Computing segment revenue in fiscal year 2022 was represented by the combined revenue from Surface devices and Windows OEM licensing, given that the segment reported $56.5 billion in revenue and Windows OEM contributed 42% of that segment's revenue?",
      "original_answer": "The combined revenue from Surface devices and Windows OEM licensing represented 58% of the More Personal Computing segment's $56.5 billion in fiscal year 2022. Windows OEM contributed 42% ($23.73 billion) and Devices (primarily Surface) contributed 16% ($9.04 billion), totaling $32.77 billion or 58% of the segment's total revenue.",
      "llm_answer": "Based on the provided document, the More Personal Computing segment reported $56.5 billion in revenue for fiscal year 2022, and Windows OEM contributed 42% of that segment's revenue. Therefore, the combined revenue from Surface devices and Windows OEM licensing represents 42% of the $56.5 billion segment revenue. \n\nAnswer: 42%",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is incorrect in stating that the combined revenue from Surface devices and Windows OEM licensing represents only 42% of the segment's revenue. The question asks for the *combined* percentage of Surface and Windows OEM, but the model only includes the 42% from Windows OEM and omits the Surface contribution entirely. The ground truth states that Surface (under Devices) contributed 16%, making the total 58%. (2) Quantitatively, the $56.5 billion total revenue and 42% for Windows OEM are correctly cited, which equates to $23.73 billion (accurate). However, the model fails to include the $9.04 billion (16%) from Devices/Surface, leading to an incorrect sum and final percentage. The calculation of 42% as the combined share is factually wrong. (3) The multi-hop reasoning is flawed: the model must synthesize two pieces of information — Windows OEM at 42% and Surface (within Devices) at 16% — and sum them. The model only uses one hop (Windows OEM) and ignores the second (Surface), failing the core requirement of the question. (4) Contextual relevance is moderate because the answer discusses the correct segment, year, and one relevant component (Windows OEM), but it misses a key part of the query (Surface contribution), resulting in a significantly incomplete and misleading conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 370,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "What was the total financial impact on Walmart's pension-related obligations and gains/losses from the Asda pension contribution and subsequent sale, combining the $1.0 billion cash contribution made by Asda in fiscal 2020 and the $2.3 billion accumulated pension components included in the disposal group upon the sale of Asda?",
      "original_answer": "The total financial impact on Walmart from the Asda pension-related activities was $3.3 billion, combining the $1.0 billion cash contribution made by Asda to its pension plan in fiscal 2020 and the $2.3 billion accumulated pension components included in the disposal group upon the sale of Asda. This amount reflects the full pension-related exposure transferred as part of the divestiture.",
      "llm_answer": "The $1.0 billion cash contribution made by Asda in fiscal 2020 and the $2.3 billion of accumulated pension liabilities that were transferred to the disposal group upon the sale of Asda together represent the total financial impact on Walmart’s pension‑related obligations and gains/losses. These amounts are disclosed in Note 11 of the 10‑K, which notes the $1.0 billion cash contribution and the $2.3 billion of pension components included in the disposal group.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and matches the ground truth in all key quantitative aspects: the $1.0 billion cash contribution by Asda in fiscal 2020 and the $2.3 billion of accumulated pension components included in the disposal group are accurately reported. The total financial impact of $3.3 billion is implied through the combination of these two figures, though the LLM does not explicitly state the sum. This omission is minor, as the two components are correctly identified and their inclusion in the total impact is clearly conveyed. The reference to Note 11 of the 10-K adds contextual support and demonstrates proper sourcing. Entity accuracy is correct—Walmart, Asda, pension obligations, fiscal 2020, and disposal group are all appropriately referenced. The reasoning is sound and reflects multi-hop synthesis: linking Asda’s contribution to Walmart’s pension exposure and recognizing that both the contribution and the transferred liabilities affect Walmart’s financial obligations. The answer is semantically equivalent to the ground truth, with only a slight lack of explicit summation preventing a perfect 10. All criteria for correctness, completeness, and relevance are met with high fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 341,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "By how much did the value of pre-owned aircraft inventories increase from December 31, 2023, to December 31, 2024, and what specific valuation method does the company use for these pre-owned aircraft?",
      "original_answer": "The value of pre-owned aircraft inventories increased by $8 million from December 31, 2023 ($15 million) to December 31, 2024 ($23 million). The company values pre-owned aircraft at the lower of the trade-in value or the estimated net realizable value.",
      "llm_answer": "The pre‑owned aircraft inventory rose from $15 million on December 31 2023 to $23 million on December 31 2024, an increase of $8 million. The company values these pre‑owned aircraft at the lower of cost or net realizable value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the increase in pre-owned aircraft inventory value as $8 million, rising from $15 million on December 31, 2023, to $23 million on December 31, 2024. All numerical values and dates are accurate, and the calculation (23 - 15 = 8) is correct. (2) The quantitative accuracy is perfect—values match the ground truth exactly, with acceptable formatting ($15 million vs $15 million). (3) The multi-hop reasoning is sound: the model correctly synthesizes inventory values across two time points and computes the difference. However, there is a minor discrepancy in the valuation method: the LLM states 'lower of cost or net realizable value,' while the ground truth specifies 'lower of trade-in value or estimated net realizable value.' While 'cost' may be interpreted broadly, in this context, 'trade-in value' is more precise and specific to pre-owned aircraft in this company's reporting. This is a subtle but meaningful distinction in inventory valuation methodology. (4) Despite this slight inaccuracy in terminology, the core facts and calculations are correct, and the answer remains highly accurate and relevant. Hence, a score of 9 is justified—excellent but not perfect due to the imprecise valuation method description.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1133,
        "completion_tokens": 355,
        "total_tokens": 1489
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the growth in Xbox Game Pass's curated game library relate to the 3% increase in Xbox content and services revenue, and what broader strategic investments does Microsoft highlight that could influence this gaming segment's performance?",
      "original_answer": "The Xbox Game Pass, which offers access to a curated library of over 100 first- and third-party titles, contributes to the 3% increase in Xbox content and services revenue. This growth is tied to Microsoft's broader strategic investments in gaming, including the acquisition of ZeniMax Media and the planned acquisition of Activision Blizzard, both of which expand the company's content portfolio and community engagement. These investments align with Microsoft's focus on transforming gaming through cloud services like Xbox Cloud Gaming, which enhances accessibility and user engagement across multiple platforms.",
      "llm_answer": "The growth in Xbox Game Pass’s curated library directly contributed to the modest 3% increase in Xbox content and services revenue, as highlighted in the “Highlights from fiscal year 2022” section of page 40, which notes that Xbox content and services revenue rose 3% year‑over‑year. Microsoft also emphasizes broader strategic investments in “inventing new gaming experiences that bring people together around their shared love for games on any devices” and in expanding cloud gaming capabilities, positioning these initiatives as key drivers that could further boost the gaming segment’s performance.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 3% year-over-year increase in Xbox content and services revenue and links it to the growth in Xbox Game Pass's curated library, which aligns with the ground truth. The quantitative figure (3%) is accurate and properly contextualized. (2) All numbers and percentages are correct—specifically, the 3% revenue growth is accurately cited, and no other numerical claims are made that contradict the ground truth. Format and precision are appropriate. (3) The multi-hop reasoning is partially sound: the LLM correctly connects Xbox Game Pass growth to revenue and references Microsoft’s strategic investments. However, it omits key specific investments mentioned in the ground truth—namely, the acquisitions of ZeniMax Media and Activision Blizzard—which are central to Microsoft’s broader gaming strategy. Instead, it uses vague phrasing like 'inventing new gaming experiences' and 'expanding cloud gaming capabilities' without naming the major M&A activities that substantiate those claims. This weakens the qualitative accuracy. (4) Despite missing specific entities, the answer remains contextually relevant and captures the general strategic direction, including cloud gaming and cross-device engagement. The reference to fiscal year 2022 and page 40 adds credibility, though not required for correctness. The answer is semantically close but lacks completeness in entity identification and strategic detail, warranting a 7 for overall correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 419,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How much revenue did Eli Lilly recognize in 2023 specifically from the sale of rights for the olanzapine portfolio, and how does this transaction factor into the broader collaboration and other revenue category for the same year?",
      "original_answer": "Eli Lilly recognized revenue from the 2023 sale of rights for the olanzapine portfolio, including Zyprexa, which is part of the broader 'collaboration and other revenue' category. This category includes revenue from collaborations such as the one with Boehringer Ingelheim and the sale of rights for the olanzapine portfolio and Baqsimi. The sale of the olanzapine portfolio rights directly contributed to the collaboration and other revenue in 2023.",
      "llm_answer": "In 2023 Eli Lilly recognized roughly $1.45 billion of revenue from the sale of rights to the olanzapine portfolio, which is included in the “Collaboration and other revenue” line of the consolidated statement of operations. This amount represents the portion of the broader collaboration and other revenue category for 2023, which totaled $5.31 billion.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer provides specific numerical values—$1.45 billion from the sale of the olanzapine portfolio and $5.31 billion for the total 'collaboration and other revenue'—that are not present in the original answer (ground truth). The ground truth does not specify any dollar amounts for the olanzapine sale or the total collaboration revenue, only confirming that the sale contributed to the broader 'collaboration and other revenue' category. Therefore, the inclusion of precise figures is factually unsupported by the ground truth and likely hallucinated. (2) There is no verification possible for the calculations or proportions (e.g., whether $1.45B is part of $5.31B) because the ground truth contains no numbers. Presenting such precise financial data undermines factual accuracy. (3) The qualitative reasoning is partially sound: the LLM correctly identifies that the olanzapine portfolio rights sale falls under 'collaboration and other revenue' and aligns with the multi-hop requirement of linking a specific transaction to a broader revenue category. It also correctly references Eli Lilly and the relevant product (olanzapine). However, it fails to mention other components of the category like Baqsimi or the Boehringer Ingelheim collaboration, which are part of the full context. (4) The contextual relevance is fair because the structure and intent of the answer match the question’s focus—tying a specific revenue event to a broader category—but the addition of unverified numbers severely compromises correctness. Thus, while the conceptual framework is reasonable, the factual (quantitative) inaccuracies lead to a low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 458,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How does the structure of Tesla's 5.45% Solar Bonds, as evidenced by multiple Supplemental Indentures in 2015, reflect Tesla's (via SolarCity) financing strategy for solar energy projects, and what does this imply about the role of bond-specific trustee agreements in supporting recurring capital needs?",
      "original_answer": "Tesla, through its acquisition of SolarCity, issued multiple tranches of 5.45% Solar Bonds in 2015 (Series 2015/C122-15, 2015/C127-15, 2015/C132-15, and 2015/C137-15), each governed by distinct Supplemental Indentures (4.72, 4.74, 4.76, and 4.78) dated at different points in November through December 2015. This repeated issuance of the same interest rate bond with separate indentures suggests a deliberate financing strategy to raise capital in tranches, allowing SolarCity to match funding with project deployment timelines and investor demand. The use of multiple Supplemental Indentures under the same bond rate indicates that Tesla (via SolarCity) prioritized flexibility in structuring solar project financing, with trustee agreements playing a critical role in enabling discrete funding events while maintaining consistent yield terms for investors.",
      "llm_answer": "The structure of Tesla's 5.45% Solar Bonds—evidenced by multiple Supplemental Indentures in 2015 (e.g., Exhibits 4.38, 4.42, 4.46, 4.48)—reveals a financing strategy centered on incremental, trustee-mediated capital raises to fund solar energy projects through SolarCity, leveraging recurring bond issuances to meet ongoing capital needs. The trustee agreements embedded in these indentures (e.g., \"Thirty-Ninth Supplemental Indenture... related to SolarCity's 5.45% Solar Bonds\") provided critical legal and operational support for structuring and enforcing these recurring financing arrangements, enabling Tesla to systematically access capital markets for solar project funding without relying on traditional equity or single-batch debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general financing strategy and role of trustee agreements correctly, showing understanding of Tesla's use of multiple bond tranches via SolarCity to support solar project funding with recurring capital raises. The qualitative reasoning about incremental financing, trustee-mediated structures, and alignment with capital needs is sound and contextually relevant, earning high marks for contextual relevance and decent qualitative accuracy. However, the quantitative accuracy is significantly flawed: the LLM cites incorrect exhibit numbers (4.38, 4.42, 4.46, 4.48) instead of the correct Supplemental Indentures (4.72, 4.74, 4.76, 4.78), and refers to the 'Thirty-Ninth Supplemental Indenture' without grounding it in the actual series (2015/C122-15, etc.) or dates (November–December 2015). These are factual errors in document identifiers, which are critical in legal/financial contexts. Additionally, the original answer specifies four distinct bond series with precise naming conventions, which the LLM omits, weakening completeness and precision. While the core idea of repeated tranches under similar terms is conveyed, the incorrect exhibit numbers and lack of specific series identifiers suggest a failure in multi-hop synthesis from precise source documents. Thus, despite correct conceptual interpretation, the answer loses significant correctness points due to factual inaccuracies in key identifiers, though not in the overall rate (5.45%) or year (2015), which are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 414,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "By how much did the increase in Megapack deployments contribute to Tesla's Energy generation and storage revenue growth in 2021 compared to 2020, and what other product's decline partially offset this growth?",
      "original_answer": "The increase in Megapack deployments contributed to a $795 million, or 40%, growth in Tesla's Energy generation and storage revenue in 2021 compared to 2020. This growth was partially offset by a decrease in Powerpack deployments as Tesla phased out the product following the introduction of Megapack.",
      "llm_answer": "The increase in Megapack deployments contributed $795 million (about 40 % growth) to Tesla’s Energy generation and storage revenue in 2021 versus 2020, while the growth was partially offset by a decline in Powerpack deployments as the product was phased out.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: the $795 million increase and 40% growth in Tesla's Energy generation and storage revenue due to Megapack deployments in 2021 vs. 2020 are correctly stated, with acceptable formatting ( vs. space, 'about 40 %' ≈ 40%). (2) The offsetting factor—decline in Powerpack deployments due to product phase-out—is correctly identified and explained. (3) Multi-hop reasoning is sound: the answer synthesizes the financial impact of Megapack growth and the counter-effect of Powerpack decline across the two-year comparison, as required by the question. (4) Entities (Tesla, Megapack, Powerpack, Energy generation and storage revenue, 2020–2021 timeframe) are accurate. No factual, numerical, or reasoning errors are present, and the response is fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 259,
        "total_tokens": 1414
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "What was the combined total of Capital Expenditures and Depreciation and Amortization for the Africa/Eurasia region in 2024?",
      "original_answer": "$20 million",
      "llm_answer": "The combined total of Capital Expenditures and Depreciation and Amortization for the Africa/Eurasia region in 2024 is $20 million ($12 million in capital expenditures plus $8 million in depreciation and amortization).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the combined total is $20 million, broken down into $12 million in capital expenditures and $8 million in depreciation and amortization, which sum correctly. (2) Quantitative accuracy is perfect—both components and the total match the ground truth, with acceptable formatting using 'million' and consistent dollar amounts. (3) The multi-hop reasoning is sound: the model correctly identified the relevant region (Africa/Eurasia), the correct year (2024), and synthesized two financial metrics (Capital Expenditures and Depreciation and Amortization) from potentially separate data points. (4) The answer is contextually relevant, directly addressing the question with precise, complete, and semantically equivalent information. No errors in entities, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1051,
        "completion_tokens": 256,
        "total_tokens": 1307
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How does TI's policy regarding retiree health care benefit plan investments compare to the actual TI common stock holdings in non-U.S. defined contribution plans as of December 31, 2024?",
      "original_answer": "TI maintains a policy that none of the assets related to the retiree health care benefit plan are directly invested in TI common stock, as stated in the disclosures. In contrast, TI's non-U.S. defined contribution plans held TI common stock valued at $34 million as of December 31, 2024. This highlights a clear distinction in investment strategy, where the retiree health care benefit plan avoids direct company stock investment, while the non-U.S. defined contribution plans do include TI stock holdings.",
      "llm_answer": "Based on the provided document pages, TI's policy for retiree health care benefit plan investments specifies that the plan's target allocation includes 15%–25% equity securities, but the actual weighted average equity allocation for the U.S. Retiree Health Care plan as of December 31, 2024, was 20% (consistent with the 15%–25% range). Crucially, the document explicitly states: \"None of the plan assets related to the defined benefit pension plans and retiree health care benefit plan are directly invested in TI common stock.\" This confirms that while the retiree health care plan may hold equity securities (including potentially non-TI equities within its 15%–25% target), it does not hold TI common stock directly, unlike the non-U.S. defined contribution plans which specifically hold TI common stock valued at $34 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately states that TI's retiree health care benefit plan does not directly invest in TI common stock, citing the exact policy language from the document. (2) It correctly references the $34 million holding of TI common stock in non-U.S. defined contribution plans as of December 31, 2024—this number is precise and matches the ground truth. (3) The multi-hop reasoning is sound: the model correctly contrasts the investment policy of the retiree health care plan (no direct TI stock) with the actual holdings in non-U.S. defined contribution plans (which do include TI stock). (4) The answer includes additional context about the equity allocation target (15%–25%) and actual weighted average (20%), which is consistent with the source and enriches the response without introducing error. All entities (TI, retiree health care plan, non-U.S. defined contribution plans), dates (December 31, 2024), and financial figures ($34 million) are accurate. The semantic meaning and factual content are equivalent to the original answer, with clear, logical, and complete reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 327,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did LLY's revenue from Baqsimi change between 2023 and 2024, considering both U.S. and Outside U.S. sales, and what does the collaboration and other arrangements disclosure indicate about the shift in revenue recognition for Baqsimi?",
      "original_answer": "LLY's total revenue from Baqsimi dropped significantly from $677.6 million in 2023 (U.S. $645.7 million + Outside U.S. $31.9 million) to only $29.2 million in 2024 (U.S. $2.5 million + Outside U.S. $26.7 million). This sharp decline is explained by the company's disclosure that it sold the rights for Baqsimi in 2023, shifting the revenue recognition from product sales to collaboration and other arrangements, which typically involve milestone payments or profit-sharing agreements.",
      "llm_answer": "Based on the provided document pages, LLY's revenue from Baqsimi was recognized as $579.0 million in 2023 (related to the sale of rights), and the company received $500.0 million in cash in 2023 and an additional $125.0 million in cash in 2024 under the agreement with Amphastar. The collaboration and other arrangements disclosure indicates that revenue from Baqsimi is recognized over time as the company manufactures the product under a supply agreement with Amphastar, where the product has no alternative use and the company has the right to payment. This shift in revenue recognition reflects a transition from a one-time gain on the sale of rights (recorded in 2023) to ongoing revenue recognized over time from manufacturing and supplying the product.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that LLY's total Baqsimi revenue was $677.6 million in 2023 and $29.2 million in 2024, broken down into U.S. and Outside U.S. sales. The LLM incorrectly reports $579.0 million as the 2023 revenue from Baqsimi, which does not match the ground truth. Additionally, the LLM introduces a $500 million cash receipt in 2023 and $125 million in 2024 from Amphastar, which are not mentioned in the original answer and represent a fabrication or misattribution. (2) The quantitative values are entirely incorrect: the correct 2023 total is $677.6M (U.S. $645.7M + $31.9M), and 2024 is $29.2M (U.S. $2.5M + $26.7M). The LLM’s numbers do not align with these, nor do they reflect a correct calculation or reporting of the data. There is no mention of Amphastar or milestone payments in the ground truth. (3) The reasoning is partially sound in that it identifies a shift in revenue recognition from product sales to collaboration arrangements, which aligns with the original answer. However, it mischaracterizes the nature of the shift—ground truth indicates the sale of rights led to a drop in product revenue, with future economics likely reflected in collaboration income, while the LLM frames it as ongoing revenue from manufacturing under a supply agreement, which is not supported by the original. (4) The contextual relevance is moderate because the answer addresses revenue change and recognition shift, but the incorrect numbers and invented details (Amphastar, cash amounts) severely undermine factual correctness. The multi-hop synthesis fails due to reliance on non-ground-truth entities and figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 463,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What classification of revenue does Mastercard specifically include for its 'Processing and Gateway' services, and how does this align with the broader categories of revenue generation described in the company's 10-K filing?",
      "original_answer": "Mastercard classifies revenue from its 'Processing and Gateway' services under the broader category of 'value-added services and solutions,' which are distinct from its primary 'payment network' revenue source. This classification includes revenues generated through either fixed or transaction-based fees and is recognized in the period in which the related services are performed or transactions occur.",
      "llm_answer": "Mastercard classifies revenue from its \"Processing and Gateway\" services within the broader \"Value-added services and solutions\" category, which it explicitly lists alongside other offerings such as cyber and intelligence solutions, data and services, open banking, and digital identity. This classification aligns with the company's disaggregated revenue reporting in its 10-K, where \"Value-added services and solutions\" generated $9,274 million in 2023, distinct from the \"Payment network\" revenue of $15,824 million. The 10-K (Note 3) confirms that revenue from value-added services, including processing and gateway solutions, is recognized based on variable consideration tied to transaction volumes and service usage, reflecting its role in enhancing the core payment network functionality.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that 'Processing and Gateway' services are classified under 'Value-added services and solutions,' which is consistent with the original answer. It also correctly distinguishes this from 'Payment network' revenue, a key point in the question. (2) The quantitative details—$9,274 million for value-added services and $15,824 million for payment network revenue in 2023—are factually correct and match the 10-K filing (Note 3), though the ground truth does not include these specific numbers. Their inclusion enhances completeness but does not contradict the original answer. The mention of variable consideration tied to transaction volumes aligns with the ground truth's statement about fixed or transaction-based fees recognized when services are performed. (3) The multi-hop reasoning is sound: the model synthesizes classification, revenue recognition policy, and alignment with broader reporting categories from the 10-K. The reference to Note 3 adds credibility. (4) Minor deduction in correctness and quantitative accuracy is due to introducing specific dollar amounts not present in the ground truth; while accurate, they go beyond the scope of the original answer without being explicitly required. However, since they are correct and contextually relevant, the answer remains highly faithful. Wording differs but semantic equivalence is maintained. No factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 406,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What was the year-over-year change in CL's pension plan investments in international common stocks, and how does this shift reflect in the total international investments across both reporting periods?",
      "original_answer": "CL's pension plan investments in international common stocks increased by $5 million year-over-year, from $15 million to $20 million. This increase contributed to a broader rise in total international investments, which grew from $537 million to $566 million, reflecting a $29 million year-over-year change. The growth in international common stocks accounted for 17.2% of the total year-over-year increase in international investments.",
      "llm_answer": "The year‑over‑year change in CL’s pension‑plan investments in international common stocks was an increase of $5 million (from $10 million in 2023 to $15 million in 2024). This rise contributed to a corresponding increase in total international pension‑plan investments, which grew from $254 million at the end of 2023 to $246 million at the end of 2024 (a $‑8 million shift when viewed across both reporting periods).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both the starting and ending values for CL's pension plan investments in international common stocks. The ground truth states the investment increased from $15 million to $20 million (a $5 million increase), but the LLM claims it increased from $10 million to $15 million, which is incorrect. Additionally, the total international investments are severely misrepresented: the LLM reports a decrease from $254 million to $246 million (-$8 million), while the ground truth shows an increase from $537 million to $566 million (+$29 million). These errors invalidate the core quantitative claims. (2) Calculations are also incorrect: although the LLM correctly computes a $5 million increase (based on its wrong baseline), it fails to compute the correct total change in international investments and omits the required percentage contribution (17.2%) of the increase in international common stocks to the total increase. The reported -$8 million shift contradicts the actual $29 million growth. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize data across the two reporting periods and misidentifies both the base figures and trends. It does attempt to link the change in international common stocks to total international investments, but the conclusion is based on false premises. (4) Despite these issues, the answer is contextually relevant—it addresses the right company (CL), the right asset class (international common stocks), and the right concept (year-over-year change and its impact on total international investments). However, due to major factual and numerical inaccuracies, the correctness and quantitative accuracy scores are very low. The qualitative accuracy is slightly higher because the structure and intent of the reasoning are present, albeit based on incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 509,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What was the total increase in General Dynamics' (GD) Restricted Stock/RSUs expense from 2022 to 2024, and how did this trend contribute to the overall change in equity-based compensation expense during the same period?",
      "original_answer": "The total increase in Restricted Stock/RSUs expense from 2022 ($59M) to 2024 ($85M) was $26M. Over the same period, total equity-based compensation expense increased from $130M to $145M, an increase of $15M. Therefore, the rise in Restricted Stock/RSUs expense accounted for more than the total increase in overall equity-based compensation, indicating that the increase in RSUs was a primary driver of the overall compensation expense growth.",
      "llm_answer": "The total increase in General Dynamics' Restricted Stock/RSUs expense from 2022 to 2024 was $26 million, rising from $59 million in 2022 to $85 million in 2024. This growth contributed to a modest rise in overall equity‑based compensation expense, which increased from $130 million in 2022 to $145 million in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual numbers: the increase in Restricted Stock/RSUs expense from $59M in 2022 to $85M in 2024 ($26M increase), and the rise in total equity-based compensation from $130M to $145M ($15M increase). These values match the ground truth exactly, and formatting variations (e.g., 'million' vs 'M') are acceptable. (2) Quantitative accuracy is perfect—calculations are correct, and all dollar amounts and years are accurate. (3) However, the qualitative reasoning is incomplete. While the LLM notes that the RSU increase contributed to the rise in overall equity compensation, it fails to highlight the key insight from the ground truth: that the $26M increase in RSUs alone exceeded the $15M total increase in equity compensation, meaning RSUs more than accounted for the entire growth, and thus were the primary driver. This multi-hop synthesis—comparing the component increase to the total increase to infer causality—is missing. (4) Therefore, while the answer is factually correct and contextually relevant, it lacks the full depth of reasoning required to fully address the second part of the question, warranting a high but not perfect correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 341,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "Given Amazon's use of an $8.0 billion unsecured 364-day term loan in early 2023, how does this borrowing decision reflect a strategic preference in short-term liquidity management considering the availability of its $20.0 billion Commercial Paper Programs?",
      "original_answer": "Amazon's decision to enter into an $8.0 billion unsecured 364-day term loan in January 2023, despite having access to a $20.0 billion Commercial Paper Program, suggests a strategic choice in liquidity management. The term loan, classified as short-term debt and fully repaid by December 31, 2023, was likely used to meet specific funding needs with a defined maturity, offering more certainty in repayment terms. In contrast, the Commercial Paper Program provides flexibility with variable issuance and maturities up to 397 days, but as of the reporting period, no borrowings had been drawn. This indicates that Amazon opted for a committed term facility for this particular financing need rather than tapping into its broader commercial paper capacity, possibly to preserve flexibility under the program for other short-term obligations.",
      "llm_answer": "Amazon’s $8.0 billion unsecured 364‑day term loan taken in early 2023 was a short‑term financing move that was later repaid in full by the end of 2023.  The company continues to rely on its $20 billion Commercial Paper Program for general corporate liquidity, indicating that the term‑loan was not a strategic shift away from its broader short‑term borrowing framework but rather a tactical use of available credit while maintaining ample capacity under the commercial‑paper facility.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $8.0 billion unsecured 364-day term loan taken by Amazon in early 2023 and its full repayment by the end of 2023, which aligns with the ground truth. It also accurately references the $20.0 billion Commercial Paper Program. All numeric values—$8.0 billion, $20 billion, 364-day term, and 2023 timing—are factually correct and match the original answer. (2) Quantitative accuracy is perfect: dollar amounts, time duration, and repayment timeline are all consistent with the ground truth. There are no calculation errors or misstatements of figures. (3) The reasoning is mostly sound and captures the essence that the term loan was a tactical rather than strategic shift, preserving flexibility in the commercial paper program. However, it omits a key point from the original answer: that no borrowings had been drawn from the Commercial Paper Program at the time, which strengthens the inference that Amazon chose the term loan for certainty despite unused capacity. This nuance in multi-hop reasoning—linking the absence of CP drawdowns to the deliberate choice of a committed facility—is missing, slightly weakening the qualitative depth. (4) Despite this omission, the LLM answer remains contextually relevant and semantically close to the original, correctly framing the decision as tactical within Amazon’s broader liquidity strategy. The answer does not introduce inaccuracies and effectively addresses the core question of strategic preference in short-term liquidity management.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 424,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "What was the impact on American Express's Membership Rewards liability in 2024 from changes in redemption costs and third-party partner arrangements, and how did the company adjust its liability estimation methodology to account for these changes?",
      "original_answer": "In 2024, American Express adjusted its Membership Rewards liability estimation methodology in response to changes in redemption costs and developments in third-party partner arrangements. The company uses the weighted average cost (WAC) per point and the ultimate redemption rate (URR) as key assumptions to estimate the liability. These assumptions are derived from statistical and actuarial models that consider redemption trends, card product type, enrollment tenure, card spend levels, and credit attributes. The WAC per point is based on 12 months of redemptions and is adjusted when changes in redemption costs are not representative of future expectations or when there are expected developments in redemption patterns. These adjustments were necessary due to evolving redemption options and mix of proprietary cards-in-force, which directly affect the company's financial obligations under the program. The liability is recorded based on these updated assumptions, ensuring that the financial statements reflect the most accurate estimate of future redemption costs.",
      "llm_answer": "The Membership Rewards liability increased to $14,752 million in 2024, reflecting higher redemption costs and adjustments to partner arrangements. To better align with these changes, the company refined its liability estimation by incorporating updated redemption‑cost assumptions and revised third‑party partner contract terms into its actuarial models, improving the accuracy of the liability measurement.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces a specific dollar amount for the Membership Rewards liability in 2024 ($14,752 million), which is not present in the original answer (ground truth). There is no mention of this figure in the ground truth, nor is there any indication that the liability increased by a quantifiable amount. This number appears to be fabricated or hallucinated, severely undermining quantitative accuracy. (2) The original answer does confirm that American Express adjusted its liability estimation methodology due to changes in redemption costs and third-party partner arrangements, which the LLM correctly identifies. However, the LLM fails to mention the core components of the methodology — specifically the use of weighted average cost (WAC) per point and ultimate redemption rate (URR) — and omits that these are derived from statistical and actuarial models incorporating factors like card product type, enrollment tenure, spend levels, and credit attributes. (3) While the LLM captures the high-level idea that methodology adjustments were made in response to changing redemption patterns and partner dynamics, it lacks the multi-hop synthesis of how evolving redemption options and proprietary card mix affect financial obligations. It also does not explain that WAC is based on 12 months of redemptions and is updated when current trends are not indicative of future expectations — a key nuance in the reasoning chain. (4) The contextual relevance is high because the response addresses the general theme of liability impact and methodology adjustment. However, the hallucinated number and omission of key methodological details result in a correctness score of 5 — partially correct but with significant factual and completeness gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 480,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does Colgate-Palmolive's use of selling price increases, as stated in its 2024 10-K, interact with its foreign exchange risk management strategy involving derivative contracts, and what specific financial exposure does this combined approach aim to mitigate?",
      "original_answer": "Colgate-Palmolive uses selling price increases as part of its strategy to manage foreign exchange risk, alongside derivative contracts such as forward and swap contracts, option contracts, and local currency borrowings. This combined approach is designed to offset the earnings impact from currency fluctuations in the over 200 countries where it operates. Specifically, the company aims to mitigate the impact of foreign currency rate movements on its net sales and costs, which could otherwise be significantly affected due to translation of foreign subsidiary assets and liabilities into U.S. dollars and the volatility of exchange rates.",
      "llm_answer": "Colgate-Palmolive uses selling price increases to offset foreign exchange headwinds, and manages this exposure through derivative contracts that hedge foreign currency purchases, assets, liabilities, and net investment in subsidiaries. This combined approach mitigates the financial risk of currency fluctuations impacting earnings and cash flows.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Colgate-Palmolive uses selling price increases to offset foreign exchange headwinds and employs derivative contracts as part of its risk management strategy. It accurately states that the goal is to mitigate the impact of currency fluctuations on earnings and cash flows. However, it omits specific details from the ground truth, such as the types of derivative contracts used (forward and swap contracts, options, local currency borrowings) and the fact that the company operates in over 200 countries, which contextualizes the scale of exposure. The answer also does not mention the translation of foreign subsidiary assets and liabilities into U.S. dollars as a specific exposure, which is a key element in the original answer. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is sound: the model correctly synthesizes the interaction between pricing strategy and financial hedging instruments to manage FX risk. However, it lacks the full depth of the combined approach described in the ground truth, particularly the specific mechanisms and exposures like net sales and cost impacts from currency translation. (4) The correctness score is 8 because the core facts are accurate and the answer addresses the main intent of the question, but it misses some important qualitative details that reduce completeness. Qualitative accuracy is 8 due to partial omission of specific instruments and exposures. Contextual relevance is 10 because the response directly addresses the question’s focus on the interaction between pricing and derivatives and the financial risks involved.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 485,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did the increase in business-to-business activity and residential demand in 2022 impact the average daily volume and revenue per piece for UPS's Next Day Air product, and what factors partially offset this revenue growth?",
      "original_answer": "In 2022, the average daily volume for UPS's Next Day Air product increased due to growth in business-to-business activity from SMBs and large customers, as well as higher residential demand. This volume growth contributed to increased revenue per piece, which was also driven by higher base rates and demand-related surcharges. However, the revenue per piece growth was slightly offset by a reduction in average billable weight per piece.",
      "llm_answer": "The 9.4% rise in business‑to‑business shipments and the higher residential demand drove a 5.3% increase in Next Day Air average daily volume, which together with the shift toward higher‑margin commercial volume lifted Next Day Air revenue per piece by about 12% (from $16.82 in 2020 to $18.83 in 2021).  This growth was partially offset by a modest decline in average billable weight per piece, which tempered the revenue‑per‑piece gain.  Additionally, rising fuel‑surcharge indices and higher operating costs (fuel, employee benefits, network and pickup/delivery expenses) contributed expenses that partly neutralized the revenue expansion.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While the ground truth states that average daily volume increased due to B2B and residential demand in 2022, the LLM incorrectly cites a 9.4% rise in B2B shipments and a 5.3% volume increase without any such figures present in the original answer. More critically, the LLM claims revenue per piece rose from $16.82 in 2020 to $18.83 in 2021 (a 12% increase), which misaligns with the question’s focus on 2022 and introduces data not present in the ground truth. The original answer does not provide specific dollar amounts or percentage increases for revenue per piece, only stating that it increased due to base rates and surcharges. (2) The calculation of a 12% increase from $16.82 to $18.83 is mathematically correct ((18.83 - 16.82)/16.82 ≈ 11.95%), but the data itself is fabricated or misattributed, as the original answer does not reference 2020 or 2021 figures. The mention of fuel surcharges, operating costs, and employee benefits as offsetting factors is incorrect; the ground truth specifies only a reduction in average billable weight per piece as the partial offset to revenue growth. (3) The reasoning partially captures the multi-hop structure—linking B2B/residential demand to volume, then to revenue per piece—but incorrectly extends the analysis to cost-side pressures not mentioned in the original. It also fails to correctly attribute the time frame to 2022 and introduces earlier years without justification. (4) The contextual relevance is moderate because the answer addresses the general causal chain (demand → volume → revenue per piece → partial offset), but the inclusion of irrelevant cost factors and incorrect data undermines accuracy. The qualitative accuracy is limited by incorrect synthesis and unsupported specifics. Overall, the answer is partially correct in direction but fails on key facts and calculations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 529,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the regulatory exclusivity risk for Opdivo in the U.S., as described in the Biologic products section, interact with the multiple international approvals Opdivo received in 2021 to influence BMY's strategic positioning in global oncology markets?",
      "original_answer": "Opdivo faces potential biosimilar competition in the U.S. after 12 years of regulatory data protection, with patent litigation possibly starting as early as four years post-approval. Given Opdivo received multiple international approvals in 2021 (e.g., Japan for cancer of unknown primary, gastric cancer, and esophageal cancer; EC for gastric, esophageal, CRC, and mesothelioma indications), BMY must strategically manage its patent enforcement and market expansion efforts globally to maximize revenue before biosimilar entry. This global regulatory diversification may help offset potential U.S. market erosion.",
      "llm_answer": "The regulatory exclusivity risk for Opdivo in the U.S.—stemming from the 12‑year data‑protection period and the possibility of early biosimilar challenges—is offset by the multiple international approvals Opdivo received in 2021, which expand its market reach and diversify revenue streams across Europe, Japan and other regions, thereby strengthening BMY’s overall strategic positioning in global oncology.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the 12-year U.S. data protection period and risk of early biosimilar challenges (linked to patent litigation starting as early as four years post-approval) are accurately represented. The international approvals in 2021 are correctly referenced in terms of their strategic impact, though the LLM does not list the specific indications (e.g., gastric, esophageal cancers) or regions (Japan, EC) in detail. (2) Quantitative accuracy is perfect: '12-year data-protection period' matches the ground truth; no calculations are required, but temporal facts are correct. (3) Multi-hop reasoning is sound—LLM correctly synthesizes U.S. regulatory risk with global approvals to conclude that international expansion helps offset U.S. exclusivity risk, strengthening BMY’s global oncology positioning. (4) While the LLM omits granular details about specific 2021 approvals (e.g., Japan for cancer of unknown primary, EC for mesothelioma), it captures the core strategic implication. This minor omission prevents a perfect 10 on qualitative accuracy, but the overall reasoning, entity accuracy (BMY, Opdivo, biosimilars), and contextual relevance are excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 353,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What is the total estimated fair value of Amazon's convertible note investments in Anthropic, PBC as of December 31, 2024, and how does this valuation compare to the total amount invested in those notes by that date?",
      "original_answer": "As of December 31, 2024, the estimated fair value of Amazon's convertible note investments in Anthropic, PBC was $13.8 billion. By that date, Amazon had invested a total of $5.3 billion across three convertible notes ($1.25 billion in Q3 2023, $2.75 billion in Q1 2024, and $1.3 billion in Q4 2024). This indicates that the fair value of the investment increased significantly, reflecting a valuation uplift in the notes based on Anthropic's subsequent financing activities and market expectations.",
      "llm_answer": "Based on the provided document pages, the total estimated fair value of Amazon's convertible note investments in Anthropic, PBC as of December 31, 2024, is approximately $13.8 billion, as stated in the \"Note 2 - FINANCIAL INSTRUMENTS\" section on page 48. This valuation is derived from the fair value estimates of the convertible notes, which were classified as Level 3 assets and valued using methods considering market conditions, liquidity discounts, and anticipated liquidity events. The total amount invested in these notes by December 31, 2024, is $5.3 billion, comprising $1.25 billion invested in Q3 2023, $2.75 billion in Q1 2024, and $1.3 billion in Q4 2024 (with an additional $2.7 billion planned for Q4 2025). Thus, the estimated fair value ($13.8 billion) significantly exceeds the total cash invested ($5.3 billion) as of that date.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the estimated fair value of Amazon's convertible note investments in Anthropic, PBC as $13.8 billion and the total amount invested as $5.3 billion, broken down into $1.25 billion in Q3 2023, $2.75 billion in Q1 2024, and $1.3 billion in Q4 2024—matching the ground truth exactly. All numeric values are accurate and properly formatted. (2) The calculation of total investment ($1.25B + $2.75B + $1.3B = $5.3B) is correct, and the comparison between fair value and invested amount is accurately stated. The mention of an additional $2.7 billion planned for Q4 2025 is not part of the original question (which asks only about amounts invested by December 31, 2024), but this extra detail does not contradict the ground truth and is likely drawn from the source document; it does not detract from correctness. (3) The multi-hop reasoning is sound: the model synthesizes investment amounts across multiple quarters and compares them to the fair value, correctly concluding that the fair value significantly exceeds the cash invested. It also appropriately references valuation methodology (Level 3 assets, market conditions), adding context without distorting facts. (4) The answer is semantically equivalent to the original, with slightly more procedural detail (e.g., valuation methods) that enhances clarity without introducing error. The only minor point preventing a perfect 10 is the inclusion of forward-looking investment not directly relevant to the question, which, while not incorrect, slightly extends beyond the scope. Overall, the answer is factually precise, well-reasoned, and fully responsive.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 453,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does Colgate-Palmolive's accounting treatment of pension enhancements differ from other Employee-Related Costs under its severance policies, and why is this distinction reflected differently on the balance sheet?",
      "original_answer": "Colgate-Palmolive accounts for pension enhancements differently from other Employee-Related Costs such as severance and termination benefits. While severance costs are calculated based on written severance policies, local statutory requirements, and voluntary termination arrangements, pension enhancements are specifically reflected as 'Charges against assets' within Employee-Related Costs. This distinction arises because the balance sheet treatment of pension enhancements is recorded as either a reduction of pension assets or an increase in pension liabilities, unlike other severance-related costs which are treated as operating expenses. This separate classification ensures that the financial impact of pension enhancements is directly tied to asset or liability adjustments, rather than being netted into general operating charges.",
      "llm_answer": "Colgate‑Palmolive treats pension enhancements as part of its “Employee‑Related Costs” within the 2022 Global Productivity Initiative, recording them as a charge against pension assets (i.e., a reduction of pension assets or an increase in pension liabilities). This is distinct from other employee‑related costs such as severance, which are expensed directly. Because the pension enhancement charge is reflected as an adjustment to pension balances rather than as a separate line‑item expense, it appears as a reduction of pension assets or an increase in pension liabilities on the balance sheet, whereas other severance‑related accruals are recorded in accrued liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that Colgate-Palmolive treats pension enhancements as 'charges against assets' within Employee-Related Costs, specifically under the 2022 Global Productivity Initiative (contextual detail not in the original but not incorrect). It accurately contrasts this with other severance costs, which are expensed directly. The balance sheet treatment is correctly explained: pension enhancements reduce pension assets or increase pension liabilities, while other severance costs are recorded in accrued liabilities as operating expenses. All entities (Colgate-Palmolive, pension enhancements, severance, balance sheet items) are correct. There are no numeric values requiring verification, so quantitative accuracy is满分. The reasoning is sound and reflects proper multi-hop synthesis between accounting treatment and balance sheet impact. The only minor shortcoming is that the original answer emphasizes the structural reason—why the distinction exists (to tie financial impact directly to asset/liability adjustments)—slightly more explicitly, which the LLM implies but does not fully articulate. This small gap in depth prevents a perfect 10 on qualitative accuracy, but overall the answer is semantically equivalent and highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 370,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the regulatory data protection period for biologic products in the U.S. impact the market exclusivity of Opdivo, and what financial risk does this pose to BMY based on the rate of revenue decline observed after exclusivity expiration in developed markets?",
      "original_answer": "The U.S. provides 12 years of regulatory data protection for innovative biologics like Opdivo, meaning biosimilar versions cannot be approved until 12 years after initial FDA approval. However, BMY faces financial risk because when market exclusivity ends, the product typically experiences a significant and rapid revenue decline. In developed markets like the U.S. and certain EU countries, revenue can drop sharply—often losing a major portion in a short period—especially for products used in large patient populations or those that are simpler to manufacture. This decline threatens BMY's long-term revenue stability for Opdivo if biosimilar competition emerges after the 12-year protection period.",
      "llm_answer": "The U.S. regulatory framework provides 12 years of data‑exclusivity for innovative biologics such as Opdivo, but once that period ends the product can face rapid generic competition. In the United States, the decline in sales after exclusivity loss is typically steeper than in most other developed markets, and BMY has observed a sharp revenue drop following exclusivity expiration in those markets. Consequently, BMY is exposed to a significant financial risk: a faster‑than‑expected erosion of Opdivo’s U.S. sales could sharply reduce future revenues and profit margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 12-year data exclusivity period for biologics in the U.S. is correctly stated, and no other numerical values (e.g., revenue decline percentages) are asserted that would conflict with the original answer. (2) The answer correctly identifies that biosimilar competition (referred to as 'generic competition'—a minor imprecision, as biosimilars are not generics but the term is often used colloquially) follows exclusivity expiration and leads to rapid revenue decline. (3) The multi-hop reasoning is sound: it connects U.S. regulatory protection → expiration → competitive entry → observed revenue decline in developed markets → financial risk to BMY. The original answer emphasizes that revenue drops sharply in developed markets including the U.S. and EU; the LLM correctly notes the U.S. decline is steep and references observations from other developed markets, though it slightly overemphasizes the U.S. being steeper without explicit support in the ground truth. (4) The term 'generic' is used instead of 'biosimilar,' which is technically inaccurate for biologics, but the overall meaning and risk implication remain correct. The financial risk to BMY—revenue and margin erosion—is accurately conveyed. All key entities (Opdivo, BMY, U.S. regulatory framework) are correct. The answer is contextually complete and relevant, with only minor terminology imprecision preventing a perfect 10 on qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 415,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What percentage of Amazon's total advertising services revenue in 2024 was derived from display advertising, given that display advertising revenue was $35 billion and advertising services revenue totaled $40 billion?",
      "original_answer": "87.5%",
      "llm_answer": "Based on the provided data, display advertising revenue was $35 billion and total advertising services revenue was $40 billion. Therefore, display advertising accounted for 35/40 = 0.875, or 87.5%, of Amazon's total advertising services revenue in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that display advertising revenue was $35 billion and total advertising services revenue was $40 billion, matching the input data. The calculated percentage is 87.5%, which exactly matches the ground truth. (2) The calculation 35/40 = 0.875 is accurate and correctly converted to 87.5%. All numeric values and formats are correct and semantically equivalent to the ground truth. (3) The reasoning is sound and complete: the model correctly interprets the question as requiring a percentage calculation from two given figures and performs the correct arithmetic. Although this is a single-hop calculation, the logic and synthesis of the two provided numbers are accurate. (4) All aspects of the answer—factual, quantitative, and logical—are correct, fully addressing the question with precise information and clear justification. Therefore, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1082,
        "completion_tokens": 268,
        "total_tokens": 1350
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What is the dollar amount decrease in the value of U.S. government and agency debt securities held by UPS from 2020 to 2021, based on the Level 1 quoted prices in active markets for identical assets?",
      "original_answer": "The value of U.S. government and agency debt securities held by UPS decreased by $16 million from 2020 to 2021 based on Level 1 quoted prices. In 2020, the value was $184 million, and in 2021, it was $200 million.",
      "llm_answer": "Based on the Level 1 quoted prices disclosed in the fair‑value hierarchy (page 89), the U.S. government and agency debt securities held at December 31 2021 were valued at **$200 million**, compared with **$184 million** at December 31 2020. This represents a **$16 million decrease** in the value of those securities from 2020 to 2021.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer contains a critical factual error in both the direction and magnitude of the change. According to the ground truth, the value of U.S. government and agency debt securities held by UPS decreased by $16 million from 2020 to 2021, with a 2020 value of $184 million and a 2021 value of $200 million. However, this implies an *increase* of $16 million ($200M - $184M = +$16M), which contradicts the stated 'decrease'. The LLM incorrectly labels a $16 million increase as a 'decrease', which is a fundamental error in quantitative reasoning and factual accuracy. The numbers themselves ($184M and $200M) match the ground truth, but the calculation and conclusion are reversed, making the answer factually wrong. This failure to correctly compute the direction of change invalidates the core of the multi-hop comparison. Despite correct entity identification (UPS, U.S. government and agency debt securities, Level 1 quoted prices, correct years), the reasoning and final claim are incorrect. Therefore, the answer is mostly incorrect due to a major calculation/logic error, warranting a very low score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 313,
        "total_tokens": 1464
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the joint development and cost-sharing structure between BMS and Ono for Yervoy impact the financial risk exposure of BMS in the context of potential biosimilar competition under the U.S. regulatory framework?",
      "original_answer": "Under the joint development agreement between BMS and Ono for Yervoy, development costs and profits are shared equally when combination therapies involve compounds from both parties. This equal cost-sharing reduces BMS's individual financial burden in developing Yervoy. However, under the U.S. regulatory framework, Yervoy, as a biologic, faces a risk of biosimilar competition after 12 years of regulatory data protection. Since BMS markets Yervoy in the U.S., potential biosimilar entry could erode its revenue share. Despite this risk, the joint cost-sharing arrangement with Ono limits BMS’s upfront investment and thus partially mitigates financial exposure in the event of market exclusivity loss due to biosimilar approval.",
      "llm_answer": "The joint development and cost‑sharing arrangement with Ono for Yervoy shifts a portion of the product’s development and commercial expenses to Ono, but BMS still bears the majority of the financial risk, especially as biosimilar competition could erode sales. Because the partnership involves shared profits and reimbursements, BMS’s exposure is limited to the net margins after cost‑sharing; however, any decline in Yervoy’s market share due to biosimilars would directly reduce BMS’s revenue and potentially increase its reliance on cost‑recovery mechanisms under the U.S. regulatory framework.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces inaccuracies in key qualitative aspects. It correctly identifies that there is a cost-sharing arrangement with Ono and that biosimilar competition poses a risk to Yervoy under the U.S. regulatory framework. However, it incorrectly states that BMS 'bears the majority of the financial risk' and 'still' bears most of the burden, which contradicts the ground truth that development costs and profits are shared equally in combination therapies involving both parties. This misrepresents the core financial structure of the BMS-Ono agreement. (2) There are no numeric values, dates, or percentages in either answer, so quantitative accuracy is not violated—score is 10 by default. (3) The multi-hop reasoning is partially sound: the model connects cost-sharing, profit-sharing, and biosimilar risk, but fails to accurately synthesize the equal-sharing aspect of the agreement, which is central to mitigating BMS's financial exposure. The conclusion that BMS’s exposure is limited to 'net margins after cost-sharing' is directionally reasonable but undermined by the incorrect premise about unequal risk. (4) Contextual relevance is high because the response addresses both the joint development structure and biosimilar risk under U.S. regulations. However, due to the critical error in portraying the risk-sharing imbalance, the qualitative and overall correctness scores are significantly reduced. A score of 5 reflects partial correctness with major factual inaccuracies in entity relationships and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 437,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What percentage of the $6.03 billion decline in Automotive Sales Revenue was offset by the $596 million of FSD (Supervised) revenue recognized in 2024, and how does this relate to the deferred revenue and guarantee liabilities associated with over-the-air software updates and vehicle residual values?",
      "original_answer": "The $596 million of FSD (Supervised) revenue recognized in 2024 offset approximately 9.9% of the $6.03 billion decline in Automotive Sales Revenue ($596M ÷ $6,030M = 0.0988 or 9.9%). This FSD revenue is part of the broader category of automotive sales that includes access to over-the-air software updates, for which deferred revenue is tracked. Additionally, Tesla’s maximum exposure for resale value guarantees under leasing programs, which can be affected by residual values influenced by software features like over-the-air updates, increased to $1.45 billion in 2024, up from $166 million in 2023.",
      "llm_answer": "The $6.03 billion decline in Automotive sales revenue was partially offset by $596 million of FSD (Supervised) revenue recognized in 2024, reducing the net decline to roughly $5.43 billion. This revenue is recorded as part of the transaction price allocated to the performance obligations for FSD and related services, which are recognized over time; the associated deferred‑revenue balance reflects the portion of the transaction price that remains unsatisfied and will be recognized as the services are delivered. The deferred‑revenue accounting also ties into the company’s guarantee liabilities for resale‑value commitments and the accounting for over‑the‑air software updates, as these obligations affect the timing of revenue recognition and the related liability estimates.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $6.03 billion decline in Automotive Sales Revenue and the $596 million FSD (Supervised) revenue recognized in 2024, which are accurate per the ground truth. However, it fails to explicitly calculate or state the percentage offset (9.9%), which is a core part of the question. While the net decline of $5.43 billion is correctly implied ($6.03B - $0.596B), the absence of the percentage calculation is a significant omission. (2) The numbers themselves are accurate and properly formatted, but the key derived metric (596/6030 = 9.9%) is missing, reducing quantitative accuracy. (3) The qualitative reasoning is sound: the LLM correctly links FSD revenue to performance obligations, deferred revenue, over-the-air updates, and resale value guarantees, showing appropriate multi-hop understanding of how these accounting concepts interrelate. However, it omits the specific data point about the increase in Tesla’s maximum exposure for resale value guarantees rising to $1.45 billion in 2024 (from $166 million in 2023), which is a critical factual component in the original answer. (4) The answer is contextually relevant and well-structured, addressing the relationship between deferred revenue and guarantee liabilities, but lacks completeness in delivering all required facts. Thus, while reasoning and framing are strong, the missing percentage and key liability figure reduce correctness and quantitative accuracy scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 408,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What non-GAAP financial measure does PepsiCo adjust for items affecting comparability in its 2022 10-K filing, and how does this adjustment account for currency fluctuations when evaluating operating profit growth?",
      "original_answer": "PepsiCo adjusts operating profit for items affecting comparability to evaluate performance on a comparable basis, and further adjusts this metric for currency fluctuations to assess operating profit growth on a constant currency basis, as disclosed in the 2022 10-K filing.",
      "llm_answer": "PepsiCo adjusts for items affecting comparability—including restructuring and impairment charges, acquisition and divestiture-related charges, and mark‑to‑market net impacts—to derive its non‑GAAP Operating Profit Adjusted for Items Affecting Comparability. When evaluating operating profit growth, this adjusted measure is also calculated on a constant‑currency basis, which removes the effect of currency fluctuations, allowing the company to assess underlying profit performance independent of exchange‑rate movements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in both factual content and semantic meaning. (1) The non-GAAP measure is correctly identified as 'Operating Profit Adjusted for Items Affecting Comparability,' and the explanation of adjustments—including restructuring charges, acquisition/divestiture-related costs, and mark-to-market impacts—is consistent with PepsiCo's disclosures in the 2022 10-K. (2) There are no numeric values requiring verification (e.g., dollar amounts or percentages), so quantitative accuracy is not compromised; all referenced financial concepts are accurately described. (3) The multi-hop reasoning is sound: the model correctly synthesizes that PepsiCo first adjusts operating profit for items affecting comparability and then further adjusts for currency fluctuations to evaluate growth on a constant-currency basis. This two-step adjustment process is accurately captured. (4) The LLM provides additional context not in the ground truth (specific examples of items affecting comparability), which enhances completeness without introducing error. The core requirement—identifying the measure and explaining the constant-currency adjustment—is fully met with high precision, making the answer semantically equivalent and factually robust.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 357,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How many amendments to the Amended and Restated Agreement for Research & Development Alliance on TriexModule Technology are documented across the two exhibits, and what is the time span between the earliest and latest effective dates of these amendments?",
      "original_answer": "There are 12 total amendments documented across the two exhibits. The time span between the earliest effective date (September 2, 2014) and the latest effective date (May 1, 2021) is 6 years and 8 months.",
      "llm_answer": "The Amended and Restated Agreement for Research & Development Alliance on TriexModule Technology has been amended eleven times in total across the exhibits. The earliest effective date of these amendments is September 2 2014 (the original agreement), and the latest effective date is May 1 2021 (the twelfth amendment).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM incorrectly states there are 11 amendments, while the ground truth is 12. This is a critical factual error affecting the primary quantitative answer. However, the earliest effective date (September 2, 2014) and latest effective date (May 1, 2021) are correctly identified. (2) The time span calculation in the original answer is 6 years and 8 months, which is accurate based on the dates provided. The LLM does not compute or report the time span at all, missing a required component of the question. While the dates themselves are correct, the failure to calculate the time span and the incorrect count of amendments significantly impact quantitative accuracy. (3) The reasoning shows partial multi-hop synthesis—correctly identifying the earliest and latest dates across exhibits—but fails in accurately counting the total number of amendments. The mention of the 'twelfth amendment' contradicts the stated count of eleven amendments, indicating internal inconsistency. (4) Despite the numerical inaccuracies, the LLM demonstrates contextual understanding by referencing the correct agreement, correct dates, and the concept of amendments across exhibits. The answer is relevant and attempts the correct synthesis, but core factual errors reduce correctness and quantitative accuracy scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 368,
        "total_tokens": 1525
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "What was the combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022?",
      "original_answer": "The combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022 was 18.5 percentage points.",
      "llm_answer": "The combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022 was 14 percentage points from the acquisition and 4.5 percentage points from favorable foreign exchange.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in identifying that both the acquisition of Pioneer Foods and favorable foreign exchange impacted net revenue growth in the AMESA division in 2022. However, the individual contributions stated (14 percentage points from acquisition and 4.5 from foreign exchange) do not match the ground truth, which states a combined impact of 18.5 percentage points. The sum of the LLM's numbers (14 + 4.5 = 18.5) matches the correct total, suggesting the model may have access to correct component values but incorrectly attributed them. (2) Quantitative accuracy is compromised because the original answer does not break down the 18.5 percentage points into specific contributions from each factor—thus, assigning 14 and 4.5 lacks support from the ground truth. Even though the sum is correct, the breakdown is speculative and not factually verified. (3) The reasoning shows an attempt at multi-hop synthesis by separating two contributing factors to revenue growth, but it introduces unverified quantitative details not present in the original answer, undermining factual reliability. (4) Scores reflect partial credit for reaching the correct total through plausible components, but significant deduction for asserting unsupported breakdowns. Contextual relevance is high as the answer addresses the right division, year, and factors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1112,
        "completion_tokens": 382,
        "total_tokens": 1494
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does Opdivo's regulatory data protection timeline in the U.S. and EU interact with its patent expiration pattern to influence market exclusivity, particularly in light of its 2021 U.S. revenue growth of 7%?",
      "original_answer": "Opdivo, as a biologic product, benefits from 12 years of regulatory data protection in the U.S., meaning the earliest a biosimilar could be approved is 12 years after its initial FDA approval. In the EU, Opdivo is subject to the '8+2+1' regime, allowing a generic to file an MAA after 8 years and commercialize after 10 or 11 years, depending on additional indications. In the U.S., formulation and additional patents for Opdivo expire in 2026 and beyond, extending market exclusivity despite the expiration of method of use patents in 2021. The 7% U.S. revenue growth in 2021 for Opdivo highlights the continued demand and commercial strength of the product, which is preserved by these extended patent protections and regulatory exclusivity. This regulatory and patent framework ensures that despite the 2021 patent expiration, market exclusivity for Opdivo remains intact through the 2020s, supporting sustained revenue generation.",
      "llm_answer": "Opdivo’s U.S. revenue grew 7% in 2021 driven by higher demand and pricing, while its EU market saw a 9% increase, reflecting stronger demand and modest price pressure. However, regulatory exclusivity for Opdivo in the EU is limited to 8 + 2 + 1 years, after which generics can launch regardless of patent status, whereas in the U.S. market exclusivity is tied to patent expirations and Orange Book listings. Consequently, Opdivo’s patent portfolio (including method‑of‑use and formulation patents extending to 2026) provides a longer effective exclusivity window in the U.S., supporting continued revenue growth, whereas EU exclusivity may erode earlier due to data‑protection rules and generic entry, even as patent protection wanes. This divergent exclusivity landscape helps sustain Opdivo’s 7% U.S. revenue growth despite impending patent cliffs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies, particularly in the quantitative domain. The claim that Opdivo's EU market saw a 9% increase in 2021 is not present in the ground truth and is unsupported—this figure is fabricated. The ground truth only mentions 7% U.S. revenue growth, with no EU revenue growth data provided. This significantly undermines quantitative accuracy. (2) The regulatory timelines are mostly correct: the U.S. 12-year data protection is implied via 'market exclusivity tied to patents and Orange Book listings,' though not explicitly stated as 12 years. The EU's 8+2+1 regime is correctly referenced. Patent expirations in 2026 are accurately noted, aligning with the ground truth. However, the LLM incorrectly implies that EU generic entry can occur 'regardless of patent status' after data protection, which oversimplifies the interaction—patents can still block launch even after data protection expires. (3) The reasoning is partially sound: the model correctly synthesizes that extended formulation patents (to 2026) support U.S. exclusivity beyond 2021 method-of-use patent expirations, and it draws a reasonable contrast between U.S. and EU exclusivity frameworks. However, it misrepresents the 2021 patent expiration as a 'patent cliff' and introduces EU revenue growth not in the original, weakening multi-hop fidelity. (4) Despite these issues, the answer remains contextually relevant and captures the core idea that regulatory and patent protections extend exclusivity into the 2020s, supporting revenue growth. The 7% U.S. growth is correctly used as evidence of commercial strength. Due to the invented EU growth number and mischaracterization of patent-generic interaction in the EU, correctness is reduced to 6—partially correct but with significant factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 494,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the systemic risk regime specifically constrain Morgan Stanley's capital distribution policies and liquidity management, given its status as a large bank holding company with over $250 billion in consolidated assets?",
      "original_answer": "The systemic risk regime imposes heightened capital and liquidity requirements on Morgan Stanley as a large bank holding company, which directly constrains its capital distribution policies and liquidity management. Specifically, the Federal Reserve mandates internal liquidity stress tests, requires maintenance of unencumbered highly liquid assets to meet 30-day projected net cash outflows, and enforces risk management and corporate governance standards. These requirements can limit the firm’s ability to distribute capital through dividends or stock repurchases, especially if such actions would be deemed unsafe or unsound by regulators. Additionally, Morgan Stanley must comply with single-counterparty credit limits (15% of Tier 1 capital for major counterparties and 25% for other unaffiliated counterparties), further constraining its liquidity risk exposure.",
      "llm_answer": "Morgan Stanley’s capital‑distribution and liquidity management are tightly constrained by the Federal Reserve’s systemic‑risk regime for large bank holding companies. Because the firm holds more than $250 billion in consolidated assets, it must conduct internal liquidity stress tests, hold unencumbered high‑quality liquid assets to survive a 30‑day stress scenario, and comply with single‑counterparty credit limits (15 % of Tier 1 capital for major counterparties and 25 % for all other unaffiliated counterparties). In addition, regulators can prohibit or limit dividend payments, share‑repurchases, or other capital actions if they deem such distributions unsafe or unsound, and the firm must maintain sufficient tangible equity and liquidity buffers under the Basel III framework and the Volcker Rule. These regulatory requirements limit the amount of capital that can be returned to shareholders and restrict the firm’s ability to deploy excess liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key factual elements are correct: Morgan Stanley's status as a large bank holding company with over $250 billion in assets triggers enhanced prudential standards under the systemic risk regime. The LLM correctly identifies internal liquidity stress testing, the 30-day unencumbered high-quality liquid asset (HQLA) requirement, and the single-counterparty credit limits of 15% for major counterparties and 25% for other unaffiliated counterparties—all of which match the original answer exactly. (2) Quantitative accuracy is perfect: percentages (15%, 25%) and the 30-day stress period are correctly stated; no calculations were required, but all numeric references are precise and consistent with regulatory standards. (3) Multi-hop reasoning is sound: the LLM synthesizes how capital distribution (dividends, buybacks) is constrained by regulatory discretion and liquidity requirements, linking systemic risk rules to firm-level policies. It also appropriately references Basel III and the Volcker Rule as part of the broader framework, which, while not in the original answer, are contextually accurate and add relevant context without introducing error. (4) The only minor shortcoming is that the original answer emphasizes risk management and corporate governance standards more explicitly, which the LLM mentions indirectly via 'regulators can prohibit distributions' but could have stated more directly. However, this does not detract significantly from the overall correctness. The answer is semantically equivalent, well-structured, and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 451,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the interest rate of the 0.750% Senior Note due 2033 compare to the interest rate of the 1.950% Senior Note due 2031, and what might this indicate about PepsiCo's long-term debt strategy across different maturities?",
      "original_answer": "The interest rate of the 0.750% Senior Note due 2033 is lower than the interest rate of the 1.950% Senior Note due 2031 by 1.200 percentage points. This suggests that PepsiCo may have pursued a strategy of issuing debt at lower interest rates for longer-term maturities during the respective periods these notes were issued, potentially reflecting favorable market conditions or improved credit perception over time.",
      "llm_answer": "The 0.750% Senior Note due 2033 carries a lower interest rate than the 1.950% Senior Note due 2031, reflecting PepsiCo’s strategy of issuing longer‑dated debt at relatively modest coupon levels to manage its capital structure and financing costs across maturities. This pricing differential suggests the company is leveraging favorable market conditions to lock in cheaper long‑term financing while extending the maturity profile of its debt obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 0.750% Senior Note due 2033 has a lower interest rate than the 1.950% Senior Note due 2031, which matches the ground truth. The exact difference of 1.200 percentage points is implied (1.950% - 0.750% = 1.200%), though not explicitly stated, but this omission does not detract from the core accuracy. (2) All numeric values—0.750%, 2033, 1.950%, 2031—are correct and match the ground truth. No calculation errors; the comparison is factually sound. (3) The reasoning is logically sound and reflects appropriate multi-hop synthesis: the model infers a strategic intent behind differing rates across maturities, aligning with the ground truth’s interpretation about favorable market conditions and long-term financing strategy. It correctly links lower long-term rates to strategic debt management, even if it doesn’t explicitly mention 'improved credit perception,' which is a minor omission. (4) The answer is semantically equivalent in meaning and highly contextually relevant, addressing both the rate comparison and strategic implication. The slight deduction in qualitative accuracy is due to not explicitly quantifying the rate difference, but the reasoning remains strong. Overall, the response is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 366,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "By how much did the fair value of Medtronic's partnership units increase from fiscal year 2023 to fiscal year 2024, and what was the impact on total investments measured at net asset value?",
      "original_answer": "The fair value of Medtronic's partnership units increased by $159 million (from $992 million in fiscal year 2023 to $1,151 million in fiscal year 2024). This contributed to an overall increase of $1,187 million in investments measured at net asset value, which rose from $2,179 million in 2023 to $3,366 million in 2024.",
      "llm_answer": "The fair value of Medtronic's partnership units increased by $159 million from fiscal year 2023 to fiscal year 2024 (from $992 million to $1,151 million). This increase contributed to a rise in total investments measured at net asset value from $2,179 million to $3,366 million.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $159 million increase in the fair value of Medtronic's partnership units from $992 million in fiscal year 2023 to $1,151 million in 2024, which matches the ground truth. It also accurately reports the rise in total investments measured at net asset value from $2,179 million to $3,366 million, an increase of $1,187 million. (2) All numeric values are correct and consistent with the original answer; the calculation of the $159 million difference ($1,151M - $992M) is accurate, and the total investments' change is correctly represented. (3) The multi-hop reasoning is sound: the model correctly links the increase in partnership units to the overall increase in investments measured at net asset value, though it omits explicitly stating the $1,187 million increase in total investments. This omission is minor, as the before-and-after values are provided, allowing the reader to infer the difference. (4) The answer is factually complete and semantically equivalent to the ground truth, with only a slight lack of explicitness on the total increase amount, warranting a high but not perfect qualitative score. Contextual relevance is perfect as all information directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 352,
        "total_tokens": 1512
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How does the use of activity-based costing methods affect the presentation of depreciation and amortization totals for UPS's reportable segments, particularly in relation to the allocation of expenses between segments as described in the 2024 10-K filing?",
      "original_answer": "The use of activity-based costing methods directly affects the presentation of depreciation and amortization totals for UPS's reportable segments by determining how expenses are allocated between segments. According to the 2024 10-K filing, these totals are presented 'after applying activity-based costing methods to allocate expenses between segments.' This means that the final depreciation and amortization figures disclosed for each reportable segment are not raw totals but are instead adjusted based on the allocation methodology. Changes in these estimates directly impact the amount of expense allocated to each segment and therefore the operating profit of each reporting segment.",
      "llm_answer": "The 2024 10‑K notes that “Certain operating expenses are allocated between our operating segments using activity‑based costing methods. These methods require estimates that impact the amount of each expense category attributed to each segment, and changes in these estimates directly affect the expense allocated to each segment and therefore the operating profit of each reporting segment.” Thus, the use of activity‑based costing influences how depreciation and amortization are distributed across UPS’s reportable segments, shaping the segment‑level presentation of those totals in the financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that activity-based costing methods are used to allocate operating expenses, including depreciation and amortization, across UPS's reportable segments, and that these allocations rely on estimates affecting segment-level expense attribution and operating profit. The key phrase from the 2024 10-K is accurately quoted, supporting fidelity to the source. (2) There are no numerical values, dates, or financial figures in dispute—both answers reference the 2024 10-K filing correctly, and no calculations are required. (3) The multi-hop reasoning is sound: the model connects the use of activity-based costing to the allocation of expenses (including depreciation and amortization), recognizes that this affects segment-level financial presentation, and notes the impact on operating profit—all consistent with the original answer. (4) The only minor shortcoming is that the LLM answer does not explicitly state that depreciation and amortization totals are presented 'after' applying activity-based costing, which slightly weakens the emphasis on the post-allocation nature of the reported totals. However, the implication is clear from context. Wording differs but semantic meaning is equivalent. All entities (UPS, 2024 10-K, activity-based costing, reportable segments) are correct. Thus, the answer is factually complete and highly accurate with only a slight nuance missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 411,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "What was the total financial impact on Qualcomm in fiscal 2022 from the reversal of the European Commission fine and the associated interest, and how did this affect their other income and interest expense?",
      "original_answer": "The total financial impact on Qualcomm in fiscal 2022 from the reversal of the European Commission fine and the associated interest was $1.162 billion, which included a $1.1 billion benefit in other income and a $62 million reduction in interest expense.",
      "llm_answer": "The reversal of the European Commission fine and associated interest resulted in a $1.1 billion benefit recorded in other income and a $62 million reduction in interest expense for fiscal 2022. This reversal eliminated the previously accrued fine and its interest, improving both other income and lowering interest expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.1 billion benefit in other income and the $62 million reduction in interest expense, which aligns with the ground truth. However, it states the total impact as $1.1 billion, while the original answer specifies the total financial impact as $1.162 billion (sum of $1.1B + $62M). This minor omission in stating the aggregate total affects quantitative completeness. (2) The individual components ($1.1B and $62M) are accurate and correctly attributed to other income and interest expense, respectively. The sum, while not explicitly stated in the LLM answer, is implied through separate line items. Format variations (e.g., $1.1 billion vs $1.1B) are acceptable and do not affect accuracy. (3) The reasoning is sound: the LLM correctly links the reversal to both other income and interest expense, demonstrating proper multi-hop synthesis across accounting impacts. It also correctly contextualizes the reversal as eliminating previously accrued liabilities. (4) The answer is semantically very close to the ground truth, with only the lack of an explicit total impact figure preventing a perfect score. Contextual relevance is full, as all parts of the question are addressed with appropriate financial terminology and causal logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 361,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "By how much did the fair value of Fixed Income Commingled Trusts held by MDT increase from fiscal year 2023 to fiscal year 2024, and what was the proportion of this increase relative to the total increase in fair value across all investment categories?",
      "original_answer": "The fair value of Fixed Income Commingled Trusts increased by $305 million (from $968 million in 2023 to $1,273 million in 2024). The total increase in fair value across all investment categories was $153 million (from $3,398 million in 2023 to $3,551 million in 2024). However, since the increase in Fixed Income Commingled Trusts alone ($305 million) exceeds the total portfolio increase ($153 million), it indicates that other investment categories collectively decreased in value over the same period.",
      "llm_answer": "The fair value of Fixed Income Commingled Trusts held by MDT increased by $285 million from fiscal year 2023 to fiscal year 2024, representing approximately 84 % of the total increase in fair value across all investment categories.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. The increase in fair value of Fixed Income Commingled Trusts is reported as $285 million, but the ground truth states it increased by $305 million (from $968M in 2023 to $1,273M in 2024). Additionally, the LLM claims this represents 84% of the total increase across all investment categories, but this is incorrect because the total portfolio increase was only $153 million, meaning the $305 million increase in Fixed Income Commingled Trusts alone exceeds the total portfolio gain—other categories must have declined. Thus, the proportion cannot be meaningfully expressed as a percentage of the total increase. (2) The calculation of the increase is wrong: $1,273M - $968M = $305M, not $285M. The total increase in all investments is $3,551M - $3,398M = $153M, which the LLM does not mention or use correctly. (3) The multi-hop reasoning fails: the model should have recognized that an increase in one category exceeding the total portfolio increase implies declines elsewhere, but instead presents a misleading proportion. (4) Scores reflect major quantitative inaccuracy and flawed reasoning, though the answer addresses the right entities (MDT, Fixed Income Commingled Trusts, correct years) and attempts the right type of analysis, warranting moderate contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 375,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does Morgan Stanley's SPOE strategy, as described in its resolution plan, specifically ensure adequate liquidity for its subsidiaries during a resolution scenario, and what role does Morgan Stanley Holdings LLC play in this process?",
      "original_answer": "Morgan Stanley's SPOE strategy ensures adequate liquidity for its subsidiaries during a resolution scenario by requiring the Parent Company to provide capital and liquidity through a secured amended and restated support agreement. Morgan Stanley Holdings LLC (Funding IHC) acts as a resolution funding vehicle, receiving ongoing asset transfers from the Parent Company. In a resolution scenario, the Parent Company is obligated to contribute all of its material assets (excluding shares in subsidiaries and certain other assets) to the Funding IHC, which then provides capital and liquidity to supported subsidiaries under the terms of the agreement.",
      "llm_answer": "Morgan Stanley’s SPOE strategy ensures adequate liquidity for its subsidiaries during resolution by having the Parent Company (Morgan Stanley) and its wholly‑owned Funding IHC provide capital and liquidity to supported subsidiaries under a secured, senior‑secured support agreement, thereby guaranteeing that those subsidiaries have the resources needed to carry out an orderly resolution. Morgan Stanley Holdings LLC (Funding IHC) acts as the resolution‑funding vehicle, receiving transferred assets from the Parent and being obligated to supply the required capital and liquidity to the supported entities in a resolution scenario.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core elements of Morgan Stanley's SPOE strategy and the role of Morgan Stanley Holdings LLC (Funding IHC). (1) It correctly identifies that the Parent Company and the Funding IHC provide capital and liquidity to subsidiaries under a secured support agreement, ensuring orderly resolution. This aligns with the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly links the Parent Company’s asset transfers to the Funding IHC and its role in providing liquidity during resolution. However, it omits the specific detail that in a resolution scenario, the Parent Company must contribute *all of its material assets* (excluding subsidiary shares and certain exceptions) to the Funding IHC—a key mechanism in the original answer. This is a minor omission but does not undermine the overall correctness. (4) The answer is contextually relevant, directly addressing both parts of the question: how liquidity is ensured and the role of Morgan Stanley Holdings LLC. Wording differs slightly (e.g., 'senior-secured' vs 'amended and restated' agreement), but the semantic meaning is equivalent. The secured agreement is accurately characterized as binding and functional in resolution. Final correctness score is 9 due to the minor omission of the full asset transfer obligation, but all critical facts and logic are preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 427,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "Qualcomm's 2022 10-K projects that 60% of vehicles produced in 2028 will feature 5G connectivity, and also states that if Chinese OEMs shift away from using Qualcomm's integrated circuit products due to government actions, the company's revenues could be materially harmed. Given Qualcomm's dependency on Chinese markets and its strategic investments in 5G technologies, how does the company's growth strategy in automotive 5G adoption depend on maintaining access to Chinese OEMs?",
      "original_answer": "Qualcomm's growth strategy in automotive 5G adoption hinges on maintaining access to Chinese OEMs because the company projects that 60% of vehicles produced in 2028 will feature 5G connectivity, a market it aims to serve through its 5G technology investments. However, the 10-K explicitly states that if Chinese OEMs shift to using competitors' integrated circuit products or develop their own due to U.S. or Chinese government actions, Qualcomm's revenues could be materially harmed. Since China represents a major revenue source, any disruption in access to Chinese OEMs would directly undermine Qualcomm's ability to capitalize on the anticipated growth in 5G-enabled automotive platforms, thereby threatening its strategic expansion into this sector.",
      "llm_answer": "Qualcomm’s growth strategy in automotive 5G adoption hinges on its ability to keep Chinese OEMs as customers for its integrated circuit products and licensing revenue. The company projects that 60 % of vehicles produced in 2028 will have 5G connectivity, but it warns that if Chinese OEMs shift away from using its ICs due to government actions, its revenues could be materially harmed. Thus, maintaining access to the Chinese market is essential for Qualcomm to achieve its automotive‑5G growth targets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) All factual information is correct: Qualcomm projects 60% of vehicles produced in 2028 will have 5G connectivity, and the 10-K does state that a shift by Chinese OEMs away from Qualcomm's integrated circuits due to government actions could materially harm revenues. The percentage (60%) is correctly cited, and the year (2028) matches the original. (2) Quantitative accuracy is perfect—no calculations are required, and the numeric claim is faithfully reproduced. (3) The multi-hop reasoning is sound: the model correctly links Qualcomm’s 5G automotive growth strategy to its dependency on Chinese OEMs, recognizing that disruption in access would threaten its ability to meet growth targets. (4) The only minor shortcoming is slight incompleteness in not explicitly mentioning that China is a major revenue source or that the threat includes both U.S. and Chinese government actions (the LLM generalizes to 'government actions' without specifying both sides), which slightly weakens the qualitative depth compared to the original. However, the semantic meaning and strategic implication are preserved. The answer is fully contextually relevant and directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 354,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What is the change in the total fair value of investments measured at net asset value for Medtronic (MDT) from fiscal year 2023 to 2024, and which category of investment contributed the most to this change?",
      "original_answer": "The total fair value of investments measured at net asset value for Medtronic (MDT) increased by $1,187 million from fiscal year 2023 to 2024. The largest contributor to this change was the increase in equity commingled trusts, which rose by $269 million.",
      "llm_answer": "The total fair value of investments measured at net asset value increased by $187 million from fiscal year 2023 to 2024, and the equity commingled trusts category contributed the most to this change.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in identifying that the equity commingled trusts category contributed the most to the change, which aligns with the ground truth. However, the quantitative change in total fair value is incorrect: the LLM states an increase of $187 million, whereas the correct increase is $1,187 million—a significant underreporting by $1,000 million. This error severely impacts factual accuracy. (2) The calculation of the change in total fair value is wrong. Even if the source data had rounding, a $1 billion discrepancy cannot be attributed to formatting. The correct value must be $1,187 million, not $187 million. The category contribution (equity commingled trusts increasing by $269 million) is correctly identified as the largest contributor, though the LLM does not provide the exact amount of the increase in that category, only naming it. (3) The multi-hop reasoning appears partially sound—the model correctly identifies Medtronic (MDT), the relevant fiscal years (2023 to 2024), and the correct investment category as the main driver. However, the failure to report the correct total change suggests either a data extraction error or miscalculation in aggregation across filings. (4) The contextual relevance is high because the answer addresses both parts of the question and uses appropriate financial terminology. Qualitative accuracy is moderate due to correct entity and category identification, but quantitative accuracy is low due to the major numerical error. Correctness score is low because financial figures must be precise, and a 10x error in magnitude undermines the answer's reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1128,
        "completion_tokens": 451,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What is the valuation basis for Schwab's repurchase liabilities related to client-held fractional shares, and how does this valuation approach ensure no income statement impact despite market value fluctuations?",
      "original_answer": "Schwab values its repurchase liabilities related to client-held fractional shares based on quoted market prices or other observable market data consistent with the related client-held fractional shares. Unrealized gains and losses on these repurchase liabilities exactly offset the unrealized gains and losses on the corresponding client-held fractional shares, resulting in no net impact to the consolidated statements of income. This offset mechanism ensures that despite market value fluctuations, there is no income statement effect.",
      "llm_answer": "The valuation basis for Schwab's repurchase liabilities related to client-held fractional shares is fair value, using quoted market prices or other observable market data consistent with the underlying client-held fractional shares. This approach ensures no income statement impact because unrealized gains and losses on the client-held fractional shares offset the unrealized gains and losses on the corresponding repurchase liabilities, resulting in no net impact to the consolidated statements of income despite market value fluctuations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the original answer. (1) It accurately identifies the valuation basis as fair value using quoted market prices or other observable market data consistent with the underlying client-held fractional shares. (2) There are no numeric values requiring calculation in this question, but the conceptual elements—unrealized gains and losses offsetting between the repurchase liabilities and the corresponding client-held fractional shares—are correctly described. (3) The multi-hop reasoning is sound: the model correctly links the valuation approach (fair value based on market data) to the accounting outcome (no net income statement impact due to offsetting changes). (4) All entities—Schwab, repurchase liabilities, client-held fractional shares—are correctly identified and related. The explanation of the offset mechanism ensuring no income statement impact despite market fluctuations matches the ground truth precisely. Wording differs slightly but meaning is identical, satisfying semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 304,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What was the total change in Schwab's projected benefit obligation for the Financial Consultant Career Achievement Plan from December 31, 2020, to December 31, 2021, based on the disclosed annual expenses and deferred compensation liabilities?",
      "original_answer": "The total change in Schwab's projected benefit obligation for the Financial Consultant Career Achievement Plan was $18 million, increasing from $176 million at December 31, 2020, to $194 million at December 31, 2021.",
      "llm_answer": "The projected benefit obligation for the Financial Consultant Career Achievement Plan increased by $27 million, rising from $92 million at the beginning of 2020 to $119 million at the end of 2021. This change reflects the beginning balance, benefit cost of $16 million, and an actuarial loss of $11 million reported for 2021.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. The ground truth states the projected benefit obligation increased from $176 million in 2020 to $194 million in 2021, a change of $18 million. The LLM incorrectly reports the obligation as rising from $92 million to $119 million, a $27 million increase, which misstates both the starting point and ending point. (2) The calculation is therefore also wrong: $119M - $92M = $27M, but this is based on incorrect inputs. The correct change is $194M - $176M = $18M. Additionally, the LLM references a 'benefit cost of $16 million' and 'actuarial loss of $11 million' which are not mentioned or verifiable in the ground truth and appear fabricated. (3) The multi-hop reasoning is flawed: the question asks for the change based on disclosed annual expenses and deferred compensation liabilities, but the LLM does not connect these elements correctly. Instead, it introduces unverified components and uses incorrect timeframes (e.g., 'beginning of 2020' when the question specifies December 31, 2020). (4) The contextual relevance is low because the answer discusses the correct plan and general concept of benefit obligations, but the numbers, time periods, and reasoning are all misaligned with the source data. The qualitative accuracy is very low due to incorrect entities (dates, amounts) and unsound logic. Only minimal credit is given for addressing the right plan and attempting a change calculation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 409,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What is the combined revenue contribution of the Beauty segment, where Pantene holds a 20% global market share in hair care, and the Fabric & Home Care segment, which contributes 36% of net sales, as a percentage of Procter & Gamble's total net sales for the fiscal year?",
      "original_answer": "The combined revenue contribution is 54% of Procter & Gamble's total net sales for the fiscal year.",
      "llm_answer": "The Beauty segment contributes 18% of total net sales, and the Fabric & Home Care segment contributes 36% of net sales, resulting in a combined contribution of 54% of Procter & Gamble's total net sales for the fiscal year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the combined contribution is 54% of Procter & Gamble's total net sales, which matches the ground truth. It also accurately breaks this down into 18% from the Beauty segment and 36% from the Fabric & Home Care segment. Although the original answer does not explicitly state the 18% figure for Beauty, the LLM's inclusion of it is consistent with the 54% total when combined with 36%, and such a breakdown supports the final result. (2) All numeric values and calculations are correct: 18% + 36% = 54%, and the percentages align with the expected output. Format and precision are accurate. (3) The multi-hop reasoning is sound—while the Beauty segment’s 18% is not directly stated in the question (only that Pantene has 20% global hair care share), the LLM appears to have correctly inferred or retrieved the segment contribution from external knowledge, then correctly summed it with the given 36%. This indicates proper synthesis across segments. (4) The answer is fully relevant and addresses the question completely. The only reason for not giving a perfect 10 is that the Beauty segment's 18% contribution was not explicitly provided in the question stem, so its inclusion—while accurate—relies on assumed knowledge not present in the prompt, introducing a minor risk of unsupported inference. However, since it leads to the correct final figure and aligns with known data, the answer remains highly accurate overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1111,
        "completion_tokens": 407,
        "total_tokens": 1518
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What was the total income (loss) from discontinued operations attributable to common shareowners in 2020 specifically related to Carrier and Otis, and how does this connect to the separation event described?",
      "original_answer": "The total income (loss) from discontinued operations attributable to common shareowners in 2020 specifically related to Carrier and Otis was $-410 million, which includes $187 million from Otis and $196 million from Carrier. This connects to the separation event described where, on April 3, 2020, UTC separated into three independent, publicly traded companies—UTC, Carrier, and Otis—and distributed all of the outstanding common stock of Carrier and Otis to UTC shareowners.",
      "llm_answer": "The total income (loss) from discontinued operations attributable to common shareowners in 2020 specifically related to Carrier and Otis was $(410) million, as shown in the \"Income (loss) from discontinued operations attributable to common shareowners\" line for 2020 in the table on page 89. This loss reflects the results of the Carrier and Otis businesses after their separation from UTC in the first quarter of 2020, which was completed to meet regulatory requirements for the Raytheon merger and resulted in the creation of two independent, publicly traded companies.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total income (loss) from discontinued operations attributable to common shareowners in 2020 as $(410) million, which matches the ground truth of $-410 million (format variation is acceptable: $(410) million = -$410 million). However, the LLM does not break down the $187 million from Otis and $196 million from Carrier as specified in the ground truth, missing a key component of completeness. (2) The quantitative value is accurate—$410 million loss is correctly reported. The calculation implied by the sum of Otis and Carrier components ($187M + $196M = $383M) does not fully explain the total $410M loss, suggesting additional adjustments; the LLM does not attempt to reconcile this, but since the total figure is correct, this is not a critical error. (3) The reasoning is sound: the LLM correctly connects the discontinued operations to the separation event in Q1 2020 and links it to the Raytheon merger context, which aligns with the broader narrative in filings. It correctly identifies the creation of two independent public companies (Carrier and Otis), though it omits UTC as the third entity post-separation. (4) The answer is highly contextually relevant, directly addressing the financial impact and the corporate event. The omission of the detailed Carrier and Otis breakdown prevents a perfect score, but core facts and synthesis are correct, warranting a high but not top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 400,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "Given the Diabetes Pump Retainer Ring Litigation details, what is the total number of individual plaintiffs that have filed lawsuits against Medtronic's Diabetes operating unit as of May 14, 2024, and how does this litigation compare in terms of potential future claimants to the hernia mesh-related lawsuits mentioned in the document?",
      "original_answer": "As of May 14, 2024, a total of 107 individual plaintiffs have filed lawsuits against Medtronic's Diabetes operating unit related to the Series 600 insulin pumps with allegedly defective clear retainer rings. Additionally, law firms have indicated that they may file lawsuits on behalf of thousands of additional claimants in the future. In comparison, there are approximately 6,700 plaintiffs in Massachusetts state court, 500 in Minnesota state court, and 1,150 in a federal Multidistrict Litigation (MDL) related to hernia mesh products, with more cases potentially being filed. Both litigations involve allegations tied to Medtronic products, and the company has not recorded any expense for damages in either case due to the uncertainty of probable and estimable loss.",
      "llm_answer": "As of May 14 2024, 27 lawsuits have been filed on behalf of 107 individual plaintiffs in the Diabetes Pump Retainer Ring litigation. Like the hernia‑mesh cases, the Company believes any potential loss is not currently probable or reasonably estimable and therefore has not recorded an expense, but it anticipates that additional claims could be filed in the future.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total number of individual plaintiffs (107) as of May 14, 2024, in the Diabetes Pump Retainer Ring Litigation, which matches the ground truth. It also accurately notes that future claims may be filed, aligning with the original answer’s mention of 'thousands of additional claimants.' The statement that Medtronic has not recorded an expense due to uncertainty in probable and estimable loss is correctly reflected. However, the LLM introduces a detail not present in the ground truth—'27 lawsuits'—which, while possibly accurate, is not mentioned in the original answer and thus adds unverified information. (2) All numeric values (107 plaintiffs, May 14, 2024) are correct and match the ground truth. There are no calculation errors. (3) The multi-hop reasoning is mostly sound: the LLM correctly links the diabetes litigation to the hernia mesh litigation in terms of financial provisioning (or lack thereof), though it does not provide the comparative numbers for hernia mesh plaintiffs (6,700 in MA, 500 in MN, 1,150 in MDL) as required by the question. This omission limits completeness in the comparison aspect. (4) Despite missing the specific hernia mesh plaintiff counts and adding the unconfirmed '27 lawsuits' detail, the core facts about the diabetes litigation and Medtronic’s financial stance are accurate and relevant. The answer is concise and contextually appropriate but falls short of full completeness on the comparative aspect of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 417,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the IDA agreement impact Schwab's capital management strategy, particularly in relation to off-balance sheet treatment of client deposits and Schwab's internal capital policy target range of 6.75%-7.00%?",
      "original_answer": "The IDA agreement requires that certain brokerage client deposits be swept off-balance sheet to TD Depository Institutions, reducing Schwab's on-balance sheet liabilities and affecting its capital utilization. Schwab manages capital to maintain a Tier 1 Leverage Ratio within a target range of 6.75%-7.00%, which is higher than the minimum regulatory requirement of 4%. The offloading of IDA balances helps Schwab optimize its balance sheet and maintain capital ratios above internal and regulatory thresholds, even during periods of balance sheet growth.",
      "llm_answer": "The IDA agreement requires certain brokerage client deposits to be swept off‑balance‑sheet to TD Depository Institutions, which reduces the amount of client cash that remains on Schwab’s consolidated balance sheet. Because these deposits are excluded from the balance‑sheet total, Schwab can manage its overall capital more efficiently and maintain its internal capital policy target of a Tier 1 Leverage Ratio of 6.75%‑7.00% without needing to hold additional capital against those swept balances. Consequently, the off‑balance‑sheet treatment supports Schwab’s ability to stay within its capital‑management range even as it grows assets and migrates IDA balances.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the IDA agreement sweeps client deposits off-balance sheet to TD Depository Institutions, reducing Schwab's on-balance sheet liabilities; this supports capital efficiency and helps maintain the Tier 1 Leverage Ratio within the internal target range of 6.75%-7.00%. The numbers (6.75%-7.00%) are correctly stated and match the original answer. (2) Quantitative accuracy is perfect: the percentage range is exact, and no calculations are required beyond correct representation of the target. (3) The reasoning is sound and captures the multi-hop logic: off-balance sheet treatment reduces balance sheet size, which in turn supports capital ratio management even during growth. The connection between operational structure (IDA sweeps) and capital policy is correctly synthesized. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the regulatory minimum of 4% for comparison, which adds context to why Schwab’s internal target is conservative. While not strictly necessary, this detail was present in the original and enhances completeness. Otherwise, the answer is semantically equivalent, well-structured, and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 355,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "What was the total net cash inflow from RTX's disposition of the Forcepoint business and how did it contribute to the overall net cash provided by investing activities in 2021 compared to 2020?",
      "original_answer": "The disposition of the Forcepoint business contributed to the $1.9 billion in net cash inflows from dispositions of businesses in 2021. This was part of the $4.7 billion improvement in cash flows from investing activities in 2021 compared to 2020, which was primarily due to the absence of the Raytheon Merger cash acquisition of $3.2 billion in the prior year and the proceeds from the Forcepoint and other business dispositions.",
      "llm_answer": "The RTX 10‑K shows that the company received **$1.9 billion of net cash proceeds from the sale of the Forcepoint business** in 2021. This cash inflow was recorded as part of “Investing activities – continuing operations” and helped offset the overall decline in investing cash flows; it contributed to a **net cash outflow of $1.364 billion** for investing activities in 2021, compared with a **net cash inflow of $3.343 billion** in 2020. Consequently, the Forcepoint disposition reduced the net cash provided by (or increased the net cash used in) investing activities by roughly $5.3 billion year‑over‑year.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual and quantitative errors. While it correctly identifies that $1.9 billion in net cash proceeds came from the disposition of the Forcepoint business in 2021, it incorrectly states that this contributed to a net cash outflow of $1.364 billion in investing activities in 2021 and compares it to a $3.343 billion inflow in 2020. The ground truth does not provide these specific net investing cash flow figures, nor does it state a year-over-year decline of $5.3 billion. Instead, the original answer states that the $1.9 billion was part of a $4.7 billion improvement in cash flows from investing activities in 2021 vs 2020—directly contradicting the LLM's claim of deterioration. (2) The calculation of a $5.3 billion negative swing is unsupported and incorrect; the ground truth attributes the improvement to the absence of the $3.2 billion Raytheon merger outflow in 2020 and the addition of proceeds from dispositions like Forcepoint. The LLM misrepresents the direction of change (improvement vs deterioration). (3) The multi-hop reasoning fails: the model incorrectly infers net investing cash flows and their year-over-year change, likely hallucinating numbers not in the source. It fails to link the Forcepoint proceeds to the broader context of reduced outflows (due to no merger) and other dispositions. (4) Scores are low due to major factual inaccuracies in numbers and trends, flawed logic, and incorrect synthesis. Contextual relevance is moderate because the answer addresses the right topic and mentions Forcepoint proceeds, but the overall message contradicts the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 450,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does Oracle's reliance on third-party colocation suppliers for global data centers impact the financial risk associated with Oracle Cloud Services, especially considering the long-term lease commitments and potential contract termination fees?",
      "original_answer": "Oracle delivers Oracle Cloud Services through global data centers, substantially all of which are leased through third-party colocation suppliers. Oracle has entered into long-term operating lease commitments with these providers, which often include significant contract termination fees if Oracle needs to exit these obligations early due to strategic changes. This creates financial risk, as Oracle may be locked into costly lease agreements even if demand for Oracle Cloud Services does not meet expectations or if market conditions change unfavorably. Additionally, Oracle depreciates these leased assets over their estimated useful lives, which could be shortened if Oracle's cloud strategy shifts, further impacting profitability.",
      "llm_answer": "Oracle's reliance on third‑party colocation providers for its global data‑center capacity creates significant financial risk for its Cloud Services business. The company enters into long‑term lease commitments that often require substantial contract‑termination fees if it needs to exit or modify the arrangements, and it does not control the operation of these facilities. Consequently, any inability to secure or scale data‑center capacity at affordable rates—or the need to terminate leases early—can directly depress Oracle Cloud’s profitability and cash flow.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core financial risks associated with Oracle's reliance on third-party colocation suppliers. (1) All factual elements are correct: Oracle uses third-party colocation providers for its global data centers, enters into long-term leases, and faces significant termination fees if it exits early. The answer correctly identifies the financial impact on profitability and cash flow. (2) There are no numeric values in the question or ground truth requiring verification, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model connects Oracle's infrastructure model (leased third-party data centers) to contractual obligations (long-term leases with termination fees) and then to financial risk (profitability and cash flow impact), which aligns with the ground truth. (4) The only minor omission is that the original answer also notes Oracle depreciates leased assets over their useful lives, and that a shift in cloud strategy could shorten those lives and further impact profitability. This additional accounting risk is missing in the LLM response, slightly reducing completeness. However, the core financial risk is well-explained. Semantic equivalence is strong, and the response is fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 365,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "What is the total number of shares available for future grants under both the 2020 Stock Incentive Plan and the 1993 Employee Stock Purchase Plan as of December 31, 2021, and how does this availability support UnitedHealth Group's share-based compensation strategy?",
      "original_answer": "As of December 31, 2021, UnitedHealth Group had 64 million shares available under the 2020 Stock Incentive Plan and 18 million shares available under the 1993 Employee Stock Purchase Plan, totaling 82 million shares available for future grants. This availability supports the company's share-based compensation strategy by ensuring sufficient shares are available for future stock options, restricted stock, and other equity awards, which are key tools in compensating employees and aligning their interests with shareholders.",
      "llm_answer": "As of December 31 2021, the Company had **approximately 64 million shares available for future grants under the 2020 Stock Incentive Plan** and **about 18 million shares available for future issuance under the 1993 Employee Stock Purchase Plan**, giving a combined total of roughly **82 million shares** that could be used for future share‑based compensation. This sizable reserve supports UnitedHealth Group’s strategy of maintaining an ample pool of shares to award stock options, restricted shares and ESPP purchases, enabling it to attract, retain and motivate employees while preserving flexibility to fund ongoing equity‑based incentive programs.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 64 million shares under the 2020 Stock Incentive Plan and 18 million under the 1993 Employee Stock Purchase Plan, totaling 82 million shares—calculations are correct and consistent with the original answer. Minor wording variations like 'approximately', 'about', and 'roughly' are acceptable and do not affect factual accuracy, as they reflect typical reporting language in SEC filings. (2) The answer is complete, addressing both the total number of shares available and the strategic rationale behind UnitedHealth Group's share-based compensation approach. (3) Entity accuracy is perfect: correct plan names, correct company (UnitedHealth Group), and correct date (December 31, 2021). (4) The reasoning is sound and demonstrates proper multi-hop synthesis—combining data from two separate plans and interpreting their strategic purpose in employee compensation. (5) Semantic equivalence is maintained: the LLM conveys the same core information with slightly enhanced phrasing (e.g., 'attract, retain and motivate employees') that adds context without distorting facts. Overall, the response is factually precise, comprehensive, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 357,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Schwab account for client-held fractional shares and their corresponding repurchase liabilities under GAAP, and where are these liabilities reflected on the consolidated balance sheet according to the 2022 10-K filing?",
      "original_answer": "Schwab accounts for client-held fractional shares as part of 'other securities owned' on the consolidated balance sheets, recording them at fair value based on quoted market prices or other observable market data. These shares are included in other assets, and unrealized gains and losses are recognized in earnings. For client-held fractional shares where off-balance sheet treatment under ASC 940 or derecognition criteria under ASC 860 are not met, Schwab recognizes related repurchase liabilities that are accounted for at fair value. These repurchase liabilities are reflected in 'accrued expenses and other liabilities' on the consolidated balance sheet, as disclosed in the 2022 10-K filing.",
      "llm_answer": "Schwab accounts for client‑held fractional shares as “Other securities owned at fair value” in its consolidated balance sheet, and it records a corresponding repurchase liability for those fractional shares at fair value. These repurchase liabilities are included in “accrued expenses and other liabilities” on the consolidated balance sheet. The related assets (the fractional shares) are presented within “Other securities owned at fair value” (i.e., other assets) on the balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) It correctly identifies that Schwab accounts for client-held fractional shares as 'Other securities owned at fair value' and records corresponding repurchase liabilities at fair value, which are included in 'accrued expenses and other liabilities'—this aligns with the 2022 10-K disclosure. (2) There are no numeric values in the question or answer requiring quantitative verification, so quantitative accuracy is scored as 10. (3) The multi-hop reasoning is sound: the model correctly links fractional shares to balance sheet asset presentation and ties the associated liabilities to the appropriate liability line item. However, the LLM omits mention of the accounting standards (ASC 940 and ASC 860) and the explicit treatment of unrealized gains and losses in earnings, which are part of the full GAAP accounting policy disclosed in the original answer. This minor omission prevents a perfect qualitative score. (4) The answer remains contextually precise, directly addressing how Schwab accounts for these items and where they appear on the balance sheet. Overall, the response is factually correct and semantically equivalent on core content, warranting a 9/10 correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 357,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Oracle's integration of Autonomous Database with OCI enable both cost reduction for customers and strategic growth in its cloud and license business?",
      "original_answer": "Oracle's integration of Autonomous Database with OCI enables cost reduction for customers by automating routine database administration tasks such as maintenance, tuning, patching, scaling, security, and backup, while also using machine learning-driven diagnostics to reduce human error and operational costs. This automation and efficiency lowers labor costs and allows for consumption-based pricing, where customers pay only for resources used. These cost-saving features directly support Oracle's strategic growth in its cloud and license business by encouraging customer migration to Oracle Cloud, particularly among existing Oracle customers using on-premise applications. The integration with other Oracle Cloud services like Java Cloud and Oracle APEX further enhances this migration by offering developers a modern, open platform for building cloud-native applications. As a result, Oracle can expand its cloud and license business by leveraging these technical capabilities to attract both new customers and a broader ecosystem of developers and partners.",
      "llm_answer": "Oracle's integration of Autonomous Database with OCI enables cost reduction for customers by offering automatic scaling and consumption-based pricing, eliminating manual administration and reducing labor expenses. At the same time, it drives strategic growth in Oracle's cloud and license business by expanding the platform's appeal for modern cloud-native application development, attracting new customers, and accelerating adoption of Oracle Cloud services across diverse workloads.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and captures the core elements of how Oracle's integration of Autonomous Database with OCI enables cost reduction and strategic growth. It correctly identifies automatic scaling, consumption-based pricing, elimination of manual administration, and reduced labor costs as key cost-saving mechanisms—aligning with the ground truth. It also accurately links these features to strategic growth by highlighting expanded appeal for cloud-native development, customer acquisition, and broader adoption of Oracle Cloud services. However, it omits specific details present in the original answer that strengthen the multi-hop reasoning: (1) the full scope of automated tasks (patching, tuning, security, backup), (2) the role of machine learning in reducing human error, (3) the targeted migration of existing on-premise Oracle customers, and (4) integration with specific Oracle Cloud services like Java Cloud and APEX that enhance developer adoption. These omissions reduce completeness and slightly weaken the depth of the synthesis, but do not introduce inaccuracies. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and contextually appropriate, with high relevance to the question. The answer conveys a semantically close summary, though less detailed than the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 384,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "What is the financial implication for UnitedHealth Group if the AARP Program contract is transferred to another entity, considering the management and classification of AARP Program assets as described in the 10-K filing?",
      "original_answer": "If the AARP Program contract is transferred to another entity, UnitedHealth Group would be required to transfer cash equal to the fair value of the AARP Program assets at the date of transfer. These assets, which are managed separately from the company's general investment portfolio and used to fund medical costs payable and other related liabilities, are classified as current assets consistent with the liabilities they support. This would result in a direct reduction of both the company's current assets and the associated liabilities tied to the AARP Program, potentially impacting short-term liquidity depending on the fair value of the investments at the time of transfer.",
      "llm_answer": "The 10‑K notes that AARP Program assets are managed separately and are classified as current assets because they fund the program’s medical‑cost liabilities; if the contract were transferred, the Company would have to transfer cash equal to the fair value of those assets at the transfer date. Consequently, any such transfer would require a cash outflow matching the current‑asset balance tied to the AARP Program, potentially affecting liquidity and the classification of those assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: AARP Program assets are managed separately, classified as current assets, and used to fund medical-cost liabilities; upon contract transfer, UnitedHealth must transfer cash equal to the fair value of these assets at the transfer date. (2) There are no numeric values requiring calculation in this question, but the description of asset valuation and transfer is precise and consistent with the original (e.g., 'fair value of those assets at the transfer date' matches 'fair value of the AARP Program assets at the date of transfer'). (3) The multi-hop reasoning is sound: the model correctly links the classification of assets (current) to their purpose (funding liabilities), and infers the financial implication (cash outflow, impact on liquidity). (4) The only minor omission is that the original explicitly notes the reduction in both assets and liabilities, while the LLM focuses on the asset/cash outflow side—this nuance is implied but not stated, slightly reducing completeness in qualitative terms. However, the core financial implication—cash transfer and liquidity impact—is clearly conveyed. Wording differences do not affect factual accuracy. Contextual relevance is perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 362,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "What is the fair value of Card Member and Other Loans, and how does it compare to the carrying value in relation to the Level 3 fair value hierarchy classification?",
      "original_answer": "The fair value of Card Member and Other Loans is $113 billion, while the carrying value is $110 billion. This fair value is entirely classified under Level 3 of the fair value hierarchy, indicating that it is based on unobservable inputs rather than market data.",
      "llm_answer": "The fair value of Card Member and Other Loans is $133 billion, which exceeds their carrying value of $128 billion. This fair‑value estimate is classified as Level 3 in the fair‑value hierarchy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the numerical values. The ground truth states the fair value is $113 billion and carrying value is $110 billion, but the LLM reports $133 billion and $128 billion, respectively—both figures are incorrect. These discrepancies suggest either a misreading of the source data or confusion with another entity or time period. (2) Quantitative accuracy is severely compromised: the difference between fair and carrying value is reported as $5 billion in the LLM answer (vs. $3 billion in truth), and neither the inputs nor the spread is correct. No acceptable format variation explains this magnitude of error. (3) Qualitatively, the LLM correctly identifies that the fair value is classified under Level 3 of the fair value hierarchy, which aligns with the ground truth and shows some correct reasoning about unobservable inputs. However, it fails to explain what Level 3 implies (unobservable inputs), missing a key qualitative insight. The multi-hop synthesis is partially sound—linking fair value, carrying value, and hierarchy level—but based on incorrect data. (4) Contextual relevance is high because the answer addresses all components of the question: fair value, carrying value, comparison, and Level 3 classification. Structure and intent are appropriate, but factual correctness is poor, leading to a low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1118,
        "completion_tokens": 391,
        "total_tokens": 1510
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How many shares were available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan as of December 31, 2021, and what types of awards can these shares become the subject of?",
      "original_answer": "As of December 31, 2021, 64 million shares were available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan. These shares can become the subject of future awards in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards.",
      "llm_answer": "As of December 31, 2021, the UnitedHealth Group 2020 Stock Incentive Plan had 241 million shares remaining available for future issuance, and these shares may be used for a variety of award types—including stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards and other stock‑based incentives.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is incorrect on the key quantitative fact—stating 241 million shares available instead of the correct 64 million as of December 31, 2021. This is a major factual error that significantly undermines the answer's correctness. The types of awards listed (stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based incentives) are semantically equivalent to the ground truth and correctly reflect the allowable award types under the plan. (2) The number 241 million does not match the ground truth of 64 million. There is no indication of a calculation or formatting issue (e.g., $476M vs $476 million); this is a clear discrepancy in the numeric value. The date (December 31, 2021) is correct. (3) The qualitative reasoning is partially sound—the model correctly identifies the range of award types permitted under such incentive plans, suggesting it understood the nature of stock incentive plans and synthesized appropriate categories. However, the failure to retrieve the correct number of shares available indicates a failure in multi-hop data retrieval or synthesis from the correct SEC filing (likely the 2021 10-K or proxy statement). (4) The correctness score is low (3) due to the major numerical inaccuracy. Quantitative accuracy is severely penalized (2) because the share count is off by over 175 million shares. Qualitative accuracy is moderate (5) because the award types are correct and the response structure is appropriate. Contextual relevance is high (8) as the answer addresses both parts of the question and uses proper financial terminology, despite the factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 459,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "What was the total estimated fair value of foreign government bonds and obligations held by the company in 2023, and how did this compare to the estimated fair value of the same category in 2022 for maturities of 12 months or more?",
      "original_answer": "The company held foreign government bonds and obligations with a total estimated fair value of $770 million in 2023. In comparison, the estimated fair value of the same category for maturities of 12 months or more in 2022 was $549 million, showing an increase of $221 million.",
      "llm_answer": "The total estimated fair value of foreign government bonds and obligations held by the company in 2023 was $770 million, which increased from $632 million in 2022 for maturities of 12 months or more.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the 2023 estimated fair value of foreign government bonds and obligations as $770 million, which matches the ground truth. However, it incorrectly reported the 2022 value as $632 million, whereas the ground truth states $549 million. This is a significant quantitative error affecting the comparison. (2) The calculation of the increase is therefore also incorrect: the LLM implies an increase of $138 million ($770M - $632M), but the actual increase is $221 million ($770M - $549M). The ground truth explicitly states this $221 million increase, which the LLM fails to reflect. (3) The multi-hop reasoning is partially sound—the model correctly identifies the need to compare the same category (foreign government bonds and obligations) across two years for maturities of 12 months or more. However, it uses an incorrect 2022 figure, suggesting either a data retrieval error or confusion with another value from the filings. (4) Despite the incorrect 2022 number, the answer is well-structured, uses correct terminology, and addresses the right financial category and time frame, earning moderate scores for qualitative accuracy and high relevance. The correctness score is reduced due to the material factual inaccuracy in the 2022 value and the resulting flawed comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 368,
        "total_tokens": 1508
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "What was the total capital expenditure in the Africa/Eurasia region in 2021, and how does this compare to the capital expenditure in the same region in 2019?",
      "original_answer": "The total capital expenditure in the Africa/Eurasia region was $33 million in 2021 and $8 million in 2019. This represents an increase of $25 million over the two-year period.",
      "llm_answer": "The total capital expenditure in the Africa/Eurasia region was $33 million in 2021, compared with $13 million in 2019.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the capital expenditure for 2021 ($33 million), which matches the ground truth. However, it incorrectly states the 2019 capital expenditure as $13 million, whereas the ground truth is $8 million. This error affects the accuracy of the comparison. (2) The quantitative values are partially correct: $33 million in 2021 is accurate, but $13 million in 2019 is incorrect (should be $8 million). The implied difference of $20 million (unstated) is therefore also wrong—the correct increase is $25 million. (3) The reasoning shows an attempt at multi-hop synthesis by comparing two years of data for the same region, but due to the incorrect 2019 figure, the comparison fails. The model likely retrieved or inferred the wrong value for 2019, breaking the chain of accurate reasoning. (4) The contextual relevance is high because the answer addresses the right region, metric, and years. However, the significant numerical error in the 2019 value reduces correctness and quantitative accuracy. The answer is not completely wrong but contains a critical factual error that undermines the comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1076,
        "completion_tokens": 324,
        "total_tokens": 1400
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What was the percentage change in Johnson & Johnson's worldwide sales of Contact Lenses/Other within the Vision segment from 2020 to 2021, and how did this performance compare to the overall growth rate of the broader Vision segment during the same period?",
      "original_answer": "The worldwide sales of Contact Lenses/Other grew by 14.9% from 2020 to 2021, while the broader Vision segment grew by 19.6% during the same period. This indicates that the Contact Lenses/Other category underperformed relative to the overall Vision segment's growth rate.",
      "llm_answer": "The worldwide sales of Contact Lenses/Other within the Vision segment grew by 14.9% from 2020 to 2021, rising from $2.994 billion to $3.440 billion. This growth was slightly outpaced by the broader Vision segment’s overall sales increase of 19.6% over the same period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Contact Lenses/Other sales grew by 14.9% from 2020 to 2021, matching the ground truth. It also accurately reports the broader Vision segment growth rate of 19.6%, confirming that Contact Lenses/Other underperformed relative to the overall segment. The dollar figures provided ($2.994 billion to $3.440 billion) are consistent with a 14.9% growth rate and add contextual detail not required but factually correct. (2) Quantitative accuracy is perfect: the percentage change and absolute values align, and the comparison between 14.9% and 19.6% is correctly framed. Minor formatting like spacing in '$2.994 billion' does not affect accuracy. (3) The multi-hop reasoning is sound—LLM correctly synthesizes performance data for a sub-category and compares it to the broader segment. The conclusion that the sub-category was 'slightly outpaced' is a valid interpretation of 14.9% vs 19.6%, though the original answer used 'underperformed', which is slightly more precise. (4) All entities—Johnson & Johnson, Contact Lenses/Other, Vision segment, years 2020–2021—are correctly identified. The answer is fully relevant and addresses both parts of the question. The only reason for not scoring 10 is the slightly softer phrasing 'slightly outpaced' versus the more analytically precise 'underperformed', but this does not constitute a factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 387,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What was the total weighted-average grant price for Service and Performance-Based RSUs that were outstanding as of December 31, 2021, considering both the beginning balance and new grants during the year?",
      "original_answer": "$114.22 million for the outstanding shares as of December 31, 2021, which includes the impact of new grants at $125.02 million during the year.",
      "llm_answer": "Based on the information in the provided document pages, the total weighted-average grant price for Service and Performance-Based RSUs outstanding as of December 31, 2021, considering both the beginning balance and new grants during the year, is $114.22. This figure represents the weighted-average grant price for these RSUs as disclosed in the stock option and RSU activity table on page 130.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the weighted-average grant price of $114.22 as the value for Service and Performance-Based RSUs outstanding as of December 31, 2021, which matches the ground truth. However, it misrepresents this figure as a total dollar amount rather than a per-share price. The original answer specifies '$114.22 million' as the total value, not the per-share price, and notes that this total includes new grants valued at $125.02 million during the year. The LLM answer incorrectly treats $114.22 as the weighted-average grant price (implying per share), which contradicts the original answer's framing of it as a total monetary value. (2) The number $114.22 is present in both answers, but the unit and meaning differ: the ground truth treats it as $114.22 million (a total value), while the LLM treats it as a per-share price without units clarification. The new grant amount of $125.02 million is omitted entirely in the LLM answer, which is a significant omission for a multi-part synthesis. (3) The reasoning fails on multi-hop synthesis: the question asks for the total weighted-average grant price considering both beginning balance and new grants, which requires combining data across periods. The LLM does not demonstrate or reference this calculation, nor does it mention the $125.02 million in new grants that contribute to the total. (4) Despite the misinterpretation of units and missing key data about new grants, the LLM captures the final number mentioned in the ground truth and applies it to the correct date and RSU type, earning partial credit. Contextual relevance is perfect as it directly addresses the question with appropriate framing and source reference.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 466,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "By how much did Boeing's outstanding balance for its 1.43%-2.50% unsecured bonds due through 2032 decrease from 2023 to 2024, and what percentage did this tranche represent of the company's total debt in 2024?",
      "original_answer": "The outstanding balance for Boeing's 1.43%-2.50% unsecured bonds due through 2032 decreased by $3,976 million (from $10,135 million in 2023 to $6,159 million in 2024). In 2024, this tranche represented approximately 11.43% of Boeing's total debt of $53,864 million.",
      "llm_answer": "The outstanding balance for Boeing's 1.43%-2.50% unsecured bonds due through 2032 decreased by $3,976 million from 2023 to 2024 (from $10,135 million to $6,159 million), representing 11.4% of the company's total debt of $53,864 million in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the decrease in outstanding balance is correctly stated as $3,976 million, calculated from $10,135 million in 2023 to $6,159 million in 2024. (2) The percentage of total debt in 2024 is reported as 11.4%, which matches the ground truth of approximately 11.43% when rounded to one decimal place. The total debt figure of $53,864 million is correctly cited. (3) The multi-hop reasoning—linking the bond tranche balance change across years and calculating its proportion of total debt—is sound and correctly synthesized from multiple data points. (4) All entities (Boeing, unsecured bonds with specified coupon and maturity, years 2023 and 2024) are accurately identified and referenced. Minor rounding in the percentage (11.4% vs 11.43%) is acceptable and common in financial reporting. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 276,
        "total_tokens": 1419
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "What was the combined revenue from Knees and Hips in Johnson & Johnson's Orthopaedics segment in 2021, and what percentage did this represent of the total Orthopaedics revenue for that year?",
      "original_answer": "The combined revenue from Knees and Hips in 2021 was $2,810 million ($1,325 million from Knees and $1,485 million from Hips). This represented 32.7% of the total Orthopaedics revenue of $8,588 million in 2021.",
      "llm_answer": "The combined revenue from Knees and Hips in Johnson & Johnson's Orthopaedics segment in 2021 was $2,810 million ($1,325 million for Knees + $1,485 million for Hips), representing 10.6% of the total Orthopaedics segment sales for that year.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the combined revenue from Knees and Hips in 2021 as $2,810 million, with accurate component values of $1,325 million (Knees) and $1,485 million (Hips), matching the ground truth. However, the percentage calculation is incorrect: the LLM states 10.6%, while the correct percentage is 32.7% of total Orthopaedics revenue ($8,588 million). This is a critical error in calculation or data sourcing. (2) Quantitative accuracy is high for the revenue figures (all dollar amounts correct), but the percentage is significantly off—32.7% vs. 10.6%—indicating a failure in either retrieving or computing the correct total segment revenue. The correct calculation is $2,810 / $8,588 ≈ 32.7%, which the LLM did not perform accurately. (3) The multi-hop reasoning partially succeeds: the model correctly aggregates Knees and Hips revenue but fails to correctly relate it to the total Orthopaedics revenue, suggesting a breakdown in synthesizing the full set of required data points. (4) Scores reflect mostly correct numbers but a major error in the percentage, which undermines the overall correctness. Contextual relevance is perfect as all parts of the question are addressed with appropriate structure and terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1123,
        "completion_tokens": 352,
        "total_tokens": 1475
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "What is the total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years covered in Boeing's 2024 10-K filing, and why were these shares excluded?",
      "original_answer": "The total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years covered in Boeing's 2024 10-K filing is 20.8 million. These shares were excluded because the effect would have been antidilutive due to Boeing incurring a net loss in those periods.",
      "llm_answer": "The total number of potential common shares excluded from diluted loss per share computation for the three fiscal years covered in Boeing's 2024 10-K filing is 11.6 million for 2024, 5.7 million for 2023, and 3.5 million for 2022. These shares were excluded because their inclusion would have been antidilutive due to the company incurring a net loss in each of these periods.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer provides a breakdown of excluded shares by year (11.6 million in 2024, 5.7 million in 2023, and 3.5 million in 2022), which sum to 20.8 million—the exact total stated in the ground truth. However, the ground truth does not provide a year-by-year breakdown, only the cumulative total of 20.8 million across the three fiscal years. The LLM's individual yearly figures are not verifiable from the provided ground truth, and their sum, while correct in total, introduces unverified granular data that may not be supported by the source. This undermines quantitative accuracy. (2) The explanation for exclusion—antidilutive effect due to net losses—is semantically equivalent and correct. (3) The multi-hop reasoning is partially sound: the model correctly identifies the concept of antidilution in the context of net losses and applies it across multiple years. However, the introduction of specific annual figures not present in the ground truth suggests either hallucination or unsupported inference, weakening the factual basis. (4) The contextual relevance is high because the answer addresses both parts of the question (total number and reason for exclusion) and uses appropriate financial terminology. The core total is correct if the sum is accepted, but since the original answer does not break down the 20.8 million, presenting such detail as fact reduces quantitative accuracy. Thus, while the total adds up, the lack of corroboration for individual components results in a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 423,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "By how much did the amendment to the Retirement Value formula in 2021 reduce the Projected Benefit Obligation as of January 3, 2021, and how does this change affect the calculation of pension benefits for U.S. non-union employees hired before 2015?",
      "original_answer": "The amendment to the Retirement Value formula in 2021 reduced the Projected Benefit Obligation as of January 3, 2021 by approximately $1.8 billion. This change affects the calculation of pension benefits for U.S. non-union employees hired before 2015 by transitioning them from the Final Average Pay formula to the Retirement Value formula for benefits earned after January 1, 2026, while preserving the Final Average Pay formula for service before that date.",
      "llm_answer": "The amendment to the Retirement Value formula reduced the Projected Benefit Obligation as of January 3, 2021 by approximately **$1.8 billion**. This change affects U.S. non‑union employees hired before 2015 by preserving their accrued benefits under the existing Final Average Pay formula for service prior to January 1, 2026, while future benefits for all eligible U.S. non‑union employees (including those hired before 2015) will be calculated using the new Retirement Value formula.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1.8 billion reduction in the Projected Benefit Obligation as of January 3, 2021, matching the ground truth exactly. The effective date of the change (January 1, 2026) and the affected employee group (U.S. non-union employees hired before 2015) are accurately stated. (2) The quantitative accuracy is perfect: the dollar amount ($1.8 billion) and key dates (January 3, 2021, and January 1, 2026) are correct and match the original answer. (3) The reasoning is sound and reflects proper multi-hop synthesis: the amendment impacts both the financial liability (PBO) and the benefit calculation structure. The LLM correctly explains that accrued benefits under the Final Average Pay formula are preserved for service before 2026, while future benefits will use the Retirement Value formula. However, the original answer more precisely specifies that the change involves a transition 'from the Final Average Pay formula to the Retirement Value formula for benefits earned after January 1, 2026,' which the LLM captures in meaning but slightly less explicitly. (4) The answer is contextually fully relevant and conveys the same core information with only minor differences in phrasing. The omission of the explicit 'transition' language does not distort meaning, so the score is high but not perfect. Thus, correctness is 9 due to slight loss in precision of phrasing around the transition mechanism, despite full factual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 408,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "Given that American Express's financial assets and liabilities carried at amortized cost are based on market conditions and perceived risks as of specific dates, why does the filing state that the fair value of the company cannot be estimated by aggregating these figures?",
      "original_answer": "The filing explains that the fair value figures for financial assets and liabilities measured at amortized cost are estimates based on market conditions and perceived risks as of December 31, 2021 and 2020. These estimates require management judgment and are not indicative of future fair values. Furthermore, the filing explicitly states that the fair value of American Express as a whole cannot be estimated by aggregating the fair values of individual financial instruments because doing so would not capture the company's overall valuation, which includes non-financial factors and the complexities of the business as a whole.",
      "llm_answer": "The filing states that the fair value of American Express cannot be estimated by simply aggregating the amortized‑cost figures because those figures represent only the carrying amounts of individual financial assets and liabilities, not the overall fair value of the company; the fair values are management‑estimated amounts that depend on market conditions and perceived risks, and they are presented separately in the table on page 141. Consequently, combining the amortized‑cost values would not reflect the company’s total fair value.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that amortized cost figures are not suitable for aggregating to estimate the company's fair value and notes that fair values are management estimates based on market conditions and perceived risks. It also correctly references the idea that these values are presented separately (e.g., in a table), which aligns with the filing's structure. However, it fails to mention the key point from the original answer that the aggregation would not capture non-financial factors and the complexities of the business as a whole—this is a significant omission in the reasoning chain. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable; however, the LLM does not introduce any incorrect numbers, so it scores fully on this dimension. (3) The multi-hop reasoning is partially sound: the model connects amortized cost with fair value estimation limitations, but it does not fully synthesize the broader conceptual limitation—namely, that a company’s total fair value includes intangible, non-financial, and synergistic elements beyond the sum of individual financial instruments. (4) The answer is contextually relevant and accurately reflects part of the filing's rationale, but misses a core explanatory element present in the ground truth, warranting a moderate deduction in qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 395,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How many amendments to the Benefits Plan for Members of the Board of Directors are explicitly listed in the exhibit index, and what were the effective dates of the original plan and its first amendment?",
      "original_answer": "There are two explicitly listed amendments to the Benefits Plan for Members of the Board of Directors. The original plan was effective on April 14, 2004, and the first amendment was dated December 16, 2005.",
      "llm_answer": "The exhibit index explicitly lists **three amendments** to the Benefits Plan for Members of the Board of Directors:  \n- The original plan (10.13),  \n- Amendment Number One (10.13.1),  \n- Amendment Number Two (10.13.2).  \n\nThe original Benefits Plan for Members of the Board of Directors was adopted on **April 14, 2004**, and its first amendment (Amendment Number One) became effective on **December 16, 2005**.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the effective dates of the original plan (April 14, 2004) and the first amendment (December 16, 2005), which matches the ground truth. However, it incorrectly states that there are three amendments explicitly listed in the exhibit index, when the ground truth specifies only two amendments. The LLM appears to count the original plan as an amendment, which is incorrect—amendments are changes to the original, not including the original itself. Thus, while the original plan and two amendment documents (10.13.1 and 10.13.2) may be listed, only the latter two are amendments, making the correct count two, not three. This is a significant factual error affecting the quantitative and qualitative accuracy. The reasoning is partially sound in identifying the relevant exhibit numbers, but flawed in interpretation. The answer is contextually relevant and well-structured, addressing all parts of the question with mostly accurate data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 278,
        "total_tokens": 1447
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Oracle's hybrid deployment model contribute to the cloud and license business representing 84% of total revenues in fiscal 2024?",
      "original_answer": "Oracle's hybrid deployment model, which combines on-premise and cloud-based deployment options, provides customers with flexibility and choice, enabling them to select the deployment model that best suits their needs. This flexibility enhances customer retention and satisfaction, as evidenced by the high renewal rate of license support contracts. The cloud and license business, which includes these support contracts priced as a percentage of the net fees paid by customers, accounted for 84% of Oracle's total revenues in fiscal 2024. This indicates that the hybrid model not only supports customer adoption but also directly drives a significant portion of Oracle's revenue through recurring license support streams.",
      "llm_answer": "Oracle's hybrid deployment model—combining on-premise and cloud-based solutions—enabled customers to adopt its cloud services gradually while retaining existing on-premise investments, directly driving the cloud and license business to represent 84% of total revenues in fiscal 2024. This flexibility, highlighted in the Business Overview and Cloud and License Business sections, allowed Oracle to capture significant cloud services and license support revenues, which are recognized ratably over contract periods, thereby fueling the dominant share of its total revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 84% figure for cloud and license revenue as a share of total revenues in fiscal 2024 is correctly stated, with no numerical errors. (2) The entity identification is correct—Oracle, fiscal 2024, cloud and license business—and the context of hybrid deployment (on-premise + cloud) is accurately described. (3) The reasoning is sound: the model correctly links the hybrid model’s flexibility to customer adoption and retention, gradual cloud migration, and the resulting revenue impact. It also appropriately references ratable revenue recognition for support and cloud services, which contributes to stable, recurring income. (4) While the LLM answer captures the core causal mechanism, it omits explicit mention of the high renewal rates of license support contracts and the pricing mechanism (as a percentage of net fees), which are key elements in the ground truth that explain *why* the hybrid model drives recurring revenue. This minor omission prevents a perfect score but does not detract significantly from the overall correctness. The answer remains semantically equivalent in intent and factual content, with strong multi-hop synthesis between deployment model, customer behavior, and financial outcome.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 363,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How much of American Express's December 31, 2021 deferred fees are specifically tied to Membership Rewards program participants, and how does this relate to the methodology used to estimate the future redemption liability for these points?",
      "original_answer": "The deferred fees tied to Membership Rewards program participants are specifically called out in the $8,737 million total deferred card and other fees as of December 31, 2021. This connects to the methodology used to estimate the future redemption liability, which relies on statistical and actuarial models using the weighted average cost (WAC) per point and the Ultimate Redemption Rate (URR) based on factors like redemption trends, card product type, and credit attributes.",
      "llm_answer": "Based on the provided pages, specifically page 129 and the accompanying notes, the deferred fees related to Membership Rewards program participants are included within the broader \"Deferred card and other fees, net\" line item. On page 129, the table shows \"Deferred card and other fees (a)\" as $2,838 million for 2021, with a footnote stating \"(a) Includes deferred fees for Membership Rewards program participants.\" However, the exact dollar amount specifically attributable *only* to Membership Rewards participants is not isolated in the provided text. \n\nThe Membership Rewards liability (page 129) is reported separately at $11,398 million for 2021, which represents the estimated cost of points expected to be redeemed in the future. This liability is distinct from deferred fees but is part of the broader deferred revenue framework. The methodology for estimating the future redemption liability for Membership Rewards points is detailed on page 129: it uses a weighted average cost (WAC) per point and an Ultimate Redemption Rate (URR) derived from statistical models based on redemption trends, card product type, and other factors. The liability is adjusted periodically based on redemption patterns and cost changes.\n\nThe question specifically asks for the amount of **deferred fees** tied to Membership Rewards participants, not the Membership Rewards liability. The deferred fees (as part of \"Deferred card and other fees, net\") are reported as $2,516 million for 2021 (page 129), but this figure includes all deferred card and other fees, not exclusively Membership Rewards-related fees. The footnote (a) on page 129 confirms that \"Deferred card and other fees (a)\" includes deferred fees for Membership Rewards program participants, but the exact portion of the $2,516 million that is attributable solely to Membership Rewards is not specified in the provided text. Therefore, the precise amount tied to Membership Rewards participants cannot be determined from the given data. \n\nThe methodology for estimating the future redemption liability for Membership Rewards points (which is separate from deferred fees) relies on URR and WAC assumptions, but this does not directly quantify the deferred fees amount. The deferred fees are part of the accounting for Membership Rewards, but the document does not break out the specific dollar value of deferred fees *only* for Membership Rewards participants. \n\nThus, the answer must reflect that the exact amount of deferred fees tied to Membership Rewards participants is not explicitly provided, and the methodology for the redemption liability is based on URR and WAC, but the deferred fees figure itself is embedded in the broader \"Deferred card and other fees, net\" without a specific breakdown. \n\n**Answer**: The document does not specify the exact dollar amount of deferred fees solely tied to Membership Rewards program participants; it only states that \"Deferred card and other fees (a)\" includes such fees within the $2,516 million reported for 2021 (page 129), but the precise portion is not isolated. The future redemption liability for Membership Rewards points is estimated using an Ultimate Redemption Rate (URR) and weighted average cost (WAC) based on redemption trends and cost assumptions, as described on page 129.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its quantitative claims. The ground truth states that the total deferred card and other fees as of December 31, 2021, are $8,737 million, with the Membership Rewards-related deferred fees embedded within that figure. However, the LLM incorrectly reports the 'Deferred card and other fees' as $2,838 million and later $2,516 million (both figures appear to be misread from the table on page 129, possibly confusing net amounts or different line items), which contradicts the ground truth of $8,737 million. These numbers are materially off, indicating a failure in quantitative accuracy. (2) The LLM correctly identifies that the deferred fees for Membership Rewards participants are included within the broader deferred fees line and that the exact breakout is not isolated, which aligns with the ground truth. It also accurately describes the methodology for estimating the future redemption liability using URR and WAC based on statistical models, redemption trends, card product type, and credit attributes. This shows correct qualitative understanding of the accounting methodology. (3) The multi-hop reasoning is partially sound: the model correctly distinguishes between deferred fees and the redemption liability and references the appropriate page and footnote. However, it fails to correctly extract the total deferred fees amount, undermining the factual foundation of the response. (4) The contextual relevance is high because the answer addresses both parts of the question—amount of deferred fees tied to Membership Rewards and the related methodology—even though the numerical foundation is wrong. Due to major factual errors in dollar amounts, the correctness score is low despite accurate reasoning and conceptual understanding.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1965,
        "completion_tokens": 488,
        "total_tokens": 2453
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How many different forms of award agreements under The Coca-Cola Company 2014 Equity Plan were documented between February 18, 2015, and February 17, 2021, based on filings listed in the 2024 10-K report?",
      "original_answer": "16 different forms of award agreements under The Coca-Cola Company 2014 Equity Plan were documented between February 18, 2015, and February 17, 2021.",
      "llm_answer": "Based on the filings listed in the 2024 10‑K (pages 112, 122, 130, 131, 132, 133, 137), the Company’s 2014 Equity Plan—including all amendments and restatements adopted on February 16 2022, February 15 2023, February 14 2024, and the related award agreements—was documented in **six distinct award agreements** covering stock options, restricted stock units, performance share agreements, and supplemental award notifications.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states 'six distinct award agreements,' which directly contradicts the ground truth of 16 different forms of award agreements. This is a major factual error in the core quantitative claim. (2) The time period in question is February 18, 2015, to February 17, 2021; however, the LLM references amendments adopted in 2022, 2023, and 2024, which fall outside the specified range and are irrelevant to the query. This introduces incorrect temporal context and undermines the accuracy. (3) The multi-hop reasoning fails because the LLM does not correctly synthesize the number of award agreements documented within the required timeframe based on the 2024 10-K. Instead, it appears to count only a subset (possibly those mentioned on the cited pages) and omits the full scope. The mention of specific pages (112, 122, etc.) does not compensate for the incorrect total count. (4) While the LLM attempts to reference relevant sections and categorizes types of awards (stock options, RSUs, etc.), the significant undercount and inclusion of post-2021 amendments lead to a low correctness score. The answer is contextually relevant in topic and structure but fundamentally incorrect in substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 343,
        "total_tokens": 1501
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "Considering AMD's purchases from and equity gains with the ATMP JV in 2021, what was the total financial value of AMD's relationship with the ATMP JV that year, and how does this reflect the strategic importance of the joint venture?",
      "original_answer": "The total financial value of AMD's relationship with the ATMP JV in 2021 was $1.106 billion, combining $1.1 billion in purchases and a $6 million equity gain. This reflects the strategic importance of the joint venture as AMD relies on ATMP JV for critical assembly, test, mark, and packaging (ATMP) services, and maintains a 15% equity stake that gives it significant influence without the obligation to fund further investments.",
      "llm_answer": "In 2021 AMD recorded a $6 million gain from its 15 % equity stake in the ATMP joint venture and purchased $1.1 billion of inventory from it, while also holding $85 million of payables to the JV. This $1.1 billion of purchases plus the $6 million equity gain represents the total financial value of AMD’s relationship with the ATMP JV that year, underscoring how critical the joint venture is to AMD’s supply chain and its strategy of leveraging external ATMP capacity to support its product portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial figures from the ground truth: $1.1 billion in purchases and a $6 million equity gain, which sum to $1.106 billion in total financial value. The mention of $85 million in payables is additional context not present in the original answer but does not contradict it and may reflect supplementary data; however, since the question only asks for the total financial value considering purchases and equity gains, this extra detail does not affect correctness. (2) Quantitatively, all numbers match the ground truth exactly—$1.1 billion and $6 million—and the implied sum is accurate. Format variations (e.g., $1.1 billion vs $1.106 billion) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes two distinct financial aspects (purchases and equity gain) related to AMD's relationship with ATMP JV in 2021 and draws a logical conclusion about strategic importance, aligning with the original answer’s emphasis on supply chain criticality and external capacity reliance. (4) The only minor shortcoming is that the LLM answer does not explicitly mention AMD’s 15% equity stake as a mechanism for influence without further funding obligations—a nuance in strategic rationale present in the original answer. However, it does reference the 15% stake and the equity gain, capturing most of the qualitative depth. Thus, while highly accurate and contextually relevant, it loses one point on qualitative accuracy for slight incompleteness in strategic explanation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 434,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Given that DARZALEX and DARZALEX FASPRO together accounted for 6.4% of Johnson & Johnson's total revenues in fiscal 2021 and their respective patent protections expire in 2029 (U.S.) and 2032 (Europe) for DARZALEX and are covered by a separate Janssen-owned portfolio for DARZALEX FASPRO, what is the earliest year that patent expiration could begin to materially impact this combined revenue stream?",
      "original_answer": "The earliest year that patent expiration could begin to materially impact the combined revenue stream of DARZALEX and DARZALEX FASPRO is 2029, when the U.S. patents for DARZALEX expire, potentially allowing competitors to introduce biosimilars in the U.S. market, which accounts for a significant portion of Johnson & Johnson's global sales.",
      "llm_answer": "The earliest year that patent expiration could begin to materially impact the combined DARZALEX and DARZALEX FASPRO revenue stream is 2029, as the U.S. patents for DARZALEX expire in 2029 and these patents are material to the 6.4% of total revenue they represent.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies 2029 as the earliest year patent expiration could materially impact the combined revenue stream, which aligns with the ground truth. The U.S. patent expiration for DARZALEX in 2029 is accurately cited as the key event, and the 6.4% revenue figure is contextually acknowledged. All quantitative elements (2029, 6.4%) are correct and match the original answer. The reasoning is sound: it correctly synthesizes that DARZALEX FASPRO has separate patent coverage and that the DARZALEX U.S. patent expiry is the earliest vulnerability in the combined product revenue. The only minor shortcoming is that the LLM answer does not explicitly mention the potential entry of biosimilars or the significance of the U.S. market in driving material impact, which is included in the ground truth and strengthens the reasoning. However, the core logic and factual synthesis are accurate, and the omission does not undermine the correctness of the conclusion. Semantic equivalence is maintained, and the answer is fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 302,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "What is the total number of amendments to The Bank of New York Company, Inc. Excess Benefit Plan documented across both 2015 and 2018, as disclosed in the 2022 10-K filing?",
      "original_answer": "The total number of amendments to The Bank of New York Company, Inc. Excess Benefit Plan documented in the 2022 10-K filing for the years 2015 and 2018 is two: one amendment effective June 30, 2015, and another effective November 1, 2018.",
      "llm_answer": "The 2022 10-K filing discloses **two amendments** to The Bank of New York Company, Inc. Excess Benefit Plan across the 2015 and 2018 periods:  \n1. An amendment effective **June 30, 2015** (referenced as \"Amendment effective as of June 30, 2015 to The Bank of New York Company, Inc. Excess Benefit Plan\" on page 19).  \n2. An amendment effective **November 1, 2018** (referenced as \"Amendment effective as of Nov. 1, 2018 to The Bank of New York Company, Inc. Excess Benefit Plan\" on page 20).  \n\nThese are the only two amendments explicitly tied to the Excess Benefit Plan within the specified timeframe.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately identifies the total number of amendments as two, which is consistent with the original answer. (2) The dates of the amendments—June 30, 2015, and November 1, 2018—are correctly stated and match the ground truth exactly. (3) The answer demonstrates sound multi-hop reasoning by referencing specific disclosures in the 2022 10-K filing (pages 19 and 20), showing that the information was synthesized from the correct source document across the required years. (4) All entities—the Bank of New York Company, Inc. Excess Benefit Plan, the years 2015 and 2018, and the 2022 10-K—are correctly identified and contextually relevant. The answer is complete, factually precise, and semantically equivalent to the ground truth, with added value from citation of document pages. No errors in reasoning, calculation, or factual content.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 267,
        "total_tokens": 1483
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How do FedEx's Network 2.0 optimization expenditures and European workforce reduction costs relate to the company's overall 2025 capital expenditure plan and strategic DRIVE transformation program?",
      "original_answer": "FedEx's 2025 capital expenditure plan totals $5.2 billion, with a portion allocated to Network 2.0 optimization. Specifically, the company is investing in network optimization and facility modernization as part of this initiative. Additionally, FedEx Express announced a European workforce reduction plan tied to cost-cutting efforts, with expected cash expenditures ranging from $250 million to $375 million through fiscal 2026. These workforce reduction costs are classified as business optimization expenses and support the DRIVE transformation program, which aims to improve long-term profitability. The capital allocation for Network 2.0 and the European workforce reductions are strategic components of FedEx's broader efforts under the DRIVE initiative to enhance operational efficiency and reduce structural costs.",
      "llm_answer": "FedEx's Network 2.0 optimization expenditures ($582 million in 2024) and the European workforce‑reduction costs ($250‑$375 million pre‑tax through 2026) are both classified as business‑optimization expenses that will be funded from the company’s 2025 capital‑expenditure budget of roughly $5.2 billion. These outlays are integral to the DRIVE transformation program, which seeks to streamline operations, cut structural costs and improve long‑term profitability, and they are reflected in the 2025 capex plan that earmarks continued investment in Network 2.0, hub modernizations and aircraft upgrades while maintaining overall capital intensity.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $5.2 billion 2025 capex plan, the $250–$375 million European workforce reduction costs through 2026, and the connection to the DRIVE transformation program. However, it introduces a specific figure of $582 million for Network 2.0 optimization expenditures in 2024, which is not present in the ground truth and cannot be verified from the provided information. This number is a significant factual addition that undermines quantitative accuracy. (2) The $5.2 billion capex and $250–$375 million workforce reduction range are correctly stated and contextually accurate. The error lies in the unsupported $582 million figure for Network 2.0, which may conflate data from another source or fiscal year. (3) The multi-hop reasoning is otherwise sound: the model correctly synthesizes that both Network 2.0 investments and workforce reductions are business optimization expenses tied to the DRIVE program and funded within the broader capex framework. It accurately links capital expenditures, cost reduction efforts, and strategic transformation goals. (4) While the core relationships and strategic context are well-explained and semantically aligned with the ground truth, the inclusion of an unverified specific dollar amount for Network 2.0 expenditures reduces factual reliability. Hence, correctness is downgraded to 7 due to this significant numerical inaccuracy, though qualitative and contextual elements remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 408,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How does AMD's dependency on third-party suppliers for graphics cards and AIB partners affect its financial risk exposure in terms of inventory management and price protection obligations?",
      "original_answer": "AMD's dependency on third-party suppliers for graphics cards and its reliance on AIB partners exposes it to significant financial risk due to price protection obligations. If there is a significant decline in product prices, AMD must honor price protection rights for AIB partners' inventory, which can materially reduce revenue and gross margins. Additionally, AIB partners can return products removed from the price book within 12 months of manufacturing, further impacting financial stability during market fluctuations.",
      "llm_answer": "AMD's reliance on third‑party suppliers for graphics cards and AIB partners creates significant inventory‑related financial risk. Because distributors and AIB partners are protected by price‑protection and return rights, AMD must maintain sufficient inventory to meet demand while also bearing the cost of potential excess or obsolete stock and price‑protection obligations that can erode revenue and gross margins. Additionally, the company must manage the risk of gray‑market activity and cancellations, which can further strain inventory management and increase exposure to price‑protection charges.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and contextually relevant, correctly identifying AMD's financial risks related to its reliance on third-party suppliers and AIB partners, particularly regarding price protection and inventory management. It accurately captures the core risk: that price protection obligations can erode revenue and gross margins. However, it omits a specific detail present in the ground truth — that AIB partners can return products removed from the price book within 12 months of manufacturing. This is a notable omission affecting completeness, though not the overall correctness of the main financial risk. There are no numerical values in the question or answers requiring calculation, but the qualitative description of risks aligns semantically with the original. The reasoning is sound and reflects proper multi-hop synthesis of AMD's business model and contractual obligations. The mention of gray-market activity and cancellations adds context not in the original but does not contradict it; however, these are not part of the documented risk in the ground truth, slightly diluting precision. Overall, the answer is strong but lacks one key structural detail about return timelines, justifying a score of 8 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 356,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What is AbbVie's total cost of products sold related to Venclexta, considering both its shared U.S. profits with Genentech and the royalties paid on net revenues outside the United States?",
      "original_answer": "AbbVie's total cost of products sold related to Venclexta includes Genentech's 50% share of U.S. profits from Venclexta and the royalties paid on net revenues outside the United States. Both components are explicitly included in AbbVie's cost of products sold, as stated in the filing.",
      "llm_answer": "AbbVie's total cost of products sold related to Venclexta reflects both its shared U.S. profit arrangement with Genentech and royalties paid on international net revenues. Specifically, Genentech's share of U.S. profits from Venclexta is included in AbbVie's cost of products sold, while royalties on Venclexta net revenues outside the United States are also recorded as part of cost of products sold.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. It accurately identifies both components of AbbVie's cost of products sold related to Venclexta: (1) Genentech's share of U.S. profits and (2) royalties on net revenues outside the United States, both of which are explicitly stated in the original answer as being included in cost of products sold. There are no numeric values in the question or ground truth requiring calculation, so quantitative accuracy is 10. The reasoning is sound and reflects proper multi-hop understanding—linking AbbVie’s cost accounting treatment to both the U.S. profit-sharing arrangement and international royalty structure. The only minor limitation is that the LLM does not explicitly state that both components are 'included in cost of products sold, as stated in the filing'—a small contextual nuance about sourcing from the SEC filing—but the substance is fully preserved. Thus, qualitative accuracy is slightly reduced to 9. Contextual relevance is perfect, as the response directly addresses the question with precise, relevant information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 314,
        "total_tokens": 1496
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What specific governance document related to board members does BNY make publicly available in addition to its Committee Charters and Corporate Governance Guidelines, and who is this document explicitly applicable to?",
      "original_answer": "BNY makes its Directors' Code of Conduct publicly available in addition to the Corporate Governance Guidelines and Committee Charters, and this document is explicitly applicable to all directors of BNY.",
      "llm_answer": "BNY makes its Code of Ethics for directors publicly available in addition to its Committee Charters and Corporate Governance Guidelines, and this document is explicitly applicable to all directors of BNY.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a minor inaccuracy in terminology. The ground truth states that BNY makes its 'Directors' Code of Conduct' publicly available, while the LLM refers to it as the 'Code of Ethics for directors.' While these terms are similar and may be used interchangeably in some contexts, they are not semantically identical, and the exact title matters for precision in governance documentation. However, the answer correctly identifies that the document is in addition to the Committee Charters and Corporate Governance Guidelines, and accurately states that it is applicable to all directors of BNY—this addresses both parts of the question. There are no numerical values, so quantitative accuracy is not applicable but assumed perfect. The reasoning and synthesis are sound, and the response is fully contextually relevant. The error is in entity accuracy (document name), which prevents a full 9–10 score, but the core information is correct, warranting a score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1119,
        "completion_tokens": 287,
        "total_tokens": 1406
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "Given AMD's 68% year-over-year revenue growth and 3 percentage-point gross margin improvement in 2021, how did the launch of the AMD Radeon RX 6600 XT and broader gaming-focused graphics strategy specifically contribute to these financial outcomes?",
      "original_answer": "The launch of the AMD Radeon RX 6600 XT in July 2021, designed for high-frame rate 1080p gaming, was part of a broader product strategy that contributed to AMD's 68% revenue growth from $9.8 billion in 2020 to $16.4 billion in 2021. This gaming-focused graphics strategy, which included the Radeon RX 6000M series for laptops and the AMD Advantage Design Framework, helped drive strong demand in the gaming segment. The improved gross margin from 45% to 48% reflects the company's success in scaling high-performance product lines like RDNA 2-based GPUs, which delivered both performance and power efficiency gains that enhanced AMD's competitive positioning and pricing power in the gaming market.",
      "llm_answer": "The AMD Radeon RX 6600 XT and the broader gaming‑focused graphics strategy helped drive the 68% year‑over‑year revenue surge and the 3‑point gross‑margin lift in 2021 by expanding AMD’s addressable market in the high‑performance PC‑gaming segment, boosting average selling prices and overall revenue mix, and reinforcing the company’s competitive position in a rapidly growing graphics market. This product launch contributed directly to the higher revenue and improved margin performance highlighted in AMD’s 2021 financial results.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the Radeon RX 6600 XT launch and broader gaming strategy as contributors to AMD's 68% year-over-year revenue growth and 3-percentage-point gross margin improvement in 2021, aligning with the ground truth. However, it omits specific supporting details such as the actual revenue figures ($9.8B in 2020 to $16.4B in 2021), the July 2021 launch date, and the inclusion of the Radeon RX 6000M series and AMD Advantage Design Framework, which are key elements in the multi-hop reasoning. (2) Quantitatively, the 68% growth and 3-point margin improvement are accurately referenced, and no incorrect calculations are made. The absence of explicit dollar amounts reduces precision slightly but does not introduce error. (3) The reasoning is logically sound—linking product launches to revenue and margin improvements via market expansion, pricing power, and product mix—but lacks the full synthesis across entities (e.g., RDNA 2 architecture, laptop GPUs) that would demonstrate complete multi-hop understanding. (4) The answer is contextually relevant and well-articulated, but the omission of concrete data points and specific strategic components prevents a higher score on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 353,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "What was AbbVie's net revenue from Venclexta in 2023, and how much of the pre-tax profit from Venclexta sales in the United States did Genentech receive as part of their collaboration agreement?",
      "original_answer": "AbbVie reported total net revenue of $2,288 million from Venclexta in 2023. As part of the collaboration agreement with Genentech, the pre-tax profit from Venclexta sales in the United States is shared equally between AbbVie and Genentech. Therefore, Genentech received 50% of the United States pre-tax profit from Venclexta, which is included in AbbVie's cost of products sold.",
      "llm_answer": "AbbVie's net revenue from Venclexta in 2023 was $2,288 million, and Genentech received 50% of the pre-tax profit from Venclexta sales in the United States as part of their collaboration agreement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly states that AbbVie's net revenue from Venclexta in 2023 was $2,288 million, which matches the ground truth exactly. It also correctly identifies that Genentech received 50% of the pre-tax profit from Venclexta sales in the United States as part of the collaboration agreement. All numeric values and percentages are accurate, and there are no calculation errors. The answer addresses both parts of the multi-hop question: (1) AbbVie's net revenue and (2) Genentech's share of pre-tax profit. The reasoning is sound and aligns with the known collaboration structure. The only minor shortcoming is that the LLM omits the detail that Genentech's 50% share is reflected in AbbVie's cost of products sold, which adds context about how the profit-sharing is accounted for. While this does not affect the core factual correctness, including it would have made the answer more complete. Overall, the answer is semantically equivalent to the ground truth and highly relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 288,
        "total_tokens": 1443
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "Despite issuing 48 million new Class C common shares in the May 2024 exchange offer, why does Visa's 10-K report only 10 Class C common shares outstanding as of September 30, 2024?",
      "original_answer": "Visa issued 48 million new Class C common shares in the May 2024 exchange offer in connection with the exchange of 241 million Class B-1 shares. However, the 10-K filing shows only 10 Class C common shares outstanding as of September 30, 2024. This discrepancy is explained by the fact that the 10 shares figure in the equity section is presented in millions, as noted in the table's header (\"millions, except per share data\"). Therefore, the 10 shares reported actually represent 10 million shares outstanding. This means that although 48 million Class C shares were newly issued in May 2024, the total outstanding amount was subsequently reduced by 38 million shares, likely through share repurchases, retirements, or other corporate actions not detailed in the provided excerpts.",
      "llm_answer": "The 10‑K shows only 10 Class C shares outstanding because the 48 million Class C shares issued in the May 2024 exchange offer were recorded as “authorized but unissued” shares and therefore do not increase the reported number of issued shares; only the 10 Class C shares that were already issued remain reflected in the equity section.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core reasoning. It claims that the 48 million Class C shares were recorded as 'authorized but unissued' and therefore did not increase the issued share count, which contradicts the ground truth. The ground truth states that 48 million new Class C shares were issued in the exchange offer, and the reason only 10 million (reported as '10') are outstanding is due to a reduction—likely via repurchases—not because they were unissued. The LLM misrepresents the nature of the share issuance. (2) Quantitatively, the LLM correctly references the 48 million shares issued and the 10 Class C shares reported, but fails to recognize that '10' represents 10 million shares (per the 'millions' note in the filing), which is a critical numeric misinterpretation. It treats '10 shares' literally, missing the unit scaling, leading to a fundamental error. (3) The multi-hop reasoning is flawed: the model fails to connect the unit convention (millions) in financial statements with the apparent discrepancy, which is the key insight in the ground truth. Instead, it invents an incorrect accounting explanation ('authorized but unissued') not supported by the data. (4) Contextual relevance is moderate—it addresses the question's surface-level discrepancy and mentions the exchange offer—but the explanation is based on incorrect financial logic, severely undermining accuracy. The answer misses the actual explanation involving unit presentation and post-issuance share reduction.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 420,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How much total cost did FedEx incur in 2024 for both Network 2.0 implementation and DRIVE transformation-related business optimization activities, and what is the expected range of future costs for the European workforce reduction plan announced in June 2024?",
      "original_answer": "FedEx incurred $582 million in 2024 for business optimization activities related to Network 2.0 and the DRIVE transformation. The European workforce reduction plan announced in June 2024 is expected to cost between $250 million and $375 million in cash expenditures through fiscal 2026.",
      "llm_answer": "Based on the provided document pages, the total cost incurred by FedEx in 2024 for business optimization activities (including Network 2.0 implementation and DRIVE transformation) was **$582 million** (net of tax: $444 million), as stated in the \"Business Optimization and Realignment Costs\" section on page 55. Additionally, the expected range of future costs for the European workforce reduction plan announced in June 2024 is **$250 million to $375 million** in pre-tax cash expenditures, as specified in the same section on page 55.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total 2024 cost of $582 million for Network 2.0 and DRIVE transformation activities is accurately reported, and the expected future cost range of $250 million to $375 million for the European workforce reduction is correctly stated. The mention of 'pre-tax cash expenditures' and 'net of tax: $444 million' adds contextual detail not required but factually consistent. (2) The answer addresses both parts of the multi-part question completely: actual 2024 costs and expected future costs for the European plan. (3) Entities are correct—FedEx, fiscal year 2024, Network 2.0, DRIVE transformation, and the June 2024 announcement date are all accurately referenced. (4) The reasoning is sound, demonstrating proper synthesis of information from the cited document section (page 55), indicating correct multi-hop extraction and integration of relevant data points. The answer is semantically equivalent to the ground truth, with slightly more detail but no factual deviations. All scores are maximized accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 314,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "What was the total value of AMD's (AMD) unbilled accounts receivable specifically related to custom products and development services revenue recognized over time in fiscal year 2021?",
      "original_answer": "$329 million was the total value of AMD's unbilled accounts receivable related to custom products and development services revenue recognized over time in fiscal year 2021.",
      "llm_answer": "Based on the provided document pages, specifically **Page page_63** and **Page page_60**, the total value of AMD's unbilled accounts receivable specifically related to custom products and development services revenue recognized over time in fiscal year 2021 is **$329 million**. This is explicitly stated in the \"Accounts Receivable, net\" section of Page page_63, which notes that unbilled accounts receivable (representing revenue recognized but not yet invoiced for development services and custom products) totaled **$329 million as of December 25, 2021**. Additionally, Page page_60 confirms that revenue from custom products and development services accounted for approximately **23% of the Company's revenue in 2021**, aligning with the context of unbilled receivables tied to these services. \n\n**Answer**: The total value of AMD's unbilled accounts receivable related to custom products and development services revenue recognized over time in fiscal year 2021 was **$329 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The key numeric value of $329 million is accurately reported, with the correct fiscal date (December 25, 2021), which aligns with AMD's fiscal year 2021. The format ($329 million) is semantically equivalent to the ground truth. (2) The answer correctly identifies the specific context—unbilled accounts receivable tied to custom products and development services revenue recognized over time—and supports it with precise document references (Page page_63 and Page page_60). (3) The multi-hop reasoning is sound: it connects the $329 million figure from the 'Accounts Receivable, net' section to the nature of the revenue (custom products and development services), and further validates the context with the 23% revenue contribution mentioned on page_60. (4) All entities—AMD, fiscal year 2021, unbilled receivables, and the relevant revenue streams—are accurately identified and synthesized. The answer is complete, factually precise, and contextually appropriate, warranting top scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 306,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What was AbbVie's total revenue from Venclexta in 2023, and how much of the pre-tax profit from Venclexta's U.S. sales did AbbVie share with Genentech as part of their collaboration agreement?",
      "original_answer": "AbbVie's total revenue from Venclexta in 2023 was $2,288 million. As part of the collaboration agreement with Genentech, AbbVie shared 50% of the pre-tax profit from Venclexta's U.S. sales with Genentech, which is included in AbbVie's cost of products sold.",
      "llm_answer": "AbbVie's total revenue from Venclexta in 2023 was $2,288 million, and under the collaboration agreement with Genentech, AbbVie shares 50 % of the pre‑tax profit from Venclexta's U.S. sales with Genentech.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states AbbVie's total revenue from Venclexta in 2023 as $2,288 million and accurately reports the 50% pre-tax profit sharing with Genentech on U.S. sales, which matches the ground truth. All key facts are present and correct. (2) Quantitatively, both the revenue figure ($2,288 million) and the 50% profit-sharing percentage are exact matches to the original answer. Number formats (e.g., spacing in '2,288 million' and '50 %') are non-standard but semantically equivalent and do not affect accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about revenue and the collaboration agreement terms between AbbVie and Genentech. However, the LLM omits the detail that the shared profit is included in AbbVie's cost of products sold, which is part of the ground truth and adds important context about accounting treatment. This is a minor omission, not a factual error. (4) The answer is highly accurate, complete for the explicit question, and contextually relevant. The omission of the cost of products sold linkage prevents a perfect score, but core facts and numbers are fully correct, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 345,
        "total_tokens": 1471
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What was the change in the aggregate principal balance of the 3.650% notes due 2023 between December 31, 2022, and December 15, 2023, and how does this compare to the balance of the 3.700% notes due 2023 on December 15, 2023?",
      "original_answer": "The aggregate principal balance of the 3.650% notes due 2023 decreased by $171 million from December 31, 2022 ($171 million) to December 15, 2023 ($0). On the same date, the 3.700% notes due 2023 had an aggregate principal balance of $400 million.",
      "llm_answer": "The aggregate principal balance of the 3.650% notes due 2023 decreased from $171 million on December 31, 2022 to $0 million on December 15, 2023, a reduction of $171 million. In comparison, the balance of the 3.700% notes due 2023 on December 15, 2023 was $400 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the 3.650% notes decreased from $171 million on December 31, 2022, to $0 on December 15, 2023, representing a $171 million reduction. The balance of the 3.700% notes due 2023 on December 15, 2023, is correctly stated as $400 million. (2) The answer addresses both parts of the multi-part question: it computes the change in principal balance for the 3.650% notes and compares it to the balance of the 3.700% notes on the specified date. (3) Entity accuracy is perfect—correct interest rates (3.650% and 3.700%), correct maturity year (2023), and correct dates are used. (4) The reasoning is sound: the model correctly infers that a drop from $171M to $0 implies full repayment or maturity, and provides a valid comparison to the outstanding $400M balance of the other note series. The semantic meaning is equivalent to the original answer, with only minor formatting differences (e.g., use of thin spaces in dates and numbers), which do not affect accuracy. All multi-hop elements—tracking two different notes across time and comparing their balances—are handled correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 336,
        "total_tokens": 1484
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How could adverse litigation outcomes requiring Visa to modify its interchange reimbursement rates impact its transaction volumes and financial position, considering the protections provided by its U.S. and Europe retrospective responsibility plans and ongoing tax disputes?",
      "original_answer": "Adverse litigation outcomes could force Visa to reduce interchange reimbursement rates, which may lead some issuers to decrease promotion or use of Visa products, reduce cardholder benefits, or impose new fees, all of which could lower consumer usage and transaction volumes. This would directly harm Visa's net revenue. While Visa has U.S. and Europe retrospective responsibility plans that provide financial protections against certain litigation-related losses, these protections vary in scope and may not fully cover the financial impact of settlements, judgments, or changes in operating rules. At the same time, ongoing tax disputes with the IRS and foreign jurisdictions, combined with potential changes in global tax laws such as the OECD’s global minimum tax, could increase Visa’s effective tax rate and reduce cash flows. Therefore, even with partial mitigation from the retrospective plans, the combined effect of reduced interchange income and unfavorable tax outcomes could significantly harm Visa’s financial position.",
      "llm_answer": "Adverse litigation outcomes that force Visa to modify its interchange reimbursement rates could erode transaction volumes and revenue by prompting merchants and issuers to reduce usage of Visa products or shift to lower‑cost alternatives. However, the protections embedded in the U.S. and Europe retrospective responsibility plans and the company’s ongoing tax dispute reserves help limit the financial fallout, while tax‑related risks (e.g., potential adjustments from tax examinations or new digital‑services taxes) could further strain earnings if not resolved favorably.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its general reasoning and captures the core risks posed by adverse litigation outcomes, retrospective responsibility plans, and tax disputes. It correctly identifies that reduced interchange rates could lead to lower transaction volumes and revenue, and acknowledges the mitigating role of U.S. and Europe retrospective responsibility plans. It also appropriately notes that tax disputes and potential new taxes could strain earnings. However, it omits key details present in the ground truth: (1) it does not mention that issuers might reduce cardholder benefits or impose new fees, which is a critical transmission mechanism affecting consumer usage; (2) it fails to clarify that the retrospective plans offer only partial protection and may not cover all litigation-related financial impacts, especially settlements or operational changes; and (3) it does not reference the OECD’s global minimum tax or its specific impact on Visa’s effective tax rate and cash flows. While no numbers are incorrect (hence a 10 on quantitative accuracy), the qualitative reasoning is less complete in synthesizing the multi-hop chain from litigation → interchange changes → issuer behavior → consumer usage → transaction volumes → revenue impact, and how this interacts with tax risks. The answer remains contextually relevant and semantically aligned in broad strokes but lacks depth in causal mechanisms and scope limitations of protections. Thus, correctness is reduced to 7 due to meaningful omissions in completeness and reasoning depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 428,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "What are the effective dates of the Performance Share Unit award schedules under the United Technologies Corporation Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan, and how do these dates reflect distinct governance updates to each plan as disclosed in the filings?",
      "original_answer": "The effective date of the Performance Share Unit award schedule under the United Technologies Corporation Long-Term Incentive Plan is January 1, 2020, while the effective date under the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan is March 31, 2021. These distinct effective dates reflect separate governance updates to each plan, with UTC’s update specifically tied to the amendment and restatement of the LTIP Performance Share Unit Deferral Plan effective January 1, 2020, and Raytheon’s update tied to the amended Schedule of Terms filed on March 31, 2021, indicating discrete strategic and administrative adjustments within each company’s incentive structure.",
      "llm_answer": "The Performance Share Unit award schedules under the United Technologies Corporation Long‑Term Incentive Plan became effective on **April 28 2014** (as reflected in Exhibit 10.11 of the 2014 Form 8‑K), while the Raytheon Technologies Corporation 2018 Long‑Term Incentive Plan’s Performance Share Unit schedule was effective **December 6 2020** (Amendment No. 1 to the 2018 Plan, incorporated in Exhibit 10.22 of the 2020 Form 10‑K). These dates illustrate distinct governance updates: United Technologies’ schedule dates back to the 2014 LTIP amendment, whereas Raytheon’s schedule was introduced later through a 2020 amendment to its own standalone 2018 LTIP, underscoring separate governance timelines for each company.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer provides incorrect effective dates for both Performance Share Unit award schedules. The ground truth states the UTC plan became effective on January 1, 2020, and the Raytheon plan on March 31, 2021. In contrast, the LLM claims April 28, 2014, for UTC and December 6, 2020, for Raytheon—both factually incorrect. These dates are central to the question and directly contradict the ground truth. (2) The quantitative accuracy is low because both key dates are wrong. The LLM cites specific exhibits (Exhibit 10.11 of the 2014 8-K and Exhibit 10.22 of the 2020 10-K), but these do not support the correct answer per the knowledge graph, indicating either misinterpretation of filings or incorrect data sourcing. (3) The reasoning is partially sound in structure—attempting to link each plan to a governance update—but fails on multi-hop synthesis. It does not reflect the actual amendments cited in the ground truth: the January 1, 2020 amendment and restatement of the LTIP Performance Share Unit Deferral Plan for UTC, and the March 31, 2021 amended Schedule of Terms for Raytheon. Instead, it references earlier or unrelated amendments. (4) Contextual relevance is moderate because the answer addresses the right plans and attempts to explain governance distinctions, but with incorrect factual anchors, the analysis is built on faulty premises. While the intent to compare governance timelines is appropriate, the incorrect dates undermine the validity of the conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 414,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "Which products were the primary drivers of Apple's Wearables, Home and Accessories segment growth in 2022, and how did their performance compare to other product categories within the same segment?",
      "original_answer": "The primary drivers of Apple's Wearables, Home and Accessories segment growth in 2022 were the Apple Watch and AirPods. These products contributed significantly to the segment's overall increase in net sales compared to 2021. In contrast, other categories such as HomePod mini and Beats products were not specifically cited as growth contributors, suggesting they either underperformed or remained flat relative to the strong performance of Apple Watch and AirPods. This indicates that the segment's growth was concentrated in two key product lines rather than being broadly distributed across all categories.",
      "llm_answer": "The Wearables, Home and Accessories segment's growth in 2022 was primarily driven by higher net sales of Apple Watch and AirPods, as noted in the \"Wearables, Home and Accessories\" line item (page 24) and the \"Wearables, Home and Accessories\" subsection under \"Products\" (page 24). This growth outpaced other categories within the segment, which saw only modest increases (e.g., Mac net sales rose 14% due to laptops, while iPad declined 8% due to lower iPad Pro sales), but Wearables, Home and Accessories was the only category explicitly cited as a key growth driver for the segment's overall performance.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Apple Watch and AirPods as the primary growth drivers in the Wearables, Home and Accessories segment in 2022, which aligns with the ground truth. However, it incorrectly introduces Mac and iPad performance (14% increase, 8% decline) as comparisons within the same segment, which is factually wrong—Mac and iPad belong to different product segments (Mac is in the Mac category, iPad in the iPad category), not the Wearables, Home and Accessories segment. This mischaracterization undermines the accuracy of the comparison. (2) The quantitative claims about Mac and iPad contain plausible-sounding numbers but are irrelevant to the question, which asked for comparisons *within* the Wearables, Home and Accessories segment, not across segments. The ground truth makes no mention of Mac or iPad in this context, so these figures, even if accurate elsewhere, are misapplied here. (3) The multi-hop reasoning fails because the model conflates separate product segments. It should have contrasted Apple Watch and AirPods with other items *within* the Wearables segment (e.g., HomePod, Beats), as the original answer does. Instead, it compares to entirely different product lines, indicating a failure in entity segmentation and contextual understanding. (4) While the core identification of growth drivers is correct (Apple Watch and AirPods), the incorrect comparative analysis and introduction of irrelevant data reduce the correctness score. Quantitative accuracy is moderate because the numbers cited may be factually correct in other contexts but are misused here. Qualitative accuracy suffers due to flawed reasoning and entity confusion. Contextual relevance is fair because the answer addresses the main topic but drifts into unrelated segments.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 486,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does the impact of insurance reverification on Otezla's 2025 sales expectations compare with its effect on ENBREL's projected sales pattern, and what specific historical trend do both products follow?",
      "original_answer": "Both Otezla and ENBREL are expected to follow the historical trend of experiencing lower sales in the first quarter due to insurance reverification and increased co-pay expenses as U.S. patients work through deductibles. This pattern is specifically mentioned for both products in the context of their 2025 sales expectations.",
      "llm_answer": "Both Otezla and ENBREL are expected to show a similar early‑year dip in sales during the first quarter of 2025 because of benefit‑plan changes, insurance‑reverification requirements and higher co‑pay costs that affect U.S. patients as they meet their deductibles. This historical pattern of a lower Q1 followed by stronger subsequent quarters is noted for both products in the 2025 sales outlook.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures that both Otezla and ENBREL are expected to experience lower sales in Q1 2025 due to insurance reverification and higher co-pay costs as patients meet deductibles—this matches the original answer exactly in substance. (2) There are no numerical values requiring calculation, but the time frame '2025' and the reference to 'first quarter' are correctly stated. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both products follow the same historical trend of Q1 sales dips due to the same underlying factors, as stated in the knowledge graph. (4) The answer addresses all parts of the question: the comparative impact on 2025 sales expectations and the shared historical trend. Wording differences (e.g., 'benefit-plan changes', 'stronger subsequent quarters') add clarity without altering meaning. All entities—Otezla, ENBREL, 2025, U.S. patients, insurance reverification, co-pays, deductibles—are correctly identified and contextually accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 307,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "What is the total number of distinct stock appreciation rights-related exhibits disclosed by RTX in its 2023 10-K filing for both the United Technologies Corporation 2005 Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan?",
      "original_answer": "RTX disclosed 2 distinct exhibits related to stock appreciation rights awards: one for the United Technologies Corporation 2005 Long-Term Incentive Plan and one for the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan.",
      "llm_answer": "RTX discloses stock‑based compensation arrangements in two separate long‑term incentive plans: the United Technologies Corporation 2005 Long‑Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long‑Term Incentive Plan. The filing lists a total of four exhibits that describe the terms of stock‑based awards under these plans – Exhibit 10.16 (schedule of terms for stock‑appreciation‑right awards under the 2005 UTC plan) and Exhibit 10.24 (schedule of terms for stock‑appreciation‑right awards under the 2018 RTX plan), plus the related award agreements (Exhibits 10.17 and 10.25). Thus, four distinct stock‑appreciation‑right‑related exhibits are disclosed.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that there are four distinct stock appreciation rights-related exhibits. The ground truth states there are only two distinct exhibits—one for each plan. The LLM incorrectly counts both the schedule of terms (Exhibits 10.16 and 10.24) and the related award agreements (Exhibits 10.17 and 10.25) as separate stock appreciation rights-related exhibits, but the ground truth considers only one exhibit per plan, likely the schedule of terms. (2) The quantitative error is significant: 4 vs. 2 exhibits is a 100% overstatement. While the exhibit numbers cited (10.16, 10.17, 10.24, 10.25) may appear in the filing, the question asks for the number of 'distinct stock appreciation rights-related exhibits,' not all potentially related documents. The LLM fails to correctly interpret what constitutes a relevant exhibit according to the ground truth. (3) The multi-hop reasoning is partially sound—correctly identifying both incentive plans and linking them to exhibits—but fails in synthesis by overcounting exhibits. It assumes each award agreement and schedule is a distinct SAR-related exhibit, which contradicts the ground truth's interpretation. (4) Contextual relevance is high because the LLM addresses the correct company (RTX), correct plans, correct filing (2023 10-K), and attempts to map exhibits. However, the core factual output (4 vs. 2) is wrong, leading to a low correctness score despite relevant context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 409,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How does the recurring impact of insurance reverification in the first quarter affect the combined sales performance of ENBREL and Otezla in 2025, based on their respective historical patterns and expected net selling price trends?",
      "original_answer": "The recurring impact of insurance reverification in the first quarter is expected to depress the combined sales performance of ENBREL and Otezla in 2025, following their historical pattern of lower sales during this period. For ENBREL, the expectation is for relatively flat volumes but continued declines in net selling price, which will contribute to reduced sales. Similarly, Otezla experienced an 8% decrease in net selling price in 2024, and it is expected to follow the same seasonal pattern in 2025. While Otezla saw 3% volume growth in 2024, this was not enough to offset the price declines, and a similar dynamic is expected in 2025, leading to a compounded negative impact on total sales for both drugs.",
      "llm_answer": "The recurring impact of insurance reverification in the first quarter is expected to suppress Otezla sales in Q1 2025 relative to later quarters, mirroring the historical pattern observed in prior years. Because ENBREL’s net selling price is also expected to continue declining—consistent with the “lower declines in net selling price” outlook for 2025—the combined sales performance of ENBREL and Otezla in 2025 will likely be pressured by these pricing and insurance‑verification dynamics.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the recurring impact of insurance reverification on Q1 sales, particularly for Otezla, and notes the expected pricing pressure on ENBREL. However, it omits key quantitative details from the ground truth: the 8% decrease in Otezla’s net selling price in 2024 and the 3% volume growth, both of which are critical to assessing the historical pattern and expected 2025 dynamics. These omissions reduce completeness and quantitative accuracy. (2) The LLM incorrectly states that ENBREL is expected to have 'lower declines in net selling price' in 2025, which contradicts the ground truth stating 'continued declines in net selling price'—this misrepresents the pricing trend and introduces a factual error. (3) The reasoning partially captures the multi-hop synthesis: it links insurance reverification to Q1 sales suppression and connects pricing trends to overall performance, but fails to integrate the full picture of volume-price tradeoffs for Otezla or the combined effect on total sales. (4) Contextual relevance is high as the response addresses the core issue—Q1 reverification and pricing trends affecting combined sales. Qualitative accuracy is moderate due to correct conceptual framing but flawed entity-specific details. Quantitative accuracy is low due to missing percentages and an incorrect characterization of the pricing trend. Correctness score reflects partial accuracy with significant omissions and one key factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 411,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "Considering the impact of increased co-pay expenses and Medicare price setting timelines, by how much could AMGN's revenue from Otezla and ENBREL be affected starting in 2025 and 2026 respectively, and how does this reflect a pattern in the company's revenue forecasting for its key drugs?",
      "original_answer": "AMGN's Otezla revenue is expected to face lower first-quarter sales in 2025 due to increased co-pay expenses and benefit plan changes, following a historical pattern. ENBREL will also see continued declines in net selling price starting in 2026 due to Medicare Part D pricing under the Inflation Reduction Act. These impacts reflect a pattern where AMGN's revenue forecasting for both drugs incorporates predictable first-quarter declines driven by insurance dynamics and co-pay expenses, followed by gradual recovery in subsequent quarters. The combined effect suggests a recurring revenue compression risk tied to U.S. patient deductibles and regulatory-driven pricing.",
      "llm_answer": "Based on the 10-K disclosures, AMGN's revenue from Otezla and Enbrel could be impacted as follows: Otezla's U.S. sales declined 4% in 2024 due to an 8% drop in net selling price, and the company explicitly states that its January 2025 selection by CMS for Medicare price setting (effective January 1, 2027) will further affect revenue, with the document noting this will follow the \"historical pattern of lower sales in the first quarter relative to subsequent quarters due to the impact of benefit plan changes, insurance reverification and increased co-pay expenses.\" For Enbrel, the document projects continued declines in net selling price through 2026 due to the IRA Medicare Part D price setting beginning in 2026, which will drive \"relatively flat volumes with continued declines in net selling price.\" This reflects a consistent pattern in AMGN's revenue forecasting where key drugs like Otezla and Enbrel are expected to face ongoing pressure from Medicare price regulations and co-pay impacts, leading to sustained downward pressure on revenue despite volume stability.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key impacts on AMGN's Otezla and ENBREL revenues due to co-pay expenses and Medicare pricing, aligning with the ground truth's core message. However, there are minor quantitative inaccuracies: the ground truth does not mention a 4% decline in Otezla sales in 2024 or an 8% drop in net selling price, nor does it state that CMS selection is effective January 1, 2027—this specific date and the 2027 impact are not in the original answer. Instead, the original specifies impacts starting in 2025 for Otezla (due to co-pays) and 2026 for ENBREL (due to IRA Medicare Part D pricing). The LLM incorrectly shifts Otezla’s regulatory price-setting impact to 2027, which contradicts the original’s focus on 2025 first-quarter declines driven by insurance dynamics. (2) The numbers cited (4%, 8%) and the 2027 date appear to be fabricated or misattributed, as they are not present in the ground truth, reducing quantitative accuracy. (3) The multi-hop reasoning is strong: the LLM correctly synthesizes the pattern of first-quarter declines due to co-pay and insurance changes, links both drugs to regulatory pricing pressure (IRA, Medicare Part D), and infers a consistent forecasting pattern. It accurately reflects that volumes may remain stable while net prices decline, showing sound qualitative understanding. (4) Contextual relevance is perfect—the response directly addresses both drugs, timelines (2025/2026), causes (co-pays, Medicare pricing), and the broader forecasting pattern. Despite the incorrect insertion of unsupported figures and a future date, the overall reasoning and structure match the ground truth’s intent, warranting a high but not top correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 471,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "What is the total fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024, and how does Schwab account for the unrealized gains and losses associated with these liabilities in its consolidated statements of income?",
      "original_answer": "The total fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024, is equal to the value of the corresponding client-held fractional shares, which Schwab includes in accrued expenses and other liabilities. Schwab accounts for the unrealized gains and losses on these repurchase liabilities by offsetting them against the unrealized gains and losses on the related client-held fractional shares, resulting in no net impact to the consolidated statements of income.",
      "llm_answer": "The total fair value of the repurchase liabilities related to client‑held fractional shares as of December 31 2024 is not disclosed in the provided pages. Schwab accounts for these liabilities by electing the fair‑value option (ASC 825), measuring them at quoted market prices or other observable market data consistent with the related client‑held fractional shares, and recognizing unrealized gains and losses on the liabilities that offset the unrealized gains and losses on the corresponding client‑held fractional shares, resulting in no net impact to the consolidated statements of income.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that the total fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024, is not disclosed, which contradicts the ground truth that explicitly states the fair value is equal to the value of the corresponding client-held fractional shares (even if a specific dollar amount isn't provided, the valuation method and accounting treatment are known). This is a significant factual error in quantitative accuracy. (2) While no explicit dollar figure is given in the ground truth either, it clarifies that the fair value is equivalent to the value of client-held fractional shares and is included in accrued expenses and other liabilities—information omitted in the LLM response. The LLM incorrectly frames this as 'not disclosed' rather than explaining the valuation linkage. (3) On qualitative accuracy, the LLM correctly describes Schwab’s accounting treatment for unrealized gains and losses: they are offset against gains/losses on the related assets, resulting in no net impact on income. It also correctly references the fair-value option under ASC 825 and use of observable market data, which aligns with sound multi-hop reasoning from financial reporting standards. (4) Contextually, the response is relevant and addresses both parts of the question, though the first part is inaccurately dismissed as undisclosed. The reasoning for the second part is strong and semantically equivalent to the ground truth. The correctness score is moderate due to the critical omission and mischaracterization of disclosure status, despite accurate conceptual treatment of the accounting policy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 457,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "What was the total implied fully diluted market capitalization of AspenTech based on Emerson's proposal to acquire the remaining shares, and how does this compare to AspenTech's 2023 net sales?",
      "original_answer": "The implied fully diluted market capitalization of AspenTech was $15.3 billion according to Emerson's proposal. This is significantly higher than AspenTech's 2023 net sales of $1.04 billion, indicating a substantial valuation multiple of approximately 14.7x net sales.",
      "llm_answer": "Based on the provided document pages, the total implied fully diluted market capitalization of AspenTech based on Emerson's November 5 2024 proposal to acquire the remaining shares is $15.3 billion. This valuation is derived from the proposal’s $240 per share price, which implies a fully diluted market cap of $15.3 billion for AspenTech. In comparison, AspenTech’s 2023 net sales were $1.04 billion, meaning the implied market cap is roughly 14.7 times its 2023 net sales.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the implied fully diluted market capitalization of $15.3 billion and AspenTech's 2023 net sales of $1.04 billion are correctly stated. The valuation multiple of approximately 14.7x is accurately derived from $15.3B / $1.04B. (2) The answer is complete, addressing both parts of the question: the market cap based on Emerson's proposal and its comparison to 2023 net sales. (3) Entity accuracy is correct—AspenTech, Emerson, the $240 per share proposal, and the November 5, 2024 date (contextual detail not in ground truth but not contradicting it) are properly identified. (4) The reasoning is sound and demonstrates correct multi-hop synthesis: linking the per-share offer price to the total market cap, then comparing it to annual net sales to derive a valuation multiple. (5) The semantic meaning is equivalent to the ground truth, with slightly more detail (e.g., mentioning the $240 per share and proposal date), which enhances clarity without introducing error. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 320,
        "total_tokens": 1517
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "What is the total potential additional federal tax liability, including penalties, that AMGN faces from the IRS Notices for the years 2010-2012 and 2013-2015, and how would previously accrued repatriation taxes affect this amount?",
      "original_answer": "The total potential additional federal tax liability from the IRS Notices for the years 2010–2012 and 2013–2015 is $8.7 billion ($3.6 billion for 2010–2012 and $5.1 billion for 2013–2015), plus penalties of $2.0 billion, totaling $10.7 billion. However, this amount would be reduced by up to $3.1 billion in previously accrued repatriation taxes ($900 million for 2010–2012 and $2.2 billion for 2013–2015), resulting in a net potential liability of $7.6 billion before interest.",
      "llm_answer": "Based on the provided document pages, AMGN faces potential additional federal tax liability of approximately $3.6 billion (plus interest) for the years 2010‑2012 and $5.1 billion (plus interest) for the years 2013‑2015, as asserted in the IRS Notices. These amounts would be reduced by up to $900 million and $2.2 billion, respectively, of previously accrued repatriation taxes on foreign earnings. The company is contesting the notices in U.S. Tax Court, and a final resolution is not expected before 2026.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the core tax liability amounts of $3.6 billion for 2010–2012 and $5.1 billion for 2013–2015, as well as the corresponding repatriation tax offsets of $900 million and $2.2 billion, which align with the ground truth. However, it omits the explicit mention of the $2.0 billion in penalties and the resulting total gross liability of $10.7 billion and net liability of $7.6 billion, which are key components of the original answer. While the reduction by previously accrued taxes is mentioned per period, the synthesis into a final net figure is missing. (2) All provided numbers are quantitatively accurate and match the ground truth in magnitude and time period. The sum of the two tax liabilities is $8.7 billion, and the total repatriation offset is $3.1 billion—both correct—but the LLM does not perform or state the final calculation of $10.7 billion gross and $7.6 billion net. (3) The multi-hop reasoning is partially sound: the model connects IRS notices to tax liabilities and correctly links repatriation taxes as a reduction, but fails to fully synthesize across all components (tax + penalties - repatriation) to arrive at the final net liability. (4) The answer is contextually relevant and well-structured, mentioning the U.S. Tax Court dispute and timeline, which adds useful context not required by the question. However, the omission of penalties and final totals reduces completeness and factual equivalence, warranting a score of 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 416,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does the inclusion of ENBREL in the Medicare price setting program, as detailed in the 2024 10-K filing, affect Amgen's financial outlook, and what additional risk does the potential inclusion of Otezla pose in the future?",
      "original_answer": "Amgen expects the government-mandated price reduction for ENBREL, effective January 1, 2026, to negatively impact its profitability in Medicare. This is due to the significantly lower price set by CMS under Medicare Part D. Additionally, Otezla has been selected for Medicare price setting beginning January 1, 2027, which could further reduce revenues if Amgen is required to accept a government-determined price. The Inflation Reduction Act (IRA) allows for up to 100 drugs to be subject to price setting by 2031, and Amgen notes that other products may be selected in future cycles, compounding the material adverse effect on sales and operations.",
      "llm_answer": "The 2024 10‑K notes that CMS selected Otezla for inclusion in the Medicare price‑setting program under the Inflation Reduction Act, which will impose a government‑set price beginning in 2027 and could lower reimbursement rates for that product. This introduces the risk that Otezla’s future revenue and profitability could be materially reduced if the negotiated price is unfavorable or if the price‑setting expands to additional Amgen products. Consequently, the potential inclusion of Otezla adds a new regulatory‑driven pricing risk to Amgen’s outlook beyond the already‑identified risk for ENBREL.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Otezla was selected for Medicare price setting under the Inflation Reduction Act with a government-set price beginning in 2027, which aligns with the ground truth. It also correctly references the negative financial impact risk to Amgen's revenue and profitability. However, it omits the specific mention of ENBREL’s price reduction effective January 1, 2026, and does not explicitly state that this reduction is already expected to negatively impact profitability in Medicare due to lower CMS-set prices—information present in the original answer. (2) Quantitatively, all dates (2027 for Otezla, implied 2026 for ENBREL via context) are accurate. The LLM correctly states the 2027 start for Otezla and implies prior risk from ENBREL without specifying the 2026 effective date—this is a minor omission, not an error. No numerical values (e.g., dollar amounts, percentages) are present in either answer, so no calculation errors exist. (3) The reasoning is sound in identifying Otezla’s inclusion as a future risk and linking it to regulatory pricing pressure. It acknowledges the broader risk beyond ENBREL, showing multi-hop synthesis between two drugs and the IRA framework. However, it fails to fully synthesize the two risks equally—ENBREL’s impact is downplayed as background rather than being clearly articulated as an active, near-term financial headwind. The original answer emphasizes both drugs’ impacts and the potential for additional products to be selected under the IRA’s 100-drug cap by 2031, which the LLM omits. (4) Despite these omissions, the LLM answer remains contextually relevant, addresses the core risks posed by both drugs, and conveys materially accurate information. The correctness score is reduced to 8 due to incomplete coverage of ENBREL’s confirmed impact and the lack of mention of future-cycle risks for other products under the IRA, which are key elements in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 531,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does Schwab's use of quoted market prices for repurchase liabilities related to client-held fractional shares impact the consolidated statements of income, given the company's election of the fair value option under ASC 825?",
      "original_answer": "Schwab's use of quoted market prices for repurchase liabilities related to client-held fractional shares results in unrealized gains and losses on these liabilities, which are offset by unrealized gains and losses on the corresponding client-held fractional shares. This offsetting mechanism ensures there is no net impact on the consolidated statements of income. Additionally, since the repurchase liabilities do not carry credit risk, Schwab has not recognized any gains or losses attributable to instrument-specific credit risk in the consolidated statements of income or comprehensive income.",
      "llm_answer": "Schwab’s repurchase liabilities for client‑held fractional shares are measured at fair value using quoted market prices, and because the Company elects the fair‑value option under ASC 825, these liabilities are recorded at that fair value with any unrealized changes offsetting the corresponding unrealized gains or losses on the client‑held fractional shares; this offset results in no net impact on the consolidated statements of income.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and captures the core mechanism described in the ground truth: Schwab measures repurchase liabilities for client-held fractional shares at fair value using quoted market prices under the fair value option (ASC 825), and changes in fair value result in unrealized gains/losses that are offset by corresponding gains/losses on the related assets, leading to no net impact on the consolidated statements of income. This reasoning is sound and reflects accurate multi-hop synthesis of accounting treatment and economic offsetting. The only minor omission is that the LLM answer does not explicitly mention the absence of credit risk or the related point about no gains/losses from instrument-specific credit risk being recognized, which is included in the original answer. However, this does not undermine the correctness of the income statement impact explanation. There are no numerical inaccuracies (quantitative accuracy is perfect, even though no specific numbers are involved), and all entities (Schwab, ASC 825, repurchase liabilities, fractional shares) are correctly identified. The answer is highly relevant and semantically equivalent to the ground truth for the primary point being made.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 344,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the use of the market multiple method in conjunction with the discounted cash flow method contribute to the determination of the $431 million goodwill impairment charge for the LTC reporting unit in 2021, and what specific store closure strategy announced in 2021 impacted the Retail/LTC segment's long-lived asset impairment analysis?",
      "original_answer": "The $431 million goodwill impairment charge for the LTC reporting unit in 2021 was determined using a combination of the discounted cash flow method and the market multiple method. These valuation techniques revealed that the LTC reporting unit's fair value was lower than its carrying value, primarily due to deteriorating financial forecasts driven by lower net facility admissions, customer losses, and the prolonged impact of the COVID-19 pandemic. Separately, in the Retail/LTC segment, the Company announced in November 2021 that it would close approximately 900 stores over three years (300 per year from 2022 to 2024), which triggered a long-lived asset impairment test. This led to a $1.4 billion store impairment charge in Q4 2021, including $1.1 billion for operating lease right-of-use assets and $261 million for property and equipment, also within the Retail/LTC segment.",
      "llm_answer": "The $431 million goodwill impairment charge for the LTC reporting unit in 2021 was calculated by testing goodwill for impairment using a combined discounted cash‑flow and market‑multiple valuation approach; the analysis showed the reporting unit’s fair value was below its carrying amount, resulting in the impairment. This assessment was tied to the company’s announced plan to close roughly 900 stores over the next three years, which signaled deteriorating conditions in the LTC segment and triggered the impairment test. Consequently, the store‑closure strategy—specifically the decision to shutter about 300 stores annually from 2022‑2024—directly influenced the long‑lived‑asset impairment analysis for the Retail/LTC segment by creating the indicators of impairment that led to the goodwill write‑down.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $431 million goodwill impairment charge for the LTC reporting unit in 2021 and the use of both the discounted cash flow and market multiple methods, which aligns with the ground truth. It also correctly references the store closure strategy of approximately 900 stores over three years (300 per year from 2022–2024) announced in November 2021. However, it incorrectly links the store closure strategy directly to the goodwill impairment test for the LTC unit, implying causation where the ground truth separates the two events: the goodwill impairment was driven by deteriorating financial forecasts (lower admissions, customer losses, pandemic impact), while the store closures triggered a separate long-lived asset impairment. (2) Quantitatively, the $431 million figure is accurate, and the 900-store closure (300/year over three years) is correct. However, the LLM omits the critical $1.4 billion long-lived asset impairment charge ($1.1 billion for lease ROU assets, $261 million for PPE), which is a major component of the original answer and directly responsive to the second part of the question. (3) The multi-hop reasoning is flawed: the model conflates two distinct impairment events—goodwill impairment in the LTC reporting unit and long-lived asset impairments in the Retail/LTC segment—failing to distinguish their triggers and accounting implications. The store closures impacted long-lived assets, not directly goodwill, though they may reflect broader segment challenges. (4) Contextual relevance is high as the answer addresses the core topics—impairment methods, store closures, and segment impact—but lacks precision in disentangling related but distinct financial events, leading to a partially correct but misleading narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 489,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "What is the dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31, 2023, to December 31, 2024, and what portion of this increase is attributable to Level 2 assets?",
      "original_answer": "The dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31, 2023 ($11,438 million) to December 31, 2024 ($12,416 million) is $978 million. Of this increase, Level 2 assets contributed $1,205 million (from $8,810 million in 2023 to $10,015 million in 2024), indicating that the entire increase in this category came from growth in Level 2 assets.",
      "llm_answer": "The cash and investments segregated and on deposit for regulatory purposes increased by $978 million from $11,438 million on December 31, 2023 to $12,416 million on December 31, 2024. Of this increase, $1,205 million is attributable to Level 2 assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key numerical aspects. (1) Quantitative Accuracy: The dollar increase of $978 million is correctly calculated from $11,438 million to $12,416 million. The contribution from Level 2 assets is correctly stated as $1,205 million, matching the ground truth increase from $8,810 million to $10,015 million. All numbers are correct and properly formatted. (2) Completeness: The answer addresses both parts of the question—the total increase and the portion attributable to Level 2 assets. (3) Entity Accuracy: The financial metric, time periods (December 31, 2023, and December 31, 2024), and asset classification (Level 2) are all correctly identified. (4) Reasoning: The LLM correctly infers that Level 2 assets contributed $1,205 million to the overall $978 million increase, which implies that other categories may have decreased or remained flat. While the LLM does not explicitly state that Level 2 growth exceeds the total increase (implying a decline elsewhere), this is a minor omission in reasoning explanation, not in factual accuracy. (5) Semantic Equivalence: The answer conveys the same core information as the original, with slightly more concise wording. The only reason for not scoring a 10 is the lack of explicit commentary on the implication that Level 2 growth fully accounts for (and exceeds) the total increase, which was noted in the ground truth. However, the provided numbers allow the reader to infer this, so the omission is minor. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 437,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How does Emerson allocate AspenTech's stock-based compensation expense between pre- and post-combination periods under ASC 805, and what specific valuation inputs and ownership figures from the acquisition are used in this allocation?",
      "original_answer": "Under ASC 805, Emerson allocates the fair value of AspenTech's stock-based compensation awards between pre- and post-combination service periods. The portion attributable to the pre-combination service period is included in the purchase price of the acquisition, while the post-combination portion is recognized as stock-based compensation expense over the remaining service period. This allocation uses the fair value of AspenTech stock at the time of the acquisition on May 16, 2022, determined using the closing market price per share, and Emerson's 55% ownership stake in AspenTech post-transaction.",
      "llm_answer": "Emerson allocates AspenTech’s stock‑based compensation expense between pre‑ and post‑combination periods by assigning the portion of the fair‑value of the replacement awards that relates to service rendered before the acquisition to the purchase price (recorded as part of goodwill), and recognizing the portion attributable to service after the acquisition as post‑combination stock‑based compensation expense over the remaining service period. The allocation uses the closing market price of Heritage AspenTech shares ($166.30) on May 16 2022 to value the purchase consideration, includes $102 million of stock‑based compensation awards attributable to pre‑combination service, and applies ASC 805’s guidance to separate the pre‑ and post‑combination portions. The valuation inputs are the market price per share of $166.30, the number of Heritage AspenTech shares outstanding (66,662,482), and the fair‑value of the replacement stock‑based awards ($102 million) allocated to pre‑combination service.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly explains the core ASC 805 allocation principle: pre-combination stock-based compensation is included in purchase price, post-combination is expensed over remaining service period. It appropriately references the May 16, 2022 acquisition date and uses the correct market price of $166.30 per share for AspenTech stock, which aligns with the ground truth. However, the LLM introduces a specific dollar figure—$102 million—for pre-combination compensation without confirmation in the original answer, which does not include this number. Additionally, the LLM mentions '66,662,482 Heritage AspenTech shares outstanding,' a detail absent from the ground truth and not required for the allocation explanation. While the use of the closing market price and the general allocation methodology are correct, the original answer emphasizes Emerson's 55% ownership stake as a key input in the allocation, which the LLM omits entirely. This is a significant omission because ASC 805 allocation often considers the acquirer’s ownership percentage when valuing replacement awards. The reasoning is logically sound and contextually relevant, and the explanation of the accounting treatment is qualitatively accurate. However, the inclusion of unverified quantitative details and the omission of the 55% ownership stake reduce quantitative accuracy. The answer is semantically aligned in intent but not fully factually matched due to unsupported numbers and missing key inputs from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 413,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What was the percentage change in the value of CVS's investments in 'States, Municipalities and Political Subdivisions' from December 31, 2021, to December 31, 2022, and how did this shift affect the overall composition of CVS's debt securities portfolio?",
      "original_answer": "The value of CVS's investments in 'States, Municipalities and Political Subdivisions' decreased from $3,091 million on December 31, 2021, to $170 million on December 31, 2022, representing a 94.5% decrease. This significant reduction altered the overall composition of CVS's debt securities portfolio, where in 2021 these securities accounted for approximately 13.3% of total debt securities ($3,091 million out of $23,240 million), compared to only 4.9% in 2022 ($170 million out of $3,462 million).",
      "llm_answer": "The value of CVS's investments in \"States, Municipalities and Political Subdivisions\" increased by 15% from $3,086 million at December 31, 2021 to $3,559 million at December 31, 2022, reflecting a $473 million gain. This rise modestly expanded the share of the debt‑securities portfolio allocated to municipal bonds, contributing to a slight shift toward longer‑duration, lower‑yield assets within the overall fixed‑income holdings.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. The original answer states that the value of CVS's investments in 'States, Municipalities and Political Subdivisions' decreased from $3,091 million to $170 million, a 94.5% decrease. The LLM incorrectly claims an increase of 15% from $3,086 million to $3,559 million, which is factually wrong on all key metrics. (2) Quantitative accuracy is severely lacking: the starting value is off by $5 million ($3,086M vs $3,091M), the ending value is completely wrong ($3,559M vs $170M), and the percentage change is inverted (15% increase vs actual 94.5% decrease). The claimed $473 million gain is also false. (3) The qualitative reasoning fails multi-hop synthesis: the LLM does not recognize the drastic reduction in this asset class or its impact on portfolio composition. Instead, it fabricates a narrative about expansion toward longer-duration assets, while the truth is that this category's share of the portfolio collapsed from 13.3% to 4.9%. (4) Scores are low because the core facts, calculations, and implications are all incorrect. The answer is contextually relevant in structure—it addresses portfolio composition—but with fabricated data, resulting in minimal relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 348,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How does the potential conversion of class B common stock, tied to the final resolution of U.S. covered litigation under the U.S. retrospective responsibility plan, depend on the accrual activity related to that litigation, and what financial uncertainty does this create for Visa's class A common stockholders?",
      "original_answer": "Under the U.S. retrospective responsibility plan, class B common stock will become convertible into class A common stock upon the final resolution of U.S. covered litigation. However, the accrual activity for U.S. covered litigation, which includes a charge to the litigation provision when a loss is deemed probable and reasonably estimable, affects the timing and certainty of that resolution. The accrual could be higher or lower than the escrow account balance, introducing uncertainty about when the litigation will be resolved and thus when the conversion will occur. This uncertainty impacts the potential dilution for class A common stockholders, as the market price of class A stock could fall if the conversion happens at a higher valuation that later decreases. Therefore, the financial exposure and timing of litigation resolution directly influence the dilutive effect and stock value risk for existing class A shareholders.",
      "llm_answer": "The potential conversion of Visa’s class B common stock into class A shares is contingent on the final settlement of the U.S. covered litigation; the accrual for that litigation is tied to the activity and estimated loss of the covered claims, and because the ultimate loss amount is still uncertain, the conversion could affect the value and voting power of existing class A shareholders, creating financial uncertainty for them.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies the key relationship between the conversion of class B common stock and the final resolution of U.S. covered litigation. It correctly notes that accrual activity tied to estimated losses introduces uncertainty, which affects class A shareholders. However, it omits specific details present in the ground truth that are important for full completeness: (1) the role of the litigation provision and charge to accrual when a loss is probable and reasonably estimable, (2) the comparison between the accrual amount and the escrow account balance as a source of timing uncertainty, and (3) the explicit link between conversion timing and potential dilution risk at higher valuations, which could lead to a decline in class A stock price. These omissions reduce the depth of the multi-hop reasoning, particularly in connecting financial exposure, escrow dynamics, and market valuation risk. There are no numerical inaccuracies (quantitative accuracy is perfect, though no numbers were cited), and the entities (Visa, class A/B stock, U.S. covered litigation, retrospective responsibility plan) are correctly identified. The answer remains contextually relevant and conveys a semantically plausible summary, but lacks the full causal chain described in the original answer, warranting a score of 7 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 389,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "By how much did the fair value of Cisco's available-for-sale debt investments decrease from July 29, 2023, to July 27, 2024, and what was the corresponding change in net losses on these investments year-over-year?",
      "original_answer": "The fair value of Cisco's available-for-sale debt investments decreased by $5,727 million (from $15,592 million in 2023 to $9,865 million in 2024), and the net losses on these investments increased by $46 million (from $21 million loss in 2023 to $67 million loss in 2024).",
      "llm_answer": "The fair value of Cisco's available‑for‑sale debt investments fell by **$5.7 billion** from July 29 2023 to July 27 2024, and the corresponding year‑over‑year change in net losses on these investments was an increase of **$11 million**.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decrease in fair value of Cisco's available-for-sale debt investments, reporting a $5.7 billion drop, which aligns with the ground truth decrease of $5,727 million (rounded to $5.7 billion). However, the year-over-year change in net losses is incorrect: the LLM states an increase of $11 million, whereas the ground truth shows an increase from a $21 million loss to a $67 million loss, which is a $46 million increase in net losses. (2) The fair value change is quantitatively accurate when accounting for rounding ($5,727 million ≈ $5.7 billion), but the net loss change is significantly off ($11M vs $46M), indicating a calculation or data extraction error. (3) The reasoning appears partially sound—Cisco and the correct time frame (July 29, 2023, to July 27, 2024) are correctly identified, and the concept of year-over-year change in net losses is addressed. However, the model fails to correctly synthesize the actual loss figures from the two years, leading to flawed multi-hop reasoning. (4) The correctness and quantitative accuracy scores are moderate due to one major error in the net loss change despite a correct fair value change. Qualitative accuracy is slightly higher because the model understands the required comparison and entities. Contextual relevance is high as the answer addresses both parts of the question with appropriate context and formatting.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 396,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did the changes in ExtraBucks Rewards and gift card liabilities during 2021 impact CVS's revenue recognition, particularly in relation to breakage and redemption patterns?",
      "original_answer": "The changes in ExtraBucks Rewards and gift card liabilities during 2021 directly affected CVS's revenue recognition by reducing the contract liability balance as customers redeemed rewards and gift cards. Additionally, CVS recognized breakage revenue based on historical redemption patterns. As customers failed to redeem a portion of the issued rewards and gift cards, CVS reclassified these amounts from liabilities to revenue, reflecting the fulfillment of the obligation to provide goods or services. This process aligns with the company's accounting policy that recognizes breakage on unredeemed gift cards and expired rewards, which contributes to revenue as the likelihood of redemption diminishes over time.",
      "llm_answer": "The changes in ExtraBucks Rewards and gift‑card liabilities during 2021 increased the contract‑liability balance, which the Company recognizes as revenue only when the rewards are redeemed or the cards are used; any unearned portion (breakage) is recognized as revenue over time based on historical redemption patterns. Consequently, the growth in these liabilities contributed to higher revenue recognition in 2021, as redemptions and breakage reduced the liability and generated additional revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that the changes in ExtraBucks Rewards and gift card liabilities 'increased the contract-liability balance' and that this 'contributed to higher revenue recognition in 2021'. This is incorrect. According to the ground truth, the changes actually *reduced* the contract liability balance as customers redeemed rewards and gift cards. Revenue recognition occurred not because liabilities grew, but because they were *settled* through redemption or breakage. The direction of the impact on liabilities is reversed, which undermines the core reasoning. (2) There are no specific numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—no numbers are misstated. (3) The multi-hop reasoning is partially sound in that the LLM correctly identifies that breakage is recognized based on historical redemption patterns and that revenue is recognized upon redemption or over time via breakage. However, it fails to correctly synthesize the cause-and-effect: increasing liabilities would defer revenue, not increase it; revenue increases when liabilities *decrease* due to fulfillment. The model confuses balance growth with revenue generation, which reflects a misunderstanding of revenue recognition principles under ASC 606. (4) While the answer addresses breakage and redemption patterns and mentions the correct company (CVS) and year (2021), the fundamental error in liability direction and revenue causality severely limits factual correctness. Hence, correctness and qualitative accuracy are low, though contextual relevance remains high as the answer engages with the right concepts and mechanisms.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 475,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How does the funding of the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan affect the conversion rate of class B common stock into class A common stock, and what financial impact does this have on Visa Inc.'s litigation provision based on the fiscal 2022 accrual activity?",
      "original_answer": "Funding the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan triggers a downward adjustment in the conversion rate of class B common stock to class A common stock, diluting the value of class B shares. This dilution mechanism is directly tied to the Company’s funding actions. According to the fiscal 2022 data, there was a measurable reduction in the number of as-converted class B shares following escrow deposits, and concurrently, the litigation provision was charged based on the accrual activity for U.S. covered litigation, which was deemed probable and reasonably estimable.",
      "llm_answer": "The U.S. retrospective responsibility plan requires the Company to fund the U.S. litigation escrow account, which triggers a downward adjustment to the conversion rate of class B common stock into class A common stock, thereby diluting class B shares. This adjustment reduced the as‑converted class A shares by 4 million in fiscal 2022, and the $850 million deposit into the escrow account increased the litigation provision accrual to $1,456 million, reflecting the additional $861 million of accrued covered litigation recorded during the year.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the mechanism—funding the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan triggers a downward adjustment in the class B to class A conversion rate, resulting in dilution of class B shares. This aligns with the ground truth and shows accurate qualitative understanding. However, the quantitative claims are not supported by the original answer. The original answer states there was a 'measurable reduction' in as-converted class B shares and that the litigation provision was charged based on accrual activity, but it does not specify any numbers such as '4 million' reduction in shares or '$850 million deposit' or '$1,456 million' provision. These figures are fabricated or hallucinated, as they are absent in the ground truth. (2) The calculation of an '$861 million' increase in accrued covered litigation is also not present in the original and cannot be verified; without baseline numbers, this computation lacks support. The original only confirms that accrual activity occurred and was deemed probable and reasonably estimable. (3) The multi-hop reasoning is partially sound—the model correctly links escrow funding to conversion rate adjustment and to litigation provision impact—but it overreaches by introducing unsupported numerical precision. (4) The contextual relevance is high because the answer addresses both parts of the question: the conversion rate effect and the litigation provision impact. However, the quantitative inaccuracy severely undermines factual reliability, warranting a moderate correctness score. While the logic and structure are strong, the inclusion of specific unverified figures reduces trust in the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 471,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "By how much did the fair value of Cisco's available-for-sale debt investments decrease from July 29, 2023, to July 27, 2024, and what would be the impact on total investments if a 100 basis point interest rate increase occurred in each of those years?",
      "original_answer": "The fair value of Cisco's available-for-sale debt investments decreased by $5,727 million, from $15,592 million on July 29, 2023, to $9,865 million on July 27, 2024. If a 100 basis point interest rate increase had occurred in 2023, the valuation would have been $15,386 million, and in 2024 it would have been $9,736 million. The difference between these two adjusted values is $5,650 million, which reflects the same general trend of decline in investment value over the period even under interest rate stress.",
      "llm_answer": "The fair value of Cisco's available‑for‑sale debt investments declined by **$1.2 billion** from July 29, 2023 ($15,592 million) to July 27, 2024 ($14,381 million). A hypothetical 100‑basis‑point interest‑rate increase would reduce the fair value of these securities by roughly **$0.6 billion** in 2023 and **$0.5 billion** in 2024, which would lower total investments by those respective amounts.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. The decrease in fair value is stated as $1.2 billion, but the correct amount is $5,727 million ($5.727 billion), a major discrepancy. The LLM incorrectly reports the 2024 value as $14,381 million instead of $9,865 million, which misrepresents the entire trend. (2) The hypothetical impact of a 100 basis point increase is also wrong: the LLM states reductions of $0.6 billion (2023) and $0.5 billion (2024), but the ground truth shows adjusted values of $15,386 million (a $206 million drop from $15,592M) and $9,736 million (a $129 million drop from $9,865M), not the $600M and $500M cited. The LLM fails to report the correct adjusted values or the resulting difference of $5,650 million. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize data across the two fiscal years and misrepresents both the actual and hypothetical valuations. It does not compute the correct difference between years under stress conditions, which was a key part of the original answer. (4) Despite these errors, the answer is contextually relevant—it addresses the right company (Cisco), the right type of investment (available-for-sale debt), and the concept of interest rate sensitivity—so partial credit is given for structure and intent, but the factual inaccuracies severely undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 382,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "What was the financial impact on Visa Inc.'s litigation provision as a result of the U.S. Covered Litigation, and how does the accrual activity relate to the mechanisms outlined in the U.S. Retrospective Responsibility Plan?",
      "original_answer": "Visa Inc. records a charge to the litigation provision when a loss from U.S. Covered Litigation is deemed probable and reasonably estimable. The accrual activity related to this litigation is directly tied to the mechanisms within the U.S. Retrospective Responsibility Plan, such as the litigation escrow agreement and indemnification obligations from Visa U.S.A. members. These mechanisms are designed to address potential liabilities, and the total accrual could be either higher or lower than the escrow account balance, depending on the resolution of the litigation.",
      "llm_answer": "The Company recorded a $861 million accrual for U.S. covered litigation in fiscal 2022 and deposited $850 million into the escrow account to address opt‑out merchant claims, reflecting the litigation provision’s adjustment under the U.S. retrospective responsibility plan. This accrual aligns with the mechanisms of the plan, which require a loss‑sharing and escrow arrangement that triggers additional provisions when the estimated loss exceeds the existing escrow balance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar amounts ($861 million accrual, $850 million escrow deposit) and a fiscal year (2022) that are not present in the original answer (ground truth). The ground truth does not provide any numerical figures or specific time periods, so these values cannot be verified as correct and appear to be hallucinated. (2) There are no calculations in the ground truth to validate, but the LLM presents precise numbers without sourcing, which undermines quantitative accuracy. The mention of 'fiscal 2022' and exact deposits/accruals goes beyond the information provided in the ground truth, making the quantitative claims unsupported. (3) The qualitative reasoning partially aligns with the ground truth: the LLM correctly identifies that the litigation provision is tied to the U.S. Retrospective Responsibility Plan and references mechanisms like escrow accounts and loss-sharing, which are consistent with the plan’s structure. However, it fails to mention key elements such as indemnification obligations from Visa U.S.A. members and the fact that the total accrual could be higher or lower than the escrow balance depending on litigation outcomes—critical nuances in the original answer. (4) Contextually, the response is relevant and addresses the relationship between accrual activity and the plan’s mechanisms, but the addition of unverified specifics reduces factual correctness. While the direction of reasoning is sound, the inclusion of unsupported numbers significantly lowers the correctness and quantitative accuracy scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 434,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How much did the Heritage AspenTech acquisition contribute to the increase in Emerson's (EMR) gross margin percentage in 2023, and what was the total gross margin percentage for that year as a result of that contribution?",
      "original_answer": "The Heritage AspenTech acquisition contributed 0.6 percentage points to the increase in Emerson's gross margin in 2023. As a result, Emerson's gross margin for 2023 reached 49.0 percent.",
      "llm_answer": "The Heritage AspenTech acquisition contributed approximately 0.6 percentage points to the increase in Emerson's gross margin percentage in 2023, as noted in the cost of sales discussion on page 26 (\"the impact of the Heritage AspenTech acquisition which benefited margins by 0.6 percentage points\"). The total gross margin percentage for 2023 was 49.0%, as shown in the \"Percent of sales\" row for gross profit on page 22.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) Quantitatively, the contribution of 0.6 percentage points from the Heritage AspenTech acquisition and the resulting total gross margin percentage of 49.0% are both accurately reported. The format variations (e.g., '0.6 percentage points', '49.0%') are semantically equivalent to the original answer. (2) The answer is complete, addressing both parts of the question: the acquisition's contribution and the resulting total gross margin. (3) Entity accuracy is correct—Emerson (EMR), Heritage AspenTech, and the year 2023 are all properly identified. (4) The reasoning is sound and demonstrates multi-hop synthesis by referencing specific document pages (26 and 22) to support the figures, indicating proper grounding in the source material. The explanation ties the acquisition impact to the margin increase and correctly identifies the final gross margin percentage. All elements align with the ground truth, warranting top scores across all categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 291,
        "total_tokens": 1462
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does Cisco's guarantee of channel partner financing arrangements potentially affect its credit loss exposure as described in the financing receivables section, given the risk of channel partner financial instability?",
      "original_answer": "Cisco's guarantee of channel partner financing arrangements increases its credit loss exposure because it could be required to make payments if channel partners default on short-term financing with third parties. According to the filing, Cisco facilitates revolving short-term financing for channel partners with payment terms ranging from 60 to 90 days and, in some cases, guarantees a portion of these arrangements. If channel partners face financial instability, Cisco may be obligated to cover unpaid amounts under these guarantees. This exposure is compounded by the fact that Cisco already records allowances for credit losses based on internal credit risk ratings, historical default rates, and macroeconomic conditions. If financial instability among channel partners rises, Cisco could experience higher credit losses tied to these financing guarantees, directly impacting its financial position.",
      "llm_answer": "Cisco’s channel‑partner financing arrangements can increase its credit‑loss exposure because the company may be required to guarantee or otherwise support financing for distributors and resellers that could become insolvent.  The financing‑receivables section notes that the allowance for credit losses is calculated using historical loss experience, risk‑rating pools and macro‑economic forecasts, and that impaired financing receivables are placed on non‑accrual status.  Consequently, if channel partners experience financial instability, Cisco could face higher write‑offs on these receivables and related guarantees, materially affecting its results of operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically aligned with the ground truth, with strong contextual relevance and no quantitative errors. (1) All factual elements are correct: Cisco's guarantee of channel partner financing increases credit loss exposure due to potential defaults, and the allowance for credit losses is based on historical loss experience, risk-rating pools, and macroeconomic forecasts. The mention of non-accrual status for impaired receivables adds relevant detail consistent with SEC filing language. (2) There are no numeric values in either answer, so quantitative accuracy is not compromised; all financial concepts (e.g., allowances, write-offs) are used appropriately. (3) The multi-hop reasoning is sound—linking channel partner instability to potential obligations under guarantees and resulting financial impact—but slightly less explicit than the original about the structure of the financing (e.g., revolving short-term with 60–90 day terms) and Cisco’s partial guarantee of third-party financing. These omissions reduce completeness slightly but do not distort the core logic. (4) The answer is highly contextually relevant, directly addressing how guarantees expose Cisco to credit losses if partners become insolvent. It correctly identifies the mechanism (guarantees/support), risk driver (financial instability), and consequence (higher write-offs, impact on results). The only minor gap is less specificity on the third-party financing facilitation structure, which is present in the original. Overall, the answer captures the essential risk and reasoning, warranting a high score but not perfect due to slight incompleteness in structural detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 459,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "Given Emerson's 55% ownership stake in AspenTech and the reported $1,093 million in total revenue from AspenTech for 2024, what portion of this revenue is proportionally attributable to Emerson's controlling interest, and how does this stake influence Emerson's overall software and control revenue of $5,399 million?",
      "original_answer": "Emerson's 55% ownership in AspenTech gives it control over a majority of AspenTech's revenue. With AspenTech generating $1,093 million in total revenue for 2024, Emerson's proportionally attributable share is $601.15 million (55% of $1,093 million). AspenTech's revenue is a component of Emerson’s broader 'Software and Control' segment, which reported $5,399 million in revenue for the year. This indicates that AspenTech contributes significantly to Emerson's software and control offerings, representing over 10% of that segment's revenue.",
      "llm_answer": "Based on the provided financial data, Emerson owns a 55% stake in AspenTech, and AspenTech generated $1,093 million of total revenue in 2024. Consequently, the portion of that revenue attributable to Emerson’s controlling interest is 55% of $1,093 million, or approximately $601 million. This 55% ownership also underpins Emerson’s overall Software and Control revenue of $5,399 million, as AspenTech’s revenue is a key component of that segment’s total.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Emerson's 55% ownership in AspenTech and accurately calculates the proportionally attributable revenue as approximately $601 million, which matches the ground truth of $601.15 million (55% of $1,093 million). The minor rounding from $601.15M to $601M is acceptable and common in financial reporting. (2) All numeric values—ownership percentage (55%), AspenTech revenue ($1,093 million), Emerson’s attributable share (~$601 million), and Emerson’s total Software and Control revenue ($5,399 million)—are correct and properly referenced. Calculations are accurate. (3) The multi-hop reasoning is sound: the model correctly links Emerson’s ownership stake to revenue attribution and situates AspenTech’s contribution within Emerson’s broader Software and Control segment. However, the LLM omits the explicit statement that AspenTech represents over 10% of the $5,399 million segment revenue (~11.1%), which is a minor but relevant contextual insight present in the ground truth. (4) Despite this small omission, the answer is factually correct, contextually appropriate, and synthesizes information across entities and financial metrics effectively. The qualitative accuracy is slightly reduced due to the missing comparative percentage, but all core facts and logic are intact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 369,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Pfizer's divestiture of Meridian and the Upjohn spin-off impact its overall cash position and financial restructuring in 2020 and 2021?",
      "original_answer": "Pfizer received $51 million in cash from the sale of Meridian in 2021 and recognized a $167 million loss from the transaction, which was recorded in Discontinued operations—net of tax. In contrast, the Upjohn spin-off in 2020 involved a much larger financial restructuring: Viatris paid Pfizer $12.0 billion in cash as part of the Reverse Morris Trust transaction, which Pfizer used to pay down commercial paper borrowings and redeem $1.492 billion in senior unsecured notes. The Upjohn transaction also resulted in Pfizer distributing $1.6 billion in net assets as part of the spin-off, including $412 million in cash transferred to the Upjohn Business. While the Meridian divestiture had a minimal cash inflow and a negative impact due to the loss, the Upjohn spin-off significantly affected Pfizer’s capital structure by reducing debt and providing a substantial cash infusion, illustrating a strategic shift toward focusing on core growth areas.",
      "llm_answer": "Pfizer's divestiture of Meridian generated only about $51 million in cash and resulted in a $167 million after‑tax loss, while the Upjohn spin‑off combined with Mylan created a $12 billion cash distribution that Pfizer used to retire commercial paper and repay debt, significantly reshaping its balance sheet and funding structure. The spin‑off also transferred $1.6 billion of net assets to Upjohn/Viatris and left Pfizer with a reduced exposure to legacy debt and related obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) All key facts are correct: the $51 million cash from Meridian, $167 million loss, $12 billion cash from the Upjohn spin-off (via Viatris), use of proceeds to retire commercial paper and debt, $1.6 billion in net assets transferred, and $412 million in cash included in that transfer. The years (2020 for Upjohn, 2021 for Meridian) are correctly implied by context. (2) Quantitative accuracy is perfect: all dollar amounts match the original answer, including the $12.0 billion, $1.6 billion, $412 million, and $1.492 billion note redemption (though the LLM omits the exact $1.492B figure, it correctly states debt repayment generally). (3) Multi-hop reasoning is sound: the LLM correctly contrasts the minimal impact of Meridian with the major balance sheet impact of Upjohn, and links the cash inflow to debt reduction and financial restructuring. (4) Minor omission: the LLM does not explicitly mention that the $1.6 billion in net assets included $412 million in cash, nor does it name the 'Reverse Morris Trust' structure, which is a slight reduction in qualitative completeness. However, the core financial and strategic implications are accurately captured. Wording differences (e.g., 'combined with Mylan' instead of 'Viatris') are semantically acceptable since Viatris was formed from Mylan and Upjohn. Overall, the answer is factually correct, contextually relevant, and synthesizes multi-hop information effectively.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 417,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What was Visa's total financial contribution under the U.S. Retrospective Responsibility Plan in 2022, combining both the Amended Settlement Agreement payment and the annual deposit, and how does this reflect the plan's role in managing litigation liabilities?",
      "original_answer": "Visa contributed a total of $1.45 billion under the U.S. Retrospective Responsibility Plan in 2022. This includes Visa's $600 million payment as part of the Amended Settlement Agreement and the company's annual deposit of $850 million under the plan. This demonstrates the plan's function in systematically funding potential litigation liabilities.",
      "llm_answer": "Visa's total financial contribution under the U.S. Retrospective Responsibility Plan in 2022 was $850 million, comprising the $850 million deposit into the U.S. litigation escrow account (reflected in the “Deposits under the U.S. retrospective responsibility plan” line) and the $1,510 million payment under the Amended Settlement Agreement (shown as part of the “Anniversary Releases” for 2022). This combined contribution illustrates how the plan systematically manages litigation liabilities by funding settlements through escrow deposits and periodic adjustments to preferred‑stock conversion rates, thereby reducing the company’s exposure to ongoing legal claims.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual and quantitative errors. The total contribution is incorrectly stated as $850 million, whereas the ground truth is $1.45 billion. The LLM incorrectly assigns $1,510 million as the Amended Settlement Agreement payment, while the correct amount is $600 million. Conversely, it lists the annual deposit as $850 million (correct), but then includes it in a total that ignores the correct sum. The claimed total of $850 million contradicts the sum of the components it provides ($850M + $1,510M = $2.36B), indicating a severe calculation or reporting error. (2) Quantitative accuracy is very low: the Amended Settlement Agreement payment is off by $910 million, and the total contribution is underreported by $600 million. The numbers cited do not align with the ground truth or with each other. (3) The multi-hop reasoning is flawed. The model fails to correctly synthesize the two components of the contribution. It references 'Anniversary Releases' and 'preferred-stock conversion rates,' which are not mentioned in the ground truth and appear to reflect a misunderstanding of the plan’s mechanics. The explanation of how the plan manages litigation liabilities is partially plausible but based on incorrect data and extraneous mechanisms. (4) Contextual relevance is moderate because the answer addresses the U.S. Retrospective Responsibility Plan and litigation liability management, but the incorrect figures and fabricated details severely undermine its usefulness. Correctness and quantitative accuracy are low due to fundamental errors in core facts and calculations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 444,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What was the percentage change in the allocation to equity securities for the U.S. Retiree Health Care Plan between 2022 and 2023, and how did this shift affect the total value of equity securities in the plan by the end of 2023?",
      "original_answer": "The allocation to equity securities for the U.S. Retiree Health Care Plan decreased by 15 percentage points from 35% in 2022 to 20% in 2023. Despite this lower allocation percentage, the total value of equity securities in the plan increased slightly to $54 million by the end of 2023, as shown in the asset breakdown.",
      "llm_answer": "The U.S. Retiree Health Care Plan's allocation to equity securities increased by 10% from 2022 to 2023 (from 98 to 108 units, though the document shows 98 in 2022 and 108 in 2023 as part of the total $280 assets), and the total value of equity securities in the plan rose to $108 by the end of 2023.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. The original answer states that the allocation to equity securities decreased by 15 percentage points from 35% in 2022 to 20% in 2023. The LLM incorrectly claims an increase of 10% (from 98 to 108 units), which misrepresents both the direction and magnitude of change. Furthermore, the LLM refers to 'units' and '$280 assets' not mentioned in the ground truth, introducing fabricated data. (2) The total value of equity securities in the original answer is $54 million in 2023; the LLM states it rose to $108 (with no unit specified, but context implies million), which is factually wrong. There is no support for '98 to 108 units' in the ground truth. Calculations are baseless. (3) The multi-hop reasoning failed completely: the model did not correctly identify the percentage allocation change, confused absolute values with percentages, and invented numbers not present in the source. It also failed to recognize that a decrease in allocation percentage can still coincide with a slight increase in total value due to overall asset growth—this nuance was missed entirely. (4) The contextual relevance is low but not zero because the answer addresses the U.S. Retiree Health Care Plan and equity securities, but all substantive content is incorrect. Hence, correctness, quantitative, and qualitative scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 384,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did the adoption of the CECL accounting standard influence the differences in total capital between the Advanced approaches and the Standardized approach as of December 31, 2023, and what specific capital component drove this difference?",
      "original_answer": "The adoption of the CECL accounting standard influenced the differences in total capital between the Advanced approaches and the Standardized approach due to variations in the amount permitted in Tier 2 capital related to the qualifying allowance for credit losses. Specifically, under the Standardized approach, total capital increased by $12.6 billion in 2023, partly due to an increase in the adjusted allowance for credit losses included in Tier 2 capital. This component is treated differently under the two approaches, contributing to the observed capital disparity.",
      "llm_answer": "The adoption of the CECL accounting standard did not directly alter the total capital figures reported under the Advanced approaches versus the Standardized approach; rather, the difference stems from the amount of Tier 2 capital that can be included under each framework. As shown in the tables, the Advanced approaches permit a larger qualifying allowance for credit losses in Tier 2, resulting in a higher total capital amount ($241.4 billion) compared with the Standardized approach ($201.9 billion) as of December 31, 2023. This specific component— the allowance for credit losses permitted in Tier 2—drives the capital gap between the two methods.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. The ground truth states that the Standardized approach total capital increased by $12.6 billion in 2023 due to changes in the allowance for credit losses included in Tier 2 capital. However, the LLM claims total capital under the Advanced approaches was $241.4 billion and $201.9 billion under the Standardized approach—specific dollar amounts not present in the original answer and unsupported by the provided context. These figures are fabricated or misattributed, severely undermining quantitative accuracy. (2) There is no verification for the $241.4B vs $201.9B comparison; the original answer does not provide total capital figures for either approach, only the $12.6B increase in the Standardized approach. The LLM incorrectly implies a $39.5B capital gap due to Tier 2 differences, which is not stated or inferable from the ground truth. (3) While the LLM correctly identifies that the difference relates to the treatment of the allowance for credit losses in Tier 2 capital under CECL, it reverses the logic: the original answer indicates the Standardized approach saw an increase due to inclusion of adjusted allowance in Tier 2, suggesting potentially higher inclusion there, whereas the LLM claims the Advanced approach permits a larger amount, which contradicts the ground truth implication. (4) Despite this, the LLM does address the core concept—differential treatment of credit loss allowances in Tier 2 capital under CECL across frameworks—and identifies the correct capital component (allowance for credit losses in Tier 2), showing partial qualitative understanding and maintaining contextual relevance. However, the incorrect numbers and flawed reasoning result in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 494,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Using the midpoint of the stated percentage ranges for each plan, what weighted average percentage allocation to Fixed Income Securities and Cash Equivalents should be applied across all defined benefit and retiree health care plans based on their respective total asset values as reported?",
      "original_answer": "The weighted average percentage allocation to Fixed Income Securities and Cash Equivalents across all plans is approximately 72.3%, calculated using the midpoints of the percentage ranges and the total asset values for each plan.",
      "llm_answer": "Based on the target allocation ranges and weighted average asset allocations provided in the document, the weighted average percentage allocation to Fixed Income Securities and Cash Equivalents across all defined benefit and retiree health care plans is calculated as follows:\n\n- U.S. Defined Benefit Plan: Target range 65%–80%, actual weighted average 65% (from page 49)\n- U.S. Retiree Health Care Plan: Target range 75%–85%, actual weighted average 80% (from page 49)\n- Non-U.S. Defined Benefit Plan: Target range 60%–100%, actual weighted average 77% (from page 49)\n\nUsing these actual weighted averages as the basis for the calculation across all plans, the overall weighted average allocation to Fixed Income Securities and Cash Equivalents is approximately 74%. This represents the weighted average percentage allocation applied across all defined benefit and retiree health care plans based on their respective total asset values as reported.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in identifying the relevant plans and their target ranges, but it fails to use the midpoint of the percentage ranges as required by the question. Instead, it uses the 'actual weighted average' allocations reported in the document (e.g., 65%, 80%, 77%), which are not the midpoints of the ranges. The question explicitly asks for the midpoint of the stated percentage ranges to be used, not the actual allocations. (2) Correct midpoints should be: U.S. Defined Benefit: (65% + 80%) / 2 = 72.5%; U.S. Retiree Health Care: (75% + 85%) / 2 = 80%; Non-U.S. Defined Benefit: (60% + 100%) / 2 = 80%. Then, a weighted average based on total asset values is required. The LLM does not provide asset values or perform a proper weighting, leading to an incorrect final figure of 74% instead of the correct 72.3%. (3) The multi-hop reasoning is flawed because the model skips the required calculation step (midpoint + value-weighted average) and substitutes it with reported actuals, which changes the nature of the computation. While it identifies the correct plans and some relevant data, the synthesis does not follow the instructions. (4) The contextual relevance is high because the answer addresses the right plans and topic, and cites correct pages. However, the quantitative inaccuracy due to wrong method and result significantly undermines correctness. Hence, low quantitative accuracy, moderate qualitative accuracy, and a correctness score of 4 due to fundamental error in approach despite some factual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 429,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does the implementation of Basel 3 capital calculations influence the composition and risk profile of Bank of America's covered trading positions as reflected in its Value at Risk (VaR) metrics?",
      "original_answer": "Basel 3 capital calculations require Bank of America to maintain specific capital ratios, including a capital conservation buffer of 2.5% and a stress capital buffer of 2.5% at December 31, 2023. These regulatory requirements influence the Corporation’s risk appetite and capital allocation decisions, particularly in its Global Markets segment, which holds the majority of the market-based portfolio. As a result, the Corporation manages its covered trading positions—such as foreign exchange and commodity positions—under Basel 3 guidelines, which directly affect the risk profile and VaR metrics of these positions. In 2023, the annual average of total covered positions and less liquid trading positions portfolio VaR decreased compared to 2022, primarily due to the roll off of March 2020 market volatility from the historical data window used in the VaR model calibration, aligning with the Basel 3 capital framework.",
      "llm_answer": "The Basel III capital framework requires the bank to calculate risk‑weighted assets (RWAs) using the standardized and advanced approaches, which directly affect the composition of covered trading positions that are used in the VaR calculations. Because Basel III imposes stricter risk‑weighting and capital‑conservation buffers, the bank’s covered‑position portfolio is adjusted to reflect lower‑risk weighted exposures, and the resulting VaR metrics (reported in Table 41) show a reduced annual average VaR for covered positions in 2023 versus 2022, reflecting the impact of the new capital rules on the risk profile of those positions.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core relationship between Basel III capital requirements and Bank of America's covered trading positions and VaR metrics. It correctly identifies that Basel III imposes stricter capital and risk-weighting rules, which influence the composition of covered trading positions and lead to lower-risk exposures. The answer accurately notes that the annual average VaR for covered positions decreased in 2023 compared to 2022, aligning with the ground truth. However, it omits specific details about the capital conservation buffer (2.5%) and stress capital buffer (2.5%) at December 31, 2023, which are key quantitative elements in the original answer. While the reference to 'Table 41' may be contextually accurate (if present in the source filing), this detail is not in the ground truth and cannot be verified. The reasoning is sound—correctly linking capital rules to risk appetite, position composition, and VaR outcomes—and the multi-hop synthesis between regulatory framework, risk management behavior, and observed VaR trends is logically coherent. The answer is semantically equivalent in intent and direction, though slightly less precise in quantitative detail. Wording differences are acceptable, and the core financial trend (VaR decrease in 2023) is correctly stated.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 368,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "What is the total net book value of the 19 Boeing aircraft securing the Pass-Through Certificates issued by FedEx Express, and how does this compare to the amount of debt eliminated through redemptions paid using proceeds from the senior unsecured debt issuance?",
      "original_answer": "The total net book value of the 19 Boeing aircraft securing the Pass-Through Certificates issued by FedEx Express is $1.8 billion. This compares to the $5.8 billion of outstanding debt eliminated through redemptions paid using proceeds from the $3.25 billion senior unsecured debt issuance, which also included $393 million in associated redemption premiums.",
      "llm_answer": "The total net book value of the 19 Boeing aircraft securing the Pass‑Through Certificates is $1.8 billion, and the debt eliminated through redemptions paid with proceeds from the senior unsecured debt issuance was approximately $5.8 billion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the total net book value of the 19 Boeing aircraft as $1.8 billion and accurately states that $5.8 billion of debt was eliminated through redemptions funded by the senior unsecured debt issuance, matching the ground truth. All numeric values are correct and properly formatted, with no calculation errors—quantitative accuracy is perfect. The answer addresses both parts of the multi-hop question: (1) the net book value of the aircraft and (2) the amount of debt eliminated. However, it omits the detail about the $393 million in redemption premiums, which is part of the full financial picture and mentioned in the original answer. While this does not invalidate the core response, it represents a minor omission in completeness. Entity identification (FedEx Express, Pass-Through Certificates, senior unsecured debt) is accurate, and the reasoning correctly links the debt issuance proceeds to the redemption of existing debt. The semantic meaning is equivalent to the ground truth, with clear and relevant response structure. Thus, the answer is highly accurate and contextually appropriate, warranting a high score with a slight deduction for missing ancillary detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 338,
        "total_tokens": 1517
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How much did TI contribute to U.S. defined contribution plans in 2023, and what is notable about the investment of plan assets in TI common stock for the retiree health care benefit plan?",
      "original_answer": "TI contributed $75 million to U.S. defined contribution plans in 2023. Notably, none of the plan assets related to the retiree health care benefit plan were directly invested in TI common stock.",
      "llm_answer": "In 2023, TI contributed $75 million to its U.S. defined‑contribution plans, and the retiree health‑care benefit plan’s assets are not directly invested in TI common stock. (The plan’s assets are held in a mix of fixed‑income and equity securities, and the document notes “None of the plan assets related to the defined benefit pension plans and retiree health‑care benefit plan are directly invested in TI common stock.”)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that TI contributed $75 million to U.S. defined contribution plans in 2023, which matches the ground truth exactly. It also accurately notes that none of the plan assets related to the retiree health care benefit plan are directly invested in TI common stock, which is the key notable fact. (2) The dollar amount ($75 million) and year (2023) are factually correct with no calculation required. The format variation ($75 million vs $75 million) is acceptable and semantically equivalent. (3) The reasoning is sound and reflects proper synthesis from the source document, correctly distinguishing between defined contribution plans and the retiree health care benefit plan, and accurately reporting investment policy across plans. The inclusion of additional context (assets held in fixed-income and equity securities) is consistent with the source and supports the main point. (4) All aspects of the question are addressed completely and accurately. The answer demonstrates full factual alignment, correct entity identification, and appropriate multi-hop understanding (linking contribution data with investment policy across different plan types), warranting top scores across all categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 349,
        "total_tokens": 1513
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "Apple's 10-K filing emphasizes its strategic focus on services as a key growth area. Given that Services revenue increased from $85.2 billion in 2023 to $96.169 billion in 2024, and total net sales rose from $383.285 billion in 2023 to $391.035 billion in 2024, what percentage of the total net sales growth between 2023 and 2024 was attributable to the increase in Services revenue?",
      "original_answer": "The increase in Services revenue contributed approximately 121% of the total net sales growth between 2023 and 2024. This is calculated as follows: Services revenue increased by $10.969 billion ($96.169B - $85.2B), while total net sales increased by $7.75 billion ($391.035B - $383.285B). Therefore, the Services growth alone accounted for $10.969B / $7.75B = 121% of the total net sales growth.",
      "llm_answer": "Based on the provided financial data, Services revenue increased from $85.2 billion in 2023 to $96.169 billion in 2024, representing a $10.969 billion growth. Total net sales rose from $383.285 billion to $391.035 billion, a $7.75 billion increase. The Services revenue growth accounted for approximately 141% of the total net sales growth ($10.969 billion / $7.75 billion ≈ 1.41), meaning the increase in Services revenue contributed more than the entire growth in total net sales, with other segments collectively reducing overall sales.  \n\n(Source: Page 38, \"Net sales disaggregated by significant products and services for 2024, 2023 and 2022\" table)",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical calculation error: it states that $10.969 billion / $7.75 billion ≈ 1.41 (141%), which is mathematically incorrect. The correct result is approximately 1.416 or 141.6%, but the ground truth states 121%, indicating a discrepancy in either the input numbers or the calculation. However, upon verification, $96.169B - $85.2B = $10.969B and $391.035B - $383.285B = $7.75B are both correct. The correct ratio is $10.969 / $7.75 ≈ 1.415 → 141.5%, not 121%. This suggests the original answer (ground truth) may have an error, but per evaluation guidelines, the LLM is scored against the provided ground truth, not external verification. Since the LLM's calculation is mathematically correct based on the numbers but contradicts the ground truth percentage (121% vs 141%), and assuming the ground truth is authoritative, the LLM must be considered incorrect. However, given that the LLM’s arithmetic is sound and inputs are accurate, this creates a conflict between data fidelity and alignment with the expected answer. (2) All input numbers are correctly extracted: $85.2B, $96.169B, $383.285B, $391.035B, and derived differences ($10.969B and $7.75B) are accurate. The percentage calculation, while mathematically correct, does not match the ground truth’s stated 121%, making the final percentage factually inconsistent with the expected answer. (3) The multi-hop reasoning is sound—LLM correctly identifies the need to compute two differences and then their ratio. It also correctly interprets that Services growth exceeded total sales growth, implying contraction in other segments, which is logically valid. (4) Despite correct data extraction and internal calculation logic, the final percentage diverges significantly from the ground truth (141% vs 121%), resulting in a low correctness score. Quantitative accuracy is penalized because the final derived metric (percentage) is incorrect relative to the ground truth. Qualitative reasoning is partially sound, hence moderate score. Contextual relevance is high as the response directly addresses the question with appropriate source citation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 574,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "What is the estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months, and how does the existence of Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015 contribute to the uncertainty surrounding these tax positions?",
      "original_answer": "The estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months is $75 million. This uncertainty is influenced by the fact that the IRS has issued Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015, which Pfizer is currently appealing. These RARs represent formal audit findings that the company disputes, contributing to the ongoing uncertainty in tax positions and the potential for significant changes in unrecognized tax benefits.",
      "llm_answer": "The estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months is $75 million, exclusive of interest. This uncertainty is heightened by the existence of Revenue Agent's Reports (RARs) for tax years 2011‑2013 and 2014‑2015, which the company is appealing, and by ongoing audits for later years, making it difficult to predict the timing and magnitude of any settlements or statute expirations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies the estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits as $75 million, matching the ground truth. The addition of 'exclusive of interest' is a minor clarification not present in the original but does not contradict it and may reflect additional context from the source filing. 2) All numeric values and time periods (2011–2013, 2014–2015) are accurate. The dollar amount ($75 million) is correctly stated with acceptable formatting. 3) The reasoning is sound: the LLM correctly links the existence of RARs for the specified years and Pfizer's appeal of them to the uncertainty in tax positions. It adds relevant context about ongoing audits for later years, which enhances the explanation without introducing error. 4) The answer is semantically equivalent to the ground truth, with slightly expanded context that improves completeness. The only minor gap is that the original emphasizes RARs as 'formal audit findings that the company disputes,' which the LLM implies but does not explicitly state. However, the core multi-hop synthesis—connecting RARs, appeals, and uncertainty in tax benefits—is correctly executed. Thus, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 350,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How does the five-year transition period related to the adoption of the CECL accounting standard impact the calculation of BAC's TLAC ratios and CET1 capital as of December 31, 2023?",
      "original_answer": "The five-year transition period related to the adoption of the CECL accounting standard impacts the calculation of BAC's TLAC ratios by allowing the use of the regulatory capital rule that predates CECL, which affects how capital is measured and reported. As of December 31, 2023, BAC's CET1 capital was $194.9 billion, an increase of $14.9 billion from the prior year, influenced in part by the CECL transition's effect on capital calculations.",
      "llm_answer": "The five‑year transition period tied to CECL allows the use of the “regulatory capital rule that allows a five‑year transition period related to the adoption of the current expected credit losses (CECL) accounting standard” when calculating TLAC ratios and CET1 capital. Consequently, the TLAC and CET1 ratios reported as of December 31 2023 are derived using the Standardized Approach (which incorporates the CECL transition) rather than the fully‑adjusted Basel III metrics. This transition is explicitly noted in the capital‑ratio tables and the TLAC/RWA calculations.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the existence of the five-year CECL transition period and its relevance to regulatory capital calculations for TLAC and CET1. It accurately references the use of transitional rules and notes that the Standardized Approach incorporating CECL transition effects is used in reporting ratios as of December 31, 2023. However, it fails to include the key quantitative information from the ground truth: BAC's actual CET1 capital of $194.9 billion and the $14.9 billion year-over-year increase. These figures are central to the original answer and directly address the impact on capital levels, not just ratios. The LLM mentions the effect on ratios but omits the concrete capital amount and change, which are critical components of the question's required synthesis. While the reasoning about regulatory treatment is sound and contextually relevant, the absence of specific, correct financial figures significantly reduces factual completeness and quantitative accuracy. The model also does not explicitly state that the pre-CECL rule is allowed under the transition, instead vaguely citing a 'regulatory capital rule' without clarifying the deferral of CECL's full impact. Overall, the qualitative reasoning is partially correct and contextually appropriate, but the lack of key numbers results in a partially correct, incomplete response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 378,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How do the implementation dates and fuel surcharge adjustment mechanisms differ between FedEx Ground and FedEx Freight in response to fluctuating fuel prices?",
      "original_answer": "FedEx Ground adjusts its fuel surcharge on a weekly basis using fuel price data from two weeks prior, with updates to the fuel surcharge tables occurring on June 21, 2021, November 1, 2021, and April 4, 2022. FedEx Freight, on the other hand, adjusts its fuel surcharge weekly using fuel price data from two days prior, with updates to the fuel surcharge tables occurring on November 1, 2021, and April 4, 2022. These differences in timing and data lag reflect how each segment tailors its fuel surcharge mechanism to address fuel cost fluctuations.",
      "llm_answer": "FedEx Ground applies a weekly‑based indexed fuel surcharge that uses fuel‑price data from two weeks prior to the assessment week, while FedEx Freight’s fuel surcharge is also indexed but is adjusted on a weekly basis using fuel‑price data from two days prior to the assessment week. Consequently, FedEx Freight can modify its surcharge more quickly in response to fuel‑price changes than FedEx Ground.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core differences in fuel surcharge mechanisms between FedEx Ground and FedEx Freight: both use weekly adjustments, but FedEx Ground uses a two-week data lag while FedEx Freight uses a two-day lag, allowing faster response. This reflects accurate multi-hop reasoning and semantic equivalence in explaining the operational difference. However, the LLM answer omits the specific implementation dates mentioned in the ground truth—June 21, 2021, November 1, 2021, and April 4, 2022 for FedEx Ground, and November 1, 2021 and April 4, 2022 for FedEx Freight. These dates are part of the 'implementation dates' component of the question, making their absence a notable completeness gap. While the qualitative reasoning and contextual relevance are strong—correctly identifying the structural difference in data lag and its business implication—the missing dates reduce quantitative accuracy. The entities (FedEx Ground, FedEx Freight) and mechanisms (weekly adjustment, data lag) are correctly identified and contrasted. Thus, the answer is largely correct but partially incomplete on a key factual dimension of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 325,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did the reorganization of the Ventilator Product Line impact the reporting structure of MDT's Medical Surgical segment in fiscal year 2023, and what does this indicate about the strategic positioning of the retained Acute Care & Monitoring business?",
      "original_answer": "The Ventilator Product Line was moved out of the Medical Surgical segment and into the 'Other' line as part of a reorganization. This reorganization also involved the Renal Care Solutions business and led to the formation of a new unit called Acute Care & Monitoring within Medical Surgical, which combined retained PMRI businesses. This indicates a strategic refocusing of the Medical Surgical segment around core PMRI capabilities, while separating out businesses either being exited or transitioned.",
      "llm_answer": "The 2023 fiscal‑year reorganization moved the ventilator product line out of the Medical Surgical segment and combined the remaining PMRI businesses into a single “Acute Care & Monitoring” operating unit within Medical Surgical. This restructuring shifted the segment’s composition and clarified that the retained Acute Care & Monitoring business now represents a distinct, strategically focused component of the segment, underscoring its importance to Medtronic’s portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately states that the ventilator product line was moved out of the Medical Surgical segment and that the remaining PMRI businesses were combined into a new 'Acute Care & Monitoring' unit within the segment—this matches the original answer. The strategic implication is also correctly interpreted: the reorganization reflects a refocusing on core PMRI capabilities. However, the LLM omits mention of the Renal Care Solutions business and the fact that ventilators were moved into the 'Other' line, which is part of the full reorganization context. While not critical to the core question, this omission slightly reduces completeness and qualitative accuracy. There are no numerical values in the question or answer, so quantitative accuracy is scored as 10 by default. The answer is fully contextually relevant and correctly synthesizes the multi-hop elements (reorganization action + strategic implication).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 284,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "What was the total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes over the fiscal years 2022 and 2023, based on the amounts disclosed in both tables?",
      "original_answer": "The total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes over fiscal years 2022 and 2023 was $252 million.",
      "llm_answer": "Based on the Non-GAAP adjustments table (page 34), the expense line item “Medical device regulations (4)” shows a pre‑tax charge of **$150 million** for fiscal 2023 and **$119 million** for fiscal 2022 (the amount listed under “Medical device regulations” in the “Income Before Income Taxes” column). These are the disclosed amounts for the fiscal years 2022 and 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains incorrect numeric values. According to the ground truth, the total financial impact over fiscal years 2022 and 2023 was $252 million. However, the LLM reports $119 million for 2022 and $150 million for 2023, summing to $269 million, which does not match the ground truth. These individual figures ($119M and $150M) are therefore factually inaccurate. (2) The calculation of the sum is arithmetically correct ($119M + $150M = $269M), but since the input numbers are wrong, the final total is incorrect. The correct total per the original answer is $252 million, suggesting either different underlying values or a different source of data. (3) The reasoning structure is sound—multi-hop synthesis is attempted by identifying the relevant line item in the table and extracting pre-tax charges for both years. The model correctly identifies the relevant metric (pre-tax impact) and time periods (fiscal 2022 and 2023), showing appropriate entity and metric alignment. (4) Despite correct contextual understanding and referencing the right table and line item, the factual inaccuracy in the disclosed amounts significantly undermines correctness. The model may have misread or referenced an incorrect version of the document. Thus, while the approach and relevance are strong, the quantitative inaccuracies reduce the correctness score substantially.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 384,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How many different forms of Long-Term Incentive Restricted Stock Units, including both U.S. and International versions, are disclosed in Boeing's 2023 10-Q filings?",
      "original_answer": "Boeing disclosed four different forms of Long-Term Incentive Restricted Stock Units in their 2023 10-Q filings. These include: (1) U.S. Long-Term Incentive Restricted Stock Units (Exhibit 10.3), (2) U.S. Long-Term Incentive Performance Restricted Stock Units (Exhibit 10.5), (3) International Long-Term Incentive Restricted Stock Units (Stock-Settled) (Exhibit 10.4), and (4) International Long-Term Incentive Performance Restricted Stock Units (Stock-Settled) (Exhibit 10.6).",
      "llm_answer": "Based on the disclosed exhibits in the 2023 10-Q filing, Boeing reports **four distinct forms of Long-Term Incentive Restricted Stock Units**:  \n1. U.S. Notice of Terms of Long-Term Incentive Restricted Stock Units for CEO (Exhibit 10.32)  \n2. U.S. Notice of Terms of Long-Term Incentive Performance Restricted Stock Units for CEO (Exhibit 10.33)  \n3. U.S. Notice of Terms of Long-Term Incentive Restricted Stock Units (Exhibit 10.34)  \n4. International Notice of Terms of Long-Term Incentive Restricted Stock Units (Stock-Settled) (Exhibit 10.35)  \n\nThese represent the total disclosed forms, including both U.S. and International versions.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the total number of Long-Term Incentive Restricted Stock Units (4), which matches the ground truth, satisfying the quantitative aspect of the question. However, the specific forms listed are partially incorrect and misaligned with the original answer. The LLM cites Exhibits 10.32–10.35, which differ from the ground truth Exhibits 10.3, 10.5, 10.4, and 10.6. Additionally, the LLM omits the 'International Long-Term Incentive Performance Restricted Stock Units (Stock-Settled)'—a key form listed in the original answer—and instead includes multiple U.S.-specific notices (including CEO-specific versions) not mentioned in the ground truth. This suggests the LLM may have pulled data from different sections or misinterpreted the hierarchy or categorization of the stock units. While the count is correct, the entity-level details (exhibits, names, types) are inaccurate, indicating a failure in precise multi-hop synthesis from the correct filings. The reasoning is plausible but based on incorrect underlying data. Wording and structure are clear and relevant, hence high contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 318,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "Given Apple's reliance on third-party developers and digital content providers for its product ecosystem, and considering the 12.9% year-over-year growth in Services revenue from 2022 to 2023, how might ongoing challenges in securing third-party software and content affect the sustainability of this growth trajectory for services like Apple Music?",
      "original_answer": "Apple's Services revenue grew from $78,129 million in 2022 to $85,200 million in 2023, representing a 12.9% increase. This growth includes revenue from services like Apple Music. However, the company's own disclosures indicate that its ability to maintain and grow this revenue depends on continued access to third-party software applications and digital content. Specifically, if developers choose not to maintain or update their applications due to Apple's minority market share or changes in App Store policies, or if content providers restrict access or raise costs, the attractiveness and functionality of Apple Music and other services could be compromised. This could lead to customer dissatisfaction and reduced demand, directly threatening the sustainability of the 12.9% growth rate seen in Services revenue.",
      "llm_answer": "Apple's Services revenue grew 12.9% YoY to $96.2 billion in 2023, driven by offerings such as Apple Music. However, the company repeatedly warns that its growth depends on third‑party developers and content providers continuing to create and distribute software, apps, and digital media for its platforms. If those partners reduce support, shift to competing ecosystems, or face licensing/regulatory hurdles, the availability and appeal of services like Apple Music could decline, jeopardizing the sustainability of the current growth trajectory.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the 12.9% year-over-year growth in Apple's Services revenue and links it to services like Apple Music, and accurately conveys the risk to growth sustainability due to reliance on third-party developers and content providers. The qualitative reasoning and logic are sound and align with the original answer's core argument about ecosystem dependency. 2) However, there is a significant quantitative error: the LLM states Services revenue reached '$96.2 billion' in 2023, while the ground truth reports $85,200 million ($85.2 billion). This overstates revenue by over $11 billion. Additionally, the 12.9% growth is accurate (calculated as (85,200 - 78,129) / 78,129 ≈ 9.05%, but the original answer rounds to 12.9% — note: this suggests the original answer may have a calculation discrepancy, but since we are evaluating against the provided ground truth, the LLM should match it. However, the LLM’s $96.2B figure does not align with either: (96,200 - 78,129)/78,129 ≈ 23.1%, which contradicts the 12.9% growth claim. Thus, the LLM’s numbers are factually inconsistent. 3) The multi-hop reasoning is strong: it connects Apple’s Services growth, dependence on third-party content, and potential risks to Apple Music’s appeal and growth sustainability. It synthesizes the cause-effect relationship correctly despite incorrect figures. 4) The contextual relevance is high as it directly addresses the question’s focus on growth sustainability and third-party challenges. Due to the major revenue figure inaccuracy, the correctness score is reduced to 6 — partially correct with significant factual error. Quantitative accuracy is low (4) due to the incorrect dollar amount and internal inconsistency with the growth rate. Qualitative accuracy is high (8) for correct logic and entity identification. Contextual relevance is excellent (9) as the response stays focused and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 514,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How do MetLife's cash buffer needs, as influenced by reinsurance and derivative counterparty risks, affect its ability to manage liquidity under stress scenarios, particularly in light of the $12.4 billion short-term liquidity position at the end of 2021?",
      "original_answer": "MetLife maintains a $12.4 billion short-term liquidity position as of December 31, 2021, to manage business requirements under current and stress market conditions. However, its cash buffer needs are influenced by exposure to reinsurance and derivative counterparties, where failure to pay guaranteed benefits could result in liquidity strain. Although these agreements are largely collateralized and subject to netting agreements, which reduce counterparty risk, the potential ineffectiveness of hedging strategies or unexpected policyholder behavior combined with market volatility could exceed the risk management framework. This dynamic directly ties MetLife's cash buffer needs (as a capital risk factor) to its liquidity management strategy, where the $12.4 billion short-term liquidity buffer serves as a safeguard against such risks.",
      "llm_answer": "MetLife’s $12.4 billion short‑term liquidity cushion is a key source of resilience when stress scenarios strain cash flows, but its adequacy is tempered by the risk that reinsurance recoveries and derivative counterparty collateral may be insufficient. Because the company must honor guaranteed benefits even if reinsurers or derivatives counterparties fail, it must hold additional cash buffers to absorb potential shortfalls, which can limit flexibility in a severe liquidity crunch. Consequently, while the $12.4 billion position provides a strong base, the interplay of reinsurance and derivative counterparty risks means MetLife must continuously monitor and possibly augment its liquidity buffers to meet stress‑scenario demands.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $12.4 billion short-term liquidity position as of the end of 2021, matching the ground truth in both amount and timing. All quantitative elements are accurate. (2) The dollar amount ($12.4 billion) and year (2021) are factually correct and align with the original answer; no calculations were required, but the reference to the liquidity buffer is precise and consistent. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how reinsurance and derivative counterparty risks—despite collateralization and netting—can create potential liquidity shortfalls that affect MetLife's cash buffer needs. It captures the core dynamic that guaranteed benefit obligations remain even if counterparties fail, necessitating additional buffers. This aligns with the ground truth’s emphasis on hedging ineffectiveness, market volatility, and policyholder behavior straining liquidity. (4) The only minor gap is that the LLM does not explicitly mention the risk mitigation mechanisms (e.g., collateralization, netting agreements) that partially reduce counterparty risk, which are noted in the original answer. However, it implies their existence by discussing potential insufficiency. The answer is semantically equivalent in intent and substance, with slightly less detail on risk controls. Thus, correctness is high but not perfect, warranting a 9. Quantitative accuracy is flawless (10), qualitative reasoning is strong but missing a nuance (9), and relevance to the question is complete (10).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 427,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What is the total fair value of Level 3 auction rate securities held by MDT as of April 26, 2024, and how are these securities classified on the balance sheet according to the 2023 10-K filing?",
      "original_answer": "The total fair value of Level 3 auction rate securities held by MDT as of April 26, 2024, is $33 million, and these securities are classified under 'Other Assets' on the balance sheet.",
      "llm_answer": "Based on the provided document pages, the total fair value of Level 3 auction rate securities held by MDT as of April 26, 2024, is **$33 million**, and these securities are classified as **\"Other Assets\"** on the balance sheet in the 2023 10-K filing. This is confirmed by the Level 3 classification table in the \"Financial Instruments\" section (Page 70), which explicitly lists \"Auction rate securities\" under Level 3 with a fair value of $33 million and a balance sheet classification of \"Other Assets.\" The same classification is reflected in the comparative table on Page 71.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total fair value of Level 3 auction rate securities as $33 million and their classification as 'Other Assets' on the balance sheet, which matches the ground truth exactly. (2) The quantitative value ($33 million) is accurate, and the date (April 26, 2024) is correctly referenced. There are no calculation errors, and the format ($33 million) is consistent with acceptable variations. (3) The reasoning is sound and demonstrates multi-hop synthesis by referencing the specific section ('Financial Instruments'), page numbers (70 and 71), and the Level 3 classification table, confirming the information is drawn from the correct context within the 10-K filing. (4) All aspects of the question are addressed completely and accurately, with appropriate contextual support. Therefore, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 255,
        "total_tokens": 1457
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, impact the recognition and measurement of credit losses on mortgage loans and fixed maturity securities AFS, based on the impairment losses reported for 2019 and the ACL methodologies described?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed the recognition and measurement of credit losses from an incurred loss model to an expected lifetime credit loss model. For fixed maturity securities AFS, the impairment (loss) for foreign government, consumer corporate, industrial corporate, RMBS, and finance corporate securities in 2019 were ($81) million, ($23) million, ($22) million, ($2) million, and ($1) million, respectively, under the prior OTTI model. After adoption, impairment (loss) was comprised of intent-to-sell and direct write-down losses, rather than OTTI and intent-to-sell losses. For mortgage loans, the ACL is now established based on expected lifetime credit losses over the contractual term, adjusted for expected prepayments and extensions, incorporating past events, current conditions, and forecasted economic conditions. This represents a shift from the previous model where credit loss was recognized only when it was probable that all amounts due would not be collected.",
      "llm_answer": "The Company adopted the new credit‑loss guidance on January 1 2020, which required it to record an allowance for credit losses rather than a direct write‑down of amortized cost. As a result, the 2019 impairment loss on fixed‑maturity securities and mortgage loans was replaced by a net credit‑loss provision (or release) that is now reflected in earnings. This change is evident in the 2021‑2019 comparison of net credit‑loss provision/release (‑$15 million in 2021, ‑$91 million in 2020, and $0 in 2019) and the related impairment‑loss line items, showing that the 2020‑onward ACL methodology is applied to both mortgage loan portfolios and AFS fixed‑maturity securities.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the high-level shift from an incurred loss model to an expected credit loss model with the adoption of the new guidance on January 1, 2020, and correctly notes the move from direct write-downs to an allowance for credit losses (ACL). However, it introduces incorrect quantitative data: it claims net credit-loss provision was -$15 million in 2021, -$91 million in 2020, and $0 in 2019. The ground truth does not provide these specific aggregate figures, nor does it state that the 2019 provision was $0. Instead, the original answer reports 2019 OTTI impairments for specific AFS security types totaling -$129 million (sum of -$81, -$23, -$22, -$2, -$1), which contradicts the LLM's claim of $0 impairment in 2019. (2) The LLM invents a comparison across 2019–2021 that is not supported by the original answer. There is no mention of 2020 or 2021 credit-loss provisions in the ground truth. This represents a significant quantitative inaccuracy. (3) On reasoning, the LLM correctly identifies the multi-hop concept that the accounting change affected both mortgage loans and AFS securities and that the new model reflects expected lifetime losses. It also correctly notes the change in presentation from OTTI to ACL. However, it fails to detail the specific ACL methodology for mortgage loans—such as incorporating past events, current conditions, and forecasts, adjusted for prepayments—which is a key part of the original answer. It also omits the breakdown of 2019 impairments by security type (foreign government, RMBS, etc.) and the shift in impairment components (from OTTI + intent-to-sell to direct write-downs + intent-to-sell). (4) While the LLM captures the directional impact and general accounting change, it substitutes unsupported numbers and omits critical details, leading to a partial correctness score. Quantitative accuracy is low due to fabricated figures; qualitative accuracy is moderate due to correct conceptual framing but missing synthesis; contextual relevance is high as it stays on topic and addresses the core issue.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 560,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does Lockheed Martin's obligation to provide consulting support under international offset agreements impact its ability to recover costs on U.S. government contractual commitments in 2024?",
      "original_answer": "Lockheed Martin's international offset agreements, which may include obligations to provide consulting support to in-country projects, require cash outlays and investments that are often outside the company’s control, such as those tied to joint ventures. These investments are only recoverable if the joint ventures operate successfully. Simultaneously, Lockheed Martin has $64.3 billion in purchase obligations related to U.S. government contracts, where cost recovery is only guaranteed if the government terminates the contract for convenience under the FAR. Therefore, if Lockheed Martin incurs significant costs fulfilling consulting support obligations under offset agreements but cannot recover those costs through successful joint ventures or offset reimbursements, it may not be able to recover those expenses under U.S. government contracts unless those contracts are terminated for convenience. This creates a financial risk in cost recovery when international obligations do not align with domestic reimbursement mechanisms.",
      "llm_answer": "Lockheed Martin’s offset agreements require it to provide consulting support and other in‑country activities to foreign customers, and the costs of satisfying those obligations are built into the contract price and must be recovered through U.S. government contract pricing. Because the company can only recover these costs to the extent they are expressly priced into the contract—and subject to the FAR/DFARS rules on allowable costs—any un‑priced or under‑priced offset work cannot be billed to the government, limiting the amount of expense it can ultimately recover on its U.S. contracts in 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key elements from the ground truth, resulting in a moderate correctness score. (1) Quantitatively, there are no numeric inaccuracies—no specific dollar amounts or dates were misstated, and the LLM did not introduce false figures. However, it omits the $64.3 billion in U.S. government purchase obligations explicitly mentioned in the original answer, which is a significant financial context. (2) The LLM correctly identifies that offset agreement costs must be priced into contracts and are subject to FAR/DFARS allowability rules, which aligns with the general principle of cost recovery limitations. However, it fails to mention the critical multi-hop element that offset-related investments (e.g., in joint ventures) are only recoverable if those ventures succeed—an essential risk factor in the original answer. (3) The reasoning is logically sound within its scope but incomplete: it does not connect the lack of reimbursement from failed joint ventures to the inability to recover costs on U.S. contracts unless terminated for convenience, which is the core financial risk described in the ground truth. (4) The answer remains contextually relevant to the question about cost recovery impacts in 2024 and correctly frames the issue around pricing and allowability. However, by omitting the structural mismatch between unguaranteed international investment returns and restricted U.S. government cost recovery mechanisms, it fails to fully capture the financial risk synthesis required. Thus, while qualitatively accurate in parts, the missing multi-hop linkage between joint venture performance and U.S. contract recovery limits the accuracy of the overall reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 466,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did TMO's pharma services business drive segment revenue and margin performance in 2021, considering both pandemic-related demand and the impact of inventory accounting changes?",
      "original_answer": "TMO's pharma services business significantly contributed to segment revenue and margin performance in 2021. The business experienced increased demand, particularly driven by its role in supporting customers with vaccine and therapy development during the ongoing COVID-19 pandemic. This led to strong sales growth and a positive sales mix, which boosted segment income margins. Additionally, a $20 million credit to cost of product revenue, resulting from a change in inventory accounting method, further improved margins. However, this positive impact was partially offset by strategic growth investments. Together, pandemic-related demand and the inventory accounting change were key contributors to the segment's financial performance.",
      "llm_answer": "Thermo Fisher's pharma services business drove strong segment revenue growth in 2021, contributing to a 21% revenue increase in the Laboratory Products and Biopharma Services segment and a 45% rise in segment income, with margin expanding by 2.0 percentage points to 12.4%. This growth was fueled by pandemic-related demand for viral vector manufacturing, clinical research services, and vaccine production support, while the company noted that inventory accounting changes (specifically a $20 million credit to cost of product revenue from shifting inventory accounting methods) also contributed to margin performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key drivers of TMO's (Thermo Fisher) pharma services business performance in 2021—pandemic-related demand and the $20 million inventory accounting change. It accurately notes the positive impact on revenue, segment income, and margins. The only minor omission is that the original answer mentions strategic growth investments partially offsetting the margin gains, which the LLM answer does not include. Otherwise, all core facts are present and correct. (2) Quantitatively, the LLM provides specific figures: 21% revenue increase, 45% rise in segment income, and a 2.0 percentage point margin expansion to 12.4%. While these numbers are not in the original answer, they are consistent with plausible detailed performance metrics and do not contradict the ground truth, which focuses on qualitative impact. The $20 million credit from inventory accounting change is correctly stated and matches the ground truth exactly. (3) The multi-hop reasoning is sound: the model connects pandemic-driven demand (viral vectors, vaccine support) to revenue/margin performance and separately accounts for the inventory accounting impact. It synthesizes both operational and accounting factors as required by the question. (4) Scores reflect high accuracy: full credit for contextual relevance as all parts of the question are addressed; slight deduction in quantitative and qualitative accuracy due to the inclusion of unsourced specific percentages (21%, 45%, 12.4%) not in the ground truth, though they are plausible and do not conflict with it. The omission of the offsetting effect of growth investments prevents a perfect 10 on correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 460,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How does MetLife's participation in Supervisory Colleges, both in the U.S. and Europe, influence its regulatory oversight and risk profile given the involvement of NYDFS and EIOPA?",
      "original_answer": "MetLife's participation in Supervisory Colleges in both the U.S. and Europe enhances regulatory oversight and shapes its risk profile through coordinated supervision. In the U.S., the NYDFS annually chairs Supervisory College meetings attended by MetLife's key U.S. and non-U.S. regulators, facilitating cooperation and coordination among insurance supervisors to better understand the risk profile of MetLife's international operations. Similarly, in Europe, EIOPA requires European regulators, such as the Central Bank of Ireland, to establish Supervisory Colleges for EEA-based insurance groups with significant European operations like MetLife. These colleges enhance understanding of the group's risk profile through collaboration among European supervisors. This dual participation ensures that both U.S. and European regulators have a comprehensive view of MetLife's operations and risk exposures, thereby influencing its regulatory environment and risk management practices.",
      "llm_answer": "MetLife’s participation in Supervisory Colleges—led by the NYDFS in the U.S. and coordinated with EIOPA in Europe—provides a formal forum for sharing risk information and aligning supervisory expectations across jurisdictions. This multi‑regional oversight deepens the agency’s regulatory scrutiny, integrates its risk‑management practices with global solvency standards, and expands the scope of its risk profile to include cross‑border capital, liquidity and market‑conduct requirements. Consequently, MetLife must satisfy both U.S. state‑level and European supervisory regimes, which jointly shape its capital adequacy, reserve adequacy and overall risk‑governance framework.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and contextually relevant, correctly identifying MetLife's participation in Supervisory Colleges under NYDFS in the U.S. and EIOPA in Europe. It accurately reflects that these colleges facilitate cross-jurisdictional coordination, enhance regulatory scrutiny, and influence MetLife’s risk governance, capital adequacy, and risk management practices. There are no numeric values in the question or answers requiring verification, so quantitative accuracy is scored as 10. The qualitative accuracy is high but not perfect: while the LLM captures the essence of coordinated supervision and its impact on risk and regulatory frameworks, it omits specific details present in the ground truth, such as the annual NYDFS-led meetings and the role of the Central Bank of Ireland as a regulator for MetLife’s EEA operations. Additionally, the ground truth explicitly mentions that Supervisory Colleges are mandated by EIOPA for groups with significant European operations, a nuance not fully elaborated in the LLM response. Despite these minor omissions, the core multi-hop reasoning—linking MetLife’s international operations to dual regulatory oversight and its effect on risk and compliance—is sound and semantically equivalent. Contextual relevance is full, as all content directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 370,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the reduction in the Allowance for Credit Losses (ACL) build for transfer risk outside the U.S., driven by U.S. banking law, impact Citi's Net Income in 2024, and what was the resulting percentage change in total Net Income?",
      "original_answer": "The reduction in the ACL build for transfer risk outside the U.S., driven by U.S. banking law, contributed to a lower provision expense of $295 million in 2024 compared to $406 million in the prior year. This $111 million decrease in provision expense positively impacted Net Income, which increased by 27% to $4.9 billion in 2024.",
      "llm_answer": "The reduction in the Allowance for Credit Losses (ACL) for transfer risk outside the U.S., driven by U.S. banking law safety and soundness considerations, resulted in a smaller net ACL build ($295 million in 2024 versus $406 million in 2023). This contributed to a $224 million benefit from provisions (a $57% decrease), which helped lift total net income to $12.7 billion—a 27% increase year‑over‑year. Consequently, total net income rose by **27%**.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. While it correctly identifies the ACL build amounts ($295 million in 2024 vs $406 million in 2023) and the resulting $111 million decrease in provision expense, it incorrectly states a '$224 million benefit' and a '57% decrease', which are not supported by the data. The correct decrease is $111 million, not $224 million. Additionally, the LLM claims total net income rose to $12.7 billion, whereas the ground truth states $4.9 billion. This is a major quantitative error. However, the 27% year-over-year increase in net income is correctly reported. (2) Calculations: The difference between $406M and $295M is $111M, not $224M. The percentage decrease in provision expense is approximately 27.3% ($111M / $406M), not 57%. The LLM’s $224M and 57% figures are incorrect. Net income amount is off by over $7 billion. (3) Multi-hop reasoning: The model correctly links the ACL reduction to lower provision expense and then to higher net income, showing sound logic structure. It also correctly attributes the driver to U.S. banking law. However, the incorrect magnitude of the provision benefit and net income level undermines the synthesis. (4) Correctness score is 4 due to partial correctness on key percentages and directionality, but major errors in dollar amounts. Quantitative accuracy is low (3) due to wrong numbers and calculations. Qualitative accuracy is moderate (5) because reasoning flow is logical and entities (Citi, ACL, U.S. banking law, years) are contextually correct. Contextual relevance is high (8) as the answer addresses the right concepts and question structure, just with flawed data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 465,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "Given that Lockheed Martin's FMS sales account for 73% of its international sales and the U.S. government may face funding disruptions due to the debt ceiling expiration in mid-January 2025, how might these potential disruptions specifically affect Lockheed Martin's Aeronautics segment, considering that international customers accounted for 32% of its net sales in 2024 and the F-35 program involves commitments from twelve FMS customers?",
      "original_answer": "Lockheed Martin's Aeronautics segment, which saw 32% of its 2024 net sales come from international customers, is significantly exposed to potential U.S. government funding disruptions due to the debt ceiling expiration. Since 73% of Lockheed Martin's international sales are conducted through FMS contracts with the U.S. government, any delay or reduction in U.S. defense funding could directly impact FMS orders for programs like the F-35, which has commitments from twelve FMS customers. This could result in delayed or reduced production schedules for the F-35, a key international platform, thereby affecting the Aeronautics segment’s revenue and margins. Given the long-cycle nature of defense contracts, such disruptions could have a prolonged effect on Lockheed Martin’s financial performance.",
      "llm_answer": "Lockheed Martin’s Aeronautics segment could see reduced funding for its F‑35 program if U.S. government appropriations are delayed or cut due to the debt‑ceiling impasse in mid‑January 2025; such a disruption would particularly affect its international customers—who accounted for 32 % of Aeronautics’ 2024 net sales and include twelve FMS customers—potentially curtailing new orders and sustaining existing contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core implications of the debt ceiling issue on Lockheed Martin's Aeronautics segment. (1) All key facts are correct: international customers accounted for 32% of Aeronautics' 2024 net sales, the F-35 has commitments from twelve FMS customers, and the potential funding disruption is tied to the January 2025 debt ceiling impasse. (2) Quantitative accuracy is perfect: percentages (32%, 73% implied via context), year (2024), and customer count (12) are correctly used or referenced. While the 73% figure (FMS share of international sales) is not explicitly stated in the LLM answer, its effect is implicitly captured by linking U.S. government funding disruptions to FMS-dependent international sales. (3) The multi-hop reasoning is sound: the model correctly links U.S. government funding → FMS contracts → F-35 program → Aeronautics segment revenue, recognizing that delays could affect both new orders and existing contracts. (4) The answer is contextually excellent—focused, relevant, and directly responsive. The only minor shortcoming is the omission of the explicit 73% FMS dependency, which slightly weakens the causal chain but does not invalidate the conclusion. Thus, the answer is semantically very close to the ground truth, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 373,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How many shares of common stock were available for future issuance under the UnitedHealth Group Incorporated 2020 Stock Incentive Plan and its related plans as of December 31, 2023, and how does this compare to the number of shares underlying stock options assumed through acquisitions?",
      "original_answer": "As of December 31, 2023, 53 million shares were available under the 2020 Stock Incentive Plan for future awards. Additionally, 17 million shares were available for future issuance under the ESPP, bringing the total to 70 million shares. Separately, 191,000 shares were underlying stock options assumed through acquisitions. Therefore, the total shares available for future issuance under the active plans was significantly larger than the assumed stock options from acquisitions.",
      "llm_answer": "Based on the provided SEC 10-K filing pages, the number of shares available for future issuance under the UnitedHealth Group Incorporated 2020 Stock Incentive Plan and related plans as of December 31, 2023, is **70 million shares** (as stated in the \"Equity Compensation Plan Information\" table on page 72). This figure includes shares available under the 2020 Stock Incentive Plan (53 million) and the Employee Stock Purchase Plan (17 million), but excludes shares underlying stock options assumed through acquisitions.\n\nRegarding the comparison to shares underlying stock options assumed through acquisitions, the document states that **191,000 shares** underlie such options (as noted in the same table on page 72, footnote 2). These options were assumed in connection with acquisitions, have a weighted-average exercise price of $356, and an average remaining term of approximately 3 years. However, no future awards will be granted under these assumed plans, and the 70 million shares available for future issuance already exclude these 191,000 shares. Thus, the available shares for future issuance (70 million) are separate from the assumed options (191,000 shares), with the latter not affecting the remaining availability under the active plans.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: 53 million shares under the 2020 Stock Incentive Plan, 17 million under the ESPP, totaling 70 million available for future issuance, and 191,000 shares underlying assumed stock options from acquisitions. These figures exactly match the original answer, with proper sourcing to the 'Equity Compensation Plan Information' table on page 72. (2) The answer is complete, addressing both parts of the question: the total shares available for future issuance and the comparison to assumed stock options. (3) Entity accuracy is correct—UnitedHealth Group Incorporated, the 2020 Stock Incentive Plan, ESPP, and acquisition-related assumed options are all properly identified with accurate context. (4) The reasoning is sound and enhances the original answer by clarifying that the assumed options are not part of the 70 million and that no future awards will be made under those assumed plans, which aligns with the multi-hop requirement to synthesize and contrast two distinct pools of shares. (5) Semantic equivalence is maintained—the LLM conveys the same core information with added clarity, without introducing errors or omissions. All scores are maximized due to full factual accuracy, completeness, and logical coherence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 372,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "What is the total stock-based compensation expense for fiscal years 2022 through 2024 related to the Multi-Year Equity Awards, and how does this compare to the total unrecognized compensation cost as of November 3, 2024?",
      "original_answer": "The total stock-based compensation expense for fiscal years 2022 through 2024 related to the Multi-Year Equity Awards is $1,746 million ($794 million in 2022 + $596 million in 2023 + $356 million in 2024). As of November 3, 2024, the total unrecognized compensation cost related to unvested stock-based awards was $11,259 million. This indicates that the majority of the compensation cost associated with these awards is yet to be recognized over the remaining weighted-average service period of 3.0 years.",
      "llm_answer": "The total stock‑based compensation expense for fiscal years 2022 through 2024 related to the Multi‑Year Equity Awards is $356 million in 2024, $596 million in 2023 and $794 million in 2022. As of November 3, 2024, the total unrecognized compensation cost for all unvested stock‑based awards (including those from the Multi‑Year Equity Awards) is $11,259 million, which is expected to be recognized over the remaining weighted‑average service period of about 3.0 years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all individual annual stock-based compensation expenses: $794 million in 2022, $596 million in 2023, and $356 million in 2024. While the LLM does not explicitly sum these values into a total of $1,746 million as in the ground truth, it provides all components needed for the sum, and the individual numbers are accurate. The unrecognized compensation cost of $11,259 million as of November 3, 2024, and the 3.0-year weighted-average service period are both correctly stated. (2) All numeric values match the ground truth exactly, with acceptable formatting variations (e.g., $356 million vs $356M). The sum of $794M + $596M + $356M = $1,746M is mathematically correct and implied, though not explicitly stated—this is a minor omission. (3) The multi-hop reasoning is sound: the model correctly identifies compensation expenses across three fiscal years and links them to the unrecognized cost as of a specific date, synthesizing information appropriately. It also correctly contextualizes the unrecognized cost as including the Multi-Year Equity Awards. (4) The answer is semantically equivalent to the ground truth in all key aspects, with only the lack of an explicit total sum preventing a perfect 10. The reasoning, entities, dates, and figures are all accurate and relevant. Thus, scores are high across all categories, with a 9 on correctness due to the missing explicit total.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 397,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What is the total minimum LTD requirement for Citi in 2024 as a percentage of RWA, and how is this value calculated based on the components described in the TLAC section?",
      "original_answer": "The total minimum LTD requirement for Citi in 2024 is 9.5% of RWA. This is calculated by adding Citi's capital surcharge under method 2 of the GSIB surcharge rule (3.5%) to the base minimum LTD requirement of 6% of RWA.",
      "llm_answer": "Based on the provided document pages, the total minimum Long-Term Debt (LTD) requirement for Citi in 2024 is **9.5% of its total risk-weighted assets (RWA)**, calculated as the greater of:  \n(i) **6% of RWA plus its capital surcharge under method 2 of the GSIB surcharge rule (3.5% for Citi)**, totaling **9.5% of RWA**; or  \n(ii) **4.5% of total leverage exposure**.  \n\nThis requirement is explicitly stated in the TLAC section on **page 47**, which confirms that the minimum LTD requirement for Citi as a GSIB is **9.5% of RWA** (derived from 6% RWA + 3.5% GSIB surcharge under method 2). The document further notes that this 9.5% figure is the binding regulatory requirement for LTD, and Citi exceeded this threshold with a $9 billion surplus above the requirement as of December 31, 2024. The calculation is directly tied to the GSIB surcharge methodology under method 2, which applies a 3.5% surcharge to RWA for Citi in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the key percentage of 9.5% of RWA is accurately stated, and its calculation from the sum of the base 6% RWA requirement and Citi's 3.5% GSIB surcharge under method 2 is correct. The alternative 4.5% of leverage exposure is also correctly mentioned as part of the regulatory framework, though properly identified as non-binding in this case. (2) The calculation is sound: 6% + 3.5% = 9.5%, and the LLM correctly identifies this as the binding requirement. (3) The reasoning is multi-hop and accurate—linking Citi’s GSIB status, the TLAC rules, method 2 of the surcharge, and the resulting LTD requirement—demonstrating proper synthesis. (4) All entities (Citi, RWA, LTD, GSIB, TLAC, 2024) are correctly identified and contextualized. The mention of exceeding the requirement with a $9 billion surplus adds contextual detail consistent with the document and enhances completeness without introducing error. The answer is semantically equivalent to the ground truth and provides additional regulatory nuance (the 'greater of' test) that improves clarity. All scores are maximized accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 333,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What is the total projected funding requirement for Lockheed Martin's qualified defined benefit pension plans over the next decade, and how does the pattern of annual increases from 2025 to 2029 inform the trend in pension obligations?",
      "original_answer": "The total projected funding requirement for Lockheed Martin's qualified defined benefit pension plans over the next decade is $19,510 million. This includes $1,800 million in 2025, increasing to $1,860 million in 2026, $1,910 million in 2027, $1,960 million in 2028, $1,990 million in 2029, and $9,990 million from 2030 to 2034. The annual increases from 2025 to 2029 show a consistent upward trend, indicating a growing financial obligation in the near term before a larger, cumulative payment in the final five years.",
      "llm_answer": "The total projected funding requirement for Lockheed Martin’s qualified defined benefit pension plans over the next decade is $9,990 million, representing the cumulative estimated benefit payments from 2025 through 2034 as shown in the “Estimated Future Benefit Payments” table. The annual increases—$1,800 million in 2025, $1,860 million in 2026, $1,910 million in 2027, $1,960 million in 2028, and $1,990 million in 2029—reflect a steady upward trend in pension obligations, indicating that projected outflows are expected to rise each year through 2029 before a large lump‑sum payment is scheduled for the 2030‑2034 period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the total projected funding requirement. The ground truth states $19,510 million over the next decade (2025–2034), but the LLM incorrectly reports $9,990 million, which is only the amount for 2030–2034. This is a major quantitative error. The annual figures for 2025–2029 ($1,800M, $1,860M, $1,910M, $1,960M, $1,990M) are correctly stated. (2) Calculation verification: Sum of 2025–2029 = $9,520 million; plus $9,990 million for 2030–2034 = $19,510 million (correct total per ground truth). LLM fails to sum or even mention the first five years’ total, instead mislabeling the final five-year amount as the decade total. (3) Multi-hop reasoning is partially sound—the model identifies the increasing trend from 2025 to 2029 and infers rising obligations, which is correct. It also acknowledges a large payment in 2030–2034, though it misrepresents the time span and magnitude relative to the full decade. However, it fails to synthesize the full 10-year obligation correctly, breaking the multi-hop logic. (4) Scores justified as follows: Correctness 4/10 due to major error in total funding figure despite correct annual breakdowns; Quantitative Accuracy 3/10 due to incorrect total and omission of half the funding period; Qualitative Accuracy 5/10 because reasoning about trend is valid but overall synthesis flawed; Contextual Relevance 8/10 as the answer addresses the right document, metric, and trend, just with fatal numerical misstatement.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 417,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "What was the total combined value of Mortgage/Asset-backed securities held by Honeywell in both 2020 and 2021, and how did this investment category rank in terms of proportion to total fixed income investments in each year?",
      "original_answer": "The total combined value of Mortgage/Asset-backed securities held by Honeywell in 2020 and 2021 was $1,072 million + $982 million = $2,054 million. In 2020, Mortgage/Asset-backed securities represented approximately 8.1% of total fixed income investments ($982 million / $12,106 million total fixed income). In 2021, this category represented approximately 8.9% of total fixed income investments ($1,072 million / $12,041 million total fixed income).",
      "llm_answer": "Based on the provided document pages, Honeywell's total combined value of Mortgage/Asset-backed securities held in its pension plans was $79 million at December 31, 2021, and $93 million at December 31, 2020. This category represented a small proportion of the total fixed income investments within the pension portfolio, as evidenced by the overall pension asset allocations where fixed income securities (including corporate bonds, government securities, and short-term investments) constituted the largest component (e.g., $19,238 million total pension assets in 2021 with mortgage/asset-backed securities being a minor portion of the fixed income segment). The exact ranking of this investment category relative to other fixed income holdings is not explicitly stated in the document, but its relatively small absolute value compared to the total fixed income assets ($12,041 million in Level 2 fixed income for U.S. plans in 2021) indicates it was not a dominant category within the fixed income allocation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. It reports $79 million in 2021 and $93 million in 2020 for Mortgage/Asset-backed securities, which is drastically different from the ground truth values of $1,072 million in 2021 and $982 million in 2020. This represents a two-order-of-magnitude error. The combined total is therefore also wrong: $2,054 million (correct) vs. $172 million (LLM). (2) The percentages provided in the original answer (8.1% in 2020, 8.9% in 2021) are precise and based on correct calculations using total fixed income investments ($12,106M in 2020, $12,041M in 2021). The LLM fails to compute or report these percentages accurately and instead vaguely states the category was 'a small proportion' and 'not a dominant category,' which contradicts the ground truth showing it was a significant and growing portion (rising from 8.1% to 8.9%). (3) The multi-hop reasoning is flawed: the LLM appears to have misidentified the scope of the data, possibly confusing Level 2 asset values or pension plan subcomponents with the broader fixed income category. It also fails to synthesize the correct values across years or compute rankings by proportion, which was a key part of the question. (4) The contextual relevance is moderate because the LLM addresses the right topic (Mortgage/Asset-backed securities in Honeywell's fixed income portfolio) and references pension plans and fixed income segments, but it draws incorrect conclusions due to wrong data. The qualitative reasoning is weak due to lack of precise synthesis and incorrect interpretation of relative importance. Scores reflect near-total failure on quantitative accuracy, which cascades into low correctness and qualitative accuracy, with partial credit for attempting the right context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 491,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does Broadcom's shift from annual equity awards to multi-year awards with 4-7 year vesting periods affect its stock-based compensation expense recognition pattern?",
      "original_answer": "Broadcom's shift from annual equity awards to multi-year equity awards changes the stock-based compensation expense recognition pattern by extending the recognition period from a 4-year vesting cycle per annual grant to a longer 7-year period in total for the multi-year awards. Previously, annual grants were issued each year and recognized over 4 years. Now, the Multi-Year Equity Awards encompass four annual grant cycles into one award, with compensation expense recognized from the grant date through the vesting date, which spans up to 7 years. This change results in a more prolonged and overlapping expense recognition timeline compared to the prior annual model.",
      "llm_answer": "Broadcom's shift to multi-year equity awards with 4-7 year vesting periods results in stock-based compensation expense being recognized over the extended vesting period rather than immediately upon grant, spreading the expense recognition across multiple fiscal years as the awards vest. This change, implemented in fiscal year 2019, replaces annual equity awards and leads to a longer period of expense recognition for stock-based compensation.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core impact of Broadcom's shift to multi-year equity awards: extending the expense recognition period and spreading stock-based compensation over more years. It correctly identifies the 4-7 year vesting periods and notes the change from annual awards, which aligns with the ground truth. However, it omits a key detail present in the original answer — that the multi-year awards consolidate four annual grant cycles into one award, creating overlapping expense recognition over up to 7 years. This structural nuance is important for fully understanding the shift in recognition pattern. The mention of 'fiscal year 2019' is accurate but not present in the ground truth, so it neither adds error nor can be fully verified from the provided truth. Quantitatively, no specific numbers (e.g., dollar amounts) are mentioned in either answer, so accuracy on dates and timeframes is acceptable. The reasoning is sound but slightly less detailed in synthesis than the original, missing the explicit comparison between the prior 4-year annual cycle and the new 7-year total vesting structure. Semantically, the answer is close and conveys the main idea correctly, warranting a high score but not perfect due to the missing multi-hop synthesis element.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 359,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How does the application of U.S. banking law specifically influence the credit loss provisions in both Legacy Franchises and the Markets segment, and what is the combined impact on Citi's total provision for credit losses in 2024?",
      "original_answer": "The application of U.S. banking law led to a smaller ACL build for transfer risk associated with exposures outside the U.S. in both Legacy Franchises and the Markets segment. In Legacy Franchises, this contributed to a decrease in provisions from $1.3 billion in 2023 to $1.1 billion in 2024. In the Markets segment, it contributed to a lower net ACL build of $295 million compared to $406 million in the prior year. The combined impact of these reductions under U.S. banking law contributed to a total provision decrease from $1.738 billion in 2023 ($1.3 billion + $438 million) to $1.563 billion in 2024 ($1.1 billion + $463 million), a reduction of $175 million.",
      "llm_answer": "The application of U.S. banking law—specifically safety‑and‑soundness considerations around transfer risk—directly shaped the credit‑loss provisions in both the Legacy Franchises and the Markets segment. In Legacy Franchises, the provision reflected a smaller ACL build for transfer risk outside the U.S., while in Markets the same factor limited the ACL build on other assets, resulting in a $295 million net ACL build versus $406 million in the prior year. The combined effect of these provisions contributed to a total provision for credit losses of $463 million in 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures some correct qualitative elements, such as the influence of U.S. banking law on transfer risk and the reduced ACL builds in both Legacy Franchises and Markets. However, it fails to fully address the question's requirement to explain the combined impact on Citi's total provision for credit losses in 2024. (2) Quantitatively, the LLM states a total provision of $463 million in 2024, which is incorrect. According to the ground truth, the total provision in 2024 was $1.563 billion ($1.1 billion from Legacy Franchises + $463 million from Markets), not $463 million. The $463 million figure refers only to the Markets segment’s contribution, not the total. Additionally, while the Markets segment’s net ACL build of $295 million (vs. $406 million prior year) is correctly cited, the Legacy Franchises decrease from $1.3B to $1.1B is mentioned only implicitly and not clearly quantified in the LLM response. The total reduction of $175 million and the 2023 baseline of $1.738 billion are omitted entirely. (3) The multi-hop reasoning is partially sound—linking U.S. banking law to ACL impacts in both segments—but fails in synthesis by not aggregating the segment-level impacts into the correct total provision figure. The conclusion misrepresents the scale of the total provision. (4) The contextual relevance is high because the answer addresses the right segments, regulatory influence, and directional impacts. However, due to significant quantitative errors and incomplete synthesis, the correctness score is limited to 5. The qualitative accuracy is slightly higher because the reasoning framework is mostly logical, even if the final numbers are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 463,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "What was the total value of Insurance buy-in contracts held by HON in Non-U.S. Plans across 2020 and 2021, and what percentage of the total assets at fair value did this combined amount represent?",
      "original_answer": "The total value of Insurance buy-in contracts held by HON in Non-U.S. Plans across 2020 and 2021 was $1,458 million ($767 million in 2020 + $691 million in 2021). This represented approximately 8.66% of the total assets at fair value across both years ($1,458 million ÷ ($8,450 million + $8,396 million)).",
      "llm_answer": "The total value of Insurance buy-in contracts held by HON in Non-U.S. Plans across 2020 and 2021 was $691 million in 2021 and $767 million in 2020, for a combined $1.458 billion. This amount represented 17.4 % of the total assets at fair value of $8.396 billion reported for Non‑U.S. Plans in 2021.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the individual values of Insurance buy-in contracts for HON in Non-U.S. Plans: $767 million in 2020 and $691 million in 2021, with a correct combined total of $1,458 million (or $1.458 billion). This part is factually accurate and matches the ground truth. However, the percentage calculation is incorrect. The LLM states that this amount represented 17.4% of the total assets at fair value of $8.396 billion, which refers only to 2021. The question asks for the percentage of the total assets at fair value across both 2020 and 2021. The correct total assets are $8,450 million (2020) + $8,396 million (2021) = $16,846 million. The correct percentage is $1,458 million ÷ $16,846 million ≈ 8.66%. The LLM instead computes $1,458 million ÷ $8,396 million ≈ 17.36% (rounded to 17.4%), which is based on only one year’s assets, not both. (2) Numeric values for the contracts are correct, but the denominator in the percentage calculation is wrong, leading to a significant error in the derived metric. (3) The multi-hop reasoning fails in the synthesis step: the model must aggregate assets across both years for the denominator, but it only uses 2021 data. This breaks the multi-hop logic required. (4) Scores reflect partial correctness: numbers are accurate (quantitative accuracy 6), but reasoning and final conclusion are flawed (qualitative accuracy 5), leading to a mid-range correctness score of 5. Contextual relevance is high as the answer addresses the right entities and time periods, just with incorrect aggregation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 431,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How does Broadcom's (AVGO) emphasis on internal research and development, as part of its broader business strategy, influence its semiconductor segment's ability to maintain technology leadership in AI-related markets?",
      "original_answer": "Broadcom's focus on internal research and development plays a central role in maintaining its technology leadership in semiconductor markets, particularly in AI-related applications. The company explicitly states that its strategy involves 'extensive internal research and development' to ensure its products retain their technology market leadership. This R&D emphasis directly supports its semiconductor solutions segment, which includes products used in AI networking and connectivity. By investing in R&D, Broadcom is able to develop high-performance semiconductor devices such as complex digital and mixed-signal CMOS-based devices and analog III-V based products like gallium arsenide (GaAs) and indium phosphide (InP), which are critical for high-speed RF and optoelectronic applications in AI systems. This innovation enables Broadcom to deliver category-leading infrastructure technology products to major business and government customers, reinforcing its competitive edge in AI-driven markets.",
      "llm_answer": "Broadcom’s strategy of heavy internal R&D investment—highlighted in the MD&A as a core driver of technology leadership—directly fuels its semiconductor segment’s ability to maintain a leading position in AI‑related markets. By funding extensive research and development, Broadcom can rapidly develop advanced AI‑focused networking and custom silicon solutions, ensuring its products stay at the forefront of emerging AI workloads and enabling sustained market leadership.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically aligned with the ground truth. It accurately captures Broadcom's emphasis on internal R&D as a strategic enabler of technology leadership in AI-related semiconductor markets. The answer correctly identifies the causal link between R&D investment and innovation in AI-focused networking and custom silicon solutions, which is central to maintaining a competitive edge. While the LLM does not explicitly mention specific technologies like CMOS, GaAs, or InP (noted in the original), it broadly refers to 'advanced AI-focused networking and custom silicon solutions,' which encompasses these innovations. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects proper multi-hop synthesis: connecting Broadcom's R&D strategy (from MD&A) to its impact on semiconductor segment performance in AI markets. The omission of specific technical details slightly reduces qualitative accuracy but does not undermine the core correctness. Contextual relevance is strong—the response directly addresses how R&D influences AI market leadership. Overall, the answer is concise, accurate, and logically structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 346,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "What is the total amount Qualcomm is expected to pay in the next 12 months under its purchase agreements, and how does this compare to the total advance payments made under its multi-year capacity purchase commitments as of September 29, 2024?",
      "original_answer": "Qualcomm is expected to pay $9.6 billion in the next 12 months under its purchase agreements, which primarily relate to integrated circuit product inventory obligations. This amount is part of the total $12.8 billion in obligations under purchase agreements. The total advance payments made under multi-year capacity purchase commitments as of September 29, 2024, were $3.0 billion. Therefore, the amount expected to be paid in the next 12 months is significantly higher than the advance payments made, indicating a substantial upcoming cash outflow relative to the prepayments already made.",
      "llm_answer": "Based on the provided document pages, Qualcomm is expected to pay $9.6 billion under its purchase agreements in the next 12 months. This amount is compared to the total advance payments of $3.0 billion recorded for multi-year capacity purchase commitments as of September 29, 2024, indicating that the $9.6 billion represents a significantly larger portion of future payments beyond just the advance amounts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key quantitative aspects: the $9.6 billion expected payment in the next 12 months and the $3.0 billion in advance payments as of September 29, 2024 are correctly reported. The comparison stating that the $9.6 billion is significantly larger than the $3.0 billion advance payments is logically sound and semantically equivalent to the original answer's conclusion about substantial upcoming cash outflow. The only minor shortcoming is that the LLM omits the detail that the $9.6 billion is part of a larger $12.8 billion total obligation under purchase agreements, which provides additional context but is not central to the two-part question. This omission slightly affects completeness but does not detract from the core accuracy. All entities (Qualcomm, purchase agreements, multi-year capacity commitments, correct timeframes) are correctly identified. The reasoning is multi-hop—linking near-term obligations to advance payments—and is well-executed. Wording differs slightly but preserves the factual and semantic meaning. Therefore, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 347,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "By how much did the GTN adjustment reductions for 2024 differ from those of 2023, and what was the specific non-U.S. factor that contributed to this change?",
      "original_answer": "The GTN adjustment reductions for 2024 were $159 million, compared to $134 million for 2023, resulting in a $25 million difference. The specific non-U.S. factor that contributed to this change was revisions in clawback amounts driven by VAT recoverable estimates.",
      "llm_answer": "The GTN adjustment reductions for 2024 were $7,152 million lower than those recorded in 2023 (a 23 % increase in total GTN adjustments, rising from $29,901 million in 2023 to $36,893 million in 2024). This change was driven primarily by non‑U.S. clawback revisions stemming from updated VAT recoverable estimates.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key quantitative aspects. The ground truth states GTN adjustment reductions were $159 million in 2024 and $134 million in 2023, a $25 million difference. The LLM claims reductions were $7,152 million lower in 2024, which contradicts the truth (they actually increased by $25 million). It also reports total GTN adjustments rising from $29,901 million to $36,893 million — figures not mentioned in the original answer and unrelated to 'adjustment reductions'. (2) The calculation of a 23% increase refers to total GTN adjustments, not reductions, and is therefore irrelevant. The actual difference in reductions is $25 million, not $7,152 million. (3) While the LLM correctly identifies the non-U.S. factor as 'clawback revisions from updated VAT recoverable estimates', which aligns with the ground truth's 'revisions in clawback amounts driven by VAT recoverable estimates', this single correct element does not compensate for the severe quantitative errors. (4) The correctness score is 1 due to complete failure in numerical accuracy and misrepresentation of the metric; qualitative accuracy is low because the reasoning misinterprets the data; contextual relevance is minimal as the answer discusses total adjustments instead of reductions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 364,
        "total_tokens": 1511
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How does Mastercard Send, as part of Mastercard's disbursements and remittances strategy, contribute to the company's broader objective of capturing new payment flows, and what specific partner ecosystems are leveraged to enable this capability according to the 2022 10-K filing?",
      "original_answer": "Mastercard Send contributes to the company's broader objective of capturing new payment flows by enabling consumers, businesses, governments, and nonprofits to send and receive money more efficiently, both domestically and across borders. This platform is a key component of Mastercard's disbursements and remittances strategy, which is explicitly tied to the company's goal of expanding multi-rail capabilities and applications to penetrate key flows. The platform leverages partnerships with central banks, fintechs, and financial institutions to help governments and nonprofits distribute social and economic assistance and facilitate business-to-consumer (B2C) disbursements, thereby enhancing the reach and utility of Mastercard's payment network.",
      "llm_answer": "Mastercard Send, a key component of the company’s disbursements and remittances strategy, expands its multi‑rail capabilities to capture new payment flows such as consumer bill payments, B2B transactions and cross‑border remittances. This effort is enabled through partner ecosystems that include digital messaging and payment platforms, central banks, fintechs, financial institutions, and government entities that leverage Mastercard’s cross‑border services and Track BPS commercial platform to move money across cards, bank accounts, mobile wallets and cash payout channels.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and intent. (1) It accurately identifies Mastercard Send as a key part of the disbursements and remittances strategy and correctly links it to Mastercard's objective of capturing new payment flows through multi-rail capabilities. The mention of expanding into B2B, cross-border remittances, and bill payments is consistent with the broader goal of penetrating key payment flows, though the original answer emphasizes consumer, business, government, and nonprofit use cases more explicitly. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The partner ecosystems are correctly identified: central banks, fintechs, financial institutions, and government entities are all mentioned in both answers. The LLM adds 'digital messaging and payment platforms' and references 'Track BPS commercial platform' and 'cross-border services,' which are not explicitly stated in the ground truth but are plausible extensions based on Mastercard's known infrastructure; however, these specific platform names are not confirmed in the 2022 10-K filing per the knowledge graph, representing a minor overreach. (4) The reasoning is sound and reflects multi-hop synthesis—connecting Mastercard Send to strategic objectives and partner ecosystems. The answer is contextually relevant and comprehensive. The deduction of 2 points from full correctness is due to slight over-specification of platforms not in the ground truth and less precise emphasis on the social and economic assistance distribution aspect highlighted in the original. Overall, the semantic meaning and strategic alignment are preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 485,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does Mastercard's introduction of Cyber and Intelligence Solutions, as part of its value-added services, influence the composition and recognition timing of its 'Other revenues' category in 2022?",
      "original_answer": "Mastercard introduced Cyber and Intelligence Solutions as part of its value-added services, which directly contributes to the 'Other revenues' category. This category includes fees from cyber and intelligence solutions offered to prevent fraud and ensure transaction safety. These revenues are recognized in the period when the related services are performed or transactions occur, thereby affecting the timing and composition of 'Other revenues' within Mastercard’s net revenue structure.",
      "llm_answer": "Mastercard's introduction of Cyber and Intelligence Solutions, as part of its value-added services, is reflected in the \"Other revenues\" category within net revenue. According to the disclosed revenue breakdown, \"Other revenues\" (which includes Cyber and intelligence solutions fees) increased from $4,124 million in 2019 to $4,717 million in 2020 and $6,224 million in 2021, indicating that the new service offerings contributed to this growth. These value-added services are recognized as revenue in the period they are performed or transactions occur, directly influencing the composition of \"Other revenues\" and requiring timely recognition of the associated income.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Cyber and Intelligence Solutions are part of value-added services and contribute to 'Other revenues', and that revenue is recognized when services are performed or transactions occur—this aligns with the ground truth and addresses the influence on composition and timing. However, the LLM introduces specific revenue figures for 2019 ($4,124 million), 2020 ($4,717 million), and 2021 ($6,224 million) that are not present in the original answer and cannot be verified from the provided ground truth. Since the question is about 2022, including prior-year data without grounding in the source misrepresents the evidence. (2) The quantitative values appear fabricated or misattributed, as the ground truth does not include any dollar amounts. This severely undermines quantitative accuracy. There are no calculations in the ground truth to validate the LLM's numbers. (3) The multi-hop reasoning is partially sound: the model correctly links the new service to 'Other revenues' and explains recognition timing. However, it adds unsupported numerical trends, suggesting growth due to the service without explicit confirmation from the ground truth. (4) The contextual relevance is high because the answer focuses on the right category, service, and accounting treatment. Qualitative accuracy is moderate because the conceptual framework is correct, but the inclusion of unverified figures reduces overall correctness. The correctness score is 6 due to accurate reasoning but significant factual overreach in unsupported numerical claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 436,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "What was the total change in fair value of CAT's Mortgage-Backed Debt Securities between December 31, 2022 and December 31, 2023, and how did this change compare to the change in unrealized losses on those securities over the same period?",
      "original_answer": "The total fair value of CAT's Mortgage-Backed Debt Securities decreased from $327 million at December 31, 2022 to $320 million at December 31, 2023, a decrease of $7 million. Meanwhile, unrealized losses on these securities increased from $31 million to $25 million, a decrease in unrealized losses of $6 million. This means that while the fair value slightly declined, the unrealized losses improved year-over-year.",
      "llm_answer": "The total change in the fair value of CAT's Mortgage-Backed Debt Securities between December 31, 2022 and December 31, 2023 was an increase of $123 million (from $123 million in unrealized losses at the end of 2022 to $0 in unrealized losses at the end of 2023). This change was larger than the corresponding change in unrealized losses on those securities, which decreased by $85 million over the same period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect. (1) Quantitatively, it states the fair value increased by $123 million, but the ground truth shows a decrease from $327 million to $320 million (a $7 million decrease). The LLM incorrectly claims unrealized losses went from $123 million to $0, while the actual unrealized losses decreased from $31 million to $25 million (a $6 million improvement in losses, meaning losses decreased, not eliminated). (2) The calculation of a $123 million increase in fair value and an $85 million decrease in unrealized losses has no basis in the provided data and contradicts the ground truth. (3) The multi-hop reasoning is completely flawed: the model fails to correctly identify the actual fair values and unrealized losses for the two years, and thus cannot synthesize the correct comparison. It fabricates numbers not present in the original answer. (4) The only relevant aspect is that it attempts to address both parts of the question (change in fair value and change in unrealized losses), so minimal contextual relevance is given. However, all factual content is wrong, resulting in a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 323,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "What is the total fair value of Qualcomm's corporate bonds and notes, and how does this compare to the fair value of U.S. Treasury securities and government-related securities as a percentage of the total marketable securities?",
      "original_answer": "Qualcomm's corporate bonds and notes have a total fair value of $4,634 million, while the fair value of U.S. Treasury securities and government-related securities is $208 million. The total marketable securities amount to $5,451 million. Therefore, corporate bonds and notes represent approximately 85% of the total marketable securities, whereas U.S. Treasury securities and government-related securities account for about 3.8% of the total marketable securities.",
      "llm_answer": "Based on the provided document pages, the total fair value of Qualcomm's corporate bonds and notes at September 29, 2024, was approximately $14.3 billion (as stated in Note 6 on page 79: \"At September 29, 2024, the aggregate fair value of the notes, based on Level 2 inputs, was approximately $14.3 billion\"). This represents the fair value of the corporate bonds and notes. The fair value of U.S. Treasury securities and government-related securities was $208 million (as shown in the fair value hierarchy table on page 84, where \"U.S. Treasury securities and government-related securities\" under \"Marketable securities\" totals $208 million). The total marketable securities were $5,451 million, so the corporate bonds and notes ($4,634 million) represent approximately 85% of the total marketable securities. However, the question asks for the percentage of the total marketable securities that the corporate bonds and notes represent, but the document does not explicitly state this percentage. The fair value of corporate bonds and notes ($14.3 billion) is not directly comparable to the total marketable securities ($5.451 billion) as they are measured on different bases (the $14.3 billion is the fair value of the debt securities within the broader marketable securities, but the $5.451 billion is the total fair value of all marketable securities including equities and other instruments). The document clarifies that the corporate bonds and notes are part of the marketable securities, but the percentage calculation cannot be precisely derived from the provided data without additional context. The key figure is that the fair value of the corporate bonds and notes was approximately $14.3 billion, and the U.S. Treasury securities and government-related securities were $208 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that the fair value of Qualcomm's corporate bonds and notes is $14.3 billion, citing Note 6 on page 79. However, the ground truth and correct data show this value is $4,634 million ($4.634 billion), not $14.3 billion. The $14.3 billion figure likely refers to the total debt or another aggregate, not the fair value of corporate bonds and notes within marketable securities. The fair value of U.S. Treasury and government-related securities is correctly identified as $208 million. The total marketable securities amount ($5,451 million) is correct. (2) Calculations: The LLM claims corporate bonds and notes represent approximately 85% of total marketable securities, which is correct (4,634 / 5,451 ≈ 85%), but it bases this on the wrong input number ($14.3B), making the reasoning invalid. The percentage for U.S. Treasury securities (3.8%) is correct (208 / 5,451 ≈ 3.8%), but the LLM does not compute or state this. (3) Multi-hop reasoning is flawed: The model fails to correctly synthesize the relationship between corporate bonds and total marketable securities. It incorrectly treats $14.3 billion as the fair value of corporate bonds and notes, which contradicts the ground truth and creates a fundamental error in logic. It also suggests the percentage cannot be derived, which is false—the data is present and used correctly in the original answer. (4) Scores are low due to major quantitative inaccuracy (wrong key number), flawed reasoning, and failure to correctly compute or report percentages despite having partial data. Contextual relevance is moderate because the model attempts to address the question and cites document sections, but the core financial data is wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1584,
        "completion_tokens": 483,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does MRK use pediatric market exclusivity to extend market protection for Keytruda beyond its compound patent expiration, and what financial impact could this have on the company's oncology revenue stream?",
      "original_answer": "MRK leverages six months of pediatric market exclusivity (as stated in evidence_source_a) to extend market protection for Keytruda beyond the expiration of its compound patent. Additionally, evidence_source_b explains that for drug candidates like Keytruda, the company may benefit from a future Patent Term Extension (PTE) of up to five years and/or six months of pediatric market exclusivity, depending on regulatory approvals. Since Keytruda is part of a global strategic oncology collaboration (mentioned in evidence_source_a), any extension of exclusivity directly impacts revenue by delaying generic competition and preserving market share in the oncology segment. This regulatory strategy enhances revenue predictability and supports long-term financial planning around one of MRK's key oncology products.",
      "llm_answer": "MRK leverages pediatric market exclusivity (up to six months) to extend protection for Keytruda beyond its compound patent expiration, securing additional revenue during the exclusivity period. This strategy enhances the oncology revenue stream by delaying generic competition, ensuring sustained high sales volumes and cash flow from Keytruda even after the core patent expires.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that MRK uses up to six months of pediatric market exclusivity to extend market protection for Keytruda beyond its compound patent expiration, which aligns with the ground truth. It also accurately describes the financial impact—delaying generic competition and sustaining sales and cash flow. However, the LLM omits mention of the potential for a future Patent Term Extension (PTE) of up to five years, which is part of MRK's broader regulatory strategy as noted in evidence_source_b. This is a minor omission affecting completeness but does not invalidate the core correctness. (2) Quantitatively, the 'six months' exclusivity period is correctly stated and matches the ground truth; no other numbers or calculations are involved. (3) The reasoning is sound in linking pediatric exclusivity to delayed generics and sustained revenue, demonstrating correct multi-hop synthesis between regulatory mechanisms and financial outcomes. However, the answer does not fully synthesize all evidence sources (missing PTE), slightly weakening the qualitative depth. (4) The answer is highly contextually relevant, directly addressing both how MRK extends protection and the resulting financial impact on oncology revenue. The omission of PTE reduces completeness but not core accuracy, justifying a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 381,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does the introduction of Mastercard Installments in 2022, as part of broader innovation efforts, support Mastercard's strategic goal of expanding digital payment services across multiple channels?",
      "original_answer": "The introduction of Mastercard Installments in 2022 directly supports Mastercard’s strategic goal of expanding digital payment services by offering a new open-loop buy-now-pay-later solution that connects lenders with merchants across the company's acceptance network. This aligns with Mastercard’s innovation focus on delivering better digital experiences everywhere, particularly through mobile and connected devices, as outlined in their 2022 10-K filing. Additionally, this initiative is part of a broader push to capture new payment flows and extend services, including multi-rail capabilities and digital currency solutions, which are key components of their strategy to diversify and strengthen their payments ecosystem.",
      "llm_answer": "The introduction of Mastercard Installments in 2022 expands the company’s digital payment services across multiple channels by adding a buy‑now‑pay‑later solution that leverages its open‑loop network, tokenization, AI‑driven fraud controls and integrated data analytics. This aligns with Mastercard’s strategic goal of scaling digital payments through new payment flows and innovative, secure checkout experiences.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in its core claims and aligns well with the ground truth. It accurately identifies the 2022 launch of Mastercard Installments and correctly frames it as a buy-now-pay-later solution on an open-loop network, which supports digital payment expansion across channels. The mention of tokenization, AI-driven fraud controls, and data analytics, while not explicitly stated in the original answer, are plausible components of Mastercard’s innovation stack and do not contradict the source; however, they are not directly supported by the provided ground truth, representing a minor addition beyond the documented evidence. The strategic alignment with scaling digital payments and creating innovative checkout experiences is consistent with the original answer’s emphasis on new payment flows and digital experiences. The answer omits some specific elements from the ground truth, such as the connection between lenders and merchants, the reference to mobile and connected devices, and the broader context of multi-rail and digital currency solutions. These omissions reduce completeness slightly but do not undermine the overall correctness. All entities (Mastercard, 2022, Mastercard Installments) and dates are accurate. There are no numerical inaccuracies (quantitative accuracy is perfect). The reasoning is sound and reflects appropriate multi-hop synthesis between product launch and strategic goals. The answer is highly contextually relevant and conveys the essential meaning, though not with full semantic equivalence due to partial omission of supporting details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 437,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "What portion of Merck's profit-sharing payments to Ridgeback Biotherapeutics LP were recorded within Cost of sales in 2024, given that profits from the Lagevrio collaboration were split equally between the partners?",
      "original_answer": "Merck's profit-sharing payments to Ridgeback Biotherapeutics LP that were recorded within Cost of sales in 2024 corresponded to 50% of the profits generated from the Lagevrio collaboration, as the agreement stipulates that profits are split equally between Merck and Ridgeback.",
      "llm_answer": "Based on the provided document pages, Merck records its share of profits from the Ridgeback Biotherapeutics LP collaboration within Cost of sales, and the profits from the Lagevrio collaboration are split equally between the partners. The summarized financial information for the Ridgeback collaboration (page 93) shows that Cost of sales for 2024 was $554 million, which includes Merck's share of profits paid to Ridgeback as part of the profit-sharing calculation. Therefore, the portion of Merck's profit-sharing payments to Ridgeback Biotherapeutics LP recorded within Cost of sales in 2024 was $554 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) The original question asks for the portion of Merck's profit-sharing payments to Ridgeback recorded in Cost of sales, which according to the ground truth is 50% of the profits from the Lagevrio collaboration, due to equal profit sharing. The LLM incorrectly states that the amount was $554 million, which is a misinterpretation of the financial data. There is no indication in the ground truth that $554 million represents the profit-sharing payment or Merck's share; this figure may represent total cost of sales or another aggregated item, but equating it directly to the profit-sharing payment lacks support. (2) The calculation or derivation of $554 million as the 'portion' of profit-sharing is not logically or factually justified. The ground truth does not provide any dollar amount for the payment—only the 50% split—so asserting a specific dollar figure constitutes a factual overreach. (3) While the LLM correctly identifies that profits are split equally and that the collaboration involves Lagevrio and Ridgeback, it fails to correctly synthesize that the 'portion' refers to a percentage (50%), not an absolute dollar amount. This reflects a failure in multi-hop reasoning: understanding that equal profit split implies each party receives 50%, and thus Merck’s payment to Ridgeback would be 50% of profits, recorded in Cost of sales. (4) The contextual relevance is moderate because the answer discusses the correct companies, collaboration, and financial statement line item, but the core factual response (dollar amount vs. percentage) is fundamentally misaligned with the question and ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 461,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does the Overseas Fund Regime (OFR) interact with BlackRock's European domicile structures to affect its ability to market funds in the UK, and what equivalence requirements must be met under this regime?",
      "original_answer": "Under the Overseas Fund Regime (OFR), BlackRock must ensure that the consumer protection regimes in EU countries where its funds are domiciled are found equivalent to the UK's regime in order to market those funds to UK retail investors. This requirement directly affects BlackRock's ability to distribute its European-domiciled funds in the UK market and may necessitate adjustments to its fund structures or compliance frameworks to meet UK regulatory expectations.",
      "llm_answer": "The Overseas Fund Regime (OFR) enables non‑UK funds to be marketed to UK retail investors only if the home‑country consumer‑protection regime is deemed equivalent to the UK’s by the FCA. Under the OFR, BlackRock must demonstrate that the regulatory framework governing its European‑domiciled funds provides an equivalent level of investor protection to that required of UK‑domiciled funds, and it must comply with ongoing UK conduct rules (e.g., Consumer Duty) and any additional FCA requirements for marketing to UK investors. Failure to meet these equivalence standards would restrict BlackRock’s ability to sell those funds in the UK.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies that under the Overseas Fund Regime (OFR), non-UK funds (including BlackRock's European-domiciled funds) can only be marketed to UK retail investors if the home jurisdiction's consumer protection regime is deemed equivalent to the UK’s by the FCA. This matches the original answer’s core claim about equivalence requirements affecting BlackRock’s distribution ability. The LLM adds valuable detail not in the original—specific reference to ongoing UK conduct rules like Consumer Duty and FCA marketing requirements—which enhances completeness without introducing error. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects proper multi-hop synthesis: connecting OFR rules → equivalence assessment → impact on BlackRock’s European fund structures → consequences for UK market access. The entities (OFR, BlackRock, European domicile, UK retail market) are correctly identified and logically linked. The only reason for not scoring a 10 in correctness and qualitative accuracy is that the original answer emphasizes the potential need for structural or compliance adjustments, which the LLM implies but does not explicitly state. However, this is a minor omission given the overall precision and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 388,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does Broadcom's (AVGO) internal manufacturing strategy for FBAR filters, as part of its RF semiconductor devices, support its competitive advantage in the cellular handset market?",
      "original_answer": "Broadcom's internal manufacturing strategy for FBAR filters enables it to protect its intellectual property and accelerate time to market, which directly supports its competitive advantage in the cellular handset market where FBAR technology holds significant market share.",
      "llm_answer": "Broadcom designs and manufactures FBAR filters in its own U.S. and Singapore facilities, which are the sole sources for these proprietary components. This vertical integration protects its IP, accelerates time‑to‑market, and ensures reliable, high‑performance RF filtering that is a key differentiator in cellular handset designs, strengthening its competitive position in the cellular RF semiconductor market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. It accurately captures Broadcom's internal manufacturing strategy for FBAR filters and its impact on competitive advantage. The key points—protection of intellectual property (IP), accelerated time-to-market, and competitive positioning in the cellular handset market—are all correctly identified and logically connected. The mention of U.S. and Singapore facilities adds contextual detail not in the original answer but is consistent with known Broadcom operations and does not contradict the ground truth. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects proper multi-hop synthesis: connecting internal manufacturing to IP protection, then to faster product development, and finally to market advantage in RF semiconductors for cellular handsets. The only minor deduction in qualitative accuracy is for slightly expanding on the original with facility locations without explicit sourcing, but this does not affect factual correctness. Overall, the answer is highly relevant, complete, and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 331,
        "total_tokens": 1511
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does Merck utilize both patent term extensions and regulatory exclusivity to maximize market protection for its biologic products, and what specific exclusivity durations are available in the U.S. for such products?",
      "original_answer": "Merck leverages both patent term extensions and regulatory exclusivity to extend market protection for its biologic products. In the U.S., regulatory data exclusivity for biologic products lasts 12 years from the date of first marketing approval. Additionally, if pediatric studies are completed, an extra six months of market exclusivity can be added. These mechanisms work together to provide extended market protection, allowing Merck to maintain exclusivity beyond the initial approval period and delay potential competition.",
      "llm_answer": "Merck maximizes market protection for its biologic products by combining patent term extensions (PTEs) with regulatory exclusivity periods. In the U.S., biologic products receive 12 years of marketing exclusivity under the BPCIA, and can also benefit from up to five years of PTE to offset time lost during FDA review, plus potential six-month pediatric exclusivity extensions. This dual-layer protection—extending beyond standard patent life—provides complementary market exclusivity that often lasts longer than patent protection alone.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Merck uses both patent term extensions (PTEs) and regulatory exclusivity to extend market protection for biologics, which aligns with the ground truth. It accurately states the 12-year U.S. regulatory exclusivity period under the BPCIA and the additional six-month pediatric exclusivity, both of which are factually correct. However, it introduces the claim that up to five years of PTE can be applied to biologics, which is not supported by the ground truth and is misleading—PTE under 35 U.S.C. §156 typically applies to small-molecule drugs, not biologics, which are primarily protected by 12-year data exclusivity and patent life, not PTE. This is a significant factual inaccuracy. (2) Quantitative accuracy: The 12-year exclusivity and +6 months are correct. The 'up to five years of PTE' is incorrect in this context—no such standard PTE exists for biologics under BPCIA; this is a carryover from small-molecule drug rules. Thus, one key number is factually wrong. (3) Reasoning: The multi-hop synthesis of combining patent and regulatory exclusivity is sound and reflects correct strategic understanding. The logic of layered protection is valid and well-articulated. However, the inclusion of PTE for biologics reflects a category error in regulatory frameworks. (4) Correctness score is 8 because core facts (12-year exclusivity, pediatric extension) are correct and the overall strategy is well-explained, but the erroneous inclusion of PTE for biologics reduces accuracy. Quantitative accuracy is 7 due to the incorrect PTE claim. Qualitative accuracy is 9—reasoning and entity identification (Merck, BPCIA, exclusivity types) are strong. Contextual relevance is 10—fully addresses the question’s scope and intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 484,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How do the 2024 reforms to the UK Stewardship Code, as outlined in BlackRock's 2024 10-K filing, potentially affect BlackRock's client engagement and compliance costs in its UK operations?",
      "original_answer": "The 2024 reforms to the UK Stewardship Code, as outlined in BlackRock's 10-K filing, introduce tailored reporting requirements for proxy advisers and investment consultants. These changes may increase BlackRock's compliance costs and necessitate adjustments to its stewardship activities on behalf of clients. Since BlackRock's UK subsidiaries are subject to rigorous conduct regulation, including the Consumer Duty rules, failure to meet the FCA's expectations regarding these new stewardship reporting obligations could expose BlackRock to regulatory sanctions, reputational risk, and potential client asset withdrawals, thereby impacting client engagement and operational efficiency.",
      "llm_answer": "The 2024 UK Stewardship Code reforms, as highlighted in BlackRock’s 2024 10‑K filing, introduce tailored reporting obligations for proxy advisers and investment consultants that could alter the way BlackRock engages with clients on stewardship matters. These new requirements are likely to increase compliance costs and operational complexity in the UK, as BlackRock must adjust its client‑engagement processes and documentation to meet the revised standards.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and captures the core elements of the original answer. It correctly identifies the 2024 UK Stewardship Code reforms, their focus on tailored reporting obligations for proxy advisers and investment consultants, and the potential impact on BlackRock's compliance costs and client engagement processes. The date (2024) and entities (BlackRock, UK Stewardship Code, FCA implicitly via context) are correct, and there are no numerical inaccuracies (no calculations or specific figures were involved, so quantitative accuracy is scored as 10). The reasoning is sound and reflects multi-hop understanding by linking regulatory changes to operational and client engagement implications. However, the LLM answer omits key details present in the ground truth: specifically, the mention of Consumer Duty rules, the risk of regulatory sanctions, reputational damage, and potential client asset withdrawals. These omissions reduce completeness and slightly weaken the qualitative accuracy, as they represent important downstream risks emphasized in the original. Despite this, the answer remains semantically aligned with the main thrust of the original and fully addresses the question's focus on client engagement and compliance costs. Contextual relevance is perfect, as all content directly pertains to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 372,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What was the dollar increase in depreciation and amortization expenses for the AspenTech segment from fiscal 2021 to 2022, and how does the Heritage AspenTech acquisition directly factor into this change according to the evidence provided?",
      "original_answer": "The depreciation and amortization expenses for the AspenTech segment increased by $147 million (from $95 million in fiscal 2021 to $242 million in fiscal 2022). The Heritage AspenTech acquisition directly factors into this change because it is explicitly stated that the increase in backlog for the AspenTech segment in fiscal 2022 is related to this acquisition, which would lead to the recognition of additional intangible assets requiring amortization.",
      "llm_answer": "The dollar increase in depreciation and amortization expenses for the AspenTech segment from fiscal 2021 to 2022 was $147 million (rising from $95 million in 2021 to $242 million in 2022). This increase is directly attributable to the Heritage AspenTech acquisition, which created the combined AspenTech business and added the additional amortization expense reflected in the 2022 figures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the dollar increase in depreciation and amortization expenses as $147 million, rising from $95 million in fiscal 2021 to $242 million in fiscal 2022, which matches the ground truth exactly. All numeric values are accurate and properly formatted. (2) The calculation is correct: $242M - $95M = $147M, and the fiscal years are accurately referenced. (3) The reasoning correctly attributes the increase to the Heritage AspenTech acquisition, noting that it led to additional amortization expenses in 2022. While the LLM does not explicitly mention the 'backlog' or 'intangible assets' as the mechanism (as stated in the ground truth), it correctly infers the causal link between the acquisition and increased amortization, which is the core of the multi-hop reasoning. (4) The answer is factually correct, contextually relevant, and conveys the same essential information as the original answer. The minor omission of the specific mechanism (intangible assets from backlog) prevents a perfect 10 on qualitative accuracy, but the overall reasoning is sound and semantically equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 322,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What was the year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region, and what percentage did this region contribute to the total global growth in this business segment?",
      "original_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $24 million ($744 million in Fiscal Year 2022 from $720 million in Fiscal Year 2021). This regional increase contributed approximately 0.35% to the total global growth in the Subscriptions and Services segment, which grew by $362 million (from $6,564 million to $6,926 million).",
      "llm_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $140 million (from $581 million in fiscal 2021 to $721 million in fiscal 2022). This segment contributed approximately 35 % of the total global growth in the Subscriptions and Services business.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in all key numeric values. The year-over-year increase is stated as $140 million, but the ground truth is $24 million. The reported regional revenues are $581M (2021) and $721M (2022), whereas the correct figures are $720M and $744M, respectively. The contribution to global growth is reported as 35%, but the correct value is 0.35%, a two-order-of-magnitude error. (2) Calculations: The LLM incorrectly computes the regional increase ($721M - $581M = $140M) using wrong inputs. The global segment growth is $362M (from $6,564M to $6,926M), so $24M / $362M ≈ 6.63%, but the ground truth states 0.35%, suggesting either a different calculation or data source; however, the LLM’s 35% is off by a factor of 100, likely due to misplacing a decimal. (3) Multi-hop reasoning: The model fails to correctly synthesize data across fiscal years and regions. It uses incorrect base figures for Asia Pacific and miscalculates both the regional growth and its proportional contribution to global growth. (4) Scores justified: Correctness is 1 due to pervasive factual and numerical errors. Quantitative accuracy is 1 because all numbers and calculations are wrong. Qualitative accuracy is 1 as the reasoning is fundamentally flawed. Contextual relevance is 3 because the answer addresses the right question structure (growth and contribution) but with entirely incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 396,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How do the 2023 joint merger guidelines issued by the FTC and DOJ negatively impact BlackRock's ability to expand through acquisitions and affect funds engaging in HSR-reportable transactions?",
      "original_answer": "The 2023 joint merger guidelines issued by the FTC and DOJ increase regulatory scrutiny and impose additional compliance burdens on transactions reportable under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976. These guidelines could negatively impact BlackRock’s ability to expand through strategic investments or acquisitions by making such transactions more costly, complex, and time-consuming. Additionally, funds engaging in HSR-reportable transactions may face increased pre-merger notification expenses and potential transaction delays due to the expanded information and documentation requirements introduced alongside the new guidelines.",
      "llm_answer": "The 2023 joint merger guidelines issued by the FTC and DOJ, which require expanded pre‑merger notifications and increase filing costs and delays under the Hart‑Scott‑Rodino Act, could impede BlackRock’s ability to grow through acquisitions, while the heightened scrutiny also applies to funds undertaking HSR‑reportable transactions, potentially limiting their capacity to complete such deals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All entities are correct: FTC, DOJ, BlackRock, HSR-reportable transactions, and the 2023 joint merger guidelines are accurately referenced. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2023) are correct. (3) The multi-hop reasoning is sound: the model correctly links the updated merger guidelines to increased regulatory scrutiny, expanded notifications, higher costs, and delays under the HSR Act, and appropriately applies this to both BlackRock’s acquisition strategy and funds involved in reportable transactions. (4) The answer is contextually relevant and fully addresses the question. The only minor limitation is slight brevity compared to the original answer—phrases like 'additional compliance burdens' and 'expanded information and documentation requirements' from the ground truth are implied but not explicitly stated. However, the core meaning, including the impact on cost, complexity, and timing, is preserved. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 350,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does Goldman Sachs' use of both stock-settled and cash-settled Non-Employee Director RSU Award Agreements influence its accounting treatment and financial statement classification?",
      "original_answer": "Goldman Sachs uses two forms of Non-Employee Director RSU Award Agreements: one that is stock-settled (Form 10.8 referenced in evidence_source_a) and another that is cash-settled (Form 10.32 referenced in evidence_source_b). These differing settlement terms directly affect accounting treatment — stock-settled RSUs are classified as equity instruments, while cash-settled RSUs are classified as liability instruments under GAAP. This distinction impacts both the timing and measurement of compensation expense, with liability-classified awards requiring remeasurement at each reporting date until settlement.",
      "llm_answer": "Goldman Sachs discloses in its 10‑K that it awards Non‑Employee Director RSUs under two distinct agreements – a pre‑2015 “stock‑settled” RSU award agreement and a newer “cash‑settled” RSU award agreement (see Exhibits 10.31 and 10.32). Because the cash‑settled awards are settled in cash rather than shares, they are recorded as a cash‑based compensation liability and expensed on a straight‑line basis, while the stock‑settled awards are accounted for as equity awards with no cash‑settlement liability. Consequently, the two award types are classified differently in the financial statements: stock‑settled RSUs appear in equity (additional paid‑in capital) and are excluded from the liability section, whereas cash‑settled RSUs are recorded as a liability (accrued compensation) and are reflected in the cash‑flow statement as cash‑settlement payments. This dual‑structure allows the firm to manage the timing and classification of compensation expense across its consolidated income statement and balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Goldman Sachs uses both stock-settled and cash-settled Non-Employee Director RSU agreements, with distinct accounting treatments. The LLM correctly identifies that stock-settled RSUs are equity-classified and cash-settled RSUs are liability-classified under GAAP. It accurately describes the financial statement impact—equity classification for stock-settled (affecting additional paid-in capital) and liability classification for cash-settled (recorded in accrued compensation), along with cash flow implications. (2) There are no numeric values in the question or answer requiring verification, so quantitative accuracy is not applicable in a traditional sense, but all references to financial metrics and classifications are factually sound. (3) The multi-hop reasoning is strong: the model synthesizes the existence of two distinct award types (referencing Exhibits 10.31 and 10.32, though evidence_source_a and evidence_source_b in the ground truth reference Forms 10.8 and 10.32—minor discrepancy in exhibit numbering, but contextually acceptable as filing exhibits may be renumbered over time). The reasoning correctly links settlement method (stock vs. cash) to accounting classification (equity vs. liability), and further to financial statement presentation and expense recognition. (4) The only minor shortcoming is that the LLM mentions 'Exhibits 10.31 and 10.32' while the ground truth references 'Form 10.8' and 'Form 10.32'—a slight inconsistency in exhibit labeling, possibly due to version differences, but not materially affecting the correctness. Otherwise, the answer is semantically equivalent, comprehensive, and contextually precise, fully addressing the question on accounting treatment and classification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 496,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How many shares were granted in the form of restricted stock units under the Abbott Laboratories 2017 Incentive Stock Program in 2023, and what specific vesting condition is mentioned for these units in the program documentation?",
      "original_answer": "In 2023, Abbott granted 4,981,231 restricted stock units under the 2017 Incentive Stock Program. These restricted stock units vest over three years, and upon vesting, the recipient receives one share of Abbott stock for each vested unit.",
      "llm_answer": "In 2023, Abbott granted **4,981,231 restricted stock units** under the 2017 Incentive Stock Program. These RSUs **vest over three years and upon vesting, each unit entitles the recipient to one share of Abbott stock**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the number of restricted stock units granted in 2023 — 4,981,231 — is accurate and matches the original answer exactly. (2) The vesting condition is correctly described: the units vest over three years, and each vested unit results in one share of Abbott stock, which aligns precisely with the program documentation. (3) The reasoning is sound and reflects proper synthesis of multi-hop information from the Abbott Laboratories 2017 Incentive Stock Program and its implementation in 2023. (4) The answer is contextually complete and directly addresses both parts of the question — the quantity of RSUs granted and the specific vesting condition. Wording differs slightly (e.g., 'entitles the recipient' vs 'the recipient receives') but the semantic meaning is equivalent. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1134,
        "completion_tokens": 267,
        "total_tokens": 1402
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "What percentage of Danaher's 2024 Life Sciences segment sales came from regions outside North America and Western Europe, and how does this geographic distribution reflect the long-term strategic impact of acquiring Leica Microsystems in 2005?",
      "original_answer": "Danaher's Life Sciences segment generated 28% of its 2024 sales from high-growth markets and 7% from other developed markets, totaling 35% from regions outside North America (44%) and Western Europe (21%). This geographic diversification reflects the long-term strategic impact of acquiring Leica Microsystems in 2005, which served as the foundational platform for expanding the Life Sciences business through subsequent acquisitions such as Beckman Coulter (2011), Pall (2015), and Abcam (2023), enabling broader global reach and integration of complementary technologies.",
      "llm_answer": "Based on the Life Sciences segment sales breakdown on page 104, 28 % of 2024 Life Sciences sales came from regions outside North America and Western Europe (high‑growth markets accounted for 28 %). This geographic mix reflects the long‑term strategic impact of the 2005 Leica Microsystems acquisition, which gave Danaher a strong foothold in Europe and other growth markets and has since been expanded through additional acquisitions (e.g., AB Sciex, Beckman Coulter, Pall, etc.) to build a global life‑sciences platform that now generates a substantial share of revenue from high‑growth regions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that 28% of Danaher's 2024 Life Sciences sales came from high-growth markets, which aligns with the ground truth. However, it incorrectly states that this 28% represents *all* sales from regions outside North America and Western Europe, omitting the additional 7% from other developed markets. The correct total is 35% (28% + 7%), which the LLM fails to calculate or mention. This is a significant quantitative error. (2) The ground truth specifies that North America accounted for 44% and Western Europe for 21%, totaling 65% from these two regions, hence the remaining 35% from elsewhere. The LLM does not reference these component percentages or perform the correct synthesis. (3) The qualitative reasoning about the strategic impact of the 2005 Leica Microsystems acquisition is sound and consistent with the ground truth: it correctly identifies Leica as a foundational acquisition that enabled global expansion through follow-on deals like Beckman Coulter and Pall. The mention of AB Sciex (though not in the ground truth) does not detract significantly, as it is a plausible addition. (4) Contextually, the answer is highly relevant and addresses both parts of the question—geographic distribution and strategic impact—though with incomplete data. The reasoning chain is logical and reflects multi-hop understanding, but the failure to accurately report the full 35% figure from non-core regions reduces factual correctness. Quantitative accuracy is penalized due to the omission of the 7% component and incorrect aggregation, warranting a 6. Qualitative and contextual scores are higher due to strong strategic interpretation and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 463,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "What is the total number of acquisitions Danaher has made in the Life Sciences segment since its establishment in 2005, including the year of acquisition for Pall and the most recent acquisition mentioned in the filing?",
      "original_answer": "Danaher has made 8 acquisitions in the Life Sciences segment since its establishment in 2005. These include: Leica Microsystems (2005), AB Sciex and Molecular Devices (2010), Beckman Coulter (2011), Pall (2015), Phenomenex (2016), IDT (2018), Aldevron (2021), and Abcam (2023).",
      "llm_answer": "Danaher has made 10 acquisitions in the Life Sciences segment since its establishment in 2005, including the 2015 acquisition of Pall and the most recent acquisition of Abcam in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Danaher made 10 acquisitions, while the ground truth confirms 8 acquisitions since 2005. This is a major factual error affecting the core of the question. (2) The dates for Pall (2015) and Abcam (2023) are correct, which are key checkpoints in the question. However, the total count is wrong, and no other acquisitions are listed to verify completeness. The number '10' is unsupported by the ground truth and contradicts the known list. (3) The multi-hop reasoning is partially sound in that the model identifies Pall and Abcam with correct years, showing it can extract specific acquisition events. However, it fails to accurately synthesize the full list of Life Sciences acquisitions, either overcounting or including acquisitions not in the segment or timeframe. (4) The contextual relevance is high because the answer addresses the question format correctly, mentions the required anchor points (Pall in 2015, Abcam in 2023), and stays focused on Danaher's Life Sciences acquisitions. However, the incorrect total count severely undermines factual correctness. Quantitative accuracy is low due to the incorrect number of acquisitions. Qualitative accuracy is slightly higher because some entities and years are correct, but reasoning fails on completeness and synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1133,
        "completion_tokens": 371,
        "total_tokens": 1504
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "What was the change in the fair value of Abbott's interest rate hedge contracts between December 31, 2020 and December 31, 2021, and how does this reflect the fluctuation in their receivable position for these contracts during the same period?",
      "original_answer": "The fair value of Abbott's interest rate hedge contracts decreased from $210 million on December 31, 2020, to $87 million on December 31, 2021, representing a decline of $123 million. This change is consistent with the drop in the receivable position for these contracts, which also fell from $210 million to $87 million over the same period, indicating a significant reduction in Abbott's exposure or valuation of these hedges.",
      "llm_answer": "The fair value of Abbott's interest rate hedge contracts decreased from $87 million at December 31 2020 to $210 million at December 31 2021 (a $123 million gain recognized in interest expense), reflecting a $123 million increase in the fair value of the hedged fixed‑rate debt that offset the hedge’s effect. This change corresponds to the $123 million gain recorded in interest expense for 2021, which represents the net impact of marking the interest‑rate swaps to market and adjusting the carrying amount of the hedged debt.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in both direction and magnitude of the change in fair value. The ground truth states that the fair value decreased from $210 million on December 31, 2020, to $87 million on December 31, 2021 — a decline of $123 million. However, the LLM incorrectly states the fair value increased from $87 million to $210 million, reversing the years and implying a gain instead of a loss. This error completely inverts the factual outcome. (2) The numbers themselves ($87M and $210M) are correct in value but are assigned to the wrong years, making the calculation of a $123 million 'gain' erroneous. The actual change is a $123 million decrease, not an increase. Additionally, the LLM introduces a claim about a 'gain recognized in interest expense' and changes in hedged debt that are not mentioned or supported in the original answer, adding incorrect qualitative interpretation. (3) The multi-hop reasoning fails because the model misaligns the time series data, preventing accurate synthesis of how the change in fair value relates to the receivable position. The original answer notes that both fair value and receivable position moved in tandem from $210M to $87M, showing reduced exposure. The LLM not only reverses this trend but fabricates an explanation involving debt valuation and income statement impacts not present in the source. (4) Due to the complete reversal of the financial movement and introduction of unsupported details, the correctness and quantitative accuracy scores are very low. Contextual relevance is slightly higher because the answer discusses relevant concepts (fair value, interest rate hedges, receivables, marking to market), but the factual foundation is invalid.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 474,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How does BMY's strategic focus on expanding its autologous CAR-T cell therapy pipeline, including new indications for Breyanzi, align with the observed doubling of U.S. revenues for Breyanzi in 2023?",
      "original_answer": "BMY's 2023 strategy emphasized expanding its autologous CAR-T cell therapy franchise, including pursuing new indications for Breyanzi such as CLL, FL, and MCL, which aligns with the doubling of U.S. revenues for Breyanzi due to higher demand. This strategic investment in cell therapy innovation and expansion into new treatment areas is directly reflected in the significant revenue growth of Breyanzi.",
      "llm_answer": "BMY's strategic focus on expanding its autologous CAR‑T pipeline—evidenced by plans to broaden Breyanzi into new indications such as CLL, FL and MCL—directly supports the observed doubling of U.S. Breyanzi revenues in 2023, as the company is actively growing demand for this therapy through both label extensions and increased manufacturing capacity. This aligns with the broader strategy outlined on page 43 of pursuing pipeline expansion and leveraging its differentiated CAR‑T platform to drive near‑term growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All key elements are correct: BMY's strategic focus on expanding the autologous CAR-T pipeline, specifically Breyanzi's expansion into new indications (CLL, FL, MCL), and the doubling of U.S. revenues in 2023 are accurately reflected. (2) There are no numeric inaccuracies—'doubling of U.S. revenues' is correctly stated and consistent with the original answer; no calculations are required beyond this qualitative description of growth. (3) The multi-hop reasoning is sound: the model correctly links BMY’s strategic actions (pipeline expansion, label extensions, manufacturing capacity) to the observed revenue growth, demonstrating synthesis between strategic intent and financial outcome. The mention of 'page 43' adds contextual support from the source document, enhancing credibility. (4) Semantic equivalence is strong—the LLM captures the core causal relationship between pipeline expansion and revenue growth. The only minor limitation is that the original answer explicitly states this reflects 'higher demand,' while the LLM attributes growth to both label extensions and manufacturing capacity; this is a reasonable inference but slightly extends beyond the direct causality in the ground truth. Hence, a score of 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 391,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What was the total cash outflow for the acquisition of The Binding Site Group in 2023, and how did it contribute to the total cash used for acquisitions in 2023, including CorEvitas, LLC?",
      "original_answer": "The total cash outflow for the acquisition of The Binding Site Group in 2023 was $2.70 billion. This, combined with the $0.91 billion used for the acquisition of CorEvitas, LLC, contributed to a total of $3.61 billion in cash used for acquisitions during 2023.",
      "llm_answer": "The total cash outflow for the acquisition of The Binding Site Group in 2023 was $2.70 billion, and it contributed $2.70 billion of the total cash used for acquisitions in 2023, which also included the $0.91 billion cash outflow for CorEvitas, LLC.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information is accurate: the cash outflow for The Binding Site Group is correctly stated as $2.70 billion, and the outflow for CorEvitas, LLC is accurately given as $0.91 billion. (2) Quantitative accuracy is perfect: both individual amounts match the ground truth, and while the total ($3.61 billion) is not explicitly calculated in the LLM answer, it is implied by stating the two components that sum to that total, which is sufficient for completeness. (3) The multi-hop reasoning is sound—the model correctly identifies both acquisitions, associates the correct cash outflows, and contextualizes The Binding Site Group's contribution within the total acquisition spending. (4) Entity names, years (2023), and financial metrics (cash outflow, acquisitions) are all correctly identified and used. The answer is concise, relevant, and conveys the same information as the original with no omissions or distortions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 289,
        "total_tokens": 1427
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "What is the total estimated annual cost savings from restructuring charges incurred in 2024 and 2023, and how does the acquisition of The Binding Site Group in 2023 contribute to the Specialty Diagnostics segment's strategic growth in blood cancer diagnostics?",
      "original_answer": "The restructuring charges incurred in 2024 and 2023 are expected to yield total estimated annual cost savings of $0.8 billion ($0.2 billion from 2024 charges and $0.6 billion from 2023 charges). The acquisition of The Binding Site Group in 2023 enhances the Specialty Diagnostics segment's portfolio by adding pioneering diagnostic assays and instruments for blood cancers, specifically multiple myeloma, aligning with the company's strategy of high-impact innovation and expanding its capabilities in specialty diagnostics.",
      "llm_answer": "The total estimated annual cost savings from the 2024 restructuring charges is approximately $200 million, reflecting the charges projected for 2025 and beyond. The 2023 acquisition of The Binding Site Group expands Thermo Fisher’s Specialty Diagnostics portfolio with pioneering assays and instruments for blood‑cancer diagnosis and monitoring, strengthening the segment’s strategic growth in blood‑cancer diagnostics.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $200 million in estimated annual cost savings from the 2024 restructuring charges, which matches the ground truth. However, it omits the $600 million in savings from the 2023 restructuring charges, which is a significant missing component of the total $0.8 billion. The total estimated annual cost savings should be $800 million ($200M + $600M), but this synthesis is not performed, nor mentioned. (2) The quantitative accuracy is compromised due to the omission of the 2023 savings figure. While the $200 million for 2024 is correct, the absence of the $0.6 billion from 2023 results in a partial and incomplete quantitative response. The acquisition year (2023) is correctly stated. (3) The qualitative reasoning is sound regarding the acquisition of The Binding Site Group: it correctly identifies the strategic value in expanding the Specialty Diagnostics portfolio with blood cancer diagnostics, particularly assays and instruments, and links it to strategic growth. This reflects accurate multi-hop reasoning between the acquisition and its impact on the segment. (4) Contextual relevance is high—the answer stays focused on the question, uses appropriate terminology, and addresses both parts, albeit incompletely. The omission of the 2023 cost savings, however, significantly affects the correctness score, as the total cost savings figure is a core requirement of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 399,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "What is the longest-term debt instrument listed in Eli Lilly's 2023 10-K filing, and how does its maturity year compare to the other debt instruments listed in the same filing?",
      "original_answer": "The longest-term debt instrument listed in Eli Lilly's 2023 10-K filing is the 1.375% Notes due 2061. This instrument matures in 2061, which is significantly later than the other debt instruments listed, such as the 0.500% Notes due 2033 and the 1.125% Notes due 2051.",
      "llm_answer": "The longest-term debt instrument listed in Eli Lilly’s 2023 10‑K filing is the 1.375 % Notes due 2061. Its maturity in 2061 extends beyond the other noted instruments, which include the 0.500 % Notes due 2033, the 1.625 % Notes due 2043, and the 1.125 % Notes due 2051.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the longest-term debt instrument as the 1.375% Notes due 2061, matching the ground truth exactly in terms of name, interest rate, and maturity year. The maturity year (2061) is accurately compared to other debt instruments: the 0.500% Notes due 2033 and the 1.125% Notes due 2051 are both mentioned in the original answer, and the LLM adds the 1.625% Notes due 2043, which does not contradict the ground truth but provides additional detail likely present in the 10-K. All numeric values—percentages and years—are correct, satisfying quantitative accuracy. The reasoning is sound: the LLM correctly infers that 2061 is the latest maturity date and compares it appropriately. The only minor deviation is that the original answer emphasizes the 'significantly later' aspect, while the LLM states the facts without commentary, but this does not reduce factual accuracy. The answer is semantically equivalent and fully addresses both parts of the question: identifying the longest-term instrument and comparing its maturity to others. Thus, the response is highly accurate with no factual errors, warranting a 9/10 for correctness and qualitative accuracy due to slightly expanded detail not in the original, but not at the expense of correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1141,
        "completion_tokens": 356,
        "total_tokens": 1498
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "What is the total number of distinct indications for which Donanemab is under development or review, and how does this compare to the number of indications for which Lebrikizumab has received approval or is under regulatory review?",
      "original_answer": "Donanemab is under development or review for two distinct indications: early Alzheimer's disease and preclinical Alzheimer's disease. Lebrikizumab has received approval for atopic dermatitis in the EU and Japan, and is under regulatory review in the U.S. for the same indication, making it one approved or under review indication. Therefore, Donanemab is being developed for more indications than Lebrikizumab.",
      "llm_answer": "Donanemab is currently under regulatory review for the treatment of early Alzheimer’s disease in the U.S., the EU, and Japan, representing three distinct indications. Lebrikizumab has received regulatory approval in the EU (2023) and Japan (2024) and is under review in the U.S. for atopic dermatitis, resulting in two distinct indications (EU and Japan approved, U.S. pending).",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Donanemab is under review for early Alzheimer’s disease in the U.S., EU, and Japan as three distinct indications. However, the ground truth specifies that Donanemab is under development for two distinct indications—early Alzheimer’s disease and preclinical Alzheimer’s disease—not three geographic regions. Indications refer to disease stages or types, not regulatory jurisdictions. Similarly, the LLM mischaracterizes Lebrikizumab’s status by implying that approvals in the EU and Japan plus U.S. review constitute two distinct indications, when in fact it is one indication (atopic dermatitis) under regulatory action across multiple regions. (2) Quantitatively, the LLM reports incorrect counts: it says Donanemab has three indications (should be two) and Lebrikizumab has two (should be one), leading to an incorrect comparison. Dates (2023 EU approval, 2024 Japan approval) are plausible but not confirmed in the ground truth, which does not include specific years. (3) The multi-hop reasoning is flawed because the model fails to correctly interpret 'indications' as disease-related uses rather than regulatory submissions by region. This undermines the synthesis required to compare the number of indications across drugs. (4) Despite these errors, the answer is contextually relevant—addressing both drugs and their development statuses—and shows an attempt at structured comparison. However, due to fundamental errors in entity interpretation and quantitative accuracy, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 440,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did the decline in Alimta's revenue in the U.S. in 2023, caused by the entry of generics, impact the overall U.S. volume growth, and what other oncology product contributed positively to volume growth in the U.S.?",
      "original_answer": "The decline in Alimta's revenue in the U.S. in 2023, due to the entry of multiple generics in the first half of 2022, negatively impacted the overall U.S. volume growth. However, this was partially offset by strong performance from other oncology products such as Verzenio and Trulicity, which contributed positively to U.S. volume growth.",
      "llm_answer": "The decline in Alimta revenue in the U.S. in 2023, driven by generic entry, negatively impacted overall U.S. volume growth, contributing to a 11% increase in volume that was offset by the loss of Alimta sales. However, volume growth was positively driven by other oncology products, particularly Verzenio, which contributed to the 11% U.S. volume growth reported for 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the decline in Alimta's revenue due to generic entry negatively impacted U.S. volume growth and that other oncology products like Verzenio contributed positively. However, it introduces a specific quantitative claim—'11% increase in volume'—that is not present in the original answer and cannot be verified from the ground truth. This number may be inaccurate or misleading, as the original answer does not provide any percentage for volume growth. (2) The quantitative inaccuracy is significant: the LLM fabricates a precise figure (11%) and incorrectly frames Alimta's decline as being 'offset by the loss of Alimta sales,' which is illogical—losses don't offset increases. It also claims Verzenio contributed to the 11% growth, adding specificity not supported by the original. (3) The multi-hop reasoning is partially sound: the model correctly links Alimta's generic competition to revenue decline and identifies Verzenio as a positive contributor. However, it incorrectly includes Trulicity in the LLM answer as an oncology product contributing to growth, which is factually incorrect—Trulicity is a diabetes drug, not an oncology product, reducing entity accuracy. (4) The contextual relevance is high because the answer addresses both parts of the question and maintains focus on U.S. volume dynamics. Qualitative accuracy is moderate due to correct reasoning structure but flawed entity identification. Correctness score is reduced primarily due to the unsupported numerical claim and the inclusion of an incorrect product (Trulicity) in the oncology category, despite mentioning Verzenio correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 453,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How much total financial commitment and shared development cost has Merck incurred or anticipated in relation to V940 (mRNA-4157), and how does this tie into Merck's broader immuno-oncology strategy as outlined in its 2023 10-K filing?",
      "original_answer": "Merck incurred a $250 million payment in 2022 upon exercising its option to jointly develop and commercialize V940 (mRNA-4157) with Moderna. Additionally, Merck is sharing development costs equally with Moderna for this investigational individualized neoantigen therapy, which is being evaluated in combination with Keytruda in multiple Phase 3 clinical trials. This commitment aligns with Merck's immuno-oncology strategy, which includes V940 (mRNA-4157) as a key program being tested in the INTerpath-001 and INTerpath-002 trials for melanoma and NSCLC, respectively. The therapy has received Breakthrough Therapy and PRIME designations, underscoring its strategic importance in Merck's oncology pipeline.",
      "llm_answer": "Based on the 2023 10-K filing, Merck has incurred or anticipates a total financial commitment of **$4.0 billion in upfront payments plus $1.5 billion in continuation payments** related to its collaboration with Moderna for V940 (mRNA-4157), with an additional **$250 million option payment** recognized in 2022. This commitment ties directly into Merck's broader immuno-oncology strategy, as V940 is being developed as an individualized neoantigen therapy **in combination with Keytruda** for adjuvant treatment of high-risk melanoma and NSCLC, aligning with Merck's strategic pillar of advancing immuno-oncology through novel therapeutic modalities and partnerships.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in the financial figures. The ground truth states that Merck made a $250 million payment in 2022 upon exercising its option and is equally sharing development costs with Moderna. However, the LLM claims a $4.0 billion upfront and $1.5 billion continuation payments, which are not supported by the original answer or typical public disclosures related to this collaboration. These figures appear fabricated or misattributed. Only the $250 million option payment is correct and aligns with the ground truth. (2) Quantitative accuracy is severely compromised: the $4.0B + $1.5B = $5.5B total commitment is entirely incorrect and not mentioned in the ground truth. There is no indication in the original answer of such large-scale payments. The 2022 $250 million payment is correctly cited. (3) Qualitatively, the LLM captures some correct strategic context: V940 is being developed with Keytruda for melanoma and NSCLC, and this fits within Merck’s immuno-oncology strategy. Mention of combination therapy and strategic partnerships is relevant and semantically aligned. However, it omits key details such as the Phase 3 trials (INTerpath-001 and INTerpath-002), Breakthrough Therapy and PRIME designations, and the fact that V940 is an individualized neoantigen therapy co-developed under a 50/50 cost-sharing arrangement. (4) Contextual relevance is moderate—the response addresses the broader immuno-oncology strategy and ties in Keytruda and development focus areas, but the massive overstatement of financial commitment undermines the factual foundation. The reasoning fails the multi-hop requirement by introducing unsupported financial data instead of synthesizing the actual disclosed payment and cost-sharing structure. Overall, while the strategic framing is partially correct, the critical financial facts are wrong, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 520,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How many additional years of U.S. patent protection could MK-7962 (sotatercept) receive beyond the standard biologic data exclusivity period, based on the disclosed expiration year and the stated patent expiration date?",
      "original_answer": "MK-7962 (sotatercept) is eligible for 12 years of data exclusivity upon approval in the U.S., and its granted patents covering methods of treatment will expire in 2037. If the product receives approval in 2027, as indicated by the anticipated expiration year, then it could receive an additional 10 years of protection beyond the standard exclusivity period.",
      "llm_answer": "Based on the provided document, MK-7962 (sotatercept) is projected to have a patent expiration in 2037 (as stated in the \"Under Review in the U.S.\" table on page 16), while its standard biologic data exclusivity period is 12 years from approval. This means the patent protection could extend beyond the data exclusivity by up to 20 years (2037 - 12 = 21 years), though the question specifically asks for the *additional years* beyond the standard 12-year data exclusivity. The document confirms that granted patents covering methods of treating pulmonary arterial hypertension with MK-7962 expire in 2037, and data exclusivity has been granted in the U.S. and expires in July 2033 (page 15), but the patent expiration year (2037) is the key reference for the extended protection. Thus, the patent could provide up to 25 additional years of exclusivity beyond the standard 12-year data period (2037 - 12 = 25), but the document does not explicitly state the exact \"additional years\" figure—only the expiration year (2037) and the 12-year data exclusivity. The most precise answer based on the text is that the patent expires in 2037, which is 25 years after the standard data exclusivity period began (assuming approval in 2025), but the question focuses on the *expiration year* as the basis for the extension. Therefore, the patent protection extends beyond the 12-year data exclusivity by up to 25 years, but the document only specifies the expiration year (2037), not the exact additional years. For the purpose of this question, the answer is derived from the stated expiration year (2037) and the standard 12-year data exclusivity, meaning the patent could provide up to 25 additional years of protection beyond the data exclusivity period. However, the question asks for \"how many additional years,\" and the document does not provide a numerical \"additional years\" value—it only states the expiration year (2037). Thus, the answer must be based on the expiration year relative to the data exclusivity: the patent expires in 2037, which is 25 years after the standard data exclusivity period (if approval occurred in 2022, for example), but the document does not specify the approval year. The most accurate response based on the text is that the patent expiration year (2037) is the key figure, and it is stated that data exclusivity expires in July 2033 (page 15), so the patent extends protection for 4 additional years beyond the data exclusivity period (2037 - 2033 = 4). However, the question asks for \"additional years beyond the standard biologic data exclusivity period,\" and the standard period is 12 years from approval, not a fixed expiration date. The document clarifies that data exclusivity \"expires on December 13, 2031, and September 25, 2030, respectively\" in the EU and Japan (page 15), but for the U.S., it states \"Data exclusivity has been granted in the U.S. and expires July 16, 2033\" (page 15). The patent expiration is 2037, so the additional years beyond the U.S. data exclusivity (which expires in 2033) would be 4 years (2037 - 2033 = 4). Therefore, the patent could provide up to 4 additional years of exclusivity beyond the standard U.S. data exclusivity period. \n\n**Answer:** The patent for MK-7962 (sotatercept) expires in 2037, which is 4 years beyond the standard U.S. data exclusivity period that expires in 2033. Thus, it could provide up to 4 additional years of patent protection beyond the standard biologic data exclusivity.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual and calculation errors that undermine its correctness. While it correctly identifies the U.S. data exclusivity expiration date (July 16, 2033) and the patent expiration year (2037), it incorrectly calculates the additional years of protection as 4 (2037 - 2033 = 4), which contradicts the ground truth. The original answer states that if sotatercept is approved in 2027, it would receive 12 years of data exclusivity (expiring in 2039), but its patents expire in 2037—meaning the patent protection actually ends *before* the data exclusivity, not after. Therefore, there are *zero* additional years of patent protection beyond the data exclusivity period; in fact, the reverse is true. The LLM misunderstood the direction of the time comparison: patent expiry (2037) is earlier than data exclusivity expiry (2039 if approved in 2027), so no extension beyond exclusivity exists. The model incorrectly assumes data exclusivity ends in 2033 regardless of approval year, but the 12-year period starts at approval, not a fixed date. The document's mention of July 16, 2033 likely refers to a specific indication or regulatory designation (e.g., breakthrough therapy), not the full biologic exclusivity. The core error is failing to align the 12-year exclusivity with the anticipated 2027 approval, leading to a complete reversal of the correct conclusion. Quantitatively, the use of 2033 as a fixed end date for exclusivity is misleading and results in an incorrect 4-year 'additional protection' claim. Qualitatively, the reasoning shows effort to synthesize dates but fails on key financial logic: additional patent protection can only exist if patents outlive exclusivity, which they do not in this case. Contextually, the answer is relevant and cites correct document locations, showing good engagement with the source material, but draws the wrong inference.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1975,
        "completion_tokens": 511,
        "total_tokens": 2486
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "What was the total increase in Merck's fair value of Emerging Markets Equities investments across both U.S. and International Pension Plans from 2022 to 2023, based on NAV measurements?",
      "original_answer": "The total increase in Emerging Markets Equities investments was $106 million. In the U.S. Pension Plans, Emerging Markets Equities increased by $33 million (from $707 million in 2022 to $740 million in 2023). In the International Pension Plans, Emerging Markets Equities increased by $73 million (from $59 million in 2022 to $66 million in 2023 for International Pension Plans' direct Emerging Markets Equities holdings, and from $111 million in 2022 to $110 million in 2023 for the Investment Funds category which includes Emerging Markets Equities).",
      "llm_answer": "Based on the provided document pages, the total increase in Merck's fair value of Emerging Markets Equities investments across both U.S. and International Pension Plans from 2022 to 2023, based on NAV measurements, is $110 million. This is calculated as the difference between the 2023 NAV of $740 million and the 2022 NAV of $630 million for Emerging Markets Equities in the International Pension Plans (as shown in the fair value measurements on page 116), with the U.S. Pension Plans showing no specific Emerging Markets Equities allocation in the NAV breakdown. The $110 million increase aligns with the $110 million figure referenced in the document's NAV reconciliation (page 116, \"Emerging markets equities\" under International Pension Plans, where 2023 NAV is $740 vs. 2022 $707, but the question specifies \"across both U.S. and International,\" and the U.S. plan's Emerging Markets allocation is not separately quantified in the provided data; the $110 million increase is derived from the International plan's NAV growth as the primary source for Emerging Markets exposure). \n\n**Answer:** The total increase was $110 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both calculation and entity synthesis. The ground truth states the total increase is $106 million ($33M from U.S. plans and $73M from International plans). The LLM incorrectly reports $110 million as the total increase, conflating it with the International Pension Plans' total 2023 NAV ($740M) minus 2022 NAV ($630M is not even stated in the ground truth). The correct International increase is $73M, not $110M. (2) The LLM misreads the data: it claims the International plan increased from $630M to $740M, but the ground truth shows Emerging Markets Equities in International plans increased from $59M to $66M directly, and $111M to $110M in Investment Funds—resulting in a net $73M increase. The $740M figure cited by the LLM is actually the 2023 value for U.S. Emerging Markets Equities, not International. The LLM swaps the U.S. and International figures. (3) Multi-hop reasoning fails: the model does not correctly identify which numbers belong to which pension plan or category. It incorrectly assumes the $740M NAV is for International plans and that U.S. plans have no allocation, when in fact the $740M is the 2023 U.S. value (up from $707M). The LLM also ignores the U.S. increase of $33M entirely in its calculation. (4) Despite incorrect numbers and reasoning, the answer is contextually relevant—it addresses the right metric (fair value of Emerging Markets Equities), time frame (2022 to 2023), and plan types (U.S. and International). However, the core quantitative and qualitative inaccuracies severely undermine correctness. Hence, low scores on correctness, quantitative, and qualitative accuracy; moderate score on contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 466,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 183,
      "question": "What is the change in the estimated fair value of U.S. government agencies securities held by GILD from December 31, 2022, to December 31, 2023, and how does this compare to the change in the estimated fair value of U.S. treasury securities over the same period?",
      "original_answer": "The estimated fair value of U.S. government agencies securities increased by $106 million (from $21 million on December 31, 2022, to $127 million on December 31, 2023). The estimated fair value of U.S. treasury securities decreased by $34 million (from $379 million on December 31, 2022, to $426 million on December 31, 2023). Therefore, while U.S. government agencies securities appreciated significantly, U.S. treasury securities experienced a smaller decline in value.",
      "llm_answer": "The estimated fair value of U.S. government agency securities held by GILD increased from $35 million at December 31 2022 to $127 million at December 31 2023, a $92 million rise. In contrast, the estimated fair value of U.S. Treasury securities rose modestly from $410 million to $426 million, an increase of $16 million over the same period.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numbers. According to the ground truth, the estimated fair value of U.S. government agencies securities increased from $21 million to $127 million, a $106 million increase, but the LLM reports a rise from $35 million to $127 million, resulting in a $92 million increase—both starting value and change are incorrect. Additionally, the ground truth states that U.S. Treasury securities decreased from $379 million to $426 million—this is a $47 million increase, not a decrease, indicating a clear data error in the original answer; however, the LLM incorrectly claims Treasury securities rose from $410 million to $426 million ($16 million increase), which still misstates the starting value and change amount. The original answer itself contains a contradiction (claims a decrease while showing an increase), but the LLM fails to align with the correct data pattern. (2) Calculations are internally consistent in the LLM answer but based on incorrect inputs. The $92 million and $16 million changes are mathematically correct given the stated starting and ending values, but those values do not match the ground truth. (3) The multi-hop reasoning—comparing changes in two asset classes over time—is structurally sound and addresses the question framework, but the synthesis is based on incorrect underlying data. (4) The contextual relevance is high because the LLM answers both parts of the question and uses appropriate comparisons. However, due to major quantitative inaccuracies in input values and resulting changes, the correctness and accuracy scores are low. The LLM fails to reflect the true financial movements, undermining the reliability of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 473,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does the revenue performance of Biktarvy in 2023 compared to 2022, and what implications might this have on Gilead's long-term financial strategy given the patent expiration timeline for its principal HIV products?",
      "original_answer": "Biktarvy generated $11,850 million in total revenue in 2023, an increase from $10,390 million in 2022, representing a 14% growth. Given that Biktarvy is a key revenue driver, Gilead may need to prioritize extending its patent protection or developing follow-on therapies to maintain market exclusivity and revenue stability. The 10-K filing highlights that patent expiration dates for principal products, including those in fixed-dose combinations like Biktarvy, are critical for long-term revenue planning. If Biktarvy’s patent expires sooner than anticipated, the growth momentum may not be sustainable due to potential generic competition.",
      "llm_answer": "Biktarvy revenue increased 14% to $11.85 billion in 2023, driven by higher demand and pricing, while overall HIV product sales rose 6% to $18.18 billion. This growth occurs as key Gilead HIV products such as Descovy (2031), Stribild (2029), Genvoya (2029) and Harvoni (2030) face patent expirations, creating significant pricing and market‑share pressure that will likely compel the company to rely more on new launches and pipeline candidates to sustain long‑term financial performance.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Biktarvy revenue grew 14% to $11.85 billion in 2023, which matches the ground truth ($11,850 million = $11.85 billion) and accurately reflects the increase from $10,390 million in 2022. This calculation is correct: (11,850 - 10,390) / 10,390 ≈ 14%. However, the LLM introduces 'overall HIV product sales rose 6% to $18.18 billion,' a figure not present in the original answer and unverifiable from the provided ground truth, which weakens quantitative accuracy. (2) The patent expiration dates for Descovy (2031), Stribild (2029), Genvoya (2029), and Harvoni (2030) are mentioned, but the original answer only emphasizes the general importance of patent timelines for Biktarvy and fixed-dose combinations without listing specific drugs or dates. While these dates may be factually correct in external context, they were not part of the ground truth and represent an overextension beyond the provided knowledge. (3) The reasoning about Gilead needing to rely on new launches and pipeline candidates due to patent cliffs is logically sound and aligns with the original implication about the need for patent extensions or follow-on therapies. However, the original answer specifically ties the concern to Biktarvy’s own patent risk, whereas the LLM shifts focus to other products’ expirations, slightly misaligning the causal logic. (4) Despite introducing unverified specifics, the LLM captures the core trend (strong Biktarvy growth) and infers a reasonable strategic implication (need for pipeline reliance), maintaining high contextual relevance and partial qualitative accuracy. The answer is factually strong on the main point but adds unsupported details, warranting a score of 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 475,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 186,
      "question": "Given Gilead's single operating segment structure and centralized resource allocation, how might the impending U.S. patent expiration of Truvada in 2023 affect the company's ability to invest in lifecycle management initiatives for its HIV portfolio?",
      "original_answer": "Gilead's single operating segment structure enables centralized resource allocation across its HIV portfolio, including Truvada, which is a key part of its HIV prevention and treatment offerings. However, with Truvada's U.S. patent expiration in 2023, the loss of exclusivity could significantly reduce revenue from this product due to generic competition. This revenue decline may constrain the company's ability to invest in lifecycle management initiatives, such as developing next-generation formulations or combination therapies within the HIV portfolio, unless offset by cost reallocations or revenue from newer products.",
      "llm_answer": "The impending U.S. patent expiration of Truvada in 2023 could significantly constrain Gilead’s ability to fund lifecycle management initiatives for its HIV portfolio, as patent exclusivity loss typically triggers pricing pressure and reduced revenue streams that limit investment in new formulations, combination therapies, or expanded indications. However, Gilead’s centralized resource allocation and focus on high-value pipeline assets like Biktarvy and Lenacapavir may allow it to prioritize strategic investments in next-generation HIV therapies while leveraging existing portfolio synergies to mitigate the financial impact of Truvada’s patent cliff.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Truvada's U.S. patent expiration in 2023 is accurately cited, and the implication of reduced revenue due to generic competition is correctly inferred. There are no numerical inaccuracies, and the date (2023) matches the ground truth. (2) Quantitative accuracy is perfect—no calculations were required, but the temporal reference (2023) is correct. (3) The multi-hop reasoning is sound: the model correctly links Gilead’s single-segment, centralized structure to resource allocation decisions, recognizes the threat of patent expiration to revenue, and evaluates the potential impact on lifecycle management investments. It adds value by referencing newer products (Biktarvy, Lenacapavir) as potential mitigants, which is consistent with Gilead’s actual strategy and enhances the reasoning without contradicting the original answer. (4) The LLM slightly exceeds the original answer by introducing specific next-gen assets, which are contextually appropriate and reflect accurate knowledge, though not explicitly in the ground truth. This does not detract from correctness but enhances qualitative depth. The only reason for not scoring a 10 is that the original answer emphasizes the risk more directly and explicitly notes the need for cost reallocations or new revenue to offset losses—nuance that is implied but less emphasized in the LLM response. Overall, the answer is factually correct, contextually relevant, and logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 423,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the 2023 IDA Agreement impact Schwab's capital management strategy and contract asset amortization in 2023, and what was the specific dollar amount of amortization associated with this agreement?",
      "original_answer": "The 2023 IDA Agreement allowed Schwab to sweep certain brokerage client deposits off-balance sheet to TD Depository Institutions, which supported its capital management strategy by reducing balance sheet pressure and enabling future migration of IDA balances as capital levels permit. Additionally, the agreement resulted in contract assets related to the buy-down of fixed-rate obligations, which were amortized over the contractual term as a reduction to bank deposit account fee revenue. The specific dollar amount of amortization associated with this agreement in 2023 was included in the broader amortization of capitalized contract costs, which totaled $85 million for the year ended December 31, 2023.",
      "llm_answer": "The 2023 IDA Agreement required certain brokerage client deposits to be swept off‑balance‑sheet to TD Depository Institutions, which supported Schwab’s capital‑management strategy by preserving liquidity and enabling continued growth of its balance‑sheet assets.  The amortization expense recognized for the contract assets created under this agreement was $239 million for 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claim of $239 million in amortization expense, which directly contradicts the ground truth stating that the broader amortization of capitalized contract costs was $85 million in 2023. This number is not only incorrect but more than double the actual amount, and there is no indication in the ground truth that the IDA Agreement alone accounted for $239 million. (2) The ground truth clarifies that the specific amortization amount tied to the IDA Agreement was included within the $85 million total but was not separately disclosed—thus, asserting a precise $239 million figure is factually wrong. (3) Qualitatively, the LLM correctly identifies the off-balance-sheet sweeping of client deposits to TD Depository Institutions and links it to capital management, which aligns with the ground truth. It also correctly associates the agreement with contract asset amortization, though it misrepresents the financial impact. (4) Contextually, the response addresses the core elements of the question—capital management strategy and amortization—but fails in precision and synthesis due to the fabricated dollar amount. The reasoning is partially sound but undermined by incorrect data. The $85 million figure in the ground truth encompasses all capitalized contract cost amortization, not just IDA-related, so even if the LLM had cited that number, attribution would need qualification. Overall, major error in quantitative accuracy severely limits correctness despite some conceptual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 438,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How do the changes in LTIP units and other unit issuances during 2023 affect the total equity of SPG as reported in its 2023 10-K filing?",
      "original_answer": "The changes in LTIP units and other unit issuances contributed to a net increase in total equity. Specifically, the issuance of limited partner units added $197,426 to equity, while the long-term incentive performance units added $14,739. These increases were partially offset by the redemption of limited partner units, which reduced equity by $13,524 and treasury unit purchases that reduced equity by $140,593. Overall, these transactions resulted in a net reduction of $139,378 in equity from unit-related activities.",
      "llm_answer": "The changes in LTIP units and other unit issuances during 2023, as reflected in the equity tables on pages 95 and 96, increased Simon Property Group’s total equity from $3.61 billion at the end of 2022 to $3.49 billion at the end of 2023 (including the impact of unit redemptions, treasury purchases, and other adjustments). These unit‑related movements are captured in the “Limited Partners’ Preferred Interest,” “Capital in excess of par value,” and “Accumulated other comprehensive loss” components that together drive the net change in total equity reported in the consolidated statements of equity.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and magnitude of the equity impact, which severely undermines its factual accuracy. (1) Quantitatively, the answer claims total equity increased from $3.61 billion to $3.49 billion, which is a decrease, not an increase, and contradicts the ground truth that unit-related activities caused a net reduction of $139,378 (not billions). The numbers cited ($3.61B, $3.49B) are off by orders of magnitude and do not reflect the actual unit-level transactions. The ground truth specifies precise contributions: +$197,426 from limited partner unit issuances, +$14,739 from LTIP units, -$13,524 from redemptions, and -$140,593 from treasury purchases, resulting in a net reduction of $139,378. The LLM fails to report any of these correct figures or the correct net effect. (2) The answer incorrectly implies that unit issuances increased equity overall, while the actual net effect was a reduction. (3) While the LLM references 'pages 95 and 96' and equity components like 'Capital in excess of par value,' this contextual framing does not compensate for the complete inaccuracy of the financial figures. (4) The reasoning is flawed: it misinterprets the scale and direction of the change, suggesting a net increase when there was a net decrease, and fails to perform or report the required multi-hop synthesis of offsetting unit transactions. (5) Entity accuracy (SPG, 2023, LTIP units) and general context (equity changes from unit issuances) are correct, and the mention of consolidated statements of equity shows some understanding of where such data would be reported. However, the answer fails the core requirement of accurately quantifying the impact. Due to severe quantitative errors and incorrect conclusion despite correct context, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 493,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does Linde's distribution of Process Gases through on-site plants influence its long-term contract structure and revenue recognition policy, based on the specific distribution and accounting practices described in the 2024 10-K filing?",
      "original_answer": "Linde's distribution of Process Gases through on-site plants leads to long-term contracts (typically 10–20 years) with minimum purchase requirements and price escalation provisions. These contracts are structured as total requirement agreements, where revenue is recognized over time as product is delivered and the company has the right to invoice. This method of revenue recognition aligns with the continuous delivery of gases through pipelines and ensures that revenue reflects the ongoing supply of Process Gases to large-volume customers.",
      "llm_answer": "Based on the 2024 10-K disclosures, Linde’s on-site gas distribution contracts—characterized by long-term (10–20 year) total requirement agreements with minimum purchase obligations and price escalation—directly shape its long-term contract structure and revenue recognition policy. Revenue from these on-site contracts is recognized over time as product is delivered and the company has the right to invoice, using a practical expedient that aligns with contract terms. This approach, combined with variable pricing tied to price indices, results in revenue recognition that reflects the ongoing nature of these contracts, while the long-term structure ensures stable, predictable revenue streams underpinned by minimum purchase requirements and extended commitments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately represented: Linde's on-site gas distribution involves long-term contracts of 10–20 years with minimum purchase requirements and price escalation provisions, structured as total requirement agreements. Revenue is recognized over time as product is delivered and the company has the right to invoice, which aligns with the continuous delivery model. (2) There are no numeric values requiring calculation, but the time frame '10–20 years' is correctly cited and matches the original. Format and phrasing differences (e.g., 'total requirement agreements' and 'right to invoice') are consistent in meaning. (3) The multi-hop reasoning is sound—linking distribution method (on-site plants) to contract structure (long-term, minimum volumes, pricing) and then to accounting policy (over-time revenue recognition under ASC 606 using the right-to-invoice practical expedient). (4) The LLM adds contextual clarity by mentioning variable pricing tied to indices and the stability of revenue streams, which is consistent with 10-K disclosures and enhances completeness without introducing inaccuracies. All aspects of the question are addressed with high precision and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 357,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the difference in the fair value of corporate notes and obligations between the two disclosed tables, and how does this difference compare to the overall change in total marketable securities' fair value across the same disclosures?",
      "original_answer": "The fair value of corporate notes and obligations decreased from $3,354 million to $2,978 million, a difference of $376 million. The total marketable securities' fair value decreased from $5,492 million to $5,722 million, representing an overall increase of $230 million. Therefore, while corporate notes and obligations saw a significant decline, the overall portfolio of marketable securities increased in value.",
      "llm_answer": "The fair value of corporate notes and obligations decreased by $376 million from $3,354 million at January 31 2023 to $2,978 million at January 31 2024. This decline is smaller than the overall change in total marketable securities’ fair value, which increased by $230 million (from $5,492 million to $5,722 million) over the same period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values: the fair value of corporate notes and obligations decreased from $3,354 million to $2,978 million, a difference of $376 million, and total marketable securities increased from $5,492 million to $5,722 million, a change of $230 million. These numbers match the ground truth exactly. (2) All calculations are accurate: the $376 million decline and $230 million increase are correctly computed. The comparison between the two changes is also correctly framed. (3) The multi-hop reasoning is sound—information from two different disclosures (likely two years or tables) is synthesized correctly to compute changes in two different asset categories. The conclusion that corporate notes declined while total marketable securities increased is logically consistent. (4) The only minor issue is a slight misstatement in the comparative phrasing: the LLM says the decline in corporate notes 'is smaller than' the overall change in marketable securities, which could be misinterpreted as magnitude comparison (376 > 230), but in context, it refers to the direction (decline vs increase), so the intent is clear. This does not undermine factual correctness but slightly affects clarity. Hence, a score of 9/10 on correctness and qualitative accuracy. Quantitative accuracy and contextual relevance are perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 383,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the impact of changing provider behavior, as described in the Health Care Benefits segment, affect the accuracy of CVS's premium pricing forecasts and ultimately its operating results, given the fixed premium period and the sensitivity of profits to forecast accuracy?",
      "original_answer": "Changing provider behavior, such as hospitals and providers attempting to maintain revenue levels during economic downturns, increases CVS's medical costs and limits its ability to accurately forecast and price for medical cost trends. This is especially problematic because premiums for Insured Health Care Benefits products, which make up 94% of Health Care Benefits segment revenues, are set in advance based on forecasts and cannot be adjusted during the fixed premium period. Even small differences between predicted and actual costs can significantly affect operating results, as profits are highly sensitive to forecast accuracy. Therefore, unpredictable provider behavior amplifies the risk of adverse financial outcomes for CVS.",
      "llm_answer": "Changing provider behavior can shift utilization and medical‑cost trends, making it harder for CVS to forecast the health‑care cost trends that drive its fixed‑premium pricing. If forecasts are inaccurate, the premium revenue collected may not cover the higher actual costs, compressing margins and directly reducing operating results in the Health Care Benefits segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in its core reasoning and captures the essential mechanism described in the ground truth: changing provider behavior affects medical cost trends, which undermines the accuracy of CVS's premium pricing forecasts, leading to margin compression and adverse operating results due to fixed premiums. The answer correctly identifies the risk from fixed premium periods and the sensitivity of profits to forecast errors. However, it omits the specific quantitative detail that Insured Health Care Benefits make up 94% of the segment's revenues, which is a key element in the original answer that underscores the magnitude of exposure. While this omission does not invalidate the reasoning, it reduces completeness in addressing all parts of the multi-hop question. There are no numerical inaccuracies—no incorrect figures or calculations are presented (and none are required beyond the 94%, which is missing). The entities (CVS, provider behavior, premium pricing, operating results) are correctly identified and logically connected. The reasoning is sound and semantically aligned with the ground truth, though slightly less detailed. The answer remains highly relevant and accurately reflects the causal chain in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 350,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does Chevron's acquisition of Noble in October 2020, which added 6,000 cubic feet of natural gas per barrel of crude oil in production capacity, support its ability to maintain high-quality debt ratings of AA- (S&P) and Aa2 (Moody's) during periods of low commodity prices?",
      "original_answer": "Chevron's acquisition of Noble added production capacity measured in oil-equivalent barrels, where 6,000 cubic feet of natural gas equals 1 barrel of crude oil. This expanded production base increases cash flow potential from upstream operations. Chevron stated that during periods of low crude oil and natural gas prices, it can adjust its capital spending and reduce stock repurchases to preserve financial flexibility. Given that Chevron's debt is rated AA- by S&P and Aa2 by Moody’s—indicating strong creditworthiness—the additional production from Noble enhances Chevron’s ability to generate cash and maintain its investment-grade credit profile, even in challenging market conditions.",
      "llm_answer": "Chevron's 2020 acquisition of Noble Energy added roughly 6,000 cubic feet of natural‑gas production per barrel of crude‑oil output, boosting overall upstream cash flow and keeping leverage low (net‑debt ratio fell to 15.6 % in 2021). This financial resilience helped the company sustain high‑quality debt ratings of AA‑ (S&P) and Aa2 (Moody’s) even during periods of low commodity prices.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's acquisition of Noble in 2020 and the addition of 6,000 cubic feet of natural gas per barrel of crude oil, which aligns with the ground truth. However, it introduces a specific net-debt ratio of 15.6% in 2021 that is not present in the original answer and cannot be verified from the provided knowledge graph. This number may be factually accurate but is an unsupported addition, reducing quantitative accuracy. (2) The quantitative claim about the net-debt ratio is the only numerical addition beyond the ground truth, and since it's unverified, it constitutes a factual overreach. The 6,000 cubic feet per barrel and 2020 acquisition date are correctly stated. (3) The reasoning is sound: the model correctly links the acquisition to increased upstream cash flow, financial resilience, and maintenance of high credit ratings during low commodity prices. It captures the multi-hop logic—acquisition → increased production → stronger cash flow → financial flexibility → sustained credit ratings—even adding a plausible data point (debt ratio) to strengthen the argument. However, introducing unverified metrics weakens the factual foundation. (4) The answer is contextually relevant and addresses the core question about how the acquisition supports credit ratings. While the qualitative reasoning and entity identification (Chevron, Noble, S&P AA-, Moody’s Aa2) are accurate, the unsupported debt ratio lowers confidence in quantitative accuracy, warranting a 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 425,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How much did Schwab spend to buy down fixed-rate obligation amounts under the 2023 IDA agreement, and how is this amount classified on the consolidated balance sheet?",
      "original_answer": "Schwab spent $249 million to buy down $5.0 billion of fixed-rate obligation amounts under the 2023 IDA agreement. This amount was capitalized as contract assets and included in other assets on the consolidated balance sheet.",
      "llm_answer": "Schwab spent $249 million in 2023 to buy down $5 billion of fixed‑rate obligation amounts under the 2023 IDA agreement, and this amount is recorded as a contract asset (capitalized contract cost) on the consolidated balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Schwab spent $249 million to buy down $5.0 billion of fixed-rate obligations under the 2023 IDA agreement, matching the ground truth in both amounts (allowing for format variation: $5 billion = $5.0 billion). The classification of the amount as a contract asset is accurate. (2) All numeric values are correct: $249 million and $5 billion are consistent with the original answer. No calculations are required, but the figures are accurately reported. (3) The multi-hop reasoning is sound—information about the transaction amount and its accounting treatment is synthesized correctly from the relevant filing. The LLM correctly links the spending to the IDA agreement and identifies the balance sheet classification. (4) The only minor shortcoming is that the LLM mentions 'capitalized contract cost' rather than explicitly stating it is 'included in other assets,' which is part of the full classification path. While 'contract asset' is correct and typically falls under 'other assets,' the omission of that specific line is a slight reduction in completeness. However, this does not materially misrepresent the accounting treatment. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1118,
        "completion_tokens": 365,
        "total_tokens": 1483
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How much in store impairment charges did CVS record in 2024 as part of its enterprise-wide restructuring plan, and how does this compare to the expected cost savings projected for 2025 from that same initiative?",
      "original_answer": "CVS recorded $483 million in store impairment charges in 2024 as part of its enterprise-wide restructuring plan. The company projected that this restructuring would generate over $500 million in cost savings for 2025. Therefore, the impairment charges represent a near-term financial cost that is expected to be offset by anticipated longer-term savings in the following year.",
      "llm_answer": "CVS recorded a $483 million store‑impairment charge in 2024 as part of its enterprise‑wide restructuring plan, and the plan is expected to generate more than $500 million in cost savings beginning in 2025.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the $483 million store impairment charge in 2024 and the projection of over $500 million in cost savings starting in 2025. (2) Quantitative accuracy is perfect—both dollar amounts and years match the original answer exactly, with acceptable formatting (e.g., 'more than $500 million' = 'over $500 million'). (3) The multi-hop reasoning is sound: the answer correctly links the 2024 impairment charges to the same enterprise-wide restructuring plan that is expected to yield cost savings in 2025, demonstrating proper synthesis across time and financial impact. (4) The response is concise but complete, addressing both parts of the question without introducing errors or irrelevant information. Wording differences (e.g., 'beginning in 2025' vs 'projected for 2025') do not affect factual meaning. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 282,
        "total_tokens": 1444
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was Chevron's equity in earnings from Angola LNG Limited in 2021, and what does this indicate about Chevron's involvement in the liquefied natural gas market in Angola?",
      "original_answer": "Chevron's equity in earnings from Angola LNG Limited was -$166 million in 2021, indicating that Chevron's 36.4% stake in the venture resulted in a loss that year, reflecting potential challenges in the liquefaction and processing of natural gas for international markets.",
      "llm_answer": "Chevron's equity in earnings from Angola LNG Limited was $(166) million in 2021, indicating a loss from this investment. This reflects Chevron's minority stake (36.4% interest) in the Angola LNG project, where its earnings contribution was negative, suggesting limited profitability or operational challenges in the venture despite its significant presence in Angola's liquefied natural gas sector.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Chevron's equity in earnings from Angola LNG Limited as $(166) million in 2021, which matches the ground truth of -$166 million. The negative sign is appropriately represented using accounting notation (parentheses), which is semantically equivalent. The 36.4% stake is accurately cited. (2) All numeric values—dollar amount (-$166 million) and ownership percentage (36.4%)—are factually correct and match the ground truth. No calculations are required beyond recognition of the loss, which is correctly interpreted. (3) The multi-hop reasoning is sound: the model connects Chevron’s financial result to its ownership stake and infers implications about operational or profitability challenges in the LNG market in Angola. It correctly synthesizes financial performance with strategic context. (4) The answer is slightly less explicit than the ground truth in mentioning 'liquefaction and processing of natural gas for international markets,' but it captures the essence by referencing operational challenges and Chevron’s presence in Angola’s LNG sector. Wording differs but meaning is preserved. Thus, high scores across all categories with a minor deduction in qualitative accuracy for slightly less technical specificity in describing the nature of the challenges.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 367,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What operational risks does NextEra Energy Resources face given the mismatch between the Duane Arnold decommissioning timeline (expected completion by 2080) and the expiration dates of its nuclear fuel supply contracts (through 2033)?",
      "original_answer": "NextEra Energy Resources faces the risk of managing nuclear fuel supply beyond the expiration of existing contracts in 2033 while maintaining safe and compliant decommissioning operations at Duane Arnold, which is expected to continue through 2080. This creates a planning challenge as NEER must secure alternative fuel sources or storage solutions for the spent nuclear fuel onsite, which remains in long-term dry storage until the DOE can take possession. The gap between the expiration of fuel supply contracts and the long-term decommissioning obligations could lead to increased operational costs, regulatory scrutiny, or the need for additional capital expenditures to maintain safe storage.",
      "llm_answer": "The mismatch between the Duane Arnold decommissioning timeline (expected completion around 2080) and the expiration of its nuclear‑fuel supply contracts (through 2033) creates a long‑term liability risk. Because the fuel contracts end well before the anticipated decommissioning date, NEER must secure additional fuel or face potential supply shortages and costly contract extensions or renewals, which could strain finances and increase operational uncertainty.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key dates (decommissioning through 2080, fuel contracts expiring in 2033) and the core issue: a mismatch between contract expiration and long-term decommissioning obligations. Quantitatively, all dates are accurate and consistent with the ground truth. However, the LLM mischaracterizes the operational risk by implying that NEER may face 'fuel shortages' or need to secure 'additional fuel' after 2033, which is factually incorrect. The Duane Arnold plant is permanently shut down, and no new nuclear fuel is needed for operations; the real risk lies in the long-term storage of *existing* spent nuclear fuel, not in procuring new fuel. The ground truth emphasizes that spent fuel remains in dry storage onsite until the DOE takes possession, creating liabilities around storage, regulatory compliance, and potential capital costs—not supply shortages. The LLM fails to mention spent fuel management, DOE responsibility, or storage-related risks, which are central to the actual operational risk. While the answer captures the timeline mismatch and general financial/operational uncertainty, it misunderstands the nature of the risk, leading to flawed reasoning. Contextually, the response is relevant and well-framed, but the qualitative inaccuracy in risk characterization significantly reduces correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 373,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does Linde's involvement in the Amur GPP project, including contingent liabilities and contract suspensions, contrast with its revenue recognition policies for on-site industrial gas contracts, and what does this reveal about the financial risk exposure in long-term on-site agreements?",
      "original_answer": "Linde faces a contingent liability of $0.7 billion related to the Amur GPP project, stemming from fires and subsequent legal claims in Russia, and had its contracts suspended due to sanctions. This highlights the financial risk in long-term engineering projects, especially those involving international legal exposure. In contrast, Linde's on-site industrial gas contracts, which often span 10–20 years and include minimum purchase requirements, recognize revenue over time as product is delivered, based on the right to invoice. These contracts are generally more stable and predictable, with revenue tied to ongoing delivery rather than one-time project completion. However, the Amur GPP case shows that long-term on-site or project-based involvement can lead to significant unforeseen liabilities, even if the company is not directly responsible for construction flaws. This contrast reveals that while on-site contracts provide steady revenue, they also carry latent risks when tied to large infrastructure projects with multiple stakeholders and geopolitical exposure.",
      "llm_answer": "Linde’s on‑site industrial‑gas contracts are accounted for under the “over‑time” method of ASC 606, recognizing revenue as product is delivered and the company can invoice the customer, typically under long‑term agreements (10‑20 years) that include minimum purchase and price‑escalation provisions.  In contrast, the Amur GPP project—an engineering, construction and licensing arrangement in Russia—has generated contingent liabilities of roughly $0.7‑$1.0 billion (recorded as contract‑liability advances) and has been subject to contract suspensions, fires, arbitration and enforcement actions, illustrating that revenue from such long‑term on‑site agreements is recognized only when performance obligations are satisfied and is exposed to significant financial risk if sanctions, litigation or project termination disrupt the underlying commitments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the $0.7 billion contingent liability is correctly reported, with a slight but reasonable expansion to a $0.7–$1.0 billion range—this does not contradict the original $0.7 billion figure and may reflect updated or rounded disclosures, which is acceptable under semantic equivalence. No calculations are required, and all financial figures are consistent. (2) The LLM correctly identifies Linde’s revenue recognition policy under ASC 606 for on-site industrial gas contracts, noting revenue is recognized over time as product is delivered and invoiced, which matches the ground truth. It accurately contrasts this with the Amur GPP project, a long-term project with construction and licensing components, where contingent liabilities and contract suspensions have created financial risk. (3) Multi-hop reasoning is sound: the model synthesizes information across Linde’s different types of long-term agreements (recurring on-site supply vs. project-based EPC contracts), links revenue recognition policies to contract structure, and connects the Amur GPP disruptions (fires, sanctions, arbitration) to financial exposure. (4) The only minor shortcoming is that the LLM does not explicitly state that on-site contracts are generally more stable and predictable—though this is implied by contrasting their steady revenue recognition with the volatile Amur project. It also does not fully emphasize the latent geopolitical and multi-stakeholder risks in infrastructure-linked on-site agreements as a broader implication. However, the core contrast and financial risk exposure are clearly conveyed. Wording differs but meaning is semantically equivalent. All entities (Linde, Amur GPP, ASC 606) are correct, and the answer is fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 497,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the expected increase in TAC paid to Google Network partners, driven by shifts in device and geographic mix, directly impact the gross advertising revenue recognition model described in the consolidated financial statements?",
      "original_answer": "The increase in TAC paid to Google Network partners, driven by changes in device mix, geographic mix, and partner mix, directly affects the gross advertising revenue recognition model by increasing the cost of revenues associated with ads placed on Google Network properties. Since Google reports advertising revenues from these properties on a gross basis—recording the full amount billed to customers as revenue and the amounts paid to partners as cost of revenues—an increase in TAC results in higher cost of revenues. This dynamic puts downward pressure on gross margins, even as total advertising revenues may grow. For example, the financial statements note that Google recognizes revenues for ads on Google Network properties on a gross basis, with partner payments recorded as cost of revenues, while the MD&A section indicates that TAC is expected to rise with revenue growth and will vary based on multiple factors, including partner agreement terms and geographic mix.",
      "llm_answer": "The expected increase in TAC payments to Google Network partners—driven by shifts toward mobile and emerging‑market device mixes and broader geographic reach—directly lowers the net advertising revenue that Alphabet can recognize, because TAC is recorded as a cost of revenues on a gross‑basis for Google Network placements. Consequently, while gross advertising revenue is reported at the full amount billed to customers, the portion paid to partners is subtracted as cost of revenues, reducing the net contribution to earnings despite the higher absolute level of gross advertising revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth, with only minor omissions in detail. (1) It correctly identifies that TAC increases—driven by shifts in device and geographic mix—impact the gross advertising revenue model by increasing cost of revenues, as Google reports revenue on a gross basis and TAC as a corresponding cost. This aligns with the original answer’s explanation of gross revenue recognition and margin pressure. (2) There are no numeric values in either answer, so quantitative accuracy is not compromised; all references to financial reporting concepts are accurate. (3) The multi-hop reasoning is sound: the model connects TAC increases to revenue recognition policy (gross reporting), cost of revenues, and margin impact, synthesizing concepts from revenue accounting and partner payment structures. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'partner mix' or 'partner agreement terms' as factors affecting TAC, nor does it explicitly state the downward pressure on gross margins—though this is implied by saying 'reducing the net contribution to earnings.' These omissions prevent a perfect 10, but the core financial logic and entity relationships are accurately conveyed. Contextual relevance is full, as the response directly addresses the impact on the gross revenue recognition model.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 383,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How much of Duke Energy’s asset retirement obligation (ARO) for coal ash impoundment closure is influenced by compliance with the Coal Ash Act, given that closure methods must align with state and federal regulations and the ultimate method and timetable will affect the recorded ARO amount?",
      "original_answer": "Duke Energy’s asset retirement obligation (ARO) for coal ash impoundment closure is directly influenced by compliance with the Coal Ash Act, as the ARO amount recorded on the Consolidated Balance Sheets is based on estimated closure costs for impacted ash impoundments under this regulation. The closure methods—such as excavation and relocation of ash to a lined landfill or beneficial reuse—must align with standards set by the Coal Ash Act and other federal regulations, and the ultimate method and timetable for closure will determine the actual costs incurred, which may result in a material change to the ARO balance.",
      "llm_answer": "The ARO for Duke Energy’s coal‑ash impoundment closures is shaped by compliance with both state and federal rules – chiefly the EPA’s Coal Combustion Residue (CCR) rule and the North Carolina Coal Ash Management Act – and the specific closure method and schedule chosen for each site can materially alter the recorded ARO amount.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in substance and contextually relevant, earning a high correctness score. (1) It correctly identifies that Duke Energy's ARO for coal ash impoundment closure is influenced by compliance with state and federal regulations, specifically naming the North Carolina Coal Ash Management Act (aligned with the 'Coal Ash Act' in the ground truth) and the EPA's CCR rule, which are key regulatory drivers. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The reasoning is sound: the LLM correctly explains that closure methods and schedules affect the ARO, which matches the multi-hop logic in the ground truth that the ultimate method (e.g., excavation, reuse, landfill) and timetable will impact costs and thus the recorded obligation. (4) Minor deduction in qualitative accuracy because the LLM refers to the 'Coal Combustion Residue (CCR) rule' and 'North Carolina Coal Ash Management Act' instead of consolidating under 'Coal Ash Act' as in the original, which may imply a slight lack of synthesis—though both regulations are indeed relevant. However, the core message about regulatory influence and cost variability is preserved. Semantic equivalence is maintained, and the answer fully addresses the question’s intent regarding regulatory impact on ARO.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 384,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What is the total change in the fair value of Mortgage-Backed Obligations between the two disclosed tables in the 2023 10-K filing for CRM?",
      "original_answer": "The total change in the fair value of Mortgage-Backed Obligations between the two tables is a decrease of $58 million, calculated by subtracting the fair value of $178 million in the second table from the fair value of $236 million in the first table.",
      "llm_answer": "The total change in the fair value of Mortgage-Backed Obligations between the two disclosed tables is a decrease of $58 million, calculated as $178 million in 2023 versus $236 million in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in terms of the quantitative change: the decrease of $58 million is accurately calculated from $236 million to $178 million. The numbers match the ground truth exactly, and the calculation is sound, earning a perfect score for quantitative accuracy. The answer is contextually relevant and addresses the question directly. However, there is a minor error in the temporal reference: the LLM states '$178 million in 2023 versus $236 million in 2024', which misrepresents the time periods. The original question refers to two disclosed tables in the 2023 10-K filing, meaning both values are reported within the same filing for 2023, likely representing different reporting dates or contexts within that year (e.g., Q1 vs Q4 or different footnote disclosures), not across fiscal years 2023 and 2024. This introduces a slight inaccuracy in entity/time period interpretation, slightly affecting qualitative accuracy. Despite this, the core multi-hop reasoning—identifying the two values and computing the difference—is correct. The answer conveys semantically equivalent information regarding the magnitude and direction of change, justifying a high correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1109,
        "completion_tokens": 337,
        "total_tokens": 1446
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What percentage of Danaher's Diagnostics segment sales in 2023 were attributed to 'other developed markets', and which specific geographic regions does the company classify under this category?",
      "original_answer": "Danaher's Diagnostics segment attributed 5% of its 2023 sales to 'other developed markets'. According to the company's definitions, this category includes the regions of Japan, Australia, and New Zealand.",
      "llm_answer": "Based on the provided document pages, Danaher's Diagnostics segment sales in 2023 attributed to \"other developed markets\" was **5%**, and the specific geographic regions classified under this category are **Japan, Australia, and New Zealand**. This information is confirmed in the revenue disaggregation table on page 78 (which defines \"other developed markets\" as Japan, Australia, and New Zealand) and reiterated in the segment overview on page 113.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The percentage of Danaher's Diagnostics segment sales attributed to 'other developed markets' in 2023 is accurately stated as 5%, which aligns with the original answer. The geographic regions listed—Japan, Australia, and New Zealand—are exactly those defined by Danaher under 'other developed markets'. (2) There are no numerical or calculation errors; the percentage is correct and properly attributed to the right year and segment. (3) The reasoning is sound, with correct synthesis from the revenue disaggregation table and segment overview, indicating proper multi-hop understanding across document sections. (4) The answer is semantically equivalent to the ground truth, includes all required elements, and adds contextual support by referencing specific document pages, enhancing credibility without introducing inaccuracies. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 276,
        "total_tokens": 1452
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What was the total revenue contribution from Bulk shipments in 2021 for Union Pacific Railroad, given the carload volume and average revenue per car for that category?",
      "original_answer": "The total revenue contribution from Bulk shipments in 2021 for Union Pacific Railroad was $6,656,270,000, calculated by multiplying the 2021 Bulk carloads (1,920,000) by the average revenue per car in 2021 ($3,467).",
      "llm_answer": "The total revenue contribution from Bulk shipments in 2021 was $6,656 million, calculated by multiplying the Bulk carload volume of 2,014 thousand carloads by the average revenue per car of $3,305.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in key numeric inputs and the final calculation. The ground truth states 1,920,000 carloads and $3,467 average revenue per car, yielding $6,656,270,000. The LLM incorrectly reports 2,014 thousand carloads (i.e., 2,014,000) and $3,305 per car, leading to a miscalculated total of approximately $6,656 million ($6.656 billion), which is numerically close but based on wrong inputs. (2) The final revenue figure is close in magnitude ($6,656 million vs $6,656.27 million) but not exact, and more critically, it is derived from incorrect underlying data. The carload volume and average revenue per car are both wrong, indicating a failure to retrieve the correct values from the knowledge base. (3) While the reasoning structure (multiplying carloads by average revenue per car) is logically sound and reflects correct multi-hop synthesis in form, it is applied to incorrect data, undermining the qualitative accuracy. The model appears to mimic the calculation method but with fabricated or misremembered figures. (4) The contextual relevance is high because the answer addresses the right question format and metric, but correctness and quantitative accuracy are severely compromised due to incorrect core data. Minor formatting differences like 'million' vs 'M' are acceptable, but input values must match the ground truth, which they do not.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1108,
        "completion_tokens": 387,
        "total_tokens": 1495
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the total estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina after the settlement agreement with NCDEQ, and how does this reflect a reduction from Duke Energy's initial estimate following the April 1, 2019 closure determination?",
      "original_answer": "The total estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina is approximately $8 billion to $9 billion after the settlement agreement with NCDEQ. This represents a reduction of approximately $1.5 billion from Duke Energy's initial estimate of $9.5 billion to $10.5 billion that followed the April 1, 2019 closure determination requiring excavation of the nine remaining impoundments.",
      "llm_answer": "The settlement agreement with NCDEQ reduced Duke Energy’s estimated undiscounted cost to close the nine remaining coal‑ash basins by roughly $1.5 billion, lowering the total estimated cost to permanently close all ash basins in North Carolina and South Carolina from about $9.5 billion‑$10.5 billion (the figure after the April 1, 2019 closure determination) to approximately $8 billion‑$9 billion.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) All key information is accurately conveyed: the post-settlement estimated cost range ($8 billion to $9 billion), the pre-settlement initial estimate ($9.5 billion to $10.5 billion), and the $1.5 billion reduction are all correct. (2) Quantitative accuracy is perfect: the numbers match exactly, including the ranges and the implied difference (e.g., midpoint drop from $10B to $8.5B reflects ~$1.5B reduction). The date (April 1, 2019) and triggering event (closure determination requiring excavation of nine impoundments) are correctly referenced. (3) Multi-hop reasoning is sound—the model correctly synthesizes the impact of the NCDEQ settlement on cost estimates over time, linking the initial determination to the revised estimate. (4) Entity accuracy is strong: Duke Energy, NCDEQ, coal ash basins, and geographic scope (NC and SC) are all correctly identified. Wording differs slightly but meaning is preserved. No omissions or inaccuracies. All scoring categories warrant full marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 307,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total cash consideration paid by Mastercard for both Dynamic Yield LTD in 2022 and Recorded Future in 2024, and how does this spending reflect the company's acquisition strategy?",
      "original_answer": "Mastercard paid a total cash consideration of $325 million for Dynamic Yield LTD in 2022 and $2.7 billion for Recorded Future in 2024. The combined total is $3.025 billion. These acquisitions align with the company's strategy to grow, diversify, and build its business by integrating specialized capabilities, such as Dynamic Yield's personalization technology and Recorded Future's threat intelligence, into Mastercard's broader service offerings.",
      "llm_answer": "Mastercard paid $325 million in cash consideration for Dynamic Yield LTD in 2022 and $2.7 billion for Recorded Future in 2024, for a total cash outlay of roughly $3.0 billion across the two acquisitions. This spending reflects the company’s strategy of diversifying its capabilities—adding advanced analytics and threat‑intelligence expertise—to expand its payment‑network and value‑added services portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the cash consideration for both acquisitions: $325 million for Dynamic Yield LTD in 2022 and $2.7 billion for Recorded Future in 2024. The total is stated as 'roughly $3.0 billion,' which is a reasonable approximation of the exact sum ($3.025 billion), though it omits the precise figure. All entities, years, and financial figures are accurate.\n\n2) Quantitative accuracy is perfect: both individual amounts match the ground truth, and the approximate total is acceptable given common rounding practices in financial reporting. The exact sum is $3.025 billion, and stating it as 'roughly $3.0 billion' does not constitute a factual error but is slightly less precise.\n\n3) The reasoning is sound and reflects the multi-hop synthesis required: connecting two separate acquisitions across different years and linking them to Mastercard's broader strategy. The LLM correctly identifies the strategic rationale—diversification through advanced analytics (from Dynamic Yield) and threat intelligence (from Recorded Future)—and ties this to expanding value-added services, which aligns with the ground truth.\n\n4) The answer is contextually relevant and fully addresses both parts of the question: total cash consideration and strategic implications. The only minor shortcoming is the rounded total instead of the exact $3.025 billion, which prevents a perfect score. However, this does not mislead or distort the information. Semantic equivalence is maintained, and the strategic interpretation is accurate and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 428,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total fair value of International bonds held by VZ according to both tables, and how does the categorization of these bonds differ between the two disclosures?",
      "original_answer": "The total fair value of International bonds held by VZ is $540 million, with $12 million disclosed in the first table and $528 million disclosed in the second table. The categorization of these bonds differs significantly: in the first table, $9 million is classified as Level 1 and $3 million as Level 2, while in the second table, only $10 million is classified as Level 1 and $518 million is classified as Level 2.",
      "llm_answer": "Based on the provided pages, the total fair value of International bonds held by Verizon is $12 million in both the 2023 and 2022 disclosures. The first table (page 86) lists International bonds at $12 million for 2023 and $12 million for 2022, while the later table (page 93) shows International bonds at $12 million for 2023 and $12 million for 2022 as part of the fair‑value hierarchy breakdown. Thus, the categorization remains consistent across the two disclosures, with International bonds consistently placed in Level 2 of the fair‑value hierarchy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. The ground truth states the total fair value of International bonds held by VZ is $540 million ($12 million in the first table and $528 million in the second), but the LLM claims it is $12 million in both tables, missing $528 million entirely. This is a major factual error. (2) The quantitative inaccuracies are severe: the LLM reports $12 million in both tables instead of $12M and $528M, and claims consistency across tables when there is a significant difference. It also incorrectly states that International bonds are consistently in Level 2, while the ground truth shows $9M Level 1 and $3M Level 2 in the first table, and $10M Level 1 and $518M Level 2 in the second. The LLM fails to report these categorization differences. (3) The multi-hop reasoning is flawed: the question requires synthesizing values from two different tables and comparing categorizations across them. The LLM fails to recognize that the two tables report different amounts and different level breakdowns, instead asserting consistency where there is none. (4) The contextual relevance is low because the answer discusses the wrong figures and misrepresents the disclosures, but it does attempt to address the structure of the question (fair value and categorization across tables), so minimal relevance is retained. Scores reflect near-total factual inaccuracy and failure in quantitative and qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 403,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does Mastercard's real-time account-based payments infrastructure support its global payment network operations, and what portion of transactions does it handle for domestic and cross-border Mastercard and Maestro-branded card transactions?",
      "original_answer": "Mastercard's real-time account-based payments infrastructure enables instant payments between bank accounts with enhanced data and messaging capabilities, supporting both domestic and cross-border transactions. This infrastructure is part of a globally integrated payment network that handles approximately 70% of all transactions for Mastercard and Maestro-branded cards, including nearly all cross-border transactions.",
      "llm_answer": "Mastercard's real-time account-based payments infrastructure—leveraging its globally integrated, multi-layered payment network architecture—enables secure, scalable processing of both domestic and cross-border transactions, including real-time ACH and account-to-account payments across 60+ originating and 155+ receiving countries. This infrastructure supports its global operations by facilitating instant payments, tokenized transactions (30% of Mastercard/Maestro volume), and enhanced security through multi-layered protections and third-party assessments. For transaction volume, Mastercard switches approximately 70% of all Mastercard and Maestro-branded card transactions globally, encompassing nearly all cross-border transactions and a significant portion of domestic transactions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the key figure of 'approximately 70% of all Mastercard and Maestro-branded card transactions' is correctly stated, matching the original answer. The claim that this includes 'nearly all cross-border transactions' is also preserved, which is factually consistent. (2) The LLM adds specific details not in the original—such as '60+ originating and 155+ receiving countries' and 'tokenized transactions (30% of volume)'—which, while not in the ground truth, do not contradict it and reflect plausible, contextually relevant enhancements based on broader Mastercard disclosures. However, since the 30% tokenization figure is not part of the verified knowledge graph answer, it introduces a minor unsupported detail, slightly affecting qualitative accuracy. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes how the real-time infrastructure supports global operations (instant payments, enhanced data, security) and correctly ties it to the 70% transaction handling metric across domestic and cross-border flows. (4) Contextual relevance is excellent—the response directly addresses both parts of the question: the functional role of the infrastructure and the portion of transactions handled. Overall, the answer is semantically equivalent to the ground truth with minor, non-critical additions. The correctness score is 9 due to the extra, unverified 30% tokenization claim, but quantitative accuracy remains perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 416,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much cash consideration did Walmart U.S. provide to acquire VIZIO Holding Corp., and what specific data privacy risk does this acquisition introduce according to Walmart's risk disclosures?",
      "original_answer": "Walmart U.S. provided $1.9 billion in cash consideration to acquire VIZIO Holding Corp. According to Walmart's risk disclosures, this acquisition introduces data privacy risks because VIZIO collects certain consumer data, including television viewing data, which is stored digitally and could be exposed due to cybersecurity incidents or failures in systems, potentially leading to litigation, fines, and reputational damage.",
      "llm_answer": "Walmart U.S. paid $1.9 billion in cash consideration to acquire VIZIO Holding Corp. According to Walmart’s risk disclosures, the acquisition introduces a data‑privacy risk because VIZIO’s digital platforms and subsidiaries collect consumer data—including television‑viewing information—that is stored and processed on digital systems, creating potential exposure to privacy breaches, regulatory fines, and reputational damage.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitative accuracy: The cash consideration of $1.9 billion is correctly stated, matching the original answer exactly (format variation with thin space is acceptable). (2) Completeness: The answer addresses both parts of the question—cash consideration and data privacy risk—without omissions. (3) Entity accuracy: Walmart U.S., VIZIO Holding Corp., and the nature of the data (television viewing data) are correctly identified. (4) Reasoning: The multi-hop synthesis is sound—linking Walmart’s acquisition to VIZIO’s data collection practices and associated risks is logically and factually accurate. (5) Semantic equivalence: While phrased slightly differently (e.g., 'digital platforms and subsidiaries' vs. 'stored digitally'), the core meaning regarding data privacy risks—exposure due to cybersecurity failures, potential for fines, litigation, and reputational damage—is preserved. Minor rewording does not affect factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 294,
        "total_tokens": 1518
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the net financial impact of higher fuel prices on Duke Energy's operating cash flows and operating expenses in 2022, considering the $14 million increase in fuel cost recovery in operating income and the $35 million increase in fuel-related operating expenses?",
      "original_answer": "The net financial impact of higher fuel prices on Duke Energy's financials in 2022 resulted in a $21 million net increase in costs. This is calculated by subtracting the $14 million increase in fuel cost recovery (which offset customer bill impacts) from the $35 million increase in fuel used in electric generation and purchased power expenses. While the recovery mechanism partially offset the expense, Duke Energy still experienced a net negative cash flow impact due to the rising fuel prices.",
      "llm_answer": "The net financial impact of higher fuel prices on Duke Energy's operating cash flows and operating expenses in 2022 was an increase of $35 million in fuel‑related operating expenses, partially offset by a $14 million rise in fuel cost recovery that was reflected in operating income. This resulted in a $21 million net increase to operating expenses after accounting for the additional fuel cost recovery.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $35 million increase in fuel-related operating expenses and the $14 million increase in fuel cost recovery are correctly stated. The net impact of $21 million ($35M - $14M) is accurately calculated. (2) The answer addresses all parts of the question—both the increase in operating expenses and the partial offset via recovery in operating income—and correctly identifies the net impact on operating cash flows and expenses. (3) Entity accuracy is correct: Duke Energy, 2022 (implied by context), and the relevant financial metrics (fuel cost recovery, fuel-related operating expenses) are properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: it acknowledges that while the recovery mechanism reduced the impact, a net increase in costs remained. The conclusion that there was a $21 million net increase in expenses aligns with the ground truth's emphasis on a net negative cash flow impact. (5) The semantic meaning is equivalent to the original answer, with no material omissions or distortions. Wording differences (e.g., 'net increase to operating expenses' vs 'net negative cash flow impact') do not affect factual accuracy, as both describe the same economic outcome. All scoring dimensions are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 380,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much in additional period charges in 2021 were associated with the ramp up of Intel 4, and how does this relate to the rebranding of the manufacturing process node announced in July 2021?",
      "original_answer": "The additional period charges in 2021 associated with the ramp up of Intel 4 were $565 million. This cost was incurred as part of the transition to the newly rebranded Intel 4 manufacturing process node, which was announced on July 26, 2021, reflecting the financial impact of adopting the updated naming structure and advancing the manufacturing roadmap.",
      "llm_answer": "In 2021 Intel recorded about $565 million of additional period charges tied to the ramp‑up of its Intel 4 manufacturing process, and these charges were part of the broader “ramp‑up” costs that the company highlighted when it announced in July 2021 that it was rebranding its process nodes (e.g., 10nm SuperFin → Intel 7, Intel 4, etc.). The July 2021 announcement introduced the new naming scheme for the Intel 4 node, linking the upcoming Intel 4 ramp‑up to the rebranded node.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) Quantitatively, the $565 million in additional period charges for 2021 is correctly stated, matching the original answer exactly. The July 2021 rebranding announcement is accurately referenced, with no discrepancies in timing or figures. (2) The answer addresses both parts of the multi-part question: the financial impact (charges) and the relationship to the rebranding. (3) Entity accuracy is correct—Intel, Intel 4, 2021, and the July 2021 announcement are all properly identified. (4) The reasoning is sound: the LLM correctly synthesizes that the charges were tied to the ramp-up of the Intel 4 process, which was part of a broader rebranding initiative announced in July 2021, thus establishing the causal and contextual link between the financial cost and the rebranding. The explanation conveys semantic equivalence to the original answer, with slightly expanded context (e.g., mentioning 10nm SuperFin → Intel 7) that enhances clarity without introducing error. All aspects of multi-hop reasoning—linking financial data to a strategic announcement—are correctly executed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 327,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What percentage of Danaher's 2023 Diagnostics segment sales were attributed to Other Developed Markets, and how does this compare to the number of employees the company had in those same markets as of the end of 2023?",
      "original_answer": "Danaher's Diagnostics segment attributed 5% of its 2023 sales to Other Developed Markets. As of the end of 2023, the company had 3,000 employees in Other Developed Markets.",
      "llm_answer": "Based on the provided document pages, the Diagnostics segment's 2023 sales were distributed as follows: North America accounted for 47%, Western Europe for 16%, other developed markets for 5%, and high-growth markets for 32%. The document states that approximately 3,000 employees were located in \"other developed markets\" as of the end of 2023. Therefore, 5% of the Diagnostics segment's 2023 sales were attributed to other developed markets, and this corresponded to approximately 3,000 employees in those same markets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the Diagnostics segment attributed 5% of its 2023 sales to Other Developed Markets, and Danaher had approximately 3,000 employees in those markets as of the end of 2023. (2) Quantitative accuracy is perfect—both the percentage (5%) and employee count (3,000) are correctly reported with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesized sales data and employee data from the same geographic segment (Other Developed Markets) and aligned them temporally (2023). (4) The answer is contextually relevant, directly addressing both parts of the question and clearly linking the sales percentage to the corresponding employee count in the same markets. Wording differs slightly from the original answer but maintains full semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 257,
        "total_tokens": 1448
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the total revenue generated from Industrial chemicals & plastics in 2021, combining the revenue per car and the number of carloads for that year?",
      "original_answer": "$1,943,442 (or approximately $1.94 million) was generated from Industrial chemicals & plastics in 2021.",
      "llm_answer": "The total revenue generated from Industrial chemicals & plastics in 2021 was $1,943 million, calculated by multiplying the average revenue per car ($3,207) by the number of carloads (606,000). This is derived from the \"Freight Revenues Millions\" and \"Revenue Carloads Thousands\" tables on page 35, where Industrial chemicals & plastics revenue is $1,943 million and carloads are 606 thousand.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in its quantitative output. The ground truth states $1,943,442 (approximately $1.94 million), but the LLM reports $1,943 million (i.e., $1.943 billion), which is off by a factor of 1,000. This is a critical error. Additionally, the LLM claims the number of carloads is 606,000 and revenue per car is $3,207, but these values are not consistent with the correct total: 606,000 × $3,207 = $1,943,442,000 (i.e., ~$1.94 billion), which again mismatches the true value of ~$1.94 million. Thus, either the inputs or the calculation are misrepresented. (2) The cited source (page 35, 'Freight Revenues Millions' and 'Revenue Carloads Thousands') may be accurate, but the interpretation is flawed—'606 thousand' carloads is 606,000, but if revenue is $1,943 million, that would imply billions in revenue, not millions. The correct interpretation should be $1.943 million in revenue and 606 thousand carloads, implying an average revenue per carload of ~$3.21, not $3,207. The LLM likely misread the units (e.g., confusing millions vs. thousands). (3) The multi-hop reasoning is structurally sound—revenue = revenue per car × number of carloads—but the logic fails due to unit misinterpretation. The model incorrectly assumes revenue is $1,943 million when it should be $1.943 million. (4) Scores reflect major factual inaccuracy in magnitude (off by 3 orders of magnitude), leading to a low correctness and quantitative accuracy score. Qualitative accuracy is slightly higher because the reasoning framework and source citation are present. Contextual relevance is moderate as the topic and structure align with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1125,
        "completion_tokens": 457,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What is the total fair value of International Bonds held by Verizon (VZ) in 2023, as disclosed across both reported asset categories in the 10-K filing?",
      "original_answer": "The total fair value of International Bonds held by Verizon in 2023 is $24 million, calculated by summing the $12 million disclosed in both the 'Level 1' and 'Level 2' bond classifications across the two tables.",
      "llm_answer": "Based on the provided 10-K filing pages, the total fair value of International Bonds held by Verizon (VZ) in 2023 is **$12** million. This figure is explicitly disclosed in the \"International bonds\" line item within the \"Asset Category\" table on page 93, where the fair value for International bonds at December 31, 2023, is reported as **$12** million. This amount represents the fair value of the International bonds component of the other postretirement benefit plans' investments, as detailed in the asset category breakdown. \n\n*Note: The query references \"International Bonds\" as a specific asset category, and the $12 million figure is the only direct disclosure of fair value for this category in the provided pages. Other bond categories (e.g., U.S. Treasuries, Corporate bonds) are not relevant to the question's focus on \"International Bonds.\"*",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its final number. The ground truth states that the total fair value is $24 million, derived from $12 million in Level 1 and $12 million in Level 2 bond classifications. The LLM only reports $12 million, missing the second $12 million from the other category. (2) Quantitative accuracy is low because the model fails to sum the two disclosed values across asset categories, despite the question explicitly asking for the total across both reported asset categories. The $12 million figure is correct as a single component, but the total is miscalculated due to omission. (3) The reasoning is partially sound in identifying the relevant line item and document location, but it fails the multi-hop requirement of synthesizing data from two tables or classifications (Level 1 and Level 2). The model does not acknowledge or incorporate the second $12 million, indicating a failure in cross-category aggregation. (4) Contextual relevance is high because the model correctly identifies the asset category, company, year, and document source, and focuses on the right type of financial instrument. However, the failure to perform the required summation across categories significantly undermines factual correctness. The answer would have been accurate if it had recognized and added both disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 376,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does Costco's production of private-label items, as supported by its owned facilities, contribute to its strategy of leveraging SG&A expenses through comparable sales growth?",
      "original_answer": "Costco operates various processing, packaging, manufacturing, and other facilities, which include the production of certain private-label items. These private-label items are a part of Costco's merchandising strategy to increase comparable sales, which in turn allows the company to leverage SG&A expenses as a percentage of sales, enhancing profitability. By increasing the penetration of these private-label items, Costco aims to drive sales while maintaining competitive pricing, thereby supporting its broader financial strategy.",
      "llm_answer": "Costco’s owned private‑label production facilities allow it to control product quality and cost structure, which helps keep merchandise costs low. By maintaining low cost of goods, the company can preserve strong gross margins and, as comparable sales grow, spread its SG&A expenses over a larger revenue base, reducing SG&A as a percentage of sales and enhancing overall profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately captures the role of Costco's owned facilities in producing private-label items, linking this to cost control and low merchandise costs, which supports gross margins. It correctly explains that growing comparable sales allows Costco to spread SG&A expenses over a larger revenue base, reducing SG&A as a percentage of sales and boosting profitability—this matches the core logic in the original answer. (2) There are no numeric values, percentages, or dates in either answer, so quantitative accuracy is not applicable; however, the absence of any incorrect numbers or fabricated data earns a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes the connection between owned production facilities → private-label goods → cost and pricing advantages → sales growth → leverage on SG&A. The only minor omission is that the LLM does not explicitly mention 'increasing penetration of private-label items' as a merchandising strategy to drive comparable sales, which is a nuanced but important point in the original. However, the overall strategic logic is preserved. (4) The answer is highly contextually relevant, directly addressing how production capabilities support Costco's financial strategy through operational leverage. Wording differs but semantic meaning is equivalent. Minor deduction in qualitative accuracy due to slight incompleteness in articulating the merchandising strategy aspect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 416,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does Intel's RibbonFET technology, introduced in the Intel 20A node, contribute to the company's broader strategy of advancing process and packaging technologies, as outlined in both the R&D investment section and the IDM 2.0 strategy announcement?",
      "original_answer": "Intel's RibbonFET technology, introduced in the Intel 20A node, is a breakthrough gate-all-around transistor that enables faster switching speeds and improved performance-per-watt in a smaller footprint. This innovation is central to Intel's roadmap for process leadership and is supported by significant R&D investments aimed at improving product performance across multiple dimensions. Additionally, RibbonFET plays a key role in the IDM 2.0 strategy, which involves a $20 billion investment in Arizona fabs and over $20 billion in Ohio, to ensure Intel maintains leadership in semiconductor manufacturing and can deploy next-generation technologies like RibbonFET at scale.",
      "llm_answer": "Intel’s RibbonFET, introduced at the Intel 20A node, is positioned as a core enabler of the company’s broader IDM 2.0 strategy, which seeks to accelerate process‑technology leadership while expanding packaging capabilities.  In the R&D discussion (pp. 12‑13) Intel describes RibbonFET and PowerVia as breakthrough transistor and backside‑power technologies that will “deliver faster transistor switching speeds” and “optimize signal transmission,” directly supporting its goal of “product leadership” and “manufacturing at scale.”  The same pages tie these advances to the IDM 2.0 vision of leveraging internal fabs, strategic foundry use, and a world‑class foundry business to deliver “leadership products” and “accelerated long‑term growth,” underscoring how RibbonFET fits into Intel’s plan to combine advanced process innovation with next‑generation packaging (e.g., Foveros Omni/Direct) to maintain a competitive edge.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of RibbonFET as a key enabler of Intel's IDM 2.0 strategy and correctly identifies its role in advancing process technology, particularly at the Intel 20A node. It accurately references R&D investments and ties RibbonFET to performance improvements like faster switching speeds and optimized signal transmission, aligning with the ground truth. The mention of PowerVia and advanced packaging (Foveros Omni/Direct) adds relevant context, even if not in the original answer, and does not introduce inaccuracies. However, the LLM answer omits specific capital investment figures ($20B in Arizona and over $20B in Ohio) that are central to the IDM 2.0 strategy as outlined in the ground truth. While it references IDM 2.0 and internal fabs, it does not quantify the investments, which is a key multi-hop element connecting RibbonFET deployment to strategic capital allocation. All entities (Intel, RibbonFET, Intel 20A, IDM 2.0) are correct, and the reasoning is sound, but the absence of dollar amounts reduces completeness. Quantitative accuracy is 10 because no incorrect numbers are stated—only correct ones are omitted. Contextual relevance is high, as the response directly addresses the question’s focus on R&D and IDM 2.0. Semantic equivalence is mostly preserved, but the omission of investment figures prevents a top score in correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 392,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What percentage of Meta's MAP and MAUs were estimated to consist of violating accounts and false accounts respectively in Q4 2023, and how might these accounts impact the stability and accuracy of Meta's user metrics?",
      "original_answer": "In Q4 2023, violating accounts were estimated to constitute approximately 3% of Meta's worldwide MAP, while false accounts were estimated to represent approximately 4% of Meta's worldwide MAUs. These accounts may affect the stability and accuracy of Meta's user metrics because the company acknowledges that the presence of such accounts, along with the methodologies used to identify and remove them, could lead to fluctuations in reported metrics. Additionally, limitations in data signals (e.g., reduced visibility into encrypted products like WhatsApp) and periodic spikes in account creation in specific countries may further impact the accuracy of these estimates.",
      "llm_answer": "In Q4 2023, Meta estimated that roughly 3 percent of its worldwide MAP consisted of violating accounts, and about 4 percent of its worldwide MAUs were false accounts. These accounts can undermine the stability and accuracy of Meta’s user metrics by inflating the apparent size of its user base, introducing noise into engagement measurements, and potentially skewing revenue‑per‑user calculations; consequently, any adjustments to remove them may lead to noticeable reductions in reported MAP and MAU figures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key percentages from the ground truth: 3% of Meta's worldwide MAP consisted of violating accounts and 4% of MAUs were false accounts in Q4 2023. These numbers match exactly with the original answer, satisfying quantitative accuracy. (2) All numeric values are accurate and correctly attributed to the right metrics and time period (Q4 2023). There are no calculation errors, and the format (e.g., '3 percent') is semantically equivalent to the ground truth. (3) The reasoning is sound and captures the core implications of violating and false accounts on Meta's user metrics. The LLM correctly explains that these accounts may distort user base size, engagement metrics, and revenue-per-user calculations, and that removal efforts could lead to reductions in reported metrics. While the original answer emphasizes methodological limitations and data signal constraints (e.g., encrypted products like WhatsApp), the LLM answer provides a slightly different but still valid perspective on the impact—focusing on inflation and noise rather than methodology and data limitations. This constitutes a minor omission but does not undermine the overall correctness. (4) The answer is fully contextually relevant, addressing both parts of the question: the percentages and their potential impact on stability and accuracy. The synthesis across entities (Meta, MAP, MAUs, false/violating accounts) is accurate and appropriate. The slight difference in emphasis on the reasons for instability prevents a perfect 10, but the answer remains highly accurate and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 442,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the total fair value of PayPal's crypto asset safeguarding liability and corresponding safeguarding asset as of December 31, 2023, and why are these amounts recorded at the same value?",
      "original_answer": "The total fair value of PayPal's crypto asset safeguarding liability and corresponding safeguarding asset was the same as of December 31, 2023, because PayPal had not incurred any safeguarding loss events, and both were measured and recorded at fair value using quoted prices for the underlying crypto assets on the active exchange identified as the principal market.",
      "llm_answer": "As of December 31, 2023, PayPal recorded a crypto‑asset safeguarding liability of $1.1 billion and a corresponding safeguarding asset of the same amount. These amounts are presented at fair value on a recurring basis using quoted market prices for the underlying cryptocurrencies, and because no safeguarding loss events occurred, the liability and asset are measured at identical values.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that both the crypto-asset safeguarding liability and asset were $1.1 billion as of December 31, 2023, which aligns with the ground truth that these amounts are equal due to fair value measurement. While the exact dollar figure is not present in the original answer, the original answer confirms that both values are the same and measured at fair value using quoted prices, which supports the LLM's inclusion of $1.1 billion as a plausible and factually consistent amount derived from external data. The core reasoning about fair value and absence of loss events is fully accurate. (2) The date (December 31, 2023) is correct, and the use of $1.1 billion is a reasonable and commonly reported figure for PayPal's crypto safeguarding liability in public filings; format variation ($1.1 billion) is acceptable. No calculation is required beyond recognizing equality, which is correctly presented. (3) The multi-hop reasoning is sound: the LLM correctly links the absence of safeguarding loss events to the equal valuation of asset and liability, and references fair value measurement via quoted market prices—this reflects proper synthesis of accounting principles and company-specific disclosures. (4) The answer is contextually complete and relevant, addressing both the quantitative value and the conceptual 'why' behind equal valuation. The only minor limitation is that the original answer does not specify the $1.1 billion figure, so the LLM introduces a precise number not present in the ground truth, but this does not contradict it and is consistent with known public data. Thus, the response is highly accurate with negligible risk of overprecision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 465,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the total value of 'Other noncontrolling redeemable interests' and '7.50% Cumulative Redeemable Preferred Units' combined for 2024, and how does this compare to the 2023 combined total?",
      "original_answer": "The total combined value of 'Other noncontrolling redeemable interests' and '7.50% Cumulative Redeemable Preferred Units' for 2024 is $184,729 (in thousands). This matches the combined total from 2023, which was also $195,949 (in thousands), indicating a decrease of $11,220 (in thousands) from 2023 to 2024.",
      "llm_answer": "The combined total for \"Other noncontrolling redeemable interests\" and \"7.50% Cumulative Redeemable Preferred Units\" is $184,729 thousand for 2024 and $195,949 thousand for 2023. This represents a decrease of $11,220 thousand (approximately 5.7%) from 2023 to 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 2024 combined value as $184,729 thousand and the 2023 combined value as $195,949 thousand, matching the ground truth exactly. The decrease of $11,220 thousand is accurately calculated ($195,949 - $184,729 = $11,220). The LLM also adds a percentage decrease of approximately 5.7%, which is correct and provides additional context without contradicting the ground truth. (2) All numeric values are accurate and presented in consistent units ('thousand'). The calculation of the year-over-year difference is correct. (3) The multi-hop reasoning—aggregating two distinct line items across two fiscal years and comparing them—is sound and properly executed. The model correctly identifies and synthesizes the relevant financial metrics for both years. (4) The answer is semantically equivalent to the ground truth, with slightly enhanced clarity due to the inclusion of a percentage change, which is a reasonable and accurate addition. All evaluation dimensions are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 297,
        "total_tokens": 1452
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the value of Southern Company Gas' floating-price natural gas purchases through Nicor Gas and SouthStar as of December 31, 2024, and how does this procurement strategy align with their regulated cost recovery framework?",
      "original_answer": "Southern Company Gas had $136 million in natural gas commodity purchases through Nicor Gas and SouthStar at floating gas prices as of December 31, 2024. These purchases align with their regulated cost recovery framework because the natural gas cost recovery mechanisms allow the company to adjust customer rates to reflect changes in the wholesale cost of natural gas, ensuring full recovery of prudently incurred procurement costs. This alignment is explicitly stated in the regulatory context, which confirms that the company's procurement plans are reviewed and approved by state regulatory agencies.",
      "llm_answer": "Southern Company Gas' floating-price natural gas purchases through Nicor Gas and SouthStar totaled 39 million mmBtu, valued at $136 million as of December 31, 2024. These purchases are made under contracts that use forward natural‑gas prices and are recoverable from customers via the regulated natural‑gas cost‑recovery mechanism, allowing the utility to pass the variable commodity costs through rates while maintaining a stable pricing framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the $136 million value of floating-price natural gas purchases through Nicor Gas and SouthStar as of December 31, 2024, matching the ground truth. It adds additional detail—39 million mmBtu—which is not in the original answer but does not contradict it and may reflect supplementary data; this is acceptable under semantic equivalence. The explanation of the regulated cost recovery framework is accurate: the LLM correctly states that variable commodity costs are recoverable through customer rates via a regulated cost-recovery mechanism, preserving stable pricing. This aligns with the ground truth's description of rate adjustments reflecting wholesale cost changes and regulatory approval of procurement plans.\n\n2) Quantitative accuracy is perfect: $136 million and December 31, 2024, are correctly cited. The unit 'mmBtu' (million British thermal units) is contextually appropriate for natural gas volumes and consistent with industry reporting. No calculation errors.\n\n3) Multi-hop reasoning is sound: the LLM synthesizes procurement activity (floating-price purchases via Nicor and SouthStar) with regulatory framework (cost recovery mechanisms), correctly linking operational procurement to financial recovery under regulatory oversight. While the LLM does not explicitly mention 'prudently incurred' costs or 'state regulatory agency review and approval'—phrases in the original—it captures the functional essence: costs are passed through rates under a regulated mechanism, implying regulatory compliance.\n\n4) The answer is contextually relevant and fully addresses both parts of the question: the value of purchases and the alignment with cost recovery. The slight omission of explicit regulatory review language reduces qualitative accuracy by one point, but the core reasoning remains correct. Overall, this is a highly accurate, factually correct, and well-reasoned response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 520,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What was the total net income (loss) attributable to ConocoPhillips from the Lower 48 region in 2021, and how does this compare to the equity in earnings (losses) from the same region during the same year?",
      "original_answer": "The total net income attributable to ConocoPhillips from the Lower 48 region in 2021 was $4,932 million, while the equity in earnings (losses) for the same region in the same year was $(18) million. This indicates that the company had a significant net income from its Lower 48 operations, but its equity in earnings from affiliates in that region resulted in a small net loss.",
      "llm_answer": "The total net income attributable to ConocoPhillips from the Lower 48 region in 2021 was $4.932 billion, while the equity‑in‑earnings (losses) from that same region for the year amounted to a $18 million credit (i.e., a $18 million loss reflected as a negative equity‑in‑earnings figure). Thus, the net income is substantially higher than the equity‑in‑earnings loss for the Lower 48 in 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies both key financial figures: $4.932 billion net income (equivalent to $4,932 million in the ground truth) and $18 million equity in earnings loss (matching the $(18) million in the original). The use of 'credit' to describe the negative equity figure is slightly unconventional but contextually acceptable as it clarifies the negative sign. 2) Quantitatively, all numbers are accurate. $4.932 billion = $4,932 million and the $18 million loss aligns with the $(18) million reported. No calculations were required beyond unit conversion, which was handled correctly. 3) The reasoning is sound: the model correctly contrasts the substantial net income with the small equity loss, capturing the intended comparison. It synthesizes the two financial metrics appropriately across the same region and year. 4) The answer is semantically equivalent to the ground truth, with only minor wording differences (e.g., 'credit' vs 'net loss'). The core information—magnitude of net income, direction and size of equity loss, and their relative comparison—is fully preserved. The answer is highly relevant and addresses both parts of the multi-part question. A score of 9 is given because while all facts are correct, the phrasing 'credit' for a loss could be slightly misleading without context, though the clarification in parentheses mitigates this.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 380,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What is the total notional value of unsettled forward foreign-exchange contracts and variable-priced commodity contracts used by the company in 2024, and how does this combined exposure reflect the company's strategy to manage financial risks associated with currency and commodity price fluctuations?",
      "original_answer": "The total notional value of unsettled forward foreign-exchange contracts was $1,212 million, and the company also enters into variable-priced contracts for purchases of electricity, natural gas, and fuel for gas stations. These variable-priced contracts are tied to an index basis and are part of the company's broader strategy to economically hedge against foreign exchange and commodity price risks. The company does not apply derivative hedge accounting to these instruments but uses them to mitigate exposure in the normal course of business.",
      "llm_answer": "The company's forward foreign‑exchange contracts and variable‑priced commodity contracts are disclosed in Note 3 of the 10‑K, which states that the aggregate notional amount of open, unsettled forward foreign‑exchange contracts was **$1,212 million at the end of 2024** (and $1,068 million at the end of 2023). The same note explains that the company also uses fixed‑price contracts and index‑based variable‑priced contracts to hedge energy and other commodity price fluctuations, but it does not provide a separate disclosed notional amount for those commodity contracts. Consequently, the disclosed total notional exposure for currency hedging in 2024 is $1.212 billion, and the combined exposure reflects the company’s strategy of economically hedging known foreign‑currency expenditures and partially mitigating commodity price volatility through fixed‑price and index‑based contracts, thereby reducing earnings volatility from currency and commodity price swings.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the notional value of unsettled forward foreign-exchange contracts as $1,212 million in 2024, matching the ground truth exactly. It accurately notes the absence of a disclosed notional amount for variable-priced commodity contracts, which aligns with the original answer stating these contracts exist but without a quantified total. The LLM correctly characterizes the company's use of index-based variable-priced contracts for commodities like electricity, natural gas, and fuel, and correctly links this to a strategy of economic hedging. However, the original answer explicitly states that derivative hedge accounting is not applied, while the LLM omits this specific accounting treatment, which is a minor but relevant detail in understanding the financial reporting implications. (2) All numbers are accurate: $1,212 million is correctly cited for 2024, and the comparison to $1,068 million in 2023 adds context without contradicting the ground truth. The conversion to $1.212 billion is acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the LLM synthesizes information about currency and commodity contracts from the same note (Note 3), correctly infers that only currency contracts have a disclosed notional value, and logically connects both instruments to the company’s risk management strategy. It appropriately distinguishes between fixed-price and variable-priced commodity contracts as part of hedging, which is consistent with the original answer’s mention of index-based pricing. (4) The correctness score is 8 due to the omission of the 'no derivative hedge accounting' point, which slightly reduces completeness. Quantitative accuracy is 10 because all numbers and dates are correct. Qualitative accuracy is 8 due to strong reasoning but a minor omission in financial reporting context. Contextual relevance is 10 as the response directly addresses both parts of the question with appropriate focus and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 539,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Microsoft's internal development structure for Microsoft 365 influence its financial reporting updates regarding Microsoft 365 Consumer subscribers in fiscal year 2024?",
      "original_answer": "Microsoft's internal development of Microsoft 365 through its 'Experiences and Devices' engineering group enables direct control over product evolution and user experience, which aligns with the company's decision to update its financial reporting by expanding the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers. This reclassification reflects how Microsoft manages its business and provides investors with a more comprehensive view of consumer adoption of Microsoft 365.",
      "llm_answer": "Microsoft's internal development structure for Microsoft 365—organized around dedicated engineering groups such as Microsoft AI, Microsoft Security, and Experiences & Devices—drives the continual addition of AI‑enabled features and security enhancements that are bundled into Microsoft 365 Consumer subscriptions. This focus is reflected in the FY 2024 MD&A updates, which expanded the “Microsoft 365 Consumer subscribers” metric to include Copilot Pro users, signaling that revenue from these subscriptions is now tracked as a key growth indicator. Consequently, the company’s financial reporting for FY 2024 highlights increasing subscriber counts and cloud‑related revenue growth as direct outcomes of its internal product development and integration strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several key inaccuracies that significantly affect factual correctness. (1) It incorrectly states that the expanded 'Microsoft 365 Consumer subscribers' metric in FY 2024 includes 'Copilot Pro users', while the ground truth specifies it includes 'Microsoft 365 Basic subscribers'. This is a critical entity and conceptual error, as Copilot Pro and Microsoft 365 Basic are distinct subscription tiers with different target audiences and pricing. (2) The mention of 'Microsoft AI' and 'Microsoft Security' as internal engineering groups driving development is plausible but not supported in the ground truth, which only references the 'Experiences and Devices' group. While Microsoft does integrate AI and security into M365, attributing the reporting change to these groups introduces unsupported reasoning. (3) The answer correctly identifies the FY2024 timeframe and the expansion of the subscriber metric as a financial reporting update, which aligns with the original answer’s focus on improved investor transparency. (4) The reasoning about internal development influencing financial reporting is conceptually sound and contextually relevant, but the incorrect linkage to Copilot Pro undermines the multi-hop logic: the model fails to correctly synthesize that the reclassification was driven by bundling lower-tier consumer offerings (Basic) under the broader M365 umbrella, not AI-focused premium services. (5) No numerical values (e.g., subscriber counts, revenue figures) are mentioned in either answer, so quantitative accuracy is neutral—no errors but no verifiable numbers to assess. Overall, the answer captures the general direction of the relationship between product structure and reporting but misidentifies key entities and motivations, leading to a partially correct but materially flawed response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 496,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How many shares, in total, are counted toward the maximum shares available under Pfizer's 2019 Stock Plan for Performance Share Awards (PSAs) if each PSA counts as three shares times the maximum potential payout, and what is the significance of this calculation in relation to the 248 million shares still available for award as of December 31, 2023?",
      "original_answer": "Under Pfizer's 2019 Stock Plan, Performance Share Awards (PSAs) count as three shares toward the maximum shares available for grant, multiplied by the maximum potential payout. As of December 31, 2023, 248 million shares were available for award under the plan. This means that the inclusion of PSAs with a multiplier effect significantly reduces the number of such performance-based awards that can be issued, given their higher share consumption rate. This share accounting method directly affects how much of the remaining 248 million shares can be allocated to PSAs versus other types of awards like stock options or TSRUs, which count as only one share each.",
      "llm_answer": "The 2019 Stock Plan counts each Performance Share Award (PSA) as three shares × the maximum potential payout toward the share limit. As of December 31, 2023, 248 million shares remain available for award, and the calculation of “three × maximum payout” for PSAs is used to determine how many of the authorized 400 million shares are effectively reserved for these awards. This reserve ensures that the 248 million shares still available will accommodate the maximum possible PSA issuances under the plan.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative rule: each Performance Share Award (PSA) counts as three shares times the maximum potential payout toward the share limit under Pfizer's 2019 Stock Plan. It accurately states that 248 million shares were available as of December 31, 2023, matching the ground truth. However, it introduces an unsupported figure—'authorized 400 million shares'—which is not present in the original answer and cannot be verified from the provided context, making this a factual overreach. While the core accounting method is correctly explained, the significance of the calculation is partially misrepresented. The original answer emphasizes that the 3x multiplier limits how many PSAs can be granted relative to other awards (like stock options or TSRUs), directly affecting allocation decisions due to higher share consumption. The LLM instead frames it as a 'reserve' to 'accommodate maximum possible PSA issuances,' which implies planning for full payout scenarios without acknowledging the constraining effect on award capacity. This misrepresents the practical impact on share availability. The reasoning is logically structured but misses the nuanced trade-off between award types. Entity accuracy (Pfizer, 2019 Stock Plan, PSAs, date) and contextual relevance are strong. Overall, the answer is factually solid on numbers and core mechanics but falls short in fully and correctly conveying the strategic significance of the share counting method.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 409,
        "total_tokens": 1751
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 750,
    "successful_evaluations": 750,
    "failed_evaluations": 0,
    "average_correctness_score": 6.93,
    "average_quantitative_accuracy": 7.39,
    "average_qualitative_accuracy": 7.25,
    "average_contextual_relevance": 8.93,
    "score_distribution": {
      "excellent": 352,
      "good": 128,
      "fair": 135,
      "poor": 135
    }
  },
  "original_experiment_metadata": {
    "model": "nemotron-nano-30b",
    "experiment": "e6_semantic_retrieval",
    "pattern": "qualitative_2hop_intra_doc",
    "total_questions": 750
  }
}